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ABSTRACT OF THE DISSERTATION 
PSEUDOMONAS AERUGINOSA AMPR  
TRANSCRIPTIONAL REGULATORY NETWORK 
by 
Deepak Balasubramanian 
Florida International University, 2013 
Miami, Florida 
Professor Kalai Mathee, Major Professor 
In Enterobacteriaceae, the transcriptional regulator AmpR, a member of the 
LysR family, regulates the expression of a chromosomal β-lactamase AmpC. The 
regulatory repertoire of AmpR is broader in Pseudomonas aeruginosa, an opportunistic 
pathogen responsible for numerous acute and chronic infections including cystic fibrosis. 
Previous studies showed that in addition to regulating ampC, P. aeruginosa AmpR 
regulates the sigma factor AlgT/U and production of some quorum sensing (QS)-
regulated virulence factors. In order to better understand the ampR regulon, the 
transcriptional profiles generated using DNA microarrays and RNA-Seq of the 
prototypic P. aeruginosa PAO1 strain with its isogenic ampR deletion mutant, 
PAO∆ampR were analyzed. Transcriptome analysis demonstrates that the AmpR regulon 
is much more extensive than previously thought influencing the differential expression of 
over 500 genes. In addition to regulating resistance to β-lactam antibiotics via AmpC, 
AmpR also regulates non-β-lactam antibiotic resistance by modulating the MexEF-OprN 
efflux pump. Virulence mechanisms including biofilm formation, QS-regulated acute 
virulence, and diverse physiological processes such as oxidative stress response, heat-
 vii
shock response and iron uptake are AmpR-regulated. Real-time PCR and phenotypic 
assays confirmed the transcriptome data. Further, Caenorhabditis elegans model 
demonstrates that a functional AmpR is required for full pathogenicity of P. aeruginosa. 
AmpR, a member of the core genome, also regulates genes in the regions of genome 
plasticity that are acquired by horizontal gene transfer. The extensive AmpR regulon 
included other transcriptional regulators and sigma factors, accounting for the extensive 
AmpR regulon. Gene expression studies demonstrate AmpR-dependent expression of the 
QS master regulator LasR that controls expression of many virulence factors. Using a 
chromosomally tagged AmpR, ChIP-Seq studies show direct AmpR binding to the lasR 
promoter. The data demonstrates that AmpR functions as a global regulator in P. 
aeruginosa and is a positive regulator of acute virulence while negatively regulating 
chronic infection phenotypes. In summary, my dissertation sheds light on the complex 
regulatory circuit in P. aeruginosa to provide a better understanding of the bacterial 
response to antibiotics and how the organism coordinately regulates a myriad of virulence 
factors. 
 
   
 
  
 viii
 
TABLE OF CONTENTS 
CHAPTER           PAGE 
 
CHAPTER 1 ....................................................................................................................... 1 
Introduction ..................................................................................................................... 1 
The model bacterium, Pseudomonas aeruginosa ....................................................... 2 
Antibiotics, antibiotic resistance and AmpR .............................................................. 5 
Antibiotic resistance .................................................................................................... 7 
Antibiotic resistance in P. aeruginosa ........................................................................ 9 
Intrinsic resistance .................................................................................................. 9 
Acquired Resistance .............................................................................................. 11 
Adaptive Resistance .............................................................................................. 12 
ß-Lactam resistance in P. aeruginosa ....................................................................... 12 
Transcriptional regulation of the ß-lactamase ampC ................................................ 13 
P. aeruginosa AmpR regulates other genes .............................................................. 14 
Role of AmpR in peptidoglycan recycling ............................................................... 16 
Transcriptional regulation: How does it work? ........................................................ 21 
Features on the DNA ............................................................................................ 21 
Features on the protein .......................................................................................... 22 
DNA-binding motifs in proteins ............................................................................... 22 
Dissertation overview ............................................................................................... 24 
 
CHAPTER 2 ..................................................................................................................... 26 
Comparative transcriptomic analyses of Pseudomonas aeruginosa ............................. 26 
Abstract ..................................................................................................................... 27 
Introduction ............................................................................................................... 28 
P. aeruginosa ............................................................................................................ 29 
P. aeruginosa transcriptome studies ......................................................................... 31 
P. aeruginosa and iron limitation ......................................................................... 31 
P. aeruginosa and oxidative stress........................................................................ 32 
P. aeruginosa and pentachlorophenol stress ......................................................... 36 
P. aeruginosa response to copper ......................................................................... 37 
P. aeruginosa and sulfate starvation ..................................................................... 38 
P. aeruginosa and osmotic stress .......................................................................... 39 
P. aeruginosa and quorum sensing ....................................................................... 40 
P. aeruginosa biofilms .......................................................................................... 41 
Transcriptomics of alginate production in P. aeruginosa ..................................... 43 
Lipopolysaccharides and lipoproteins as virulence determinants ......................... 44 
Transcriptome of a post transcriptional regulator ................................................. 45 
P. aeruginosa interactions with human cells ........................................................ 45 
Comparative analysis of all transcriptomes .............................................................. 48 
Conclusions ............................................................................................................... 51 
 ix
CHAPTER 3 ..................................................................................................................... 53 
Transcriptional regulatory network in Pseudomonas aeruginosa ................................ 53 
Abstract ..................................................................................................................... 54 
Introduction ............................................................................................................... 55 
Families of transcriptional regulators in P. aeruginosa ............................................ 59 
LysR Family.......................................................................................................... 60 
IclR Family ........................................................................................................... 64 
LacI/GalR Family ................................................................................................. 65 
GntR Family.......................................................................................................... 66 
LuxR Family ......................................................................................................... 67 
RpoN-Binding Family .......................................................................................... 68 
MerR Family ......................................................................................................... 70 
TetR Family .......................................................................................................... 71 
AraC Family.......................................................................................................... 72 
Cro-C1 Family ...................................................................................................... 73 
AsnC Family ......................................................................................................... 74 
ArsR Family .......................................................................................................... 75 
Other Families ....................................................................................................... 76 
Unclassified Regulators ........................................................................................ 76 
P. aeruginosa transcriptional regulatory network .................................................... 77 
Virulence regulatory systems in P. aeruginosa ........................................................ 80 
Quorum sensing (QS) ........................................................................................... 80 
Conclusions and perspectives ................................................................................... 85 
Acknowledgements ................................................................................................... 86 
 
CHAPTER 4 ..................................................................................................................... 87 
The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator 
AmpR includes virulence genes .................................................................................... 87 
Abstract ..................................................................................................................... 88 
Introduction ............................................................................................................... 90 
Results ....................................................................................................................... 92 
Deletion of ampR reduces β-lactam resistance of PAO1 ...................................... 92 
Loss of ampR affects ability of PAO1 to kill C. elegans ...................................... 95 
AmpR regulates numerous genes in P. aeruginosa .............................................. 97 
AmpR regulates genes both in the absence and presence of β-lactam stress ...... 100 
Functional categorization of AmpR-regulated genes ......................................... 103 
AmpR binding site analysis ................................................................................ 105 
Regulation of the amp genes by AmpR .............................................................. 106 
AmpR regulates the expression of antibiotic resistance and virulence systems . 109 
Resistance-Nodulation-Division (RND) efflux systems ................................. 109 
QS-regulated virulence factors ....................................................................... 112 
Biofilms........................................................................................................... 115 
Secretory systems............................................................................................ 118 
AmpR regulates genes found in regions of genome plasticity ........................... 121 
 x
AmpR regulates other transcriptional regulators ................................................ 122 
Subtractive transcriptomics of the AmpR regulon .............................................. 127 
Phenotypic microarray analysis of PAO∆ampR ................................................. 129 
Discussion ............................................................................................................... 130 
Materials and Methods ............................................................................................ 138 
Bacterial strains, nematodes, media and primers ................................................ 138 
Construction of deletion mutants, complementation clones ............................... 141 
C. elegans virulence assay .................................................................................. 142 
RNA isolation, generation of cDNA probes, microarray experiments and data 
analysis ................................................................................................................ 142 
Bioinformatics analysis of the AmpR-binding site ............................................. 143 
Quantitative real-time PCR ................................................................................. 144 
Determination of minimum inhibitory concentration (MIC) .............................. 145 
Quantifying β-lactamase activity ........................................................................ 145 
Biofilm assays ..................................................................................................... 146 
Motility assays .................................................................................................... 146 
Protease assays .................................................................................................... 146 
Pyocyanin production ......................................................................................... 147 
Phenotypic Microarray (PM) .............................................................................. 147 
Statistical analysis ............................................................................................... 148 
Acknowledgements ................................................................................................. 148 
 
Chapter 5 ......................................................................................................................... 149 
Deep Sequencing Expands the Pseudomonas aeruginosa .......................................... 149 
AmpR Regulon to Include Regulatory RNAs ............................................................ 149 
Abstract ................................................................................................................... 150 
Introduction ............................................................................................................. 151 
Results ..................................................................................................................... 153 
RNA-Seq analysis expands the AmpR regulon .................................................. 153 
Identification of AmpR- and AmpR-ß-lactam-dependent gene sets ................... 156 
AmpR-regulated genes are enriched in specific functional categories ............... 159 
Regulation of small RNAs (sRNAs) by AmpR .................................................. 162 
AmpR regulates iron uptake positively ............................................................... 163 
P. aeruginosa AmpR regulates heat-shock response by modulating rgP32 
expression ........................................................................................................... 168 
AmpR positively regulates P. aeruginosa oxidative stress response ................. 171 
AmpR regulates phenazine production by modulating expression of phzA1-G1 
and phzA2-G2 operons ........................................................................................ 174 
The PQS system is also positively regulated by AmpR ..................................... 176 
V5-tagged AmpR is functional in vivo ............................................................... 178 
Identifying direct AmpR targets by ChIP-Seq .................................................... 179 
Binding site analysis ........................................................................................... 183 
LasR is a direct target of AmpR ......................................................................... 185 
Comparison of microarray, RNA-Seq and proteome data .................................. 186 
 xi
Discussion ............................................................................................................... 189 
Materials and methods ............................................................................................ 196 
Strains, media and culture conditions ................................................................. 196 
Library preparation for RNA-Seq analysis ......................................................... 198 
ChIP-Seq sample preparation ............................................................................. 199 
Data analysis for RNA-Seq and ChIP-Seq ......................................................... 200 
Enrichment of functional categories ................................................................... 200 
Quantitative real-time PCR (qPCR) assays ........................................................ 201 
Hydrogen peroxide sensitivity ............................................................................ 201 
Growth in iron-limited media ............................................................................. 202 
Temperature sensitivity assays ........................................................................... 202 
Statistical analyses .............................................................................................. 202 
Acknowledgments................................................................................................... 202 
 
CHAPTER 6 ................................................................................................................... 204 
Discussion ................................................................................................................... 204 
P. aeruginosa AmpR is a major regulator of antibiotic resistance ......................... 207 
AmpR regulates quorum sensing in P. aeruginosa ................................................ 209 
Clinical significance of AmpR ................................................................................ 210 
Major virulence regulatory systems in P. aeruginosa ............................................ 212 
Quorum Sensing.................................................................................................. 213 
AHL-mediated QS .......................................................................................... 213 
AQ-mediated QS ............................................................................................. 214 
QS regulation .................................................................................................. 214 
Two component regulatory systems (TCSs) ........................................................... 217 
Formation of biofilms ............................................................................................. 221 
Alginate production ................................................................................................ 225 
Regulation of iron uptake........................................................................................ 227 
Toxins and exoproteins ........................................................................................... 230 
Regulatory RNAs in P. aeruginosa virulence ........................................................ 232 
Conclusions and perspectives ................................................................................. 235 
Future directions ..................................................................................................... 240 
Identifying effectors that modulate AmpR activity ............................................ 241 
Identification of small molecule inhibitors of AmpR ......................................... 245 
Known, putative and novel small regulatory RNAs in the AmpR regulon ........ 246 
 
APPENDICES ................................................................................................................ 249 
Supplementary information for Chapter 2 .................................................................. 249 
Supplementary information for Chapter 3 .................................................................. 292 
Supplementary information for Chapter 4 .................................................................. 331 
Supplementary information for Chapter 5 .................................................................. 373 
 
 
 xii
BIBLIOGRAPHY ........................................................................................................... 454 
 
VITA ............................................................................................................................... 545 
 
 xiii
LIST OF TABLES 
 
 
TABLE TITLE PAGE 
2.1 Comparative analysis of significantly differentially 
regulated genes from various studies within each condition 
49 
3.1 Characteristics of the major families of transcriptional 
regulators in P. aeruginosa 
61 
4.1 Microarray vs. qPCR 99 
4.2 ampR deletion affects susceptibility to MexEF-OprN 
substrates 
111 
4.3 Effect of deletion of ampR on QS-regulated virulence 
phenotypes 
114 
4.4 Transcriptional regulators and sigma factors regulated by 
AmpR 
123 
4.5 Strains and plasmids used in this study 139 
5.1 AmpR ChIP peaks 180 
5.2 Strains and plasmids 197 
 xiv
LIST OF FIGURES 
 
FIGURE TITLE PAGE 
1.1 Antibiotic resistance mechanisms in P. aeruginosa 10 
1.2 Components of the bacterial peptidoglycan function as effectors in modulating AmpR activity 20 
3.1 P. aeruginosa transcriptional regulatory protein families 58 
3.2 Interaction among transcriptional regulators 78 
3.3 Association between QS regulators in P. aeruginosa 82 
4.1 Antibiotic resistance profile of PAO∆ampR 94 
4.2 Effect of ampR deletion on pathogenicity to C. elegans 96 
4.3 Scatter plots of significantly regulated genes 98 
4.4 Venn diagram of differentially regulated genes 101 
4.5 Enrichment of functional categories 104 
4.6 AmpR binding site analysis 107 
4.7 Expression of amp genes in PAO∆ampR 108 
4.8 AmpR affects biofilm formation 117 
4.9 Regulation of secretion genes by AmpR 120 
4.10 Gene expression in PAO∆ampR at 40 minutes and two hours post 
ß-lactam exposure 
126 
4.11 Comparison of the AmpR transcriptome with other transcriptomes 128 
 
 xv
4.12 AmpR is a master regulator of gene expression in P. aeruginosa 
PAO1 
135 
5.1 Gene expression in PAO∆ampR 155 
5.2 Venn diagram of differentially regulated genes 157 
5.3 Functionally categorization of AmpR-regulated genes 160 
5.4 AmpR regulates iron uptake 166 
5.5 Regulation of heat-shock response by AmpR 170 
5.6 AmpR regulates resistance to oxidative stress 173 
5.7 Regulation of phenazines genes by AmpR 175 
5.8 AmpR positively regulates critical QS regulators of the Las, Rhl 
and PQS systems 
177 
5.9 Quantitative PCR analysis of Gac-Rsm pathway genes 182 
5.10 ChIP-Seq data based AmpR binding site analysis 184 
5.11 Comparative analyses of AmpR microarray, RNA-Seq and 
proteome datasets 
187 
5.12 AmpR-mediated regulation of virulence and physiological 
processes in P. aeruginosa 
192 
6.1 P. aeruginosa virulence determinants 206 
6.2 The P. aeruginosa virulence regulatory network 219 
   
 
 xvi
 
LIST OF SYMBOLS 
            
            SYMBOL 
 
TERM/ UNIT 
ß Beta 
°C Degree celsius  
∆ Delta (deletion) 
et al. et alia (Latin: and others)  
μg Microgram 
μl Microliter 
% Percentage  
 
 
 
 
 
 xvii
LIST OF ACRONYMS AND ABBREVIATIONS 
 
ACRONYM/ 
ABBREVIATION 
TERM 
ADP Adenosine diphosphate 
AHL N-acyl homoserine lactone 
AQ 2-alkyl-4 quinolone 
ATP Adenosine triphosphate 
bp Base pairs 
cDNA Complementary deoxyribonucleic acid 
CFU Colony forming unit 
ChIP Chromatin immunoprecipitation 
C. elegans Caenorhabditis elegans 
DNA Deoxyribonucleic acid 
ECF Extracytoplasmic function 
E. coli Escherichia coli 
FDR False discovery rate 
GC Guanine-cytosine 
GlcNAc N-acetyl glucosamine 
GOID Gene ontology identification 
HLH Helix-loop-helix 
HTH Helix-turn-helix 
 xviii
IclR Isocitrate lyase regulator 
LB Luria Bertani 
LPS Lipopolysaccharide 
LTTR LysR-type transcriptional regulator 
MB Mega base pairs 
MDR Multi drug resistant 
MFS Major facilitator superfamily 
MIC Minimum inhibitory concentration 
ml Milliliter 
mm Millimeter 
mM Millimolar 
MurNAc N-acetyl muramic acid 
NaCl Sodium chloride 
NADH Nicotiamide adenine dinucleotide 
NaOCl Sodium hypochloride 
OM Outer membrane 
ORF Open reading frame 
P. aeruginosa Pseudomonas aeruginosa 
PBP Penicillin binding protein 
 xix
PCP Penta chlorophenol 
PCR Polymerase chain reaction 
PFAM Protein family 
PQS Pseudomonas quinolone signaling 
qPCR Quantitative real-time polymerase chain reaction 
QS Quorum sensing 
RGP Regions of genome plasticity 
RNA Ribonucleic acid 
RND Resistance nodulation division 
rrn Ribosomal RNA locus 
SAGE Serial analysis of gene expression 
SSM Synthetic succinate medium 
T3SS Type III secretion system 
T6SS Type VI secretion system 
TCS Two component system 
TFP Type IV pili 
wHTH Winged helix-turn-helix 
XDR Extremely drug resistant 
 1
CHAPTER 1 
 
 
 
 
 
Introduction 
 
 
 
 2
The model bacterium, Pseudomonas aeruginosa 
The genus Pseudomonas encompasses metabolically versatile bacteria that can 
utilize a wide range of organic and inorganic substrates. It comes as no surprise then that 
members of this genus are found in a variety of habitats in soil and water and are also 
important pathogens of plants, animals and humans (1). Walter Migula of the Karlsruhe 
Institute in Germany named the genus Pseudomonas in the 1894. He defined the genus 
based on cell morphology as,  
‘Cells with polar organs of motility. Endospore formation of spores occurs in some 
species but infrequently (for instance, Pseudomonas violacea)’ (2).  
The definition was brief and somewhat vague. We now know that none of the 
pseudomonads produce spores and what Migula observed were probably refractile 
granules. In Greek, Pseudes means false, Monas means units, and the genus was described 
as such in the Bergey’s Manual of Determinative Bacteriology and later in the Bergey’s 
Manual of Systematic Bacteriology (3,4). However, it has been hypothesized that Migula 
was actually referring to the nanoflagellate Monas whose cells bear a close resemblance to 
Pseudomonas cells and did not define the genus as ‘false units’ (5). Pseudomonads have 
now been studied extensively and the genus is now described as follows in the Bergey’s 
Manual of Systematic Bacteriology:  
Straight or slightly curved rods but not helical, 0.5-1.0 µm in diameter by 1.5-5.0 
µm in length. Most of the species do not accumulate granules of poly-ß-hydroxybutyrate, 
but the accumulation of poly-hydroxyalkanoates of monomer lengths higher than C4 may 
occur when growing on alkanes or gluconate. Do not produce prosthecae and are not 
surrounded by sheaths. No resting stages are known. Gram-negative. Motile by one or 
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several polar flagella; rarely non-motile. In some species, lateral flagella of short 
wavelength may also be formed. Aerobic, having a strictly respiratory type of metabolism 
with oxygen as the terminal electron acceptor; in some cases, nitrate can be used as an 
alternate electron acceptor, allowing growth to occur anaerobically. Xanthomonadins are 
not produced. Most, if not all, species fail to grow under acid conditions (pH 4.5 or lower). 
Most species do not require organic growth factors. Oxidase positive or negative. 
Catalase positive. Chemoorganotrophic. Strains of the species include in their 
composition the hydroxylated fatty acids 3-OH 10:0 and 12:0, and 2-OH 12:0, and 
ubiquinone Q-9. Widely distributed in nature. Some species are pathogenic for humans, 
animals or plants. The mol% G+C content of the DNA is 58-69. 
Type species: Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 
Classification of strains into this genus now requires extensive polyphasic data, 
including molecular and biochemical characterization. Many strains produce pili and 
fimbriae. The cells are non-capsulated though they produce at least three different 
extracellular polysaccharides (alginate, Pel and Psl) under some growth conditions. The 
cells are aerobic but can grow anaerobically using nitrate as the terminal electron acceptor. 
This makes some species function as denitrifiers in the soil environment, though all 
species can use nitrate as a carbon source (6). Metabolic versatility is a hallmark of this 
genus and can utilize a wide range of organic and inorganic substrates as carbon source.  
The type species of this genus is P. aeruginosa. The species name aeruginosa is 
Latin for verdigris meaning copper rust, referring to the blue-green pigment seen in lab 
cultures. The coloration is due to production of two extracellular pigments, pyocyanin and 
pyoverdin. P. aeruginosa can switch lifestyles from being an environmental isolate, found 
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in the soil and water, to a human pathogen (7). It is an epitome of opportunistic human 
pathogens, being implicated in a wide range of infections of the pulmonary tract (8,9), 
urinary tract (10-13), burns (14-16), wounds (17,18),  lung cancer patients  (19),  chronic 
obstructive pulmonary disease (20), bronchiectasis (21) and in pediatric and adult AIDS 
patients (22). It causes persistent nosocomial infections (23,24) and is also a major 
pathogen in cystic fibrosis patients. One of the major weapons in its arsenal is its 
resistance to antibiotics. It is both inherently resistant and can also acquire resistance 
genes from other bacteria making it a notorious pathogen. Understandably, numerous 
studies over the years have focused on elucidating the mechanisms of pathogenesis and 
antibiotic resistance of P. aeruginosa. Since the sequencing of the genome (25), the 
emphasis of these studies has shifted from conventional pathogenesis research, where the 
focus was on individual virulence determinants, to a much larger scale involving whole 
genome analyses.  
The prototypic reference strain of P. aeruginosa is PAO1, isolated from a burn 
wound (26), and was the first P. aeruginosa strain to be sequenced (25). The most 
prominent feature of the PAO1 genome is its size. It has one of the largest bacterial 
genomes with 6.26 million base pairs comprising of almost 90% protein coding genes 
(25,27). The genome complexity of P. aeruginosa explains its versatile nature to adapt 
and thrive in a wide range of environments. The genome has 5,570 open reading frames 
(ORFs), a number that is close to simple eukaryotes like Saccharomyces cerevisiae. Other 
features of the PAO1 genome include the presence of four ribosomal RNA loci (rrn) that 
are the regions of the longest repeats and a high GC ratio at 66.6% (25). Following the 
sequencing of the genome, high-density DNA microarrays were developed for P. 
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aeruginosa (28) that offered us a chance to take snapshots of the dynamic responses of 
this versatile genome to various stimuli.  An important study in this context, which 
analyzed the genomes of both environmental and clinical isolates of P. aeruginosa, 
suggested the presence of a core genome in different strains and expression of different 
sets of genes to facilitate growth in particular environments (29). This calls for a robust 
control over gene expression mediated by transcriptional regulators. About 10% of the 
PAO1 genome is comprised of transcriptional regulators suggesting a tight control over 
the way genes are expressed in P. aeruginosa (25).  
Subsequent to PAO1, other P. aeruginosa strains such as PA14 (30), PA2192 (a 
CF isolate) (31), C3719 (the Manchester epidemic strain) (32), and PACS2 (33), have 
been sequenced. Comparative genome analysis of the five sequenced P. aeruginosa 
strains has led to the identification of a set of core shared genes that all the genomes 
contain, the majority of which are housekeeping genes (33). In addition, there are 
accessory genomes comprising of mostly hypothetical ORFs or those related to 
transposons and bacteriophages, and genes involved in adaptation specific to each of the 
five strains (33). The accessory gene set also contains transcriptional regulators that may 
control expression of ORFs in the core genome. In order to better manage P. aeruginosa 
infections, it is imperative for us to understand the workings of the bacterium, what are 
the environmental signals it recognizes, how are these signals translated into a 
transcriptional response and how can we interfere with any of these processes.  
Antibiotics, antibiotic resistance and AmpR 
Antibiotics are antimicrobials that are produced by certain soil bacteria and 
actinomycetes as secondary metabolites. They kill other bacteria at low concentrations 
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and have been used to treat bacterial infections, in human and veterinary medicine, and in 
agriculture. The antibiotic era was ushered in by the serendipitous discovery of penicillin 
by Alexander Fleming. Subsequently, the ‘father of antibiotics’ Selman Waksman, 
identified over 20 different antibiotics that have revolutionized the way we manage 
bacterial infections. The mode of action of antibiotics varies but fall into two main 
categories: bactericidal and bacteriostatic. Bactericidal antibiotics kill bacteria while 
bacteriostatics only inhibit growth.  
Antibiotics are also classified based on their chemical structure and mode of 
action. For example, DNA synthesis is inhibited directly by fluoroquinolones (nalidixic 
acid and ciprofloxacin) by affecting the topoisomerases, and indirectly by trimethoprim-
sulfamethaxazole by inhibiting tetrahydrofolic acid synthesis. Rifamycins (rifamycin, 
rifampicin, rifapentine) inhibit RNA synthesis by acting on the DNA-dependent RNA 
polymerase. Protein synthesis inhibitors (aminoglycosides, macrolides, tetracyclines, 
ketolides, phenicols) act primarily by interfering with the activity of the 30S and 50S 
ribosomes affecting translation. Cell wall synthesis inhibitors include ß-lactams 
(penicillins, cephalosporins, carbapenems), glycopeptides (vancomycin, teicoplanin) and 
lipopeptides (daptomycin, polymixin B) that inhibit various stages of the peptidoglycan 
synthesis process.  
Antibiotics affect disparate cellular functions and four groups of genes have been 
identified based on their expression response to antibiotic treatment: genes that are 
directly affected by target inhibition (group 1); genes affected indirectly by antibiotic 
action (group 2); genes affected due to secondary effects of antibiotics (group 3); those 
that are differentially regulated in response to antibiotics but are not related to the drug 
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target (group 4) (34). Determining the transcriptional response of novel antimicrobials 
and comparing it to the transcriptional profiles of known antibiotics can potentially also 
provide information on the mechanism of action (35).  
The role of antibiotics in nature is much debated. The contention is that if the 
initial intent of antibiotics production by bacteria was to wipe out the competition, one 
should find antibiotics at inhibitory concentrations in, for example, soil but this is not the 
case. Moreover, antibiotics are produced as secondary metabolites, during the late-log to 
stationary phase. If the primary role of antibiotics was to provide a growth advantage by 
wiping out competition, they should be produced in the log phase when the producer cell 
needs the most nutrients. Recent studies have shown that antibiotics at low concentration 
can in fact enhance biofilm growth and motility (36). It has therefore been proposed that 
antibiotics could function as signaling molecules in the environment (37). In 
Streptomyces spp., antibiotic production is under the control of a cell-cell communication 
mechanism called quorum sensing (QS) (38). In P. aeruginosa, PQS, the signaling 
molecule of one of the three QS systems, possess antibacterial activity at very high 
concentrations (39,40). In addition, some antibiotics have immunomodulatory effects; 
macrolides have anti-inflammatory properties and are used in CF patients to exploit this 
property rather than as an antibacterial (41). Rifampicin, on the other hand has pro-
inflammatory activity (42).  
Antibiotic resistance  
 ß-Lactamases, enzymes that degrade ß-lactam antibiotics, are presumed to have 
evolved around 2 million years ago (43). However, the race to evolve resistance to the 
newer antimicrobials has been accelerated in the recent decades with the widespread use 
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of antibiotics. Bacteria have quickly become resistant to almost all natural, synthetic and 
semi-synthetic antibiotics used to eradicate them (44). In fact, microbes seem to have the 
upper hand in the arms race. In spite of their evolutionary simplicity, bacteria possess 
extreme adaptability that has helped them survive over millions of years.  
 Bacteria resist antibiotics in a variety of mechanisms that include reduced 
membrane permeability, target alteration, efflux pumps, and hydrolytic enzymes (Figure 
1.1). Some bacteria, such as P. aeruginosa, are intrinsically resistant to antibiotics while 
most of them can acquire antibiotic resistance genes from other organisms via horizontal 
gene transfer. Transfer can occur on mobile elements such as transposons, uptake of free 
DNA, be mediated by bacteriophages or by conjugation between the donor and recipient 
bacteria. Acquisition of such genes can lead to enhanced resistance to antimicrobials for 
the recipient bacteria. On the other hand, some mutations can reduce resistance, though 
typically the reduction in levels of resistance is not dramatic. Such low level increases in 
resistance are important in the clinical setting (45).  
Development of resistance to an antibiotic is seen to follow soon after its 
introduction. Fleming noted this soon after he discovered penicillin. Penicillin had a MIC 
of 0.04 µg/ml when first introduced in 1940 against Streptococcus pneumonia (46), 
increased to 0.12-1 µg/ml in 1980 (47) and by the 1990s, the strains became completely 
resistant prompting discontinued usage. With other bacteria, the development of 
resistance is even more drastic. Quinolones, such as ciprofloxacin, were first used to treat 
P. aeruginosa in 1990 when the MIC was <0.5 µg/ml (48). In less than 8 years, clinical 
isolates started displaying intermediate resistance (8 µg/ml in 1998) (49) and in 2009, the 
resistance has increased to 32-64 µg/ml (50). The same trend is also seen with the 
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aminoglycoside, tobramycin for P. aeruginosa. The clinical isolates started displaying 
resistance (<2 µg/ml in 1980, 8 µg/ml in 1987 and ≥ 16 µg/ml in 2000) in a very short 
time span (51-53).  
Antibiotic resistance in P. aeruginosa 
 P. aeruginosa displays a high level of resistance to many of the clinically relevant 
antibiotics. Resistance is a cumulative measure of three main types mechanisms: intrinsic, 
acquired and adaptive. Whereas intrinsic and acquired resistances are stable and heritable, 
adaptive resistance is dependent on the environment and is inducible. The antibiotic 
resistance mechanisms of P. aeruginosa are summarized in Figure 1.1. 
Intrinsic resistance 
Intrinsic resistance is a characteristic feature of P. aeruginosa and is principally 
mediated by low outer membrane permeability. The outer membrane in Gram-negative 
bacteria act as molecular sieves, and uptake of hydrophilic molecules is by diffusion 
through water-filled porins. The major porin in P. aeruginosa is OprF and most OprF 
channels are small similar to OprD and OprB. 
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Figure 1.1: Antibiotic resistance mechanisms in P. aeruginosa. Schematic representation of the multiple 
mechanisms of antibiotic resistance in P. aeruginosa. Cellular appendages and intracellular components are 
not shown for simplicity. 
 
The P. aeruginosa outer membrane is thus 12 to 100 times less permeable 
compared to that of E. coli (54). Antibiotics enter P. aeruginosa through the porins (for 
example, imipenem through OprD), self-promoted uptake (polycationic antibiotics) or by 
diffusion through the membrane (hydrophobic molecules). Hydrophilic molecules, 
however, still equilibrate across the outer membrane quickly and this is where the other 
mechanisms of intrinsic resistance play a role. Efflux pumps such as MexAB-OprM, 
MexXY-OprM (55-57) and induction of the ß-lactamase AmpC (58) effectively deal with 
the antibiotics by either pumping them out of the cell thereby reducing cytoplasmic 
retention time or by hydrolyzing them, respectively. These secondary resistance 
mechanisms rely on the reduced permeability for enhanced effectiveness. In addition, 
recent studies have identified many mechanisms that contribute to ß-lactam resistance in 
P. aeruginosa (59-61). P. aeruginosa adaptively regulates resistance mechanisms in 
response to antibiotics contributing to the resistance profile seen with this pathogen 
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(34,62). Intrinsic resistance is thus multifactorial and a major contributing factor to the 
high level of clinical resistance displayed by P. aeruginosa.  
Acquired Resistance 
 Acquired resistance of P. aeruginosa to antibiotics is achieved by horizontal gene 
transfer or by mutations. Resistance genes can be acquired on plasmids, pathogenicity 
islands, prophages, transposons or integrons, sometimes harboring resistance against 
multiple antibiotics. Typically, horizontal gene transfer affects resistance to 
aminoglycosides and ß-lactams (63,64). Many plasmids that harbor genes encoding 
resistance to extended spectrum ß-lactams and metallo ß-lactams have now been 
identified (65).  
Mutations can also lead to acquired resistance. Natural resistance frequencies for 
individual antibiotics vary between 10-6 to 10-9, which can increase under conditions such 
as biofilm growth, DNA damage or in hypermutator strains (66-68). Mutations in the 
porin (69) or in their regulators (70) can lead to reduced uptake of antibiotics. Enhanced 
expression/activity of efflux pumps can also occur due to regulator mutations (71,72). 
Mutations can also lead to overexpression of hydrolytic enzymes that inactivate 
antibiotics conferring resistance to specific classes of antibiotics such as ß-lactamases 
(73-76). Strains develop resistance to fluoroquinolones due to target alterations, a 
consequence of mutations (77-79). Recent work has also defined the phenomenon of 
‘creeping baselines’, where resistance is acquired in seemingly non-significant increases 
in MIC but the cumulative resistance is clinically significant (35). 
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Adaptive Resistance 
In response to specific environmental cues, cells display enhanced resistance to 
one or more antibiotics. When the stressor/signal is removed, the cells lose the resistance 
phenotype, though ‘normal’ levels of resistance are typically not restored (80). This 
phenomenon is termed ‘adaptive resistance’. Though the phenomenon was observed in 
the 1960s (81), it has not been studied in detail. The four main defining features of 
adaptive resistance are (i) it is transient, (ii) not heritable, (iii) generally reverts upon 
removal of the inducing signal and (iv) is dependent on the environment (35). In addition 
to sub-MIC antibiotics, other identified triggers of adaptive resistance are environmental 
cues (anaerobiosis, ions and ionic binding, pH, carbon sources, polyamines), biofilm 
formation and swarming motility (35). Two-component systems such as ParRS and 
CprRS sense cationic peptides in the environment and trigger adaptive resistance (72,82). 
 In many cases, P. aeruginosa infections can be effectively dealt with. However, 
when P. aeruginosa forms biofilms, for example in the cystic fibrosis lung, eradication of 
infection becomes very difficult due to antibiotic resistance. The presence of persister 
cells further compounds this problem (83). This calls for urgent steps to not only find 
new treatment options but also to devise measures for more prudent use of antibiotics. 
ß-Lactam resistance in P. aeruginosa 
ß-Lactam antibiotics, in combination with aminoglycosides, are part of the current 
treatment regimen for P. aeruginosa infections (84). However, the phenomenon of ß-
lactam resistance is a major issue with P. aeruginosa acute and chronic infections. 
Antibiotic resistant isolates of P. aeruginosa are selectively favored in vivo in CF patients 
(85,86). A major mechanism of ß-lactam resistance in P. aeruginosa is the 
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overproduction of the chromosomal ß-lactamase, AmpC. Hyperexpression and presence 
of ß-lactamases in the biofilm matrix, either free or in membrane vesicles, has been 
linked to the reduced effectiveness of ß-lactam treatment (87-89). In the 90s, many P. 
aeruginosa CF isolates were found to either express high inducible or constitutively 
overexpress ß-lactamase (90,91). One of the molecular mechanisms of overproduction of 
ß-lactamases was attributed to insertional inactivation of the ampD gene in P. aeruginosa 
(73,92). Studying the regulation of amp genes will aid in understanding the molecular 
mechanisms of ß-lactamase overexpression in P. aeruginosa.  
Transcriptional regulation of the ß-lactamase ampC 
The LysR-type transcriptional regulator AmpR regulates inducible ampC ß-
lactamase expression. The genes ampR and ampC have been found in many organisms 
(93-97). In systems with inducible ampC, the ampR gene is always present adjacent to 
ampC but is divergently transcribed (98-100). The ampR-ampC arrangement in P. 
aeruginosa is similar to that seen in other organisms including Citrobacter freundii and 
Enterobacter cloacae. AmpR of C. freundii and E. cloacae can cross-complement each 
other (101) and sequence analysis revealed that P. aeruginosa AmpR is similar to that 
found in C. freundii (58%) and E. cloacae (62%) (102). In C. freundii, AmpR recognizes 
a 15-bp sequence 5’ TCTGCTGCTAAATTT 3’ in PampC (98,102). There is a putative 
AmpR binding site 5’ TCTGCTCCAAATTT 3’ in the ampR-ampC intergenic region in P. 
aeruginosa. AmpR has a helix-turn-helix (HTH) motif that is typical of DNA binding 
proteins (102). C. freundii AmpR has been shown to bind DNA through its HTH motif 
(98). In P. aeruginosa, the third helix of the AmpR HTH motif is critical for DNA 
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binding and amino acid residues important for DNA binding have been identified (O. 
Caille, unpublished data). 
AmpR belongs to the LysR family of transcriptional regulators that typically 
autorepress their own expression (103,104). This has been suggested to be the case with 
C. freundii (98). The ampR-ampC intergenic region in P. aeruginosa is only 149 bp 
suggesting that ampR expression is autoregulated (102). Previous studies from our lab 
using PampR-lacZ fusion have shown that there is no difference in the expression from the 
ampR promoter between the wild-type and ampR mutant strains suggesting that ampR is 
not autoregulated in P. aeruginosa (105).  
P. aeruginosa AmpR regulates other genes  
The regulatory role of AmpR was determined by comparing the properties of P. 
aeruginosa PAO1 with its isogenic ampR insertion mutant, PAOampR::aacC1, 
henceforth referred to as PAOampR (105). PAOampR expressed high basal levels of ß-
lactamase even in the absence of antibiotic stress (105). Inducibility was restored by 
transcomplementation of ampR. There was no expression from PampC in PAOampR (105). 
These data indicate that AmpR positively regulates ampC similar to data from other 
bacterial genera.  
Interestingly, loss of ampC reduced but did not completely abolish ß-lactamase 
activity. This, and previous observations with PampC-lacZ, led to the discovery of a second 
chromosomal ß-lactamase, an oxacillinase PoxB (106). The poxB gene is part of a two-
gene operon (poxAB). Introduction of this operon on a plasmid into E. coli, in the 
presence and absence of P. aeruginosa ampR, resulted in higher levels of ß-lactamase 
activity only in the absence of ampR. Reduction of activity in the presence of ampR 
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suggested that AmpR negatively regulates poxB (106). Ongoing work in the Mathee lab 
is aimed at better understanding AmpR-regulation of poxB. 
The PAOampR strain also produced higher levels of pigments when cultured on 
plates or in broth suggesting that ampR may be involved in regulating pigment 
production (105). Pseudomonas produces green pigments that act as siderophores, 
chelating iron from the environment, offering the bacteria a survival advantage and 
enhancing virulence (107,108). Pyocyanin production was significantly higher in 
PAOampR compared to PAO1, suggesting that AmpR negatively regulates pyocyanin 
production (105).  
Pyocyanin production in P. aeruginosa is under the regulation of the las quorum-
sensing (QS) system that along with the rhl system controls expression of many virulence 
genes in P. aeruginosa (109). Thus, AmpR dependence of two other virulence factors 
under QS control, LasA protease and LasB elastase were analyzed (105). LasA is a zinc 
metalloprotease of the ß-lytic endopeptidase family (110). PAOampR produced more 
LasA compared to PAO1, and the levels were restored on ampR complementation 
suggesting that AmpR negatively regulates LasA (105). This was also shown with PlasA-
lacZ fusions in PAO1 and PAOampR. LasB elastase is a zinc metalloprotease that can 
inactivate a wide range of biological tissues and immunological agents (111). In 
PAOampR, there was a two-fold induction in LasB production that was ß-lactam-
independent. The inducible phenotype was restored on complementing ampR in trans 
(105). This suggests that AmpR positively regulates LasB. PlasB-lacZ fusions however, 
did not show a significant change in lacZ expression between PAO1 and PAOampR 
indicating that AmpR does not regulate PlasB directly. Expression of lasI and lasR, two 
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other QS genes, were shown to be higher in PAOampR than in PAO1 (105) that 
demonstrates negative regulation of LasI and LasR by AmpR. These studies suggest that 
AmpR plays a central role in a regulon.  
Role of AmpR in peptidoglycan recycling 
 The purported ‘natural’ role of AmpR in the cell is in the recycling of 
peptidoglycan. The peptidoglycan layer provides rigidity and shape to the bacterial cell. 
Not only is the peptidoglycan layer strong enough to withstand the internal pressure of 
the cell (~25 atm), it is also flexible and porous enough to allow diffusion of large 
molecules (112). The bacterial peptidoglycan is a complex polysaccharide of N-acetyl 
muramic acid (MurNAc) and N-acetyl glucosamine (GlcNAc) linked by ß-1,4 glycosidic 
linkages (113). Multiple GlcNAc-MurNAc polymer chains are crosslinked by 
pentapeptide bridges (L-alanine-D-glutamine-meso diaminopimelic acid-D-alanine-D-
alanine) forming a complex network of peptidoglycan (113,114).  
 Most of the peptidoglycan required for the growing cell is synthesized de novo 
(115). Biosynthesis of peptidoglycan is a complex process involving over 20 steps that 
take place in the cytoplasm, and on the inner and outer sides of the cytoplasmic 
membrane (115-117). However, not all of the peptidoglycan incorporated in the growing 
cell wall is newly synthesized. Both Gram-positive and Gram-negative bacteria are 
known to recycle peptidoglycan during cell division (118,119).  
In P. aeruginosa and other bacteria, this recycling process is tied in with ß-lactam 
resistance. The continuous breakdown and regeneration of peptidoglycan as part of 
remodeling in a growing cell is called turnover (120). The turnover process releases the 
disaccharide GlcNAc-anhydrous MurNAc (GlcNAc-AnhMurNAc) still attached to the 
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peptide chain. The chain may be three, four or five peptides long (GlcNAc-AnhMurNAc 
tri-, tetra-, and pentapeptides, respectively). These are transported into the cytoplasm by 
the AmpG permease (121). In E. coli, the acetylglucosaminidase NagZ acts on these 
products to cleave off GlcNAc resulting in tri-, tetra- and penta-peptides of AnhMurNAc 
(122). The NagZ homolog in P. aeruginosa (PA3005) has not been functionally 
demonstrated to be a glucosaminidase but its role in ß-lactam resistance is established 
(123,124). Following NagZ, the amidase AmpD breaks the amide bond between the 
sugar and amino acid (121). The AmpD amidase was identified as being important in ß-
lactamase induction in Citrobacter freundii and Enterobacter cloacae (101,125). In 
addition to AmpD, P. aeruginosa has two other homologs, AmpDh2 and AmpDh3, and 
all three play a role in ß-lactam resistance (73).  
The recycled peptides and sugars then enter the de novo synthesis pathway where 
uridyl diphosphate (UDP)-GlcNAc is first converted to UDP-MurNAc by the enzymes 
MurA and MurB followed by addition of the pentapeptide side chain, forming UDP-
MurNAc pentapeptide (115). The enzyme MraY then links UDP-MurNAc pentapeptide 
to an undecaprenyl attached on the inner side of the cytoplasmic membrane forming lipid 
I (116). Addition of a molecule of GlcNAc to lipid I results in the formation of lipid II 
(116). A flippase enzyme, presumably MurJ in E. coli, then flips lipid II to the 
periplasmic side of the cytoplasmic membrane (126). Penicillin binding proteins (PBPs) 
then take over the process of incorporating the newly synthesized sugar-peptide complex 
to the growing peptidoglycan chain (117).  
Studies show that though this system is similar in P. aeruginosa, there are 
important differences. Details of peptidoglycan recycling and their ties with ß-lactam 
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resistance have been studied in Enterobacteriaceae members and due to the homology of 
the corresponding proteins in P. aeruginosa, the proteins are presumed to be orthologous. 
The role of many players including AmpR, AmpC, AmpD and AmpG has been 
demonstrated in P. aeruginosa and are similar to their Enterobacteriaceae counterparts. In 
addition, new players have been identified in P. aeruginosa, such as the AmpD homologs 
AmpDh2 and AmpDh3 (73), and AmpP (127) adding to the complexity of the process. 
Further, studies in the Mathee lab have demonstrated that AmpR is an inner membrane 
protein (Caille et al., personal communication), which leads to unique questions in how 
the effector molecules are transported to their binding sites on AmpR. In Figure 1.2, we 
propose a model that links cell wall recycling and ß-lactam resistance in P. aeruginosa 
based on our current understanding of this process.  
 ß-Lactam antibiotics target the PBPs, thus interfering with cell wall synthesis. 
When there are no ß-lactams in the milieu, the concentration of the GlcNAc-UDP-
MurNAc pentapeptide is high and this binds to the effector binding sites in AmpR, 
allowing AmpR to repress ampC ß-lactamase expression. In the face of ß-lactam attack, 
however, inhibition of PBP activity by the antibiotics leads to accumulation of the 
peptidoglycan degradation products (GlcNAc-AnhMurNAc tri-, tetra peptides), which 
serve as effectors by binding AmpR and activating ampC expression. Enhanced 
production of AmpC results in degradation of the antibiotics inactivating them, thus 
providing resistance. Recently, a second permease AmpP has been shown to be important 
in ß-lactamase induction in P. aeruginosa (127). Further, AmpR has been demonstrated 
to be a membrane-bound regulator, with the HTH domain in the cytoplasm and effector-
binding domain in the periplasm (Caille et al., manuscript in preparation). We 
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hypothesize that AmpP siphons off some of the UDP-MurNAc pentapeptide from the 
cytoplasm for it to bind to the effector-binding domain of AmpR in the periplasm, 
repressing ampC expression.  
 
 
 
Fig 1.2. Components of the bacterial peptidoglycan function as effectors in modulating AmpR 
activity. As part of the cell wall recycling process, the GlcNAc-anhyd-MurNAc-tri and tetrapeptides 
released are transported into the cytoplasm by AmpG. NagZ activity results in anhyd-MurNAc-peptides 
(potential positive regulators). They are recycled to UDP-MurNAc-pentapeptide (a negative regulator of 
AmpR activity) that subsequently forms lipid I. MurG adds GlcNAc to this molecule to form lipid II. Lipid 
II is transported to the periplasm by flippase activity utilizing energy from UDP hydrolysis and 
transglycosylases add it to the growing peptidoglycan chain. In our model, AmpR is an integral membrane 
protein and we propose a second transport protein, AmpP, transports the negative regulator (UDP-
MurNAc-pentapeptide) to the periplasm to affect AmpR regulation. In the presence of ß-lactam antibiotics, 
a different positive regulator (GlcNAc-anhyd-MurNAc pentapeptide) is formed due to antibiotic action on 
transglycosylases and this has been proposed to positively regulate AmpR action, leading to production of 
ß-lactamases. 
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Transcriptional regulation: How does it work? 
All cells, prokaryotes and eukaryotes, contain hundreds of thousands of genes that 
define and dictate everything about the organism. However, not the entire complement of 
the genome is expressed at any given time. Gene expression is both condition- and time-
specific. Synthesis of proteins, the workhorses of the cell, is regulated at several stages 
and regulation of transcription is the first. One of the first steps in transcription is the 
binding of transcription factors to DNA. There are specific features in both DNA and 
proteins that are critical to this process. This section deals with the basics of protein-DNA 
interaction.  
Features on the DNA 
 The outer surface of the DNA double helix is studded with sequence information 
that proteins recognize. On the helix, the edges of the base pairs are exposed and have 
hydrogen bond donors (H attached to N), hydrogen bond acceptors (N, O) and 
hydrophobic patches (methyl group on thymidine).  The pattern of arrangement of these 
features is distinct for different bases only in the major groove of the DNA. In addition to 
these, transcriptional regulators also recognize the ‘distortions’ that are generated by the 
specific arrangement of nucelotides that alter the geometry of the double helix. For 
example, the repeat 5’ AAAANNN 3’ at 10 nucleotide intervals causes a slight local 
bending in the DNA. Such natural curves (bends) help form a tight fit between 
transcriptional regulators and DNA. 
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Features on the protein 
 DNA-binding proteins recognize specific sequences on the DNA because the 
surface features of the protein and the DNA they bind to bear extensive complementarity. 
DNA-protein interactions involve hydrogen bonds, ionic bonds and hydrophobic 
interactions. Though these binds are individually weak, there are typically about 20 
interactions per recognition site, which is strong enough to bring about binding. The 
weakness of the individual interactions is also critical for reversal of the process, 
allowing control of regulation. Features on both DNA and protein determine binding 
specificity. Specific amino acids bond with specific bases on the DNA. Asparagine, for 
example, binds with adenine and arginine binds with guanine. Given that there are only 
four types of nucleotide bases while there are 20 amino acids, some amino acids can bind 
multiple bases. In addition to arginine, guanine can also bind with serine, lysine and 
histidine; adenine binds serine and asparagine; thymine interacts with alanine and serine 
while cytosine binds aspartic acid. Most regulatory proteins bind DNA as dimers or 
multimers because it is a simple way to achieve strong specific binding.  
DNA-binding motifs in proteins 
 The regions of the protein that bind DNA can be classified on a structural basis 
into different types.  
Helix-turn-helix (HTH) motif: HTH was the first DNA-binding motif to be discovered. 
It is the most common motif found in DNA-binding proteins and is prevalent in both 
prokaryotes and eukaryotes. The HTH motif is composed of two α-helices connected by a 
short extended chain of amino acids, which form the turn. The helices are held at a fixed 
angle of 120˚ by interactions between the helices. Typically, the helix at the C-terminal 
 23
end of the protein (the second helix) is the recognition helix that interacts with the major 
groove of the DNA. The way that this helix is presented to the exposed bases in the major 
groove depends on the structure of the rest of the protein and how it contacts the DNA. 
The side chain amino acids vary between proteins and confer specificity. While the HTH 
motif is more or less conserved, barring the variation that confers specificity, the proteins 
can differ enormously outside of the HTH motif. The regions outside the HTH also, 
sometimes, interact with the DNA to fine tune recognition. Typically, HTH motif-
containing proteins bind DNA as symmetrical dimers to two similar/identical half-sites. 
Homeodomains are a special class of HTH motifs that are present in eukaryotes. 
An important difference between regulators that contain HTH motif or homeodomain is 
that the latter can bind DNA as a monomer whereas the former binds DNA as a dimer or 
multimer.  
Another variation of the HTH motif is the helix-loop-helix (HLH) motif. HLH 
motifs consist of a short α-helix connected by a loop to a longer α-helix. The loop 
connecting the two helices is flexible such that one helix folds back and packs against the 
other. The loop is also the site of dimerization (homo or heterodimers). Many HLH 
proteins lack a α-helical extension needed to bind DNA. When these truncated proteins 
form homo or heterodimers with other full-length proteins, they form partially active 
dimers that make only half of the necessary contacts. This is one way of keeping such 
regulatory proteins in check.  
 
Zinc-finger motifs: These motifs are composed of amino acids and zinc atoms as part of 
the structure. All groups of zinc-finger motif-containing proteins have zinc as a structural 
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element and bind DNA via a α-helix. Several groups have been identified based on 
structural studies.  
In the first type, a zinc molecule holds together a α-helix and a ß-sheet. This type 
of arrangement is typically found in a cluster with other zinc fingers in tandem. Each α-
helix contacts the major groove of the DNA. The specificity and strength of the 
interactions are enhanced by the presence of tandem repeats of α-helices. A second type 
of a zinc-finger motif is where two α-helices are packed together with zinc atoms in an 
arrangement that is similar to a HTH motif. They form dimers, which allows one of the 
two α-helices to bind DNA.  
Leucine zipper coiled-coil: Originally identified as a dimerization motif, leucine zippers 
are α-helical segments. Leucine zippers mediate DNA binding and protein dimerization. 
Secondary α-helices, one from each monomer, join to form a short coiled-coil. The 
helices are held together by interactions between hydrophobic side chains, often at a 
leucine. The two helices separate just beyond the dimerization interface to form a Y-
shaped structure, thus allowing the side chains to interact with the DNA.  
ß-ribbon proteins: ß-ribbons can also bind DNA. The major groove of the DNA is 
recognized by a two-stranded ß-sheet with side chains of amino acids extending from the 
sheet toward the DNA. DNA recognition depends on the amino acid sequence, like with 
α-helices. 
 
Dissertation overview 
P. aeruginosa is a bacterium that has fascinated researchers for decades and has 
been extensively studied. Numerous studies have addressed different regulatory aspects 
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of metabolism, physiology and pathogenesis. This has led to a great deal of 
understanding of the molecular mechanisms of gene regulatory processes in P. 
aeruginosa. However, with the advent of high-throughput genomics, our traditional 
understanding of regulatory repertoires is changing.  
With this in mind, my study has two main objectives: 
To better understand gene regulation in P. aeruginosa: This was achieved by 
performing global analyses of published data, specifically metaanalysis of transcriptome 
studies, and analyses of putative and established regulatory networks in P. aeruginosa. 
This objective is the basis of chapters 2 and 3 of this dissertation. 
To exemplify the regulatory complexity in P. aeruginosa using AmpR: Previous 
studies in the lab have established that AmpR regulates some non-ß-lactam resistance 
genes, in addition to regulating its primary target, ampC that encodes a ß-lactamase. I 
explore the regulatory repertoire of the ß-lactamase regulator AmpR adopting global 
approaches such as microarrays, RNA-Seq and ChIP-Seq. Chapters 4 and 5 of this 
dissertation address this objective. 
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Abstract  
One of the hallmarks of bacterial survival is their ability to adapt rapidly to 
changing environmental conditions. Niche adaptation is a response to the signals received 
that are relayed, often to regulators that modulate gene expression. In the post-genomic 
era, DNA microarrays are used to study dynamics of gene expression on a global scale. 
Numerous studies have used Pseudomonas aeruginosa, a Gram-negative environmental 
and opportunistic human pathogenic bacterium, as the model organism in whole genome 
transcriptome analysis. Here, we review the transcriptome studies that have led to 
immense advances in our understanding of the biology of this intractable human 
pathogen. Comparative analysis of 23 P. aeruginosa transcriptome studies has led to the 
identification of a unique set of genes that are signal-specific and a core set that was 
differentially regulated. The 303 genes in the core set are involved in bacterial 
homeostasis making them attractive therapeutic targets. 
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Introduction  
 Bacteria rapidly adapt to changing conditions by altering gene expression. The 
process of bacterial adaptation has fascinated researchers as it provides important insights 
into their physiology. This information is especially useful for human pathogens because 
it can be applied to better combat infections. This premise has led to studies that examine 
gene expression on a global scale. An entire set of RNA transcripts produced by a 
population of cells at any given time during gene expression is referred to as a 
transcriptome (128). Variations in the external environment or genome perturbations, 
such as mutations, can alter the transcriptome of a cell. Transcriptome studies thus 
provide us with a snapshot of the organisms’ response based on the genes that are 
expressed. Though there is not always a linear relationship between the expressed genes 
and the proteins synthesized, such studies give us a reasonable insight into the state of the 
cell.  
In the pre-genomic era, transcriptome analysis relied on techniques such as 
differential display and RNA arbitrary primed PCR (129-131), cDNA-amplified 
restriction fragment length polymorphism (132-134), random expressed sequence tag 
sequencing (135), serial analysis of gene expression [SAGE; (136)], LongSAGE (137), 
SuperSAGE (138,139), and massively parallel signature sequencing (140). Prior 
sequence information is not required for these methods but they are both labor and time-
intensive. Bacterial studies entered the genomic era with the sequencing of the 
Hemophilus influenzae genome in 1995 (141). Since then, the genomes of over 1000 
bacteria have been fully sequenced. Large-scale sequencing has ushered the development 
of high throughput genome-wide expression techniques such as DNA microarrays. This 
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powerful technology has been harnessed in numerous studies, under diverse conditions to 
elucidate whole genome expression in both prokaryotes and eukaryotes. One such 
prokaryote is Pseudomonas aeruginosa, where DNA microarrays have been of immense 
help in understanding its complex biology. 
P. aeruginosa 
P. aeruginosa is a Gram-negative human pathogen of the family 
Pseudomonadaceae and can switch from being an environmental isolate, found in the soil 
and water, to a human pathogen (7). It is an epitome of opportunistic human pathogens, 
being implicated in a wide range of infections of the pulmonary tract (8,9), urinary tract 
(10,11,13), burns (14-16) and wounds (17,18) among others. It causes persistent 
nosocomial infections (23,24) and is also a major pathogen in cystic fibrosis patients. 
One of the major weapons in its arsenal is its resistance to antibiotics. It is both inherently 
resistant and can also acquire resistance genes from other bacteria making it a notorious 
pathogen. Understandably, numerous studies over the years have focused on elucidating 
the mechanisms of pathogenesis and antibiotic resistance of P. aeruginosa. Since the 
sequencing of the genome (25), the emphasis of these studies has shifted from 
conventional pathogenesis research, where the focus was on individual virulence 
determinants, to a much larger scale involving whole genome analyses.  
The prototypic reference strain of P. aeruginosa is PAO1, isolated from a burn 
wound, and was the first P. aeruginosa strain to be sequenced (25). The most prominent 
feature of the PAO1 genome is its size. It has one of the largest bacterial genomes with 
6.26 million base pairs comprising of almost 90% protein coding genes. The genome 
complexity of P. aeruginosa explains its versatile nature to adapt and thrive in a wide 
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range of environments. The genome has 5,570 open reading frames (ORFs), a number 
that is close to simple eukaryotes like Saccharomyces cerevisiae. Other features of the 
PAO1 genome include the presence of four ribosomal RNA loci (rrn) that are the regions 
of the longest repeats and a high GC ratio at 66.6% (25). Following the sequencing of the 
genome, high-density DNA microarrays were developed for P. aeruginosa (28) that 
offered us a chance to take snapshots of the dynamic responses of this versatile genome 
to various stimuli.  An important study in this context (29), which analyzed the genomes 
of both environmental and clinical isolates of P. aeruginosa, suggested the presence of a 
core genome in different strains and expression of different sets of genes to facilitate 
growth in particular environments. This calls for a robust control over transcription 
mediated by transcriptional regulators. Analysis revealed that about 10% of the PAO1 
genome is comprised of transcriptional regulators (25). This suggests the existence of a 
tight control over the way genes are expressed in P.aeruginosa.  
Subsequent to PAO1, other P. aeruginosa strains such as PA14 (142), PA2192 [a 
CF isolate, (31)], C3719 [the Manchester epidemic strain, (32)] and PACS2 (33), have 
been sequenced. Comparative genome analysis of the five sequenced P. aeruginosa 
strains has led to the identification of a set of core shared genes that all the genomes 
contain, the majority of which are housekeeping genes (33). In addition, there is an 
accessory genome comprising of mostly hypothetical ORFs or those related to 
transposons and bacteriophages, and genes involved in niche adaptation specific to each 
of the five strains (33). The accessory set also contains transcriptional regulators that may 
control expression of ORFs in the core genome. Since the currently available microarray 
chips are based on the PAO1 genome, performing microarray studies with non-PAO1 
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strains would seriously underestimate the transcriptional profile. Though GeneChip 
(Affymetrix) contains 117 probe sets for ORFs from non-PAO1 P. aeruginosa, it is not 
sufficient to cover the accessory genomes from all the other sequenced strains. Analysis 
of five P. aeruginosa genomes revealed that 5021 genes are conserved between the 
strains (core gene set) and that the genome of each strain has anywhere between 79 to 
507 unique genes that are part of the accessory genome for that strain (33). There is thus 
a gross under-representation of non-PAO1 genes on the Affymetrix GeneChip that will 
undoubtedly affect data interpretation. Thus, the next major advance in P. aeruginosa 
microarrays would be the development of a pangenome array, comprised of probe sets for 
the core and accessory genomes from all sequenced strains. This will greatly advance our 
understanding of the system by allowing researchers to study non-PAO1 strains and help 
appreciate better the biology of this versatile bacterium. 
P. aeruginosa transcriptome studies 
P. aeruginosa and iron limitation 
Iron is an important cofactor that plays a critical role in many cellular processes. 
Low iron availability in host tissues is a major impediment that the bacteria have to 
overcome in establishing an infection. Bacteria have evolved an elaborate system of 
acquiring iron from the surroundings. P. aeruginosa secretes siderophores (pyochelin and 
pyoverdine) that chelate iron and bring it back into the cell via specific cell-surface 
receptors (108). Fur is a major repressor that tightly regulates this uptake process by 
controlling expression of the regulators, PvdS and PchR (143). 
In one of the initial transcriptome studies of the response of P. aeruginosa to iron 
(144), stationary phase P. aeruginosa cells were grown in the presence and absence of 
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iron at 32 ˚C followed by gene expression analysis. Results indicated that 137 genes were 
upregulated on iron depletion (144). A more systematic study was performed by Palma et 
al., which addressed how the transcriptome changes when iron-starved P. aeruginosa 
cells are fed with iron (145). Differential regulation was seen in mRNA levels of 177 
genes. Most of the genes were down regulated, especially genes involved in transport of 
small molecules, transcriptional regulators and hypothetical proteins. It was interesting to 
note that genes involved in virulence were upregulated, some of which probably help the 
cells in overcoming the host innate immune system (145). An important finding was that 
38 genes, including those coding for siderophore receptors, iron transport, regulators, 
sensors, sigma factors were identified whose transcription decreased on iron treatment. 
These 38 genes were proposed to be part of a regulon involved in iron response in P. 
aeruginosa. In another study, Zheng and coworkers identified a hypothetical protein, 
PA2384, that regulates over 70 genes involved in the iron uptake process in a Fur-
independent manner (146). Moreover, deleting PA2384 also led to differential expression 
of many genes involved in cellular physiology, like translation, metabolism and electron 
transfer indicating a broader role for this protein.  
 
 
 
P. aeruginosa and oxidative stress 
For bacteria to successfully infect a human host, they should be able to overcome 
many barriers. One primary defense mechanism is production of reactive oxygen species 
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(ROS) by the host cells that leads to oxidative stress in bacteria. Palma et al., studied the 
response of P. aeruginosa to a natural oxidant in human systems, hydrogen peroxide, as 
an indication of the global transcriptional status of the cell’s early response (147). The 
study confirmed that some of the genes that were earlier found to be important in a cell’s 
response to oxidants were upregulated in addition to identifying 520 genes with a 
significant (>5-fold) change in mRNA levels (147). Of these, 216 genes were upregulated, 
seven of which were upregulated more than 50-fold, primarily hypothetical proteins of 
unknown function. Further, upregulated genes included cytotoxin genes such as 
exoenzymes S and T, and PvdS that control PrpL proteinase and exotoxin A expression 
and could potentially inhibit the cells of the innate immune system. Most of the genes 
that were down regulated are involved in metabolic pathways and ribosomal synthesis, 
which makes sense, for the cell under oxidative stress would not want to actively 
metabolize or grow but deal with the stress first (147).  
In another study looking at response to hydrogen peroxide, stationary phase cells 
of three strains belonging to two clonal types were tested (148). Two of the strains, TB 
and 892 were cystic fibrosis (CF) isolates and their response was compared with PAO1, 
which belongs to a different clonal type. The expression profiles of the CF isolates were 
more similar to each other than to PAO1, sharing more than 80% of the differentially 
expressed genes with each other. This study highlighted the importance of clone-specific 
transcriptome profiles, variations seen in both intraclonal (between the two CF isolates) 
and interclonal (between CF isolates and PAO1) strains. 
Genome-wide transcriptomes of the three strains, P. aeruginosa PAO1 and the 
two CF isolates TB and 892 were also analyzed for their response to superoxide-
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generating paraquat (149). Less than 30 genes were differentially expressed in each of the 
three strains, of which only six were upregulated in all three. Upregulated genes belonged 
to oxidative stress response, transport and acetyl-CoA and acetoin metabolism. Four 
genes of a single operon coding for the superoxide dismutase SodB, catalase KatA and 
alkylhydroperoxide reductase AhpC were upregulated in three strains, highlighting their 
importance in P. aeruginosa superoxide stress response. Energy metabolism genes were 
downregulated to counter the superoxide stress (149). 
Two recent papers by Small et al., looked at the oxidative stress response of P. 
aeruginosa. Both of these articles focused on the effect of oxidizing agents routinely used 
in hospitals for surface sterilization and their effect on P. aeruginosa. The first is a 
transcriptome analysis of sodium hypochlorite (NaOCl)-induced oxidative stress (150). In 
this study, Luria-Bertani (LB) broth grown mid-log phase P. aeruginosa PAO1 cells were 
treated for 20 minutes with sub-lethal concentrations of bleach. RNA extraction and 
microarray analysis followed. Results were compared with similarly grown untreated 
cells. About 20% of the 5570 genes of P. aeruginosa were differentially expressed in 
response to the treatment, approximately 10% each being up- and downregulated. 
Responses similar to that seen with hydrogen peroxide were generated, with upregulation 
of catalase, alkyl hydroperoxide reductase, and glutathione peroxide/reductase genes 
indicating that the mode of action of bleach is similar to that of hydrogen peroxide in 
inducing the oxidant defense system genes. Genes involved in transport of sulfur 
compounds were highly upregulated. A possible explanation for this observation is that 
the free electrons in the sulfhydryl groups in the biological molecules react with the 
hypochlorous acid formed by exposure to NaOCl, a known strong oxidizer, countering its 
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effect. This would increase chances for cell survival (150). Genes that are repressed are 
primarily the ones involved in oxidative phosphorylation and electron transport indicating 
that the cells under NaOCl-induced stress would have lowered energy due to impaired 
metabolic processes.   
Another study compared and analyzed the transcription patterns of three different 
oxidative damage-inducing agents: NaOCl, peracetic acid and hydrogen peroxide on P. 
aeruginosa (151). Over 550, 300 and 200 genes were differentially regulated as a result 
of NaOCl, peracetic acid and hydrogen peroxide, respectively. Of these, 63 genes were 
common to all three agents, 40 upregulated and 23 downregulated. About 25% of the 
common upregulated genes were ‘related to phage, transposon or plasmid’ and eight were 
to membrane protein. The primary downregulated genes were those involved in transport 
of small molecules. Other prominent gene categories included membrane proteins and 
putative enzymes. It is surprising to note that membrane protein genes were both up and 
downregulated. NaOCl resulted in the most downregulation of genes involved in energy 
metabolism suggesting that NaOCl may be more effective in limiting energy production 
than the other two agents. Peracetic acid exposure resulted in stimulating expression of 
genes involved in adaptation and protection and downregulation of transcriptional 
regulators. Several protective mechanisms were triggered after exposure of cells to 
hydrogen peroxide. A significant finding of this study was positive expression of the 
pyocin genes of the F-, R- and S- types after hydrogen peroxide treatment but was 
downregulated with the other two treatments. This has been linked to DNA damage and 
RecA activation that has been known to induce pyocins. RecA has been demonstrated to 
cleave single stranded DNA with the help of hydroxyl radicals that are formed by 
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exposure of cells to hydrogen peroxide. The induction of pyocin genes in response to 
hydrogen peroxide treatment, published separately (152), demonstrates that NaOCl 
exposure leads to significant differences in the transcription pattern of P. aeruginosa and 
is more lethal to the cell compared to either hydrogen peroxide or peracetic acid (151). 
Nde et al., tested the response of P. aeruginosa to ortho-phenylphenol (OPP) 
(153), a widely used disinfectant and antimicrobial agent whose mode of action on 
bacteria has not yet been elucidated. Using two different exposure times (15 minutes and 
60 minutes), they identified genes coding for virulence, membrane and ribosomal 
proteins upregulated at both time points. Forty-five genes of the translation, post-
translation modification and degradation were upregulated, primarily initiation, 
elongation and release factors (153). Genes encoding components of the SecY system, 
involved in export of various proteins, toxins and enzymes, showed enhanced expression 
as were some membrane associated proteins involved in small molecule transport, 
possibly indicating that the OPP-treated bacteria were transporting proteins across the 
cell membrane as part of an adaptive process. Also upregulated were genes of type IV pili 
assembly proteins, fatty acid biosynthesis and energy metabolism, all of which indicate 
adaptation (153).  
 
 
P. aeruginosa and pentachlorophenol stress 
Response of P. aeruginosa to pentachlorophenol (PCP) was carried out recently 
(154). PCP is thought to embed in the membrane where it acts as a proton shuttle 
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uncoupling oxidative phosphorylation (155). In addition, since RpoS is the stationary 
phase sigma factor thought to be an important factor in the cell’s stress response, rpoS 
mutants were also examined under the same conditions. Sixty genes showed two-fold or 
greater increase in transcription. RpoS did not play a protective role in the cell’s response 
to PCP-induced stress. The highlight of this study is the induction of multiple operons 
involved in multidrug efflux, the first anthropogenic induction of the MexAB-OprM 
system with chemicals. Notably, two operons of the resistance-nodulation-cell division 
(RND) pumps were upregulated in addition to one operon that positively regulates 
MexAB-OprM. These are involved in antibiotic and solvent efflux. Putative major 
facilitator superfamily (MFS) proteins were also upregulated in response to PCP-induced 
stress. Selective downregulation of genes involved in central metabolism, fatty acid 
metabolism, energy metabolism and adaptation/ protection was observed (154). 
P. aeruginosa response to copper 
Copper is one of the essential micronutrients playing an important role in cellular 
respiration, as part of electron transport and many biological reactions (156). Bacteria 
have to tightly control cellular levels of copper to prevent toxicity or starvation. Two 
studies looked at how P. aeruginosa responds to varying levels of copper.  
Tietzal et al., identified 41 genes that form a core response of P. aeruginosa to 
copper, comparing transcriptomes of cells exposed to high levels of copper either for a 
short time (copper-shocked, 405 genes) to those grown in copper [copper-adapted, 331 
genes; (157)]. Genes involved in active efflux of copper included transporters, copper 
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oxidase, periplasmic thiol-disulfide interchange proteins, lyases, and transcriptional 
regulators. 
Copper starvation of P. aeruginosa under aerobic conditions (158) led to 
downregulation of 132 genes while only 10 genes were upregulated. The most strongly 
downregulated genes were the iron acquisition genes, mostly those repressed by Fur, the 
iron-uptake regulator. One of the downregulated transcriptional regulators, PA3410, 
encodes a probable extracellular sigma factor (157). The upregulated genes included 
mostly hypothetical genes, and a bacterioferritin involved in iron storage. In fact, copper 
starvation and iron depletion (144,145) led to the expression of similar sets of genes but 
have opposite effects on them. 
P. aeruginosa and sulfate starvation 
The CF lung mucin is highly sulfated, probably a defense mechanism to prevent 
degradation by bacterial enzymes (159,160). The metabolically versatile P. aeruginosa 
can utilize a variety of organic and inorganic compounds for growth. Under limiting 
conditions of inorganic sulfate, the cells can uptake organosulfur compounds for growth 
without affecting the growth rate (161). Global response to sulfate starvation on a non-
mucoid CF isolate of P. aeruginosa E601 and PAO1 was addressed (162). The study was 
aimed at determining the genes regulated by sulfur supply and whether this was altered 
during CF infection, a condition simulated by exposure to mucin. Three groups of 
responses were observed: response to sulfur starvation, to mucin as a sulfur source and to 
mucin exposure (162). Functional analysis of differentially expressed genes revealed that 
both strains showed similar responses in the different functional classes, the maximally 
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regulated genes belonging to hypothetical proteins, transport of small molecules and 
putative enzymes. Unlike PAO1, the CF isolate E601 was shown to utilize mucin as a 
sulfur source. Moreover, several genes involved in the type III secretion system and 
exoenzyme S were induced, suggesting that cells recognize mucin not only as a sulfur 
source but also as a host component: a dual response (162).  
P. aeruginosa and osmotic stress 
P. aeruginosa, being a versatile pathogen, can survive in a wide range of 
environments, some of which can be osmotically stressful. Transcriptional profiling of 
osmotically-stressed P. aeruginosa was studied (163). P. aeruginosa PA14 cells, grown 
in glucose minimal media, were exposed to osmotic stress, either under steady-state 
conditions (0.3 M NaCl and 0.7 M sucrose) or osmotically up-shocked (0.3 M NaCl for a 
short time). A major difference in the expression pattern between these two conditions is 
the number of genes that are differentially regulated. While 431 genes were differentially 
regulated on osmotic up shocking, only about 100 genes were more than 3-fold regulated 
under either condition of steady-state osmotic shock. These studies led to the 
identification of a steady-state osmotic shock regulon comprised of 66 genes. Forty of 
these are virulence-associated, primarily genes of the type III secretion system, two type 
III exotoxins and two chaperones. In contrast, the osmotically up-shocked cells showed 
repression of the type III secretion system genes that the authors hypothesize to be an 
energy-saving step. In addition, the sigma factor AlgT/U, previously known to be 
induced in varied stress conditions, and genes known to be involved in osmoprotection, 
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including hydrophilins whose exact role in osmoprotection has not yet been conclusively 
proven in bacteria (164) were induced in all the conditions of osmotic shocking (163). 
P. aeruginosa and quorum sensing 
P. aeruginosa senses the cell density for coordinated expression of virulence 
factors using a global regulatory system called quorum sensing (QS). Sensing is achieved 
using small diffusible molecules that in P. aeruginosa and in other Gram-negative 
bacteria are the N- acylated homoserine lactones (165). P. aeruginosa has two N- 
acylated homoserine lactone systems, las and rhl (166). Transcriptome analyses of lasI 
rhlI mutants were performed by three groups (167-169). Two of these groups (167,168) 
identified about 300 genes that were induced by quorum sensing while the other group 
got only 163 differentially expressed genes as a result of use of more stringent criteria. 
The three studies had approximately 100 common genes and most belonged to the 
functional class of secreted factors. This group included toxins and extracellular enzymes. 
In addition, above average expression changes were seen in genes involved in 
metabolism, biosynthesis of cofactors and fatty acid metabolism, implying that QS 
signals mediated by N- acylated homoserine lactones were involved in regulation of 
many genes other than those involved in virulence. The third group, Hentzer et al., 
targeted the QS system in an attempt to mitigate P. aeruginosa virulence (169) using a 
furanone isolated from the Australian seaweed Delisea pulchra. The authors elegantly 
show using transcriptome analyses that about 80% of the genes that were downregulated 
by the furanone were also repressed in an N- acylated homoserine lactones mutant. The 
furanone compound also affected biofilm formation and persistence of infection in a 
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mouse lung model. The three studies together led to he identification of a core set of 77 
genes of the QS regulon that are positively regulated (169). Schuster and Greenberg (170) 
review many other studies of regulators that further elucidate the complex QS system and 
the intricate interconnections. They propose a complex network that involves 13 different 
regulators that interact with LasI and RhlI and form the QS regulon.  
P. aeruginosa biofilms 
Quorum sensing has been implicated to be an important step in the formation of 
ordered, antibiotic-resistant bacterial communities called biofilms (171,172). Planktonic 
cells, in response to external stimuli, form biofilms in varied habitats, like in the CF lung, 
surgical implants and in various environmental situations exhibiting drastically altered 
physiology that lead to the hypothesis that the gene expression between these two states 
of cells are very different. One of the earliest studies that employed microarrays to 
understand differences in gene expression patterns between planktonic and biofilm cells, 
in addition to antibiotic resistance mechanisms in biofilms, was by Whiteley et al (173). 
Using chemostats, it was found that a surprisingly small number (1%) of genes were 
differentially regulated between planktonic and biofilm cells. The most highly 
upregulated genes were those of the Pf1-like prophage with nine of the 11 genes on the 
chromosome induced over 100-1000 fold in the biofilm cells. This could imply higher 
rates of gene transfer in biofilms via transduction. Genes involved in bacterial motility 
were repressed, as was rpoS, the stationary phase sigma factor. Strains harboring a 
mutant rpoS were shown to form larger more drug-resistant biofilms. Exposure of the 
biofilm to the antibiotic tobramycin followed by transcriptional analysis showed tolA was 
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upregulated, which can serve as a barrier to aminoglycoside uptake. Cytochrome C 
oxidase genes were repressed, probably slowing growth, negating antibiotic effect. In 
addition, antibiotic exposure also induced two probable efflux systems and many 
hypothetical genes. 
Effect of the β-lactam imipenem on gene expression in planktonic and biofilm 
cells of P. aeruginosa was examined by Bagge et al (174). Microarray analysis of 
imipenem-exposed planktonic and biofilm cells revealed that the chromosomal ß-
lactamase ampC was overexpressed on imipenem exposure in biofilms and planktonic 
cells. Thirty-four genes were more than five-fold differentially regulated and included 
genes involved alginate production, flagella biosynthesis, cell division, peptidoglycan-
related and type 4 pili biogenesis. In addition, biofilm cells also showed enhanced 
production of alginate, unlike in the Whiteley study with tobramycin. Bagge et al could 
not ascribe higher antibiotic resistance of biofilm cells to a specific set of genes due to 
similar expression patterns in planktonic and biofilm cells (174). 
A more recent study makes a comprehensive analysis of transcriptomes of 
planktonic cultures (in log and stationary phase) and biofilms at 8, 14, 24 and 48 hours 
(microcolony and mature biofilms) using a static biofilm model (173). This study shows a 
similar gene expression pattern between developing biofilms and log phase planktonic 
cultures while mature biofilms have expression patterns similar to stationary phase cells. 
The most highly upregulated genes in biofilm cells were those of a Pf1-related temperate 
bacteriophage suggesting an important role for phage-mediated gene transfer in biofilm 
cells. Downregulated genes include those coding for pili that suggests that though pili are 
required for establishment of biofilms, they are not essential in mature biofilms. Also, 
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expression is relatively stable in developed biofilms with only 1% of the genes 
differentially expressed. This was the first study to look at global gene expression for two 
planktonic and two biofilm states of the cells and the authors have generated a 
comprehensive dataset for reference that compares transcriptomes of planktonic, 
developing and mature biofilms.  
Transcriptomics of alginate production in P. aeruginosa 
Alginate gene upregulation in P. aeruginosa is one of the primary modes of 
survival in the cystic fibrosis lung and converts the non-mucoid cells to a mucoid 
phenotype (175) as a result of over-production of the extracellular polysaccharide 
alginate. Production of alginate is part of a stress response in P. aeruginosa and is 
mediated by the alternate sigma factor AlgT/U, a sigma E homolog. AlgT/U is held 
sequestered by the anti-sigma factor MucA. Release of AlgT/U leads to alginate 
production and is part of a much larger response to help the cells adapt (176). 
Transcriptome analysis of the mucA, algT/U- mucA mutants and the wild type PAO1 
showed that alginate was upregulated in the mucA mutant where there was no control on 
AlgT/U production. This control was lost in the double mutant as expected (177). What 
was exciting was that many genes responsible for toxin production, enzymes and 
transport were also upregulated indicating that AlgT/U was part of a regulon that 
coordinated expression of many genes, ultimately enhancing P. aeruginosa survival in 
the harsh CF lung environment.  
P. aeruginosa, like other bacteria, produces flagella only when needed, for 
example in biofilm formation and has been implicated in establishing pulmonary 
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infections (178). AlgT/U was shown to negatively regulate flagella production in P. 
aeruginosa by downregulating an essential flagella regulator, FleQ (179). There are many 
regulators in flagella biosynthesis and a systematic study of several regulator mutants was 
performed by Dasgupta et al (180). Using transcriptome analysis, they found that flagella 
are assembled in a four-step process that is controlled by the sequential expression of 
different regulators.  
Lipopolysaccharides and lipoproteins as virulence determinants 
Lipopolysaccharides play a major role in P. aeruginosa virulence (181). The 
bacteria are known to modify their lipopolysaccharide layer in response to the milieu. 
Lipid A, a major constituent of the bacterial liposaccharide is hepta- or hexa-acetylated in 
strains causing acute infections while it is penta-acetylated in chronic infections like in 
the cystic fibrosis lung (182). Lipopolysaccharide changes with alginate production (183) 
and production of both of these important virulence factors are influenced by oxygen 
concentration (184,185,186). Though microarray studies that compare lipopolysaccharide 
mutants have not been published yet, Firoved et al., have demonstrated that lipoprotein 
genes are the most highly upregulated when P. aeruginosa switches over to the mucoid 
phenotype by comparing the expression patterns of a mucoid (PAO578II) and the 
isogenic non-mucoid parent [PAO6865; (187)]. Eight of the nine genes that were 
upregulated over 30-fold encoded lipoproteins, which can have toxic effects in environs 
like the cystic fibrosis lung by disrupting host Toll-like receptor 2 signaling and are also 
antigenic, activating host defense mechanisms. Citing these reasons, some of these 
lipoproteins have been termed lipotoxins (187). Elucidating mechanisms of coregulation 
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of LPS production/ modification and conversion of the strains to mucoidy would help us 
better understand the adaptation/ pathogenesis of this versatile bacterium in chronic 
infections, like in the cystic fibrosis lung. 
Transcriptome of a post transcriptional regulator 
Burrowes et al., studied the role of a small posttranscriptional regulatory protein 
RsmA (188). RsmB, a small untranslated regulatory RNA, binds RsmA limiting its 
activity (189). RsmA controls expression of many virulence genes and QS signaling 
molecule synthesis (189,190) and thus plays an important role in P. aeruginosa 
pathogenesis. Though some of the targets of RsmA were known this study focused on 
determining the direct and indirect regulatory control exerted by RsmA in P. aeruginosa 
(188). Transcriptional analysis of PAO1 and the rsmA mutant revealed that of the 506 
genes that had significantly altered expression, genes involved in iron acquisition and 
antibiotic resistance, especially genes involved in the MexEF-OprN pump were 
upregulated and genes involved in Pseudomonas quinolone signal biosynthesis, and 
motility were downregulated. The data obtained suggests that RsmA is a global regulator 
(188). 
P. aeruginosa interactions with human cells 
When a bacterium comes into contact with a host cell for the first time, there is a 
drastic change in the lifestyle of the bacteria that aid in colonization. The host, on the 
other hand, recognizes this threat and mounts an immune response. As one can predict, 
this race between the pathogen and host to outdo each other will undoubtedly be 
accompanied by changes in the gene expression profile in both organisms. Numerous 
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studies have looked at the response of the human immune system to P. aeruginosa 
exposure and we have a fairly good idea of the immune signals and molecules involved. 
One of the first studies to employ transcriptomics to investigate host responses to initial 
contact with P. aeruginosa was carried out by Ichikawa and Lory (191). Using a time 
course microarray experiment with lung epithelial cells exposed to P. aeruginosa and 
custom made cDNA microarrays containing about 1500 human clones with both 
characterized and uncharacterized genes, they determined that about 25% of the human 
genes represented on the array were differentially regulated. Of interest was a 
lipopolysaccharide-independent two-fold activation of the interferon regulatory factor-1 
gene with no activation of other downstream genes that are normally interferon-activated. 
This indicated that P. aeruginosa activation of interferon regulatory factor-1 is different 
from the normal mechanism of interferon regulatory factor-1 activation mediated by 
cognate receptor binding (191). Using a type IV pili mutant, they demonstrate that PilA is 
the ligand responsible for LPS-independent activation of interferon regulatory factor-1. 
This study demonstrates the power of microarrays in understanding host-pathogen 
interactions by elucidating potentially new signaling pathways and by characterizing 
roles of different virulence factors involved in pathogen recognition and mounting an 
immune response.  
Two other studies have employed DNA microarrays to study the interactions of P. 
aeruginosa to human epithelial cells but the results are contradictory with respect to the 
regulation of iron-responsive genes. In the first study by Frisk et al (192), P. aeruginosa 
was exposed to primary human airway epithelial cells for 4 and 12 hours in vitro and 
analyzed transcription post-exposure. Two major groups of genes were differentially 
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regulated: phosphate uptake genes were upregulated whereas iron acquisition genes were 
downregulated. This was contrary to the notion that iron is a very important limiting 
factor in the human host and one would have expected upregulation of the iron 
acquisition genes. The authors concluded that P. aeruginosa was able to acquire enough 
iron for infection that led to deregulation of those genes.  The reverse was true for 
phosphate.  
In an attempt to better understand the initial adaptation processes of P. aeruginosa, 
especially on interaction with human epithelia, a second study from the Greenberg lab 
(193) compared transcriptomes of P. aeruginosa PAO1 wild-type with a double mutant 
that was deficient in Type III secretion system and rhamnolipid biosynthesis. These two 
bacterial systems are key factors contributing to human airway epithelial cell damage. 
Strain-specific responses were seen. Whereas virulence genes like PA-1 galactophilic 
lectin were induced in the wild-type strain, alginate regulatory genes were induced in the 
mutant along with gacA (193), which is known to be upregulated in chronic P. 
aeruginosa infections (28). Also, Vfr, a known upregulated regulator in acute infections 
was downregulated indicating early stages of a chronic infection.  
In contrast to the results obtained by Frisk et al (192), the Chugani study showed 
that iron starvation genes were positively regulated indicating that the infecting cells had 
little iron to utilize. This is in concordance with the belief that infecting bacterial cells 
have little access to iron in the human body. One possible explanation for these 
discordant results, as noted by the authors, is that the epithelial cell integrity in the 
previous study could have been compromised leading to leakage of intracellular iron 
resulting in iron-replete conditions. This would explain the increased expression of iron 
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dependent genes over time seen in the Frisk study. Epithelial cell integrity was monitored 
in the Chugani study by monitoring the transepithelial electrical resistance (Rt). An 
interesting finding by Chugani et al. is that the general pattern of gene expression is 
similar to that seen in CF isolates from chronic human infections. 
Many bacteria use Type III secretion systems to inject proteins directly into host 
cells. An interesting whole genome array study by Wolfgang et al (29) looked at the 
conditions and regulatory mechanisms that control expression of the Type III secretion 
systems. They utilized the observation that Type III secretion system is induced by either 
growth in low-calcium medium or by cell contact and found eleven calcium dependent 
regulators that were involved in the process by growing cells in low calcium. Analysis of 
these proteins led to the discovery that a membrane-associated adenylate cyclase initiates 
a signaling pathway that controls expression of Type III secretion system genes (29). 
The transcriptome studies of P. aeruginosa with human cells indicate the presence 
of as yet unidentified signals, from both the host and the bacteria during interactions. 
Unraveling these signals could provide us with valuable information to effectively 
counter infections by P. aeruginosa and microarrays will undoubtedly prove vital in this 
endeavor.  
 
Comparative analysis of all transcriptomes 
 In order to better understand the response of P. aeruginosa to the different stress 
conditions, we compared significantly differentially regulated genes from the studies 
within each stress condition. This analysis was performed only for those conditions that 
had multiple studies and had publicly available gene lists. Our comparative analysis led 
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to the identification of common sets of genes that are regulated in response to each 
particular stress condition across the different studies. Additionally, we also identified 
unique genes that are specifically regulated only in individual studies. This data has been 
summarized in Table 2.1. 
 
Table 2.1: Comparative analysis of significantly differentially regulated genes from 
various studies within each condition. 
 
 
Analysis of significantly differentially regulated genes from all of the above 
studies led to the identification of 303 genes that form a core set and are differentially 
expressed in all the different conditions (Appendix; Supplementary information for 
Chapter 2, Table 1). This suggests that this set of core genes is important for maintaining 
homeostasis in P. aeruginosa. Functional categorization of the core set genes (Appendix; 
Supplementary information for Chapter 2, Figure 1) reveals that apart from the 
hypothetical genes (27%), the most highly differentially regulated genes encode 
membrane proteins (15%) followed by genes involved in transport of small molecules 
(11%), adaptation and protection (7%) and transcriptional regulators (6%) clearly 
indicating an adaptive response of P. aeruginosa to the changing environment. We then 
Stress condition # of studies 
Differentially regulated 
genes 
Common Unique 
Iron 3 69 220 
Quorum sensing 3 121 862 
Copper 2 26 209 
Oxidative stress 7 83 386 
Biofilms 3 55 650 
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compared this microarray core set of 303 genes with the core genome of P. aeruginosa 
that contains genes found in all P. aeruginosa sequenced strains (33). Most of these genes 
(90%) belong to the P. aeruginosa core genome, but we identified 29 genes belonging to 
the PAO1 accessory genome (Appendix; Supplementary information for Chapter 2, Table 
1). This set of 29 genes contains two type 4 pili-related genes, genes involved in 
adaptation and protection, membrane proteins, transport of small molecules, metabolism 
and hypothetical genes, among others. A caveat to this analysis is that unlike PAO1, the 
other sequenced P. aeruginosa genomes do not have 100% coverage.  
After subtracting the core set, we compiled sets of unique genes that are 
specifically differentially regulated in each of the conditions examined. Functional 
categorization of all the genes in the unique gene sets (Appendix; Supplementary 
information for Chapter 2, Table 2) revealed that overall, as expected, hypothetical genes 
were the most differentially regulated. In addition, genes involved in adaptation 
(membrane proteins, transport of small molecules, putative enzymes, transcriptional 
regulators and energy metabolism), showed the highest percentage of differential 
regulation.  
Table 3 (Appendix; Supplementary information for Chapter2) lists all the unique 
genes identified under the various conditions used in these studies.  In the iron studies, 
for example, genes of the secreted factors group (toxins, enzymes, alginate) constitute 7% 
of the differentially regulated genes. This supports the view that P. aeruginosa 
upregulates virulence genes in response to iron limitation to help survival in the host 
system (145). Analysis of the data from response of P. aeruginosa to copper reveals that 
33% of the differentially regulated genes are membrane proteins, much more than the 
 51
small molecule transport genes (19%) or hypothetical genes (14%) suggesting that copper 
stress primarily affects the membrane. By far, the most interesting observation was from 
the osmotic shock study. A stark contrast to the other studies, there were only a very 
small percentage of hypothetical genes (3%) that were differentially regulated. 
Transcriptional regulators (37%), protein secretion/ export apparatus (33%) and two-
component regulatory systems (10%) form over 70% of the genes differentially regulated 
under osmotic stress. The osmotic study was performed using P. aeruginosa PA14, 
which is known to be more virulent than P. aeruginosa PAO1 in a wide range of hosts 
(194-196). Since the chips used were designed for PAO1 that has 5571 ORFs as 
compared to 5905 ORFs in PA14, there could be an underrepresentation of the genes that 
are differentially regulated.  
Conclusions 
The transcriptome analysis studies that have been reviewed here provide evidence 
of the immense power of the DNA microarray. Microarray profiling generates an 
enormous amount of data that adds to our knowledge database. Genes that are 
differentially regulated by transcription factors, by host environment, by changing 
physiological conditions including response to external stimuli that could range from 
nutrients to other factors affecting growth, interactions with host cells all have been 
studied by microarrays. Analysis of transcriptome data generated in P. aeruginosa has 
been performed previously by Goodman and Lory (28), who show that about a quarter of 
the P. aeruginosa genome is differentially regulated in response to various stimuli. Our 
comparative analysis of the significantly differentially regulated genes from all these 
various studies show that about 35% of the P. aeruginosa genome (1932 genes) is 
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regulated overall. To arrive at more comprehensive understanding on how bacteria react 
to the ever-changing environment, we would need to recognize the importance of 
physiological experiments before the analysis of data, protocol standardization and 
appropriate controls.  
The next major advances in DNA microarrays would be to develop technologies 
to analyze the changing transcriptome of the host-pathogen interaction process in vivo 
that would provide us with vital clues to better understanding the organism, and the 
development of pangenome arrays that would give us insights into the workings of this 
versatile bacterium. Together, these will help devise ways to better counter P. aeruginosa 
infections.  
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Abstract  
Pseudomonas aeruginosa is found in a wide range of habitats, primarily in soil and 
water and is the epitome of opportunistic human pathogens. A myriad of virulence factors 
produced by the bacterium ensure its success as a pathogen. P. aeruginosa has one of the 
largest genomes among eubacteria and transcriptional regulators comprise about 8% of 
the genome. Sequence analysis of the regulators belonging to different families shows 
clustering while network analysis shows extensive crosstalk, and reveals empirically 
identified and novel interactions between regulators. Gene expression in P. aeruginosa is 
an intricately interlinked process and is exemplified in the regulation of virulence factor 
expression. Major regulatory processes such as quorum sensing involving multiple 
regulators translate external signals perceived by the bacterium into gene 
expression/repression via regulatory cascades. Many global regulators have been 
identified that serve to link different virulence systems. Understanding the role of the as 
yet uncharacterized transcriptional regulatory proteins will provide important insights 
into the physiology of this important human pathogen and has potential therapeutic 
implications.  
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Introduction  
Pseudomonas aeruginosa is an environmental saprophyte that can cause a number 
of opportunistic infections in humans including infections of the pulmonary and urinary 
tracts, and skin (9,11,13). It is notably known for its ability to cause acute (15,18,24,197) 
and chronic (198-200) infections. P. aeruginosa is inherently resistant to antibiotics and 
can also acquire resistance genes by horizontal gene transfer (201). The ability of P. 
aeruginosa to infect animals, nematodes, plants and insects is due to the expression of a 
wide range of virulence factors that are either cell-associated or secreted. Cell-associated 
factors are involved primarily in adherence and colonization (pili, LPS, flagella) and 
motility (type IV pili, flagella). In addition, some components have multiple functions. 
The LPS, for example induces the immune system and has been linked to dysregulation 
of the host response and sepsis (202). In chronic infections, however, LPS modifications 
have been identified that make the bacteria less ‘visible’ to the immune system (203). In 
addition, P. aeruginosa secretes a plethora of extracellular virulence factors; a majority of 
them (LasA, LasB, protease IV, exotoxinA, lipases, phospholipase C) secreted via the 
Xcp Type II secretion system (204,205). P. aeruginosa can also specifically deliver 
toxins directly into the host cell using the sophisticated type III and type VI secretion 
systems [T3SS and T6SS, respectively; (206,207)]. 
Pathogenesis of P. aeruginosa is thus due to the concerted action of multiple 
virulence mechanisms and is typically not due to the specific action of a single virulence 
factor. An intricate network of regulation involving multiple transcriptional regulators 
(transcriptional control), and small RNA-binding proteins and regulatory RNA (post-
transcriptional control) orchestrate the timed co-expression of multiple virulence 
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mechanisms. At the heart of the P. aeruginosa pathogenesis network is quorum sensing 
(QS), a system of interconnected sensors and regulators that control expression of 
virulence and other bacterial traits in a cell-density dependent manner (208). Key to the 
QS regulatory network are autoinducers (also known as quoromones): small diffusible 
chemical signals that help bacteria sense self and non-self population densities and 
coordinate expression of virulence factors under high cell numbers thus increasing the 
chances of a successful infection (208). To further enhance survival P. aeruginosa, like 
other bacteria, has evolved to combine signal recognition with transcriptional regulation 
for a quick and efficient response to changes in the environment. Critical to this process 
are the two-component systems (TCS) comprised of an inner membrane-bound sensor 
kinase that transduces the signal to a cytoplasmic response regulator, either directly or via 
a phosphorelay. In some cases, the two components are part of the same protein, the so-
called hybrid sensor kinases that are known to be critical for P. aeruginosa pathogenesis 
(209-212). Auxiliary regulators connect histidine kinases with regulatory processes 
forming three-component regulatory signaling systems (213).  
If genome sizes are any indication of complexity, P. aeruginosa is indeed a highly 
complex bacterium. With strains harboring 6-7 MB chromosomes (33,214), P. 
aeruginosa has one of the largest genomes in bacteria closely approaching that of lower 
eukaryotes such as Saccharomyces. In bacteria like P. aeruginosa, where the genome 
repertoire far exceeds many others, regulatory genes are acquired through horizontal gene 
transfer or evolution of paralogs that have new specificities for new sets of target genes. 
This is underscored by the comparative analyses of transcription factors from 175 
prokaryotic genomes showing reduced conservation as compared to their target genes 
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(215).  However, such extensive analysis still precludes our ability to predict the new 
lineage-specific transcription factors and the new interactions that continue to evolve as 
the organisms fight for their survival in a myriad of environments. Thus it is not 
surprising that a single species, such as P. aeruginosa with its ability to thrive in diverse 
environments, has a mosaic genome consisting of a conserved core component 
interrupted in each strain by combinations of specific blocks of genes (33). These strain-
specific segments of the genome are found in limited chromosomal locations, referred to 
as regions of genomic plasticity (RGP), and favors survival by enhancing the bacteria’s 
metabolic and/or virulence capabilities (33). 
Transcriptional regulation in P. aeruginosa is a complex and intricately 
interlinked process. Many ‘global’ regulators have been identified (Vfr, MvfR, AmpR, 
Rsm, LasR, RhlR) that have a profound effect on the gene expression pattern. Though 
many transcriptomic studies have looked at global scale expression of genes, 
understanding the role of transcription factors, structure-function and interaction analyses 
and the associated networks in P. aeruginosa still lags behind Escherichia coli. However, 
certain networks such as QS and alginate regulation are much better characterized in P. 
aeruginosa than in others.  
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Figure 3.1: P. aeruginosa transcriptional regulatory protein families. A total of 434 amino acid 
sequences of transcription factors (Appendix; Supplementary information for Chapter 3, Table 1) were 
aligned using ClustalW (Version 2.1.10) (216). The first tree out of 31 most parsimonious trees (length = 
69259) is shown. The consistency index is 0.155474 (0.147175), the retention index is 0.298198 
(0.218198), and the composite index is 0.046362 (0.043887) for all the sites and parsimony-informative 
sites (in parentheses). The maximum parsimony tree was obtained using the Close-Neighbor-Interchange 
algorithm (217) with search level 2 (217,218) in which the initial trees were obtained with the random 
addition of sequences (10 replicates). All alignment gaps were treated as missing data. There were a total of 
1137 positions in the final dataset, out of which 743 were parsimony informative. Phylogenetic analyses 
were conducted in MEGA4 (219). The different families that cluster together are colored. Members of 
families that do not form tight clusters (IclR, LacI/GalR, MerR, Cro-C1, CRP, ArsR, H-NS, OmpC, RpiR, 
and Dks/TraR) are colored black. 
 
 
The key to understanding P. aeruginosa pathogenesis is to have a unified view of 
how the different regulators and regulatory networks are linked. This review will focus 
on the genome composition of the transcription factors in P. aeruginosa and attempt to 
glean meaningful interactions.  
Families of transcriptional regulators in P. aeruginosa 
Transcriptional regulators are grouped into numerous families based on their 
functional domains, particularly DNA and effector binding domains. Even though many 
regulators have been studied in P. aeruginosa and in silico analyses group them into 
different families (Figure 1), experimental evidence assigning function for most of the 
434 regulators is still lacking. Phylogenetic analysis shows that not all members fall into 
tight groups indicating that sequence homology is not sufficient to cluster all the 
members (Figure 3.1). Some families, like MerR and Cro-cI (labeled in black font in 
Figure 3.1), are scattered all over the tree. Others, like the GntR family, form multiple 
clusters, while some members of well-formed clusters fall in other clusters. For example, 
PA5261 of the LysR family is grouped with one of the GntR clusters (Figure 3.1). 
Interestingly, the unclassified proteins, which do not have a known signature sequence, 
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cluster together (Figure 3.1). Experimental data such as structure analysis will help 
classify these proteins as well as the outliers into families. 
This section deals with the major transcriptional regulator families in P. 
aeruginosa PAO1 and their prominent members. The characteristics of the major families 
are listed in Table 3.1. 
LysR Family 
 LysR-type transcriptional regulators (LTTRs) are the largest family of prokaryotic 
transcriptional regulators (103,104). Many LTTRs are global activators/repressors of 
target gene expression. The targets are either divergently transcribed from them or are 
part of unlinked regulons at different locations on the chromosome (220,221). Divergent 
transcription from the target gene allows for autoregulation, though there are exceptions 
(104,105). This family is the namesake for the prototypic member LysR that activates 
lysA transcription involved in lysine biosynthesis in E. coli (222). LTTR members 
typically have a N-terminal winged helix-turn-helix (wHTH)-DNA binding domain 
(residues 1-65), C-terminus effector-binding domain (residues 100-173 and 196-206) and 
a domain that is needed for both functions (residues 227-253) (103). DNA binding, either 
as dimers or tetramers, occurs at the target promoters even in the absence of the effector 
signals. In most cases, co-inducer binding causes a change in footprint resulting in DNA 
bending and transcription activation (104).  
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Table 3.1: Characteristics of the major families of transcriptional regulators in P. aeruginosa 
Family # in P.aeruginosa 
# in 
E.coli 
DNA 
binding 
motif 
Other domains Regulation Oligomerization Prototype 
LysR 127 45 N-term wHTH 
C-term effector-binding; 
a DNA/effector-binding 
Activator/ 
repressor Dimer/tetramer E. coli LysR 
AraC/XylS 61 21 C-term HTH 
N-term 
dimerization/sugar-
binding 
Activator Dimer E. coli AraC 
TetR 39 11 N-term HTH 
C-term effector-
binding/oligomerization Repressor Dimer/octamer 
Enterobacte
rial TetR 
LuxR 32 17 C-term HTH 
N-term regulatory 
domain Activator Mutimer 
V. fisheri 
LuxR 
GntR 31 3 N-term HTH 
C-term effector-
binding/oligomerization 
Repressor/ 
activator Homodimer 
B. subtilis 
GntR 
RpoN-
binding 22 2 
C-term 
HTH 
Central RpoN-
interacting; N-term 
effector-binding 
Activator Dimer/multimer E. coli NtrC 
Cro-C1 17 3 N-term HTH C-term oligomerization Repressor Homodimer 
Phage 434 
(Cro); 
Phage 
lambda (C1) 
IclR 9 8 N-term wHTH 
C-term effector-
binding/oligomerization 
Repressor/ 
activator Dimer/tetramer E. coli IclR 
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Family # in P.aeruginosa 
# in 
E.coli 
DNA 
binding 
motif 
Other domains Regulation Oligomerization Prototype 
 AsnC 9 3 N-term HTH 
C-term effector-
binding/oligomerization 
Repressor/ 
activator Multimer 
E. coli 
AsnC 
    LacI 7 15 N-term HTH 
C-term effector-
binding/oligomerization Repressor Dimer/tetramer E. coli LacI 
    MerR 7 5 N-term HTH C-term effector-binding 
Activator/ 
repressor Dimer 
E. coli 
MerR 
ArsR 4 2 N-term HTH 
C-term effector-
binding/dimerization Repressor Homodimer E. coli ArsR 
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P. aeruginosa PAO1 has 127 LTTR members that despite controlling diverse 
functions (Appendix; Supplementary information for Chapter 3, Table 1) group together 
on amino acid sequence analysis (Figure 3.1). Though the functions of many members 
remain unknown, the few that are known are regulators of critical processes including 
virulence in P. aeruginosa. MvfR (PA1003), for example regulates QS in a LasIR/RhlIR-
independent manner by modulating PqsE (PA1000), the quinolone response signal 
protein (223,224). The chromosomal ß-lactamase regulator AmpR (PA4109) is a global 
regulator of virulence in P. aeruginosa. In addition to regulating ß-lactam and non-ß-
lactam resistance, AmpR also positively modulates expression of many acute virulence 
factors and negatively regulates chronic infection phenotypes (105,225,226). OxyR 
(PA5344) is an example of a regulator controlling expression of multiple related 
phenotypes. Under oxidative stress, OxyR enhances expression of antioxidant genes like 
katB, ahpCF and ahpB (227). In addition, OxyR also plays a role in virulence (228), 
cytotoxicity (229), pyoverdine utilization, and pyocyanin and rhamnolipid production 
(230,231). Turner et al. recently identified the bistable regulon of a LysR-type regulator 
BexR (PA2432) that regulates virulence factors like AprA (232). Other characterized 
LysR-type members include an efflux pump regulator, MexT (PA2492) that has been 
recently shown to regulate other genes (233) and MetR (PA3587), a regulator of genes 
involved in methionine synthesis (234). Except for PA0207 (RGP1), PA1223 (RGP11), 
PA2054 (RGP20), PA2056 (RGP20), and PA2220 (RGP53), all LysR members are part 
of the core genome (Appendix; Supplementary information for Chapter 3, Table 1). 
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IclR Family 
 The isocitrate lyase regulator (IclR) family controls gene expression in 
prokaryotes in a signal-dependent manner (235). IclR members are distributed in over 46 
species of eubacteria and archea and typically regulate genes and operons involved in 
carbon metabolism or virulence. In the absence of specific substrates, IclR regulators 
typically repress specific catabolic genes, and in the presence of excess signaling 
molecules, de-repress expression (236). Two domains in the protein bring about 
regulation: a winged HTH domain at the N-terminus that binds DNA, and an effector-
binding domain at the C-terminus. IclR-like regulators form dimers or tetramers and 
recognize palindromic sequences on the DNA (235). Some of the well-studied members 
of this family include the family namesake in E. coli IclR, a glyoxalate shunt repressor of 
the aceBAK operon involved in acetate utilization, the glycerol catabolism pathway 
repressor GlyR in Streptomyces coelicolor and KdgR, the pectin degradation pathway 
repressor in Erwinia chrysanthemi. A Thermatoga maritima IclR member TM0065, 
involved in xylulose metabolism was the first member of this family to be crystallized 
(237).   
P. aeruginosa PAO1 has nine IclR homologs and all of them are yet to be 
characterized. A PA0155 (PcaR) homolog in P. putida has been demonstrated to regulate 
the pca operon involved in p-hydroxybenzoate degradation by binding both the -35 and -
10 regions in the promoter (238). PA1015 is 42% similar to GlyR, a glycerol catabolic 
operon (gylABX) regulatory protein in S. coelicolor and is present immediately upstream 
of the gylABX promoter (239). In P. aeruginosa however, there is no gylABX operon in 
the immediate vicinity and the role of PA1015 remains unclear. All IclR members are 
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part of the core genome with the exception of PA3508 (RGP34) (Appendix; 
Supplementary information for Chapter 3, Table 1). 
LacI/GalR Family  
 The LacI/GalR family members are metabolic regulators in prokaryotes that 
recognize sugar inducers. The prototypic members are the E. coli lactose repressor LacI 
and the galactose operon repressor GalR (240). They are typically localized in the 
cytoplasm and possess a N-terminal HTH motif of about 50-60 residues. The C-terminus 
contains regions that are involved in oligomerization and signal molecule recognition 
(241). LacI members function as either dimers or tetramers (242). Well-studied proteins 
with a LacI-type HTH include the Bacillus subtilis CcpA and CcpB involved in 
repression of several operons (243), the Hemophilus influenzae galactose repressor GalR 
(244), the E. coli lactose operon repressor LacI (245), and the Salmonella typhimurium 
fructose repressor FruR (246).  
Five of the seven LacI homologs in P. aeruginosa, all of which are part of the 
core genome, are involved in carbohydrate transport/metabolism (Appendix; 
Supplementary information for Chapter 3, Table 1). A fructose transport repressor (FruR) 
homolog is found in P. aeruginosa PAO1 (PA3563). However, others are involved in 
virulence. NfxB (PA4600), a regulator of the MexCD-OprJ efflux pump has also been 
shown to affect motility, probably through its effect on the motility regulator MorA 
(PA4601), and QS-dependent phenotypes by inappropriate MexCD-OprJ efflux 
expression (247). Interestingly, there is another LacI-like regulator in the same locus, 
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PA4596, upstream of the MexCD-OprJ operon that is 74% similar to NfxB. Whether this 
is also involved in regulating MexCD-OprJ remains to be determined.  
PtxS (PA2259) is an example of a transcriptional regulator controlling two very 
different pathways in P. aeruginosa. It is a repressor of the exotoxin A regulator PtxR 
(PA2258) (248) not by direct binding at PptxR from which it is divergently transcribed but 
through an unknown mechanism (249). PtxS is also part of a 5-gene kgu operon 
(PA2259-PA2263) involved in 2-ketoglutonate utilization, which it regulates by binding 
to two different operator sequences (250). 
GntR Family 
The prototypic member of this family is Bacillus subtilis GntR, a repressor of the 
gluconate operon (251,252). Many of the members of this family have been shown 
experimentally to be autoregulatory, enabling the prediction of operator sites and the 
discovery of cis/trans relationships (253). This family is further subdivided into four 
major (FadR, HutC, PlmA, MocR) and two minor (YtrA, AraR) subfamilies, which 
regulate various biological processes and important bacterial metabolic pathways (254). 
DNA binding by GntR members is inducer-independent. For example, GntR binds to the 
promoter of the operon in the absence of gluconate but not in the presence (255). This 
family of proteins has a wHTH domain about 60-70 residues at the N-terminus whereas 
the C-terminus contains a subfamily-specific effector-binding domain and/or an 
oligomerization domain (252). The GntR family of regulators binds as homodimers to 
two-fold symmetric DNA elements (256,257).  
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P. aeruginosa PAO1 genome harbors 31 regulators belonging to the GntR family, 
of which many are grouped together by sequence analysis (Figure 1) and only two are 
part of RGPs (PA2032 and PA2100 in RGP20 and RGP21, respectively). Based on 
sequence analysis, six of the transcriptional regulators are presumed to be involved in 
glycolate (PA5356), lactate (PA4769), gluconate (PA2320), histidine (PA5105), 
phosphate (PA3381) and N-acetyl-D-glucosamine (PA3757) catabolism. Of the 31 only 
the role of PA5499 (Np20) has been experimentally elucidated. Expression of np20 is 
inducible in vitro by respiratory mucus, in vivo during infection of mice and was shown 
to be important in bacterial virulence in a neutropenic-mouse infection model (258). 
However, no structure-function studies are available.  
LuxR Family 
The LuxR-type transcription regulator superfamily derives its name from the 
Vibrio fisheri LuxR protein, which alters transcription in response to QS to produce 
bioluminescence (259-262). LuxR proteins contain two functional domains: a C-terminus 
HTH DNA binding domain and an N-terminal regulatory domain (263). The DNA 
binding domain consists of a four-helix bundle. The LuxR proteins bind promoters as 
multimers (264).  Based upon the N-terminus, the LuxR family may be further 
subdivided into at least four groups: the FixJ group (265-268), the LuxR group [reviewed 
in (263)], the large ATP-binding regulators of the LuxR superfamily (LAL) group 
(269,270), and the autonomous effector domain LuxR-type regulators (264,271). Many 
proteins that have been classified as LuxR superfamily members do not belong to any of 
these groups. Moreover, new groups are still being identified (272). 
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P. aeruginosa PAO1 harbors 32 members of the LuxR superfamily (Appendix; 
Supplementary information for Chapter 3, Table 1) that group together in neighbor-
joining trees (Figure 3.1). Half of these appear to belong to the FixJ group. Of these, six 
have been demonstrated to function as TCS response regulators and 10 are predicted to 
be response regulators based upon PFAM analysis (Appendix; Supplementary 
information for Chapter 3, Table 1). A LuxR member, NarL (PA3879), acting in concert 
with the sensor kinase NarX (PA3878), represses expression of proteins involved in the 
arginine fermentation pathway for ATP generation. In addition, NarL also activates 
proteins in the nitrate reductase operon (NarH, PA3874), the porin OprE (PA0291) and 
the class II ribonucleotide reductase components NrdJa (PA5497) and NrdJb [PA5496, 
(273)]. RocA1 (PA3948), and its cognate sensor kinase RocS1 (PA3946), were identified 
as regulators of fimbril cup genes [cupB and cupC, (274)]. Other studied members of this 
family include BfiR [PA4196, (275,276)], ErdR [PA3604, (277)], GacA [PA2586, (278)], 
and the QS regulators LasR (PA1430), RhlR (PA3477), QscR (PA1898), and VqsR 
(PA2591) [see section on QS below; (279-282)]. All LuxR superfamily members are 
encoded by the P. aeruginosa core genome (Appendix; Supplementary information for 
Chapter 3, Table 1). 
RpoN-Binding Family 
This family of transcriptional regulators activates the expression of genes from 
promoters recognized by core RNA polymerase associated with the alternative sigma-54 
factor (RpoN). RpoN enhancer binding proteins share a conserved domain of about 230 
residues involved in the ATP-dependent interaction with RpoN (283). The RpoN-binding 
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domain, which has ATPase activity, contains an atypical ATP-binding motif A (P-loop), 
and a motif B (284). These proteins are part of the ATPases associated with diverse 
cellular activities clan: proteins that perform chaperone-like functions and assist in the 
assembly, operation, or disassembly of protein complexes (285). 
In P. aeruginosa, there are 22 RpoN-binding proteins, encoded by the core 
genome, which are involved in the regulation of metabolism, production of the 
exopolysaccharide alginate, virulence as well as biofilm formation (Appendix; 
Supplementary information for Chapter 3, Table 1). Nine of the 22 RpoN interacting 
proteins belong to signal transduction TCS and contain an N-terminal domain that can be 
phosphorylated by a sensor-kinase protein. Almost all of these proteins possess a HTH 
DNA binding domain in their C-terminus. At least six are NtrC-like RpoN enhancer 
binding proteins (PilR-PA4547, CbrB-PA4726, NtrC-PA5125, AlgB-PA5483, MifR-
PA5511 and FleQ-PA1097).  NtrC transcriptional activators, first described in the 
regulation of nitrogen metabolism of enteric bacteria, possess three primary domains: a 
RpoN-interacting conserved central domain, a C-terminal domain which contains the 
HTH DNA binding motif and a homologous receiver N-terminal domain (286).  
The transcriptional regulator CbrB is part of the TCS CbrAB (PA4725-PA4726), 
involved in regulating the carbon-nitrogen balance in P. aeruginosa.  Phosphorylated 
CbrB activates the expression of the aot–argR operon (arginine catabolism) and the hiu 
operon (histidine catabolism) (287). Two biofilm regulators, MifR (PA5511), part of a 
signal transduction network in microcolony formation (275), and RocR of the RocSAR 
(SadARS) three-component signaling system involved in biofilm maturation (288), have 
been defined. RocSAR consists of the histidine kinase RocS1 and two response regulators, 
 70
RocA1 (PA3948) and RocR (PA3947). The RocSAR system controls bacterial biofilm 
formation and virulence gene expression by regulating the transcription of various genes, 
including the cup fimbrial-gene clusters and Type III secretion system genes (288). AlgB 
(PA5483), also a part of TCS, activates alginate production in mucoid P. aeruginosa. 
Alginate has been implicated in the pathogenesis of P. aeruginosa including resistance to 
phagocytosis and adherence mechanisms (289). 
MerR Family 
 The classical MerR proteins are dimeric transcriptional regulators of Gram-
negative mercury resistance operons present in transposons Tn21 and Tn50 (290). Like 
many of the regulators already discussed, these regulators consist of two domains, a 70-
amino acid N-terminal DNA-binding domain and a C-terminal effector-binding domain. 
The carboxy-terminus contains specific effector binding regions to respond to 
environmental stimuli such as heavy metals, oxidative stress, antibiotics or metal ions 
(290,291). The MerR proteins differ from many other classes of regulators in that they 
function as both an activator and repressor of the same gene. They achieve this by 
binding to the same cis element between -10 and -35 promoter regions containing a 
critical 19 bp region essential for MerR-dependent activation (290). MerR acts as a weak 
repressor in the absence of ligand (Hg(II)) and as an activator when bound to Hg(II) 
(292). 
 P. aeruginosa contains seven MerR regulators, two of which, SoxR (PA2273) and 
CueR (PA4778) are characterized. Like its E. coli homologue, the P. aeruginosa SoxR 
contains a [2Fe-2S] center (293). In E. coli, SoxR regulates genes involved in the 
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oxidative stress response to superoxide anions or nitric oxide by activating an AraC-type 
regulator SoxS (294,295), which is not conserved in P. aeruginosa. SoxR, however, 
binds weakly and activates transcription of the promoter from its divergently transcribed 
neighbor, PA2274, encoding a hypothetical protein (293). CueR controls a copper 
resistance regulon consisting of five operons and 11 genes (296), and is under regulation 
of LasR (PA1430), a LuxR member (296). PA3689 is similar to CadR, a MerR family 
member from P. putida involved in cadmium resistance (297). All MerR proteins are 
encoded as part of the P. aeruginosa core genome (Appendix; Supplementary 
information for Chapter 3, Table 1). 
TetR Family 
The TetR family is named after the enterobacterial TetR repressor protein that 
confers resistance to tetracycline (298) and subsequently a family profile was developed 
(299). TetR members are typically repressors that contain a 60 residue N-terminal HTH 
DNA binding domain and a C-terminus effector-binding/oligomerization domain that 
bind DNA either as dimers or octamers (300-302). TetR, a well-studied example, is a 
repressor of the enterobacterial tetracycline exporter, TetA and binds to the operator sites 
in PtetA. Binding of the tetracycline-Mg complex to DNA-bound TetR leads to depression 
of tetA and confer tetracycline resistance (303). TetR members primarily control 
multidrug efflux pumps, biosynthesis of antibiotics, catabolic pathways and virulence in 
both Gram-positive and Gram-negative bacteria.   
There are 39 TetR members in P. aeruginosa PA01, all of which are encoded by 
the core genome (Appendix; Supplementary information for Chapter 3, Table 1). The 
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expression of the MexAB-OprM efflux pump (PA0425-PA0427) that confers resistance 
to ß-lactams, in addition to diverse substrates, is under the control of two TetR members 
NalC (PA3721) and NalD (PA3574), of which NalC is thought to act via the primary 
repressor MexR (PA0424) (304-306). PsrA (PA3006) has been demonstrated to control 
expression of the P. aeruginosa T3SS (307), probably through its regulatory effect on 
RpoS (308). A TetR member, CifR (PA2931) represses expression of a toxin, CFTR 
inhibitory factor (Cif, PA2934) (309). Cif has been demonstrated to reduce expression of 
the CFTR protein in cell lines and proposed to play a role in aiding initial colonization by 
P. aeruginosa (310). CifR regulation of Cif thus aids in the later stages on infection when 
Cif function is no longer required (309). Other characterized P. aeruginosa TetR 
members (AguR-PA0294, AtuR-PA2885, DesT-PA4890, BetI-PA5374) are primarily 
metabolic repressors [Appendix; Supplementary information for Chapter 3, Table 1; 
(311-314)]. 
AraC Family 
The E. coli L-arabinose operon activator, AraC exemplifies this group of 
transcriptional regulators with which members share a 99-residue C-terminus homology 
(315-317).  AraC proteins harbor a C-terminus HTH motif, a N-terminus 
dimerization/sugar-binding domain and primarily activate expression of genes involved 
in sugar metabolism, stress response and virulence (299,318). Most AraC members, 
together with cAMP-receptor protein (CRP), activate promoters, either as monomers or 
dimers (319,320).  
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 P. aeruginosa PAO1 has 61 AraC members (Appendix; Supplementary 
information for Chapter 3, Table 1). PchR (PA4227), an AraC member, is a regulator of 
the biosynthesis of an iron uptake protein, pyochelin, and acts both as a positive and 
negative regulator of fptA (PA4221) and pchR expression (321). PchR binds to a 32 bp 
PchR box in the promoter of genes that it regulates (322). ExsA (PA1713), a Yersinia 
enterocolitica VirF homolog, was initially identified as part of a trans-regulatory locus 
involved in the expression of the T3SS effector exoenzyme S (323,324) and has since 
been shown to regulate expression of the T3SS genes (reviewed in (325). MmsR 
(PA3571) regulates the mmsAB operon (PA3569-PA3570) that encodes enzymes 
involved in valine metabolism (326). Other than PA1380 (RGP15) and PA2047 (RGP20), 
AraC protein-encoding genes belong to the core genome of P. aeruginosa (Appendix; 
Supplementary information for Chapter 3, Table 1). 
Cro-C1 Family 
This superfamily is named after the Cro and C1 repressors of the lysogenic 
phages 434 and lambda, respectively, where they are part of a binary switch that regulates 
lytic/lysogenic growth of the phage by differential binding to the operator sites (327,328). 
They generally have a 50-60 residue HTH domain at the N-terminus of the protein while 
oligomerization occurs at the C-terminus. The lambda Cro repressor is a 66 amino acid 
protein and binds DNA as a homodimer (329).  
  P. aeruginosa has 17 regulators belonging to this family, all of which are encoded 
by the core genome (Appendix; Supplementary information for Chapter 3, Table 1). 
Pyocin production in P. aeruginosa is under the tight regulation of PrtR (PA0611). As 
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part of the SOS response, RecA (PA3617) degrades PrtR, which inhibits transcription of 
the pyocin gene activator, PrtN [PA0610, (330)]. PrtR also modulates activity of a 
Dks/TraR member PtrB (PA0612), a repressor of the T3SS (331), linking secretion and 
pyocin synthesis in response to DNA damage. Two other hypothetical Cro/C1 members, 
PA0906 and PA4077 are 66% similar to PrtR, and PA4077 is co-transcribed with a 
hypothetical inner membrane protein PA4076 (332). Whether these are also involved in 
pyocin regulation is unclear. PA1359, a hypothetical regulator, bears 49% similarity to E. 
coli HipB, a known regulator of persister formation by modulation of HipA activity (333-
335). Interestingly, PA1359 is part of a two-gene operon (332), similar to the hipBA 
operon in E. coli. None of the other members of this family have been characterized in 
PAO1. 
AsnC Family 
This family of transcriptional regulators is typified by aspargine synthase C of E. 
coli and is part of the feast/famine regulatory proteins (FFRP) that includes Lrp and Asn 
(336). Members of this family are distributed in both archea and eubacteria.  They 
typically contain a HTH DNA binding domain at the N-terminus and a 
dimerization/effector-binding domain at the C-terminus, which also plays a role in 
assembly of the protein. FFRP members bind DNA as dimers, tetramers, octamers or 
hexamers (337,338) and regulate genes in response to diverse signals. Identification of 
FFRPs is often complicated by the fact that the amino acid homologies between members 
are often only about 30% (336). 
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P. aeruginosa has nine AsnC members (Appendix; Supplementary information 
for Chapter 3, Table 1), all of which except PA2028 (RGP20) are encoded by the core 
genome. PA0513, an as yet uncharacterized regulator, is part of an 11-gene nir operon 
that is involved in the denitrification pathway (339). PA0515 is also part of the same 
operon and is listed as a probable AsnC-type transcriptional regulator in the 
Pseudomonas database (332) but has been excluded from our list (Appendix; 
Supplementary information for Chapter 3, Table 1) because it lacked a DNA binding 
motif in our analysis. BkdR (PA2246) is divergently transcribed from the bkd operon that 
is involved in valine, leucine, isoleucine degradation and has been characterized in P. 
putida (340). The P. aeruginosa homolog of Lrp (PA5308), which regulates the global 
leucine response in E. coli, regulates the dadA (PA5304) and dadX (PA5302) genes that 
are required for L-alanine utilization (341).  
ArsR Family 
 The E. coli ArsR that represses the ars operon in response to arsenic is the 
prototype for this family of transcriptional repressors (342). This family of proteins binds 
the promoter region of genes that they regulate (primarily metal transport and 
detoxification) and dissociate upon effector binding due to allosteric changes, allowing 
transcription by derepression (343). The metal-binding site is at the C-terminus of the 
protein whereas the DNA binding domain is at the N-terminus. ArsR members typically 
function as homodimers (344). 
 There are four members in P. aeruginosa encoded by the core genome 
(Appendix; Supplementary information for Chapter 3, Table 1). arsR (PA2277) is part of 
 76
a four-gene cluster that has been demonstrated to confer resistance to arsenic and 
antimony when expressed in a heterologous E. coli ars mutant (345). PA0547 is an 
uncharacterized ArsR-type regulator that is part of a two-gene operon with the S-
adenosylmethionine synthetase gene, metK (PA0546). The other two ArsR members in P. 
aeruginosa are also uncharacterized (Appendix; Supplementary information for Chapter 
3, Table 1). 
Other Families 
 Other P. aeruginosa regulatory families include the Dks/TraR family (PtrB 
(PA0612) and DksA (PA4723)), H-NS silencing proteins (MvaT (PA4315) and MvaU 
(PA2667)), CRP family (Vfr- PA0652 and Anr- PA1544), OmpC family (AmgR- 
PA5200), OmpR-PhoP class (PA4381) and the RpiR family (PA5506).  
Unclassified Regulators 
 In addition to the families listed above, 37 regulators do not contain the signature 
motif for any family but still are significant contributors to the regulatory processes in P. 
aeruginosa (Appendix 2; Supplementary Table 1). Of these, 27 have been characterized. 
CreB (PA0463), the regulator of the CreBC TCS operon, along with CreD (PA0465), 
encoded immediately downstream, are involved in colicin resistance in E. coli (346). The 
CreBC TCS is involved in regulating ß-lactam resistance in Aeromonas spp. (347) while 
in P. aeruginosa it contributes to resistance only in a ∆PBP4 background (348). LexA 
(PA3007) is a repressor of RecA and is induced upon DNA damage, as part of the SOS 
response (349). IrlR (PA4885) is part of a two-component system, a homolog of which 
has been shown to be involved in heavy metal homeostasis in Alcaligenes eutrophus 
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(350). A few other members [KdpE (PA1637), DauR (PA3864), GltR (PA3192)] are 
metabolic regulators. 
P. aeruginosa transcriptional regulatory network 
Studying regulatory networks aid in elucidating interactions between the different 
transcriptional regulators and provide important insights into processes and pathways. To 
better understand regulatory networks and identify network motifs, analysis of network 
structure has proved useful. Two major network motifs that aid in bacterial response to 
environmental signals have been described: feed-forward motifs, and single-input and 
multiple-input motifs (215). Using published data on bacterial regulatory networks (215) 
and STRING analysis (351) of P. aeruginosa PAO1 regulators, a transcriptional 
regulatory network was obtained (Figure 3.2a) consisting of 288 regulators and 593 target 
genes. As seen in regulatory networks in other bacteria (215), the P. aeruginosa network 
also consists of feed-forward motifs, and single- and multiple-input motifs  (Figure 3.2a). 
Vfr (PA0652), the P. aeruginosa homolog of E. coli cyclic AMP receptor protein and a 
regulator of virulence and QS, has the highest number of interacting partners, followed 
by the anaerobic growth and cyanide synthesis regulator Anr, an E. coli Fnr homolog 
(Figure 3.2a). Interestingly, both these regulators belong to the diverse Crp family of 
transcriptional regulators that have a N-terminal nucleotide-binding domain similar to 
CRP, in addition to a C-terminus HTH (352).  
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Figure 3.2a: Transcriptional regulators and interacting partners. Previously inferred regulators of P. 
aeruginosa (215) and those obtained by text mining using STRING (351) analysis, were used to construct 
the transcriptional regulatory network using Cytoscape (Version 2.7.0) (353). The network consists of 288 
regulators and 593 target genes resulting in 1095 interactions. The transcriptional regulators with the 
highest interactions are shown in the figure (See also Appendix; Supplementary information for Chapter 3, 
Table 2). 
Figure 3.2b: Interactions among transcriptional regulators. VisANT [Version 3.86; (354)] was used to 
visualize a total of 63 interactions between the regulators from the 1095 interactions of Fig 2a.  Vfr 
emerges as the key regulator. Other interactions such as the pyocin induction network and an 
uncharacterized network appear isolated from these interactions. 
 
 
Conclusions about hierarchy among the regulators are difficult to draw from this 
network but we used the data to identify interactions between the regulators alone 
without their corresponding target genes. The Vfr regulatory hub stood out in this 
analysis (Figure 3.2b). Vfr has been demonstrated experimentally to regulate multiple 
virulence mechanisms in P. aeruginosa. Network analysis shows that Vfr is linked to 
various other critical pathogenesis networks including alginate production, efflux systems, 
quorum sensing, iron uptake, flagella, T3SS, and metabolic regulons (Figure 3.2b). While 
some of these links have already been established (355-357), it would be interesting to 
see whether the other interactions pan out. Our Cytoscape analysis also revealed the 
established interactions between PrtR, PrtN and PtrB to regulate pyocin production and 
T3SS in P. aeruginosa [Figure 3.2b; (330,331)]. Moreover, PA5157, an uncharacterized 
regulator that bears 60% similarity to the E. coli MarR protein involved in regulating 
multiple antibiotic resistance and oxidative stress (358), interacts with three other 
hypothetical regulators PA1619, PA3898 and PA2028 (Figure 3.2b). Whether these 
genes are part of a network contributing to the antibiotic resistance profile of P. 
aeruginosa is not known. 
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Virulence regulatory systems in P. aeruginosa 
Network modeling, while providing us with a framework to study, has its 
limitations in requiring confirmation. The absolute proof of a regulatory interaction 
comes from empirical data, which serves to either confirm or negate findings from the 
bioinformatics analyses. We chose the QS system in P. aeruginosa, to highlight the 
similarities in complexity between modeled and established regulatory networks. 
Quorum sensing (QS) 
QS, a cell population density-dependent signaling system important in host-
pathogen interaction, is involved in regulating virulence factor production, swarming 
motility, biofilm maturation, and efflux pump expression (reviewed in (208)). Two types 
of QS signals are produced by P. aeruginosa, N-acylhomoserine lactones and 4-
quinolones (359-361). Central to N-acylhomoserine lactone QS signaling are LasR  
(PA1430) and RhlR (PA3477), two LuxR-type regulators that respectively bind N-(3-
oxododecanoylhomoserine lactone (3-oxo-C12-HSL) and N-butanoylhomoserine lactone 
(C4-HSL) (359,360). These HSLs are synthesized by the cognate synthetases, LasI and 
RhlI (279,362). Expression of lasI and rhlI is regulated by positive feedback loops 
mediated by 3-oxo-C12-HSL:LasR and C4-HSL:RhlR. LasR is higher up in the P. 
aeruginosa QS hierarchy and 3-oxo-C12-HSL:LasR activates rhlR and rhlI expression 
(363,364). The binding site for LasR and RhlR has been termed the las-rhl box [CT-N12-
AG; (365,366)] and LasR binding sites have been identified in the promoters of many 
genes including known and putative regulators such as MvfR (PA1003), RsaL (PA1431), 
VqsR (PA2591), RhlR (PA3477), PvdS (PA2426), AmrZ (PA3385), PA2588, PA4778, 
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and PA1760 (365). In addition, three microarray studies identified a common set of 102 
genes in the LasR/RhlR regulons (167-170,367).   
Most QS-regulated genes are expressed during stationary phase and are dependent 
on the stationary phase sigma factor RpoS (PA3622, (366,368)). Several additional 
regulators also play a role in QS (Figure 3.3). Vfr binds and activates transcription of 
PlasR (369) and PrhlR (370), and represses the 4-hydroxy-2-quinolone-dependent QS 
pathway (371). Transcriptome analysis indicates that Vfr affects the expression of more 
than 100 genes in P. aeruginosa including T3SS genes (29). RsaL (PA1431), which is 
divergently transcribed from the lasI gene, encodes an autoregulating repressor that 
inhibits not only lasI transcription, but also genes involved in pyocyanin and cyanide 
synthesis (372,373). Interestingly, RsaL repression is dominant over 3-oxo-C12-
HSL:LasR activation of lasI to counteract the positive feedback loop (372). RsaL binds 
as a dimer (373) and regulates expression of 130 genes, including those involved in 
virulence, independent of its QS effect (373). Another transcription factor that appears to 
co-regulate QS genes with LasR and RhlR is the anaerobic regulator Anr (PA1544). 
Together with LasR and RhlR, Anr directly activates the hydrogen cyanide biosynthetic 
hcnABC genes [PA2193-PA2195, (374)]. Bioinformatic analysis identified putative Anr 
consensus binding sites, the Fnr/Anr box, in about 25% of QS regulated genes, 
suggesting that Anr may regulate these genes under oxygen limiting conditions (170). 
Interestingly, studies suggest that the growth conditions affect the las-rhl hierarchy 
(375,376).  
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Figure 3.3: Association between QS regulators in P. aeruginosa. Interactions between the different 
transcriptional regulators (blue boxes) and sigma factors (yellow boxes) to control QS gene expression are 
depicted. The regulation is positive (green lines), negative (red lines), or both (black lines) and can be 
direct or indirect. PQS refers to the Pseudomonas quinolone signaling molecule. See text for details and 
references of individual interactions.  
 
 
 
 P. aeruginosa synthesizes over 50 4-quinolones, however, two, 2-heptyl-4-
quinolone (HHQ) and 2-heptyl-3-hydroxy-4-quinolone (PQS) have been shown to act as 
QS signals (361,377,378). Synthesis of these 4-quinolones is dependent upon the 
pqsABCDE (PA0996-PA1000) and phnAB (PA1001-PA1002) operons (377). The pqsE 
gene is dispensible for 4-quinolone synthesis but is required for virulence (379,380). A 
LTTR member, MvfR (also known as PqsR; PA1003), regulates the pqs operon (381). 
MvfR expression is positively regulated by LasR:3-oxo-C12-HSL, and negatively 
regulated by RhlR (382) and the PqsR-mediated PQS regulator, PmpR (PA0964, (383)). 
Transcriptome analysis revealed an extensive MvfR regulon that includes RsaL (PA1431), 
AlgT/U (PA0762), RsmA (PA0905), and LasR (PA1430) (224). Promoter binding of 
MvfR is enhanced by either HHQ or PQS (381). HHQ is converted to PQS by PqsH 
(PA2587) whose expression is LasR:3-oxo-C12-HSL-dependent (377,380). PQS differs 
from HHQ in that it can sequester iron and induce an iron starvation response by 
activating genes involved in siderophore biosynthesis and iron scavenging (378,384). 
Thus PQS affects gene expression in multiple ways: mvfR- and pqsE-dependent 
expression, mvfR-dependent and pqsE-independent expression, and through iron 
sequestration in a mvfR- and pqsE-independent manner (378). 
 QscR (PA1898) and VqsR (PA2591) are two additional LuxR-type QS regulators 
in P. aeruginosa (Figure 3.3). QscR closely resembles the HSL-responsive LuxR 
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homologues and has been proposed to control the timing of QS-regulated genes by 
repressing lasI expression (280).  Transcriptome analysis identified 400 genes as being 
part of the QscR regulon (385). Additional experiments suggest that QscR can also act by 
mediating a response to 3-oxo-C10-HSL produced by other bacteria or form heterodimers 
with LasR or RhlR (386). The vqsR promoter contains a las-rhl box and in vivo 
occupancy of LasR has been demonstrated (282,365). Consistent with this finding, vqsR 
mutants failed to produce C4-HSL or 3-oxo-C12-HSL, showed reduced pyocyanin and 
protease production, and reduced virulence in a C. elegans model system due to a 
negative impact on expression of the QS regulon (282). VqsR functions downstream of 
VqsM (PA2227), an AraC type regulator (282,387). Mutation in vqsM reduced 
expression of rhlR, rsaL, vqsR, mvfR, pprB, rpoS, lasI and rhlI (387).  
Other regulators have also been implicated in QS signaling. Mutations in the gene 
encoding the FIS regulator, PA1196, downregulate expression of rhlI and rhlR in addition 
to pqsA, which encodes the enzyme that modifies anthranilate for entry into the 
Pseudomonas quinolone signal (PQS) biosynthetic pathway (388). Transposon 
insertional mutants of PA5499 (np20) reduce rhlI expression as well as phenazine and 
cyanide production (380). Mutations in a LTTR AmpR have also been shown to 
modulate QS activity, linking QS with ß-lactam resistance in P. aeruginosa 
(105,225,226). 
  QS is also regulated post-transcriptionally through the action of the small 
regulatory RNAs, rsmZ (PA3621.1) and rsmY (PA0527.1) (389,390). rsmYZ antagonize 
the RNA-binding protein RsmA (PA0905), which negatively regulates QS genes. The 
GacSA two-component system is activated at high cell densities and most of the effects 
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of the Gac/Rsm pathway on QS can be attributed to increased C4-HSL levels (389,391). 
QteE (PA2593), though not a transcriptional regulator, controls the QS threshold by 
lowering LasR protein stability without affecting lasR transcription or translation, and by 
reducing RhlR levels (392). The stringent response also affects the QS regulon. Under 
starvation conditions, RelA (PA0934) enhances production of guanosine tetraphosphate 
(ppGpp) (393). Overexpression of RelA, also caused by decreased membrane fluidity 
(394), resulted in premature expression of rpoS, lasR and rhlR and premature synthesis of 
3-oxo-C12-HSL and C4-HSL (395). Both expression and stringent response of 
expression of 3-oxo-C12-HSL is induced by a serine animo acid analogue (395).   
Although there have been many advances, much remains unknown in our 
understanding of QS regulation in P. aeruginosa. Recent studies by Chugani and 
Greenberg showed that a lasR, rhlR, and qscR triple mutant retained the ability to 
regulate 37 genes, including those in the kynurenine pathway, in response to 
acylhomoserine lactones (396). The kynurenine pathway serves as the source of 
anthranilate for the synthesis of the PQS (396,397). 
Conclusions and perspectives 
 Computational analyses and mathematical models have greatly advanced our 
understanding of regulatory networks (215,398,399), some of which have been confirmed 
by empirical data. Our enhanced understanding of gene regulation in bacteria has come a 
far way from transcriptional regulators alone, as traditionally thought, to include post-
transcriptional and post-translational control, including regulatory RNAs, RNA-binding 
proteins, sigma factors, DNA supercoiling, proteolysis and others. In P. aeruginosa, as 
with numerous other bacteria, a majority of the transcriptional regulators and open 
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reading frames have yet to be characterized in terms of gene function and mode of 
regulation, which in itself undermines our efforts in predicting gene networks. 
Nevertheless, such models provide us with insight into potential interactions and give us 
a framework to design experiments to elucidate complex networks, and further reinforce 
empirical data. In addition, they also help identify paralogs and orthologs between genera. 
The wealth of data that we now possess from numerous P. aeruginosa whole genome 
transcriptome analyses [reviewed in (28,400)], though critical in our understanding of the 
system and in identifying potential therapeutic targets, further expose the gap in our 
knowledge in accurately determining links between signals recognized by the regulators 
and how they are transduced to their target genes. Analysis of regulator-mutant 
transcriptomes helps fill in the gap, but warrant further studies, especially in linking 
metabolic regulation with virulence. It is exciting to know that complementing data from 
traditional molecular biological experiments with data from high-throughput, whole 
genome analyses such as microarray, RNA deep sequencing, and network modeling will 
undoubtedly advance our understanding of how bacteria regulate gene expression, as 
individuals and as communities in response to environmental signals. 
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Abstract 
In Enterobacteriaceae, the transcriptional regulator AmpR, a member of the 
LysR family, regulates the expression of a chromosomal β-lactamase AmpC. The 
regulatory repertoire of AmpR is broader in Pseudomonas aeruginosa, an opportunistic 
pathogen responsible for numerous acute and chronic infections including cystic fibrosis. 
In addition to regulating ampC, P. aeruginosa AmpR regulates the sigma factor AlgT/U 
and production of some quorum sensing (QS)-regulated virulence factors. In order to 
better understand the ampR regulon, we compared the transcriptional profile generated 
using DNA microarrays of the prototypic P. aeruginosa PAO1 strain with its 
isogenic ampR deletion mutant, PAO∆ampR. Transcriptome analysis demonstrates that 
the AmpR regulon is much more extensive than previously thought, with the deletion 
of ampR influencing the differential expression of over 500 genes. In addition to 
regulating resistance to β-lactam antibiotics via AmpC, AmpR also regulates non-β-
lactam antibiotic resistance by modulating the MexEF-OprN efflux pump. Other 
virulence mechanisms including biofilm formation and QS-regulated acute virulence 
factors are AmpR-regulated. Real-time PCR and phenotypic assays confirmed the 
microarray data. Further, using a Caenorhabditis elegans model, we demonstrate that a 
functional AmpR is required for P. aeruginosa pathogenicity. AmpR, a member of the 
core genome, also regulates genes in the regions of genome plasticity that are acquired by 
horizontal gene transfer. Further, we show differential regulation of other transcriptional 
regulators and sigma factors by AmpR, accounting for the extensive AmpR regulon. The 
data demonstrates that AmpR functions as a global regulator in P. aeruginosa and is a 
positive regulator of acute virulence while negatively regulating biofilm formation, a 
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chronic infection phenotype. Unraveling this complex regulatory circuit will provide a 
better understanding of the bacterial response to antibiotics and how the organism 
coordinately regulates a myriad of virulence factors in response to antibiotic exposure. 
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Introduction 
Pseudomonas aeruginosa is one of the leading opportunistic Gram-negative 
nosocomial pathogens. This is particularly true in critically ill patients, where multi-drug 
resistant P. aeruginosa is a severe problem. It is the leading pathogen in ventilator-
associated pneumonia with a mortality rate of 40-60% (401). P. aeruginosa is also a 
primary cause of urinary tract infections in the US and Europe (402), wound infections 
leading to bacteremia with one-third to two-thirds mortality rate (403,404), pulmonary 
infections including cystic fibrosis (CF) (405), lung cancer patients (19) and in pediatric 
and adult AIDS patients (22). Inability to eradicate the infection is partly due to intrinsic 
and acquired antibiotic resistance of P. aeruginosa. Antibiotic resistant isolates of P. 
aeruginosa are selectively favored in vivo in CF patients (85,86). Resistance of P. 
aeruginosa to the β-lactam class of antibiotics, currently used to treat P. aeruginosa 
infections, is partly mediated by a group of genes belonging to the amp system.  
The amp genes were first discovered in Enterobacter cloacae to confer resistance 
to β-lactams (93) and later in other members of Enterobacteriaceae (94-97). The 
products of amp genes in E. cloacae and other organisms include the AmpC β-lactamase, 
the AmpG permease, a putative AmpE permease, the AmpD cytoplasmic amidase, and 
the transcriptional regulator AmpR (93-97). Recent studies have identified another 
permease, AmpP that is required for β-lactamase induction in P. aeruginosa (406). 
Expression of ampC is regulated by AmpR. The ampR gene is located adjacent to ampC 
and is divergently transcribed in C. freundii and E. cloacae, as well as in P. aeruginosa 
(98-100). AmpR of C. freundii and E. cloacae can cross-complement each other (101) 
and P. aeruginosa AmpR is similar to that found in C. freundii (58%) and E. cloacae 
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(62%) (102). In C. freundii, AmpR binds to a 15 bp sequence 5’ TCTGCTGCAAATTT 3’ 
(98,102) and there is a nearly identical putative AmpR binding site (5’ 
TCTGCTCCAAATTT 3’) in the ampR-ampC intergenic region in P. aeruginosa (105). 
AmpR has a helix-turn-helix motif that is typical of DNA-binding proteins and the C. 
freundii AmpR binds DNA using this motif (98). The AmpR-AmpC system is also 
conserved in many other pathogens including Burkholderia cenocepacia (407), Yersinia 
enterocolitica (408), and Stenotrophomonas maltophilia (409).  
AmpR belongs to the LysR family of transcriptional regulators that typically 
autorepress their own expression (103) which has been demonstrated in C. freundii (98). 
In P. aeruginosa, however, there is no evidence of autoregulation (105). It has been 
postulated that the signals mediating ampC regulation by AmpR are peptidoglycan 
degradation products that function as effector molecules and are brought into the cell 
cytoplasm from their point of origin in the periplasm via the AmpG permease (79). In 
vitro studies have demonstrated that C. freundii AmpR can both activate and repress 
ampC expression depending on its interaction with specific peptidoglycan degradation 
products (410). Thus the levels of these cell wall intermediates dictate AmpR regulation 
of ampC and the known regulatory repertoire of AmpR in Enterobacteriaceae have been 
limited to regulating ampC expression (79,95,410). Previous studies comparing the 
properties of P. aeruginosa PAO1 with its isogenic ampR insertion mutant, 
PAOampR::aacC1, have shown that AmpR regulates ampC as well as some quorum 
sensing (QS) genes (105). This led us to hypothesize that the regulatory role of P. 
aeruginosa AmpR is more extensive than previously thought. 
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To test the hypothesis that AmpR regulates different pathways in P. aeruginosa 
and to identify the AmpR regulon, we compared the expression profile of wild-type 
PAO1 and that of an in-frame ampR deletion mutant, PAO∆ampR, with and without sub-
MIC β-lactam stress. Our data suggests that P. aeruginosa AmpR is a master regulator 
affecting the expression of over 500 genes. Functional analyses demonstrate the negative 
regulatory role of AmpR of multiple virulence mechanisms including biofilm formation 
and the MexEF-OprN multidrug efflux pump. Further, we demonstrate that AmpR 
positively regulates multiple acute virulence factors. Using a C. elegans model, we 
demonstrate that AmpR is required for pathogenesis in P. aeruginosa. This study 
establishes the critical regulatory role that AmpR plays in antibiotic resistance, virulence 
and general metabolism in P. aeruginosa.  
Results 
Deletion of ampR reduces β-lactam resistance of PAO1 
 In contrast to previous studies that looked at the role of P. aeruginosa AmpR 
using an insertion mutant, this study employed PAO∆ampR, an in-frame deletion mutant 
in the prototypic P. aeruginosa PAO1. The presence of the ampR deletion was confirmed 
by PCR and restriction digestion of the amplicons (data not shown). AmpR is a known 
positive regulator of the chromosomal AmpC β-lactamase in different bacterial species 
(96,102,411). Consequently, after constructing PAO∆ampR, the strains were tested for 
altered production of β-lactamase. The resistance profile of β-lactam antibiotics for 
PAO1, PAO∆ampR and PAO∆ampR (pAmpR) shows that, as expected, loss of ampR 
enhances strain sensitivity to β-lactams and expressing ampR in trans on a low-copy 
plasmid can restore this defect with multiple β-lactam antibiotics (Fig 4.1a). Loss of 
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ampR seems to have a stronger effect on penicillins (ampicillin, amoxicillin and 
piperacillin, with and without β-lactamase inhibitors), imipenem and tazobactam than the 
cephalosporins tested. This finding is interesting because AmpC is a cephalosporinase. 
Overexpression of ampC under Ptac control, however, results in enhanced resistance to the 
cephalosporin ceftazidime (D. Zincke, personal communication). β-Lactamase 
quantification showed that PAO∆ampR produced significantly lower amounts in response 
to β-lactam stress compared to PAO1 (PAO1: 11.27 mU vs. PAO∆ampR: 6.5 mU, p 
value 0.0003; Fig 4.1b), which is in agreement with the E-test data. The loss of induction 
was recovered by expressing ampR from a low-copy plasmid (PAO∆ampR: 6.5 mU vs. 
PAO∆ampR (pAmpR): 11.35 mU, p value 0.004; Fig 4.1b). These data clearly reiterate 
the role of AmpR in β-lactam resistance in P. aeruginosa as previously described (105). 
The PAO∆ampR strain was used for all further assays. 
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Figure 4.1. Antibiotic resistance profile of PAO∆ampR. A clean in-frame deletion of ampR was 
generated in P. aeruginosa PAO1 as described in the methods section to generate PAO∆ampR. Fig 4.1a 
shows the resistance profile of the strains to the four major classes of β-lactam antibiotics. Representative 
data from three different biological replicate trials are shown. The amount of β-lactamase produced was 
quantified (Fig 4.1b) in the presence (+) and absence (-) of sub-MIC concentration of a β-lactam inducer. 
 
 
Loss of ampR affects ability of PAO1 to kill C. elegans 
The importance of ampR in virulence was determined in a C. elegans model, as 
reported previously (412,413). Using the fast killing (paralytic) assay, we monitored the 
ability of PAO1 and its isogenic ampR mutant, PAO∆ampR to kill C. elegans over eight 
hours. PAO∆ampR showed reduced pathogenicity, killing only 15% of the nematodes 
compared to the 38% killed by the wild-type PAO1 at the end of the study period (p 
value < 0.05 at all time points; Fig 4.2). The results indicate that a functional AmpR is 
required for full pathogenicity of P. aeruginosa in the nematode model. To characterize 
the full extent of AmpR-mediated regulation of P. aeruginosa pathogenesis, we analyzed 
PAO∆ampR further.
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Figure 4.2. Effect of ampR deletion on pathogenicity to C. elegans. The fast killing assay was used to test the effect of loss of ampR on the C. elegans 
killing ability of PAO1. p-value < 0.05 at all time points. 
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AmpR regulates numerous genes in P. aeruginosa 
Using DNA microarrays, we compared the expression profiles of PAO1 and 
PAO∆ampR, without (uninduced) and with (induced) sub-MIC β-lactam stress to identify 
genes that are regulated under the different conditions. Pair-wise comparisons of the 
datasets of significantly differentially regulated genes (p value < 0.01, > two-fold) either 
with or without sub-MIC β-lactam stress led to the identification of 32 genes (PAO1 
uninduced vs. PAO1 induced; Condition A), 258 genes (PAO∆ampR uninduced vs. 
PAO∆ampR induced; Condition B), 345 genes (PAO1 uninduced vs. PAO∆ampR 
uninduced; Condition C) and 338 genes (PAO1 induced vs. PAO∆ampR induced; 
Condition D) (Fig 4.3). As seen in Fig 4.3, the expression of 345 genes is altered in the 
absence of AmpR (Condition C), clearly indicating that AmpR influences the expression 
of numerous genes in P. aeruginosa.  
Quantitative real-time PCR (qPCR) was used to verify the microarray results. 
Genes for the verification analysis were selected across the spectrum of regulation, based 
on the raw microarray reads after normalization, including both up and downregulated 
genes. Twelve genes were selected for initial qPCR analysis, six each from the up and 
downregulated sets, using clpX (PA1802) as the reference control gene since clpX 
expression did not change in our microarray data between the strains and conditions 
tested. qPCR data showed the same trend of either up- or downregulation of the genes as 
in the microarray, validating our microarray observations, notwithstanding the variations 
expected due to differences in the sensitivity of the two assays (Table 4.1).
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Figure 4.3. Scatter plots of significantly regulated genes. Only genes that showed significant (p < 0.01) differential regulation under the various 
conditions are depicted as colored squares. The colors represent the extent of gene expression from low (blue) to high (red) in either condition, as depicted in 
the color scale. The two outer green diagonal lines in each plot represent the two-fold cutoff. Each sub-plot depicts the differential gene expression between 
two strains/conditions (shown along the plot axes): Condition A- PAO1 uninduced vs. PAO1 induced; Condition B- PAO∆ampR uninduced vs. PAO∆ampR 
induced; Condition C- PAO1 uninduced vs. PAO∆ampR uninduced; Condition D- PAO1 induced vs. PAO∆ampR induced. 
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Table 4.1: Microarray vs. qPCR. Confirmation of microarray data was performed by 
qPCR, using RNA isolated from cells as explained in the text. Data shown is gene 
expression in penicillin non-treated PAO∆ampR cells, normalized to expression in PAO1. 
 
 
Locus ID/ Gene 
Fold change 
Microarray qPCR 
PA0610/ prtN 12 6 
PA0762/ algU 5 3 
PA3602 5 10 
PA2493/ mexE 108 8089 
PA4121 7 2 
PA1708/ popB -8 -4 
PA2193/ hcnA -7 -3 
PA1078/ flgC -5 -2 
PA2069 -38 -93 
PA2331 -7 -40 
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AmpR regulates genes both in the absence and presence of β-lactam stress 
Subsets of genes that are differentially regulated either due to loss of ampR or due 
to β-lactam antibiotic exposure or both (Fig 4.3) could potentially be regulated under 
more than one condition and this overlap would be misinterpreted in the total number of 
genes regulated in each condition. To address this issue, the 973 differentially regulated 
genes (p < 0.01, FC > 2-fold) in the four pair-wise comparisons (Conditions A-D in Fig 
4.3) were plotted in 4-way Venn diagrams and separated into upregulated (Fig 4.4a) and 
downregulated (Fig 4.4b) genes.   
From these two Venn diagrams, genes that were dependent exclusively on either 
AmpR or β-lactams or on both were identified. Comparison of Conditions A and B yield 
genes unique to each condition (U1, D1 and U2, D2 respectively in Fig 4.4a-4.4b). There 
are 18 upregulated genes (U1 in Fig 4.4a) that are unique to Condition A (response of 
PAO1 to β-lactam stress). This includes AmpR-dependent genes (there is a functional 
AmpR in these strains that helps in the response to β-lactams) and AmpR-independent 
genes (some of these genes may be regulated in an AmpR-independent manner). In 
contrast, in Condition B (response of PAO∆ampR to β-lactam stress), 61 genes are 
upregulated in response to antibiotics (U2 in Fig 4.4a). AmpR may negatively regulate 
these genes, since their expression is enhanced in the absence of AmpR, or their 
expression is AmpR-independent. The observation that loss of ampR leads altered gene 
expression in PAO1 in response to sub-MIC β-lactam stress (similar to that seen in the 
absence of β-lactam stress) further hints at a global regulatory role for AmpR in P. 
aeruginosa.  
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Figure 4.4. Venn diagram of the differentially regulated genes. Distribution of significantly (p < 0.01) 
differentially regulated (>2-fold) genes in PAO1 and PAO∆ampR with (induced) and without (uninduced) 
β-lactam treatment showing upregulated (Fig 4.4a) and downregulated (Fig 4.4b) genes. The transcriptional 
regulators, sigma factors and small RNAs in each group are identified either by their gene names or PA 
numbers. Annotations are from the Pseudomonas Genome database (332). 
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Of the 18 upregulated genes in U1 (PAO1 induced), there could also be a subset 
of genes that are AmpR- and β-lactam dependent due to a functional AmpR in PAO1. In 
order to identify and separate exclusively β-lactam regulated genes, we compared these 
18 upregulated genes to see if they were downregulated in Condition B (in D2) and 
identified PA0465 (creD), PA0466 (hypothetical) and PA3889 (hypothetical). So, of the 
18 genes in U1, only these three genes are specifically AmpR-regulated. Using a similar 
logic (for key, see (Appendix; Supplementary information for Chapter 4, Table S1), we 
identified β-lactam dependent genes (Appendix; Supplementary information for Chapter 
4, Tables S2A, S2B) to fall in regions U6, D6, U7, D7, U8 and D8 in addition to U1 and 
D1 of the Venn diagram (Fig 4.4a, 4.4b). The genes that were regulated exclusively in 
response to β-lactam antibiotics include mrcB, a penicillin-binding protein 1 (PBP1) that 
is involved in peptidoglycan synthesis and is upregulated 3.5-fold (corrected p-value 
3.71E-03). Genes of putative RND efflux and ABC transporters are also upregulated 
(Appendix; Supplementary information for Chapter 4, Table S2A), as are genes involved 
in flagellar biosynthesis and the sox operon (PA5416-PA5419; involved in amino acid 
metabolism). Genes that are downregulated in response to β-lactam exposure include 10 
membrane proteins suggesting adaptation to stress, in addition to genes of the phz2 
phenazine biosynthetic operon.  
The genes that are AmpR-dependent (U2, D2, U4 and D4: 387 genes) and AmpR-
β-lactam dependent (U3, D3, U5 and D5: 282 genes) (Fig 4a, 4b) are of interest to us, 
since AmpR influences both these gene sets. To further eliminate β-lactam specific genes, 
we compared the AmpR-dependent and AmpR-β-lactam dependent gene lists between 
themselves as well as to the 206 β-lactam-specific genes (Appendix; Supplementary 
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information for Chapter 4, Table S2A). This led to the identification of 520 genes whose 
expression is influenced by AmpR, of which 313 are AmpR-dependent (Appendix; 
Supplementary information for Chapter 4, Table S3A, Table S3B) and a further 207 that 
are AmpR-β-lactam dependent (Appendix; Supplementary information for Chapter 4, 
Table S4A, Table S4B). 
Functional categorization of AmpR-regulated genes 
Functional categorization of the 520 AmpR-regulated genes was then performed 
and compared to the distribution in the P. aeruginosa PAO1 genome from the 
Pseudomonas Genome database (332) to look for enrichment of specific classes of genes 
in the different conditions (Fig 4.5). Category N genes (secreted factors, toxins, enzymes, 
alginate) were found to be downregulated in an AmpR-dependent manner and this 
correlated with decreased production of some secreted virulence factors (elaborated in the 
following sections). Similarly, genes in category G (cell wall, LPS, capsule) were 
downregulated, indicating that AmpR positively regulates these genes. Moreover, 
metabolic genes (amino acid biosynthesis - category E; central intermediary metabolism - 
category Q) show marginal downregulation in the ampR mutant. Genes involved in 
carbon compound catabolism (category S), adaptation and protection (category K), and 
those related to phage/transposon/plasmid (category V) were upregulated in the 
PAO∆ampR, indicating negative AmpR regulation in an AmpR-dependent manner (Fig 
4.5). Interestingly, genes encoding transcriptional regulators (category L) show 
differential regulation indicating that AmpR could potentially regulate other genes 
indirectly via intermediate transcriptional regulators.  
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Figure 4.5. Enrichment of functional categories. Functional categorization of the AmpR-dependent and 
AmpR-β-lactam dependent genes was performed to identify enrichment of specific classes of genes relative 
to their distribution in PAO1. ‘+’ and ‘–‘ refers to upregulation and downregulation of genes, respectively 
in either an AmpR-dependent or AmpR-β-lactam-dependent manner. The most differentially regulated 
categories are labeled in the figure using the corresponding code, mentioned in the figure table. Functional 
categories, and their codes and percentages in PAO1 are from the Pseudomonas Genome database (332). 
 
In the presence of β-lactam stress, loss of ampR leads to downregulation of 
membrane proteins (category D), putative enzymes (category O) and those involved in 
translation (category F), while motility and attachment genes (category T) were 
upregulated (Fig 4.5). In addition to membrane proteins (category D), the most 
differential regulation across all conditions was of the hypothetical proteins (category C), 
but until the functions of these proteins are determined, no significant conclusions can be 
drawn. 
AmpR binding site analysis 
In an attempt to identify the genes that are directly regulated by AmpR, a 
bioinformatics approach was adopted. IEM and RSA analyses were performed to identify, 
refine and scan the P. aeruginosa genomes as well as the AmpR-regulated genes from the 
microarray data for potential AmpR-binding sites. The consensus sequences derived from 
the AmpR- and AmpR-β-lactam dependent genes are similar, yet distinct (Fig 4.6 A, C). 
Using these consensus sequences to search the upstream regulatory regions of the PAO1 
genome led to the identification of the AmpR-dependent element in the upstream region 
of 244 genes and the AmpR-β-lactam-dependent element in the upstream region of 207 
genes. The motifs derived from the IEM and RSA analysis for both the AmpR-dependent 
and AmpR-β-lactam-dependent genes are almost identical (Fig 6). Of the genes identified 
in the microarray analysis, only 11.9% of AmpR-dependent and 14.5% of AmpR-β-
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lactam-dependent upstream regulatory regions were identified by IEM or RSA analysis 
as having an AmpR binding site. This suggests that perhaps AmpR is exerting its effect 
by either directly or indirectly altering expression of a global transcription regulator. 
Studies aimed at identifying the direct targets of AmpR are needed to identify genes that 
are directly regulated by AmpR. 
Regulation of the amp genes by AmpR 
β-Lactam resistance in P. aeruginosa is mediated, in part, by the amp genes that 
are also tied in with the cell wall recycling process (414). The genes involved in this 
process include the regulator AmpR (105,415), the chromosomal β-lactamase AmpC 
(95,96,411,416), the permeases AmpG and AmpP (406,417) and the amidases AmpD, 
AmpDh2 and AmpDh3 (73,418). In addition, the hydrolase NagZ also plays a role in β-
lactam resistance (419,420). Since AmpR is known to positively regulate AmpC 
expression, we hypothesized that AmpR also regulates the other amp genes. qPCR 
analysis revealed downregulation of the amp genes in PAO∆ampR, normalized to 
expression in PAO1 (Fig 4.7), indicating a positive regulatory role for AmpR in the 
expression of ampG (RQ - uninduced: 0.59 + 0.01, p-value 0.006; induced: 0.63 + 0.01, 
p-value 0.04), ampP (RQ - uninduced: 0.1 + 0.01, p-value 0.004; induced- 0.86 + 0.01, p-
value NS)  , ampD (RQ - uninduced: 0.82 + 0.01, p-value NS; induced 0.67 + 0.01, p-
value 0.04), ampDh2 (RQ - uninduced: 1.01 + 0.05, p-value NS; induced- 0.56 + 0.01, p-
value 0.002), ampDh3 (RQ - uninduced: 0.98 + 0.007, p-value NS; induced: 0.66 + 0.04, 
p-value 0.02) and nagZ (RQ - uninduced: 0.27 + 0.06, p-value 0.002; induced: 0.51 + 
0.01, p-value 0.0002). 
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Figure 4.6: AmpR binding site analysis. The putative AmpR binding site was refined using IEM 
algorithm and used to search the upstream promoter elements of AmpR-regulated and AmpR-β-lactam 
regulated genes (listed in Appendix, Supplementary information for Chapter 4, Tables S3, S4) in PAO1 and 
other P. aeruginosa strains. DOOR database (421,422) was used to identify the operons. The RSAT tool 
(423) was used to identify PAO1 promoter sequences containing the identified AmpR- and AmpR-β-
lactam-regulated genes. The output is represented using WebLogo (424) for the AmpR-dependent genes 
from IEM (A) and RSA (B), and AmpR-β-lactam dependent genes from IEM (C) and RSA (D) 
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Figure 4.7. Expression of the amp genes in PAO∆ampR. RNA was isolated from cells exposed to β-
lactam antibiotic, reverse transcribed to cDNA and tested in triplicate by qPCR with gene-specific primers, 
as described in the text. The expression of ampC (β-lactamase), ampD, ampDh2, and ampDh3 (amidases), 
ampG and ampP (permeases), and nagZ (glycoside hydrolase) were tested in the ampR mutant relative to 
PAO1. Values have been normalized to expression in PAO1 under the same conditions (log10 RQ=1) and 
bars above or below the line represent up- and down-regulation, respectively. * p value <0.05 
 
 
Specifically, when the cells are exposed to β-lactams, they need amidase activity 
to help in the peptidoglycan recycling process. This is reflected in upregulation of the 
amidases, (AmpD, AmpDh2, and AmpDh3) and AmpC only when the cells are exposed 
to β-lactams. Simultaneously, AmpG, which functions to transport the degraded 
peptidoglycan material into the cytoplasm (406) is upregulated by AmpR (downregulated 
in PAO∆ampR) in an inducer-independent manner. This shows that AmpR upregulates 
the amidases and AmpC β-lactamase in response to β-lactams while upregulating AmpG 
(Fig 4.7), and agrees with the proposed model for peptidoglycan recycling in P. 
aeruginosa (406). The data, thus, demonstrates the central role of AmpR in influencing 
expression of the cell wall recycling/AmpC-mediated β-lactam resistance machinery in P. 
aeruginosa. 
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AmpR regulates the expression of antibiotic resistance and virulence systems 
It has previously been shown that AmpR regulates the expression of genes related 
to QS and protease production (425). Microarray analyses from this study show that 
AmpR affects the expression of multiple virulence systems in P. aeruginosa, as explained 
further in this section. 
Resistance-Nodulation-Division (RND) efflux systems 
RND transporters are tripartite pumps present in Gram-negative bacteria that are 
involved in the efflux of antibiotics and several other compounds decreasing cytoplasmic 
retention and thus conferring resistance (426). All of the P. aeruginosa strains sequenced 
so far carry 12 known and putative RND efflux pumps, suggesting that the efflux pumps 
are an integral part of the P. aeruginosa genome (25,33). The MexEF-OprN efflux 
system that is primarily concerned with resistance to fluoroquinolones, chloramphenicol 
and trimethoprim (427) was significantly upregulated in PAO∆ampR. The genes mexE 
(seven-fold), mexF (89-fold) and oprN (103-fold) are overexpressed in the ampR mutant 
in the absence of antibiotic stress in microarray studies (Appendix; Supplementary 
information for Chapter 4, Table S3A) and overexpression of the first gene of the operon, 
mexE, was confirmed by qPCR (Table 4.1). MexT, an activator of this efflux system 
(427,428), is not significantly differentially regulated (1-fold) in the microarray studies, 
but is upregulated in an inducer-independent manner when tested by qPCR (RQ: 
uninduced 7.5 + 0.11, p-value 0.02; induced 7.0 + 0.25, p-value 0.02). However, the 
negative regulator MexS shows no differential regulation either in microarray or qPCR 
analysis (data not shown). Carbapenems use the outer membrane porin OprD to gain 
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entry into the cell (429) and MexT negatively regulates this porin both at the 
transcriptional and post-transcriptional level (79,430,431). Indeed, qPCR analysis shows 
that with upregulation of mexT, there is a downregulation of oprD expression in the 
ampR mutant compared to PAO1 (RQ: uninduced 0.31 + 0.004, p-value 0.001; induced 
0.08+ 0.000002, p-value <0.0001). Surprisingly, OprD downregulation did not lead to 
increased resistance to imipenem and meropenem (Fig 1a). In addition, we did not see 
differential regulation of the other known MexT regulator, MvaT (432) in our microarray 
analysis. 
To further investigate whether upregulation of this pump translates into a 
resistance phenotype, we determined the MICs for MexEF-OprN substrate antibiotics by 
the standard broth microdilution method (433). PAO∆ampR showed enhanced resistance 
to four of the antibiotics tested when compared to the resistance profile of wild-type 
PAO1, correlating microarray and qPCR data with the phenotype (Table 4.2). This 
suggests that AmpR is involved in resistance to β-lactam antibiotics by regulating AmpC 
as shown earlier, and non-β-lactam antibiotics via the MexEF-OprN efflux pump. 
Analysis of the promoter regions of the genes of this pump and their regulators (MexS 
and MexT) using the putative AmpR-binding site (434) as a query sequence did not 
reveal signs of AmpR binding, suggesting indirect regulation by AmpR. 
 MexAB-OprM was the first RND-type efflux pump to be reported in P. 
aeruginosa and has very broad substrate specificity including β-lactam antibiotics and 
non-antibiotic substrates (435). In fact, it has been implicated to play a more significant 
role in resistance to β-lactam antibiotics than β-lactamases (58,436). Using the putative P. 
aeruginosa AmpR binding site (434), we identified a potential AmpR binding site 
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Table 4.2: ampR deletion affects susceptibility to MexEF-OprN substrates. The 
minimum inhibitory concentrations (in µg/ml) of MexEF-OprN substrate antibiotics to 
PAO1 and PAO∆ampR were determined by broth microdilution method (see text for 
details). 
 
 
 
 
 
 
 
 
 
upstream of the MexR repressor of this pump in the MexR-MexA intergenic region (5’ 
AAGCCTGCAAATGT 3’) indicating possible regulation of this pump by AmpR. qPCR 
analysis of mexR expression revealed downregulation of this gene in PAO∆ampR 
compared to PAO1 (RQ: uninduced 0.46 + 0.006, p-value 0.002; induced 0.4 + 0.007, p-
value 0.01). It is thus interesting to note that AmpR not only positively regulates AmpC 
β-lactamase but potentially also MexAB-OprM, two different mechanisms of resistance 
to β-lactams. The MexAB-OprM efflux can also pump out fluoroquinolones (79) and the 
enhanced quinolone resistance of PAO∆ampR seen in the MIC studies is potentially due 
to a combined effect of upregulation of the MexEF-OprN and the MexAB-OprM efflux 
pumps. In addition, AmpR negatively regulates a two-gene putative RND efflux operon 
PA1435-PA1436 (nine-fold and four-fold respectively in microarray) that codes for a 
Antibiotic MIC (µg/ml) 
  PAO1 PAO∆ampR  
Ofloxacin 4 32 
Ciprofloxacin 0.25 2 
Chloramphenicol 128 512 
Trimethoprim 200 >200 
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membrane fusion protein and efflux transporter, respectively. Potential AmpR regulation 
of the MexGHI-OpmD efflux pump is discussed in the QS section. 
QS-regulated virulence factors 
Many of P. aeruginosa virulence factors are QS-regulated and form a critical 
component of pathogenesis (208,437). In our previous meta-analysis of published P. 
aeruginosa transcriptomes, we identified differentially regulated sets of system-specific 
and condition-specific genes, including QS-regulated genes (400). Using this as our 
knowledge base, the ampR microarray profile was compared to identify differentially 
regulated QS-specific genes. The microarray data shows that AmpR influences 
expression of many QS-regulated genes (Appendix; Supplementary information for 
Chapter 4, Table S5).  
To further verify AmpR-mediated regulation of QS virulence factors, we 
quantified the production of pyocyanin, LasA protease, and LasB elastase. Pyocyanin is a 
redox active exotoxin pigment that contributes to lung pathophysiology of chronic P. 
aeruginosa infections (438) and interferes with multiple host cellular functions (439). 
Genes in the locus of the phz1 operon that is involved in QS-regulated phenazine 
synthesis, including phzA1 (PA4210, 4-fold down), phzB1 (PA4211, 21-fold down), phzS 
(PA4217, 28-fold down), phzM (PA4209, 4-fold down), and the MexGHI-OpmD efflux 
pump (PA4205-PA4208, 11-30-fold down) that plays a role in pumping out the pigments 
(440), show decreased expression in PAO∆ampR. In agreement with this data, there was 
a statistically significant (p-value <0.0001) reduction in pyocyanin production by the 
ampR mutant, compared to PAO1 and this effect was independent of β-lactam stress on 
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the cells (Table 4.3). The data indicates that AmpR influences pyocyanin production 
which is in agreement with the C. elegans killing data (Fig 4.2), since phenazines are 
major players in C. elegans mortality in the fast-killing assay (413). 
Elastases (pseudolysins) are highly toxic zinc metalloproteases that play a critical 
role in immunomodulation (441,442), host tissue damage aiding invasion (443) and 
biofilm formation (444). The LasB elastase production was also severely affected due to 
the loss of ampR (p-value < 0.02) in an inducer-independent manner (Table 4.3). Along 
with LasB, a zinc metalloendopeptidase, LasA plays a major role in P. aeruginosa-
induced keratitis (445). Reduction in LasA protease production, however, was 
significantly lower (p-value < 0.05) in PAO∆ampR only when the strains were exposed 
to sub-MIC β-lactam stress (Table 4.3), and this is in agreement with data from 
microarray (8-fold downregulated) and qPCR (RQ: uninduced- NS; induced 0.21 + 0.07, 
p-value < 0.0001) analysis.  
Microarray data shows that loss of ampR also affects other QS-regulated 
virulence genes, such as the hcn operon PA2193-PA2195 (5- to 7-fold downregulated) 
that is involved in the production of hydrogen cyanide. Cyanide toxicity is the primary 
mode of fast killing of C. elegans by P. aeruginosa PAO1 (446). The downregulation of 
the hcn operon concurs with reduced killing by PAO∆ampR. 
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aPyocyanin concentrations were expressed as µg pyocyanin produced per µg protein. 
bLasA activity was expressed as change in OD600 per hour per µg of protein. 
cLasB elastase activity was expressed as change in OD495 per µg of protein. 
dInduction was carried out with 100 µg/ml penicillinG. 
e,,fp-value<0.0001 when comparing PAO1 and PAO∆ampR 
g,hp-value<0.02 when comparing PAO1 and PAO∆ampR 
ip-value<0.01 when comparing PAO1 and PAO∆ampR 
Table 4.3: Effect of deletion of ampR on QS-regulated virulence phenotypes 
Strain 
Pyocyanin productiona LasA activityb LasB activityc 
UI INd UI INd UI INd 
PAO1 22.31 + 0.18 24.30 + 1.10 0.37 + 0.005 0.39 + 0.004 1.65 + 0.25 1.54 + 0.15 
PAO∆ampR 2.29 + 0.11e 5.74 + 0.56f 0.26 + 0.002 0.19 + 0.002g 0.5 + 0.03h 0.57 + 0.08i 
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The expression of the galactophilic lectin lecA (PA2570) is also downregulated in 
PAO∆ampR (RQ: uninduced- 0.22 + 0.0005, p-value 0.0001; induced: 0.16 + 0.003, p-
value 0.0005) indicating positive AmpR regulation. LecA facilitates bacterial entry into 
host cells by aiding in adhesion to endothelia and epithelia (447) and is involved in 
biofilm formation (448). It has previously been shown that lecA expression is regulated 
by the sigma factor RpoS (449) and by the QS regulator RhlR (449). Thus, the effect of 
AmpR on lecA expression could be mediated indirectly via RpoS and/or RhlR. As 
predicted, RpoS was downregulated (RQ: uninduced- 0.55 + 0.08, p-value 0.01; induced 
0.51 + 0.02, p-value 0.0003), indicating AmpR positive regulation in a β-lactam-
independent manner. Also, since we see downregulation of multiple QS phenotypes, 
RhlR is also potentially involved in AmpR-mediated lecA regulation.  
QS activates the operon PA2327-PA2331 (168) coding for a probable ABC 
transporter. Wolfgang et al. found this operon to be repressed when P. aeruginosa was 
grown in CF respiratory liquid containing media (450). Genes of the operon are 
significantly upregulated (6- to 18-fold) in PAO∆ampR indicating that AmpR negatively 
regulates this operon and further connects AmpR to QS regulation, adding another 
regulatory player in this complex regulatory network.  
Biofilms 
 Successful biofilm formation is dependent on nutrient availability, motility and 
QS (451). Comparison of gene expression profiles from this study with the biofilm-
specific gene list generated from our previous analysis of P. aeruginosa transcriptomes 
(400) revealed the differential regulation of many biofilm genes in PAO∆ampR 
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(Appendix; Supplementary information for Chapter 4, Table S6). This suggests a role for 
AmpR in biofilm regulation, either directly or indirectly. Testing the tube biofilm-
forming ability of the strains revealed that PAO∆ampR formed better biofilms, compared 
to PAO1 (Fig 4.8). The difference was significant at all time points tested (p-value < 
0.03) over a period of 72 hours indicating that AmpR is a negative regulator of biofilm 
formation.  
Microarray data also revealed upregulation of PA4651 (encoding a probable pili 
assembly protein; 11.6-fold), and PA4306 (coding for Flp, Type IVb pilin, 36-fold) in 
PAO∆ampR, in the absence of antibiotics. Since type IV pili-mediated twitching and 
flagella-mediated swimming motilities are known proponents for biofilm formation at 
different stages (452), we tested for these phenotypes with PAO1 and PAO∆ampR. In the 
absence of β-lactam antibiotic stress, the PAO∆ampR strain demonstrated enhanced 
twitching ability (PAO∆ampR: 15.1 mm + 1.1 mm; PAO1: 2 mm + 0.1 mm; p value < 
0.0001) potentially explaining its ability to form better biofilms. Moreover, unlike in 
PAO1, under sub-MIC β-lactam stress, PAO∆ampR showed a marginal but statistically 
significant increase in twitching zones (uninduced: 15.1 mm + 1.1 mm; induced: 16.5 
mm + 0.8 mm; p-value 0.04). This observation is in agreement with the enrichment of the 
gene set for the ‘motility and attachment’ functional category under β-lactam stress in 
PAO∆ampR (see section above). There was, however, no difference in the swimming 
motility of the strains (data not shown), although fleR of the FleSR two-component 
system that is involved in the flagella biosynthesis regulatory pathway (180) was 
differentially regulated in the ampR mutant (RQ: uninduced- 0.45 + 0.1, p-value 0.0007; 
induced- 0.32 + 0.01, p-value 0.0006).  
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Figure 4.8. AmpR affects biofilm formation. AmpR regulates many genes involved in biofilm formation 
(Appendix, Supplementary information for Chapter 4, Table S6) that is reflected in the tube biofilm assay 
monitored for 72 hours. The strains tested were wild type PAO1, PAO∆ampR, PAO∆retS (positive control), 
and PAO∆pel∆psl∆algD (negative control). The inset, taken at 72 hours, demonstrates the superior biofilm 
formation capacity of PAO∆ampR compared to PAO1. p-values comparing PAO∆ampR with PAO1: 24 
hrs- 0.002; 48 hrs- 0.03; 72 hrs- 0.007. 
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The Pel polysaccharide is a glucose-rich exopolymer, encoded by the pel operon 
(PA3058-PA3064) that along with the mannose-rich Psl polysaccharide plays a major 
role in pellicle formation (453,454). PAO∆ampR forms darker red colonies on Tryptone-
Congo red agar plates compared to PAO1 (data not shown) signifying higher Pel 
production (453). This is consistent with the observation that the ampR mutant produces 
better biofilms. Collectively, these data suggest that AmpR negatively influences biofilm 
formation in P. aeruginosa either directly or indirectly.  
Recently, a novel efflux pump that confers antibiotic resistance in P. aeruginosa 
biofilms has been identified (455). Deletion of the operon (PA1874-1877) encoding this 
pump in PAO1 enhances sensitivity to gentamycin, tobramycin and ciprofloxacin, 
especially in biofilm cells. Genes in this operon are downregulated four-fold in the ampR 
mutant strain. This observation, though not verified separately, suggests that AmpR 
positively regulates this operon, thus possibly contributing to non-β-lactam antibiotic 
resistance in biofilms.  
Secretory systems 
 The type III secretion system (T3SS) is essential for P. aeruginosa not only for 
contact-dependent toxin delivery to host cells but also for phagocyte evasion (206,456). 
Using a burn mouse model, it was shown that loss of T3SS results in reduced virulence 
(457). The genes encoding the regulatory and structural components of the T3SS in P. 
aeruginosa are concentrated in one locus (PA1690-PA1725) whereas the effectors and 
their chaperones are scattered in the genome (332). Deletion of ampR from PAO1 led to 
the downregulation of a few T3SS genes in the regulatory-structural gene cluster (Fig 
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4.9) indicating positive AmpR-regulation. These include the genes encoding the 
regulators PcrH (involved in regulating ExoS synthesis) and ExsE (a secreted regulator of 
the ExsCED regulatory cascade), and the translocator proteins PopB and PopD. qPCR 
confirmation of the microarray findings for the T3SS genes was done using RNA isolated 
from Ca2+ depleted inducing media (MinS-NTA), since Ca2+ is a known inhibitor of 
T3SS (325). Since pcrH, popB and popD are the last three genes of a 12-gene operon, we 
tested expression of only pcrH by qPCR, which showed a downregulation in PAO∆ampR 
compared to PAO1 (RQ: uninduced- 0.71 + 0.06, p-value 0.02; induced- 0.88 + 0.03, p-
value 0.003). Similarly, exsE, the second gene of the exsCEB operon was also 
downregulated in PAO∆ampR (RQ: uninduced- 0.57 + 0.01, p-value 0.001; induced- 
0.69 + 0.18, p-value NS) indicating positive regulation of these genes by AmpR.  
Transcriptional regulation of T3SS in P. aeruginosa is a complex process and 
involves multiple tiers of regulation (325). One of the mechanisms of control involves a 
small RNA-binding protein RsmA and non-coding small RNAs (sRNA), rsmY and rsmZ. 
Sequestration of RsmA by the sRNAs inhibits its activity. RsmA has an extensive 
virulence regulon that is tied in with the GacSA two-component system regulatory 
cascade (390,458). In PAO∆ampR, rsmZ is downregulated (RQ: uninduced- 0.21 + 0.03, 
p-value 0.01; induced- 0.78 + 0.09, p-value NS) and corresponds with an upregulation of 
RsmA (in microarray, uninduced - 2.3 fold; corrected p-value 0.009; induced- NS). Some 
of the T3SS genes are, however, downregulated in the ampR mutant (Fig 4.9). RsmA is a 
positive regulator of T3SS. This suggests that the effect of AmpR on T3SS is probably 
not via RsmA, or involves an additional step of post-transcriptional regulation. PtrB  
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Figure 4.9. Regulation of secretion genes by AmpR. Fold changes (FC) as determined by microarray 
experiments in the absence of β-lactam stress of the Type VI secretion ( , HSI-I) and Type III secretion 
() genes in the ampR mutant strain, normalized to expression in the wild-type strain PAO1. Gene 
annotations are from the Pseudomonas Genome database (332). 
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represses T3SS gene expression (331) and since AmpR regulates PtrB expression (see 
section below), AmpR regulation of T3SS is potentially via PtrB.  
P. aeruginosa T6SS is involved in chronic CF infections (459). RsmA also 
negatively regulates genes of the Type 6 secretion system (T6SS), particularly of the 
HSI-I system (458). Thus, downregulation of genes of the T6SS in PAO∆ampR (Fig 4.9) 
is possibly through an indirect effect of AmpR on RsmA.  
AmpR regulates genes found in regions of genome plasticity 
Comparative analysis of five P. aeruginosa chromosomes identified RGPs that 
are strain-specific (33). These are genome segments that can be acquired by horizontal 
gene transfer, bacteriophages or transposons (33). We wanted to determine whether an 
endogenous transcriptional regulator, such as AmpR, could regulate expression of genes 
acquired by the strain, such as RGP genes. Microarray analysis revealed that in the 
PAO∆ampR mutant, 31 RGP genes are regulated in an AmpR-dependent manner and an 
additional eight RGP genes under sub-MIC β-lactam stress (Appendix; Supplementary 
information for Chapter 4, Table S7).  
Most of the RGP03 (PA0612-PA0628) and RGP04 (PA0641-PA0648) ORFs 
belong to functional category V (related to phage, transposon and plasmid) and code for 
the two classes of high molecular weight pyocins, types R and F. Pyocins R and F are 
related to bacteriophage tails and kill susceptible cells thus conferring a survival 
advantage on the producing strain (460). Thirty-two percent of the RGP genes regulated 
in an AmpR-dependent manner are clustered and localized to RGP03. The expression of 
10 RGP03 genes and two RGP04 genes (59% and 20% of genes in RGP03 and RGP04, 
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respectively) are significantly upregulated (6-8-fold) in PAO∆ampR as seen in 
microarray data (Appendix; Supplementary information for Chapter 4, Table S7). This 
suggests that AmpR is involved in negatively regulating these genes, either directly or 
indirectly.  
PrtN (PA0610), and the product of the first gene in RGP03, ptrB (PA0612), is a 
positive regulator of pyocin production, both of which are repressed by PrtR (PA0611) 
(330). Upon DNA damage, RecA (PA3617) degrades PrtR, thus inducing pyocin 
production (330). In PAO∆ampR subjected to sub-MIC β-lactam stress compared to 
PAO1, prtN (12-fold), recA (3-fold) and ptrB (20-fold) are upregulated, while the 
negative regulator PrtR is downregulated (qPCR relative quantity: uninduced- 0.88 + 0.4, 
p-value p-value 0.004; induced- 0.76 + 0.109 p-value 0.0002) implying that AmpR is a 
negative regulator of pyocin production.  
AmpR regulates other transcriptional regulators 
The AmpR-regulation of hundreds of genes (Fig 4.4a, 4.4b) could be by direct 
binding to the promoters or in a subset of genes, indirectly through intermediate 
transcriptional regulators, sigma factors or regulatory RNAs. In a preliminary attempt to 
further elucidate the AmpR regulon, we looked at the transcriptional regulators and sigma 
factors that are AmpR-regulated. Of the 430 transcriptional regulators in P. aeruginosa 
PAO1 (332), 19 met the selection criteria in our microarray analysis (see materials and 
methods) and are over 2-fold significantly differentially regulated in the ampR mutant 
(Table 4.4). This suggests that AmpR regulates a proportion of the genes through 
intermediate transcriptional regulators. 
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Table 4.4: Transcriptional regulators and sigma factors regulated by AmpR 
Transcriptional regulators 
Locus 
Tag 
Gene 
Name Product Name 
Corrected p-
value 
Fold 
change 
PA0463 creB 
two-component response regulator 
CreB 
8.39E-03 -2.1 
PA0479 probable transcriptional regulator 9.90E-03 -2.1 
PA0610 prtN transcriptional regulator PrtN 3.81E-03 11.6 
PA0611 prtR transcriptional regulator PrtR 6.10E-03 -3.9 
PA0612 ptrB repressor, PtrB 3.44E-03 19.5 
PA1196 probable transcriptional regulator 9.89E-03 2.6 
PA1663 probable transcriptional regulator 5.13E-03 -3.9 
PA1707 pcrH regulatory protein PcrH 3.98E-03 -3.8 
PA2281 probable transcriptional regulator 9.89E-03 -2.1 
PA2588 probable transcriptional regulator 3.77E-03 -27.9 
PA3508 probable transcriptional regulator 1.60E-03 3.5 
PA3604 
 
probable two-component response 
regulator 
6.96E-03 -2.2 
PA4296 pprB 
two-component response regulator, 
PprB 
6.01E-03 7.4 
PA4781 
 
probable two-component response 
regulator 
9.10E-03 2.8 
PA4853 fis DNA-binding protein Fis 6.65E-03 -3.3 
PA5059 probable transcriptional regulator 6.33E-03 4.0 
PA5105 hutC histidine utilization repressor 8.27E-03 -3.1 
PA5380 gbdR GbdR 5.75E-03 2.6 
PA5483 algB 
two-component response regulator 
AlgB 
7.83E-03 2.4 
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Three of the 24-known/putative sigma factors (461) are also over 2-fold 
differentially regulated, including RpoS and AlgT/U (Table 4.4). The stationary sigma 
factor, RpoS controls virulence in different bacteria including P. aeruginosa (462-464). 
Since rpoS expression is upregulated in the stationary phase (461,463) and the RNA used 
for microarray analysis was harvested two hours post-β-lactam induction (at OD ~3.0), 
some of the phenotypic changes seen in PAO∆ampR is likely to be RpoS-mediated. 
To investigate this possibility, RNA was harvested 40 minutes post-induction (OD600 of 
~1.0) and the expression of known RpoS-dependent and RpoS-independent genes was 
compared between PAO1 and PAO∆ampR. As expected, RpoS expression was 
significantly higher at 2 hours than at 40 minutes in PAO∆ampR compared to PAO1 (p-
value: uninduced 0.0049, induced 0.0023; Fig 4.10), and this increase in RpoS expression 
corresponded with a growth phase-dependent increase in the expression of two of the 
RpoS-dependent genes, lecA (p-value: uninduced 0.0061; induced 0.0043) and lecB (p-
value: uninduced NS; induced 0.0002) (Fig 4.10). However, expression of the MexEF-
OprN activator, MexT, which is regulated in an RpoS-independent manner, did not 
change at the different time points tested (Fig 4.10). This suggests that AmpR, via RpoS, 
Sigma factors 
Locus Tag 
Gene 
Name 
Product Name 
Corrected p-
value 
Fold 
change 
PA0762 algT sigma factor AlgU 3.35E-03 5.4 
PA1300 
 
probable sigma-70 factor, ECF 
subfamily 
9.59E-03 2.5 
PA3622 rpoS sigma factor RpoS 6.65E-03 2.2 
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regulates genes of the RpoS regulon in P. aeruginosa in a growth phase- and stress-
dependent manner, which is in agreement with previous studies (463,464). Moreover, the 
MexT data suggests that harvesting the cells either after 40 minutes or 2 hours of β-
lactam treatment does not affect AmpR-mediated gene expression for non-RpoS-
dependent genes (Fig 10). 
The sigma factor AlgT/U is a master regulator of alginate biosynthesis (465,466) 
and we have shown previously with an ampR insertion mutant that there is crosstalk 
between AmpR and AlgT/U (425). Our microarray data shows upregulation of AlgT/U in 
PAO∆ampR (5.4-fold, corrected p-value 3.35E-03), indicating negative AmpR regulation 
(Table 4.4) in agreement with previous findings (425).  
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Figure 4.10. Gene expression in PAO∆ampR at 40 minutes and 2 hrs post-β-lactam exposure. RNA was isolated from PAO1 and PAO∆ampR cells 
exposed to β-lactams for either 40 minutes or 2 hours and reverse transcribed to cDNA. The expression of the sigma factor rpoS, lecA and lecB 
(galactophilic lectin genes known to be RpoS-regulated), and mexT (MexEF-OprN efflux pump regulator that is not RpoS-regulated) were tested by qPCR 
with gene-specific primers, as described in the text. Values have been normalized to expression in PAO1 under the respective conditions. ** p-value <0.006; 
*** p-value 0.0002 as determined by unpaired t test. 
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Subtractive transcriptomics of the AmpR regulon 
 Meta analysis of 18 condition-specific P. aeruginosa transcriptomes led to the 
identification of an expression core gene set of 303 genes that are significantly 
differentially regulated under all the different conditions analyzed and were proposed to 
be involved in maintaining cell homeostasis (400). Comparing the 520 genes whose 
regulation is AmpR-dependent to the core led to the identification of 57 genes (of the 
520) that were part of the expression core genes (Fig 4.11). Further, we wanted to 
identify genes that are specifically under AmpR-regulation and those that are not 
involved in other pathways. To derive this list, we compared the 463 AmpR-dependent 
genes (520 minus 57 core genes) with the 1726 genes that are regulated in other 
conditions/by other regulators [1598 condition-specific genes (400), and 128 genes that 
are either RpoS (368) or AlgT/U-regulated (467)]. This comparison reduced the number 
of AmpR-dependent genes to 133 (from 313) and the AmpR-β-lactam-dependent genes 
to 86 (from 207) (Fig 4.11; Appendix; Supplementary information for Chapter 4, Table 
S8). 
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Figure 4.11. Comparison of the AmpR transcriptome with other transcriptomes. AmpR-dependent 
and AmpR-β-lactam-dependent genes were compared with the 303 genes of the expression core and the 
1726 condition-specific genes identified previously as part of a meta-analysis of 18 P. aeruginosa 
transcriptomes (400).  
 
The exclusively AmpR-dependent genes include the O antigen chain regulator 
wzz, the pca genes involved in carbon compound catabolism and creB, which codes for 
the response regulator of the CreBC TCS (Table S8). The CreBC TCS has been 
demonstrated to be involved in β-lactam resistance in Aeromonas spp. (468). CreBC 
positively regulates expression of an inner membrane protein CreD in E. coli (469) and in 
P. aeruginosa the CreBCD system contributes to β-lactam resistance only in a ∆PBP4 
background (348).  Microarray analysis of PAO∆ampR in the presence β-lactam stress 
shows reduced creB expression (-2.1, corrected p-value 8.4E-03). Expression of creD, 
however, is significantly increased in PAO∆ampR compared to PAO1 under β-lactam 
stress as determined by qPCR (RQ: induced 11.04 + 0.0001, p-value < 0.0001). This is in 
agreement with a previous report that also showed creD overexpression in cefoxitin-
treated PAO∆ampR cells (348). AmpR thus positively regulates creB while negatively 
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regulating creD expression suggesting potential AmpR regulation of creD in a CreB-
independent manner. 
Phenotypic microarray analysis of PAO∆ampR 
 Since loss of ampR led to dysregulation of over 500 genes as seen in DNA 
microarrays, we decided to characterize its metabolic effect using phenotypic microarrays. 
Biolog analysis was performed with PAO1 and PAO∆ampR in the absence of antibiotic 
stress. In all, seven phenotypes were gained and 47 phenotypes were lost (Appendix; 
Supplementary information for Chapter 4, Table S9). PAO∆ampR grew marginally better 
in media containing nutritional supplements including citrulline, histidine, shikimic acid, 
leucine, serine, spermidine and pyridoxal. This indicates that AmpR is a negative 
regulator of utilization of these agents. Of the 47 observed phenotypes that were lost in 
PAO∆ampR, 45 belong to the sensitivity panel. Fourteen of the 45 observed phenotypes 
were associated with antibiotics, further supporting the role of AmpR as a major regulator 
of antibiotic resistance in P. aeruginosa.  
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Discussion  
P. aeruginosa AmpR, a LysR-type transcriptional regulator and a positive 
regulator of the chromosomal ampC β-lactamase expression, has been shown previously 
to play a role in regulating a few QS-dependent phenotypes and the alginate master 
regulator, AlgT/U (105,425). In this study, we determined the whole genome expression 
profiles of a clean in-frame deletion mutant of ampR in P. aeruginosa PAO1 under 
normal conditions and under sub-MIC β-lactam stress, using DNA microarrays. The 
results demonstrate that AmpR influences the expression of 313 genes in the absence of 
β-lactam stress and an additional 207 genes when exposed to sub-MIC β-lactam stress. 
The AmpR regulon is thus much more extensive than previously thought including 
virulence, antibiotic-resistance and metabolic genes.  
Multi-drug resistant P. aeruginosa isolates are a frequent occurrence in many 
acute and chronic infections (201). β-lactamases and efflux pumps are major mediators of 
antibiotic resistance in P. aeruginosa (79). We show that in addition to positively 
regulating the ampC and potentially the MexAB-OprM efflux pump by modulating 
expression of the MexR repressor, AmpR also mediates non-β-lactam resistance by 
negatively regulating the MexEF-OprN efflux pump. The PAO1 strain used for 
constructing PAO∆ampR was the strain used in the genome-sequencing project (25), 
which has an 8 bp insertion in the MexEF-OprN activator mexT leading to premature 
mexT termination (470) and consequent non-inducibility of the MexEF efflux pump. 
Strains with a nfxC mutation, however, have different ways to overcome this, including 
secondary mutations and deletion of the 8 bp insertion (428,470), leading to activation of 
the MexEF-OprN efflux. This was also observed in nfxC mutants isolated in a mouse 
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model (471). However, there was no differential expression of the MexT activator in both 
these studies (470,471). With PAO∆ampR, even though mexT expression is upregulated 
in a β-lactam-independent manner, this will still not be able to overcome the effect of the 
8 bp deletion. It has, however been suggested that there is a putative LacI-like repressor 
binding site in the mexT-mexE intergenic region (472) and that there is a second repressor 
that binds this site regulating expression of mexEF-oprN (473). This suggests that the 
LTTR AmpR potentially regulates this LacI-type repressor, leading to induction of the 
MexEF-OprN pump in a MexT-independent manner. The outer membrane porin OprD 
serves as a conduit for the entry of carbapenems into the cell (429). Although we see 
decreased expression of oprD, the strain is still sensitive to imipenem and meropenem, 
which is contrary to expectation. However, our finding is in agreement with a previous 
observation where mexEF-oprN overexpressing strains showed no altered imipenem 
susceptibility (474), the associated mechanism remains to be elucidated. Previous studies 
have also demonstrated an inverse correlation between β-lactam resistance and biofilm 
formation, both in vitro and in CF isolates (475-477). Our data supports these findings as 
far as β-lactam antibiotics are concerned, since AmpR positively regulates production of 
AmpC β-lactamase while negatively regulating biofilm formation. However, negative 
regulation of the MexEF-OprN efflux (providing resistance to fluoroquinolones, 
chloramphenicol and trimethoprim) by AmpR (Table 4.2, Fig 4.12) suggests that the 
antagonistic regulation of antibiotic resistance and biofilm formation is dependent on the 
class of antibiotics. The physiological advantage to the bacteria in this context is unclear. 
Co-regulation of β-lactam and fluoroquinolone resistance by AmpR is significant in itself, 
since this puts AmpR among one of the few proteins that regulates resistance to multiple 
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classes of antibiotic (478). In addition, since fluoroquinolones are part of the current 
systemic antibiotic treatment regimen for P. aeruginosa infections (201), this finding 
could potentially have important therapeutic implications. 
 QS is at the heart of the virulence regulatory network in P. aeruginosa with 
multiple regulators feeding into the regulation process (170). We have shown previously 
that AmpR is also part of the QS regulatory process and regulates production of proteases 
and pyocyanin (105,425), but the determined extent of the regulation was limited due to 
the experimental approaches adopted. Using whole genome transcriptome, we show here 
that the AmpR-influenced QS regulon is much more extensive than previously thought 
(Appendix; Supplementary information for Chapter 4, Table S5).  QS regulated 
phenotypes, such as pyocyanin and protease production are positively regulated by 
AmpR in the current study (Fig 4.12), which is in contrast to that seen in our previous 
analyses (105). We believe that this difference stems from the fact that in our previous 
studies, we used an insertion mutant (aacC1 cassette inserted into the PstI site of ampR) 
whereas in this study, we have used a clean in-frame deletion mutant of ampR. One 
potential reason for the discrepancy may be that the gentamycin cassette insertion at the 
PstI site (554 bases into the ampR coding region) (105) did not disrupt the N-terminus 
HTH motif of AmpR. Since LysR members are known to bind DNA even in the absence 
of inducer signals (104), this intact HTH motif might have somehow interfered with the 
regulatory process. The P. aeruginosa PAO1 insertion ampR mutant in the previous study 
produced more pyocyanin compared to the wild-type PAO1 (105). In contrast, in this 
study, we find that PAO∆ampR produces significantly lower amounts of phenazines as 
compared to PAO1 (Table 4.3). The differences in phenazine production were also 
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translated into differential susceptibilities in the C. elegans paralytic assays [Fig 4.2; 
(425)] since phenazines are one of the major contributors to C. elegans toxicity in this 
assay (195) explaining the reduced killing of C. elegans with this strain (Fig 4.2). 
Furthermore, with PAO∆ampR, the microarray, qPCR and phenotypic data concur, and 
support our current findings. 
The MexGHI-OpmD (PA4205-PA4208) efflux pump is involved in the efflux of 
acriflavin, ethidium bromide, novobiocin, rhodamine, and vanadium, and in maintaining 
QS homeostasis (440). Mutants of mexI and opmD have been demonstrated to be 
impaired in QS-related phenotypes including swarming motility, production of elastase, 
rhamnolipids, pyocyanin and pyoverdine (440). This pump is downregulated in 
PAO∆ampR indicating positive AmpR regulation and correlates with some of the 
observed phenotypes, such as decreased production of elastase and pyocyanin. 
Furthermore, SoxR is known to regulate this pump (479), but is not differentially 
regulated in the microarray data.  
AlgR regulates the hcnABC operon genes (PA2193-PA2195) involved in 
hydrogen cyanide synthesis in P. aeruginosa (480). In the ampR mutant, these genes are 
downregulated five- to seven-fold without a corresponding significant differential 
regulation of algR (< two-fold). AmpR, however, negatively regulates AlgT/U (5.4-fold 
upregulated in PAO∆ampR in the absence of antibiotics) in agreement with previous 
findings (425), and AlgT/U regulates algR (481,482). Thus the regulation of the hcnABC 
operon in PAO∆ampR is potentially through AlgT/U-mediated regulation of AlgR (Fig 
4.12). Moreover, RpoS, in conjunction with the Gac-Rsm regulatory system, has been 
shown to regulate oxidative stress-mediated resistance in P. fluorescens (483). In our 
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study, both RpoS and the sRNA, rsmZ are regulated in an AmpR-β-lactam-dependent and 
AmpR-dependent manner, respectively. This could also be a potential mode of regulation 
of the hcn operon in PAO∆ampR, provided the regulatory mechanism is conserved in P. 
aeruginosa. AmpR also negatively influences expression of the galactophilic lectin LecA 
(PA2570) (Fig 4.10) that is RpoS and QS-regulated. LecA has been shown to be critical 
to the gut pathogenicity of P. aeruginosa and to enhance cytotoxic effects of exotoxins 
by inducing a permeability defect (484). These results further support the hypothesis that 
AmpR regulates virulence in P. aeruginosa. 
P. aeruginosa produces bacteriocins called pyocins that kill susceptible cells 
through either pore-formation and subsequent leakage of cytoplasmic contents, or by 
endonuclease activity (460). The two high molecular weight pyocins, types R and F, are 
proposed to be remnants of lysogenic phages and resemble phage tails. Like lysogenic 
phages, they are induced in response to DNA damage, linked to the RecA-mediated SOS 
response (485) and other stress conditions such as exposure to hydrogen peroxide (152) 
or ciprofloxacin (486). AmpR influences the expression of many of these genes including 
the regulators PrtR, PtrN, PtrB, and the SOS response mediator RecA (Table 4.4; section 
in results). Specific and significant differential regulation of these genes under β-lactam 
stress in PAO∆ampR implies a role for AmpR in influencing expression of these genes 
under stress conditions. Moreover, pyocin production confers a survival advantage by 
killing neighboring susceptible cells and 97% of the P. aeruginosa CF isolates tested 
showed bacteriocin-like killing activity (487).  
 135
 136
Figure 4.12. AmpR is a master regulator of gene expression in P. aeruginosa PAO1. AmpR positively 
regulates resistance to β-lactam antibiotics by upregulating expression of the amp genes, nagZ and 
downregulating creD. In addition, AmpR affects fluoroquinolone resistance by negatively regulating 
expression of mexT, the positive regulator of the MexEF-OprN efflux pump. Expression of the virulence 
and stress response sigma factor, RpoS and QS-regulated acute virulence factors is downregulated in 
PAO∆ampR, indicating positive AmpR regulation. AmpR also negatively regulates biofilm formation via 
an unknown mechanism. AmpR modulates levels of the small RNA rsmZ, whose levels are lower in 
PAO∆ampR with a corresponding enhanced expression of RsmA. Downregulation of some of the T3SS 
genes in the ampR mutant is possibly by regulating ptrB expression, via PrtR. Further, two major regulators 
of the alginate biosynthetic pathway, AlgT/U and AlgB are negatively regulated by AmpR, thereby 
potentially also regulating alginate production. Whether these AmpR interactions are direct or indirect 
needs to be investigated. 
 
  
The pyocin genes are located in RGP03 and RGP04 and are acquired by P. 
aeruginosa (33). Though some RGP loci contain regulators that control expression of 
RGP genes (488), it is interesting to note that an endogenous regulator such as AmpR is 
able to regulate acquired genes and highlights the transcriptional versatility of P. 
aeruginosa.   
 Negative regulation of the genes involved in biofilm formation and pyocin 
biosynthesis by AmpR (Fig 4.12) fits with the profile of AmpR as a negative regulator of 
chronic infection phenotypes and positive regulator of acute infection, as seen with the 
QS-regulated phenotypes. RsmA, a small RNA-binding protein, is a global regulator of 
virulence in P. aeruginosa and is intricately tied in with the GacSA TCS (390,458). Two 
small RNAs, rsmZ and rsmY, which bind and sequester RsmA, keep RsmA activity in 
check in Pseudomonas and other bacteria (389,458,489-491). In P. aeruginosa, RsmA 
positively regulates T3SS and negatively regulates biofilm formation (492,493). AmpR 
positively regulates rsmZ (downregulated in PAO∆ampR), resulting in downregulation of 
RsmA (upregulated in PAO∆ampR). PAO∆ampR forms enhanced biofilms (Fig 4.8) and 
shows decreased production of QS regulated phenotypes compared to PAO1 (Table 4.3). 
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These data suggest that regulation of some of the phenotypes seen in an ampR mutant is 
not via modulating the activity of rsmZ and consequently RsmA. However, analysis of 
the rsmZ promoter for potential AmpR binding sites using a previously identified putative 
AmpR binding site (434) revealed a weak AmpR consensus (5’ CCCGCGCCTTTTGT 
3’). The possibility of direct AmpR regulation of rsmZ remains to be elucidated.  
In conclusion, unlike AmpR found in other Enterobacteriaceae members, the 
targets of P. aeruginosa AmpR are widely distributed in the genome and consist of over 
500 genes. Since the genes regulated include transcriptional regulators, sigma factors and 
non-coding RNAs, a subset of these genes are possibly regulated indirectly by AmpR via 
intermediate regulators. It is also interesting to note that AmpR regulates genes that have 
been acquired by horizontal gene transfer, which reflects on the transcriptional versatility 
of P. aeruginosa. Although the exact AmpR regulatory mechanisms are as yet unclear, 
this study highlights the complexity and multi-tiered regulatory processes by which P. 
aeruginosa controls expression of genes of diverse functions. Teasing apart the AmpR 
regulatory network will involve differentiating direct and indirect AmpR-regulated genes 
that will advance our understanding of how this bacterium regulates multiple different 
pathogenesis and metabolic mechanisms. This understanding will potentially lead to 
identifying mechanistic targets that can help in dealing with intractable P. aeruginosa 
infections, and other bacterial pathogens that harbor similar systems. 
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Materials and Methods 
Bacterial strains, nematodes, media and primers 
All experiments were performed with either the wild type or derivatives of P. 
aeruginosa PAO1 (25) and Escherichia coli DH5α cultivated in Luria Bertani (LB) broth 
(Difco, USA) incubated at 37 ˚C unless specified otherwise. The strains and plasmids 
used in this study are listed in Table 4.5. Nematode assays were performed with 
Caenorhabditis elegans strain N2 (Bristol) and E. coli OP50 obtained from the 
Caenorhabditis Genetics Center, which is funded by the NIH National Center for 
Research Resources (NCRR). E. coli OP50 was grown in nematode growth medium 
(1.7 % agar, 0.35 % peptone, 0.34 % K2HPO3, 0.3 % NaCl, 0.012 % MgSO4, 0.011 % 
CaCl2, 0.0005 % cholesterol) whereas the P. aeruginosa strains used in the nematode 
assays were grown on brain-heart infusion agar (Difco, USA). Biofilm assays were 
performed in T-broth (tryptone 10.0 g/L, NaCl 5.0 g/L). T-agar plates were prepared by 
addition of 1% agar to T-broth. MinS-NTA minimal media (494) was used for RNA 
isolation to determine expression of T3SS genes. Cation-adjusted Mueller Hinton broth 
and agar (Difco, USA) was used in MIC assays. For pyocyanin production, strains were 
cultivated in King A medium (Difco, USA). Antibiotics were supplemented, when 
needed, at the following concentrations for E. coli: ampicillin (Ap) 100 µg/ml, 
gentamycin (Gm) 15 µg/ml, tetracycline (Tc) 15µg/ml; for P. aeruginosa: Gm 75 µg/ml, 
Tc 60 µg/ml. Primers used in this study are listed in Appendix; Supplementary 
information for Chapter 4, Table S10. 
 
 139
 
Table 4.5: Strains and plasmids used in this study 
Strain/ plasmid Relevant characteristics Source 
Strains 
Escherichia coli 
DH5α General purpose cloning strain; Δ(lacZ)M15 
New 
England 
Biolabs 
OP50 Food source for culturing C. elegans 
C. elegans 
Genetics 
Center 
DBS7 DH5α harboring pEXG2 carrying the 1520 bp ∆ampR fragment (pDBS7) This study 
DBS220 DH5α harboring the 944 bp promoterless ampR ORF cloned into pCR2.1 TOPO (pDBS220) This study 
DBS271 
DH5α containing the 944 bp ampR ORF subcloned 
as a EcoRI-SacI fragment from pDBS220 into 
pMMB67EHGm 
This study 
  
  
 
  
Strain/ plasmid Relevant characteristics Source 
Pseudomonas aeruginosa 
PAO1 Wild-type (25) 
PKM314 PAO1 with pMMB67EH-Gm (empty vector) This study 
PKM315 PAO∆ampR; In-frame deletion of ampR (PA4109) This study 
PKM316 PAO∆ampR with pMMB67EH-Gm (empty vector) This study 
PKM317 
PAO∆ampR (pAmpR); ampR ORF on 
pMMB67EH-Gm (pDBS271) moved into 
PAO∆ampR; IPTG-inducible; GmR; ampR 
complementing clone 
This study 
PAOretS::aacC1 Gm insertion mutant of retS; hyper biofilm-former S. Lory 
PAO∆pel∆psl       
∆algD 
In-frame triple deletion of the algD ORF and pel 
and psl operons; biofilm non-former S. Lory 
Staphylococcus aureus 
DBS116 Wild type S. aureus used for LasA assays Lab collection 
Plasmids 
pCR2.1 TOPO TA cloning vector for PCR products; Ap
R, KmR; 
ColE1 f1 ori lacZα Invitrogen 
pRK600 Helper plasmid for conjugation [133] 
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pEXG2 Allelic exchange vector; Gm
R, colE1 ori, oriT, 
sacB (495) 
pMMB67EH-Gm GmR; IncQ, RSF1010, lacIq Ptac expression vector (496) 
pDBS7 pEXG2 with the ∆ampR fragment, flanked by EcoRI and BamHI sites This study 
pDBS220 
pCR2.1 TOPO containing the 944 bp ampR ORF, 
PCR amplified from the PAO1 genome using 
DBS_ampRF2 and DBS_ampRR2 
This study 
pDBS271 
pMMB67EH-Gm containing the ampR ORF, 
subcloned as an EcoRI-SacI fragment from 
pDBS220 
This study 
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Construction of deletion mutants, complementation clones 
An unmarked ampR null mutant of P. aeruginosa was generated by gene splicing 
(497) using primers KMampRUF1 and KMampRUR1 (to generate the upstream product 
P1, flanked by EcoRI and NheI sites), and primers KMampRDF1 and KMampRDR2 (to 
generate the downstream product P2, flanked by NheI and BamHI sites). After 
sequencing to ensure absence of mutations, P1 and P2 were spliced together to obtain a 
1520 bp deletion fragment of ampR containing stop codons in all three reading frames at 
their junction (inserted as part of the NheI sites in the primer). This was then sequenced 
and subcloned into a P. aeruginosa non-replicative plasmid pEXG2 (495) as an EcoRI-
BamHI fragment and moved into PAO1 by allelic exchange (498) using pRK600 (499) as 
the helper plasmid. Double crossover mutants were selected for the loss of plasmid 
(gentamycin-sensitive, sucrose counter-selection). The presence of deletion in 
PAO∆ampR was confirmed using standard molecular methods (PCR and restriction 
analysis of amplicons) and biological assays (antibiotic sensitivity pattern and β-
lactamase assays). Complementation of the ampR deletion was achieved by amplifying 
the ampR ORF along with the ampR-ampC intergenic region using primers 
DBS_ampRF2 and DBS_ampRR2 and cloning into pCR2.1 TOPO using TA cloning 
technique. After confirming absence of mutations by sequencing, the 944 bp ampR ORF 
was moved into pMMB67EH-Gm (496) as an EcoRI-SacI fragment. The plasmid was 
then moved into PAO∆ampR by electroporation (500), selecting for gentamycin-resistant 
colonies.  
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C. elegans virulence assay 
The P. aeruginosa - C. elegans standard paralysis assay was modified from 
previous protocols (446). Overnight bacterial cultures were diluted 1:1000 and plated 
onto brain heart infusion agar plates. The plates were incubated for 18-24 hours at 37 ˚C 
for the formation of bacterial lawns. Meanwhile, a synchronized culture of L4 stage 
larvae hermaphrodite Bristol N2 C. elegans was washed off E. coli OP50-seeded 
nematode growth medium plates using M9 media. The nematodes were centrifuged at 
1300 x g for two minutes and washed twice with M9 medium to remove residual E. coli 
bacteria. Thirty to 35 nematodes were then added to each of the P. aeruginosa bacterial 
lawns. Both live and paralyzed nematodes were scored at two-hour intervals for eight 
hours via microscopic observation. Nematodes were considered dead when they did not 
respond to physical stimuli. Each strain was tested in triplicate. 
RNA isolation, generation of cDNA probes, microarray experiments and data 
analysis  
P. aeruginosa strains PAO1 and PAO∆ampR, with and without β-lactam 
antibiotic treatment were used for RNA extraction.  The cells were subcultured at 37˚C, 
300 rpm from overnight cultures grown in LB broth to an OD600 of 0.01. When the cells 
reached an OD600 of 0.5-0.6, they were split into two flasks. One of the flasks was 
treated with sub-MIC concentration of penicillin (100 µg/ml penicillin G Potassium salt, 
Fisher Bioreagents) for two hours. The RNA was stabilized by addition of phenol-ethanol 
mixture (390) prior to extraction (RNeasy Mini Kit, Qiagen) following manufacturer 
protocols. Residual DNA was removed using RQ1 RNase-free DNase (Promega) and the 
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RNA repurified using the kit. After quantification by measuring absorbance at 260nm 
(Beckman DU640, Beckman Coulter), and preliminary quality check on a denaturing 
agarose gel (NorthernMax Gly, Ambion), the RNA integrity was analyzed using RNA 
Nano chips in an Agilent Bioanalyzer 2100. cDNA was then synthesized by annealing 
NS5 random primers to total purified RNA, spiked with Bacillus subtilis internal control 
RNAs and subsequent extension carried out using SuperScript III reverse transcriptase 
(Invitrogen). Fragmentation of cDNA was performed using RQ1 DNase (Promega), and 
the fragments were biotin labeled. Hybridization with GeneChip P. aeruginosa genome 
array (Affymetrix) and scanning were performed according to manufacturer 
specifications.  
Data analyses from three biological replicates for each of the conditions tested 
were performed after normalizing and summarizing probe level measurements using 
Guanine Cytosine - Robust Multiarray Average (GC-RMA). Only genes that fit stringent 
criteria (expression cutoff: 50-100% stringency; p-value < 0.01 of one-way ANOVA data 
corrected by Benjamini Hochberg FDR; fold-change >2.0) were selected for further 
analysis. All microarray data analysis was performed using GeneSpring GX 10.0 
Expression Analysis software (Silicon Genetics). The microarray data is MIAME 
compliant and has been deposited in NCBI GEO (accession number GSE33188). 
Bioinformatics analysis of the AmpR-binding site   
The promoters of AmpR-dependent and AmpR-β-lactam-dependent genes (listed 
in Appendix; Supplementary information for Chapter 4, Tables S3 and S4) were used to 
refine the AmpR binding motif using the Iterative Enhancement of Motifs (IEM) 
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algorithm (434). The AmpR binding site in the promoter of ampC (5’-
TCTGCTCCAAATTT-3’) was used to search the AmpR-dependent or AmpR-β-lactam-
dependent promoters from P. aeruginosa PAO1 and their orthologs from P. aeruginosa 
strains PA14, PA2192, C3719 and PACS2. The output of IEM was a motif matrix. 
WebLogo (424) was used to graphically represent the multiple sequence alignment of the 
output. The Regulatory Sequence Analysis Matrix Scan Tool (RSA) (423) was then used 
to identify PAO1 promoter sequences containing the identified AmpR-dependent or 
AmpR-β-lactam-dependent motifs in the respective gene sets. The RSA output was then 
used to generate a WebLogo for the gene sets. 
Quantitative real-time PCR 
Specific genes that were significantly, over two-fold up or down regulated 
between P. aeruginosa PAO1 and PAO∆ampR as seen in microarray experiments were 
verified by qPCR. Total RNA isolation and reverse transcription into cDNA was as 
described for the microarrays without addition of spike transcripts, fragmentation or 
labeling. For qPCR, the ABI Step One (Applied Biosystems) cycler was used with 
PowerSYBR Green PCR MasterMix with ROX (Applied Biosystems). Expression was 
normalized to clpX (PA1802), whose expression was determined to remain constant 
between the samples and conditions tested. Assays were performed at least in biological 
triplicate, each with technical triplicates, for every gene analyzed. Melt curves were 
determined to ensure primer specificity. The cycling conditions used were 95 ˚C/ 2 
minutes (holding); 40 cycles of 95 ˚C/ 15 sec, 60 ˚C/ 1 min (cycling); 95 ˚C/ 15 sec, 60 
˚C/ 1 min, 95 ˚C/ 15 sec (melt curve). Differential regulation of the T3SS genes, 
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including rsmZ was determined using RNA isolated from cells grown in MinS-NTA 
inducing media (494) from PAO1 and PAO∆ampR, essentially as described above. 
Gene expression in PAO∆ampR were normalized to the corresponding PAO1 
values, for both the β-lactam uninduced and induced conditions and is presented as 
relative expression in PAO∆ampR + standard error.  
Determination of minimum inhibitory concentration (MIC) 
 MICs were determined one of two ways. For testing the MIC of β-lactams, E-test 
was used following manufacturer protocols (BioMerieux). The MICs of the MexEF-
OprN efflux pump substrates (ofloxacin, chloramphenicol, ciprofloxacin, and 
trimethoprim) were determined by standard broth microdilution method (433). Briefly, 
serial two-fold dilutions of the antibiotics were incubated at 37 ˚C for 16-18 hrs with 5 x 
105 CFU/ml of bacteria in a total volume of 200 µl in 96-well flat bottom polystyrene 
plates. The highest dilution of antibiotic that prevented bacterial growth was considered 
as the MIC. The assays were performed at least in triplicate, each with technical triplicate, 
for each antibiotic in cation-adjusted Mueller Hinton broth.  
Quantifying β-lactamase activity 
 β-lactamase activity was quantified as described previously (105). Briefly, cells in 
LB broth at an OD600 of 0.5-0.6 were treated with 100 µg/ml Penicillin G for two hours 
at 37 ˚C. The cells were then harvested, OD normalized, and lysed with BugBuster 
Protein Extraction Reagent (Novagen) and r-Lysozyme (Novagen), and treated with 
Benzonase nuclease (Novagen). The amount of β-lactamase was quantified in the soluble 
fraction by determining hydrolyzing activity on nitrocefin (Oxoid, England). Protein 
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concentrations in the samples were determined by Bradford assay. Enzyme activity was 
expressed as milliunits of β-lactamase (nanomoles of nitrocefin hydrolyzed per minute 
per microgram of protein). 
Biofilm assays 
 Time course biofilm assays were performed in 12x75mm round-bottom glass 
culture tubes (VWR) as described previously (453). Briefly, fresh overnight T-agar plate 
cultures of the test strains were scraped into 1 ml T-broth and diluted to a final OD600 of 
0.0025. Aliquots of 1 ml per tube were made at time zero and incubated static at room 
temperature for 24, 48, 72 and 96 hours. To assay for pellicle formation, the tubes were 
washed with running tap water five times, after discarding the cultures and stained with 
1% crystal violet for 20 minutes. After pouring off the dye, the tubes were washed 
thoroughly with running tap water 10 to 15 times. Quantification of the attached and 
stained cells was done at 590 nm after solubilization of the dye with absolute ethanol. 
Motility assays 
 Twitching and swimming assays were performed on 1% and 0.3% agar plates, 
respectively, as described previously (501). 
Protease assays 
 LasA protease activity was measured by the ability of the strain supernatant to lyse 
boiled Staphylococcus aureus cells as described (502). Overnight culture supernatants of 
the test strains (100 µl) were mixed with 900 µl of a Tris-HCl (pH 8.5) suspension of 
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boiled S. aureus culture diluted to a final OD600 of 0.8. The lysis was monitored over an 
hour and LasA activity was expressed as the change in OD600 per hour per µg protein. 
 LasB elastolytic assay was performed with an elastin-congo red (ECR, Sigma) 
conjugate (503). The overnight culture supernatants (100 µl) were mixed with 900 µl of 
ECR buffer (100 mM Tris, 1 mM CaCl2, pH 7.5) containing 20 µg of ECR. Tubes were 
incubated shaking for one hour at 37 ˚C, and the supernatant was read at 495 nm. LasB 
activity was expressed as change in A495 per µg protein compared to an LB control. 
Pyocyanin production 
 The amount of pyocyanin produced was determined by extracting the pigment from 
overnight King A culture supernatants. A 5 ml 18-hour supernatant was mixed with 3 ml 
of chloroform to extract pyocyanin into the chloroform phase. Pyocyanin was then 
extracted with 0.2 N HCl, the absorbance measured at 520 nm, and the pyocyanin 
concentration expressed as µg pyocyanin produced per µg of protein (504).  
Phenotypic Microarray (PM) 
 PM profiles of PAO∆ampR were compared to that of wild-type PAO1 in the 
absence of antibiotic stress to test the effect of ampR deletion. PM arrays (Biolog Inc., 
Hayward, CA, USA) comprise of about 2000 tests spanning 20 96-well plates and 
include ~800 tests for carbon, nitrogen, phosphorous and sulfur utilization, ~100 tests 
each for pH growth range and osmotic sensitivity, and ~1000 tests for chemical 
sensitivity. Suspensions of control and test strains, in duplicate, were prepared in 
inoculating fluid containing 0.01% tetrazolium violet and transferred to the PM plates. 
After incubation for 24 hours, growth differences between the strains were determined 
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from the kinetic response curves obtained by measuring changes in the color of the redox 
dye in each well in the OmniLog® incubator reader. Better growth of PAO∆ampR in the 
presence of a specific test compound compared to PAO1 indicates gain of the phenotype 
(AmpR negatively regulates the phenotype) whereas poorer growth of the mutant 
compared to the wild type in a specific well indicates loss of phenotype due to ampR 
deletion (AmpR positively regulates the phenotype). OmniLog® PM software was used 
for data analysis. 
Statistical analysis 
 All data were analyzed for statistical significance using t-test on GraphPad 
statistical analysis software, except for the microarray data, which was performed on 
GeneSpring GX 10.0 as mentioned earlier. 
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Abstract 
 A Gram-negative opportunistic bacterium, Pseudomonas aeruginosa is a major 
human pathogen implicated in a number of acute and chronic infections. Of particular 
concern is the wide prevalence of P. aeruginosa in hospitals. Multiple virulence factors 
determine pathogenicity in P. aeruginosa. Virulence factor expression is a tightly 
regulated process and about 8-10% of the P. aeruginosa genome encodes transcriptional 
regulators. Some regulators control the expression of different pathogenic determinants in 
response to largely unidentified signals. Previously, using DNA microarrays we 
identified that AmpR, a transcriptional regulator of the LysR family and a positive 
regulator of the AmpC ß-lactamase, also regulates other virulence phenotypes in P. 
aeruginosa. Specifically, AmpR turns on acute virulence factor production and represses 
chronic ones. Using RNA-Seq, this study further expands the regulatory role of P. 
aeruginosa AmpR. Further, quantitative real-time PCRs and phenotypic assays establish 
the role of AmpR in regulating diverse processes such as oxidative stress response, heat-
shock response and iron uptake. The Gac-Rsm pathway is a major regulatory switch in 
determining expression of acute versus chronic virulence factors in P. aeruginosa. Gene 
expression studies demonstrate AmpR-dependent expression of the QS master regulator, 
LasR. ChIP-Seq studies with a chromosomally tagged AmpR show direct AmpR binding 
to the lasR promoter. Our studies establish the global regulatory role of P. aeruginosa 
AmpR in pathogenesis by contributing to regulation of quorum sensing and the quorum-
sensing pathway. This is the first study that analyzes the response of P. aeruginosa to 
antibiotics using RNA-Seq and ChIP-Seq. 
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Introduction 
 Pseudomonas aeruginosa is a ubiquitous bacterium and can be isolated from 
diverse sources, including plants, animals and humans. A high degree of nutritional 
versatility and adaptability ensures that P. aeruginosa is able to colonize a wide range of 
natural and man-made habitats. In humans, P. aeruginosa is seldom part of the microbial 
flora and is found in less than 2% - 6% of individuals in the skin, throat and nasal mucosa 
(505). An opportunistic, nosocomial pathogen, P. aeruginosa colonization rates in 
hospitalized patients, however, can be over 50% and especially so in cases of mucosal or 
cutaneous breach, or in immunocompromised individuals (506). P. aeruginosa is also the 
leading cause of mortality in cystic fibrosis patients (84). 
The pathogenic potential of P. aeruginosa is multifactorial and can be broadly 
classified into cell-associated and secreted virulence factors. The cell-associated 
virulence factors are typically structural components of the cell, such as the 
lipopolysaccharide (LPS), pili and flagella (507-509). The process of quorum sensing 
(QS) regulates expression of many of the major secreted virulence factors. QS is a 
mechanism of coordinating gene expression based on the population density, employed 
by both non-pathogenic and pathogenic bacteria (165). Quoromones (acyl homoserine 
lactones) are small diffusible molecules that mediate QS communication between cells to 
synchronize virulence gene expression (208). Precise signaling is ensured by the species-
specific nature of quoromones, although crosstalk between related bacteria is known to 
occur (510). P. aeruginosa employs three interdependent mechanisms of QS namely the 
Las, Rhl and Pseudomonas quinolone system (PQS). The Las system is at the top of the 
regulatory hierarchy, above the Rhl system, while PQS interacts with both Las and Rhl 
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[reviewed in (511,512)]. In P. aeruginosa, the QS process controls production of secreted 
enzymes and toxins such as LasA, LasB and ToxA, redox-active compounds such as 
phenazines (512), and in the case of chronic infections, the formation of bacterial 
communities called biofilms (451). In addition, some efflux pumps, such as MexGHI-
OpmD, which play a role in pumping out quoromones from the cytoplasm to the cell 
exterior, are also QS-regulated (440,513). A majority of the 12 putative and established 
RND efflux pumps in P. aeruginosa, however, are involved in antibiotic resistance 
(79,514).   
Antibiotic resistance is a major problem in dealing with P. aeruginosa infections. 
The current treatment regimen for P. aeruginosa is typically a combination therapy of ß-
lactams, aminoglycosides and quinolones (84,515). However, a six-year survey by the 
National Nosocomial Infections Surveillance System of the CDC revealed that P. 
aeruginosa isolates were resistant to many commonly used antibiotics in both ICU and 
non-ICU patients (516). The infection rates with antibiotic-resistant P. aeruginosa were 
as high as 36% (516).  
P. aeruginosa has multiple mechanisms of antibiotic resistance (79). Resistance to 
the ß-lactam class of antibiotics is primarily conferred by the chromosomally encoded ß-
lactamase AmpC, whereas the MexEF-OprN efflux pump mediates quinolone resistance 
(79,427). Our recent study demonstrated that the LysR-type transcriptional regulator 
AmpR that positively regulates ampC expression, also regulates the MexEF-OprN efflux 
pump (225). In addition, P. aeruginosa AmpR has a global regulatory effect on gene 
regulation and is a regulator of many virulence determinants and transcriptional 
regulators (225,425). Using DNA microarrays and complementary assays, we have 
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demonstrated that the AmpR regulon consists of over 500 genes, involved in virulence 
and metabolism (225). AmpR thus activates expression of many acute virulence 
phenotypes while chronic infection phenotypes were repressed. Interestingly, the AmpR 
regulon included the small regulatory RNA rgRsmZ (225). Given the extensive nature of 
the AmpR regulon, we hypothesized that other small regulatory RNAs could also be 
AmpR-regulated. The microarray platform, however, is not designed to detect small 
RNAs effectively. Moreover, given the limited sensitivity of microarrays, genes that were 
not identified in the study could also potentially be AmpR-regulated. In addition, 
proteomic analyses identified targets that were not identified in the microarray studies 
(unpublished data). This prompted use of RNA-Seq and ChIP-Seq to identify some non-
coding RNAs to be part of the AmpR regulon and determine direct targets of AmpR 
regulation. Furthermore, we assign a role for AmpR in previously unidentified critical 
cellular processes such as iron uptake, and in response to oxidative stress and heat shock. 
This study establishes AmpR as a critical regulator of P. aeruginosa virulence and 
physiology.  
Results  
RNA-Seq analysis expands the AmpR regulon 
 In order to study the function of AmpR in P. aeruginosa, a clean in-frame 
deletion strain (PAO∆ampR) was constructed in PAO1 in a previous study (225). PAO1 
and its isogenic ampR mutant, PAO∆ampR were used for gene expression profiling using 
RNA-Seq. In order to be able to compare results from the two studies, the experimental 
conditions for RNA-Seq was similar to the microarray experiments that were performed 
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earlier (225). PAO1 and PAO∆ampR were subjected to sub-MIC ß-lactam stress before 
RNA isolation and cDNA synthesis as described in the methods section.  
Using RNA-Seq, the transcription profiles of PAO1 and PAO∆ampR were compared 
in the presence (induced) and absence (uninduced) of sub-MIC ß-lactam stress. After data 
normalization between the replicates under each condition, the expression values across 
the entire genome for PAO∆ampR was normalized to PAO1. The PAO∆ampR data in the 
uninduced (Panel A, Figure 5.1) and induced (Panel B, Figure 5.1) were plotted. The 
expression profiles were markedly different in PAO∆ampR compared to PAO1, both in 
the absence and presence of antibiotic exposure, attesting to the global regulatory role of 
AmpR in P. aeruginosa. As expected, the ß-lactamase ampC, which is under positive 
AmpR regulation (105,225), is significantly downregulated under ß-lactam stress in 
PAO∆ampR (Panel B, Figure 5.1). Expression of genes identified in a previous study to 
be positively regulated by AmpR such as the elastase lasB (225) were also differentially 
regulated  here (Panels A, B; Figure 5.1). The MexEF-OprN efflux pump that provides 
resistance against fluoroquinolones and chloramphenicol is negatively regulated by 
AmpR [Panels A, B; Figure 5.1, (225)]. We had demonstrated AmpR to be a positive 
regulator of the QS system and in agreement, genes such as pqsA and rhlA, which are key 
players in QS-mediated gene regulation, are downregulated in the ampR mutant (Panel A, 
Figure 5.1). These findings, in addition to others discussed in the following sections, add 
credence to the current study. 
In addition to the genes that were identified in the microarray, the normalized data 
identified two transcriptional regulators (PA1015 and PA2588) and one ECF sigma factor 
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Figure 5.1: Gene expression in PAO∆ampR. Relative gene expression in PAO∆ampR compared to PAO1 (normalized to one), based on RNA-Seq 
data, is shown in the absence (top panel) and presence (bottom panel) of sub-MIC ß-lactam stress. Some significantly regulated genes are named. 
Gene annotations are from the Pseudomonas Genome Database (27).
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(FemI, PA1912) to be differentially regulated (Panel A, Figure 5.1). PA2588 is a putative 
transcriptional regulator of the AraC family (27). Interestingly, it is located downstream 
of pqsH, which is an important component of the PQS system (380). The role of AmpR 
in regulating the PQS system is discussed in a later section. The ECF sigma factor FemI, 
upregulated in PAO∆ampR, is part of a two-gene operon with femR (PA1911). FemR, 
along with FemA (PA1910), are involved in uptake of the mycobacterial siderophore 
mycobactin (517). Differential regulation of femI, along with the gene encoding the 
pyochelin receptor fptA (Panel B in Figure 5.1), suggests a role for AmpR in iron uptake 
regulation and is further explored in the later sections of this study. In addition, non-
coding RNAs such as P36, PA2744.1 and PA3133.1 are also differentially regulated 
(Figure 5.1).  
Identification of AmpR- and AmpR-ß-lactam-dependent gene sets 
The RNA-Seq data was normalized and pairwise comparisons were performed to 
determine differential gene expression (fold change > 2.0, Bonferroni correction of p-
value < 0.05). The four pairwise comparisons performed were PAO1 uninduced vs. 
PAO1 induced (Condition I), PAO∆ampR uninduced vs. PAO∆ampR induced (Condition 
II), PAO1 uninduced vs. PAO∆ampR uninduced (Condition III), and PAO1 induced vs. 
PAO∆ampR induced (Condition IV). This led to the identification of a total of 2568 
genes that were differentially expressed across all four pair-wise comparisons: Condition 
I-384 genes, Condition II- 672 genes, Condition III- 532 genes, and Condition IV- 980 
genes. Although these numbers are indicative, they are not a true measure of the AmpR 
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Figure 5.2: Venn diagram of differentially regulated genes. Distribution of significantly (p-value < 0.01) regulated genes (> 2.0-fold) in PAO1 
and PAO∆ampR without (uninduced) and with (induced) sub-MIC ß-lactam stress. 
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regulatory repertoire due to potential overlaps between the conditions, i.e., individual 
genes could be differentially expressed under more than one condition. In order to 
address this issue, the pair-wise comparison data was plotted using a four-way Venn 
diagram (Figure 5.2). Of the 2568 genes that were identified in the original pair-wise 
analysis under all four conditions, 865 genes were found to be redundant. From Figure 
5.2, 1703 non-redundant genes were identified across the four conditions, representing 
31% of the PAO1 genome. Further, genes that were dependent on AmpR, AmpR-ß-
lactam, and ß-lactam were identified in accordance with the expression criteria listed in 
the Appendix (Supplementary information for Chapter 5, Table 1). For example, genes in 
category B (Figure 5.2) are regulated in an AmpR-dependent manner, independent of ß-
lactam stress. 
Twenty-four genes (category O) were omitted from further analysis since they were 
differentially regulated under all four pair-wise analysis conditions, irrespective of AmpR 
and/or antibiotic stress. A further 56 genes could not be assigned unambiguously for 
analysis [category H (44 genes), category K (1 gene), category M (4 genes), category N 
(7 genes)] and were omitted. Thus, of the remaining 1623 genes, we identified a total of 
654 AmpR-dependent genes (Appendix; Supplementary information for Chapter 5, Table 
2), 483 genes that were AmpR-dependent only under ß-lactam stress (Appendix; 
Supplementary information for Chapter 5, Table 3), and 486 genes that are differentially 
expressed in response to ß-lactam stress independent of AmpR (Appendix; 
Supplementary information for Chapter 5, Table 4). 
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AmpR-regulated genes are enriched in specific functional categories 
The positively and negatively AmpR-regulated genes, both in the presence and 
absence of sub-MIC ß-lactam exposure, were functionally categorized based on the 
Pseudomonas Genome Database [(27), Figure 5.3]. The AmpR-regulated genes were 
expressed as a percentage of the distribution of each functional category in the PAO1 
genome (taken as 100%). This revealed a gross upregulation of genes related to phage, 
transposon or plasmid (45% genes of category ‘v’ genes in AmpR-positive regulated 
gene set; Figure 5.3). Functional class ‘v’ was shown to be positively regulated by AmpR 
in a previous transcriptome study as well (225). Similarly, genes of functional class ‘n’ 
(secreted factors- toxins, enzymes, alginate) were also shown to be under AmpR positive 
regulation (46% of genes of the category ‘n’ genes in the AmpR-positive regulated gene 
set; Figure 5.3). We have previously demonstrated that ampR mutants are impaired in 
production of extracellular enzymes such as LasA and LasB, and some of the type III 
secretion genes (225). Similarly, genes belonging to functional categories ‘k’ (adaptation 
and protection; 19%), ‘zA’ (antibiotic resistance and susceptibility; 10%) and ‘q’ (central 
intermediary metabolism; 11%) were also positively regulated by AmpR (Figure 5.3). 
This finding agrees with our previous observations from DNA microarrays and 
phenotypic microarrays that AmpR is an important regulator of antibiotic resistance, cell 
wall recycling enzymes and metabolism in P. aeruginosa (225). 
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Figure 5.3: Functional categorization of AmpR-regulated genes. AmpR differentially regulated 
genes are functionally categorized and expressed as a percentage of the respective category in the 
PAO1 genome (27). The functional categories are (a) DNA replication, recombination, modification 
and repair; (b) fatty acid and phospholipid metabolism; (c) hypothetical; (d) membrane proteins; (e) 
amino acid biosynthesis, metabolism; (f) translation, post-translational modification, degradation; 
(g) cell wall/LPS/capsule; (h) transport of small molecules; (i) energy metabolism; (j) biosynthesis of 
cofactors, prosthetic groups, carriers; (k) adaptation, protection; (l) transcriptional regulators; (m) 
two-component regulatory systems; (n) secreted factors- toxins, enzymes, alginate; (o) putative 
enzymes; (p) chaperones, heat-shock proteins; (q) central intermediary metabolism; (r) nucleotide 
biosynthesis and metabolism; (s) carbon compound catabolism; (t) motility and attachment; (u) 
chemotaxis; (v) related to phage, transposon, plasmid; (w) non-coding RNA genes; (x) protein 
secretion, export apparatus; (y) cell division; (zA) antibiotic resistance, susceptibility; (zB) 
transcription, RNA processing, degradation. 
 
 
 
The AmpR negatively regulated genes are involved in translation (category f - 
17%), energy metabolism (category i - 12%), nucleotide metabolism (category r - 11%), 
chaperones and heat shock (category p - 13%), and cell division (category y - 13%). 
Genes involved in motility and attachment (category t - 10%) are positively regulated by 
AmpR under ß-lactam stress. Similarly, AmpR negatively regulates genes involved in 
chemotaxis under ß-lactam stress (Figure 5.3). 
To determine whether the functional categorization in the different gene sets is 
significant, enrichment analysis was performed using GOEAST (518). Primarily, gene 
ontology identifications (GOIDs) belonging to biological processes and cellular 
components were enriched in the AmpR positively regulated and negatively regulated 
gene sets, respectively (Appendix; Supplementary information for Chapter 5, Table 5). 
GOIDs belonging to ribosomal protein biosynthesis and oxidative phosphorylation were 
statistically significantly enriched in the AmpR-dependent negatively regulated gene set 
[log odd ratio >1.5; p-value <0.05; (Appendix; Supplementary information for Chapter 5, 
Table 5)]. There was no enrichment in the AmpR-ß-lactam-dependent gene sets. 
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In the AmpR-positively regulated gene set, many genes involved in pyoverdine 
biosynthesis were significantly enriched [log odd ratio >2.5, p-value <0.03; (Appendix; 
Supplementary information for Chapter 5, Table 5)]. Also enriched in the same gene set 
are the genes encoding the major catalase KatA, and the superoxide dismutase SodA. The 
physiological effects of enrichment of these genes on iron acquisition and oxidative stress 
response, and the role of AmpR in their regulation are discussed in later sections. 
Furthermore, genes such as the QS regulator rhlR, the stress phase sigma factor rpoS, 
which were identified to be AmpR-regulated previously (225), also showed significant 
enrichment (Appendix; Supplementary information for Chapter 5, Table 5). 
Regulation of small RNAs (sRNAs) by AmpR 
 RNA-Seq allows detection of expression profiles of sRNAs. Previous microarray 
studies with PAO∆ampR showed dysregulation of the small regulatory RNA rgRsmZ 
(225). This led us to hypothesize that other sRNAs may also be AmpR-regulated but 
were not detected in the microarray studies due to technical limitations. RNA-Seq 
analysis of the ampR mutant revealed dysregulation of many non-coding RNAs 
(ncRNAs), both in the absence and presence of sub-MIC ß-lactam stress (Appendix; 
Supplementary information for Chapter 5, Tables 2, 3). Some of these were tRNAs, 
which is expected given their abundance. Downregulated ncRNAs in PAO∆ampR 
(AmpR positive regulation) include PA1030.1 (P8; uninduced -30-fold, p-value 2.14E-
06; induced -92-fold, p-value 1.03E-14), and prrF1 (PA4704.1; uninduced -4-fold, p-
value 0.00E+00; induced NS), whereas expression of P7 (PA0887.1; uninduced 6.3-fold, 
p-value 0.00E+00; induced 3.1-fold, p-value 5.35E-14) and amiL (PA3366.1; uninduced 
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2.5-fold, p-value 1.82E-13; induced NS) were upregulated (AmpR negative regulation). 
Interestingly, rgRsmZ, which was detected in the microarray analysis, was not detected in 
RNA-Seq but dysregulation was confirmed by qPCR (discussed in the following 
sections).  
 AmpR mediated regulation of some of the sRNAs was determined by qPCR. 
AmpR was found to positively regulate expression of PA5181.1 (P34; RQ: uninduced 
0.39 + 0.06, p-value 0.0003; induced 0.38 + 0.016, p-value 0.002). Expression of P34 
requires RpoS (519). Since AmpR positively regulates RpoS (225), AmpR regulation of 
P34 is likely via RpoS. Positive regulation of P32 (PA4758.1) by AmpR and its 
physiological effects on the AmpR mutant strain are discussed in the section on heat-
shock response. Further, AmpR was also found to positively regulate the antisense RNA 
asPrrF1 (Appendix; Supplementary information for Chapter 5, Table 2) and is discussed 
further in the following section.    
AmpR regulates iron uptake positively 
Iron is critical in many biological reactions across kingdoms and P. aeruginosa is 
no exception. However, freely available iron is in a poorly soluble and biologically 
unusable ferric (Fe3+) form at neutral pH in aerobic conditions (107). In order to 
circumvent this issue, P. aeruginosa has evolved high affinity iron uptake systems 
mediated by siderophores. Siderophores are iron chelators that bind extracellular iron and 
transport it to receptors on the cell surface [reviewed in (107)]. P. aeruginosa can 
produce and take up heme- or iron-siderophore complexes (520). In addition, P. 
aeruginosa also synthesizes outer membrane receptors for siderophores produced by 
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other bacteria including pyoverdines produced by other pseudomonads (521), aerobactin 
(522) and enterobactin (522,523). P. aeruginosa produces two main types of siderophores, 
pyoverdine and pyochelin (107). Pyoverdine is the green-yellow fluorescent pigment that 
is produced typically under conditions of iron limitation (524). The pvd genes encode 
pyoverdine and are clustered (PA2385-PA2426) on the PAO1 genome (27). RNA-Seq 
analysis of the ampR mutant revealed downregulation (3-fold to 103-fold) of many pvd 
genes (Appendix; Supplementary information for Chapter 5, Table 2). This includes pvdS 
(PA2426), the ECF sigma factor (uninduced -7.6, p-value 3.49E-09, induced -38.2. p-
value 1.93E-08) that is known to regulate expression of the pvd genes (525). Genes 
encoding the second siderophore system, pyochelin, are part of a gene cluster (PA4220-
PA4231) and consist of three operons (PA4220-PA4221, PA4222-PA4226, PA4228-
PA4231). Genes of all these operons (PA4224-PA4226, PA4228-PA4231) are 
significantly downregulated (14-fold to 193-fold) in PAO∆ampR in a ß-lactam-
independent manner (Appendix; Supplementary information for Chapter 5, Table 2). This 
is also reflected in the GOEAST analysis of the AmpR-positively regulated gene set 
revealing a significant enrichment (log odds ratio > 1.0, p-value < 0.05) of the pvd genes 
(Appendix; Supplementary information for Chapter 5, Table 5). These findings suggest 
that AmpR is potentially involved in iron uptake. 
Further, comparison of AmpR-regulated genes from this study with the iron-
related genes identified as part of a previous transcriptome metaanalysis study (400) 
revealed overlaps (Figure 5.4A). Genes involved in pyochelin biosynthesis are part of the 
19 genes that are shared between the iron-regulated gene set and AmpR-positively 
regulated genes (Figure 5.4A). The overlapping genes also include prpL, a PvdS-
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regulated protease that has been implicated in virulence (526) and pfeR encoding the 
transcriptional regulator of the PfeSR two-component system that positively regulates the 
enterobactin outer membrane receptor [PfeA; (527)]. Moreover, asPrrF1, which is a 
positive regulator of iron uptake, is also downregulated in PAO∆ampR in the RNA-Seq 
(uninduced: 4-fold, p-value <0.001; induced: NS) and qPCR (uninduced: 0.47 + 0.04, p-
value 0.004; induced: NS) assays. However, the master repressor of iron uptake Fur (143) 
is not significantly differentially regulated in the ampR RNA-Seq analyses. 
Downregulation of genes involved in siderophore biosynthesis, and comparison with 
previous metaanalysis studies led us to hypothesize that AmpR plays a positive 
regulatory role in iron uptake. 
To further study the function of AmpR in iron uptake, growth curves were 
performed in iron-limited synthetic succinate media [SSM, (528)]. Deletion of AmpR 
resulted in impaired growth in SSM compared to PAO1 (orange lines; Figure 5.4B). 
Maximum growth difference between the strains was seen in the log and early stationary 
phases (p-value <0.0001 at all time points between 4 and 14 hours) of growth (orange 
lines; Figure 5.4B). The reduced growth of PAO∆ampR in iron-deficient media can be a 
result of impairment in either uptake or utilization of iron. To address this question, 
growth curves were performed with exogenously added FeCl3, making the media iron-
replete (blue lines; Figure 5.4B). Addition of iron to the media enhances the growth rate 
of both PAO1 and PAO∆ampR (blue lines; Figure 5.4B), compared to growth in SSM 
without exogenously added iron (orange lines; Figure 5.4B). Moreover, under iron-
replete conditions, growth of the two strains is very similar till about 10 hours after which 
the ampR mutant again shows significantly reduced growth (blue lines; Figure 5.4B).
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Figure 5.4: AmpR regulates iron uptake. (A) Comparing the AmpR positively and negatively regulated genes against the iron-regulated gene set 
shows overlaps between the datasets. (B) Growth in iron-limited media of PAO1 (solid lines) and PAO∆ampR (dashed lines) in the absence (orange 
lines) and presence (blue lines) of exogenously added FeCl3.
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Thus, in the presence of excess iron in the log phase, PAO∆ampR shows no growth 
deficiency. 
This observation, and the transcriptome data, strongly suggests that AmpR plays a 
role in iron uptake, and not iron utilization. The growth impairment seen under iron-
replete conditions with PAO∆ampR between 10 and 16 hours is significant (blue lines, 
Figure 5.4B; p-value < 0.0003 at all points). This is possibly due to the fact that 
PAO∆ampR uses up all the freely available iron to maintain growth rates similar to PAO1 
for the first 10 hours of the experiment. When conditions start to become iron limiting 
(after 10 hours, Figure 5.4B), continued growth of PAO∆ampR is hampered due to 
impaired iron uptake. Moreover, under iron-replete conditions, neither strain produced 
pyoverdine, seen visually as a lack of yellow-green color of the cultures (data not shown), 
suggesting pyoverdine-independent iron uptake. P. aeruginosa also has an 
uncharacterized low affinity iron uptake system that functions under iron replete 
conditions (P. Cornelis, personal communication) and a citrate-mediated iron uptake 
system (529), potentially explaining growth. 
In addition to the siderophore-mediated uptake, expression of the heme 
acquisition protein HasAp (PA3407) is downregulated in an AmpR-ß-lactam-dependent 
manner [34.9-fold downregulated, p-value 8.5E-08; (Appendix; Supplementary 
information for Chapter 5, Table 3)]. This further attests to the role of AmpR in iron 
uptake in P. aeruginosa. The pH of the media is known to influence growth in SSM (528) 
but there was no difference in the pH of the media between the strains (data not shown). 
Thus, the gene expression and phenotypic data clearly indicate a positive regulatory role 
for AmpR in iron uptake in P. aeruginosa. 
 168
P. aeruginosa AmpR regulates heat-shock response by modulating rgP32 expression  
RNA-Seq analysis revealed that AmpR positively regulates the small RNA rgP32 
[20.8-fold downregulated in PAO∆ampR, p-value 7.77E-14; (Appendix; Supplementary 
information for Chapter 5, Table 2)]. P32 is the last gene of a three-gene operon with 
dnaJ and dapB (27). DnaJ is part of the Hsp70 heat-shock response system (530). The 
DnaJ-DnaK-GrpE (PA4760-PA4762) chaperone Hsp70 system prevents premature 
folding of nascent polypeptides and, along with the GroEL (Hsp60) system, helps in the 
heat-shock response in bacteria (530,531). DnaK is the P. aeruginosa homolog of E. coli 
Hsp70 (27). Conversion between the ATP- or ADP-bound forms of DnaK are controlled 
by DnaJ and GrpE, which function as a co-chaperone and a nucleotide exchange factor, 
respectively (532). Given that the small RNA is part of the operon encoding for the 
Hsp70 system, we hypothesized differential regulation of the Hsp70 heat shock system in 
PAO∆ampR. qPCR analysis showed that the expression of grpE (RQ: uninduced 0.51 + 
0.004, p-value 0.0017; induced 0.38 + 0.003, p-value  0.0003), dnaJ (RQ: uninduced 0.65 
+ 0.045, p-value 0.015; induced 0.6 + 0.005, p-value 0.0004), and dnaK (RQ: uninduced  
0.45 + 0.02, p-value 0.0019; induced  0.62 + 0.007, p-value 0.0028) are downregulated in 
PAO∆ampR (Figure 5.5A). The positive regulation is independent of sub-MIC ß-lactam 
in the system (Figure 5.5A). This suggests that the cell wall intermediate products, shown 
previously to be probable AmpR effector molecules in inducing ß-lactam resistance 
(121,410), play no role in AmpR-mediated regulation of Hsp70-encoding genes. 
Downregulation of the Hsp70 heat-shock system genes in the ampR mutant led us 
to hypothesize that, compared to PAO1, PAO∆ampR would behave differently at higher 
temperatures. However, growth curves of the ampR mutant were not different from 
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PAO1 at 30˚C, 37˚C or 43˚C (data not shown). The heat tolerance of the two strains was 
then examined by enumerating CFUs after exposure of both log- and stationary-phase 
cells to 50˚C, inducing the cellular heat-shock response. There was no significant 
difference between the input cells and the control cells (grown at 30˚C) for either the log 
or stationary phases. However, PAO∆ampR log-phase cells were more susceptible 
compared to PAO1, with >90% of cells killed after three hours of 50˚C exposure (p-value 
0.0018; Figure 5.5B). The stationary phase cells also followed a similar trend as the log 
phase cells. Loss of ampR led to a 99.9% loss in cell viability compared to PAO1 when 
stationary phase cells were exposed to 50˚C for one hour (p-value 0.0014; Figure 5.5B).  
The stationary phase cells are more sensitive to the elevated temperature 
compared to the log phase cells, and show a 2-log greater drop in CFU even after a brief 
exposure (Figure 5.5 B). This is counterintuitive since stationary phase cells are thought 
to be more resistant to changing conditions compared to log phase cells. Downregulation 
of the stationary phase sigma factor RpoS in PAO∆ampR (225) potentially plays a role in 
the enhanced sensitivity of PAO∆ampR cells. Regulation of the heat-shock sigma factor 
RpoH was also not significantly different between the strains in the RNA-Seq analysis 
(data not shown). This, however, is not surprising since expression of transcriptional 
regulators are typically not highly differentially regulated to achieve effective function. 
Dysregulation of the hsp70 genes, confirmed by reduced temperature tolerance of 
PAO∆ampR, suggests a positive regulatory role for AmpR in the heat-shock response of 
P. aeruginosa. 
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Figure 5.5: Regulation of heat-shock response by AmpR. (A) qPCR of hsp70 genes: RNA was 
isolated from PAO1 and PAO∆ampR cells, without and with sub-MIC ß-lactam stress, reverse 
transcribed to cDNA, and tested by qPCR with gene-specific primers, as described in the text. Relative 
gene expression in PAO∆ampR is shown without (grey bars) and with (black bars) sub-MIC ß-lactam 
exposure. Values have been normalized to expression in PAO1 under the same conditions (log10 
RQ=1) and bars above and below the threshold represent up- and down-regulation, respectively. (B) 
CFU counts of heat-shock exposed and unexposed cells in the log and stationary growth phases: Cells 
grown at 30˚C were OD600 normalized, split into two aliquots and maintained at 30˚C and 50˚C for 
varying periods of time (3 hours for log phase, 1 hour for stationary phase) before enumeration. Data 
of PAO1 (grey bars) and PAO∆ampR (black bars) are represented. p-values * <0.02, ** < 0.003, *** 
<0.0005. 
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AmpR positively regulates P. aeruginosa oxidative stress response 
Hydrogen peroxide (H2O2) is a byproduct of O2 metabolism whose deleterious 
effects on cells include altered membrane potential (533) and DNA mutation caused by 
single-stranded nicks (534). Intracellular H2O2 detoxification is achieved by the enzyme 
catalase and P. aeruginosa has four homologs: KatA (PA4236), KatB (PA4613), KatE 
(PA2147) and KatN [PA2185; (535)]. Of these, KatA is the major catalase and is 
expressed in all stages of cell growth but is produced more in the stationary phase (535). 
RNA-Seq analysis of PAO∆ampR revealed downregulation of katA expression (-2.1-fold) 
compared to PAO1 in the absence of antibiotic stress, suggesting AmpR-dependent 
expression (Appendix; Supplementary information for Chapter 5, Table 2). Differential 
expression of katA was validated using qPCR (RQ uninduced: 0.12 + 0.01, p-value 
0.0012). The small RNA rgRgsA (PA2958.1), which requires GacA and RpoS for its 
expression, contributes to hydrogen peroxide resistance (536). Expression of rgRgsA is 
downregulated over 2-fold in PAO∆ampR (Appendix; Supplementary information for 
Chapter 5, Table 2), indicating positive AmpR regulation.  
Previous meta-analysis studies of P. aeruginosa transcriptomes led to the 
identification of genes that were specifically differentially regulated under oxidative 
stress conditions (400). The differential regulation of katA and rgRgsA in PAO∆ampR 
prompted comparison of the AmpR-regulated genes with the oxidative stress gene set. 
Seventy genes were shared between the two conditions, 48 and 22 of which are positively 
and negatively regulated by AmpR, respectively (Figure 5.6A). The 48 positively 
regulated genes include the major P. aeruginosa catalase katA, and four genes involved 
in PQS signal biogenesis [pqsA (PA0996), pqsE (PA1000), phnA (PA1001) and phnB 
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(PA1002)]. Interestingly, 22 of the 48 genes are clustered in a single locus on the genome 
that is involved in the production of R- and F-type pyocins (460,537), and are located in 
RGPs, RGP03 and RGP04 (33). These genes were also identified in a previous 
transcriptome study to be AmpR-regulated (225). Most of these 22 AmpR-downregulated 
genes that are shared with the oxidative stress gene set are involved in metabolism 
including six of the nuo genes, which synthesize components of NADH dehydrogenase I 
(538). Another member of the LTTR family of transcriptional regulators, OxyR regulates 
katA expression in response to oxidative stress (539). Although ampR deletion in PAO1 
did not affect oxyR expression in the RNA-Seq analysis (data not shown), qPCR analysis 
revealed that AmpR positively regulates oxyR expression (RQ uninduced: 0.31 + 0.012, 
p-value 0.001). 
To determine whether reduced expression of katA and other oxidative stress-
response genes translates into an observable phenotype, the H2O2 sensitivity of PAO1 and 
PAO∆ampR was compared using the gradient plate method (540). PAO∆ampR 
demonstrates a concentration-dependent reduced growth compared to PAO1 on the H2O2 
gradient (Figure 5.6B), suggesting an impaired resistance to oxidative stress. This finding 
is in agreement with downregulation of oxidative stress response genes in PAO∆ampR. 
Thus, the transcriptomic and phenotypic data demonstrate a role for AmpR in 
positively regulating oxidative stress response in P. aeruginosa. 
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Figure 5.6: AmpR regulates resistance to oxidative stress. (A) Comparing the AmpR positively and negatively regulated genes against the 
oxidative stress gene set shows overlaps between the datasets. Overlapping genes include those identified previously to play a role in the oxidative 
stress response. (B) Gradient plates demonstrate decreased resistance of PAO∆ampR to H2O2, compared to the control plate without H2O2. 
Representative data from four independent experiments is shown. 
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AmpR regulates phenazine production by modulating expression of phzA1-G1 and 
phzA2-G2 operons 
The PAO∆ampR strain is impaired in producing pyocyanin (225). P. aeruginosa 
PAO1 and PA14 have two redundant operons phzA1-G1 (PA4210-PA4216; phz1 operon) 
and phzA2-G2 (PA1899-PA1905; phz2 operon) that are involved in biosynthesis of the 
phenazine precursor, phenazine-1-carboxylic acid (27). This precursor is then 
sequentially modified by a methyltransferase (PhzM, PA4209) and a monooxygenase 
(PhzS, PA4217) to form pyocyanin (541). All the genes involved in pyocyanin 
biosynthesis and export (phz1 and phz2 operons, phzM, phzS, mexGHI-opmD) was 
significantly downregulated in the ampR mutant (positive AmpR regulation) in the RNA-
Seq analysis [Figure 5.7A; (Appendix; Supplementary information for Chapter 5, Table 
2)]. Positive AmpR regulation of phzA1, phzA2 (the first genes of phz operons), phzH and 
phzM was also confirmed by qPCR (Figure 5.7B). The GOIDs under which phzM and 
phzS are classified (antibiotic metabolic processes, antibiotic biosynthetic processes, drug 
metabolic processes) also showed functional enrichment [log-odd ratio 3.46, p-value 
0.03; (Appendix; Supplementary information for Chapter 5, Table 5)]. Recently, it has 
been demonstrated that, in P. aeruginosa PA14, the phz1 operon is expressed in liquid 
cultures whereas the phz2 operon is responsible for phenazine production in solid cultures 
(541). It is therefore interesting to note that in PAO∆ampR, both operons are 
downregulated in liquid cultures, indicating positive AmpR regulation. The findings are 
possibly attributable to strain differences but are worth further investigation. 
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Figure 5.7: Regulation of phenazine genes by AmpR. (A) Genes involved in phenazine biosynthesis are 
significantly downregulated in PAO∆ampR as seen in RNA-Seq analysis. (B) Differential regulation of the 
first genes of the phenazine biosynthetic operons phzA1 and phzA2, and the modifying enzymes phzH and 
phzM were validated by qPCR. 
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The phz1 operon is known to be QS regulated while the regulators of the phz2 
operon are not known (388,541). Downregulation of the phz2 operon in PAO∆ampR 
suggests a potential positive regulatory role for AmpR of this operon and is a novel 
finding.  
The PQS system is also positively regulated by AmpR 
Of the 654 AmpR-dependent genes, 313 and 341 genes are positively and 
negatively regulated, respectively. Genes that are positively regulated include the QS-
regulated genes lasA, lasB, rhlAB and rhlR (Appendix; Supplementary information for 
Chapter 5, Table 2). In addition, AmpR also positively regulates the hcnABC operon, 
which is QS-regulated and is responsible for hydrogen cyanide biosynthesis (373). These 
concur with our previous findings that AmpR is a positive regulator of some QS 
phenotypes (225) and positive regulation of lasR and rhlR expression by AmpR was 
confirmed by qPCR (Figure 5.8). Furthermore, even under sub-MIC ß-lactam stress, 
AmpR positively regulated expression of lasR (RQ induced: 0.84 + 0.03, p-value 0.001) 
and rhlR (RQ induced: 0.71 + 0.007, p-value 0.0001). 
The PQS system is a critical part of QS signaling in P. aeruginosa, and 
complements the las and rhl systems (361,542). Genes of the two operons pqsABCDE 
(PA0996-PA1000) and phnAB (PA1001-PA1002), and pqsH (PA2587) are involved in 
PQS biosynthesis (543). PhnAB converts the PQS precursor chorismate to anthralinate, 
which is further converted to the signaling molecule PQS by PqsA-D and PqsH (380,543). 
The RNA-Seq data shows that AmpR positively regulates all these genes except for pqsH 
(Appendix; Supplementary information for Chapter 5, Table 2). 
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Figure 5.8: AmpR positively regulates critical QS regulators of the Las, Rhl and PQS systems. Expression of the genes was determined by qPCR. The 
expression levels in PAO∆ampR are shown, normalized to expression in PAO1. p-values * <0.02, ** < 0.003, *** <0.0005. 
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We validated the RNA-Seq data using qPCR and demonstrate positive regulation 
of the first gene of the pqs operon (pqsA), in addition to pqsH (Figure 5.8).  MvfR 
(PA1003) lies downstream of the pqs genes and positively regulates genes in this cluster 
(224,544). qPCR analysis reveals that AmpR positively regulates mvfR expression 
(Figure 5.8). Thus, it is likely that AmpR-mediated regulation of the PQS system in P. 
aeruginosa is via MvfR.  
In addition, QscR (PA1898), which is a QS regulator in P. aeruginosa (280) and 
is in the same locus as and upstream of the phzA2 operon, was also downregulated in the 
ampR mutant, as determined by qPCR (RQ: uninduced- 0.38 + 0.17, p-value 0.0057). 
This further supports the role of AmpR as a QS regulator.  
V5-tagged AmpR is functional in vivo 
 The previous and current study suggests that the AmpR regulon in P. aeruginosa 
is extensive (225,425). However, it is highly unlikely that all the genes are under direct 
AmpR regulation. AmpR possibly indirectly controls a subset of genes. Accordingly, we 
identified transcriptional regulators in the AmpR regulon that could be potential targets of 
AmpR direct regulation [Appendix; Supplementary information for Chapter 5, Tables 2, 
3, (225)]. Moreover, using the putative AmpR binding site (434), in silico analysis of the 
P. aeruginosa PAO1 genome identified potential genes that have an AmpR-binding site 
in their promoter (225). Some of these targets were confirmed to be differentially 
regulated using DNA microarrays (225). However, direct AmpR targets have not been 
demonstrated as yet. 
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 In order to identify the direct targets of AmpR, ChIP-Seq studies were performed 
using a 3x-V5-tagged AmpR integrated as a single copy on the chromosome. Since 
AmpR has a positive regulatory role in ß-lactam resistance, the functionality of the 
tagged AmpR was verified by determining the MIC. Amoxicillin had an MIC of 4 µg/ml 
for PAO∆ampR whereas the wild-type PAO1 is resistant (>256 µg/ml). The MIC of 
amoxicillin on PAO∆ampR::ampR-V5 was >256 µg/ml, similar to PAO1 indicating that 
tagging AmpR at the C-terminus did not inhibit function. Chromatin 
immunoprecipitation was then performed both in the presence and absence of sub-MIC ß-
lactam stress. Before proceeding with the high-throughput sequencing, validity of the 
pulldown was tested by qPCR for PampC. AmpR occupancy data for the ampC promoter 
revealed that compared to the input DNA, the ChIP DNA showed a 17.1 + 1.2-fold and 
21.5 + 4.3-fold higher occupancy, in the absence and presence of ß-lactam stress, 
respectively. This demonstrated that the tagged AmpR protein was able to effectively 
bind the ampC promoter in vivo. Thus, the MIC and ChIP-qPCR studies confirmed in 
vivo functionality of the V5-tagged AmpR protein. 
Identifying direct AmpR targets by ChIP-Seq 
After confirming functionality of the tagged AmpR protein in vivo, ChIP and 
input DNA samples were processed on the Helicos sequencer. Data analysis was 
performed on the CLC Genomics Workbench as described in the methods section. The 
target regions on the PAO1 genome that AmpR binds to are shown in Table 1. All the 
loci in the table have Wilcoxon p-values < 3.0E-05 and, thus, are significant. In 
agreement with the ChIP-qPCR data (previous section), ChIP-Seq data showed that  
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Table 5.1: AmpR ChIP peaks. ChIP-Seq studies were performed on P. aeruginosa 
PAO∆ampR strain harboring V5-tagged AmpR in the absence (uninduced) and presence 
(induced) of sub-MIC ß-lactam stress. Regions on the chromosome that were enriched in 
the ChIP DNA samples compared to the input DNA are shown. All readings have a 
Wilcoxon Filter p-value < 3.0E-05. 
 Uninduced 
Chromosomal Locus 
Average 
Read 
Length 
% Reads 
mapping 
to locus 
Strand FDR (%) 
Flanking Genes 
5' 3' 
586888-586930 42 88 + 2.0E-01 rsmY PA0528 
797294-797374 80 53 + 7.5E-01 PA0728 PA0729 
901840-901853 13 95 - 1.9E-01 PA0826 ssrA 
1668963-1669003 40 95 + 1.0E+00 ffs PA1531 
1921430-1921543 113 95 + 1.2E+00 oprF cobA 
3123393-3123411 18 83 - 5.3E-02 PA2763 PA2764 
4057616-4057641 25 89 - 1.6E-09 fdxA rsmZ 
4592895-4593005 110 97 - 1.3E-04 PA4108 ampR 
4362457-4362649 192 88 + 1.6E+00 PA4140 PA4141 
4782725-4783036 311 89 - 3.4E+00 rplA rplK 
4956459-4956671 212 91 - 1.9E+00 rnpB PA4422 
5387789-5387840 51 95 - 6.8E-02 PA4802 PA4802.1 
5884393-5884467 74 94 + 1.3E+00 ssrS PA5228 
5986032- 5986133 101 90 - 1.7E+00 rpmG rpmB 
6183549-6183590 41 88 - 2.6E+00 PA5492 polA 
 
 
Induced 
Chromosomal Locus 
Average 
Read 
Length 
% Reads 
mapping 
to locus 
Strand FDR (%) 
Flanking Genes 
5' 3' 
586884-586929 45 96 + 2.3E-03 rsmY PA0528 
901794-901852 58 92 - 3.1E-03 PA0826 ssrA 
1668962-1669008 46 98 + 6.3E-02 ffs PA1531 
3206872-3207029 157 96 + 1.0E-02 PA2852.1 oprI 
4057616-4057641 25 88 - 3.2E-05 fdxA rsmZ 
4592896-4593007 111 73 - 2.5E-03 PA4108 ampR 
4956491-4956668 177 91 - 1.9E-03 rnpB PA4422 
5308608-5308852 244 93 + 3.8E-02 crcZ PA4726.2 
5387787-5387840 53 94 - 7.2E-02 PA4802 PA4802.1 
5884382-5884467 85 93 + 3.7E-01 ssrS PA5228 
6183549-6183593 44 90 - 1.3E+00 PA5492 polA 
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AmpR binds to promoter DNA upstream of ampC under both induced and uninduced 
conditions (Table 1). This is typical of LysR-type transcriptional regulators, which bind 
their target sequences irrespective of effector binding (103,104) and is also seen in the 
PampC ChIP-qPCR (previous section).  
The region with the least % false discovery rate (FDR) value, irrespective of 
inducer presence, is within rgRsmZ (PA3621.1). The locus that was pulled down in ChIP 
is on the negative strand (Table 5.1) and corresponds to a 25 bp region within the rsmZ 
gene. AmpR-dependent regulation of the rsmZ gene was also seen previously in 
transcriptome studies using microarrays (225) and in the current RNA-Seq analysis 
(Appendix; Supplementary information for Chapter 5, Table 2). The rgRNAs rsmY and 
rsmZ are thought to be functionally redundant (545) and play a major role in the acute to 
chronic lifestyle transition of P. aeruginosa (209,210,390). Transcription of rsmY and 
rsmZ is repressed by NarL [PA3879, (546)], CafA [PA4477, (547)], and MvaT/U 
[PA4315, (390)] and is activated by GacA [PA2586, (548,549)].  
In an attempt to understand the role of AmpR this process, qPCR assays were 
performed with the other players of this well-established regulatory cascade (Figure 5.9). 
Two hybrid sensor kinases LadS (PA3974) and RetS (PA4856) have a positive and 
negative effect, respectively on the sensor kinase GacS (209,210). GacS activates 
transcription of rgRsmZ and rgRsmY indirectly through GacA (390). The rgRNAs rsmY 
and rsmZ sequester the RNA-binding protein RsmA (PA0905), which plays a key role in 
regulating over 500 genes, controlling the acute versus chronic lifestyle transition (458). 
qPCR analysis revealed that in the ampR mutant, expression of ladS (RQ: uninduced 0.35 
+ 0.018, p-value <0.0001 ; induced 0.42 + 0.012, p-value <0.0001), and rgRsmZ (RQ: 
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Figure 5.9: Quantitative PCR analysis of Gac-Rsm pathway genes. Relative expression of genes of 
the RetS-LadS-GacSA-Rsm pathway in PAO∆ampR compared to PAO1 was analyzed in the absence 
(grey bars) and presence (black bars) of sub-MIC b-lactam stress. Gene expression in the ampR 
mutant has been normalized to the corresponding condition in the wild-type strain and expressed as 
relative numbers of gene-specific transcripts. p-values: * < 0.02, *** < 0.0001. 
 
 
uninduced 0.43 + 0.059, p-value = 0.01; induced 0.71 + 0.006, p-value = 0.02) was 
downregulated, indicating that AmpR is required for their expression (Figure 5.9). No 
dysregulation of retS, gacS or gacA was observed (Figure 5.9). Our previous microarray 
studies (225), and our current RNA-Seq, qPCR and ChIP-Seq studies show that AmpR 
activates transcription of rgRsmZ. Furthermore, P. aeruginosa AmpR is a positive 
regulator of acute virulence factors, many of which were QS-regulated, while negatively  
regulating chronic infection phenotypes such as biofilm formation (225). The current 
ChIP-Seq data seems to suggest that this regulation by AmpR is mediated by the 
regulatory RNA rgRsmZ.  
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Binding site analysis 
 The ChIP data was used to identify the AmpR binding site. A region of about 200 
bp upstream of the genes that were identified to be AmpR-bound (Table 5.1) was used as 
input for regulatory sequence analysis tools [RSAT; rsat.ulb.ac.be; (423)]. These regions 
were queried using the putative AmpR-binding site identified earlier (434) and the matrix 
derived as part of genome-wide analysis of AmpR-binding (225). The AmpR binding 
sites that were identified in the promoter regions of the AmpR-regulated genes were then 
used as input to generate a WebLogo under both uninduced and induced conditions 
(Figure 5.10). The DNA motif that AmpR seems to bind, both in the presence and 
absence of effectors, is almost identical except for minor changes at positions 1, 2, 3 and 
5 (Panels A and B, Figure 5.10). The AmpR motif, like the LTTR box (104), is AT-rich 
and the bases that are critical for AmpR-binding seems to be A’s and T’s (at positions 1, 
6, 9, 10, 13 and 14; Figure 5.10).  
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Figure 5.10: ChIP-Seq data based AmpR binding site analysis. Promoters of the geens that were identified by ChIP-Seq to be AmpR-regulated, 
either in the absence or presence of ß-lactam stress, were scanned for the presence of the putative AmpR-binding motif using RSAT. The binding 
sites upstream of each gene were then used as input to generate a WebLogo for the uninduced (top panel) and induced (bottom panel). p-value 
0.001
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LasR is a direct target of AmpR 
 The regulator LasR is at the top of the QS regulatory hierarchy in P. aeruginosa 
(363,364,370). Other regulators, in addition to LasR, regulate the Rhl and PQS systems 
[reviewed in (511)]. Our findings have identified that AmpR is one of these regulators 
[Figure 5.8; (225)]. One of these regulators is AmpR, which has been demonstrated 
previously to positively regulate the Las and Rhl systems transcriptionally (PQS section 
above) and phenotypically (225). ChIP-Seq data suggested that AmpR regulates the QS 
master regulator LasR directly (Table 5.1), and the presence of a putative AmpR binding 
motif upstream of the LasR ORF strengthens the finding. In order to validate the ChIP-
Seq data, ChIP-qPCR was performed for selected targets using the V5-tagged AmpR 
strain. 
 As expected, the ampC promoter showed 79-fold enrichment in the ChIP DNA 
compared to the control DNA, demonstrating strong AmpR binding. AmpR pulldown of 
PampC was also confirmed using a VSVG-tagged AmpR (data not shown), and agrees with 
previous observations that AmpR is a positive regulator of ampC expression by direct 
binding to PampC (550). ChIP-qPCR data also showed that the lasR promoter showed 3-
fold enrichment compared to the input DNA indicating direct binding of AmpR to PlasR. 
This binding, though not as strong as AmpR binding at PampC, is significant. 
Transcriptome and phenotypic data show that even at this reduced binding AmpR is able 
to bring about significant changes in the QS system [Figure 5.8, (225)].     
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Comparison of microarray, RNA-Seq and proteome data  
 In order to get a comprehensive picture of AmpR regulation in P. aeruginosa, we 
have performed transcriptomics studies, using DNA microarrays (225) and RNA-Seq 
(this study), and proteomics analysis (unpublished data). The transcriptomics and 
proteomics studies were performed using the same two strains (PAO1 and PAO∆ampR), 
under identical conditions (without and with sub-MIC ß-lactam stress). Comparing the 
microarray and RNA-Seq datasets revealed little overlap in the number of genes 
regulated (Figure 5.11). This seems contrary to previous findings that demonstrate a 
better overlap between data from the two techniques (551-553). However, several genes 
that were identified in the microarray studies to be AmpR-regulated (225) were also 
identified in the RNA-Seq study. Examples have been discussed in the previous sections 
and include both positively regulated (numerous QS-regulated genes, ampC) and 
negatively regulated (mexEF-oprN, alginate regulators) genes. Thus, though the total 
number of genes showed poor overlap between the transcriptome assays, the phenotypes 
regulated are the same. Further, similar to previous studies with other systems (554,555), 
there is a poor overlap between the AmpR transcriptome and proteome studies (Figure 
5.11). This can be attributed to a variety of reasons that may be technical (sample 
preparation, sensitivities of the techniques) or functional (post-transcriptional and/or post-
translational regulation). For example, in Desulfovibrio vulgaricans, variations between 
mRNA and protein levels were attributed to differences in expression (34-44%), stability 
of protein (5%) and mRNA (2%) (556). Codon usage, amino acid composition, and the 
Shine-Dalgarno sequence contributed to an additional 15-26% variation (555). 
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Figure 5.11: Comparative analyses of AmpR microarray, RNA-Seq and proteome datasets. The AmpR positive (A), AmpR-negative (B), AmpR-
ß-lactam positive (C) and AmpR-ß-lactam negative (D) gene sets from our previous microarray (225) and the proteome (unpublished) studies were 
compared with the RNA-Seq data from the current study.
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With the AmpR-positively regulated gene set (Figure 5.11A), genes of the type VI 
secretion system (PA1657, PA1662, PA1664), the hydrogen cyanide biosynthetic operon 
hcnABC (PA2193-PA2195), and the membrane fusion component of the MexGHI-OpmD 
efflux pump (MexH, PA4206) are positively regulated in both the microarray and RNA-
Seq datasets. In agreement with our previous phenotypic assays (225), LasA (PA1871), a 
QS-regulated protease is also differentially expressed at the protein level (Figure 5.11A). 
PopD (PA1709), which along with PopB (PA1708) forms the translocation pore on the 
eukaryotic cell surface for injection of T3SS effectors (557), is AmpR-positively 
regulated in both the microarray and proteome analyses. 
 Using an insertion mutant of ampR and transcriptional fusions, we have 
previously demonstrated crosstalk between AmpR and the alginate master regulator 
AlgT/U, where AmpR negatively regulates AlgT/U, which in turn positively regulates 
ampR expression (425). In addition, AmpR also negatively regulates the anti-anti-sigma 
factor MucB (PA0764), as seen in both microarray and RNA-Seq analyses (Figure 5.11 
B). The genes encoding AlgT/U and MucB are part of the same operon (algT/U-mucA-
mucB-mucC-mucD) and the apparent contradiction in AmpR-mediated regulation of 
algT/U and mucB is most likely resolved at the posttranscriptional level. Genes of the 
mexEF-oprN efflux pump are also downregulated in both the transcriptome analyses 
(Figure 5.11B), and concurs with data from MIC studies (225). The positive regulator of 
pyocin production PrtN (PA0610) was identified in both the microarray (AmpR 
negatively regulated) and proteome studies (AmpR negatively regulated under ß-lactam 
stress; Panels B, D, Figure 5.11). This concurs with the upregulation of about 39 genes of 
the pyocin cluster PAO∆ampR in the microarray analysis (225).  
 189
 AmpR negatively regulates PA4378 in the microarray, and RNA-Seq analyses. 
PA4378 is annotated as InaA that has a 61% similarity to the pH-inducible protein InaA 
in E. coli (27). It is part of a three-gene operon (PA4377-PA4379) and both the array and 
RNA-Seq data show that in addition to PA4378, PA4379 is also upregulated (AmpR 
negative regulation). In P. aeruginosa PA7, the gene PA4378 is annotated as a 
lipopolysaccharide kinase (27). BLASTP analysis reveals that the PA4378 has homologs 
in other species of Pseudomonas in addition to strains of P. aeruginosa (data not shown) 
and the operon is part of the core genome in P. aeruginosa strains (33). InaA has also 
been identified previously in Erwinia ananas to be involved in ice nucleation (558). In E. 
coli, inaA expression is regulated by SoxRS, the superoxide stress response system, and 
marRAB the multiple antibiotic resistance (Mar) operon (559). Downregulation of inaA 
expression by AmpR in both transcriptome studies, along with positive regulation of 
oxidative stress (Figure 5.6), suggests that AmpR might regulate inaA and oxidative 
stress via SoxRS. However, there was no differential regulation of soxRS in the 
transcriptome studies.  
Discussion 
In the opportunistic human pathogen P. aeruginosa, gene expression is a tightly 
controlled process and many regulators act in concert to control virulence traits (511,512). 
In silico analyses and empirical evidence have identified critical regulators such as Vfr, 
the P. aeruginosa homolog of the E. coli cAMP receptor protein (CRP), to be central to P. 
aeruginosa pathogenicity (355,560-562). This study establishes the role of P. aeruginosa 
AmpR as not only a regulator of virulence factors but also important physiological 
processes such as response to oxidative stress and heat shock. AmpR positively regulates 
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the stress sigma factor RpoS and a growth phase-dependent expression of some RpoS-
regulated virulence factors has been demonstrated in PAO∆ampR (225). So, a subset of 
the AmpR-regulated genes is possibly regulated via RpoS. In addition, subtractive 
transcriptomics of the AmpR regulon identified AmpR-regulated genes that were not 
shared with other transcriptomes (225). RNA-Seq has a better coverage than microarrays 
in detecting transcript levels (563). Expression of some genes that were not identified in 
the microarrays was differentially regulated in the AmpR RNA-Seq study. In this study, 
we identified some sRNAs to be targets of AmpR regulation. Selected sRNAs were 
pursued further to establish a phenotypic difference arising due to AmpR-mediated 
regulation.  
Iron acquisition is a critical determinant of P. aeruginosa pathogenicity and has 
been proposed as a potential target to counter infections (564). In the healthy lung, iron is 
typically bound by ferritin and transferrin, and free iron is available only in very low 
quantities (565). In the CF lung, however, higher iron concentration is a potential reason 
that allows bacteria such as P. aeruginosa to colonize (565). The primary mode of 
sequestration of extracellular iron in P. aeruginosa is by use of the siderophores 
pyoverdine and pyochelin produced under iron-limiting conditions (566,567). AmpR 
positively regulates iron uptake, as evidenced by a reduced expression of both 
siderophore gene expression and PQS in PAO∆ampR, and growth impairment under iron-
limited conditions (Figure 5.4). However, since iron is not a limiting factor in the CF lung, 
as evidenced by iron-rich CF sputa (565,568), AmpR is likely not important in iron 
uptake in this setting.  
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In the CF lung, P. aeruginosa turns mucoid by overproducing the extracellular 
polysaccharide alginate in response to the H2O2 released by polymorphonuclear 
leukocytes (569). It has also been established that the ECF sigma factor AlgT/U is the 
master regulator of alginate production by turning on expression of the algD operon 
(481). Thus, the enhanced sensitivity of PAO∆ampR to H2O2 is interesting in the light of 
the fact that AmpR negatively regulates algT/U expression in response to unidentified 
signals (425). Taken together, these studies suggest that, on one hand, AmpR negatively 
regulates alginate production by repressing algT/U transcription, while on the other hand, 
is required for resistance against H2O2, which turns on alginate production. Thus, when 
the bacterium is in the CF lung, the role of AmpR in establishing chronic infections 
seems conflicting. One possible explanation for this seemingly contradictory data is the 
role of other regulators. Even though loss of AmpR leads to enhanced algT/U 
transcription, posttranslational control by the anti-sigma factor MucA prevents AlgT/U-
mediated algD transcription (570). Moreover, gene regulation is a complex interlinked 
process in P. aeruginosa and multiple tiers of regulation for critical pathways is common 
(511,560,571).  
Positive regulation of iron uptake, PQS and oxidative stress by AmpR seem to be 
disparate phenotypes but they are, in fact, interlinked [Figure 5.12, (511)]. The 
relationship between iron uptake and QS is complex and some transcriptional regulators 
involved in QS regulation also modulate iron response (168,572,573). MvfR is one such 
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Figure 5.12: AmpR-mediated regulation of virulence and physiological processes in P. aeruginosa. AmpR affects expression of QS genes by 
directly binding to PlasR and modulating lasR expression. AmpR also positively regulates the PQS system by modulating levels of the antisense RNA 
asPrrF1, thus also affecting iron uptake. By regulating expression of the stationary phase sigma factor RpoS (225), oxyR and the small RNA rgRgsA, 
AmpR positively regulates the oxidative stress response. The genes encoding the Hsp70 heat-shock response system are also positively regulated 
by AmpR. This, and previous findings (225) demonstrate that AmpR is a major regulator of virulence and physiological processes in P. aeruginosa.
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example. The iron-responsive sigma factor PvdS (PA2426) turns on mvfR transcription in 
response to iron starvation (144,574). Our data demonstrates that AmpR positively 
regulates mvfR expression (Figure 5.8). Furthermore, the antisense RNAs asPrrF1 and 
asPrrF2 positively regulate production of the signaling molecule PQS (575), which helps 
in iron chelation, facilitating the activity of pyoverdine and pyochelin (378,384,576). We 
show here that AmpR positively regulates asPrrF1, but not asPrrF2, in addition to the pvd 
and pch genes, thus affecting iron uptake and PQS synthesis. AmpR also positively 
regulates the stationary phase sigma factor RpoS and some RpoS-regulated genes such as 
the galactophilic lectins LecA and LecB (225). Since the link between QS and RpoS is 
established (366,368), AmpR regulation of both these processes is not surprising (Figure 
5.12). RpoS also positively regulates expression of the sRNA rgsA (PA2958.1), which is 
also regulated by GacA, and contributes to hydrogen peroxide resistance in P. aeruginosa 
(536). AmpR also plays a role in this process, as demonstrated here (Figure 5.12). 
PAO∆ampR shows dysregulation of not only rpoS and the sRNA rgsA but also OxyR, the 
major regulator of the catalase KatA that ultimately affects resistance to hydrogen 
peroxide (Figure 5.12).   
CF lung isolates are known to be heterogeneous genotypically and phenotypically 
[reviewed in (577)]. Higher mutation rates are the driving force for the P. aeruginosa 
population heterogeneity in the CF lung (578-580). Specifically, mutations in mucA and 
lasR arise early in the colonization process, followed by mutations in anti-mutator genes 
such as mutS, mutT, mutY and mutM (581). MucA mutations trigger the regulated 
intramembrane proteolytic cascade, freeing AlgT/U and allowing for overexpression of 
alginate [reviewed in (582)]. Mutations in lasR would abolish expression of QS-regulated 
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acute virulence factors [reviewed in (583)]. In the CF lung, P. aeruginosa loses the 
ability to produce acute virulence phenotypes after initial colonization and starts to 
overexpress chronic infection traits (584). AmpR negatively regulates algT/U expression, 
which is a chronic infection phenotype (425). AmpR mutant strains display some 
characteristics reminiscent of CF isolates, including acquisition of fluoroquinolone 
resistance, reduced production of QS-regulated virulence factors such as proteases and 
pyocyanin, and enhanced biofilm formation [this study, (225)]. Furthermore, PAO∆ampR 
RNA-Seq studies show upregulation of the genes mutY (PA5147; 2.4-fold, p-value 9.25E-
06) and mutM (PA0357; 2.6-fold, p-value 5.28E-06) under ß-lactam stress (Appendix; 
Supplementary information for Chapter 5, Table 3), indicating negative AmpR regulation. 
So, one would expect the mutation frequencies of PAO∆ampR to be lower than PAO1, 
given that some anti-mutators are overexpressed. However, the mutation frequencies for 
rifampicin and streptomycin were not significantly different between PAO1 and 
PAO∆ampR (data not shown). This seeming contradiction is not surprising since mutY 
and mutM are known to be weak anti-mutators in P. aeruginosa and potentially have a 
lower effect than strong anti-mutators such as MutS (581). The data suggests that 
inactivating ampR in the CF lung, in addition to other mutations, will help P. aeruginosa 
colonize better. However, the occurrence and frequency of ampR mutations in CF isolates 
needs to be determined. 
Our previous and current analyses showed that AmpR positively regulates QS by 
modulating expression of major QS regulators such as LasR [Figure 5.8, (225)]. ChIP-
Seq and complementary data demonstrate that AmpR directly binds to and activates lasR 
expression, thus modulating QS phenotypes. AmpR binding site analysis using the ChIP-
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Seq data revealed a motif that was very similar to that identified in our previous studies 
using microarray studies (225). Comparatively however, the motif in Figure 5.10 appears 
to be more refined and is likely to resemble the AmpR binding site closely because it is 
based on the promoters of genes identified in the ChIP study. Minor motif variations 
from the consensus sequence are expected. For this reason, identifying consensus 
sequences for transcription factor binding motifs using data from multiple promoters is 
likely to be more accurate compared to footprinting studies that look at individual 
promoters. 
In conclusion, the data presented here, and previously by our lab, demonstrate that 
P. aeruginosa AmpR is a critical component of not only virulence and metabolic 
regulation but also physiological processes. The clinical significance of AmpR is 
highlighted in a recent study, which demonstrated that constitutive AmpR-activating 
mutations were responsible for AmpC overproduction in extremely drug-resistant high-
risk P. aeruginosa clinical isolates (585). Moreover, given the global effect that AmpR 
has on the regulatory repertoire of P. aeruginosa, it is likely that other virulence traits 
exhibited by high-risk clinical isolates (585) are also AmpR-mediated. Small molecule 
inhibitors targeting specific proteins such as P. aeruginosa NagZ (123) and Vibrio 
cholera LuxO (586) show therapeutic promise. Inhibitors of AmpR function will render 
the strain sensitive to ß-lactam antibiotics and reduce the production of acute virulence 
factors. Thus, combination therapies using AmpR inhibitors and antibiotics will 
potentially provide us with means to counter P. aeruginosa infections, and warrants 
further investigation. 
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Materials and methods 
Strains, media and culture conditions 
 The strains used in this study are listed in Table 5.2. The wild-type P. aeruginosa 
PAO1 and its isogenic in-frame ampR deletion strain, PAO∆ampR used in this study are 
described earlier (25,225). These strains were used for the RNA-Seq study, with and 
without sub-MIC ß-lactam stress, essentially as described previously (225). 
 For ChIP-Seq studies, AmpR was tagged at the 3’ end with a 3x-V5 epitope tag. 
Briefly, the 3x-V5 epitope was PCR amplified from plasmid ZM474 (587) using primers 
DBS_V5F and DBS_V5R containing KpnI and NheI sites, respectively. The NheI site 
also contains termination codons in all three reading frames to prevent runoff 
transcription into the plasmid. The 3x-V5 amplicon was cloned into pCR2.1 TOPO 
(Invitrogen) to generate plasmid pDBS206 and sequenced to ensure absence of mutations. 
The ampR ORF with the native promoter but without the stop codon was PCR amplified 
using primers DBS_ampRF1 (with a KpnI site) and DBS_ampRR (with a SacI site), 
cloned into pCR 2.1 TOPO (pDBS215) and sequenced. The 1112-bp ampR ORF with the 
native promoter was then moved as a KpnI-SacI fragment from pDBS215 upstream of 
and in-frame with the 3x-V5 tag in pDBS206 to obtain plasmid pDBS222. The 3x V5-
tagged ampR was then moved into mini-CTX2 [pDBS227; (588)] as a KpnI-NheI 
fragment, generating plasmid pDBS234. After confirmation by PCR and restriction 
digestion, the plasmid pDBS234 was moved into PAO∆ampR by electroporation (500). 
This resulted in strain DBS248 that was used for the ChIP-Seq studies. Functionality of 
the tagged AmpR in DBS248 was verified by determining the MIC of the ß-lactams 
ampicillin-sulbactam and amoxicillin, and by ChIP-qPCR. 
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Table 5.2: Strains and plasmids used in this study 
Strain/ plasmid Relevant characteristics Source 
Strains 
  Escherichia coli 
      DH5α General purpose cloning strain; Δ(lacZ)M15  New England Biolabs 
      DBS206 E. coli DH5α harboring 3x-V5 tag on pCR2.1 TOPO This study 
      DBS215 DH5α with ampR ORF and the ampR-ampC intergenic region PCR cloned into pCR2.1 TOPO This study 
      DBS222 DH5α harboring ampR ORF tagged with 3x V5-tag on pCR2.1 TOPO This study 
      DBS234 DH5α with mini CTX2, containing 3x V5-tagged ampR This study 
  Pseudomonas aeruginosa 
      PAO1 Wild-type (25) 
      PKM315 PAO∆ampR; In-frame deletion of ampR (PA4109)  (225) 
      DBS248 PAO∆ampR::ampR-V5; 3x-V5-tagged ampR cloned onto mini-CTX2 and moved into PKM315 This study 
Plasmids 
      pCR2.1 TOPO TA cloning vector for PCR products; ApR, KmR; 
ColE1 f1 ori lacZα 
Invitrogen 
      ZM747-V5 3x V5 tag C-term and N-term of yeast URA-3 in 
pBlueScript; pDBS193 
(587) 
      Mini CTX2 Plasmid for single-copy gene integration in P. 
aeruginosa; TcR 
(588) 
      pDBS206 3x V5 tag PCR amplified from ZM747-V5 and 
cloned into pCR2.1 TOPO 
This study 
      pDBS215 1112 bp ampR ORF along with the ampR-ampC 
intergenic region, PCR amplified with primers 
DBS_ampRF1 and DBSampR; cloned into pCR2.1 
TOPO 
This study 
      pDBS222 ampR ORF from pDBS215 subcloned as KpnI-SacI 
upstream of and inframe with 3x V5 tag in 
pDBS206 
This study 
      pDBS234 3x V5-tagged ampR ORF from pDBS222 
subcloned as a KpnI-NotI fragment into mini-CTX2 
This study 
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All strains were grown in standard LB media with aeration, unless otherwise 
specified. Synthetic succinate medium (SSM) was used as the iron-limited media (528) 
and contained (g/l) K2HPO4 6.0, KH2PO4 3.0, (NH4)2SO4 1.0, MgSO4.7H2O 0.2, sodium 
succinate 4.0, pH 7.0. Antibiotics were used at the following concentrations: for E. coli - 
gentamycin 15 µg/ml, tetracycline 15 µg/ml, ampicillin 100 µg/ml; for P. aeruginosa - 
gentamycin 75 µg/ml, tetracycline 60 µg/ml, carbenicillin 150 µg/ml. 
Library preparation for RNA-Seq analysis  
Total RNA was isolated from PAO1 and PAO∆ampR with and without sub-MIC ß-
lactam stress as described previously (225) using the hot-phenol extraction protocol (589). 
RNA quality was analyzed on the Agilent Bioanalyzer and those with RNA Integrity 
Numbers of 8.0 or above was used for rRNA depletion using the MICROBExpress Kit 
(Ambion). After rRNA depletion, cDNA synthesis was performed using the SuperScript 
III First-Strand Synthesis System (Invitrogen) as per manufacturer protocols. Terminal 
transferase (New England Biolabs) and dATP (New England Biolabs) were used to poly-
A tail the cDNA samples to obtain tail lengths of 100-300 bases following manufacturer 
instructions. The 3’ ends were then blocked with biotinylated ddATP (Perkin Elmer) 
using terminal transferase (New England Biolabs), flowed by cleanup with the MinElute 
cleanup kit (Qiagen). Tailed and blocked samples were then processed on the HeliScope 
Single Molecule Sequencer at the Molecular Biology Core Facility, Dana Farber Cancer 
Institute, Boston, MA. 
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ChIP-Seq sample preparation 
For ChIP-Seq studies, the 3x-V5-tagged AmpR containing strain (DBS248) was 
grown and exposed to sub-MIC ß-lactam stress as described previously (225). Protein-
DNA interactions were then crosslinked in vivo with formaldehyde (final concentration 
of 1%) at room temperature for 20 minutes and quenched for 15 minutes with 0.25 M 
glycine. After three washes with 1X PBS, the cells were resuspended in 1 ml lysis buffer 
(10 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% deoxycholic 
acid and 0.5% N-laurylsarcosine) containing a protease inhibitor cocktail (Roche). After 
chilling on ice, the cells were sonicated to shear the DNA to a size range of 0.5-1 kb. 
Cellular debris was removed by centrifugation and a 3 µl aliquot of the supernatant was 
checked on an agarose gel. A 50 µl aliquot of the supernatant was stored as the input 
DNA and the rest was immunoprecipitated using DynaBeads Protein G (Life 
Technologies), which was previously equilibrated and bound with anti-V5 monoclonal 
antibody (Sigma) as per manufacturer instructions. After immunoprecipitation overnight, 
the beads were washed 5x with RIPA buffer (50 mM HEPES pH 7.5, 500 mM LiCl, 1 
mM EDTA, 1% NP40, 0.7% deoxycholic acid, 50 mM NaCl in 1xTE). The beads were 
resuspended in 100 µl elution buffer (50 mM Tris-HCl, 10 mM EDTA, 1% SDS) at 65˚C 
for 30 minutes, centrifuged to remove residual beads and incubated at 65˚C overnight to 
reverse the crosslink. TE buffer was then added (100 µl) and the samples were treated 
with RNase (37˚C for 2 hours). The immunoprecipitated proteins were removed with 
proteinase K (55˚C for 2 hours), and the DNA cleanup performed using the Qiagen Mini 
Reaction Cleanup kit. RNase and proteinase K treatment was also performed for the input 
DNA. DNA concentrations were determined using Quant-iT PicoGreen dsDNA Kit (Life 
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Technologies).  Before proceeding further, AmpR occupancy of the ampC promoter was 
determined using qPCR as described previously (225). 
The DNA samples were then poly-A tailed, blocked with biotinylated ddATP, 
purified and processed on the Helicos sequencer as described in the RNA-Seq section. 
Data analysis for RNA-Seq and ChIP-Seq 
 The raw data files for both RNA-Seq and ChIP-Seq studies from the Helicos 
sequencing runs were converted to the FASTA format using Helisphere Open Source 
project. The sequence reads were then mapped to the P. aeruginosa PAO1 genome 
(NCBI reference sequence NC_002516.2) using CLC Genomics Workbench, version 5 
(CLC Bio). For RNA-Seq analysis, replicates of each sample were merged and pairwise 
comparisons were performed to obtain comparative expression. The total number of reads 
per gene between samples was normalized using RPKM ([reads/kb gene]/[million reads 
aligning to the genome]). Bonferroni correction was performed and FDR p-values were 
calculated. For RNA-Seq, only genes with a proportions fold-change of >2.0 and with 
Bonferroni corrected p-value of <0.05 were considered for further analysis. For ChIP-Seq, 
in addition to calculating FDR, peaks were shifted based on read length and filtered using 
a maximum Wilcoxon p-value of 1.0E-04. 
Enrichment of functional categories  
 The gene sets that were positively and negatively regulated by AmpR without and 
with ß-lactam stress were functionally categorized based on the Pseudomonas Genome 
Database (27). Gene distribution under individual categories in PAO1 was considered as 
100% and the relative distributions in each of the four gene sets were plotted. Enrichment 
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of specific functional categories in the individual datasets were determined using 
GOEAST (518). The Log odds-ratio was calculated for the GOEAST enrichment. The 
bigger the value of the ratio, the higher the relative abundance of the GO term is 
compared to a random condition. 
Quantitative real-time PCR (qPCR) assays 
 Genes that were differentially regulated in the RNA-Seq analysis, and those that 
had not been tested in our previous microarray analysis (225) were selected for qPCR 
confirmation. RNA isolation and cDNA synthesis were performed as described 
previously (225). Ten nanograms of cDNA were used per reaction well in the qPCR 
assays. Expression of the test genes was normalized to clpX (PA1802).  
Hydrogen peroxide sensitivity 
 To determine differences in H2O2 sensitivities of PAO1 and PAO∆ampR, 
gradient-plate assay was used (540). Briefly, 37 ml of LB agar held at 50˚C was 
supplemented with 4-8 µM H2O2 and poured onto tilted 90 mm petri dishes. After 
solidification, 37 ml of LB agar without H2O2 was poured onto the plates on a flat surface 
to generate a gradient. OD600 normalized overnight LB cultures of the strains were then 
used to form a 75 mm streak across the gradient using a cotton swab. H2O2 sensitivity 
was scored as the extent of growth into the gradient, compared to the control (on LB 
plates without H2O2). The assay was performed in triplicate and representative results are 
shown. 
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Growth in iron-limited media 
 The differential growth abilities of the ampR mutant vis-à-vis the wild-type strain 
were determined on SSM (528). Input cells for the growth curve assays were grown 
overnight in SSM from fresh LB plates. For the assay, the OD600 of the SSM cultures 
were normalized to 0.02 in SSM and the OD 600 of 200 µl aliquots in 96-well flat bottom 
tissue culture plates (Nunc) was monitored for 17 hours at 37 ˚C. Conditions were made 
iron-replete conditions by supplementing SSM with 100 µM FeCl3 (528).  
Temperature sensitivity assays 
 The ability of PAO1 and PAO∆ampR to resist elevated temperatures was 
examined. Briefly, cells grown in LB broth to either the log (OD600 0.6-0.8) or 
stationary (OD600 >2.0) phase at 30˚C were exposed to 50˚C for 1-3 hours. Control 
aliquots were maintained at 30˚C as controls. Cell counts were determined for test and 
control samples before and after exposure by plating for CFUs. 
Statistical analyses 
 All the data from qPCR and phenotypic assays were examined for statistical 
significance using the unpaired two-tailed t-test on GraphPad analysis software 
(www.graphpad.com). RNA-Seq and ChIP-Seq data were analyzed for significance on 
CLC Genomics Workbench as described above. 
 
Acknowledgments 
I thank Hansi Kumari (Mathee lab, FIU) for help with the experiments and critical 
reading of the manuscript, Deborah Yoder-Himes (University of Louisville), Bryan 
  203
Davies and William Robins (Mekalanos lab, Harvard Medical School) for guidance and 
helpful discussions with RNA-Seq and ChIP-Seq. This work was funded by National 
Institutes of Health-Minority Biomedical Research Support SCORE grants (S06 
GM08205 and 5SC1AI081376, to K.M.), Florida International University (FIU) Research 
Assistantship (Herbert Werthiem College of Medicine, to D.B.) and FIU University 
Graduate School Dissertation Year Fellowship (to D.B.).  
 
 
  204
 
 
CHAPTER 6 
 
 
Discussion 
 
 
 
 
Parts of this chapter have been published: 
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A dynamic and intricate regulatory network determines Pseudomonas aeruginosa 
virulence. Nucleic Acids Research. 41(1): 1-20. 
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Metabolic versatility, intrinsic and acquired antibiotic resistance, biofilm 
formation, and production of multiple virulence factors make P. aeruginosa a formidable 
pathogen. The virulence machinery of P. aeruginosa is comprised of both cell-associated 
determinants (such as lipopolysaccharides, pili, flagella) and numerous secreted factors 
(such as elastases, proteases, exotoxins, pyocyanin, extracellular polysaccharides; Figure 
6.1). One of the mechanisms by which P. aeruginosa senses external signals is using 
sensor proteins that, via phosphotransfer or phosphorelay, activate specific transcriptional 
regulators. These sensor-regulator protein pairs are called two-component systems (TCS). 
The P. aeruginosa PAO1 genome encodes about 127 TCS members, compared to 60 in 
Escherichia coli (590) and 70 in Bacillus subtilis (591), reflecting the adaptability of P. 
aeruginosa. TCS and their modifications also feed into major regulatory pathways and 
play a critical role in allowing cells to modulate gene expression in response to 
environmental conditions (213,592). Many of the secreted virulence factors and 
phenotypes such as biofilm formation are under the control of a cell density recognition 
mechanism called quorum sensing (QS) that aids in the coordinated expression of genes 
(208,451). QS is key to virulence gene expression in many bacteria and serves as an 
attractive target for antibacterial chemotherapy (593).  
In humans, acute P. aeruginosa infections in specific sites such as the CF lung 
eventually lead to chronic infections. This is caused by adaptive modifications in the 
infecting clonal type resulting in diverse morphotypes (594). The transition to a chronic 
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Fig 6.1: P. aeruginosa virulence determinants. The major cell-associated and secreted virulence factors 
of P. aeruginosa are shown. 
 
 
infection phase is the result of numerous changes in cellular physiology in response to 
external stimuli. The changes include downregulation of acute virulence genes with a 
concomitant upregulation of chronic infection phenotypes and antibiotic resistance, 
facilitating recalcitrant infections [reviewed in (595)]. Successful establishment of 
chronic infection (host invasion, establishment of acute infection and the subsequent 
transition to the chronic phase) involves tightly regulated expression of many genes 
associated with metabolism, virulence and antibiotic resistance. Several key players in 
these transition processes have been identified and include transcriptional and post-
transcriptional regulators (209,210,225).  
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Gene regulation in P. aeruginosa is a complex process involving numerous 
transcriptional regulators, regulatory RNAs (rgRNA) and sigma factors. The P. 
aeruginosa genome is over 6 MB (25), approaching that of lower eukaryotes. The 
genome is plastic and has acquired genes and undergone extensive rearrangements in 
order to adapt to specific niches (33). The large genome of P. aeruginosa supports a 
multitude of regulatory networks with approximately 8% of the total genome dedicated to 
the regulatory proteins (27). P. aeruginosa PAO1 encodes 434 putative and identified 
transcriptional regulators, 24 putative sigma factors and 34 predicted small RNAs 
(25,519,560,596). Moreover, predicted regulatory networks indicate that there is an 
extensive crosstalk between the different transcriptional regulators (560,597). These 
networks, however, are based in part on in silico analyses and their validity needs to be 
established. Understanding the virulence regulatory networks in P. aeruginosa will 
provide a framework for future studies to better understand pathogenic processes in P. 
aeruginosa and in related bacteria. 
P. aeruginosa AmpR is a major regulator of antibiotic resistance 
Antibiotic resistance is a major concern when dealing with P. aeruginosa 
infections in the hospitals. The current treatment regimen for P. aeruginosa infections is 
a combination therapy of aminoglycosides, quinolones and ß-lactam antibiotics (84). The 
major chromosomally encoded ß-lactamase that determines ß-lactam resistance in P. 
aeruginosa is AmpC. Previous studies have established that mutations leading to loss of 
AmpR function render the strain sensitive to ß-lactam antibiotics (105). Also, 
transcriptional fusions and mutation studies of PampC in ampR knockout strains have been 
used to demonstrate the positive regulatory role of AmpR at the ampC promoter [O. 
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Caille, unpublished data, (105)]. AmpR, a member of the LysR family of transcriptional 
regulators, is thus a critical player in determining resistance to the ß-lactam class of 
antibiotics. AmpR also positively regulates MexR (Chapter 4), a positive regulator of the 
MexAB-OprM efflux pump, which contributes to ß-lactam resistance. The CreBCD 
system is known to be involved in regulating ß-lactam resistance (124,348) and AmpR 
regulates CreD in a CreB-independent manner (Chapter 4). Thus, AmpR regulates ß-
lactam resistance in more ways than one.  
Furthermore, AmpR functions as a negative regulator of a second chromosomal ß-
lactamase, an oxacillinase termed PoxB, whose activity spectrum is limited primarily to 
carbapenems [D. Zincke, unpublished data; (106)]. The physiological significance of 
negative regulation of poxB ß-lactamase expression by AmpR is not yet clear. EMSA 
studies suggest indirect regulation of poxB by AmpR (O. Caille, unpublished data), 
although it is possible that recognition and binding of Ppox by AmpR requires as yet 
unidentified signals. Interestingly, although PoxB is classified as an oxacillinase based on 
sequence homology with other oxacillinases, it demonstrates no significant activity 
against oxacillin (D. Zincke, personal communication).    
In addition to regulating ß-lactam resistance positively, AmpR also regulates 
quinolone resistance (Chapter 4). Gene expression and phenotypic assays indicate that 
AmpR negatively regulates transcription and ultimately function of the mexEF-oprF 
efflux system, by modulating expression of the positive regulator MexT (Chapter 4). 
Repression of mexT expression by AmpR is ß-lactam independent (Chapter 4). It is 
interesting that AmpR positively and negatively regulates resistance to ß-lactams and 
quinolones, respectively. Furthermore, phenotypic microarray data suggests that AmpR 
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influences resistance to many multiple antibiotics (Chapter 4), and is thus among the very 
few identified transcriptional regulators in P. aeruginosa that regulate resistance to 
different classes of antibiotics.  
AmpR regulates quorum sensing in P. aeruginosa 
 Quorum sensing (QS) is a mechanism that bacterial cells use to gauge population 
densities that allow them to coordinate gene expression (165). Intercellular 
communication is particularly useful in the case of opportunistic pathogens to coordinate 
expression of virulence factors, and when the cells are part of microbial communities 
called biofilms (208). In P. aeruginosa, expression of many of the acute virulence factors 
is under QS regulation [reviewed in (598)]. Also, the decision to form biofilms in 
planktonic cultures is QS-influenced (599). Previous studies using an insertion mutant of 
ampR indicated that AmpR is a negative regulator of some QS-regulated virulence factors, 
such as the production of pyocyanin, and extracellular proteases such as LasA and LasB 
(105). However, using a clean in-frame deletion strain, gene expression and phenotypic 
studies, this dissertation shows that AmpR is really a positive regulator of QS-regulated 
acute virulence factors that are under Las-Rhl regulation (Chapter 4). The discrepancy 
between the insertion and deletion mutants is probably because in the insertion mutant, 
the AmpR HTH domain remains unaffected [Chapter 4; (106)]. Furthermore, RNA-Seq 
data also shows that AmpR positively regulates the PQS signaling system (Chapter 5). 
Thus, AmpR positively regulates all three the QS systems, and consequently, the 
associated virulence mechanisms in P. aeruginosa.  
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Clinical significance of AmpR  
The infecting clonal types of P. aeruginosa undergo many changes at the site of 
infection in order to adapt and colonize, a process driven by mutations (577,600,601). 
Several recent studies have identified genes that are mutated in either clinical isolates of 
P. aeruginosa or in strains that have been subjected to CF-like growth conditions 
(600,602-604). Mechanisms that contribute to ß-lactam resistance are also affected in the 
adaptation process including overexpression of efflux pumps, downregulation of the 
carbapenem porin OprD, and hyperproduction of AmpC (76,348,605). Some strains that 
have been implicated in outbreaks harbor more than one mutation resulting in multidrug-
resistant (MDR) and extensively drug-resistant (XDR) clones (606,607). The incidence of 
MDR and XDR clones of P. aeruginosa in patients is on the rise and undermines 
treatment strategies (608,609). Some MDR/XDR clones that disseminate to multiple 
hospitals worldwide posing a grave threat to human health have been termed ‘high-risk 
clones’ (610). Three such clones ST235, ST111 and ST175 are more prevalent than the 
rest. A recent study analyzing 190 bloodstream isolates from 10 hospitals determined that 
about 57% of them were antibiotic-resistant, of which 33% of isolates were MDR/XDR 
(585). Genetic analysis of the molecular mechanisms contributing to enhanced resistance 
of the XDR clones revealed combinations of resistance to ß-lactams (AmpC 
overproduction, inactivation of OprD), fluoroquinolone resistance (point mutations in 
GyrA), resistance to gentamycin and tobramycin (aadB gene acquired on a class I 
integron), and upregulation of aminoglycoside resistance (mutation in the mexZ repressor 
of the MexXY-OprM efflux pump) (585).  
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Specifically, in a majority of the most-prevalent ST175 high-risk XDR/MDR 
isolates analyzed, a novel mutation in AmpR (Glycine 154 Arginine) was the reason for 
constitutive activation of ampC expression (585). The G154R mutation was found only in 
strains that overproduce AmpC. In the sporadic XDR/MDR and moderately resistant 
strains, other ampR mutations were detected (E114A, G283E, M288R, A51T) but these 
polymorphisms are also found in wild-type strains such as PA14 (27,585). 
Complementing an ampR deletion strain in trans with a plasmid harboring ampR-G154R 
enhanced ampC expression and resistance to ceftazidime (585). In the light of studies in 
dissertation that demonstrates AmpR to be a positive regulator of acute virulence factors 
and antibiotic resistance (Chapters 4, 5), it is very possible that AmpR overexpression 
contributes to the success of high-risk XDR clones such as ST175. This, however, 
remains to be examined. 
In C freundii, AmpR becomes a constitutive activator of ampC expression due to 
amino acid substitutions R86C, G102E and D135N (611,612), of which only the D135N 
mutation has been found in a clinical isolate (92). Studies in our lab have demonstrated 
that mutating the aspartic acid residue at position 135 to asparagine (D135N) in P. 
aeruginosa AmpR locks it in the constitutively active conformation (O. Caille, 
unpublished data). However, the G102E mutation in P. aeruginosa AmpR seems to affect 
AmpR stability more than activity (O. Caille, unpublished data). These studies from the 
Mathee lab and elsewhere demonstrate that AmpR plays an important role in regulating 
antibiotic resistance in P. aeruginosa. Moreover, as demonstrated in Chapters 4 and 5, 
AmpR is also a critical regulator of P. aeruginosa virulence and metabolism.  
  212
 AmpR is one of 434 transcriptional regulators identified in the PAO1 genome, 
many of which remain uncharacterized. With such a large complement of regulatory 
proteins and accessory metabolic genes, it is no surprise that P. aeruginosa is able to 
adapt and thrive in a wide range of habitats. Understanding how AmpR and other 
regulators orchestrate the virulence and metabolic processes in P. aeruginosa in response 
to external signals is critical to dealing with infections caused by this successful 
opportunistic pathogen. 
Major virulence regulatory systems in P. aeruginosa 
The experimentally established virulence regulatory network in P. aeruginosa is 
depicted in Figure 6.2. Our lab and others have previously performed in silico analyses of 
the P. aeruginosa transcriptional regulatory network (560,597,613). Comparing those 
networks with the network depicted in Figure 6.2 clearly demonstrates the gap in 
knowledge between predicted networks and established ones. An important contributing 
factor to this discrepancy is the fact that the functions of the majority of the genes in the 
PAO1 genome remain unknown. Deep sequencing, transcriptome metaanalysis (28,400), 
and complementary studies will aid in assigning functions to the hypothetical genes and 
undoubtedly narrow this knowledge gap.  
Cis regulatory elements (CREs) form a critical part of transcription. CREs are 
non-coding DNA sequences present in or near a gene, and often contain binding sites for 
transcription factors and/or other regulators of transcription (614). The two major CREs 
are promoters and enhancers (615,616).  The promoters contain the binding sites for 
transcription factors and other regulatory molecules such as sigma factors and regulatory 
RNAs (617-619). Enhancers, once thought to be part of only eukaryotes, are found 
  213
widely in prokaryotes also and function in conjunction with the σ54-RNA polymerase 
(620-622). This section will focus on the transcriptional and post-transcriptional 
regulation of critical pathways that determine P. aeruginosa pathogenesis.  
Quorum Sensing 
QS is a signaling mechanism that bacteria use to regulate gene expression in a 
population density-dependent manner and was first demonstrated in Vibrio fischeri (623). 
In QS, the bacteria produce and secrete small molecules called autoinducers or 
quoromones. When these molecules reach a concentration threshold, they diffuse back 
into the cell to elicit a coordinated response promoting group survival (624). P. 
aeruginosa uses QS to regulate production of various virulence determinants such as 
extracellular proteases, iron chelators, efflux pump expression, biofilm formation, 
motility, and the response to host immune signals (625). This is achieved using two types 
of autoinducers, N-acyl-homoserine lactones (AHLs) and 2-alkyl-4 quinolones (AQs) 
(512). 
AHL-mediated QS 
P. aeruginosa has two canonical AHL QS signaling pathways, the las and rhl 
systems. Together, these pathways affect expression of approximately 10% of the P. 
aeruginosa transcriptome (170). The lasI (PA1432) and rhlI (PA3476) genes encode the 
N-3-oxododecanoylhomoserine lactone (3-oxo-C12-AHL) synthetase (359,626) and N-
butyrylhomoserine lactone (C4-AHL) synthetase, respectively (360,362,627,628). The 
resulting AHLs then bind and activate their cognate LuxR family regulators, LasR 
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(PA1430) (359) or RhlR (PA3477) (362). LasR and RhlR multimerize in the presence of 
their cognate AHL (629,630). In in vitro studies, LasR-DNA interaction is cooperative 
and non-cooperative in the presence or absence of a dyad symmetery in the binding sites, 
respectively (631). Rhl-regulated promoters have binding sites with a dyad symmetry 
(366).  
AQ-mediated QS 
P. aeruginosa synthesizes two AQ QS signals, 2-heptyl-3-hydroxy-4-quinolone 
(PQS) and its precursor, 2-heptyl-4-quinolone (HHQ) (378). Both PQS and HHQ 
enhance in vitro binding of the LysR-type transcription regulator, MvfR (also known as 
PqsR, PA1003), to the promoter of the pqsABCDE operon (PA0996-PA1000), suggesting 
that they function as MvfR effectors (381). Microarray analysis identified 141 genes 
differentially expressed in a mvfR mutant strain, including lasR, algT/U (PA0762), rsmA 
(PA0905), and rsaL (PA1431) (224). PQS also acts independently of MvfR to induce 
expression of the Fur regulon through its ability to bind iron (378,384) and membrane 
vessicle formation by inducing membrane curvature (576,632). PmpR (PA0964), a YebC 
member, negatively regulates MvfR (Figure 6.2) (383). 
QS regulation 
The las, rhl, and PQS/HHQ/MvfR systems all exhibit positive feed-forward 
autoregulation (544,633). In addition, the P. aeruginosa AHL systems function in a 
hierarchical manner, as the 3-oxo-C12-AHL-LasR complex positively regulates rhlI, rhlR 
and mvfR expression as well as lasI (363,364,634). Exceptions to this have been noted. 
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RhlR has been shown to regulate LasR-dependent genes in strains lacking lasR (375), and 
timing of lasI, lasR, rhlI and rhlR expression can vary drastically depending upon growth 
conditions (376).  
Many global regulators have been shown to modulate QS-dependent genes. RpoS 
(PA3622), the stationary phase sigma factor affects approximately 40% of the QS 
regulon (366,368). RpoS binding sites have been identifed in several of the QS-dependent 
promoters. RpoS also affects lasR and rhlR expression and LasR binding sites have been 
identified in promoters of other transcriptional regulators in the QS regulon, including 
PA2588, PA4778, pvdS (PA2426), vqsR (PA2591) and rsaL (365). Chromatin 
immunoprecipitation studies have shown occupancy by histone-like silencers MvaT 
(PA4315) and MvaU (PA2667) on lasI, lasR, mvfR, rpoS and rsaL (635). RsaL plays an 
important role in las signaling homeostasis, by binding to the lasI promoter and 
preventing LasR-mediated activation (373). In addition to affecting gene expression 
through las regulation, microarray analyses indicate that RsaL affects expression of 130 
genes, including direct regulation of pyocyanin and hydrogen cyanide genes (373). RsaL 
also appears to be important in regulating the transition from planktonic to a sessile state 
as rsaL mutants exhibit increased swarming motility and fail to form biofilms (636). 
RsaL expression is under the control of LysR-type regulator OxyR (PA5344) (637). The 
lasI promoter region has also been shown to be bound by CzcR (PA2523), which is 
required for expression of rhlI and rhlR in addition to lasI (Figure 6.2) (638). CzcR is 
part of the CzcRS TCS, shown to be involved in carbapenem and heavy metal resistance 
(639).  
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VqsR (PA2591), which is induced by H2O2 or human serum (282) and is under 
LasR regulation (640), regulates QS through inhibition of the LuxR-type regulator, QscR 
(PA1898, Figure 6.2) (641). Though QscR binds 3-oxo-C12-AHL, its specificity is not as 
stringent as LasR (642). The QscR regulon partially overlaps that ascribed to the las and 
rhl systems, but also has unique targets (385). In the absence of AHL, QscR can 
multimerize and form heterodimers with LasR and RhlR (643). QscR also plays a role in 
LasI homeostasis as mutations in qscR result in premature lasI expression (280). An 
AraC family member VqsM (PA2227) regulates VqsR in addition to numerous genes 
involved in QS including RsaL, PprB (PA4296), MvfR, RpoS as well as AlgT/U and 
MexR (PA0424) (644).  
Additionally, pqsH (PA2587), which encodes the enzyme responsible for 
oxidation of HHQ to form PQS, is positively regulated by the las system (377,380) and 
negatively regulated by the rhl system (544). PQS is derived from anthranilate, which is 
synthesized by the kynurenine pathway (645). Kynurenine pathway anthranilate is also 
required for N-decanoyl-homoserine lactone (C10-AHL) dependent signaling that is 
indepdendent of las, rhl, and qscR (645). The receptor for this signaling is yet to be 
identified (396). Besides potential heterodimerization with QscR, additional post-
transcriptional regulation of QS has been described. In one such mechanism, QteE 
(PA2593) destabilizes LasR and RhlR and in the absence of qteE the quorum threshold-
requirement for activation of QS-dependent genes is lost (646). RsmA negatively 
regulates rhl and las signaling, resulting in reduced AHL levels (190). Moreover, it has 
been shown the RNA chaperone Hfq (PA4944) positively regulates rhlI translation via 
rsmY and RsmA (647).  
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 Recently, our lab has established a role for the ß-lactamase regulator AmpR 
(PA4109) in activating QS-regulated genes [Chapter 4, (225)]. The production of QS-
regulated secreted virulence factors such as LasA (PA1871) and LasB (PA3724) 
proteases, and pyocyanin production is significantly impaired in AmpR-deficient strains. 
Further, loss of ampR reduced virulence in the Caenorhabditis elegans toxicity assay 
[Chapter 4, (225)]. In addition, AmpR regulates non-ß-lactam resistance by repressing 
activity of the MexEF-OprN (PA2493-PA2495) efflux pump, the alginate master 
regulator AlgT/U (226) and biofilm formation [Chapter 4, (225)], suggesting that it plays 
a role in maintaining the acute mode of infection.  
Two component regulatory systems (TCSs) 
TCS are sophisticated signaling mechanisms marked by a highly modular design 
that have been adapted and integrated into a wide variety of cellular signaling circuits. 
The archetypical TCS is composed of a membrane integrated sensory histidine kinase  
(HK) and a cytoplasmic response regulator (RR) (648). The HK contains a periplasmic 
N-terminal domain that detects specific stimuli (sensing domain) and a C-terminal 
cytoplasmic transmitter domain that is comprised of a dimerization domain, a conserved 
histidine, and an ATP catalytic domain (649). HKs can have two or more transmembrane 
domains with little or no periplasmic domain while others are completely cytoplasmic. 
The cognate response regulator (RR) contains a conserved receiver domain and a variable 
output domain (650). 
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Figure 6.2: The P. aeruginosa virulence regulatory network 
The pathogenic potential of P. aeruginosa is dictated by multiple virulence systems that 
are regulated transcriptionally, post-transcriptionally and post-translationally. The central 
mechanism for P. aeruginosa virulence regulation is QS, which controls expression of many 
virulence factors in a population density-dependent manner. Key activators of this system are 
LasR, RhlR, MvfR, VqsR, the cAMP receptor protein Vfr, and the stationary phase sigma factor 
RpoS. Las system repressors include RsaL, the H-NS protein MvaT, the sigma factor RpoN, and 
the small RNA binding protein RsmA, while others like QscR repress both the Las and Rhl 
systems. Other regulators such as AmpR affect QS genes by an unknown mechanism. QS plays a 
role in regulating critical pathogenic mechanisms including biofilm formation, secretion systems, 
production of numerous virulence factors, efflux pumps, antibiotic resistance and motility.  
Acute P. aeruginosa infections can lead to chronic infections in response to largely 
unidentified signals. A key regulatory pathway that controls this lifestyle switch is the RetS-
LadS-GacSA-RsmA pathway. RetS and LadS are hybrid sensor proteins that, in response to 
external signals, either activate or repress the GacSA TCS. The GacA regulator then activates 
transcription of two rgRNAs, rgRsmZ and rgRsmY that sequester and inhibit activity of the small 
RNA binding protein, RsmA. RsmA is a key activator/repressor that post-transcriptionally 
regulates numerous acute and chronic infection phenotypes including multiple QS-regulated 
virulence factors, biofilm formation, type 2, type 3 and type 6 secretion systems, and motility.  
Another major phenotypic change associated with the switch from acute to chronic 
phases of infection is the formation of biofilm. This is associated with extensive changes in 
transcription. Three key TCS involved in activating biofilm formation are BfiSR, MifR and 
BfmSR. Cyclic-di-GMP is another major player influencing this process, whose levels are 
controlled by diguanylate cyclases and phosphodiesterases. QS and the cup genes enhance 
biofilms, while regulators like AmpR repress it. An important component of P. aeruginosa 
biofilms are extracellular polysaccharides such as alginate, Pel and Psl. Alginate production is 
under the control of the master regulator ECF AlgT/U, whose activity is regulated 
transcriptionally by AmpR, post-translationally by MucA and MucB, and by regulated 
intermembrane proteolysis involving MucP, AlgW, ClpXP and others. AlgT/U activates the 
alginate biosynthetic operon via AlgR, AlgB and AmrZ. In addition, biofilm formation is also 
affected by iron concentration, a process governed by the master repressor of iron uptake, Fur. 
Fur controls uptake of iron by regulating the sigma factor PvdS, thereby modulating sidephore 
levels. Fur also modulates transcription of two key regulatory RNAs, asPrrF1 and asPrrF2. These 
two sRNAs are involved not only in regulating iron-uptake related genes, but also enzymes of the 
TCA cycle, and genes involved in anthranilate synthesis. Anthralinate, a precursor for synthesis 
of PQS, is a key regulatory molecule of the PQS signaling system in P. aeruginosa that is 
involved in expression of QS-regulated virulence factors. 
Details on the individual interactions and the appropriate references can be found in the 
text. Some of the interactions labeled as indirect are regulated by unknown mechanisms and 
warrant further investigation. In the figure, some regulators and phenotypes have been mentioned 
more than once. 
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Upon receiving a signal, two HK monomers dimerize and cross-phosphorylate at 
the conserved histidine residue, and the phosphate is subsequently transferred to an 
aspartate residue in the receiver domain of the cognate RR (651).The phosphotransfer is 
catalyzed by the receiver domain and results in a conformational change that activates the 
output domain, which often binds DNA and modulates gene expression or enzymatic 
activity (592,650,652). Variations to this model occur in phosphorelays where a sensor 
kinase first transfers the phosphoryl group to a RR that has no output domain. This P~RR 
then transfers the phosphoryl group to a histidine-containing phosphotransfer protein 
(HPT), and this in turn serves as a phosphate donor to a terminal RR which has an output 
domain mediating a cellular response (213). In other cases, the sensor kinase and the RR 
lacking an output domain are fused into one protein (hybrid sensor kinase) (653). Other 
variations include the TCS connectors, a group of proteins that modulate the 
phosphorylation state and activity of sensor HK and RR and establish regulatory links 
between otherwise independent signal transduction pathways (654). 
P. aeruginosa, equipped with 55 HKs, 89 RRs and 14 HK-RR hybrids, possesses 
one of the largest pool of TCS proteins identified in any microorganism thus far analyzed 
(25). This provides the bacterium with a sophisticated capability to regulate diverse 
metabolic adaptations, virulence and antibiotic resistance processes that are hallmark of P. 
aeruginosa infections. One of the critical TCSs is GacSA (GacS-PA0928, GacA-
PA2586) that is central to expression of virulence factors, secondary metabolites, biofilm 
formation and QS (190,655), and the switch between acute and chronic infections 
(656,657). GacS is a hybrid sensor HK that contains a HK domain, a RR domain and a 
histidine phosphotransfer (Hpt) domain (210,658). GacS phosphorylation is under the 
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control of two hybrid sensor kinases, RetS (PA4856) (210) and LadS (PA3974) (209) 
(Figure 6.2). RetS can directly interact with GacS and prevent GacS phosphorylation 
(209,659) while LadS phosphorylates GacS (209). Phosphorylated GacA positively 
regulates the transcription of two small regulatory RNAs, rgRsmZ (PA3621.1) and 
rgRsmY (PA0527.1), which block the negative regulator RNA-binding protein RsmA 
(PA0905). RsmA positively regulates genes of the Type 3 secretion system, type IV pili 
formation and iron homeostasis while repressing QS, Type 6 secretion, and potentially 
other transcription factors (29,391,458). The GacSA TCS is also involved in antibiotic 
resistance to three different families of antibiotics: tobramycin, ciprofloxacin and 
tetracycline (660) apparently through RsmA/rgRsmZ.  
In P. aeruginosa, PhoPQ (PA1179-PA1180) together with PmrAB (PA4776-
PA4777) are two TCSs that respond to limiting concentrations of cations, and regulate 
resistance to polymyxin B and cationic antimicrobial peptides through the regulation of 
the arnBCADTEF-pmrE (PA3552-PA3559) LPS modification operon (661,662). PhoQ is 
involved in swarming and twitching motility as well as in biofilm formation and is 
required for virulence without affecting the T3SS or QS systems (Figure 6.2) (663). The 
HK PhoQ activates the RR PmrA independently of PmrB suggesting an interaction 
between these TCSs (664). In addition, increased resistance to antibiotics including 
polymyxin B, aminoglycosides and quinolones in phoQ mutants suggests crosstalk 
between PhoPQ and other TCSs (665,666). 
Formation of biofilms 
Biofilms are surface-associated multicellular bacterial communities encapsulated 
in a self-produced extracellular matrix composed of polysaccharides, proteins and nucleic 
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acids that mediate cell-to-cell and cell-to-surface interactions (667). P. aeruginosa 
biofilms, typically associated with poor patient prognosis, signify the switch from an 
acute to a chronic infection. Biofilms can be formed on abiotic (environment), or biotic 
(wounds, surgical implants, cystic fibrosis lung) surfaces (668). Biofilm formation and 
maintenance is tightly regulated in response to environmental cues, conferring enhanced 
resistance against antimicrobial agents and immune defense mechanisms on the biofilm 
bacteria (451). Formation of biofilms is a multi-stage process that is initiated by the 
surface attachment of planktonic bacteria to form a monolayer, clonal growth/aggregation 
leading to the formation of microcolonies, maturation to form mushroom-shaped 
structures, and dispersal (171,669,670). As can be imagined, this complex transition in 
the bacterial lifestyle is accompanied by drastic changes in gene regulation. 
Surface attachment by P. aeruginosa to form microcolonies has been attributed to 
Type IV pili, flagella, free DNA, alginate, and Pel and Psl polysaccharides, though pili, 
alginate and flagella mutants also form biofilms (670,671). Attachment is a reversible 
process and the commitment to form biofilms is partly under positive SadB (PA5346) 
regulation (672). SadB upregulates both Pel polysaccharide production, and the 
chemotaxis-like cluster CheIV (PA0408-PA0417) that is thought to regulate flagellar 
motion by an unknown mechanism (673).  
The Cup fimbriae, encoded by three distinct gene clusters cupA (PA2128-
PA2133), cupB (PA4081-PA4086), and cupC (PA0992, PA0993, PA0994) in P. 
aeruginosa PAO1, have been demonstrated to play a role in different stages of biofilm 
formation on biotic and abiotic surfaces (674). Regulation of the cup genes is complex 
involving a phase variation-dependent repression of cupA expression by a H-NS member 
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MvaT (675,676). MvaT also regulates the cupB and cupC loci to a lesser extent (675). 
The cupB and cupC clusters are under the primary regulation of the RocS1-RocR-RocA1 
(PA3946-PA3948) three-component system (274). This system is similar to the 
Bordetella pertussis BvgASR system (677) and consists of the hybrid sensor kinase 
RocS1, the response regulator RocA1, and the RocA1-repressor RocR (274,288). RocR 
has been hypothesized to bind c-di-GMP via its EAL (diguanylate phosphodiestrerase) 
domain and prevent phosphotransfer from RocS1 to RocA1, thus preventing RocA1 
activation (274,288). P. aeruginosa PA14 has a fourth cup cluster (cupD) on the 
pathogenicity island PAPI-I that is controlled positively by the response regulator RcsB 
(PA4080), and negatively by the EAL-domain containing response regulator PvrR (678). 
In addition, diguanylate cyclases and phosphodiesterases of the wsp gene cluster 
(PA3702-PA3708) (679,680) MorA (PA4601) (681) and TpbA-TpbB (PA3885, PA1120) 
(682) modulate intracellular levels of c-di-GMP to exert a regulatory effect on the cup 
gene clusters (Figure 6.2).  
The main components of of the extracellular polymeric substance matrix of 
biofilms are Pel and Psl polysaccharides, alginate, and free DNA (451,670). Both pel and 
psl gene loci are post-transcriptionally regulated by the RetS-LadS (PA4856 and PA3974, 
respectively) system via rsmY and rzmZ (209,210,659) and by c-di-GMP levels, either 
directly (679) or by binding the transcriptional regulator FleQ (PA1097).(683) The pel 
operon is also repressed by the las QS system via the tyrosine phosphatase TpbA 
(PA3885) (682). A membrane-bound sensor, PpyR (PA2663) enhances biofilm formation 
via the psl operon, and virulence via modulating QS (684). Although alginate is a major 
component of biofilms and affects biofilm structure, it is not essential for biofilm 
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formation (670). Alginate regulation is discussed in a separate section (see below). QS 
regulates cell lysis in biofilms (685-687) thereby controlling the release of extracellular 
DNA, a major component of the biofilm matrix (688,689). The QS system also regulates 
rhamnolipid production (362) that promotes motility and hence formation of the cap in 
the mushroom structure of mature biofilms (690), and maintenance of biofilm channels 
(691). BfiRS (PA4196-PA4197), BfmRS (PA4101-PA4102) and MifR (PA5511) are 
TCSs shown to regulate biofilm development and maturation by sequential 
phosphorylation (275). They activate biofilm formation at different transition stages: 
reversible to irreversible attachment (BfiRS), irreversible attachment to maturation stage-
1 (BfmRS), and maturation stage-1 to mushroom structure formation (MifR) (Figure 6.2) 
(275). The BfiRS system may function in conjunction with the GacSA TCS and feed into 
the Rsm loop of regulation to control biofilm formation (275). SagS (PA2824), the 
cognate sensor of HptB (PA3345), modulates biofilm development (by controlling BifS 
phosphorylation) and other virulence phenotypes (by modulating rgsRmZ levels) 
depending on whether the cells are in the planktonic or biofilm phase (692).    
Analyses of clinical isolates reveal a positive correlation between expression of 
lasR, rhlR and acute virulence factors (693,694) suggesting that QS is required for 
virulence in vivo. QS is also important when P. aeruginosa grows as biofilms in the CF 
lung (695). In vivo studies show that lasI and rhlI mutants produce milder chronic lung 
infections compared to their wild-type counterparts (696), and form more susceptible 
biofilms (697). However, in some in vitro studies, there was no apparent difference in the 
biofilms formed by the QS mutants and the wild-type strains (698,699). This discrepancy 
in the requirement of QS for biofilm formation and establishment of a successful chronic 
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infection is probably not surprising since QS regulates many different functions. Further, 
it has been demonstrated that the CF environment selects for strains with lasR mutations, 
though the rhl system is intact (700). Although lasR is higher up in the QS hierarchy, 
studies have shown that secondary mutations can reestablish rhl expression in las mutants 
(701). This suggests that in CF biofilms, the rhl system is more important and lasR 
inactivation serves to downregulate the acute virulence factors (702). 
A major cause of antibiotic resistance in biofilms has recently been attributed to 
the phenomenon of persistence. Persister cells are small subpopulations of antibiotic-
sensitive cells that have acquired transient antibiotic tolerance (703). When the antibiotic 
levels drop, the persisters grow into a population of sensitive cells, again with a small 
sub-population of persisters (704,705). Many genes involved in the formation of 
persisters have been identified in P. aeruginosa PA14, including two transcriptional 
regulators AlgR (PA5261) and PilH (PA0409) (706). However, this topic is outside the 
scope of this dissertation but has been extensively reviewed elsewhere (83,707). 
Alginate production 
In the lungs, especially of patients with cystic fibrosis, P. aeruginosa can convert 
from a non-mucoid to an alginate-overproducing mucoid phenotype signaling chronic 
infection (708). Chronic P. aeruginosa infection seems to be localized to foci within the 
anaerobic mucus environment in the lung’s respiratory zone (709-712). These foci lead to 
tissue damage decreasing lung function and the appearance of the mucoid phenotype 
correlates with poor patient prognosis (713,714). The exopolysaccharide alginate is a 
linear polymer of β-D-mannuronic acid and α-L-guluronic acid (715), which stimulates 
production of IgG and IgA antibodies (716). Although production of alginate is 
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metabolically taxing, it protects the bacteria from phagocytosis and antibodies thus 
conferring a survival advantage (717,718). Conversion to mucoidy occurs when biofilms 
are treated with activated polymorphonuclear leukocytes (569), hydrogen peroxide (569), 
antibiotics (719),  and nutrient starvation (720,721). 
A complex regulatory pathway controls alginate biosynthesis. The central player 
is the σE family extracytoplasmic function sigma factor AlgT/U (PA0762) (465,722) 
whose activity is inhibited post-transcriptionally by the anti-sigma factor MucA 
(PA0763), and by MucB (PA0764) (570,723,724). Loss of function mutations in mucA or 
mucB result in a mucoid phenotype (466,723,725) due to release of AlgT/U from MucA 
by a regulated intramembrane proteolytic pathway (reviewed in (582,726)). It was 
recently demonstrated that MucA proteolysis is regulated not only by AlgW (PA4446) 
but also by MucD (PA0766) by activating the MucP protease (PA3649) (727). In addition, 
AmpR links alginate production with antibiotic resistance and QS by negatively 
regulating algT/U expression (Figure 6.2) (226). AlgT/U regulates alginate production at 
least in part by autoregulation (465), controlling expression of the transcriptional 
regulators algR (481,482), algB (481,725), amrZ (728), and the algD (PA3540) alginate 
biosynthetic operon (481,729,730). AlgB (731), AlgR (732-734), and AmrZ (735) all 
directly bind to the algD operon to activate transcription. The alternative sigma factor 
RpoN (PA4462) is also required for high levels of algT/U and algD expression (736).    
The algB (PA5483) and algR (PA5261) genes respectively encode NtrC and LytR 
subfamily of TCS RRs (737). Interestingly, aspartic acid phosphorylation in the 
regulatory domain is not essential for alginate production (738). Transcriptome analysis 
of a PAOmucA22 mucoid strain (PDO300) (570) identified seven predicted 
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transcriptional regulators, PA1235, PA1261, PA1637 (KdpE), PA2881, PA3420, PA3771, 
and PA5431, and one sensor kinase, EraS (PA1979), whose expression was 
downregulated in an algB mutant but not in a strain containing a mutation in its cognate 
TCS sensor, KinB (PA5484) (731). In addition to regulating the algD operon, AlgR 
directly activates transcription of algC (PA5322), which encodes a 
phosphomannomutase/phosphoglucomutase essential for Psl, alginate and rhamnolipid 
synthesis (Figure 6.2) (739-742). AlgR also is important for mature biofilm formation, 
possibly by directly repressing rhl-QS (743), type IV pilus formation by binding to the 
fimTU-pilVWXY1Y2E promoter (744,745), and hydrogen cyanide (HCN) production by 
binding to the hcnA (PA2193) promoter (480). Interestingly, in contrast to alginate 
production, the phosphorylation site is required for regulating cyanide production and 
twitching motility (744,746). AlgR has also been shown to indirectly regulate the cyclic 
AMP/Vfr-dependent pathway (747). The AlgR regulon has been characterized by several 
transcriptome studies (480,743,748). Two other regulators of alginate production in P. 
aeruginosa are Alg44 (PA3542) (749) and a diguanylate cyclase, MucR (PA1727) (750). 
MucR produces a pool of c-di-GMP in the vicinity of the PilZ domain of Alg44 
(PA3542), which then positively regulates alginate production (Figure 6.2) (749-751).  
Regulation of iron uptake 
Iron is critical for growth of all organisms and P. aeruginosa is no exception. 
Transcriptome studies reveal that a large number of genes are regulated in response to 
iron (144,145). Biologically useful iron (Fe2+) in the environment is scarce and is 
available mostly in the insoluble Fe3+ form.  To help scavenge this free iron, bacteria 
produce siderophores that bind extracellular iron and transport them back into the cell via 
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TonB-dependent receptors on the cell surface (752). P. aeruginosa produces two 
siderophores, pyoverdine and pyochelin, and can also subvert siderophores produced by 
other organisms to take up heme (753,754). However, excess free iron in the cell leads to 
formation of toxic reactive oxygen species and so cells tightly regulate the uptake (755). 
The ferric uptake regulator (Fur, PA4769) is a conserved protein in P. aeruginosa and 
other Gram-negative bacteria, and is a major iron acquisition regulator (756). Fur 
dimerizes rapidly after synthesis and it takes a minimum of two dimers to bind promoters 
of genes under Fur regulation in P. aeruginosa (757). Fur control the iron regulon 
directly by binding the Fur box (758), and indirectly by modulating expression of other 
regulators including the pyochelin uptake regulator PchR (PA4227), ECF sigma factors 
like PvdS, TCS regulators and small regulatory RNAs (asPrrF1 (PA4704.1), asPrrF2 
(PA4704.2; Figure 6.2) (758-760).  
Iron concentrations in the cell also influence expression of virulence factors in P. 
aeruginosa. PvdS, for example, is critical in linking iron and virulence by controlling the 
production of pyoverdine, an outer membrane pyoverdine receptor (FpvA (PA2398)) and 
two important extracellular virulence factors (PrpL (PA4175) and exotoxin A (PA1148); 
Figure 6.2) (761-763). Also, pvdS mutants showed reduced virulence in a rabbit 
endocarditis model (764). Human lactoferrin inhibits P. aeruginosa biofilm formation 
indicating a role for iron in the process (765). Iron chelation by lactoferrin induces 
twitching motility in P. aeruginosa negating colonization and ultimately, biofilm 
formation (765,766). Intracellular iron concentrations are one of the signals for biofilm 
development in a process involving Fur but not the iron uptake regulatory RNAs asPrrF1 
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and asPrrF2 (767). Further, high levels of iron suppress the PQS system, release of 
extracellular DNA and biofilm formation (768).  
The link between iron and QS systems in P. aeruginosa is complex. QS systems 
are enhanced under limiting iron concentrations (376,769,770) and major QS regulators 
are also involved in regulating iron responsive genes (168,224,573). MvfR, for example, 
has been demonstrated to control transcription of iron-related genes and itself has an iron-
starvation (IS) box in its promoter, a site recognized by PvdS (PA2426) to turn on 
transcription under low iron conditions (144,771). It was recently demonstrated that iron 
levels affect activity of the MvfR signaling molecule HAQ, adding another layer of 
complexity to the role of iron in QS (772). Another major QS and virulence regulator, 
VqsR regulates phenazine production by modulating phnAB expression (282). Moreover, 
the small regulatory RNAs asPrrF1 and asPrrF2, which are negatively regulated by Fur, 
positively regulate PQS production (Figure 6.2) (773). PQS has been shown to 
accumulate in the outer membrane and in membrane vesicles (576). PQS chelates iron 
and this facilitates pyochelin and pyoverdin in scavenging iron (378,384).  
Thus, iron uptake regulation in P. aeruginosa is a complex affair and involves 
multiple regulators that affect expression of numerous genes either by themselves or 
through other regulators. In addition, the interconnections between iron uptake 
mechanisms and other virulence systems such as QS and biofilm formation demonstrates 
the versatility of this bacterium in being able to pragmatically read environmental signals 
to accordingly modulate gene expression. 
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Toxins and exoproteins 
 Exoproteins are an important component of bacterial survival because not only do 
they allow the bacteria to interact with their immediate environment and other organisms 
in the vicinity, but also because they play a critical role in virulence. P. aeruginosa has a 
large complement of secreted proteins and five (type I, II, III, V and VI) of the seven 
secretion systems characterized in bacteria (774). A majority of the secreted proteins are 
toxins that aid in P. aeruginosa virulence, most of which, including LasA, LasB, PrpL, 
ToxA, and phospholipases (PlcH (PA0844), PlcN (PA3319), PlcB (PA0026)), are 
secreted via the Xcp type II secretion system (T2SS) (774). Effector molecules that are 
crucial for evading the host phagocytic response are secreted via a dedicated T3SS (206), 
whereas the type I system (T1SS) secretes the alkaline protease AprA (445,775) and the 
hemophore HasAp (PA3407) (776). Substrates of the recently identified T6SS are just 
being discovered (777). In addition, c-di-GMP levels, modulated by the diguanylate 
cyclase WspR (PA3702) is involved in the switch between T3SS and T6SS independent 
of RetS but dependent on rgRsmY and rgRsmZ (Figure 6.2) (778). 
 HasAp, a T1SS-secreted heme-uptake protein in P. aeruginosa, is under QS 
control (168). QS is also known to regulate PrpL that targets the human lactoferrin (see 
section above) (761). Thus, QS in P. aeruginosa not only regulates enzymes to degrade 
the human lactoferrin but also produces proteins to retrieve the iron from the degraded 
lactoferrin. The other known T1SS substrate, AprA, is regulated by a novel LTTR named 
BexR (PA2432) that controls bistability in P. aeruginosa (Figure 6.2) (232). Inactivation 
of QS has been demonstrated to reduce expression of T2SS-secreted proteases, chitinases 
and lipases (626,779) due to downregulation of the Xcp T2SS (780,781). The TCS 
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PhoBR (PA5360-PA5361) regulates other T2SS-secreted exoproteins such as PlcH, PlcC, 
PlcN and the Hxc T2SS secreted alkaline phosphatase LapA (782,783). Microarray 
analysis revealed that a novel cell-surface signaling system PUMA3 regulates Hxc T2SS 
genes (784). The three T6SS systems (HSI-I, HSI-II and HSI-III) in P. aeruginosa are 
differentially regulated by the QS systems (785). Whereas LasR and MvfR negatively 
regulate the HSI-I system, they positively regulate expression of the functionally 
redundant HSI-II and HSI-III (Figure 6.2) (785). In addition, a putative regulator Sfa3 
(SfnR) in P. aeruginosa PA14 (an ortholog of PA2359 in PAO1) potentially regulates the 
HSI-III cluster (785). HSI-I expression is also regulated by RetS via RsmA (459).  
P. aeruginosa T3SS is regulated in a complex and multi-tiered process, and is 
probably the most well understood (325). Expression of T3SS is regulated 
transcriptionally and post-transcriptionally in response to host cell contact and 
environmental Ca2+ levels (786,787). ExsA (PA1713), an AraC member regulates 
expression of the 43 genes that form the T3SS in P. aeruginosa by binding as a monomer 
to an A-rich 8-bp region upstream of the -35 in the promoter of genes under its regulation 
(786,788). ExsA autoregulates its own expression and is also activated by PsrA (PA3006), 
a member of the TetR family (307,308). Two anti-activators (ExsD (PA1714) and PtrA 
(PA2808)) also regulate ExsA-mediated activation (Figure 6.2). T3SS transcription is 
coupled to secretion and involves the anti-activator ExsD and the anti-anti-activator ExsC 
(PA1710) that regulate ExsA function. Under non-inducing conditions (high Ca2+), ExsE 
(PA1711) binds the anti-anti-activator ExsC, allowing the anti-activator ExsD to bind 
ExsA and inhibit transcription. Under Ca2+ delimiting conditions, ExsE is secreted 
freeing ExsC to bind ExsD. Free ExsA then activates T3SS expression (Figure 6.2) (789). 
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Though this is the primary mode of control, T3SS can also be triggered by stress due to 
DNA damage (RecA-mediated activation of PtrB) (331), high salt (790,791), metabolic 
stress (29,791,792), alginate regulators AlgT/U, AlgR and MucA (793), the MexEF-
OprN efflux pump regulator MexT (PA2492) via PtrC (794), and the RetS/LadS/Gac-
Rsm TCSs (209,210,493). Under low oxygen conditions, the anaerobic regulator Anr 
activates the response regulator NarL (PA3879), which in turn represses rgRsmY and 
rgRsmZ expression, allowing RsmA to activate T3SS (546). Expression of T3SS, 
however, happens only in a subset of the population even under inducing conditions 
(791,795). Multiple levels of control allow fine-tuning of T3SS expression allowing P. 
aeruginosa to sense various environmental conditions and regulate expression in 
conjunction with other virulence factors. 
Regulatory RNAs in P. aeruginosa virulence 
 RNAs other than messenger RNAs, transfer RNAs or ribosomal RNAs are termed 
small RNAs (sRNAs) and affect all steps in gene expression pathways in both 
prokaryotes and eukaryotes (796). In general, sRNA-mediated regulation occurs in one of 
two ways: base pairing with DNA or mRNA, or by affecting the activity of a protein or 
protein complex (796). Not surprisingly, virulence gene expression in P. aeruginosa also 
relies on small regulatory RNA (rgRNA)-mediated post-transcriptional regulation. The 
importance of rgRNAs in regulation of bacterial virulence is well established 
(619,797,798). Most of the P. aeruginosa rgRNAs that have been characterized play a 
role in virulence gene regulation (discussed below). A recent study identified about 150 
novel sRNAs using sRNA-Seq in P. aeruginosa PAO1 and PA14, which includes both 
strain-specific and shared ones (799). 
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Perhaps the most well characterized system involves the rgRNAs, rgRsmY and 
rgRsmZ (whose roles in virulence regulation have been discussed in the TCS, and toxins 
and exoproteins sections). These are two functionally redundant rgRNAs in P. 
aeruginosa that play a critical role in the switch between acute and chronic infections 
(210,800). GacA of the GacSA TCS positively regulates expression of rgRsmY and 
rgRsmZ, which then bind to and sequester the small RNA binding protein RsmA via the 
GGA motif (548,549,801), leading to derepression of the genes that RsmA represses 
(190,458,545,802). The consequences of RsmA sequestration results in dysregulation of 
the expression of numerous virulence factors, as discussed in the TCS section. Given the 
importance of this regulatory process in P. aeruginosa pathogenesis, regulation of 
expression of rgRsmY and rgRsmZ is multi-tiered. The histidine phosphotransfer protein 
HptB is phosphorylated by a phosphorelay involving the three sensor kinases PA2824, 
PA1611 and PA1976 (803). Phosphorylated HptB then transfers the phosphate to an anti-
anti-sigma factor PA3374, to negatively regulate expression of rsmY (803,804). In 
another mode of regulation, the BfiSR TCS activates expression of the ribonuclease CafA 
(PA4477), which specifically targets rgRsmZ (547). Further regulation is achieved by the 
global regulators of the H-NS family of proteins MvaT and MvaU, which bind to AT-rich 
regions upstream of the rsmZ gene repressing their expression (390). In addition to all 
this, there is a negative autoregulatory feedback mechanism, the details of which have not 
been elucidated yet (805). Upon synthesis, rgRsmY is stabilized by Hfq binding, either 
alone or in conjunction with RsmA (647,806). 
Another example of post-transcriptional regulation by sequestering a RNA-
binding protein links virulence with metabolism. P. aeruginosa Crc (PA5332) is a RNA-
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binding protein that recognizes CA-motifs around the ribosome binding sites of the 
mRNA of carbon compound catabolism genes. Crc thus represses genes whose products 
help utilize less preferred carbon sources (807-809). When less preferred substrates such 
as mannitol have to be utilized, expression of catabolic genes is achieved by sequestration 
of Crc by the rgRNA, rgCrcZ (810). Expression of rgCrcZ is under the control of the 
TCS CbrAB (PA4725-PA4726), which in conjunction with Crc plays a role in carbon 
compound catabolism, biofilm formation, antibiotic resistance, secretion systems and 
swarming (811-817).  
P. aeruginosa antisense small RNAs (asRNAs) can also act by base-pairing with 
target mRNAs, thus inhibiting translation (818). One such example is asPhrS (PA3305.1) 
that plays a role in PQS and pyocyanin expression (819). Transcriptome studies indicate 
an extensive overlap between the genes that are positively regulated by the transcriptional 
regulator PqsR (also known as MvfR, PA1003) and asPhrS suggesting that asPhrS 
regulates pqsR mRNA (224,819). Interestingly, it was shown that asPhrS specifically 
targets a region in the RBS of a small ORF (uof) that is present upstream of PqsR (819). 
Since translation of pqsR and uof are coupled, asPhrS regulates pqsR translation by 
modulating translation of uof (819). Expression of asPhrS is under the control of the 
oxygen responsive regulator Anr (819). Hfq controls asPhrS expression indirectly by 
regulating Anr expression, whose mechanism of action is yet to be elucidated (819,820). 
 Small asRNAs also play a role in regulation of iron uptake and involves base 
pairing by the sRNAs asPrrF1 and asPrrF2, which are the P. aeruginosa orthologs of E. 
coli RyhB (758,821). Expression of asPrrF1 and asPrrF2 is repressed by Fur when iron 
concentrations are high (758). Under iron starvation conditions, asPrrF1 and asPrrF2 are 
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expressed and base pair with the mRNA of target genes, which include the superoxide 
dismutase sodB (PA4366), genes involved in the TCA cycle, and anthranilate and 
cathechol degradation (107). Thus, asPrrF1 and asPrrF2 link carbon metabolism, iron 
uptake and QS-mediated virulence. Another asRNA gene, asPrrH is located in the same 
locus as asPrrF1 and asPrrF2. The asPrrH asRNA (at 325 nt) is longer than asPrrF1 (116 
nt) and asPrrF2 (114 nt), and the coding region of asPrrH overlaps with the asPrrF1 
terminator, the intergenic region between asPrrF1 and asPrrF2, and the 5’ end of the 
asPrrF2 ORF (822). The expression of asPrrH is maximal in the stationary phase of 
growth, similar to asPrrF1 and asPrrF2, and under iron-deplete conditions (822). Heme 
represses asPrrH expression and this involves the outer membrane heme receptors PhuR 
(PA4710) and HasR (PA3408) (822). Interestingly, under conditions of heme starvation, 
asPrrH expression leads to the repression of achAB and sdhCDAB, which are also targets 
of the PrrF asRNAs (822). In addition to these targets, asPrrH also represses NirL, a 
protein involved in biosynthesis of heme, under heme and iron limitation (822). 
Conclusions and perspectives 
P. aeruginosa  is a very versatile bacterium that can thrive in a wide range of 
habitats. This is achieved by an intricately interlinked regulatory system of transcriptional 
regulators, sigma factors, small RNAs, and their regulons. The exquisite control of gene 
expression is exemplified in the virulence regulatory network (Figure 6.2), which 
demonstrates that none of the virulence mechanisms are isolated. Expression of 
individual virulence networks is under transcriptional and post-transcriptional regulation 
of multiple regulatory systems, either directly or indirectly. Furthermore, some signaling 
cascades inversely regulate the acute and chronic virulence phenotypes depending on the 
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signals sensed. The next critical phase of research should focus on the signals that the 
bacteria recognizes in order to achieve gene regulation. 
The extent of crossregulation between the transcriptional regulators highlights the 
global nature of the regulation where individual subnetworks (such as the QS network, 
alginate network, etc.,) are interlinked to form a hyperconnected network (Figure 6.2). 
Given the complexity of the connections, one can expect the response of a cell to be 
elaborate even when faced with a simple stress condition. A fundamental point in a 
network setting is that one should evaluate the role of individual players (such as a 
regulator) not in isolation, but with the knowledge that the entire network will react to 
what it does. In other words, local changes can have global effects. This, in turn, results 
in very subtle cause-effect relationships. Studying the functions of a regulator by 
generating deletion or overexpression strains is often performed under the assumption 
that other regulators will remain static. In reality, however, such modifications can lead to 
abberant changes across the network in ways that were initially unintended.  Moreover, 
there is a possibility that such changes can occur because the network connections might 
not always be obvious. This can be attributed, in part, to as yet uneludicated implicit 
players in the network that dictate or otherwise influence cellular response. This is a 
likely explanation for the many ‘global’ regulators in P. aeruginosa and in similar 
bacteria that have complex regulatory networks. In such cases, many of the phenotypes 
observed with single regulator mutant strains can be part of a ripple effect that propagates 
through the network affecting disparate phenotypes.  
A simplified model of gene regulatory network treats genes as being on or off i.e., 
taking binary values. It is therefore no surprise that Boolean networks (discrete 
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dynamical network models) have been used to model and study gene regulatory circuits 
(823-825). Probabilistic Boolean networks, which take into account molecular and 
genetic noise (826,827) and stochastic Boolean networks, which permit the modeling of 
gene perturbations (828), provide important insights into the dynamical behavior of the 
system. Though they are computationally complex, they are a valuable addition to the 
numerous other programs that are available to analyze gene regulatory networks 
(613,829,830). 
Dynamical systems theory helps us to analyze the behavior of complex systems 
that can frequently be expressed by time-differential equations.  When the behavior of a 
dynamical system depends very sensitively on small changes in initial conditions, then 
the system is said to be chaotic, i.e., capable of exhibiting chaotic behavior. Researchers 
have investigated whether regulatory networks can have subsystems that are capable of 
exhibiting chaotic behavior (831). It has been shown that competition between two or 
more subnetworks of comparable importance can lead to chaos (832-834). In fact, chaos 
has been shown to be possible in biochemical systems with only two feedback loops and 
positive feedback is known to be necessary for chaotic behavior (835). So, one would 
expect chaotic subsystems in a regulatory network as complex as the one that controls P. 
aeruginosa virulence (Figure 6.2). In spite of this predisposition, gene regulatory 
networks seldom exhibit chaotic behavior. This could be because the competitions 
between opposing nodes are not strong enough (836), or that chaotic behaviors are short-
lived due to triggering of other pathways such as cell-cell communication (837). Another 
possibility is that the natural random variability of biochemical systems masks the chaotic 
  238
behavior (836). However, maintaining a low level of chaos in such a complex network is 
probably a combination of the above mentioned and, potentially, as yet unknown factors.  
In gene regulatory networks, a particular dynamical system is characterized by 
time-evolving variables (chemical concentrations, gene expression, etc.) and by 
parameters (temperature, ambient chemical concentrations, etc). A network can exhibit 
chaotic or non-chaotic behavior depending on the parameters that influence it (838). 
Environmental factors such as the temperature or the nutritional status of the cells 
parameterize the relationship between transcription factors and the genes that they 
regulate. While it is understood that some choices of parameters can induce chaotic 
behaviors, the parameter may not even be achievable, such as very high temperatures 
(838). Mutations can also alter relationships in regulatory networks by causing changes in 
existing links or forming new ones. In a dynamically robust (non-chaotic) system, small, 
finite changes in the parameters lead to only qualitative changes in the dynamical 
behavior. However, there are boundaries in the parameter space where the behavior of the 
system changes qualitatively, and may include the possibility of chaotic dynamics. 
Predicting whether a network will be stable or chaos-prone under some conditions has 
proven to be difficult and remains poorly characterized. Recent work has identified the 
minimum number, types and interactions among three and four nodes/subnetworks that 
can lead to chaos in a gene regulatory network (836). Such minimal subnetworks have 
been termed ‘chaotic motifs’ and networks with these motifs can exhibit chaotic behavior 
under the right parameters (836). Analysis of the network in Figure 6.2 does not readily 
show such chaotic motifs. This could be because the network is incomplete (lack of data 
on the interactions among the P. aeruginosa regulators) or due to errors in the inferred 
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interactions. Though P. aeruginosa virulence regulation has been extensively studied, 
there is yet much to learn. Thus, absence of empirical evidence does not preclude a 
propensity to chaos and is worth further investigation.  
Depending on an elaborate network to achieve gene regulation is likely an 
adaptive mechanism by P. aeruginosa. Possessing alternate pathways to regulate the 
same phenotype ensures a rapid response to stimuli even if one of the pathways is 
affected, thus enhancing survival. Such examples can be seen throughout the network. As 
discussed in the section on toxins and exoproteins, expression of T3SS genes can be 
regulated at multiple levels, in response to various different signals and stress conditions, 
and is not entirely dependent on any one signal. However, the extent of contributions of 
the individual regulators and consequently, the fine balance that exists in some regulatory 
cascades within the network, are sometimes not easily apparent. Network dependence is 
also a probable reason for regulator genes being non-essential, in the sense that deleting a 
transcriptional regulator gene typically does not affect cell viability due to the presence 
alternate regulatory mechanisms. Having key regulators modulate different related 
phenotypes has the added advantage in allowing the cells to adapt to external signals by 
modulating one or a few regulators instead of individually regulating different virulence 
systems. A case in point is AmpR that positively regulates acute virulence factors while 
downregulating chronic infection phenotypes (225). Also of importance is the co-
regulation of metabolism and virulence. Studies have identified regulators like CbrB that, 
with its cognate sensor CbrA, not only regulate carbon metabolism but also virulence 
phenotypes via the rgRNA, rgCrcZ and the RNA-binding protein Crc (811,812). 
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Moreover, there is crosstalk between CbrA and regulators other than CbrB, highlighting 
the complexity of the system (811).  
The plethora of transcriptome studies using microarrays, or deep sequencing will 
add to the database of genes that are differentially expressed in response to regulator 
mutations or specific growth conditions. Differentiating the direct effect of a change from 
a ripple effect can, at least partly, be achieved by metaanalysis studies that look at 
multiple transcriptomes, identifying effects unique to each condition and differentiating 
them from the so-called ripple (28,400). Network analyses can help us understand the 
relationship between different regulators, group them based on function and, more 
importantly, help identify critical nodes and prominent players. This can serve as a means 
of target identification in attempting to deal with P. aeruginosa infections. In Figure 6.2, 
we see that some parts of the network are more densely connected than others, with 
central cores containing most of the links. A case in point is LasR of the QS subnetwork. 
It is well known that QS is central to virulence regulation in P. aeruginosa and targeting 
key regulators will have a better chance of therapeutic success. Recently, inhibitors of a 
key QS regulator were shown to reduce pathogenicity in Vibrio cholera (586). 
Future directions 
Taking the AmpR project forward will involve working on two main aspects: 
mechanistic and application-oriented.  
The mechanistic basis of the regulatory process, such as the effectors recognized 
by P. aeruginosa AmpR, is not known. This will be aided by resolving the AmpR 
structure. Further, the details of the AmpR regulatory cascade remains largely unsolved. 
For example, data from my dissertation identified the QS master regulator LasR to be a 
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direct target of AmpR. However, this does not fully explain the extensive AmpR regulon. 
The role of sRNAs in the AmpR regulon needs to be elucidated.  
Data from my dissertation has identified AmpR to be a major regulator of 
pathogenesis and metabolism in P. aeruginosa. So, an application-oriented extension of 
my project will be to identify inhibitors of AmpR function that will help manage P. 
aeruginosa infections in the clinical setting. These have been discussed in more detail in 
the following section. 
Identifying effectors that modulate AmpR activity 
It has been well established that LTTRs regulate expression of target genes in 
response to effectors (103,104). Analysis of the P. aeruginosa AmpR protein sequence 
reveals a predicted N-terminal DNA-binding HTH domain (amino acids 1-63), and C-
terminal effector-binding domain (amino acids 90-290). In vitro analyses have shown that 
the anhydro-MurNAc tripeptide activates C. freundii AmpR whereas in the presence of 
antibiotics, anhydro-MurNAc-pentapeptides positively activate E. cloacae AmpR 
(121,410,839). In C. freundii, UDP-MurNAc-pentapeptide represses AmpR activity 
(121,410). In P. aeruginosa, although these effectors have been suggested to play a role 
in AmpC ß-lactamase induction (73,348), there is no supporting experimental evidence.  
To date, AmpR is believed to be a soluble cytoplasmic protein (410). In the 
purification of AmpR from C. freundii, most of the protein was found to be in the 
insoluble fraction but this was attributed to protein aggregation (410). However, research 
in the Mathee lab shows that P. aeruginosa AmpR is an inner membrane protein, with a 
single predicted transmembrane domain between the HTH and effector-binding domains 
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(O. Caille, personal communication). Since the effector-binding domain is in the 
periplasm, the activating and repressing effectors molecules have to be found in 
periplasm. Based on what is known about E. coli cell-wall synthesis and recycling, one 
could predict the putative effectors to be one of the following molecules: GlcNAc-
anhydroMurNAc tri- or tetra-peptides, GlcNAc-anhydroMurNAc, anhydroMurNAc-tri- 
or tetra-peptides, free peptides (tri- and tetrapeptides) GlcNAc-anhydroMurNAc-
pentapeptide or anhydroMurNAc-pentapeptide (pentapeptides only in the presence of 
antibiotics) (Chapter 1, Figure 3). Identification of AmpR effector molecules can 
therefore be addressed with three specific aims: 
a. Analysis of specific cellular fractions by HPLC to identify the muramyl peptide 
effectors. 
b. Determine the role of effectors in activation and repression of AmpR using in 
vitro transcription assays.  
c. Crystallizing the AmpR protein in the presence and absence of the effector 
molecules. 
 
Experimental Design to identify effectors of P. aeruginosa AmpR 
 Construction of lysA strain of PAO1 Previous work in the lab to label P. 
aeruginosa diaminopimelate (DAP) peptidoglycan showed that PAO1 was very 
refractory to labeling (840). This is due to the enzymatic activity of LysA (PA5277 
encoding a diaminopimelate decarboxylase) that converts DAP to L-lysine. In the 
presence of LysA, DAP cannot be labeled with 3[H]. Labeling was achieved in E. coli 
only in the absence of lysA (840). In order to label the P. aeruginosa peptidoglycan 
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precursors, the lysA gene will have to be deleted in PAO1. The permease AmpG has been 
demonstrated to transport the muramyl degradation products (GlcNAc-anhydroMurNAc-
peptides) into the cytoplasm for recycling (121). We propose that an AmpG homolog, 
AmpP, is also involved in this process in P. aeruginosa and transports UDP-MurNAc-
pentapeptide into the periplasm (Chapter 1, Figure 2). These genes should also be deleted 
in the lysA mutant strain background (PAO∆lysA∆ampG and PAO∆lysA∆ampP) to 
ensure isolation of a high concentration of peptidoglycan degradation products from the 
periplasm and cytoplasm.  
Labeling, fractionation and HPLC analysis To isolate labeled muropeptides, 
PAO∆lysA, PAO∆lysA∆ampG and PAO∆lysA∆ampP should be grown in LB broth 
containing 3[H], thus labeling the DAP in the peptidoglycan layer. The periplasmic and 
cytoplasmic contents can then be isolated using commercially available kits (Epicentre 
Biotechnologies). Log/late-log phase cells, with and without exposure to sub-MIC ß-
lactams, should be used for the fractionation process. Spheroplasts can be generated by 
treating the cells with lysozyme and EDTA followed by osmotic shocking. This will 
release the periplasmic contents to form spheroplasts (841), which can be purified and 
lysed to obtain the cytoplasmic contents. The cytoplasmic, periplasmic and whole cell 
fractions from PAO1 and the mutant strains can then be analyzed by HPLC to determine 
the fractions that contain the putative effectors. As controls to ensure proper fractionation, 
the different fractions can be subjected to Western blot analysis using antibodies against 
ß-lactamase (periplasmic fraction) and σ70 (cytoplasmic fraction).  
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HPLC analysis of the different cellular fractions will identify the fractions 
containing the putative effectors. Fractions that contain radioactivity (due to DAP) and 
absorb UV (due to uridine) are the ones that contain the compounds of interest.  
Purification of AmpR For the in vitro transcription assays, purified AmpR is 
required. For purification of AmpR, expression clones (pMMB67EH-Gm, Ptac) 
containing a C-terminal 6-His tag of the whole ORF (290 amino acids) should be used. 
This overexpression construct in PAO∆ampR has already been generated (DBS39, 
DBS176). The overexpressed protein can be purified by affinity chromatography on Ni-
NTA matrix. We already have data from radioactive mobility-shift assays of the ampC 
promoter with AmpR-containing membrane fractions of overexpression strains (O. Caille, 
unpublished data).  
In vitro transcription assay The ampC promoter from PAO1 can be cloned into 
pUC19-spf’ and used as the template for the in vitro transcription assay. This plasmid is a 
derivative of pUC19 that contains a spf transcription terminator downstream of the 
multiple cloning site (842). Transcription termination will occur at spf to produce 
discrete-sized transcripts. Purified E. coli RNA polymerase (USB-Affymetrix) can be 
used for the assay. This approach should work because AmpR activation of ampC occurs 
in E. coli (105).  
Testing effector molecules to influence ß-lactamase production Purified 
AmpR with the template (target promoter cloned in pUC19-spf’) can be incubated in a 
Tris-HCl buffer containing DTT, KCl, MgCl2 and glycerol. Following this, RNA 
polymerase and NTPs (with ∝32-labeled UTP, other bases unlabeled) should be added 
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and incubated to allow in vitro transcription. The samples must then be DNase-treated, 
spiked with unlabeled tRNA followed by the phenol-chloroform protocol to isolate 
nucleic acids. The samples should then be run on a denaturing polyacrylamide gel, and 
exposed to film to locate the bands. 
  Once this assay has been standardized for AmpR concentration and conditions, 
effector molecule fractions can be tested for activation or repression of ampC expression 
(incubated in the first step with AmpR). Activation of ampC expression by the effectors 
will lead to a higher concentration of mRNA, whereas repression will have the opposite 
effect. Pure effectors can be synthesized for this experiment. 
Crystallization of AmpR with and without effectors This aspect of the project 
can be performed in collaboration with Emerald Biostructures. The non-effector bound 
AmpR can be crystallized to determine the pocket where the effector molecule would 
bind. Modeling and docking studies can then be done to correlate our in vitro data on 
effector molecules and compare with the in vivo and in vitro analysis. Subsequently, co-
crystallization can be done. Emerald Biostructures also provides analysis of potential 
inhibitors that are likely to bind. The process to crystallize AmpR in collaboration with 
Emerald Biostructures has already been initiated. 
Identification of small molecule inhibitors of AmpR 
Once the AmpR effectors are determined, the next logical step would be to 
design/identify inhibitors of AmpR function. Small molecule inhibitors of AmpR can be 
potential therapeutic agents against P. aeruginosa virulence and reduce resistance to ß-
lactams. The screening can be performed at the National Screening Laboratory for the 
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Regional Centers for Biodefense and Emerging Infectious Diseases (NSRB; 
nsrb.med.harvard.edu), which has a library of over 100,000 structurally diverse 
compounds. Reporter strains that harbor promoter fusions of ampC (AmpR-positively 
regulated) or mexE (AmpR negatively-regulated) can be used to determine small 
molecule potentiators or inhibitors of AmpR function. Following the initial screen to 
identify compounds of interest, further assays such as qPCRs, MICs, in vitro production 
of various virulence factors, cytotoxicity, virulence in C. elegans can be performed to 
validate the efficacy of the inhibitor compounds. After the compounds have been 
identified and their inhibitory roles confirmed, one could model the compound with 
AmpR to identify potential interaction domains. 
The studies that have identified AmpR effectors in Enterobacteriaceae members 
(121,410,839) consider AmpR to be only a positive regulator of ampC expression. 
However, data from my dissertation demonstrates that AmpR is a major transcriptional 
regulator that affects expression of diverse phenotypes. Whether AmpR-mediated 
regulation of the non-AmpC phenotypes is in response to the cell wall intermediates or 
other, as yet unidentified, effectors is a major question that needs to be answered. 
Answering this question will also help synthesize effector mimics that can potentially be 
used to inactivate AmpR function in the clinical setting, thus reducing virulence and 
rendering the cells sensitive to ß-lactam antibiotics. 
Known, putative and novel small regulatory RNAs in the AmpR regulon 
 Microarrays, RNA-Seq, qPCR and complementary studies have identified some 
known sRNAs (rgRsmZ, asPrrF1, rgRgsA) to be under AmpR regulation (Chapters 4, 5). 
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This clearly shows that the AmpR regulon includes sRNAs. However, recent studies have 
identified over 500 novel sRNAs in P. aeruginosa PAO1 (843,844) whose function and 
regulation have not been elucidated. Given the extensive nature of the AmpR regulon, it 
is very likely that many more sRNAs are AmpR-regulated. The next phase of research 
will involve determining the sRNAs that are regulated by AmpR. Further, detailing the 
mode of action of the AmpR-regulated sRNAs will make for exciting research.  
Moreover, it is possible that there are novel sRNAs that have not been identified 
yet. Quantitative analysis of the RNA-Seq data will provide insights into novel ncRNAs. 
These can be regulatory RNAs or antisense RNAs and are explained below.  
a. Regulatory RNAs: RNA-Seq reads that map to intergenic regions, or even within 
ORFs, need to be analyzed further in silico (look for putative promoters and 
terminators, secondary structures of the reads, differential expression between the 
conditions) and in vitro (deletion and overexpression phenotypic analyses, 
Northern blot analysis) in PAO1 and the ampR mutant strains to confirm presence, 
and AmpR-mediated regulation. 
b. Antisense RNAs (asRNAs): These are RNA-Seq reads that map to within the pre-
annotated ORFs in the Pseudomonas Genome Database (27), but in the opposite 
strand to the ORF in the RNA-Seq data. In addition to the in silico and in vitro 
analyses mentioned in the previous section, potential targets of asRNAs can be 
determined by BLAST analysis of the asRNA sequence against the PAO1 
genome. 
With the extensive use of high-throughput transcriptomics, gene regulation 
studies are now focusing on the role of non-coding RNAs in bacteria. rgRNAs have been 
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shown to be extensively involved in gene regulation in P. aeruginosa and other bacteria 
(390,458,758,810,819,845). Moreover, the interplay of rgRNAs and transcriptional 
regulators in controlling critical functions in bacteria is being increasingly appreciated. 
Given the important regulatory role of AmpR in P. aeruginosa virulence and metabolism, 
it is not surprising that rgRNAs such as rgRsmZ are AmpR-regulated (Chapter 5). 
Elucidating the mechanism of regulation of AmpR, the regulatory interaction of AmpR 
with rgRNAs and the signals that determine AmpR-mediated regulation would be the 
natural extension of my work. Other groups, by crystallizing the effector-binding domain, 
have initiated biochemical studies detailing AmpR (612). Moreover, techniques such as 
RNA-Seq allow for the entire transcriptome to be sequenced, giving us an unprecedented 
insight into non-coding RNAs, asRNAs and sRNAs involved in regulation. Preliminary 
studies using prediction software and complementary experiments have already advanced 
our understanding (390,458,519,647,819,846). Given the many different ways in which 
small RNAs can modulate gene expression (818) and potentially undiscovered ones, we 
can look forward to exciting new discoveries in bacterial gene regulation in the coming 
years. 
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Supplementary Fig 1: Core set of gene differentially regulated in all the studies 
0 5 10 15 20 25 30
DNA replication, recombination, modification and repair
Fatty acid and phospholipid metabolism
Hypothetical, unclassified, unknown
Membrane proteins
Amino acid biosynthesis and metabolism
Translation, post-translational modification, degradation
Cell wall / LPS / capsule
Transport of small molecules
Energy metabolism
Biosynthesis of cofactors, prosthetic groups and carriers
Adaptation, Protection
Transcriptional regulators
Two-component regulatory systems
Secreted Factors (toxins, enzymes, alginate)
Putative enzymes
Chaperones & heat shock proteins
Central intermediary metabolism
Nucleotide biosynthesis and metabolism
Carbon compound catabolism
Motility & Attachment
Chemotaxis
Related to phage, transposon, or plasmid
Non-coding RNA gene
Protein secretion/export apparatus
Cell division
Antibiotic resistance and susceptibility
Transcription, RNA processing and degradation
Percentage
  251
Supplementary Table 1: Comparison of all the genes that are differentially regulated in the 18 
transcriptomes. The list of ORFs are divided into core and accessory gene set, as defined in Mathee et 
al (PMID 18287045). 
 
ORF Product name Function class
Transcriptional core set ORFs present in the P. aeruginosa  core genome
PA0044 exoenzyme T Secreted Factors (toxins, enzymes, alginate) 
PA0045 hypothetical protein Hypothetical, unclassified, unknown 
PA0059 osmotically inducible protein OsmC Adaptation, Protection 
PA0070 hypothetical protein Membrane proteins 
PA0078 hypothetical protein Hypothetical, unclassified, unknown 
PA0082 hypothetical protein Hypothetical, unclassified, unknown 
PA0084 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0085 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0140 alkyl hydroperoxide reductase subunit F Adaptation, Protection 
PA0141 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0162 histidine porin OpdC Membrane proteins 
PA0183 arylsulfatase Central intermediary metabolism 
PA0184 probable ATP-binding component of ABC transporter Transport of small molecules 
PA0185 probable permease of ABC transporter Membrane proteins 
PA0186 probable binding protein component of ABC transporter Transport of small molecules 
PA0229 dicarboxylic acid transporter PcaT Membrane proteins 
PA0284 hypothetical protein Hypothetical, unclassified, unknown 
PA0290 hypothetical protein Hypothetical, unclassified, unknown 
PA0291 Anaerobically-induced outer membrane porin OprE precursor Membrane proteins 
PA0424 multidrug resistance operon repressor MexR Transcriptional regulators 
PA0447 glutaryl-CoA dehydrogenase Fatty acid and phospholipid metabolism 
PA0460 hypothetical protein Hypothetical, unclassified, unknown 
PA0471 probable transmembrane sensor Two-component regulatory systems 
PA0472 probable sigma-70 factor, ECF subfamily Transcriptional regulators 
PA0514 heme d1 biosynthesis protein NirL Hypothetical, unclassified, unknown 
PA0517 probable c-type cytochrome precursor Biosynthesis of cofactors, prosthetic groups and carriers 
PA0518 cytochrome c-551 precursor Biosynthesis of cofactors, prosthetic groups and carriers 
PA0519 nitrite reductase precursor Energy metabolism 
PA0524 nitric-oxide reductase subunit B Energy metabolism 
PA0572 hypothetical protein Hypothetical, unclassified, unknown 
PA0604 probable binding protein component of ABC transporter Transport of small molecules 
PA0605 probable permease of ABC transporter Membrane proteins 
PA0672 heme oxygenase Biosynthesis of cofactors, prosthetic groups and carriers 
PA0688 probable binding protein component of ABC transporter Transport of small molecules 
PA0762 sigma factor AlgU Transcriptional regulators 
PA0763 anti-sigma factor MucA Transcriptional regulators 
PA0764 negative regulator for alginate biosynthesis MucB Transcriptional regulators 
PA0775 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0848 probable alkyl hydroperoxide reductase Adaptation, Protection 
PA0849 thioredoxin reductase 2 Nucleotide biosynthesis and metabolism 
PA0852 chitin-binding protein CbpD precursor Secreted Factors (toxins, enzymes, alginate) 
PA0866 aromatic amino acid transport protein AroP2 Transport of small molecules 
PA0874 hypothetical protein Hypothetical, unclassified, unknown 
PA0929 two-component response regulator Transport of small molecules 
PA0938 hypothetical protein Hypothetical, unclassified, unknown 
PA0958 Outer membrane porin OprD precursor Transport of small molecules 
PA0962 probable dna-binding stress protein Adaptation, Protection 
PA1071 branched-chain amino acid transport protein BraF Transport of small molecules 
PA1156 NrdA, catalytic component of class Ia ribonucleotide reductase Nucleotide biosynthesis and metabolism 
PA1179 two-component response regulator PhoP Transcriptional regulators 
PA1180 two-component sensor PhoQ Two-component regulatory systems 
PA1230 hypothetical protein Membrane proteins 
PA1245 hypothetical protein Membrane proteins 
PA1246 alkaline protease secretion protein AprD Secreted Factors (toxins, enzymes, alginate) 
PA1249 alkaline metalloproteinase precursor Secreted Factors (toxins, enzymes, alginate) 
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PA1289 hypothetical protein Hypothetical, unclassified, unknown 
PA1300 probable sigma-70 factor, ECF subfamily Transcriptional regulators 
PA1317 cytochrome o ubiquinol oxidase subunit II Energy metabolism 
PA1318 cytochrome o ubiquinol oxidase subunit I Energy metabolism 
PA1319 cytochrome o ubiquinol oxidase subunit III Energy metabolism 
PA1323 hypothetical protein Hypothetical, unclassified, unknown 
PA1324 hypothetical protein Hypothetical, unclassified, unknown 
PA1346 hypothetical protein Hypothetical, unclassified, unknown 
PA1408 hypothetical protein Membrane proteins 
PA1541 probable drug efflux transporter Membrane proteins 
PA1544 transcriptional regulator Anr Transcriptional regulators 
PA1546 oxygen-independent coproporphyrinogen III oxidase Biosynthesis of cofactors, prosthetic groups and carriers 
PA1555 probable cytochrome c Energy metabolism 
PA1556 probable cytochrome c oxidase subunit Energy metabolism 
PA1557 probable cytochrome oxidase subunit (cbb3-type) Energy metabolism 
PA1657 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1673 hypothetical protein Hypothetical, unclassified, unknown 
PA1691 translocation protein in type III secretion Protein secretion/export apparatus 
PA1696 translocation protein in type III secretion Protein secretion/export apparatus 
PA1698 Type III secretion outer membrane protein PopN precursor Membrane proteins 
PA1699 conserved hypothetical protein in type III secretion Protein secretion/export apparatus 
PA1700 conserved hypothetical protein in type III secretion Protein secretion/export apparatus 
PA1701 conserved hypothetical protein in type III secretion Protein secretion/export apparatus 
PA1705 regulator in type III secretion Protein secretion/export apparatus 
PA1706 type III secretion protein PcrV Protein secretion/export apparatus 
PA1707 regulatory protein PcrH Secreted Factors (toxins, enzymes, alginate) 
PA1708 translocator protein PopB Protein secretion/export apparatus 
PA1709 Translocator outer membrane protein PopD precursor Protein secretion/export apparatus 
PA1710 ExsC, exoenzyme S synthesis protein C precursor . Translation, post-translational modification, degradation 
PA1711 ExsE Hypothetical, unclassified, unknown 
PA1712 exoenzyme S synthesis protein B Translation, post-translational modification, degradation 
PA1713 transcriptional regulator ExsA Protein secretion/export apparatus 
PA1714 ExsD Hypothetical, unclassified, unknown 
PA1715 type III export apparatus protein Protein secretion/export apparatus 
PA1716 Type III secretion outer membrane protein PscC precursor Protein secretion/export apparatus 
PA1717 type III export protein PscD Protein secretion/export apparatus 
PA1719 type III export protein PscF Protein secretion/export apparatus 
PA1720 type III export protein PscG Protein secretion/export apparatus 
PA1721 type III export protein PscH Protein secretion/export apparatus 
PA1722 type III export protein PscI Protein secretion/export apparatus 
PA1723 type III export protein PscJ Protein secretion/export apparatus 
PA1761 hypothetical protein Hypothetical, unclassified, unknown 
PA1793 peptidyl-prolyl cis-trans isomerase B Translation, post-translational modification, degradation 
PA1869 probable acyl carrier protein Fatty acid and phospholipid metabolism 
PA1894 hypothetical protein Hypothetical, unclassified, unknown 
PA1902 phenazine biosynthesis protein PhzD Secreted Factors (toxins, enzymes, alginate) 
PA1904 probable phenazine biosynthesis protein Secreted Factors (toxins, enzymes, alginate) 
PA1982 quinoprotein alcohol dehydrogenase Carbon compound catabolism 
PA2080 hypothetical protein Hypothetical, unclassified, unknown 
PA2081 kynurenine formamidase, KynB Hypothetical, unclassified, unknown 
PA2087 hypothetical protein Hypothetical, unclassified, unknown 
PA2088 hypothetical protein Hypothetical, unclassified, unknown 
PA2111 hypothetical protein Hypothetical, unclassified, unknown 
PA2112 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2113 pyroglutamate porin OpdO Transport of small molecules 
PA2114 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA2143 hypothetical protein Hypothetical, unclassified, unknown 
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PA2146 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2158 probable alcohol dehydrogenase (Zn-dependent) Putative enzymes 
PA2159 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2166 hypothetical protein Hypothetical, unclassified, unknown 
PA2171 hypothetical protein Hypothetical, unclassified, unknown 
PA2173 hypothetical protein Hypothetical, unclassified, unknown 
PA2177 probable sensor/response regulator hybrid Two-component regulatory systems 
PA2191 adenylate cyclase ExoY Secreted Factors (toxins, enzymes, alginate) 
PA2193 hydrogen cyanide synthase HcnA Central intermediary metabolism 
PA2194 hydrogen cyanide synthase HcnB Central intermediary metabolism 
PA2195 hydrogen cyanide synthase HcnC Central intermediary metabolism 
PA2247 2-oxoisovalerate dehydrogenase (alpha subunit) Amino acid biosynthesis and metabolism 
PA2248 2-oxoisovalerate dehydrogenase (beta subunit) Amino acid biosynthesis and metabolism 
PA2260 hypothetical protein Hypothetical, unclassified, unknown 
PA2261 probable 2-ketogluconate kinase Carbon compound catabolism 
PA2262 probable 2-ketogluconate transporter Membrane proteins 
PA2263 probable 2-hydroxyacid dehydrogenase Putative enzymes 
PA2264 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2265 gluconate dehydrogenase Carbon compound catabolism 
PA2266 probable cytochrome c precursor Carbon compound catabolism 
PA2299 probable transcriptional regulator Transcriptional regulators 
PA2302 probable non-ribosomal peptide synthetase Putative enzymes 
PA2304 hypothetical protein Hypothetical, unclassified, unknown 
PA2305 probable non-ribosomal peptide synthetase Putative enzymes 
PA2307 probable permease of ABC transporter Membrane proteins 
PA2309 hypothetical protein Hypothetical, unclassified, unknown 
PA2310 hypothetical protein Putative enzymes 
PA2331 hypothetical protein Membrane proteins 
PA2385 PvdQ Adaptation, Protection 
PA2386 L-ornithine N5-oxygenase Adaptation, Protection 
PA2389 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2392 PvdP Adaptation, Protection 
PA2393 probable dipeptidase precursor Central intermediary metabolism 
PA2394 PvdN Adaptation, Protection 
PA2396 pyoverdine synthetase F Secreted Factors (toxins, enzymes, alginate) 
PA2397 pyoverdine biosynthesis protein PvdE Membrane proteins 
PA2403 hypothetical protein Membrane proteins 
PA2404 hypothetical protein Membrane proteins 
PA2405 hypothetical protein Hypothetical, unclassified, unknown 
PA2407 probable adhesion protein Motility & Attachment 
PA2408 probable ATP-binding component of ABC transporter Transport of small molecules 
PA2409 probable permease of ABC transporter Membrane proteins 
PA2410 hypothetical protein Hypothetical, unclassified, unknown 
PA2411 probable thioesterase Adaptation, Protection 
PA2412 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2413 L-2,4-diaminobutyrate:2-ketoglutarate 4-aminotransferase, PvdH Adaptation, Protection 
PA2414 L-sorbosone dehydrogenase Carbon compound catabolism 
PA2415 hypothetical protein Membrane proteins 
PA2424 PvdL Adaptation, Protection 
PA2425 PvdG Adaptation, Protection 
PA2426 sigma factor PvdS Transcriptional regulators 
PA2433 hypothetical protein Hypothetical, unclassified, unknown 
PA2468 ECF sigma factor FoxI Transcriptional regulators 
PA2505 tyrosine porin OpdT Transport of small molecules 
PA2523 probable two-component response regulator Transcriptional regulators 
PA2548 hypothetical protein Hypothetical, unclassified, unknown 
PA2588 probable transcriptional regulator Transcriptional regulators 
  254
ORF Product name Function class
PA2592 probable periplasmic spermidine/putrescine-binding protein Transport of small molecules 
PA2630 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2634 isocitrate lyase Putative enzymes 
PA2687 two-component sensor PfeS Two-component regulatory systems 
PA2747 hypothetical protein Hypothetical, unclassified, unknown 
PA2760 probable outer membrane protein precursor Transport of small molecules 
PA2808 two-component response repressor , PtrA Transcriptional regulators 
PA2850 organic hydroperoxide resistance protein Adaptation, Protection 
PA2896 probable sigma-70 factor, ECF subfamily Transcriptional regulators 
PA3235 conserved hypothetical protein Membrane proteins 
PA3278 hypothetical protein Membrane proteins 
PA3281 hypothetical protein Membrane proteins 
PA3283 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3284 hypothetical protein Hypothetical, unclassified, unknown 
PA3287 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3328 probable FAD-dependent monooxygenase Putative enzymes 
PA3369 hypothetical protein Membrane proteins 
PA3371 hypothetical protein Hypothetical, unclassified, unknown 
PA3413 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3414 hypothetical protein Hypothetical, unclassified, unknown 
PA3416 probable pyruvate dehydrogenase E1 component, beta chain Energy metabolism 
PA3446 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3447 probable ATP-binding component of ABC transporter Transport of small molecules 
PA3448 probable permease of ABC transporter Membrane proteins 
PA3450 probable antioxidant protein Adaptation, Protection 
PA3460 probable acetyltransferase Putative enzymes 
PA3461 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3515 hypothetical protein Hypothetical, unclassified, unknown 
PA3516 probable lyase Putative enzymes 
PA3517 probable lyase Carbon compound catabolism 
PA3518 hypothetical protein Hypothetical, unclassified, unknown 
PA3519 hypothetical protein Hypothetical, unclassified, unknown 
PA3520 hypothetical protein Hypothetical, unclassified, unknown 
PA3523 probable RND efflux membrane fusion protein precursor Transport of small molecules 
PA3531 bacterioferritin Transport of small molecules 
PA3573 probable major facilitator superfamily (MFS) transporter Adaptation, Protection 
PA3600 conserved hypothetical protein Translation, post-translational modification, degradation 
PA3690 probable metal-transporting P-type ATPase Membrane proteins 
PA3691 hypothetical protein Hypothetical, unclassified, unknown 
PA3709 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3790 Putative copper transport outer membrane porin OprC precursor Transport of small molecules 
PA3842 probable chaperone Secreted Factors (toxins, enzymes, alginate) 
PA3899 probable sigma-70 factor, ECF subfamily Transcriptional regulators 
PA3900 probable transmembrane sensor Membrane proteins 
PA3904 hypothetical protein Hypothetical, unclassified, unknown 
PA3936 probable permease of ABC taurine transporter Membrane proteins 
PA3937 probable ATP-binding component of ABC taurine transporter Transport of small molecules 
PA3938 probable periplasmic taurine-binding protein precursor Transport of small molecules 
PA3954 hypothetical protein Hypothetical, unclassified, unknown 
PA4067 Outer membrane protein OprG precursor Membrane proteins 
PA4139 hypothetical protein Hypothetical, unclassified, unknown 
PA4156 probable TonB-dependent receptor Transport of small molecules 
PA4168 second ferric pyoverdine receptor FpvB Transport of small molecules 
PA4171 probable protease Putative enzymes 
PA4179 probable porin Membrane proteins 
PA4217 flavin-containing monooxygenase Putative enzymes 
PA4218 probable transporter Membrane proteins 
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PA4219 hypothetical protein Membrane proteins 
PA4220 hypothetical protein Hypothetical, unclassified, unknown 
PA4221 Fe(III)-pyochelin outer membrane receptor precursor Transport of small molecules 
PA4222 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4224 pyochelin biosynthetic protein PchG Transport of small molecules 
PA4225 pyochelin synthetase Secreted Factors (toxins, enzymes, alginate) 
PA4226 dihydroaeruginoic acid synthetase Secreted Factors (toxins, enzymes, alginate) 
PA4227 transcriptional regulator PchR Transcriptional regulators 
PA4228 pyochelin biosynthesis protein PchD Secreted Factors (toxins, enzymes, alginate) 
PA4229 pyochelin biosynthetic protein PchC Secreted Factors (toxins, enzymes, alginate) 
PA4230 salicylate biosynthesis protein PchB Secreted Factors (toxins, enzymes, alginate) 
PA4231 salicylate biosynthesis isochorismate synthase Secreted Factors (toxins, enzymes, alginate) 
PA4296 two-component response regulator, PprB Transcriptional regulators 
PA4359 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4429 probable cytochrome c1 precursor Energy metabolism 
PA4430 probable cytochrome b Energy metabolism 
PA4431 probable iron-sulfur protein Putative enzymes 
PA4467 hypothetical protein Membrane proteins 
PA4468 superoxide dismutase Adaptation, Protection 
PA4469 hypothetical protein Hypothetical, unclassified, unknown 
PA4470 fumarate hydratase Energy metabolism 
PA4471 hypothetical protein Hypothetical, unclassified, unknown 
PA4480 rod shape-determining protein MreC Cell wall / LPS / capsule
PA4501 Glycine-glutamate dipeptide porin OpdP Transport of small molecules 
PA4563 30S ribosomal protein S20 Central intermediary metabolism 
PA4570 hypothetical protein Hypothetical, unclassified, unknown 
PA4590 protein activator Transport of small molecules 
PA4613 catalase Adaptation, Protection 
PA4670 ribose-phosphate pyrophosphokinase Carbon compound catabolism 
PA4673 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4708 Heme-transport protein, PhuT Transport of small molecules 
PA4709 probable hemin degrading factor Putative enzymes 
PA4710 Haem/Haemoglobin uptake outer membrane receptor PhuR precursor Transport of small molecules 
PA4719 probable transporter Membrane proteins 
PA4738 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4739 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4876 osmotically inducible lipoprotein OsmE Membrane proteins 
PA4880 probable bacterioferritin Central intermediary metabolism 
PA4896 probable sigma-70 factor, ECF subfamily Transcriptional regulators 
PA4909 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4981 probable amino acid permease Membrane proteins 
PA5261 alginate biosynthesis regulatory protein AlgR Secreted Factors (toxins, enzymes, alginate) 
PA5311 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA5315 50S ribosomal protein L33 Translation, post-translational modification, degradation 
PA5407 hypothetical protein Hypothetical, unclassified, unknown 
PA5469 conserved hypothetical protein Membrane proteins 
PA5482 hypothetical protein Membrane proteins 
PA5530 probable MFS dicarboxylate transporter Membrane proteins 
Transcriptional core set ORFs present in the P. aeruginosa PAO1 accessory genome
PA0203 probable binding protein component of ABC transporter Transport of small molecules 
PA0204 probable permease of ABC transporter Membrane proteins
PA0205 probable permease of ABC transporter Membrane proteins
PA0206 probable ATP-binding component of ABC transporter Transport of small molecules 
PA0633 hypothetical protein Related to phage, transposon, or plasmid 
PA0691 hypothetical protein Hypothetical, unclassified, unknown 
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PA1414 hypothetical protein Hypothetical, unclassified, unknown 
PA1592 hypothetical protein Hypothetical, unclassified, unknown 
PA1718 type III export protein PscE Protein secretion/export apparatus 
PA2033 hypothetical protein Hypothetical, unclassified, unknown 
PA2034 hypothetical protein Hypothetical, unclassified, unknown 
PA2184 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2190 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2308 probable ATP-binding component of ABC transporter Transport of small molecules 
PA2398 ferripyoverdine receptor Transport of small molecules 
PA2399 pyoverdine synthetase D Secreted Factors (toxins, enzymes, alginate) 
PA2400 PvdJ Adaptation, Protection 
PA2402 probable non-ribosomal peptide synthetase Putative enzymes 
PA2452 hypothetical protein Hypothetical, unclassified, unknown 
PA3370 hypothetical protein Membrane proteins
PA3477 transcriptional regulator RhlR Adaptation, Protection 
PA3841 exoenzyme S Secreted Factors (toxins, enzymes, alginate) 
PA3866 pyocin protein Adaptation, Protection 
PA3923 hypothetical protein Hypothetical, unclassified, unknown 
PA4193 probable permease of ABC transporter Membrane proteins
PA4223 probable ATP-binding component of ABC transporter Membrane proteins
PA4306 Type IVb pilin, Flp Motility & Attachment 
PA4555 type 4 fimbrial biogenesis protein PilY2 Motility & Attachment 
PA4748 triosephosphate isomerase Central intermediary metabolism  
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Supplementary Table 2: Functional categorization of genes that are uniquely expressed under the different study conditions. 
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Supplementary Table 3: List of genes that are uniquely expressed in the various transcriptome 
studies. The various conditions include iron response, quorum sensing, oxidative stress, 
pentachlorophenol stress, copper stress, sulfate starvation, osmotic shock, biofilm formation, alginate 
production and loss of the post-transcriptional regulator RsmA. 
 
Iron
ORF Product name Function class
PA0013 conserved hypothetical protein Membrane proteins 
PA0027 hypothetical protein Hypothetical, unclassified, unknown 
PA0128 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0203 probable binding protein component of ABC transporter Transport of small molecules 
PA0223 probable dihydrodipicolinate synthetase Cell wall / LPS / capsule
PA0224 probable aldolase Putative enzymes 
PA0251 hypothetical protein Hypothetical, unclassified, unknown 
PA0252 hypothetical protein Hypothetical, unclassified, unknown 
PA0265 succinate-semialdehyde dehydrogenase Central intermediary metabolism
PA0266 4-aminobutyrate aminotransferase Central intermediary metabolism
PA0296 probable glutamine synthetase Putative enzymes 
PA0346 hypothetical protein Hypothetical, unclassified, unknown 
PA0417 probable chemotaxis protein Chemotaxis 
PA0433 hypothetical protein Hypothetical, unclassified, unknown 
PA0460 hypothetical protein Hypothetical, unclassified, unknown 
PA0470 Ferrichrome receptor FiuA Transport of small molecules 
PA0471 probable transmembrane sensor Two-component regulatory systems 
PA0472 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA0500 biotin synthase Biosynthesis of cofactors, prosthetic groups and carriers
PA0527 transcriptional regulator Dnr Transcriptional regulators 
PA0539 hypothetical protein Membrane proteins 
PA0605 probable permease of ABC transporter Membrane proteins 
PA0672 heme oxygenase Biosynthesis of cofactors, prosthetic groups and carriers
PA0707 transcriptional regulator ToxR Transcriptional regulators 
PA0725 hypothetical protein of bacteriophage Pf1 Hypothetical, unclassified, unknown 
PA0774 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0801 hypothetical protein Membrane proteins 
PA0802 hypothetical protein Membrane proteins 
PA0818 hypothetical protein Hypothetical, unclassified, unknown 
PA0842 probable glycosyl transferase Putative enzymes 
PA0844 hemolytic phospholipase C precursor Secreted Factors (toxins, enzymes, alginate) 
PA0848 probable alkyl hydroperoxide reductase Adaptation, Protection
PA0930 two-component sensor Transport of small molecules 
PA0931 ferric enterobactin receptor PirA Transport of small molecules 
PA0968 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1003 Transcriptional regulator MvfR Biosynthesis of cofactors, prosthetic groups and carriers
PA1108 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1134 hypothetical protein Hypothetical, unclassified, unknown 
PA1148 exotoxin A precursor Secreted Factors (toxins, enzymes, alginate) 
PA1211 hypothetical protein Hypothetical, unclassified, unknown 
PA1247 alkaline protease secretion protein AprE Secreted Factors (toxins, enzymes, alginate) 
PA1248 Alkaline protease secretion outer membrane protein AprF precursor Secreted Factors (toxins, enzymes, alginate) 
PA1249 alkaline metalloproteinase precursor Secreted Factors (toxins, enzymes, alginate) 
PA1300 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA1301 probable transmembrane sensor Membrane proteins 
PA1302 probable heme utilization protein precursor Membrane proteins 
PA1316 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1317 cytochrome o ubiquinol oxidase subunit II Energy metabolism 
PA1318 cytochrome o ubiquinol oxidase subunit I Energy metabolism 
PA1319 cytochrome o ubiquinol oxidase subunit III Energy metabolism 
PA1320 cytochrome o ubiquinol oxidase subunit IV Energy metabolism 
PA1321 cytochrome o ubiquinol oxidase protein CyoE Energy metabolism 
PA1363 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA1365 probable siderophore receptor Transport of small molecules 
PA1431 regulatory protein RsaL Secreted Factors (toxins, enzymes, alginate) 
PA1556 probable cytochrome c oxidase subunit Energy metabolism 
PA1559 hypothetical protein Hypothetical, unclassified, unknown 
PA1654 probable aminotransferase Putative enzymes 
PA1655 probable glutathione S-transferase Putative enzymes 
PA1687 spermidine synthase Amino acid biosynthesis and metabolism 
PA1908 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1911 probable transmembrane sensor Membrane proteins 
PA1917 hypothetical protein Hypothetical, unclassified, unknown 
PA1972 conserved hypothetical protein Membrane proteins 
PA2002 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2021 hypothetical protein Hypothetical, unclassified, unknown 
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PA2034 hypothetical protein Hypothetical, unclassified, unknown 
PA2038 hypothetical protein Hypothetical, unclassified, unknown 
PA2039 hypothetical protein Membrane proteins 
PA2041 probable amino acid permease Transport of small molecules 
PA2131 fimbrial subunit CupA4 Motility & Attachment 
PA2181 hypothetical protein Hypothetical, unclassified, unknown 
PA2258 transcriptional regulator PtxR Secreted Factors (toxins, enzymes, alginate) 
PA2383 probable transcriptional regulator Transcriptional regulators 
PA2384 hypothetical protein Hypothetical, unclassified, unknown 
PA2387 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA2388 probable transmembrane sensor Membrane proteins 
PA2390 probable ATP-binding/permease fusion ABC transporter Membrane proteins 
PA2391 probable outer membrane protein precursor Membrane proteins 
PA2395 PvdO Adaptation, Protection
PA2406 hypothetical protein Hypothetical, unclassified, unknown 
PA2420 probable porin Membrane proteins 
PA2427 hypothetical protein Hypothetical, unclassified, unknown 
PA2437 hypothetical protein Membrane proteins 
PA2441 hypothetical protein Hypothetical, unclassified, unknown 
PA2451 hypothetical protein Hypothetical, unclassified, unknown 
PA2467 Anti-sigma factor FoxR Membrane proteins 
PA2490 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2531 probable aminotransferase Amino acid biosynthesis and metabolism 
PA2637 NADH dehydrogenase I chain A Energy metabolism 
PA2638 NADH dehydrogenase I chain B Energy metabolism 
PA2686 two-component response regulator PfeR Transcriptional regulators 
PA2688 Ferric enterobactin receptor , outer membrane protein PfeA  precursor Membrane proteins 
PA2691 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2753 hypothetical protein Hypothetical, unclassified, unknown 
PA2761 hypothetical protein Membrane proteins 
PA2767 probable enoyl-CoA hydratase/isomerase Putative enzymes 
PA2776 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2910 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2916 hypothetical protein Membrane proteins 
PA2917 probable transcriptional regulator Transcriptional regulators 
PA3049 ribosome modulation factor Translation, post-translational modification, degradation
PA3165 histidinol-phosphate aminotransferase Amino acid biosynthesis and metabolism 
PA3221 CsaA protein Protein secretion/export apparatus
PA3222 hypothetical protein Membrane proteins 
PA3233 hypothetical protein Hypothetical, unclassified, unknown 
PA3355 hypothetical protein Membrane proteins 
PA3397 ferredoxin--NADP+ reductase Biosynthesis of cofactors, prosthetic groups and carriers
PA3407 heme acquisition protein HasAp Transport of small molecules 
PA3408 Haem uptake outer membrane receptor HasR precursor Transport of small molecules 
PA3409 probable transmembrane sensor Membrane proteins 
PA3410 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA3436 hypothetical protein Hypothetical, unclassified, unknown 
PA3530 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3553 ArnC Adaptation, Protection
PA3556 inner membrane L-Ara4N transferase ArnT Adaptation, Protection
PA3558 ArnF Membrane proteins 
PA3608 polyamine transport protein PotB Membrane proteins 
PA3749 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3767 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3768 probable metallo-oxidoreductase Putative enzymes 
PA3775 hypothetical protein Membrane proteins 
PA3811 heat shock protein HscB Chaperones & heat shock proteins 
PA3812 probable iron-binding protein IscA Biosynthesis of cofactors, prosthetic groups and carriers
PA3814 L-cysteine desulfurase (pyridoxal phosphate-dependent) Amino acid biosynthesis and metabolism 
PA3885 hypothetical protein Hypothetical, unclassified, unknown 
PA3901 Fe(III) dicitrate transport protein FecA Membrane proteins 
PA4090 hypothetical protein Hypothetical, unclassified, unknown 
PA4091 4-hydroxyphenylacetate 3-monooxygenase lar ge chain Carbon compound catabolism 
PA4158 ferric enterobactin transport protein FepC Transport of small molecules 
PA4175 protease IV Secreted Factors (toxins, enzymes, alginate) 
PA4223 probable ATP-binding component of ABC transporter Membrane proteins 
PA4224 pyochelin biosynthetic protein PchG Transport of small molecules 
PA4225 pyochelin synthetase Secreted Factors (toxins, enzymes, alginate) 
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PA4226 dihydroaeruginoic acid synthetase Secreted Factors (toxins, enzymes, alginate) 
PA4227 transcriptional regulator PchR Transcriptional regulators 
PA4228 pyochelin biosynthesis protein PchD Secreted Factors (toxins, enzymes, alginate) 
PA4229 pyochelin biosynthetic protein PchC Secreted Factors (toxins, enzymes, alginate) 
PA4230 salicylate biosynthesis protein PchB Secreted Factors (toxins, enzymes, alginate) 
PA4231 salicylate biosynthesis isochorismate synthase Secreted Factors (toxins, enzymes, alginate) 
PA4288 probable transcriptional regulator Transcriptional regulators 
PA4357 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4358 probable ferrous iron transport protein Membrane proteins 
PA4359 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4370 Insulin-cleaving metalloproteinase outer membrane protein precursor Membrane proteins 
PA4371 hypothetical protein Hypothetical, unclassified, unknown 
PA4372 hypothetical protein Hypothetical, unclassified, unknown 
PA4500 probable binding protein component of ABC transporter Transport of small molecules 
PA4503 probable permease of ABC transporter Membrane proteins 
PA4513 probable oxidoreductase Putative enzymes 
PA4514 probable outer membrane receptor for iron transport Transport of small molecules 
PA4515 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4516 hypothetical protein Hypothetical, unclassified, unknown 
PA4517 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4519 ornithine decarboxylase Amino acid biosynthesis and metabolism 
PA4629 hypothetical protein Hypothetical, unclassified, unknown 
PA4630 hypothetical protein Hypothetical, unclassified, unknown 
PA4633 probable chemotaxis transducer Adaptation, Protection
PA4654 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA4675 probable TonB-dependent receptor Transport of small molecules 
PA4687 ferric iron-binding periplasmic protein HitA Transport of small molecules 
PA4688 iron (III)-transport system permease HitB Membrane proteins 
PA4706 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4773 hypothetical protein Hypothetical, unclassified, unknown 
PA4785 probable acyl-CoA thiolase Putative enzymes 
PA4826 hypothetical protein Hypothetical, unclassified, unknown 
PA4833 conserved hypothetical protein Membrane proteins 
PA4838 hypothetical protein Hypothetical, unclassified, unknown 
PA4858 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4860 probable permease of ABC transporter Membrane proteins 
PA4861 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4862 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4883 hypothetical protein Hypothetical, unclassified, unknown 
PA4892 urease accessory protein UreF Biosynthesis of cofactors, prosthetic groups and carriers
PA4893 urease accessory protein UreG Biosynthesis of cofactors, prosthetic groups and carriers
PA4894 hypothetical protein Membrane proteins 
PA4895 probable transmembrane sensor Membrane proteins 
PA4897 hypothetical protein Hypothetical, unclassified, unknown 
PA4973 thiamin biosynthesis protein ThiC Biosynthesis of cofactors, prosthetic groups and carriers
PA5119 glutamine synthetase Amino acid biosynthesis and metabolism 
PA5124 two-component sensor NtrB Two-component regulatory systems 
PA5125 two-component response regulator NtrC Transcriptional regulators 
PA5150 probable short-chain dehydrogenase Putative enzymes 
PA5217 probable binding protein component of ABC iron transporter Transport of small molecules 
PA5287 ammonium transporter AmtB Membrane proteins 
PA5309 probable oxidoreductase Putative enzymes 
PA5312 probable aldehyde dehydrogenase Putative enzymes 
PA5313 probable pyridoxal-dependent aminotransferase Putative enzymes 
PA5314 hypothetical protein Hypothetical, unclassified, unknown 
PA5386 probable 3-hydroxyacyl-CoA  dehydrogenase Putative enzymes 
PA5479 proton-glutamate symporter Membrane proteins 
PA5526 hypothetical protein Hypothetical, unclassified, unknown 
PA5531 TonB protein Transport of small molecules 
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Quorum Sensing
PA0006 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0048 probable transcriptional regulator Transcriptional regulators 
PA0049 hypothetical protein Hypothetical, unclassified, unknown 
PA0050 hypothetical protein Hypothetical, unclassified, unknown 
PA0051 potential phenazine-modifying enzyme Putative enzymes 
PA0052 hypothetical protein Hypothetical, unclassified, unknown 
PA0055 hypothetical protein Hypothetical, unclassified, unknown 
PA0079 hypothetical protein Hypothetical, unclassified, unknown 
PA0080 hypothetical protein Hypothetical, unclassified, unknown 
PA0097 hypothetical protein Hypothetical, unclassified, unknown 
PA0105 cytochrome c oxidase, subunit II Energy metabolism 
PA0106 cytochrome c oxidase, subunit I Energy metabolism 
PA0107 conserved hypothetical protein Energy metabolism 
PA0108 cytochrome c oxidase, subunit III Energy metabolism 
PA0112 hypothetical protein Membrane proteins 
PA0113 probable cytochrome c oxidase assembly factor Energy metabolism 
PA0119 probable dicarboxylate transporter Transport of small molecules 
PA0122 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0129 gamma-aminobutyrate permease Transport of small molecules 
PA0130 probable aldehyde dehydrogenase Putative enzymes 
PA0131 hypothetical protein Hypothetical, unclassified, unknown 
PA0132 beta-alanine--pyruvate transaminase Amino acid biosynthesis and metabolism 
PA0144 hypothetical protein Hypothetical, unclassified, unknown 
PA0145 hypothetical protein Hypothetical, unclassified, unknown 
PA0153 protocatechuate 3,4-dioxygenase, beta subunit Carbon compound catabolism 
PA0154 protocatechuate 3,4-dioxygenase, alpha subunit Carbon compound catabolism 
PA0160 hypothetical protein Hypothetical, unclassified, unknown 
PA0167 probable transcriptional regulator Transcriptional regulators 
PA0191 probable transcriptional regulator Transcriptional regulators 
PA0200 hypothetical protein Hypothetical, unclassified, unknown 
PA0209 conserved hypothetical protein Putative enzymes 
PA0210 malonate decarboxylase delta subunit Carbon compound catabolism 
PA0211 malonate decarboxylase beta subunit Carbon compound catabolism 
PA0212 malonate decarboxylase gamma subunit Carbon compound catabolism 
PA0213 hypothetical protein Carbon compound catabolism 
PA0214 probable acyl transferase Carbon compound catabolism 
PA0221 probable aminotransferase Putative enzymes 
PA0226 probable CoA transferase, subunit A Carbon compound catabolism 
PA0227 probable CoA transferase, subunit B Carbon compound catabolism 
PA0228 beta-ketoadipyl CoA thiolase PcaF Fatty acid and phospholipid metabolism 
PA0234 hypothetical protein Hypothetical, unclassified, unknown 
PA0235 4-hydroxybenzoate transporter PcaK Membrane proteins 
PA0239 hypothetical protein Membrane proteins 
PA0241 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA0251 hypothetical protein Hypothetical, unclassified, unknown 
PA0264 hypothetical protein Hypothetical, unclassified, unknown 
PA0265 succinate-semialdehyde dehydrogenase Central intermediary metabolism 
PA0266 4-aminobutyrate aminotransferase Central intermediary metabolism 
PA0269 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0270 hypothetical protein Hypothetical, unclassified, unknown 
PA0271 hypothetical protein Hypothetical, unclassified, unknown 
PA0274 hypothetical protein Hypothetical, unclassified, unknown 
PA0287 3-guanidinopropionate transport protein Transport of small molecules 
PA0297 probable glutamine amidotransferase Amino acid biosynthesis and metabolism 
PA0298 probable glutamine synthetase Putative enzymes 
PA0299 putrescine aminotransferase Putative enzymes 
PA0300 polyamine transport protein Transport of small molecules 
PA0301 polyamine transport protein Transport of small molecules 
PA0302 polyamine transport protein PotG Transport of small molecules 
PA0303 polyamine transport protein PotH Membrane proteins 
PA0304 polyamine transport protein PotI Membrane proteins 
PA0305 hypothetical protein Hypothetical, unclassified, unknown 
PA0321 probable acetylpolyamine aminohydrolase Putative enzymes 
PA0363 phosphopantetheine adenylyltransferase Central intermediary metabolism 
PA0364 probable oxidoreductase Putative enzymes 
PA0385 hypothetical protein Hypothetical, unclassified, unknown 
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PA0399 cystathionine beta-synthase Amino acid biosynthesis and metabolism 
PA0436 probable transcriptional regulator Transcriptional regulators 
PA0439 probable oxidoreductase Putative enzymes 
PA0440 probable oxidoreductase Putative enzymes 
PA0441 dihydropyrimidinase Nucleotide biosynthesis and metabolism 
PA0443 probable transporter Membrane proteins 
PA0444 N-carbamoyl-beta-alanine amidohydrolase Nucleotide biosynthesis and metabolism 
PA0453 hypothetical protein Hypothetical, unclassified, unknown 
PA0456 probable cold-shock protein Transcriptional regulators 
PA0459 probable ClpA/B protease ATP binding subunit Translation, post-translational modification, degradation 
PA0467 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0468 hypothetical protein Hypothetical, unclassified, unknown 
PA0469 hypothetical protein Hypothetical, unclassified, unknown 
PA0473 probable glutathione S-transferase Putative enzymes 
PA0474 hypothetical protein Hypothetical, unclassified, unknown 
PA0480 probable hydrolase Putative enzymes 
PA0482 malate synthase G Central intermediary metabolism 
PA0489 probable phosphoribosyl transferase Putative enzymes 
PA0497 hypothetical protein Hypothetical, unclassified, unknown 
PA0498 hypothetical protein Hypothetical, unclassified, unknown 
PA0512 conserved hypothetical protein Biosynthesis of cofactors, prosthetic groups and carriers 
PA0513 probable transcriptional regulator Biosynthesis of cofactors, prosthetic groups and carriers 
PA0527 transcriptional regulator Dnr Transcriptional regulators 
PA0542 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0610 transcriptional regulator PrtN Transcriptional regulators 
PA0614 hypothetical protein Hypothetical, unclassified, unknown 
PA0615 hypothetical protein Hypothetical, unclassified, unknown 
PA0616 hypothetical protein Related to phage, transposon, or plasmid 
PA0617 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0618 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0619 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0620 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0621 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0622 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0623 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0624 hypothetical protein Related to phage, transposon, or plasmid 
PA0625 hypothetical protein Related to phage, transposon, or plasmid 
PA0626 hypothetical protein Related to phage, transposon, or plasmid 
PA0627 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0628 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0629 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0630 hypothetical protein Related to phage, transposon, or plasmid 
PA0631 hypothetical protein Related to phage, transposon, or plasmid 
PA0632 hypothetical protein Related to phage, transposon, or plasmid 
PA0635 hypothetical protein Related to phage, transposon, or plasmid 
PA0636 hypothetical protein Related to phage, transposon, or plasmid 
PA0637 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0638 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0639 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0640 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0641 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0642 hypothetical protein Related to phage, transposon, or plasmid 
PA0643 hypothetical protein Related to phage, transposon, or plasmid 
PA0644 hypothetical protein Related to phage, transposon, or plasmid 
PA0645 hypothetical protein Related to phage, transposon, or plasmid 
PA0646 hypothetical protein Related to phage, transposon, or plasmid 
PA0647 hypothetical protein Related to phage, transposon, or plasmid 
PA0648 hypothetical protein Related to phage, transposon, or plasmid 
PA0671 hypothetical protein Hypothetical, unclassified, unknown 
PA0683 probable type II secretion system protein Protein secretion/export apparatus 
PA0701 probable transcriptional regulator Transcriptional regulators 
PA0717 hypothetical protein of bacteriophage Pf1 Hypothetical, unclassified, unknown 
PA0718 hypothetical protein of bacteriophage Pf1 Hypothetical, unclassified, unknown 
PA0719 hypothetical protein of bacteriophage Pf1 Hypothetical, unclassified, unknown 
PA0720 helix destabilizing protein of bacteriophage Pf1 DNA replication, recombination, modification and repair 
PA0721 hypothetical protein of bacteriophage Pf1 Hypothetical, unclassified, unknown 
PA0723 coat protein B of bacteriophage Pf1 Related to phage, transposon, or plasmid 
PA0736 hypothetical protein Membrane proteins 
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PA0740 SDS hydrolase SdsA1 Putative enzymes 
PA0745 probable enoyl-CoA hydratase/isomerase Putative enzymes 
PA0746 probable acyl-CoA dehydrogenase Putative enzymes 
PA0747 probable aldehyde dehydrogenase Putative enzymes 
PA0776 hypothetical protein Hypothetical, unclassified, unknown 
PA0783 sodium/proline symporter PutP Membrane proteins 
PA0826 hypothetical protein Hypothetical, unclassified, unknown 
PA0841 hypothetical protein Hypothetical, unclassified, unknown 
PA0845 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0854 fumarate hydratase Energy metabolism 
PA0867 hypothetical protein Hypothetical, unclassified, unknown 
PA0870 aromatic amino acid aminotransferase Amino acid biosynthesis and metabolism 
PA0871 pterin-4-alpha-carbinolamine dehydratase Amino acid biosynthesis and metabolism 
PA0885 probable C4-dicarboxylate transporter Transport of small molecules 
PA0910 hypothetical protein Hypothetical, unclassified, unknown 
PA0938 hypothetical protein Hypothetical, unclassified, unknown 
PA0943 hypothetical protein Hypothetical, unclassified, unknown 
PA0997 Homologous to beta-keto-acyl-acyl-carrier protein synthase Biosynthesis of cofactors, prosthetic groups and carriers 
PA0998 Homologous to beta-keto-acyl-acyl-carrier protein synthase Biosynthesis of cofactors, prosthetic groups and carriers 
PA0999 3-oxoacyl-[acyl-carrier -protein] synthase III Biosynthesis of cofactors, prosthetic groups and carriers 
PA1018 hypothetical protein Hypothetical, unclassified, unknown 
PA1019 cis,cis-muconate transporter MucK Membrane proteins 
PA1025 probable porin Membrane proteins 
PA1049 pyridoxine 5'-phosphate oxidase Biosynthesis of cofactors, prosthetic groups and carriers 
PA1051 probable transporter Membrane proteins 
PA1070 branched-chain amino acid transport protein BraG Transport of small molecules 
PA1072 branched-chain amino acid transport protein BraE Membrane proteins 
PA1073 branched-chain amino acid transport protein BraD Membrane proteins 
PA1074 branched-chain amino acid transport protein BraC Transport of small molecules 
PA1106 hypothetical protein Hypothetical, unclassified, unknown 
PA1113 probable ATP-binding/permease fusion ABC transporter Membrane proteins 
PA1123 hypothetical protein Hypothetical, unclassified, unknown 
PA1127 probable oxidoreductase Adaptation, Protection 
PA1130 rhamnosyltransferase 2 Cell wall / LPS / capsule 
PA1131 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1137 probable oxidoreductase Putative enzymes 
PA1143 hypothetical protein Hypothetical, unclassified, unknown 
PA1144 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1150 pyocin S2 Adaptation, Protection 
PA1166 hypothetical protein Hypothetical, unclassified, unknown 
PA1183 C4-dicarboxylate transport protein Transport of small molecules 
PA1186 hypothetical protein Hypothetical, unclassified, unknown 
PA1190 conserved hypothetical protein Membrane proteins 
PA1197 hypothetical protein Hypothetical, unclassified, unknown 
PA1206 hypothetical protein Hypothetical, unclassified, unknown 
PA1207 glutathione-regulated potassium-ef flux system protein KefB Transport of small molecules 
PA1220 hypothetical protein Hypothetical, unclassified, unknown 
PA1223 probable transcriptional regulator Transcriptional regulators 
PA1228 hypothetical protein Hypothetical, unclassified, unknown 
PA1236 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1239 hypothetical protein Hypothetical, unclassified, unknown 
PA1242 hypothetical protein Hypothetical, unclassified, unknown 
PA1250 alkaline proteinase inhibitor AprI Secreted Factors (toxins, enzymes, alginate) 
PA1262 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1266 probable oxidoreductase Putative enzymes 
PA1338 gamma-glutamyltranspeptidase precursor Amino acid biosynthesis and metabolism 
PA1340 probable permease of ABC transporter Transport of small molecules 
PA1341 probable permease of ABC transporter Membrane proteins 
PA1342 probable binding protein component of ABC transporter Transport of small molecules 
PA1344 probable short-chain dehydrogenase Putative enzymes 
PA1367 hypothetical protein Hypothetical, unclassified, unknown 
PA1377 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1379 probable short-chain dehydrogenase Putative enzymes 
PA1386 probable ATP-binding component of ABC transporter Transport of small molecules 
PA1395 hypothetical protein Hypothetical, unclassified, unknown 
PA1399 probable transcriptional regulator Transcriptional regulators 
PA1400 probable pyruvate carboxylase Energy metabolism 
PA1416 conserved hypothetical protein Hypothetical, unclassified, unknown 
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PA1418 probable sodium:solute symport protein Transport of small molecules 
PA1419 probable transporter Membrane proteins 
PA1426 hypothetical protein Hypothetical, unclassified, unknown 
PA1431 regulatory protein RsaL Secreted Factors (toxins, enzymes, alginate) 
PA1440 hypothetical protein Hypothetical, unclassified, unknown 
PA1519 probable transporter Membrane proteins 
PA1537 probable short-chain dehydrogenase Putative enzymes 
PA1538 probable flavin-containing monooxygenase Putative enzymes 
PA1540 conserved hypothetical protein Membrane proteins 
PA1542 hypothetical protein Hypothetical, unclassified, unknown 
PA1568 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1569 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1575 hypothetical protein Hypothetical, unclassified, unknown 
PA1576 probable 3-hydroxyisobutyrate dehydrogenase Putative enzymes 
PA1608 probable chemotaxis transducer Adaptation, Protection 
PA1609 beta-ketoacyl-ACP synthase I Fatty acid and phospholipid metabolism 
PA1610 beta-hydroxydecanoyl-ACP  dehydrase Fatty acid and phospholipid metabolism 
PA1617 probable AMP-binding enzyme Putative enzymes 
PA1650 probable transporter Membrane proteins 
PA1746 hypothetical protein Hypothetical, unclassified, unknown 
PA1759 probable transcriptional regulator Transcriptional regulators 
PA1763 hypothetical protein Hypothetical, unclassified, unknown 
PA1768 hypothetical protein Hypothetical, unclassified, unknown 
PA1772 probable methyltransferase Biosynthesis of cofactors, prosthetic groups and carriers 
PA1774 CfrX protein Hypothetical, unclassified, unknown 
PA1775 conserved cytoplasmic membrane protein, CmpX protein Membrane proteins 
PA1776 ECF sigma factor SigX Transcriptional regulators 
PA1781 assimilatory nitrite reductase lar ge subunit Central intermediary metabolism 
PA1784 hypothetical protein Hypothetical, unclassified, unknown 
PA1789 hypothetical protein Hypothetical, unclassified, unknown 
PA1790 hypothetical protein Hypothetical, unclassified, unknown 
PA1812 membrane-bound lytic murein transglycosylase D precursor Amino acid biosynthesis and metabolism 
PA1824 conserved hypothetical protein Membrane proteins 
PA1852 hypothetical protein Hypothetical, unclassified, unknown 
PA1853 probable transcriptional regulator Transcriptional regulators 
PA1871 LasA protease precursor Secreted Factors (toxins, enzymes, alginate) 
PA1875 probable outer membrane protein precursor Protein secretion/export apparatus 
PA1891 hypothetical protein Membrane proteins 
PA1892 hypothetical protein Hypothetical, unclassified, unknown 
PA1893 hypothetical protein Putative enzymes 
PA1895 hypothetical protein Membrane proteins 
PA1896 hypothetical protein Hypothetical, unclassified, unknown 
PA1897 hypothetical protein Hypothetical, unclassified, unknown 
PA1898 quorum-sensing control repressor Transcriptional regulators 
PA1901 phenazine biosynthesis protein PhzC Secreted Factors (toxins, enzymes, alginate) 
PA1903 phenazine biosynthesis protein PhzE Secreted Factors (toxins, enzymes, alginate) 
PA1905 probable pyridoxamine 5'-phosphate oxidase Secreted Factors (toxins, enzymes, alginate) 
PA1922 probable TonB-dependent receptor Transport of small molecules 
PA1924 hypothetical protein Hypothetical, unclassified, unknown 
PA1927 5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase Amino acid biosynthesis and metabolism 
PA1935 hypothetical protein Hypothetical, unclassified, unknown 
PA1942 hypothetical protein Hypothetical, unclassified, unknown 
PA1946 binding protein component precursor of ABC ribose transporter Transport of small molecules 
PA1947 ribose transport protein RbsA Transport of small molecules 
PA1955 hypothetical protein Hypothetical, unclassified, unknown 
PA1974 hypothetical protein Hypothetical, unclassified, unknown 
PA1976 probable two-component sensor Two-component regulatory systems 
PA1977 hypothetical protein Membrane proteins 
PA1978 probable transcriptional regulator Transcriptional regulators 
PA1979 probable two-component sensor Two-component regulatory systems 
PA1980 probable two-component response regulator Transcriptional regulators 
PA1981 hypothetical protein Hypothetical, unclassified, unknown 
PA1983 cytochrome c550 Energy metabolism 
PA1984 probable aldehyde dehydrogenase Putative enzymes 
PA1991 probable iron-containing alcohol dehydrogenase Putative enzymes 
PA1992 probable two-component sensor Two-component regulatory systems 
PA2000 probable CoA transferase, subunit B Amino acid biosynthesis and metabolism 
PA2001 acetyl-CoA acetyltransferase Central intermediary metabolism 
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PA2002 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2003 3-hydroxybutyrate dehydrogenase Carbon compound catabolism 
PA2004 conserved hypothetical protein Membrane proteins 
PA2006 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA2012 methylcrotonyl-CoA carboxylase, alpha-subunit (biotin-containing) Carbon compound catabolism 
PA2013 putative 3-methylglutaconyl-CoA  hydratase Carbon compound catabolism 
PA2014 methylcrotonyl-CoA carboxylase, beta-subunit Carbon compound catabolism 
PA2015 putative isovaleryl-CoA dehydrogenase Carbon compound catabolism 
PA2018 Resistance-Nodulation-Cell Division (RND) multidrug ef flux transporter Transport of small molecules 
PA2030 hypothetical protein Hypothetical, unclassified, unknown 
PA2031 hypothetical protein Hypothetical, unclassified, unknown 
PA2041 probable amino acid permease Transport of small molecules 
PA2060 probable permease of ABC transporter Transport of small molecules 
PA2066 hypothetical protein Hypothetical, unclassified, unknown 
PA2067 probable hydrolase Putative enzymes 
PA2068 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA2069 probable carbamoyl transferase Putative enzymes 
PA2079 probable amino acid permease Transport of small molecules 
PA2091 hypothetical protein Membrane proteins 
PA2109 hypothetical protein Hypothetical, unclassified, unknown 
PA2110 hypothetical protein Hypothetical, unclassified, unknown 
PA2116 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2119 alcohol dehydrogenase (Zn-dependent) Putative enzymes 
PA2122 hypothetical protein Hypothetical, unclassified, unknown 
PA2129 chaperone CupA2 Motility & Attachment 
PA2134 hypothetical protein Hypothetical, unclassified, unknown 
PA2160 probable glycosyl hydrolase Putative enzymes 
PA2161 hypothetical protein Hypothetical, unclassified, unknown 
PA2169 hypothetical protein Hypothetical, unclassified, unknown 
PA2172 hypothetical protein Hypothetical, unclassified, unknown 
PA2185 non-heme catalase KatN Adaptation, Protection 
PA2198 hypothetical protein Hypothetical, unclassified, unknown 
PA2201 hypothetical protein Hypothetical, unclassified, unknown 
PA2209 hypothetical protein Hypothetical, unclassified, unknown 
PA2210 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA2211 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2212 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2213 probable porin Membrane proteins 
PA2214 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA2217 probable aldehyde dehydrogenase Putative enzymes 
PA2225 hypothetical protein Hypothetical, unclassified, unknown 
PA2228 hypothetical protein Hypothetical, unclassified, unknown 
PA2249 branched-chain alpha-keto acid dehydrogenase (lipoamide component) Amino acid biosynthesis and metabolism 
PA2250 lipoamide dehydrogenase-Val Amino acid biosynthesis and metabolism 
PA2258 transcriptional regulator PtxR Secreted Factors (toxins, enzymes, alginate) 
PA2274 hypothetical protein Hypothetical, unclassified, unknown 
PA2300 chitinase Carbon compound catabolism 
PA2303 hypothetical protein Hypothetical, unclassified, unknown 
PA2313 hypothetical protein Membrane proteins 
PA2322 gluconate permease Transport of small molecules 
PA2328 hypothetical protein Hypothetical, unclassified, unknown 
PA2329 probable ATP-binding component of ABC transporter Transport of small molecules 
PA2330 hypothetical protein Hypothetical, unclassified, unknown 
PA2334 probable transcriptional regulator Transcriptional regulators 
PA2359 probable transcriptional regulator Transcriptional regulators 
PA2423 hypothetical protein Hypothetical, unclassified, unknown 
PA2439 hypothetical protein Membrane proteins 
PA2453 hypothetical protein Hypothetical, unclassified, unknown 
PA2474 hypothetical protein Hypothetical, unclassified, unknown 
PA2499 probable deaminase Putative enzymes 
PA2507 catechol 1,2-dioxygenase Carbon compound catabolism 
PA2508 muconolactone delta-isomerase Carbon compound catabolism 
PA2509 muconate cycloisomerase I Carbon compound catabolism 
PA2511 probable transcriptional regulator Transcriptional regulators 
PA2512 anthranilate dioxygenase lar ge subunit Carbon compound catabolism 
PA2513 anthranilate dioxygenase small subunit Carbon compound catabolism 
PA2514 anthranilate dioxygenase reductase Carbon compound catabolism 
PA2515 cis-1,2-dihydroxycyclohexa-3,4-diene carboxylate dehydrogenase Carbon compound catabolism 
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PA2516 toluate 1,2-dioxygenase electron transfer component Energy metabolism 
PA2517 toluate 1,2-dioxygenase beta subunit Carbon compound catabolism 
PA2518 toluate 1,2-dioxygenase alpha subunit Carbon compound catabolism 
PA2519 transcriptional regulator XylS Transcriptional regulators 
PA2529 hypothetical protein Hypothetical, unclassified, unknown 
PA2554 probable short-chain dehydrogenase Putative enzymes 
PA2555 probable AMP-binding enzyme Putative enzymes 
PA2557 probable AMP-binding enzyme Fatty acid and phospholipid metabolism 
PA2564 hypothetical protein Hypothetical, unclassified, unknown 
PA2566 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2567 hypothetical protein Hypothetical, unclassified, unknown 
PA2570 LecA Adaptation, Protection 
PA2587 probable FAD-dependent monooxygenase Biosynthesis of cofactors, prosthetic groups and carriers 
PA2591 probable transcriptional regulator Transcriptional regulators 
PA2595 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2625 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2629 adenylosuccinate lyase Amino acid biosynthesis and metabolism 
PA2654 probable chemotaxis transducer Adaptation, Protection 
PA2660 hypothetical protein Hypothetical, unclassified, unknown 
PA2667 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2682 conserved hypothetical protein Putative enzymes 
PA2711 probable periplasmic spermidine/putrescine-binding protein Transport of small molecules 
PA2717 chloroperoxidase precursor Central intermediary metabolism 
PA2719 hypothetical protein Hypothetical, unclassified, unknown 
PA2753 hypothetical protein Hypothetical, unclassified, unknown 
PA2754 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2769 hypothetical protein Hypothetical, unclassified, unknown 
PA2776 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2778 hypothetical protein Hypothetical, unclassified, unknown 
PA2779 hypothetical protein Hypothetical, unclassified, unknown 
PA2780 hypothetical protein Hypothetical, unclassified, unknown 
PA2781 hypothetical protein Hypothetical, unclassified, unknown 
PA2801 hypothetical protein Hypothetical, unclassified, unknown 
PA2805 hypothetical protein Hypothetical, unclassified, unknown 
PA2819 hypothetical protein Hypothetical, unclassified, unknown 
PA2838 probable transcriptional regulator Transcriptional regulators 
PA2847 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2851 translation elongation factor P Translation, post-translational modification, degradation 
PA2876 orotidine 5'-phosphate decarboxylase Nucleotide biosynthesis and metabolism 
PA2892 GCase, alpha-subunit (biotin-containing) Putative enzymes 
PA2905 precorrin isomerase CobH Biosynthesis of cofactors, prosthetic groups and carriers 
PA2915 hypothetical protein Hypothetical, unclassified, unknown 
PA2922 probable hydrolase Putative enzymes 
PA2924 histidine transport system permease HisQ Membrane proteins 
PA2927 hypothetical protein Hypothetical, unclassified, unknown 
PA2938 probable transporter Membrane proteins 
PA2939 probable aminopeptidase Secreted Factors (toxins, enzymes, alginate) 
PA2942 probable magnesium chelatase Biosynthesis of cofactors, prosthetic groups and carriers 
PA2950 hypothetical protein Hypothetical, unclassified, unknown 
PA2960 type 4 fimbrial biogenesis protein PilZ Motility & Attachment 
PA2966 acyl carrier protein Fatty acid and phospholipid metabolism 
PA2967 3-oxoacyl-[acyl-carrier -protein] reductase Fatty acid and phospholipid metabolism 
PA2968 malonyl-CoA-[acyl-carrier -protein] transacylase Fatty acid and phospholipid metabolism 
PA3032 cytochrome c Snr1 Energy metabolism 
PA3035 probable glutathione S-transferase Putative enzymes 
PA3036 hypothetical protein Hypothetical, unclassified, unknown 
PA3062 PelC Cell wall / LPS / capsule 
PA3066 hypothetical protein Hypothetical, unclassified, unknown 
PA3079 hypothetical protein Membrane proteins 
PA3131 probable aldolase Central intermediary metabolism 
PA3139 probable amino acid aminotransferase Amino acid biosynthesis and metabolism 
PA3186 Glucose/carbohydrate outer membrane porin OprB precursor Transport of small molecules 
PA3188 probable permease of ABC sugar transporter Transport of small molecules 
PA3189 probable permease of ABC sugar transporter Transport of small molecules 
PA3208 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3209 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3213 hypothetical protein Hypothetical, unclassified, unknown 
PA3221 CsaA protein Protein secretion/export apparatus 
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PA3234 probable sodium:solute symporter Membrane proteins 
PA3236 probable glycine betaine-binding protein precursor Adaptation, Protection 
PA3237 hypothetical protein Hypothetical, unclassified, unknown 
PA3249 probable transcriptional regulator Transcriptional regulators 
PA3270 hypothetical protein Hypothetical, unclassified, unknown 
PA3283 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3295 probable HIT family protein Putative enzymes 
PA3301 hypothetical protein Putative enzymes 
PA3309 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3313 hypothetical protein Transport of small molecules 
PA3326 probable Clp-family ATP-dependent protease Translation, post-translational modification, degradation 
PA3329 hypothetical protein Hypothetical, unclassified, unknown 
PA3330 probable short chain dehydrogenase Putative enzymes 
PA3331 cytochrome P450 Adaptation, Protection 
PA3332 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3333 3-oxoacyl-[acyl-carrier -protein] synthase III Fatty acid and phospholipid metabolism 
PA3334 probable acyl carrier protein Fatty acid and phospholipid metabolism 
PA3335 hypothetical protein Hypothetical, unclassified, unknown 
PA3336 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3337 ADP-L-glycero-D-mannoheptose 6-epimerase Cell wall / LPS / capsule 
PA3361 fucose-binding lectin PA-IIL Motility & Attachment 
PA3362 hypothetical protein Membrane proteins 
PA3363 aliphatic amidase regulator Carbon compound catabolism 
PA3364 aliphatic amidase expression-regulating protein Transcriptional regulators 
PA3365 probable chaperone Chaperones & heat shock proteins 
PA3366 aliphatic amidase Carbon compound catabolism 
PA3394 NosF protein Energy metabolism 
PA3422 hypothetical protein Hypothetical, unclassified, unknown 
PA3431 conserved hypothetical protein Membrane proteins 
PA3432 hypothetical protein Membrane proteins 
PA3458 probable transcriptional regulator Transcriptional regulators 
PA3466 probable ATP-dependent RNA helicase Transcription, RNA processing and degradation 
PA3467 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3478 rhamnosyltransferase chain B Secreted Factors (toxins, enzymes, alginate) 
PA3479 rhamnosyltransferase chain A Secreted Factors (toxins, enzymes, alginate) 
PA3480 probable deoxycytidine triphosphate deaminase Nucleotide biosynthesis and metabolism 
PA3507 probable short-chain dehydrogenase Putative enzymes 
PA3524 lactoylglutathione lyase Central intermediary metabolism 
PA3529 probable peroxidase Adaptation, Protection 
PA3535 probable serine protease Putative enzymes 
PA3542 alginate biosynthesis protein Alg44 Cell wall / LPS / capsule 
PA3555 ArnD Adaptation, Protection 
PA3559 probable nucleotide sugar dehydrogenase Putative enzymes 
PA3560 phosphotransferase system, fructose-specific IIBC component Carbon compound catabolism 
PA3562 probable phosphotransferase system enzyme I Central intermediary metabolism 
PA3564 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3565 probable transcriptional regulator Transcriptional regulators 
PA3568 probable acetyl-coa synthetase Putative enzymes 
PA3569 3-hydroxyisobutyrate dehydrogenase Carbon compound catabolism 
PA3570 methylmalonate-semialdehyde dehydrogenase Amino acid biosynthesis and metabolism 
PA3572 hypothetical protein Hypothetical, unclassified, unknown 
PA3581 glycerol uptake facilitator protein Transport of small molecules 
PA3582 glycerol kinase Central intermediary metabolism 
PA3586 probable hydrolase Putative enzymes 
PA3595 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3608 polyamine transport protein PotB Membrane proteins 
PA3613 hypothetical protein Hypothetical, unclassified, unknown 
PA3614 hypothetical protein Hypothetical, unclassified, unknown 
PA3618 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3621 ferredoxin I Energy metabolism 
PA3661 hypothetical protein Hypothetical, unclassified, unknown 
PA3662 hypothetical protein Hypothetical, unclassified, unknown 
PA3674 hypothetical protein Hypothetical, unclassified, unknown 
PA3682 hypothetical protein Hypothetical, unclassified, unknown 
PA3686 adenylate kinase Nucleotide biosynthesis and metabolism 
PA3692 probable outer membrane protein precursor Membrane proteins 
PA3699 probable transcriptional regulator Transcriptional regulators 
PA3710 probable GMC-type oxidoreductase Carbon compound catabolism 
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PA3718 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3724 elastase LasB Secreted Factors (toxins, enzymes, alginate) 
PA3737 thiol:disulfide interchange protein DsbC Translation, post-translational modification, degradation 
PA3779 hypothetical protein Hypothetical, unclassified, unknown 
PA3780 hypothetical protein Membrane proteins 
PA3781 probable transporter Membrane proteins 
PA3789 hypothetical protein Membrane proteins 
PA3795 probable oxidoreductase Putative enzymes 
PA3836 hypothetical protein Hypothetical, unclassified, unknown 
PA3837 probable permease of ABC transporter Membrane proteins 
PA3838 probable ATP-binding component of ABC transporter Transport of small molecules 
PA3839 probable sodium:sulfate symporter Membrane proteins 
PA3840 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3865 probable amino acid binding protein Transport of small molecules 
PA3880 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3887 Na+/H+ antiporter NhaP Membrane proteins 
PA3906 hypothetical protein Hypothetical, unclassified, unknown 
PA3908 hypothetical protein Hypothetical, unclassified, unknown 
PA3913 probable protease Putative enzymes 
PA3940 probable DNA binding protein DNA replication, recombination, modification and repair 
PA3959 hypothetical protein Hypothetical, unclassified, unknown 
PA3960 hypothetical protein Hypothetical, unclassified, unknown 
PA3966 hypothetical protein Membrane proteins 
PA3967 hypothetical protein Hypothetical, unclassified, unknown 
PA3984 apolipoprotein N-acyltransferase Cell wall / LPS / capsule 
PA4021 probable transcriptional regulator Transcriptional regulators 
PA4023 probable transport protein Transport of small molecules 
PA4024 ethanolamine ammonia-lyase lar ge subunit Central intermediary metabolism 
PA4025 probable ethanolamine ammonia-lyase light chain Carbon compound catabolism 
PA4031 inorganic pyrophosphatase Central intermediary metabolism 
PA4055 riboflavin synthase alpha chain Biosynthesis of cofactors, prosthetic groups and carriers 
PA4057 NrdR Nucleotide biosynthesis and metabolism 
PA4058 hypothetical protein Hypothetical, unclassified, unknown 
PA4070 probable transcriptional regulator Transcriptional regulators 
PA4072 probable amino acid permease Transport of small molecules 
PA4073 probable aldehyde dehydrogenase Putative enzymes 
PA4078 probable nonribosomal peptide synthetase Adaptation, Protection 
PA4079 probable dehydrogenase Putative enzymes 
PA4091 4-hydroxyphenylacetate 3-monooxygenase lar ge chain Carbon compound catabolism 
PA4092 4-hydroxyphenylacetate 3-monooxygenase small chain Carbon compound catabolism 
PA4093 hypothetical protein Hypothetical, unclassified, unknown 
PA4094 probable transcriptional regulator Transcriptional regulators 
PA4120 probable transcriptional regulator Transcriptional regulators 
PA4121 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4122 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4123 5-carboxy-2-hydroxymuconate semialdehyde dehydrogenase Carbon compound catabolism 
PA4124 homoprotocatechuate 2,3-dioxygenase Carbon compound catabolism 
PA4125 5-carboxymethyl-2-hydroxymuconate isomerase Carbon compound catabolism 
PA4126 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA4127 2-oxo-hept-3-ene-1,7-dioate hydratase Carbon compound catabolism 
PA4128 conserved hypothetical protein Putative enzymes 
PA4129 hypothetical protein Hypothetical, unclassified, unknown 
PA4130 probable sulfite or nitrite reductase Central intermediary metabolism 
PA4131 probable iron-sulfur protein Putative enzymes 
PA4132 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4133 cytochrome c oxidase subunit (cbb3-type) Energy metabolism 
PA4134 hypothetical protein Hypothetical, unclassified, unknown 
PA4136 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA4137 probable porin Transport of small molecules 
PA4140 hypothetical protein Hypothetical, unclassified, unknown 
PA4141 hypothetical protein Hypothetical, unclassified, unknown 
PA4142 probable secretion protein Protein secretion/export apparatus 
PA4147 transcriptional regulator AcoR Transcriptional regulators 
PA4148 probable short-chain dehydrogenase Putative enzymes 
PA4150 probable dehydrogenase E1 component Carbon compound catabolism 
PA4151 acetoin catabolism protein AcoB Carbon compound catabolism 
PA4152 probable hydrolase Carbon compound catabolism 
PA4153 2,3-butanediol dehydrogenase Carbon compound catabolism 
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PA4175 protease IV Secreted Factors (toxins, enzymes, alginate) 
PA4180 probable acetolactate synthase lar ge subunit Amino acid biosynthesis and metabolism 
PA4205 hypothetical protein Membrane proteins 
PA4206 probable Resistance-Nodulation-Cell Division (RND) ef flux membrane fusion protein pTransport of small molecules 
PA4207 probable Resistance-Nodulation-Cell Division (RND) ef flux transporter Membrane proteins 
PA4208 probable outer membrane protein precursor Membrane proteins 
PA4209 probable phenazine-specific methyltransferase Putative enzymes 
PA4210 probable phenazine biosynthesis protein Secreted Factors (toxins, enzymes, alginate) 
PA4211 probable phenazine biosynthesis protein Secreted Factors (toxins, enzymes, alginate) 
PA4288 probable transcriptional regulator Transcriptional regulators 
PA4293 two-component sensor PprA Two-component regulatory systems 
PA4294 hypothetical protein Hypothetical, unclassified, unknown 
PA4297 TadG Membrane proteins 
PA4298 hypothetical protein Hypothetical, unclassified, unknown 
PA4316 exodeoxyribonuclease I DNA replication, recombination, modification and repair 
PA4324 hypothetical protein Hypothetical, unclassified, unknown 
PA4328 hypothetical protein Hypothetical, unclassified, unknown 
PA4329 pyruvate kinase II Energy metabolism 
PA4348 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4351 probable acyltransferase Fatty acid and phospholipid metabolism 
PA4352 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4357 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4358 probable ferrous iron transport protein Membrane proteins 
PA4377 hypothetical protein Hypothetical, unclassified, unknown 
PA4394 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4433 50S ribosomal protein L13 Translation, post-translational modification, degradation 
PA4436 probable transcriptional regulator Transcriptional regulators 
PA4496 probable binding protein component of ABC transporter Transport of small molecules 
PA4497 probable binding protein component of ABC transporter Transport of small molecules 
PA4498 probable metallopeptidase Translation, post-translational modification, degradation 
PA4500 probable binding protein component of ABC transporter Transport of small molecules 
PA4502 probable binding protein component of ABC transporter Transport of small molecules 
PA4503 probable permease of ABC transporter Membrane proteins 
PA4504 probable permease of ABC transporter Membrane proteins 
PA4505 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4506 probable ATP-binding component of ABC dipeptide transporter Transport of small molecules 
PA4520 probable chemotaxis transducer Adaptation, Protection 
PA4569 octaprenyl-diphosphate synthase Energy metabolism 
PA4577 hypothetical protein Hypothetical, unclassified, unknown 
PA4588 glutamate dehydrogenase Amino acid biosynthesis and metabolism 
PA4596 probable transcriptional regulator Transcriptional regulators 
PA4606 conserved hypothetical protein Adaptation, Protection 
PA4611 hypothetical protein Hypothetical, unclassified, unknown 
PA4632 hypothetical protein Hypothetical, unclassified, unknown 
PA4633 probable chemotaxis transducer Adaptation, Protection 
PA4654 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA4676 probable carbonic anhydrase Putative enzymes 
PA4677 hypothetical protein Hypothetical, unclassified, unknown 
PA4681 hypothetical protein Hypothetical, unclassified, unknown 
PA4682 hypothetical protein Hypothetical, unclassified, unknown 
PA4683 hypothetical protein Hypothetical, unclassified, unknown 
PA4695 acetolactate synthase isozyme III small subunit Biosynthesis of cofactors, prosthetic groups and carriers 
PA4715 probable aminotransferase Putative enzymes 
PA4733 acetyl-coenzyme A synthetase Carbon compound catabolism 
PA4757 conserved hypothetical protein Membrane proteins 
PA4758 carbamoyl-phosphate synthase small chain Amino acid biosynthesis and metabolism 
PA4759 dihydrodipicolinate reductase Amino acid biosynthesis and metabolism 
PA4770 L-lactate permease Transport of small molecules 
PA4773 hypothetical protein Hypothetical, unclassified, unknown 
PA4779 hypothetical protein Membrane proteins 
PA4782 hypothetical protein Hypothetical, unclassified, unknown 
PA4808 L-seryl-tRNA(ser) selenium transferase Translation, post-translational modification, degradation 
PA4817 hypothetical protein Hypothetical, unclassified, unknown 
PA4851 hypothetical protein Hypothetical, unclassified, unknown 
PA4852 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4860 probable permease of ABC transporter Membrane proteins 
PA4862 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4867 urease beta subunit Central intermediary metabolism 
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PA4884 hypothetical protein Hypothetical, unclassified, unknown 
PA4893 urease accessory protein UreG Biosynthesis of cofactors, prosthetic groups and carriers 
PA4894 hypothetical protein Membrane proteins 
PA4899 probable aldehyde dehydrogenase Putative enzymes 
PA4901 benzoylformate decarboxylase Carbon compound catabolism 
PA4908 hypothetical protein Hypothetical, unclassified, unknown 
PA4910 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4911 probable permease of ABC branched-chain amino acid transporter Membrane proteins 
PA4912 probable permease of ABC branched chain amino acid transporter Membrane proteins 
PA4913 probable binding protein component of ABC transporter Transport of small molecules 
PA4943 probable GTP-binding protein Putative enzymes 
PA4979 probable acyl-CoA dehydrogenase Putative enzymes 
PA4983 probable two-component response regulator Transcriptional regulators 
PA4984 probable transcriptional regulator Transcriptional regulators 
PA4985 hypothetical protein Hypothetical, unclassified, unknown 
PA4986 probable oxidoreductase Putative enzymes 
PA4997 transport protein MsbA Fatty acid and phospholipid metabolism 
PA5020 probable acyl-CoA dehydrogenase Putative enzymes 
PA5025 homocysteine synthase Amino acid biosynthesis and metabolism 
PA5027 hypothetical protein Hypothetical, unclassified, unknown 
PA5028 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5030 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA5051 arginyl-tRNA synthetase Translation, post-translational modification, degradation 
PA5059 probable transcriptional regulator Transcriptional regulators 
PA5082 probable binding protein component of ABC transporter Transport of small molecules 
PA5096 probable binding protein component of ABC transporter Transport of small molecules 
PA5097 probable amino acid permease Membrane proteins 
PA5098 histidine ammonia-lyase Amino acid biosynthesis and metabolism 
PA5106 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5112 esterase EstA Secreted Factors (toxins, enzymes, alginate) 
PA5129 glutaredoxin Energy metabolism 
PA5130 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5137 hypothetical protein Hypothetical, unclassified, unknown 
PA5149 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5152 probable ATP-binding component of ABC transporter Transport of small molecules 
PA5153 probable periplasmic binding protein Transport of small molecules 
PA5154 probable permease of ABC transporter Membrane proteins 
PA5155 probable permease of ABC transporter Membrane proteins 
PA5161 dTDP-D-glucose 4,6-dehydratase Carbon compound catabolism 
PA5162 dTDP-4-dehydrorhamnose reductase Cell wall / LPS / capsule 
PA5163 glucose-1-phosphate thymidylyltransferase Cell wall / LPS / capsule 
PA5164 dTDP-4-dehydrorhamnose 3,5-epimerase Cell wall / LPS / capsule 
PA5168 probable dicarboxylate transporter Membrane proteins 
PA5169 probable C4-dicarboxylate transporter Membrane proteins 
PA5174 probable beta-ketoacyl synthase Fatty acid and phospholipid metabolism 
PA5180 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5220 hypothetical protein Hypothetical, unclassified, unknown 
PA5237 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5240 thioredoxin Translation, post-translational modification, degradation 
PA5249 hypothetical protein Membrane proteins 
PA5275 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5285 hypothetical protein Hypothetical, unclassified, unknown 
PA5286 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5288 nitrogen regulatory protein P-II 2 Central intermediary metabolism 
PA5289 hypothetical protein Hypothetical, unclassified, unknown 
PA5297 pyruvate dehydrogenase (cytochrome) Central intermediary metabolism 
PA5303 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5309 probable oxidoreductase Putative enzymes 
PA5324 probable transcriptional regulator Transcriptional regulators 
PA5325 hypothetical protein Hypothetical, unclassified, unknown 
PA5328 probable cytochrome c(mono-heme type) Energy metabolism 
PA5329 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5338 guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase Nucleotide biosynthesis and metabolism 
PA5344 probable transcriptional regulator Transcriptional regulators 
PA5348 probable DNA-binding protein DNA replication, recombination, modification and repair 
PA5351 Rubredoxin 1 Carbon compound catabolism 
PA5353 glycolate oxidase subunit GlcF Central intermediary metabolism 
PA5355 glycolate oxidase subunit GlcD Central intermediary metabolism 
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PA5380 GbdR Transcriptional regulators 
PA5381 hypothetical protein Hypothetical, unclassified, unknown 
PA5400 probable electron transfer flavoprotein alpha subunit Energy metabolism 
PA5409 hypothetical protein Membrane proteins 
PA5427 alcohol dehydrogenase Energy metabolism 
PA5434 tryptophan permease Membrane proteins 
PA5435 probable transcarboxylase subunit Central intermediary metabolism 
PA5436 probable biotin carboxylase subunit of a transcarboxylase Central intermediary metabolism 
PA5442 conserved hypothetical protein Membrane proteins 
PA5445 probable coenzyme A transferase Putative enzymes 
PA5451 membrane subunit of A-band LPS efflux transporter Cell wall / LPS / capsule 
PA5452 phosphomannose isomerase/GDP-mannose WbpW Cell wall / LPS / capsule 
PA5461 hypothetical protein Hypothetical, unclassified, unknown 
PA5475 hypothetical protein Hypothetical, unclassified, unknown 
PA5491 probable cytochrome Energy metabolism 
PA5506 hypothetical protein Hypothetical, unclassified, unknown 
PA5507 hypothetical protein Hypothetical, unclassified, unknown 
PA5508 probable glutamine synthetase Putative enzymes 
PA5509 hypothetical protein Hypothetical, unclassified, unknown 
PA5510 probable transporter Membrane proteins 
PA5522 probable glutamine synthetase Putative enzymes 
PA5523 probable aminotransferase Putative enzymes 
PA5533 hypothetical protein Hypothetical, unclassified, unknown 
PA5536 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5542 hypothetical protein Putative enzymes 
PA5543 hypothetical protein Hypothetical, unclassified, unknown 
PA5544 conserved hypothetical protein Membrane proteins 
PA5545 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5546 conserved hypothetical protein Putative enzymes 
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Oxidative stress
PA0007 hypothetical protein Membrane proteins
PA0069 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0105 cytochrome c oxidase, subunit II Energy metabolism 
PA0106 cytochrome c oxidase, subunit I Energy metabolism 
PA0107 conserved hypothetical protein Energy metabolism 
PA0109 hypothetical protein Membrane proteins
PA0122 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0128 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0158 RND; triclosan efflux transporter, TriC Antibiotic resistance and susceptibility 
PA0171 hypothetical protein Motility & Attachment 
PA0173 probable methylesterase Adaptation, Protection 
PA0174 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0176 aerotaxis transducer Aer2 Adaptation, Protection 
PA0177 probable purine-binding chemotaxis protein Adaptation, Protection 
PA0178 probable two-component sensor Chemotaxis  
PA0179 probable two-component response regulator Chemotaxis  
PA0182 probable short-chain dehydrogenase Putative enzymes 
PA0250 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0280 sulfate transport protein CysA Transport of small molecules 
PA0281 sulfate transport protein CysW Membrane proteins
PA0282 sulfate transport protein CysT Membrane proteins
PA0283 sulfate-binding protein precursor Transport of small molecules 
PA0335 hypothetical protein Hypothetical, unclassified, unknown 
PA0337 phosphoenolpyruvate-protein phosphotransferase PtsP Transport of small molecules 
PA0352 probable transporter Membrane proteins
PA0382 DNA mismatch repair protein MicA DNA replication, recombination, modification and repair 
PA0385 hypothetical protein Hypothetical, unclassified, unknown 
PA0459 probable ClpA/B protease ATP binding subunit Translation, post-translational modification, degradation 
PA0492 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0493 probable biotin-requiring enzyme Putative enzymes 
PA0494 probable acyl-CoA carboxylase subunit Putative enzymes 
PA0495 hypothetical protein Hypothetical, unclassified, unknown 
PA0555 fructose-1,6-bisphosphate aldolase Central intermediary metabolism 
PA0582 dihydroneopterin aldolase Biosynthesis of cofactors, prosthetic groups and carriers 
PA0586 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0587 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0612 repressor, PtrB Transcriptional regulators 
PA0613 hypothetical protein Hypothetical, unclassified, unknown 
PA0614 hypothetical protein Hypothetical, unclassified, unknown 
PA0615 hypothetical protein Hypothetical, unclassified, unknown 
PA0616 hypothetical protein Related to phage, transposon, or plasmid 
PA0617 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0618 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0619 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0620 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0621 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0622 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0623 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0624 hypothetical protein Related to phage, transposon, or plasmid 
PA0625 hypothetical protein Related to phage, transposon, or plasmid 
PA0626 hypothetical protein Related to phage, transposon, or plasmid 
PA0627 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0628 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0629 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0630 hypothetical protein Related to phage, transposon, or plasmid 
PA0631 hypothetical protein Related to phage, transposon, or plasmid 
PA0634 hypothetical protein Related to phage, transposon, or plasmid 
PA0635 hypothetical protein Related to phage, transposon, or plasmid 
PA0636 hypothetical protein Related to phage, transposon, or plasmid 
PA0637 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0638 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0639 conserved hypothetical protein Related to phage, transposon, or plasmid 
PA0640 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0641 probable bacteriophage protein Related to phage, transposon, or plasmid 
PA0642 hypothetical protein Related to phage, transposon, or plasmid 
PA0643 hypothetical protein Related to phage, transposon, or plasmid 
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PA0645 hypothetical protein Related to phage, transposon, or plasmid 
PA0646 hypothetical protein Related to phage, transposon, or plasmid 
PA0669 probable DNA polymerase alpha chain Putative enzymes 
PA0670 hypothetical protein Hypothetical, unclassified, unknown 
PA0671 hypothetical protein Hypothetical, unclassified, unknown 
PA0743 probable 3-hydroxyisobutyrate dehydrogenase Carbon compound catabolism 
PA0745 probable enoyl-CoA hydratase/isomerase Putative enzymes 
PA0746 probable acyl-CoA dehydrogenase Putative enzymes 
PA0747 probable aldehyde dehydrogenase Putative enzymes 
PA0873 transcriptional regulator PhhR Transcriptional regulators 
PA0887 acetyl-coenzyme A synthetase Carbon compound catabolism 
PA0887.1 aaa Non-coding RNA gene 
PA0889 arginine/ornithine transport protein AotQ Membrane proteins
PA0905 RsmA, regulator of secondary metabolites Translation, post-translational modification, degradation 
PA0915 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0916 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0922 hypothetical protein Hypothetical, unclassified, unknown 
PA0975 probable radical activating enzyme Putative enzymes 
PA0976 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0983 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0996 probable coenzyme A ligase Biosynthesis of cofactors, prosthetic groups and carriers 
PA1000 Quinolone signal response protein Biosynthesis of cofactors, prosthetic groups and carriers 
PA1001 anthranilate synthase component I Adaptation, Protection 
PA1002 anthranilate synthase component II Amino acid biosynthesis and metabolism 
PA1041 probable outer membrane protein precursor Membrane proteins
PA1112 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1150 pyocin S2 Adaptation, Protection 
PA1151 pyocin S2 immunity protein Adaptation, Protection 
PA1172 cytochrome c-type protein NapC Energy metabolism 
PA1173 cytochrome c-type protein NapB precursor Energy metabolism 
PA1174 periplasmic nitrate reductase protein NapA Energy metabolism 
PA1175 NapD protein of periplasmic nitrate reductase Energy metabolism 
PA1176 ferredoxin protein NapF Energy metabolism 
PA1177 periplasmic nitrate reductase protein NapE Energy metabolism 
PA1228 hypothetical protein Hypothetical, unclassified, unknown 
PA1320 cytochrome o ubiquinol oxidase subunit IV Energy metabolism 
PA1321 cytochrome o ubiquinol oxidase protein CyoE Energy metabolism 
PA1372 hypothetical protein Hypothetical, unclassified, unknown 
PA1432 autoinducer synthesis protein LasI Adaptation, Protection 
PA1466 hypothetical protein Hypothetical, unclassified, unknown 
PA1552 probable cytochrome c Energy metabolism 
PA1553 probable cytochrome c oxidase subunit Energy metabolism 
PA1554 probable cytochrome oxidase subunit (cbb3-type) Energy metabolism 
PA1574 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1581 succinate dehydrogenase (C subunit) Energy metabolism 
PA1582 succinate dehydrogenase (D subunit) Energy metabolism 
PA1583 succinate dehydrogenase (A  subunit) Energy metabolism 
PA1584 succinate dehydrogenase (B subunit) Energy metabolism 
PA1634 potassium-transporting ATPase, B chain Transport of small molecules 
PA1687 spermidine synthase Amino acid biosynthesis and metabolism 
PA1759 probable transcriptional regulator Transcriptional regulators 
PA1760 probable transcriptional regulator Transcriptional regulators 
PA1776 ECF sigma factor SigX Transcriptional regulators 
PA1837 hypothetical protein Hypothetical, unclassified, unknown 
PA1845 hypothetical protein Hypothetical, unclassified, unknown 
PA1852 hypothetical protein Hypothetical, unclassified, unknown 
PA1865 hypothetical protein Hypothetical, unclassified, unknown 
PA1930 probable chemotaxis transducer Adaptation, Protection 
PA1946 binding protein component precursor of ABC ribose transporter Transport of small molecules 
PA1951 hypothetical protein Hypothetical, unclassified, unknown 
PA2006 probable major facilitator superfamily (MFS) transporter Membrane proteins
PA2007 maleylacetoacetate isomerase Carbon compound catabolism 
PA2008 fumarylacetoacetase Carbon compound catabolism 
PA2009 homogentisate 1,2-dioxygenase Carbon compound catabolism 
PA2012 methylcrotonyl-CoA carboxylase, alpha-subunit (biotin-containing) Carbon compound catabolism 
PA2288 hypothetical protein Hypothetical, unclassified, unknown 
PA2290 glucose dehydrogenase Carbon compound catabolism 
PA2321 gluconokinase Energy metabolism 
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PA2322 gluconate permease Transport of small molecules 
PA2338 probable binding protein component of ABC maltose/mannitol transporter Transport of small molecules 
PA2339 probable binding-protein-dependent maltose/mannitol transport protein Transport of small molecules 
PA2340 probable binding-protein-dependent maltose/mannitol transport protein Transport of small molecules 
PA2341 probable ATP-binding component of ABC maltose/mannitol transporter Transport of small molecules 
PA2342 mannitol dehydrogenase Carbon compound catabolism 
PA2344 fructokinase Carbon compound catabolism 
PA2453 hypothetical protein Hypothetical, unclassified, unknown 
PA2552 probable acyl-CoA dehydrogenase Putative enzymes 
PA2553 probable acyl-CoA thiolase Putative enzymes 
PA2555 probable AMP-binding enzyme Putative enzymes 
PA2557 probable AMP-binding enzyme Fatty acid and phospholipid metabolism 
PA2573 probable chemotaxis transducer Adaptation, Protection 
PA2579 hypothetical protein Putative enzymes 
PA2619 initiation factor Translation, post-translational modification, degradation 
PA2637 NADH dehydrogenase I chain A Energy metabolism 
PA2638 NADH dehydrogenase I chain B Energy metabolism 
PA2639 NADH dehydrogenase I chain C,D Energy metabolism 
PA2640 NADH dehydrogenase I chain E Energy metabolism 
PA2641 NADH dehydrogenase I chain F Energy metabolism 
PA2642 NADH dehydrogenase I chain G Energy metabolism 
PA2643 NADH dehydrogenase I chain H Energy metabolism 
PA2644 NADH Dehydrogenase I chain I Energy metabolism 
PA2645 NADH dehydrogenase I chain J Energy metabolism 
PA2646 NADH dehydrogenase I chain K Energy metabolism 
PA2647 NADH dehydrogenase I chain L Energy metabolism 
PA2648 NADH dehydrogenase I chain M Energy metabolism 
PA2649 NADH dehydrogenase I chain N Energy metabolism 
PA2653 probable transporter Membrane proteins
PA2667 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2730 hypothetical protein Hypothetical, unclassified, unknown 
PA2746 hypothetical protein Membrane proteins
PA2911 probable TonB-dependent receptor Membrane proteins
PA2937 hypothetical protein Hypothetical, unclassified, unknown 
PA3007 repressor protein LexA Adaptation, Protection 
PA3008 hypothetical protein Hypothetical, unclassified, unknown 
PA3009 hypothetical protein Hypothetical, unclassified, unknown 
PA3080 hypothetical protein Hypothetical, unclassified, unknown 
PA3147 probable glycosyl transferase WbpJ Putative enzymes 
PA3149 probable glycosyltransferase WbpH Putative enzymes 
PA3150 LPS biosynthesis protein WbpG Cell wall / LPS / capsule 
PA3181 2-keto-3-deoxy-6-phosphogluconate aldolase Central intermediary metabolism 
PA3183 glucose-6-phosphate 1-dehydrogenase Energy metabolism 
PA3186 Glucose/carbohydrate outer membrane porin OprB precursor Transport of small molecules 
PA3187 probable ATP-binding component of ABC transporter Transport of small molecules 
PA3188 probable permease of ABC sugar transporter Transport of small molecules 
PA3189 probable permease of ABC sugar transporter Transport of small molecules 
PA3190 probable binding protein component of ABC sugar transporter Transport of small molecules 
PA3194 phosphogluconate dehydratase Energy metabolism 
PA3237 hypothetical protein Hypothetical, unclassified, unknown 
PA3282 hypothetical protein Hypothetical, unclassified, unknown 
PA3311 conserved hypothetical protein Membrane proteins
PA3404 probable outer membrane protein precursor Protein secretion/export apparatus 
PA3415 probable dihydrolipoamide acetyltransferase Energy metabolism 
PA3417 probable pyruvate dehydrogenase E1 component, alpha subunit Energy metabolism 
PA3418 leucine dehydrogenase Amino acid biosynthesis and metabolism 
PA3441 probable molybdopterin-binding protein Transport of small molecules 
PA3442 probable ATP-binding component of ABC transporter Transport of small molecules 
PA3443 probable permease of ABC transporter Membrane proteins
PA3444 conserved hypothetical protein Putative enzymes 
PA3445 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3446 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3449 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3496 hypothetical protein Hypothetical, unclassified, unknown 
PA3561 1-phosphofructokinase Central intermediary metabolism 
PA3574 probable transcriptional regulator Transcriptional regulators 
PA3581 glycerol uptake facilitator protein Transport of small molecules 
PA3582 glycerol kinase Central intermediary metabolism 
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PA3584 glycerol-3-phosphate dehydrogenase Central intermediary metabolism 
PA3600 conserved hypothetical protein Translation, post-translational modification, degradation 
PA3607 polyamine transport protein PotA Transport of small molecules 
PA3608 polyamine transport protein PotB Membrane proteins
PA3609 polyamine transport protein PotC Membrane proteins
PA3610 polyamine transport protein PotD Transport of small molecules 
PA3616 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3617 RecA protein DNA replication, recombination, modification and repair 
PA3621 ferredoxin I Energy metabolism 
PA3672 probable ATP-binding component of ABC transporter Transport of small molecules 
PA3712 hypothetical protein Hypothetical, unclassified, unknown 
PA3713 spermidine dehydrogenase, SpdH Hypothetical, unclassified, unknown 
PA3723 probable FMN oxidoreductase Putative enzymes 
PA3753 conserved hypothetical protein Transport of small molecules 
PA3767 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3787 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3808 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3870 molybdopterin biosynthetic protein A1 Biosynthesis of cofactors, prosthetic groups and carriers 
PA3871 probable peptidyl-prolyl cis-trans isomerase, PpiC-type Translation, post-translational modification, degradation 
PA3872 respiratory nitrate reductase gamma chain Energy metabolism 
PA3873 respiratory nitrate reductase delta chain Energy metabolism 
PA3874 respiratory nitrate reductase beta chain Energy metabolism 
PA3875 respiratory nitrate reductase alpha chain Energy metabolism 
PA3876 nitrite extrusion protein 2 Membrane proteins
PA3877 nitrite extrusion protein 1 Membrane proteins
PA3901 Fe(III) dicitrate transport protein FecA Membrane proteins
PA3913 probable protease Putative enzymes 
PA3922 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3935 taurine dioxygenase Carbon compound catabolism 
PA3967 hypothetical protein Hypothetical, unclassified, unknown 
PA3986 hypothetical protein Hypothetical, unclassified, unknown 
PA4055 riboflavin synthase alpha chain Biosynthesis of cofactors, prosthetic groups and carriers 
PA4131 probable iron-sulfur protein Putative enzymes 
PA4132 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4133 cytochrome c oxidase subunit (cbb3-type) Energy metabolism 
PA4141 hypothetical protein Hypothetical, unclassified, unknown 
PA4199 probable acyl-CoA dehydrogenase Putative enzymes 
PA4236 catalase Adaptation, Protection 
PA4390 hypothetical protein Hypothetical, unclassified, unknown 
PA4427 stringent starvation protein B Adaptation, Protection 
PA4432 30S ribosomal protein S9 Translation, post-translational modification, degradation 
PA4496 probable binding protein component of ABC transporter Transport of small molecules 
PA4553 type 4 fimbrial biogenesis protein PilX Motility & Attachment 
PA4563 30S ribosomal protein S20 Central intermediary metabolism 
PA4573 hypothetical protein Hypothetical, unclassified, unknown 
PA4582 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4583 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4584 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4585 RNA 3'-terminal phosphate cyclase Transcription, RNA processing and degradation 
PA4607 hypothetical protein Hypothetical, unclassified, unknown 
PA4612 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4642 hypothetical protein Hypothetical, unclassified, unknown 
PA4645 probable purine/pyrimidine phosphoribosyl transferase Nucleotide biosynthesis and metabolism 
PA4648 hypothetical protein Hypothetical, unclassified, unknown 
PA4651 probable pili assembly chaperone Motility & Attachment 
PA4672 peptidyl-tRNA hydrolase Translation, post-translational modification, degradation 
PA4687 ferric iron-binding periplasmic protein HitA Transport of small molecules 
PA4688 iron (III)-transport system permease HitB Membrane proteins
PA4702 hypothetical protein Hypothetical, unclassified, unknown 
PA4703 hypothetical protein Hypothetical, unclassified, unknown 
PA4732 glucose-6-phosphate isomerase Carbon compound catabolism 
PA4746 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4747 secretion protein SecG Membrane proteins
PA4748 triosephosphate isomerase Central intermediary metabolism 
PA4753 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4759 dihydrodipicolinate reductase Amino acid biosynthesis and metabolism 
PA4763 DNA repair protein RecN DNA replication, recombination, modification and repair 
PA4839 biosynthetic arginine decarboxylase Amino acid biosynthesis and metabolism 
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PA4840 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4843 probable two-component response regulator Transcriptional regulators 
PA5024 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5049 50S ribosomal protein L31 Translation, post-translational modification, degradation 
PA5074 probable ATP-binding component of ABC transporter Transport of small molecules 
PA5167 probable c4-dicarboxylate-binding protein Membrane proteins
PA5235 glycerol-3-phosphate transporter Membrane proteins
PA5351 Rubredoxin 1 Carbon compound catabolism 
PA5380 GbdR Transcriptional regulators 
PA5401 hypothetical protein Hypothetical, unclassified, unknown 
PA5436 probable biotin carboxylase subunit of a transcarboxylase Central intermediary metabolism 
PA5446 hypothetical protein Hypothetical, unclassified, unknown 
PA5452 phosphomannose isomerase/GDP-mannose WbpW Cell wall / LPS / capsule 
PA5453 GDP-mannose 4,6-dehydratase Cell wall / LPS / capsule 
PA5465 hypothetical protein Hypothetical, unclassified, unknown 
PA5470 probable peptide chain release factor Translation, post-translational modification, degradation 
PA5471 hypothetical protein Hypothetical, unclassified, unknown 
PA5479 proton-glutamate symporter Membrane proteins
  277
ORF Product name Function class
PCP
PA0224 probable aldolase Putative enzymes 
PA0246 probable major facilitator superfamily (MFS) transporter Membrane proteins
PA0263 secreted protein Hcp Secreted Factors (toxins, enzymes, alginate) 
PA0355 protease PfpI Translation, post-translational modification, degradation 
PA0417 probable chemotaxis protein Chemotaxis 
PA0425 RND multidrug efflux membrane fusion protein MexA  precursor Transport of small molecules 
PA0426 RND multidrug efflux transporter MexB Transport of small molecules 
PA0427 Major intrinsic multiple antibiotic resistance ef flux outer membrane protein OprM prec Antibiotic resistance and susceptibility
PA0445 probable transposase Related to phage, transposon, or plasmid 
PA0526 hypothetical protein Hypothetical, unclassified, unknown 
PA0579 30S ribosomal protein S21 Translation, post-translational modification, degradation 
PA0726 hypothetical protein of bacteriophage Pf1 Hypothetical, unclassified, unknown 
PA0868 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1178 PhoP/Q and low Mg2+ inducible outer membrane protein H1 precursor Membrane proteins
PA1198 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1281 cobalamin (5'-phosphate) synthase Biosynthesis of cofactors, prosthetic groups and carriers 
PA1393 adenosine 5'-phosphosulfate (APS) kinase Amino acid biosynthesis and metabolism 
PA1493 sulfate-binding protein of ABC transporter Transport of small molecules 
PA1588 succinyl-CoA synthetase beta chain Energy metabolism 
PA1656 hypothetical protein Hypothetical, unclassified, unknown 
PA1658 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1660 hypothetical protein Hypothetical, unclassified, unknown 
PA1664 hypothetical protein Hypothetical, unclassified, unknown 
PA1780 assimilatory nitrite reductase small subunit Central intermediary metabolism 
PA2062 probable pyridoxal-phosphate dependent enzyme Putative enzymes 
PA2562 hypothetical protein Hypothetical, unclassified, unknown 
PA2658 hypothetical protein Hypothetical, unclassified, unknown 
PA2669 hypothetical protein Hypothetical, unclassified, unknown 
PA2906 probable oxidoreductase Putative enzymes 
PA2941 hypothetical protein Hypothetical, unclassified, unknown 
PA2951 electron transfer flavoprotein alpha-subunit Energy metabolism 
PA3136 probable secretion protein Transport of small molecules 
PA3137 probable major facilitator superfamily (MFS) transporter Membrane proteins
PA3159 probable UDP-glucose/GDP-mannose dehydrogenase WbpA Putative enzymes 
PA3162 30S ribosomal protein S1 Translation, post-translational modification, degradation 
PA3266 cold acclimation protein B Transcriptional regulators 
PA3547 poly(beta-d-mannuronate) lyase precursor AlgL Cell wall / LPS / capsule 
PA3552 ArnB Cell wall / LPS / capsule 
PA3676 probable Resistance-Nodulation-Cell Division (RND) ef flux transporter Membrane proteins
PA3677 probable RND efflux membrane fusion protein precursor Transport of small molecules 
PA3678 probable transcriptional regulator Transcriptional regulators 
PA3679 hypothetical protein Hypothetical, unclassified, unknown 
PA3719 hypothetical protein Hypothetical, unclassified, unknown 
PA3720 hypothetical protein Hypothetical, unclassified, unknown 
PA3721 probable transcriptional regulator Transcriptional regulators 
PA3814 L-cysteine desulfurase (pyridoxal phosphate-dependent) Amino acid biosynthesis and metabolism 
PA3815 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3819 conserved hypothetical protein Membrane proteins
PA3905 hypothetical protein Hypothetical, unclassified, unknown 
PA4033 hypothetical protein Hypothetical, unclassified, unknown 
PA4037 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4053 6,7-dimethyl-8-ribityllumazine synthase Biosynthesis of cofactors, prosthetic groups and carriers 
PA4178 hypothetical protein Hypothetical, unclassified, unknown 
PA4344 probable hydrolase Putative enzymes 
PA4386 GroES protein Chaperones & heat shock proteins 
PA4443 ATP sulfurylase small subunit Central intermediary metabolism 
PA4568 50S ribosomal protein L21 Translation, post-translational modification, degradation 
PA4816 hypothetical protein Hypothetical, unclassified, unknown 
PA4847 biotin carboxyl carrier protein (BCCP) Fatty acid and phospholipid metabolism 
PA5013 branched-chain amino acid transferase Amino acid biosynthesis and metabolism 
PA5157 probable transcriptional regulator Transcriptional regulators 
PA5158 probable outer membrane protein precursor Transport of small molecules 
PA5159 multidrug resistance protein Transport of small molecules 
PA5160 drug efflux transporter Membrane proteins
PA5182 hypothetical protein Membrane proteins
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PA5212 hypothetical protein Hypothetical, unclassified, unknown 
PA5216 probable permease of ABC iron transporter Membrane proteins
PA5253 alginate regulatory protein AlgP Transcriptional regulators 
PA5312 probable aldehyde dehydrogenase Putative enzymes 
PA5326 hypothetical protein Hypothetical, unclassified, unknown 
PA5369 phosphate ABC transporter, periplasmic phosphate-binding protein, PstS Transport of small molecules 
PA5390 probable peptidic bond hydrolase Putative enzymes 
PA5481 hypothetical protein Hypothetical, unclassified, unknown 
PA5570 50S ribosomal protein L34 Central intermediary metabolism 
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Copper
PA0149 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA0150 probable transmembrane sensor Membrane proteins 
PA0397 probable cation ef flux system protein Transport of small molecules 
PA0423 PasP Secreted Factors (toxins, enzymes, alginate) 
PA0450 probable phosphate transporter Membrane proteins 
PA0802 hypothetical protein Membrane proteins 
PA0913 probable Mg transporter MgtE Transport of small molecules 
PA0918 cytochrome b561 Energy metabolism 
PA0931 ferric enterobactin receptor PirA Transport of small molecules 
PA1134 hypothetical protein Hypothetical, unclassified, unknown 
PA1286 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA1297 probable metal transporter Membrane proteins 
PA1301 probable transmembrane sensor Membrane proteins 
PA1302 probable heme utilization protein precursor Membrane proteins 
PA1363 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA1364 probable transmembrane sensor Membrane proteins 
PA1365 probable siderophore receptor Transport of small molecules 
PA1390 probable glycosyl transferase Putative enzymes 
PA1435 RND efflux membrane fusion protein precursor Transport of small molecules 
PA1436 probable RND efflux transporter Membrane proteins 
PA1437 probable two-component response regulator Transcriptional regulators 
PA1438 probable two-component sensor Two-component regulatory systems 
PA1562 aconitate hydratase 1 Energy metabolism 
PA1909 hypothetical protein Hypothetical, unclassified, unknown 
PA1910 probable tonB-dependent receptor protein Transport of small molecules 
PA1911 probable transmembrane sensor Membrane proteins 
PA1912 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA2064 copper resistance protein B precursor Adaptation, Protection 
PA2065 copper resistance protein A precursor Adaptation, Protection 
PA2277 ArsR protein Transcriptional regulators 
PA2278 ArsB protein Membrane proteins 
PA2279 ArsC protein Adaptation, Protection 
PA2384 hypothetical protein Hypothetical, unclassified, unknown 
PA2390 probable ATP-binding/permease fusion ABC transporter Membrane proteins 
PA2391 probable outer membrane protein precursor Membrane proteins 
PA2395 PvdO Adaptation, Protection 
PA2406 hypothetical protein Hypothetical, unclassified, unknown 
PA2451 hypothetical protein Hypothetical, unclassified, unknown 
PA2466 Ferrioxamine receptor FoxA Transport of small molecules 
PA2467 Anti-sigma factor FoxR Membrane proteins 
PA2476 thiol:disulfide interchange protein DsbG Translation, post-translational modification, degradation 
PA2477 probable thiol:disulfide interchange protein Membrane proteins 
PA2478 probable thiol:disulfide interchange protein Membrane proteins 
PA2479 probable two-component response regulator Transcriptional regulators 
PA2480 probable two-component sensor Two-component regulatory systems 
PA2520 RND divalent metal cation ef flux transporter CzcA Membrane proteins 
PA2521 RND divalent metal cation ef flux membrane fusion protein CzcB precursor Membrane proteins 
PA2522 outer membrane protein precursor CzcC Membrane proteins 
PA2524 probable two-component sensor Two-component regulatory systems 
PA2664 flavohemoprotein Energy metabolism 
PA2686 two-component response regulator PfeR Transcriptional regulators 
PA2688 Ferric enterobactin receptor , outer membrane protein PfeA  precursor Membrane proteins 
PA2807 hypothetical protein Hypothetical, unclassified, unknown 
PA2809 two-component response regulator , CopR Transcriptional regulators 
PA2810 two-component sensor , CopS Two-component regulatory systems 
PA2826 probable glutathione peroxidase Adaptation, Protection 
PA2953 electron transfer flavoprotein-ubiquinone oxidoreductase Energy metabolism 
PA3392 nitrous-oxide reductase precursor Energy metabolism 
PA3407 heme acquisition protein HasAp Transport of small molecules 
PA3408 Haem uptake outer membrane receptor HasR precursor Transport of small molecules 
PA3409 probable transmembrane sensor Membrane proteins 
PA3410 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA3411 hypothetical protein Hypothetical, unclassified, unknown 
PA3412 hypothetical protein Hypothetical, unclassified, unknown 
PA3521 probable outer membrane protein precursor Membrane proteins 
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PA3522 probable Resistance-Nodulation-Cell Division (RND) ef flux transporter Membrane proteins 
PA3530 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3601 conserved hypothetical protein Translation, post-translational modification, degradation 
PA3602 conserved hypothetical protein Membrane proteins 
PA3749 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3920 probable metal transporting P-type ATPase Membrane proteins 
PA3921 probable transcriptional regulator Transcriptional regulators 
PA4158 ferric enterobactin transport protein FepC Transport of small molecules 
PA4159 ferrienterobactin-binding periplasmic protein precursor FepB Transport of small molecules 
PA4160 ferric enterobactin transport protein FepD Membrane proteins 
PA4192 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4194 probable permease of ABC transporter Membrane proteins 
PA4195 probable binding protein component of ABC transporter Transport of small molecules 
PA4513 probable oxidoreductase Putative enzymes 
PA4514 probable outer membrane receptor for iron transport Transport of small molecules 
PA4515 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4655 ferrochelatase Biosynthesis of cofactors, prosthetic groups and carriers 
PA4675 probable TonB-dependent receptor Transport of small molecules 
PA4705 hypothetical protein Hypothetical, unclassified, unknown 
PA4706 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4707 probable permease of ABC transporter Membrane proteins 
PA4711 hypothetical protein Hypothetical, unclassified, unknown 
PA4818 conserved hypothetical protein Membrane proteins 
PA4819 probable glycosyl transferase Putative enzymes 
PA4820 hypothetical protein Hypothetical, unclassified, unknown 
PA4825 Mg(2+) transport ATPase, P-type 2 Transport of small molecules 
PA5230 probable permease of ABC transporter Membrane proteins 
PA5231 probable ATP-binding/permease fusion ABC transporter Membrane proteins 
PA5300 cytochrome c5 Energy metabolism 
PA5304 D-amino acid dehydrogenase, small subunit Energy metabolism 
PA5531 TonB protein Transport of small molecules 
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Sulfate
PA0192 probable TonB-dependent receptor Membrane proteins 
PA0193 hypothetical protein Putative enzymes 
PA0194 hypothetical protein Putative enzymes 
PA0197 hypothetical protein Transport of small molecules 
PA0198 transport protein ExbB Transport of small molecules 
PA0199 transport protein ExbD Transport of small molecules 
PA2085 probable ring-hydroxylating dioxygenase small subunit Carbon compound catabolism 
PA2086 probable epoxide hydrolase Carbon compound catabolism 
PA2092 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA2292 hypothetical protein Hypothetical, unclassified, unknown 
PA2293 hypothetical protein Hypothetical, unclassified, unknown 
PA2294 probable ATP-binding component of ABC transporter Transport of small molecules 
PA2295 probable permease of ABC transporter Membrane proteins 
PA2296 hypothetical protein Hypothetical, unclassified, unknown 
PA2297 probable ferredoxin Energy metabolism 
PA2298 probable oxidoreductase Putative enzymes 
PA2324 hypothetical protein Putative enzymes 
PA2325 hypothetical protein Putative enzymes 
PA2326 hypothetical protein Putative enzymes 
PA2346 conserved hypothetical protein Putative enzymes 
PA2347 hypothetical protein Putative enzymes 
PA2348 conserved hypothetical protein Putative enzymes 
PA2349 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2350 probable ATP-binding component of ABC transporter Transport of small molecules 
PA2351 probable permease of ABC transporter Membrane proteins 
PA2354 probable transcriptional regulator Transcriptional regulators 
PA2355 probable FMNH2-dependent monooxygenase Putative enzymes 
PA2356 methanesulfonate sulfonatase MsuD Carbon compound catabolism 
PA2357 NADH-dependent FMN reductase MsuE Carbon compound catabolism 
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Osmotic shock
PA0236 probable transcriptional regulator Transcriptional regulators 
PA0448 probable transcriptional regulator Transcriptional regulators 
PA1159 probable cold-shock protein Transcriptional regulators 
PA1226 probable transcriptional regulator Transcriptional regulators 
PA1243 probable sensor/response regulator hybrid Two-component regulatory systems 
PA1690 translocation protein in type III secretion Protein secretion/export apparatus 
PA1692 probable translocation protein in type III secretion Protein secretion/export apparatus 
PA1693 translocation protein in type III secretion Protein secretion/export apparatus 
PA1694 translocation protein in type III secretion Protein secretion/export apparatus 
PA1695 translocation protein in type III secretion Protein secretion/export apparatus 
PA1697 ATP synthase in type III secretion system Protein secretion/export apparatus 
PA1702 conserved hypothetical protein in type III secretion Protein secretion/export apparatus 
PA1703 type III secretory apparatus protein PcrD Protein secretion/export apparatus 
PA1704 transcriptional regulator protein PcrR Transcriptional regulators 
PA1724 type III export protein PscK Protein secretion/export apparatus 
PA1725 type III export protein PscL Protein secretion/export apparatus 
PA2147 catalase HPII Adaptation, Protection 
PA2152 probable trehalose synthase Putative enzymes 
PA2417 probable transcriptional regulator Transcriptional regulators 
PA2665 probable transcriptional regulator Transcriptional regulators 
PA3049 ribosome modulation factor Translation, post-translational modification, degradation 
PA3459 probable glutamine amidotransferase Amino acid biosynthesis and metabolism 
PA3462 probable sensor/response regulator hybrid Two-component regulatory systems 
PA3689 probable transcriptional regulator Transcriptional regulators 
PA3831 leucine aminopeptidase Transcription, RNA processing and degradation
PA3843 hypothetical protein Hypothetical, unclassified, unknown 
PA4135 probable transcriptional regulator Transcriptional regulators 
PA4581 transcriptional regulator RtcR Transcriptional regulators 
PA5483 two-component response regulator AlgB Transcriptional regulators 
PA5484 probable two-component sensor Two-component regulatory systems 
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Biofilms
PA0026 phospholipase C,  PlcB Hypothetical, unclassified, unknown 
PA0027 hypothetical protein Hypothetical, unclassified, unknown 
PA0028 hypothetical protein Hypothetical, unclassified, unknown 
PA0038 hypothetical protein Hypothetical, unclassified, unknown 
PA0040 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0046 hypothetical protein Hypothetical, unclassified, unknown 
PA0047 hypothetical protein Hypothetical, unclassified, unknown 
PA0061 hypothetical protein Hypothetical, unclassified, unknown 
PA0062 hypothetical protein Hypothetical, unclassified, unknown 
PA0074 serine/threonine protein kinase PpkA Adaptation, Protection 
PA0075 probable phosphoprotein phosphatase Putative enzymes 
PA0076 hypothetical protein Hypothetical, unclassified, unknown 
PA0083 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0086 hypothetical protein Hypothetical, unclassified, unknown 
PA0087 hypothetical protein Hypothetical, unclassified, unknown 
PA0088 hypothetical protein Hypothetical, unclassified, unknown 
PA0089 hypothetical protein Hypothetical, unclassified, unknown 
PA0090 probable ClpA/B-type chaperone Translation, post-translational modification, degradation 
PA0091 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0092 hypothetical protein Hypothetical, unclassified, unknown 
PA0094 hypothetical protein Hypothetical, unclassified, unknown 
PA0102 probable carbonic anhydrase Central intermediary metabolism 
PA0126 hypothetical protein Hypothetical, unclassified, unknown 
PA0134 probable guanine deaminase Nucleotide biosynthesis and metabolism 
PA0170 hypothetical protein Hypothetical, unclassified, unknown 
PA0224 probable aldolase Putative enzymes 
PA0237 probable oxidoreductase Putative enzymes 
PA0238 hypothetical protein Hypothetical, unclassified, unknown 
PA0252 hypothetical protein Hypothetical, unclassified, unknown 
PA0276 hypothetical protein Membrane proteins 
PA0320 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0327 hypothetical protein Hypothetical, unclassified, unknown 
PA0346 hypothetical protein Hypothetical, unclassified, unknown 
PA0347 glycerophosphoryl diester phosphodiesterase, periplasmic Fatty acid and phospholipid metabolism 
PA0355 protease PfpI Translation, post-translational modification, degradation 
PA0376 sigma factor RpoH Transcriptional regulators 
PA0409 twitching motility protein PilH Two-component regulatory systems 
PA0410 twitching motility protein PilI Chemotaxis 
PA0411 twitching motility protein PilJ Chemotaxis 
PA0413 still frameshift probable component of chemotactic signal transduction system Two-component regulatory systems 
PA0414 probable methylesterase Chemotaxis 
PA0430 5,10-methylenetetrahydrofolate reductase Amino acid biosynthesis and metabolism 
PA0431 hypothetical protein Hypothetical, unclassified, unknown 
PA0432 S-adenosyl-L-homocysteine hydrolase Amino acid biosynthesis and metabolism 
PA0446 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0451 conserved hypothetical protein Membrane proteins 
PA0452 probable stomatin-like protein Membrane proteins 
PA0462 hypothetical protein Hypothetical, unclassified, unknown 
PA0464 two-component sensor CreC Two-component regulatory systems 
PA0465 inner membrane protein CreD Membrane proteins 
PA0466 hypothetical protein Hypothetical, unclassified, unknown 
PA0490 hypothetical protein Hypothetical, unclassified, unknown 
PA0515 probable transcriptional regulator Biosynthesis of cofactors, prosthetic groups and carriers 
PA0516 heme d1 biosynthesis protein NirF Energy metabolism 
PA0523 nitric-oxide reductase subunit C Energy metabolism 
PA0526 hypothetical protein Hypothetical, unclassified, unknown 
PA0529 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0530 probable class III pyridoxal phosphate-dependent aminotransferase Putative enzymes 
PA0531 probable glutamine amidotransferase Putative enzymes 
PA0543 hypothetical protein Hypothetical, unclassified, unknown 
PA0547 probable transcriptional regulator Transcriptional regulators 
PA0557 hypothetical protein Hypothetical, unclassified, unknown 
PA0585 hypothetical protein Hypothetical, unclassified, unknown 
PA0588 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA0601 probable two-component response regulator Transcriptional regulators 
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PA0603 probable ATP-binding component of ABC transporter Transport of small molecules 
PA0674 hypothetical protein Hypothetical, unclassified, unknown 
PA0675 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA0676 probable transmembrane sensor Membrane proteins 
PA0693 transport protein ExbB2 Membrane proteins 
PA0696 hypothetical protein Hypothetical, unclassified, unknown 
PA0697 hypothetical protein Hypothetical, unclassified, unknown 
PA0698 hypothetical protein Hypothetical, unclassified, unknown 
PA0699 probable peptidyl-prolyl cis-trans isomerase, PpiC-type Translation, post-translational modification, degradation 
PA0707 transcriptional regulator ToxR Transcriptional regulators 
PA0732 hypothetical protein Hypothetical, unclassified, unknown 
PA0737 hypothetical protein Hypothetical, unclassified, unknown 
PA0738 conserved hypothetical protein Membrane proteins 
PA0752 conserved hypothetical protein Membrane proteins 
PA0753 hypothetical protein Membrane proteins 
PA0755 cis-aconitate porin OpdH Membrane proteins 
PA0765 positive regulator for alginate biosynthesis MucC Transcriptional regulators 
PA0788 hypothetical protein Hypothetical, unclassified, unknown 
PA0842 probable glycosyl transferase Putative enzymes 
PA0853 probable oxidoreductase Putative enzymes 
PA0877 probable transcriptional regulator Transcriptional regulators 
PA0878 hypothetical protein Hypothetical, unclassified, unknown 
PA0879 probable acyl-CoA dehydrogenase Putative enzymes 
PA0880 probable ring-cleaving dioxygenase Putative enzymes 
PA0882 hypothetical protein Putative enzymes 
PA0884 probable C4-dicarboxylate-binding periplasmic protein Transport of small molecules 
PA0886 probable C4-dicarboxylate transporter Transport of small molecules 
PA0921 hypothetical protein Membrane proteins 
PA0952 hypothetical protein Hypothetical, unclassified, unknown 
PA0985 pyocin S5 Membrane proteins 
PA1029 hypothetical protein Hypothetical, unclassified, unknown 
PA1065 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1066 probable short-chain dehydrogenase Putative enzymes 
PA1078 flagellar basal-body rod protein FlgC Cell wall / LPS / capsule 
PA1079 flagellar basal-body rod modification protein FlgD Cell wall / LPS / capsule 
PA1080 flagellar hook protein FlgE Cell wall / LPS / capsule 
PA1081 flagellar basal-body rod protein FlgF Cell wall / LPS / capsule 
PA1084 flagellar P-ring protein precursor FlgI Cell wall / LPS / capsule 
PA1111 hypothetical protein Hypothetical, unclassified, unknown 
PA1114 hypothetical protein Hypothetical, unclassified, unknown 
PA1115 hypothetical protein Membrane proteins 
PA1118 hypothetical protein Membrane proteins 
PA1155 NrdB, tyrosyl radical-harboring component of class Ia ribonucleotide reductase Nucleotide biosynthesis and metabolism 
PA1168 hypothetical protein Hypothetical, unclassified, unknown 
PA1178 PhoP/Q and low Mg2+ inducible outer membrane protein H1 precursor Membrane proteins 
PA1195 hypothetical protein Hypothetical, unclassified, unknown 
PA1216 hypothetical protein Hypothetical, unclassified, unknown 
PA1217 probable 2-isopropylmalate synthase Amino acid biosynthesis and metabolism 
PA1247 alkaline protease secretion protein AprE Secreted Factors (toxins, enzymes, alginate) 
PA1285 probable transcriptional regulator Transcriptional regulators 
PA1333 hypothetical protein Hypothetical, unclassified, unknown 
PA1345 hypothetical protein Hypothetical, unclassified, unknown 
PA1404 hypothetical protein Hypothetical, unclassified, unknown 
PA1470 probable short-chain dehydrogenase Putative enzymes 
PA1471 hypothetical protein Hypothetical, unclassified, unknown 
PA1514 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1517 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1518 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1523 xanthine dehydrogenase Nucleotide biosynthesis and metabolism 
PA1524 xanthine dehydrogenase Nucleotide biosynthesis and metabolism 
PA1560 hypothetical protein Hypothetical, unclassified, unknown 
PA1600 probable cytochrome c Energy metabolism 
PA1601 probable aldehyde dehydrogenase Putative enzymes 
PA1602 probable oxidoreductase Carbon compound catabolism 
PA1603 probable transcriptional regulator Transcriptional regulators 
PA1606 hypothetical protein Hypothetical, unclassified, unknown 
PA1625 conserved hypothetical protein Membrane proteins 
PA1659 hypothetical protein Hypothetical, unclassified, unknown 
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PA1730 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1780 assimilatory nitrite reductase small subunit Central intermediary metabolism 
PA1786 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1791 hypothetical protein Hypothetical, unclassified, unknown 
PA1847 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA1870 hypothetical protein Hypothetical, unclassified, unknown 
PA1889 hypothetical protein Hypothetical, unclassified, unknown 
PA1931 probable ferredoxin Energy metabolism 
PA1932 probable hydroxylase molybdopterin-containing subunit Carbon compound catabolism 
PA1933 probable hydroxylase lar ge subunit Carbon compound catabolism 
PA2017 hypothetical protein Hypothetical, unclassified, unknown 
PA2021 hypothetical protein Hypothetical, unclassified, unknown 
PA2022 probable nucleotide sugar dehydrogenase Putative enzymes 
PA2024 probable ring-cleaving dioxygenase Putative enzymes 
PA2042 probable transporter (membrane subunit) Transport of small molecules 
PA2071 elongation factor G Translation, post-translational modification, degradation 
PA2076 probable transcriptional regulator Transcriptional regulators 
PA2107 hypothetical protein Hypothetical, unclassified, unknown 
PA2136 hypothetical protein Hypothetical, unclassified, unknown 
PA2140 probable metallothionein Central intermediary metabolism 
PA2149 hypothetical protein Hypothetical, unclassified, unknown 
PA2155 probable phospholipase Putative enzymes 
PA2167 hypothetical protein Hypothetical, unclassified, unknown 
PA2168 hypothetical protein Hypothetical, unclassified, unknown 
PA2170 hypothetical protein Hypothetical, unclassified, unknown 
PA2174 hypothetical protein Hypothetical, unclassified, unknown 
PA2175 hypothetical protein Hypothetical, unclassified, unknown 
PA2176 hypothetical protein Hypothetical, unclassified, unknown 
PA2178 hypothetical protein Hypothetical, unclassified, unknown 
PA2179 hypothetical protein Hypothetical, unclassified, unknown 
PA2181 hypothetical protein Hypothetical, unclassified, unknown 
PA2186 hypothetical protein Hypothetical, unclassified, unknown 
PA2188 probable alcohol dehydrogenase (Zn-dependent) Putative enzymes 
PA2243 hypothetical protein Hypothetical, unclassified, unknown 
PA2365 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2366 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2367 hypothetical protein Hypothetical, unclassified, unknown 
PA2369 hypothetical protein Membrane proteins 
PA2441 hypothetical protein Hypothetical, unclassified, unknown 
PA2444 serine hydroxymethyltransferase Amino acid biosynthesis and metabolism 
PA2445 glycine cleavage system protein P2 Central intermediary metabolism 
PA2446 glycine cleavage system protein H2 Amino acid biosynthesis and metabolism 
PA2459 hypothetical protein Hypothetical, unclassified, unknown 
PA2462 hypothetical protein Hypothetical, unclassified, unknown 
PA2485 hypothetical protein Hypothetical, unclassified, unknown 
PA2486 hypothetical protein Hypothetical, unclassified, unknown 
PA2491 probable oxidoreductase Putative enzymes 
PA2493 RND multidrug efflux membrane fusion protein MexE precursor Transport of small molecules 
PA2494 RND multidrug efflux transporter MexF Transport of small molecules 
PA2495 Multidrug efflux outer membrane protein OprN precursor Membrane proteins 
PA2533 probable sodium:alanine symporter Membrane proteins 
PA2536 probable phosphatidate cytidylyltransferase Fatty acid and phospholipid metabolism 
PA2562 hypothetical protein Hypothetical, unclassified, unknown 
PA2569 hypothetical protein Hypothetical, unclassified, unknown 
PA2618 hypothetical protein Translation, post-translational modification, degradation 
PA2635 hypothetical protein Hypothetical, unclassified, unknown 
PA2658 hypothetical protein Hypothetical, unclassified, unknown 
PA2659 hypothetical protein Hypothetical, unclassified, unknown 
PA2708 hypothetical protein Hypothetical, unclassified, unknown 
PA2718 probable transcriptional regulator Transcriptional regulators 
PA2761 hypothetical protein Membrane proteins 
PA2777 conserved hypothetical protein Membrane proteins 
PA2782 hypothetical protein Hypothetical, unclassified, unknown 
PA2799 hypothetical protein Hypothetical, unclassified, unknown 
PA2803 hypothetical protein Hypothetical, unclassified, unknown 
PA2804 hypothetical protein Hypothetical, unclassified, unknown 
PA2815 probable acyl-CoA dehydrogenase Putative enzymes 
PA2816 hypothetical protein Hypothetical, unclassified, unknown 
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PA2827 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA2880 hypothetical protein Hypothetical, unclassified, unknown 
PA2881 probable two-component response regulator Transcriptional regulators 
PA2882 probable two-component sensor Two-component regulatory systems 
PA2883 hypothetical protein Hypothetical, unclassified, unknown 
PA2895 hypothetical protein Hypothetical, unclassified, unknown 
PA2931 probable transcriptional regulator Transcriptional regulators 
PA2939 probable aminopeptidase Secreted Factors (toxins, enzymes, alginate) 
PA2969 fatty acid biosynthesis protein PlsX Fatty acid and phospholipid metabolism 
PA2970 50S ribosomal protein L32 Translation, post-translational modification, degradation 
PA3023 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3031 hypothetical protein Hypothetical, unclassified, unknown 
PA3079 hypothetical protein Membrane proteins 
PA3082 glycine betaine transmethylase Amino acid biosynthesis and metabolism 
PA3105 general secretion pathway protein D Protein secretion/export apparatus 
PA3121 3-isopropylmalate dehydratase lar ge subunit Amino acid biosynthesis and metabolism 
PA3205 hypothetical protein Hypothetical, unclassified, unknown 
PA3218 hypothetical protein Hypothetical, unclassified, unknown 
PA3219 hypothetical protein Hypothetical, unclassified, unknown 
PA3221 CsaA protein Protein secretion/export apparatus 
PA3229 hypothetical protein Hypothetical, unclassified, unknown 
PA3249 probable transcriptional regulator Transcriptional regulators 
PA3273 hypothetical protein Hypothetical, unclassified, unknown 
PA3274 hypothetical protein Hypothetical, unclassified, unknown 
PA3280 Pyrophosphate-specific outer membrane porin OprO precursor Transport of small molecules 
PA3296 alkaline phosphatase Central intermediary metabolism 
PA3309 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3319 non-hemolytic phospholipase C precursor Secreted Factors (toxins, enzymes, alginate) 
PA3326 probable Clp-family ATP-dependent protease Translation, post-translational modification, degradation 
PA3327 probable non-ribosomal peptide synthetase Adaptation, Protection 
PA3329 hypothetical protein Hypothetical, unclassified, unknown 
PA3330 probable short chain dehydrogenase Putative enzymes 
PA3331 cytochrome P450 Adaptation, Protection 
PA3332 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3333 3-oxoacyl-[acyl-carrier -protein] synthase III Fatty acid and phospholipid metabolism 
PA3334 probable acyl carrier protein Fatty acid and phospholipid metabolism 
PA3335 hypothetical protein Hypothetical, unclassified, unknown 
PA3336 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA3337 ADP-L-glycero-D-mannoheptose 6-epimerase Cell wall / LPS / capsule 
PA3368 probable acetyltransferase Putative enzymes 
PA3376 probable ATP-binding component of ABC transporter Transport of small molecules 
PA3377 conserved hypothetical protein Transport of small molecules 
PA3380 conserved hypothetical protein Transport of small molecules 
PA3381 probable transcriptional regulator Transcriptional regulators 
PA3382 phosphonate transport protein PhnE Membrane proteins 
PA3383 binding protein component of ABC phosphonate transporter Transport of small molecules 
PA3384 ATP-binding component of ABC phosphonate transporter Transport of small molecules 
PA3389 probable ring-cleaving dioxygenase Putative enzymes 
PA3397 ferredoxin--NADP+ reductase Biosynthesis of cofactors, prosthetic groups and carriers 
PA3431 conserved hypothetical protein Membrane proteins 
PA3432 hypothetical protein Membrane proteins 
PA3436 hypothetical protein Hypothetical, unclassified, unknown 
PA3476 autoinducer synthesis protein RhlI Adaptation, Protection 
PA3478 rhamnosyltransferase chain B Secreted Factors (toxins, enzymes, alginate) 
PA3484 hypothetical protein Hypothetical, unclassified, unknown 
PA3540 GDP-mannose 6-dehydrogenase AlgD Cell wall / LPS / capsule 
PA3541 alginate biosynthesis protein Alg8 Cell wall / LPS / capsule 
PA3542 alginate biosynthesis protein Alg44 Cell wall / LPS / capsule 
PA3543 alginate biosynthetic protein AlgK precursor Cell wall / LPS / capsule 
PA3544 Alginate production outer membrane protein AlgE precursor Membrane proteins 
PA3545 alginate-c5-mannuronan-epimerase AlgG Cell wall / LPS / capsule 
PA3546 alginate biosynthesis protein AlgX Cell wall / LPS / capsule 
PA3547 poly(beta-d-mannuronate) lyase precursor AlgL Cell wall / LPS / capsule 
PA3548 alginate o-acetyltransferase AlgI Cell wall / LPS / capsule 
PA3549 alginate o-acetyltransferase AlgJ Cell wall / LPS / capsule 
PA3550 alginate o-acetyltransferase AlgF Cell wall / LPS / capsule 
PA3551 phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase Cell wall / LPS / capsule 
PA3553 ArnC Adaptation, Protection 
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PA3554 ArnA Putative enzymes 
PA3555 ArnD Adaptation, Protection 
PA3556 inner membrane L-Ara4N transferase ArnT Adaptation, Protection 
PA3557 ArnE Adaptation, Protection 
PA3559 probable nucleotide sugar dehydrogenase Putative enzymes 
PA3569 3-hydroxyisobutyrate dehydrogenase Carbon compound catabolism 
PA3577 hypothetical protein Hypothetical, unclassified, unknown 
PA3578 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3598 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3651 phosphatidate cytidylyltransferase Fatty acid and phospholipid metabolism 
PA3655 elongation factor Ts Translation, post-translational modification, degradation 
PA3688 hypothetical protein Hypothetical, unclassified, unknown 
PA3692 probable outer membrane protein precursor Membrane proteins 
PA3724 elastase LasB Secreted Factors (toxins, enzymes, alginate) 
PA3743 tRNA (guanine-N1)-methyltransferase Transcription, RNA processing and degradation 
PA3744 16S rRNA processing protein Transcription, RNA processing and degradation 
PA3819 conserved hypothetical protein Membrane proteins 
PA3820 secretion protein SecF Protein secretion/export apparatus 
PA3821 secretion protein SecD Membrane proteins 
PA3840 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3890 probable permease of ABC transporter Membrane proteins 
PA3905 hypothetical protein Hypothetical, unclassified, unknown 
PA3906 hypothetical protein Hypothetical, unclassified, unknown 
PA3907 hypothetical protein Hypothetical, unclassified, unknown 
PA3908 hypothetical protein Hypothetical, unclassified, unknown 
PA3909 hypothetical protein Hypothetical, unclassified, unknown 
PA3910 hypothetical protein Hypothetical, unclassified, unknown 
PA3929 cyanide insensitive terminal oxidase Energy metabolism 
PA3944 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA3952 hypothetical protein Hypothetical, unclassified, unknown 
PA3957 probable short-chain dehydrogenase Putative enzymes 
PA3964 hypothetical protein Hypothetical, unclassified, unknown 
PA4017 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4040 hypothetical protein Hypothetical, unclassified, unknown 
PA4063 hypothetical protein Hypothetical, unclassified, unknown 
PA4110 beta-lactamase precursor Adaptation, Protection 
PA4111 hypothetical protein Hypothetical, unclassified, unknown 
PA4112 probable sensor/response regulator hybrid Two-component regulatory systems 
PA4154 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4155 hypothetical protein Hypothetical, unclassified, unknown 
PA4190 probable FAD-dependent monooxygenase Putative enzymes 
PA4238 DNA-directed RNA polymerase alpha chain Transcription, RNA processing and degradation 
PA4243 secretion protein SecY Membrane proteins 
PA4244 50S ribosomal protein L15 Translation, post-translational modification, degradation 
PA4246 30S ribosomal protein S5 Translation, post-translational modification, degradation 
PA4247 50S ribosomal protein L18 Translation, post-translational modification, degradation 
PA4248 50S ribosomal protein L6 Translation, post-translational modification, degradation 
PA4255 50S ribosomal protein L29 Translation, post-translational modification, degradation 
PA4261 50S ribosomal protein L23 Translation, post-translational modification, degradation 
PA4262 50S ribosomal protein L4 Transcription, RNA processing and degradation 
PA4272 50S ribosomal protein L10 Translation, post-translational modification, degradation 
PA4293 two-component sensor PprA Two-component regulatory systems 
PA4317 hypothetical protein Membrane proteins 
PA4344 probable hydrolase Putative enzymes 
PA4345 hypothetical protein Hypothetical, unclassified, unknown 
PA4348 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4350 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4351 probable acyltransferase Fatty acid and phospholipid metabolism 
PA4354 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4355 probable major facilitator superfamily (MFS) transporter Membrane proteins 
PA4356 xenobiotic reductase Adaptation, Protection 
PA4357 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4371 hypothetical protein Hypothetical, unclassified, unknown 
PA4407 cell division protein FtsZ Cell division 
PA4408 cell division protein FtsA Cell division 
PA4409 cell division protein FtsQ Cell division 
PA4410 D-alanine--D-alanine ligase Cell wall / LPS / capsule 
PA4411 UDP-N-acetylmuramate--alanine ligase Cell wall / LPS / capsule 
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PA4412 UDP-N-acetylglucosamine--N-acetylmuramyl undecaprenol N-acetylglucosamine trans Carbon compound catabolism 
PA4413 cell division protein FtsW Cell division 
PA4414 UDP-N-acetylmuramoylalanine--D-glutamate ligase Cell wall / LPS / capsule 
PA4415 phospho-N-acetylmuramoyl-pentapeptide-transferase Cell wall / LPS / capsule 
PA4416 UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate--D-alanyl-D-alanyl ligCell wall / LPS / capsule 
PA4419 cell division protein FtsL Cell division 
PA4421 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4498 probable metallopeptidase Translation, post-translational modification, degradation 
PA4500 probable binding protein component of ABC transporter Transport of small molecules 
PA4502 probable binding protein component of ABC transporter Transport of small molecules 
PA4503 probable permease of ABC transporter Membrane proteins 
PA4504 probable permease of ABC transporter Membrane proteins 
PA4505 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4506 probable ATP-binding component of ABC dipeptide transporter Transport of small molecules 
PA4507 hypothetical protein Membrane proteins 
PA4525 type 4 fimbrial precursor PilA Motility & Attachment 
PA4526 type 4 fimbrial biogenesis protein PilB Motility & Attachment 
PA4569 octaprenyl-diphosphate synthase Energy metabolism 
PA4575 hypothetical protein Hypothetical, unclassified, unknown 
PA4588 glutamate dehydrogenase Amino acid biosynthesis and metabolism 
PA4589 probable outer membrane protein precursor Membrane proteins 
PA4621 probable oxidoreductase Putative enzymes 
PA4623 hypothetical protein Hypothetical, unclassified, unknown 
PA4632 hypothetical protein Hypothetical, unclassified, unknown 
PA4657 hypothetical protein Hypothetical, unclassified, unknown 
PA4658 hypothetical protein Hypothetical, unclassified, unknown 
PA4671 probable ribosomal protein L25 Adaptation, Protection 
PA4674 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4691 hypothetical protein Hypothetical, unclassified, unknown 
PA4697 hypothetical protein Hypothetical, unclassified, unknown 
PA4713 hypothetical protein Hypothetical, unclassified, unknown 
PA4742 tRNA pseudouridine 55 synthase Translation, post-translational modification, degradation 
PA4743 ribosome-binding factor A Translation, post-translational modification, degradation 
PA4744 translation initiation factor IF-2 Translation, post-translational modification, degradation 
PA4773 hypothetical protein Hypothetical, unclassified, unknown 
PA4781 probable two-component response regulator Transcriptional regulators 
PA4782 hypothetical protein Hypothetical, unclassified, unknown 
PA4785 probable acyl-CoA thiolase Putative enzymes 
PA4786 probable short-chain dehydrogenase Putative enzymes 
PA4811 nitrate-inducible formate dehydrogenase, beta subunit Energy metabolism 
PA4813 lipase LipC Fatty acid and phospholipid metabolism 
PA4844 probable chemotaxis transducer Adaptation, Protection 
PA4858 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4862 probable ATP-binding component of ABC transporter Transport of small molecules 
PA4870 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4877 hypothetical protein Hypothetical, unclassified, unknown 
PA4879 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA4881 hypothetical protein Hypothetical, unclassified, unknown 
PA4896 probable sigma-70 factor , ECF subfamily Transcriptional regulators 
PA4933 hypothetical protein Membrane proteins 
PA5033 hypothetical protein Hypothetical, unclassified, unknown 
PA5040 Type 4 fimbrial biogenesis outer membrane protein PilQ precursor Motility & Attachment 
PA5041 type 4 fimbrial biogenesis protein PilP Motility & Attachment 
PA5042 type 4 fimbrial biogenesis protein PilO Motility & Attachment 
PA5043 type 4 fimbrial biogenesis protein PilN Motility & Attachment 
PA5044 type 4 fimbrial biogenesis protein PilM Motility & Attachment 
PA5075 probable permease of ABC transporter Membrane proteins 
PA5097 probable amino acid permease Membrane proteins 
PA5099 probable transporter Membrane proteins 
PA5116 probable transcriptional regulator Transcriptional regulators 
PA5124 two-component sensor NtrB Two-component regulatory systems 
PA5125 two-component response regulator NtrC Transcriptional regulators 
PA5128 secretion protein SecB Protein secretion/export apparatus 
PA5129 glutaredoxin Energy metabolism 
PA5139 hypothetical protein Hypothetical, unclassified, unknown 
PA5169 probable C4-dicarboxylate transporter Membrane proteins 
PA5170 arginine/ornithine antiporter Membrane proteins 
PA5180 conserved hypothetical protein Hypothetical, unclassified, unknown 
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PA5182 hypothetical protein Membrane proteins 
PA5183 hypothetical protein Membrane proteins 
PA5192 phosphoenolpyruvate carboxykinase Carbon compound catabolism 
PA5202 hypothetical protein Hypothetical, unclassified, unknown 
PA5209 hypothetical protein Hypothetical, unclassified, unknown 
PA5212 hypothetical protein Hypothetical, unclassified, unknown 
PA5220 hypothetical protein Hypothetical, unclassified, unknown 
PA5232 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5262 alginate biosynthesis protein AlgZ/FimS Secreted Factors (toxins, enzymes, alginate) 
PA5275 conserved hypothetical protein Hypothetical, unclassified, unknown 
PA5287 ammonium transporter AmtB Membrane proteins 
PA5299 hypothetical protein Hypothetical, unclassified, unknown 
PA5322 phosphomannomutase AlgC Cell wall / LPS / capsule 
PA5360 two-component response regulator PhoB Transcriptional regulators 
PA5361 two-component sensor PhoR Two-component regulatory systems 
PA5366 ATP-binding component of ABC phosphate transporter Membrane proteins 
PA5367 membrane protein component of ABC phosphate transporter Membrane proteins 
PA5368 membrane protein component of ABC phosphate transporter Membrane proteins 
PA5415 serine hydroxymethyltransferase Amino acid biosynthesis and metabolism 
PA5422 hypothetical protein Hypothetical, unclassified, unknown 
PA5441 hypothetical protein Hypothetical, unclassified, unknown 
PA5460 hypothetical protein Hypothetical, unclassified, unknown 
PA5473 conserved hypothetical protein Membrane proteins 
PA5475 hypothetical protein Hypothetical, unclassified, unknown 
PA5476 citrate transporter Membrane proteins 
PA5498 probable adhesin Motility & Attachment 
PA5499 transcriptional regulator np20 Transcriptional regulators 
PA5524 probable short-chain dehydrogenase Putative enzymes 
PA5525 probable transcriptional regulator Transcriptional regulators 
PA5526 hypothetical protein Hypothetical, unclassified, unknown 
PA5549 glucosamine--fructose-6-phosphate aminotransferase Central intermediary metabolism 
PA5555 ATP synthase gamma chain Energy metabolism 
PA5556 ATP synthase alpha chain Energy metabolism 
PA5557 ATP synthase delta chain Energy metabolism 
PA5558 ATP synthase B chain Energy metabolism 
PA5559 atp synthase C chain Energy metabolism 
PA5560 ATP synthase A chain Energy metabolism 
PA5568 conserved hypothetical protein Membrane proteins 
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Alginate
PA2867 probable chemotaxis transducer Adaptation, Protection
PA3819 conserved hypothetical protein Membrane proteins
PA5182 hypothetical protein Membrane proteins
RsmA
PA0105 cytochrome c oxidase, subunit II Energy metabolism 
PA0108 cytochrome c oxidase, subunit III Energy metabolism 
PA0129 gamma-aminobutyrate permease Transport of small molecules 
PA0173 probable methylesterase Adaptation, Protection 
PA0210 malonate decarboxylase delta subunit Carbon compound catabolism 
PA0212 malonate decarboxylase gamma subunit Carbon compound catabolism 
PA0235 4-hydroxybenzoate transporter PcaK Membrane proteins 
PA0396 twitching motility protein PilU Motility & Attachment 
PA0652 transcriptional regulator Vfr Transcriptional regulators 
PA0673 hypothetical protein Hypothetical, unclassified, unknown 
PA0706 chloramphenicol acetyltransferase Antibiotic resistance and susceptibility 
PA0710 lactoylglutathione lyase Central intermediary metabolism 
PA0723 coat protein B of bacteriophage Pf1) Related to phage, transposon, or plasmid 
PA0843 phospholipase accessory protein PlcR precursor Secreted Factors (toxins, enzymes, alginate) 
PA0844 hemolytic phospholipase C precursor Secreted Factors (toxins, enzymes, alginate) 
PA0905 RsmA, regulator of secondary metabolites Translation, post-translational modification, degradation 
PA0994 usher CupC3 Motility & Attachment 
PA1001 anthranilate synthase component I Adaptation, Protection 
PA1092 flagellin type B Motility & Attachment 
PA1148 exotoxin A precursor Secreted Factors (toxins, enzymes, alginate) 
PA1151 pyocin S2 immunity protein Adaptation, Protection 
PA1173 cytochrome c-type protein NapB precursor Energy metabolism 
PA1247 alkaline protease secretion protein AprE Secreted Factors (toxins, enzymes, alginate) 
PA1251 probable chemotaxis transducer Adaptation, Protection 
PA1338 gamma-glutamyltranspeptidase precursor Amino acid biosynthesis and metabolism
PA1393 adenosine 5'-phosphosulfate (APS) kinase Amino acid biosynthesis and metabolism
PA1409 acetylpolyamine aminohydrolase Carbon compound catabolism 
PA1635 potassium-transporting ATPase, C chain Transport of small molecules 
PA1695 translocation protein in type III secretion Protein secretion/export apparatus 
PA1758 para-aminobenzoate synthase component I Biosynthesis of cofactors, prosthetic groups and carriers 
PA1770 phosphoenolpyruvate synthase Energy metabolism 
PA1781 assimilatory nitrite reductase lar ge subunit Central intermediary metabolism 
PA1947 ribose transport protein RbsA Transport of small molecules 
PA1949 ribose operon repressor RbsR Carbon compound catabolism 
PA1983 cytochrome c550 Energy metabolism 
PA2007 maleylacetoacetate isomerase Carbon compound catabolism 
PA2009 homogentisate 1,2-dioxygenase Carbon compound catabolism 
PA2064 copper resistance protein B precursor Adaptation, Protection 
PA2129 chaperone CupA2 Motility & Attachment 
PA2337 transcriptional regulator MtlR Transcriptional regulators 
PA2493 RND multidrug efflux membrane fusion protein MexE precursor Transport of small molecules 
PA2494 RND multidrug efflux transporter MexF Transport of small molecules 
PA2495 Multidrug efflux outer membrane protein OprN precursor Membrane proteins 
PA2509 muconate cycloisomerase I Carbon compound catabolism 
PA2926 histidine transport protein HisP Amino acid biosynthesis and metabolism
PA3540 GDP-mannose 6-dehydrogenase AlgD Cell wall / LPS / capsule 
PA3543 alginate biosynthetic protein AlgK precursor Cell wall / LPS / capsule 
PA3544 Alginate production outer membrane protein AlgE precursor Membrane proteins 
PA3549 alginate o-acetyltransferase AlgJ Cell wall / LPS / capsule 
PA3603 diacylglycerol kinase Fatty acid and phospholipid metabolism 
PA4110 beta-lactamase precursor Adaptation, Protection 
PA4127 2-oxo-hept-3-ene-1,7-dioate hydratase Carbon compound catabolism 
PA4138 tyrosyl-tRNA synthetase Amino acid biosynthesis and metabolism
PA4158 ferric enterobactin transport protein FepC Transport of small molecules 
PA4205 hypothetical protein Membrane proteins 
PA4210 probable phenazine biosynthesis protein Secreted Factors (toxins, enzymes, alginate) 
PA4307 chemotactic transducer PctC Adaptation, Protection 
PA4310 chemotactic transducer PctB Adaptation, Protection 
PA4356 xenobiotic reductase Adaptation, Protection 
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PA4522 beta-lactamase expression regulator AmpD Cell wall / LPS / capsule 
PA4527 still frameshift type 4 fimbrial biogenesis protein PilC Motility & Attachment 
PA4855 phosphoribosylamine--glycine ligase Nucleotide biosynthesis and metabolism 
PA4953 chemotaxis protein MotB Membrane proteins 
PA4954 chemotaxis protein MotA Adaptation, Protection 
PA5041 type 4 fimbrial biogenesis protein PilP Motility & Attachment 
PA5042 type 4 fimbrial biogenesis protein PilO Motility & Attachment 
PA5043 type 4 fimbrial biogenesis protein PilN Motility & Attachment 
PA5044 type 4 fimbrial biogenesis protein PilM Motility & Attachment 
PA5243 delta-aminolevulinic acid dehydratase Biosynthesis of cofactors, prosthetic groups and carriers 
PA5355 glycolate oxidase subunit GlcD Central intermediary metabolism 
PA5361 two-component sensor PhoR Two-component regulatory systems 
PA5501 permease of ABC zinc transporter ZnuB Membrane proteins 
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Supplementary Table 1: Family-wise list of transcription factors found in P. aeruginosa PAO1. The table shows the genomic 
location of the protein (core/RGP) (Mathee et al. 2008) and the different PFAM domains (Winzor et al. 2011, 
http://pfam.sanger.ac.uk/ and http://expasy.org/prosite/). ORF (PA) numbers, protein name, homolog and amino acid information are 
from the Pseudomonas database (Winzor et al. 2011). 
 
PA # Protein name 
# of 
amino 
acids 
Subfamily Nearest Homolog Core/ RGP 
Domain 
1 
Domain 1 
Details 
Domain 
2 
Domain 2 
Details 
Other 
Domains 
Domain 
Details 
AraC                       
PA0306 Core 
PA0163   265   52% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC         
PA0248 PobR 288  
87% similar to putative regulator PobR 
[Pseudomonas aeruginosa] Core PF00165 HTH_AraC     
PA0416 ChpD 264   
40% similar to regulatory protein mmsR which 
is a member of the AraC/XylS family of 
transcriptional regulators [Pseudomonas 
aeruginosa] 
Core PF02311 AraC_binding PF00165 HTH_AraC     
PA0564  303  
57% similarity to hypothetical transcriptional 
regulator HI1052 from [[Haemophilus 
influenzae]] 
Core PF00165 HTH_AraC     
PA0748   306   55% similar to regulatory protein mmsR [Pseudomonas aeruginosa] Core PF00165 HTH_AraC         
PA0780 PruR 250  
54% similar to lumQ gene product 
[Photobacterium leiognathi] Core PF00165 HTH_AraC     
PA0791   262   
50% similarity to hypothetical yeaM gene 
product of [Escherichia coli], a putative 
regulatory protein. 
Core PF00165 HTH_AraC         
PA0831 OruR 339  
100% identical to OruR, transcriptional 
regulator required for growth on ornithine as 
the sole carbon source [Pseudomonas 
aeruginosa] 
Core PF00165 HTH_AraC     
PA0864   262   50% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC         
PA0893 ArgR 329 0 Core PF00165 HTH_AraC 
PA1109   259   52% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC         
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PA1182  333  
47% similar to transcriptional regulator OruR 
[Pseudomonas aeruginosa] Core PF00165 HTH_AraC     
PA1229 YeaM 268   67% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC         
PA1235  260  
51% similar to putative regulatory protein 
YeaM [Escherichia coli] Core PF00165 HTH_AraC     
PA1261   224   
62% similar to a region of probable 
transcriptional regulator LumQ 
[Photobacterium leiognathi] 
Core PF00165 HTH_AraC         
PA1380  321  
60% similar to putative regulatory protein 
YqhC [Escherichia coli]  
RGP 
15 PF00165 HTH_AraC     
PA1599   260   56% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC         
PA1619  274  
45% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core PF00165 HTH_AraC     
PA1713 ExsA 278   
71% similar to thermoregulatory transcription 
factor LcrF [Yersinia pestis] ; 72% similar to 
transcriptional activator VirF [Yersinia 
enterocolitica] ; 99% similar to exoenzyme S 
synthesis regulatory protein ExsA 
[Pseudomonas aeruginosa] 
Core PF00165 HTH_AraC         
PA1850  334  
57% similar to AraC-like protein 
[Azorhizobium caulinodans] Core PF00165 HTH_AraC     
PA2047   329   51% similar to putative regulatory proteinYqhC [Escherichia coli] 
RGP 
20 PF00165 HTH_AraC         
PA2096  344  
51% similar to hypothetical transcriptional 
regulator CY21B4.12 [Mycobacterium 
tuberculosis] 
Core PF00165 HTH_AraC     
PA2227 VqsM 325   47% similar to regulator OruR [Pseudomonas aeruginosa] Core PF00165 HTH_AraC         
PA2276  296  
62% similar (over C-terminal 3/4ths of ORF) 
to yqhC gene product of [Escherichia coli], a 
putative transcriptional regulator. 
Core PF00165 HTH_AraC     
PA2281   284   64% similar to the C-terminal end of regulatory protein PchR Synechocystis sp. Core PF00165 HTH_AraC         
PA2332  301  
46% similar to putative regulator HI1052 
[Haemophilus influenzae Rd] Core PF00165 HTH_AraC     
PA2337 MtlR 301   84% similar to putative activator protein MtlR [Pseudomonas fluorescens] Core PF00165 HTH_AraC         
PA2488  254  
47% similar to putative regulatory protein 
YeaM [Escherichia coli] Core PF00165 HTH_AraC     
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PA2489   271   46% similar to putative transcriptional regulator [Streptomyces coelicolor] Core PF00165 HTH_AraC         
PA2511  333  
50% similar to putative regulatory protein 
OxoS Pseudomonas putida Core PF00165 HTH_AraC     
PA2519 XylS 318   70% similar to positive regulatory protein XylS [TOL plasmid] Core PF00165 HTH_AraC         
PA2556  361  
42% similar to regulator OruR [Pseudomonas 
aeruginosa] Core PF00165 HTH_AraC     
PA2588   342   48% similar to regulator OruR [Pseudomonas aeruginosa] Core PF00165 HTH_AraC         
PA2696  297  
52% similar to regulatory protein GdhBR 
[Pantoea citrea] Core PF00165 HTH_AraC     
PA2704   339   54% similar to transcriptional regulator OruR [Pseudomonas aeruginosa] Core PF00165 HTH_AraC         
PA2917  278  
47% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core PF00165 HTH_AraC     
PA3027   343   49% similar to transcriptional regulator OruR [Pseudomonas aeruginosa] Core PF00165 HTH_AraC PF08281 
Sigma70_r4
_2 PF09312 SurA_N 
PA3094  345  
80% similar to putative virulence regulator 
[Pseudomonas alcaligenes] Core PF00165 HTH_AraC     
PA3215   337   52% similar to transcriptional regulator PhbR [Pseudomonas sp. 61-3] Core PF00165 HTH_AraC         
PA3220  254  
48% similar to probable transcriptional 
regulator LumQ [Photobacterium leiognathi] Core PF00165 HTH_AraC PF07883 Cupin_2   
PA3269   284   49% similar to putative transcriptional regulator [Streptomyces coelicolor] Core PF00165 HTH_AraC PF02311 
AraC_bindi
ng     
PA3423  247  
52% similar to a region of putative araC-type 
regulatory protein [Escherichia coli] Core PF00165 HTH_AraC PF07366 SnoaL   
PA3571 MmsR 307     Core PF00165 HTH_AraC PF00165 HTH_AraC PF07883; PF03079 
Cupin_2; 
ARD 
PA3782  317  
49% similar to a region of ArgR regulatory 
protein [Pseudomonas aeruginosa] Core PF00165 HTH_AraC PF01965 DJ-1_PfpI   
PA3830   270   51% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC PF07883 Cupin_2 PF02311 
AraC_bin
ding 
PA3898  293  
54% similar to regulatory protein GdhBR 
[Pantoea citrea] Core PF00165 HTH_AraC     
PA3927   262   53% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC PF02311 
AraC_bindi
ng PF07883 Cupin_2 
PA4070  316  
45% similar to the regulatory protein for 2-
phenylethylamine catabolism FeaR 
[Escherichia coli] 
Core PF00165 HTH_AraC     
PA4094   319   42% similar to nitrilase regulator Core PF00165 HTH_AraC         
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[[Rhodococcus rhodochrous]] 
PA4120  303  
63% similar to the HpaA gene product of 
[Escherichia coli] Core PF00165 HTH_AraC PF02311 
AraC_bindi
ng PF07883 Cupin_2 
PA4184   340   48% similar to ArgR regulatory protein [Pseudomonas aeruginosa] Core PF00165 HTH_AraC PF01965 DJ-1_PfpI     
PA4227 PchR 296  
100% similar to regulatory protein PchR 
[Pseudomonas aeruginosa] Core PF00165 HTH_AraC     
PA4288   267   51% similar to putative regulatory protein YeaM [Escherichia coli] Core PF00165 HTH_AraC PF07883 Cupin_2 PF02311 
AraC_bin
ding 
PA4436  299  
45% similar to ArgR regulatory protein 
[Pseudomonas aeruginosa] Core PF00165 HTH_AraC     
PA4787   333   42% similar to regulator OruR [Pseudomonas aeruginosa] Core PF00165 HTH_AraC         
PA5032  357  
53% similar to regulator OruR [Pseudomonas 
aeruginosa] Core PF00165 HTH_AraC     
PA5324   356   46% similar to hypothetical transcriptional regulator [Mycobacterium tuberculosis] Core PF00165 HTH_AraC PF09312 SurA_N     
PA5342  266  
46% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core PF00165 HTH_AraC PF02311 
AraC_bindi
ng PF07883 Cupin_2 
PA5380 GbdR 367   59% similar to ArgR regulatory protein [Pseudomonas aeruginosa] Core PF00165 HTH_AraC PF01965 DJ-1_PfpI     
PA5389 CdhR 336   58% similar to ArgR regulatory protein [Pseudomonas aeruginosa] Core PF00165 HTH_AraC PF01965 DJ-1_PfpI     
ArsR                       
PA0279 YdfF 232  
59% similar to hypothetical protein YdfF 
[[Bacillus subtilis]] Core PS00846 
 Bacterial 
regulatory 
proteins, arsR 
family 
signature 
    
PA0547   333   49% similar to a region of unknown protein [Streptomyces fradiaeTransposon Tn4556] Core PS00846 
 Bacterial 
regulatory 
proteins, arsR 
family 
signature 
PF01022 
HTH_5, 
Bacterial 
regulatory 
protein, 
arsR family. 
    
PA2277 ArsR 116  
82% identical to arsR gene product of [P. 
aeruginosa] ; 73% similar (over 3/4ths of ORF 
length) to arsR gene product of [Escherichia 
coli] 
Core       
PA4354   100   76% similar to a region of hypothetical protein [Agrobacterium radiobacter] Core PS00846 
 Bacterial 
regulatory 
proteins, ArsR 
family  
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AsnC                       
PA0513 NirG 147  
77% similar to NirG protein [Pseudomonas 
stutzeri] Core PF01037  AsnC family     
PA2028   157   62% similar to AzlB protein [[Bacillus subtilis]] RGP20 PF01037  AsnC family         
PA2082  158  
57% similar to leucine-responsive regulatory 
protein Lrp [Escherichia coli] Core PF01037  AsnC family     
PA2246 BkdR 153   64% similar to BkdR protein [P. putida] Core PF01037  AsnC family         
PA2577  145  
55% similar to hypothetical protein Rv3291c 
[Mycobacterium tuberculosis] Core PF01037  AsnC family     
PA3965   169   63% similar to Leucine-responsive regulatory protein Lrp [Escherichia coli] Core PF01037  AsnC family PF01047 
 MarR 
family     
PA4508  157  
70% similar to transcription regulatory protein 
PdhR [Ralstonia eutropha] Core PF01037  AsnC family     
PA4784   155   57% similar to putative transcriptional regulator [[Bacillus subtilis]] Core PF01037  AsnC family         
PA5308 Lrp, DadR 162   
79% similar to global response regulator Lrp 
[Escherichia coli] Core PF01037  AsnC family         
Cro/ cI                       
PA0048  127  
55% similar to a region of TrbA [plasmid 
RK2, [Escherichia coli]] Core       
PA0225   179   51% similar to putative epoxidase [Methanobacterium thermoautotrophicum] Core             
PA0535  184  
48% similar to putative aldehyde 
dehydrogenase [Azotobacter vinelandii] Core       
PA0611 PrtR 256   0 Core             
PA0906  68  
70% similar to hypothetical repressor protein 
AF1793 [Archaeoglobus fulgidus] Core       
PA1359   103   0 Core             
PA1879  238  
60% similar to regulator PhnR [Salmonella 
typhimurium] Core       
PA1884   72   73% similar to hypothetical protein YozG [Bacillus subtilis] Core             
PA2312 114 Core 
PA2780   193   54% similar to hypothetical protein [Bacillus sp.] Core             
PA2785  183  
51% similar to putative transcriptional 
regulator protein [Bacillus sp.] Core       
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PA3260   218   
Small portion 64% similar to PvuII restriction 
endonuclease regulator pvuIIC of [Proteus 
vulgaris] ; 49% similar to hypothetical hipB 
protein of [Escherichia coli] 
Core             
PA4077  237  
66% similar to pyocin synthesis negative 
regulatory protein PrtR [Pseudomonas 
aeruginosa] 
Core       
PA4499   187   44% similar to hypothetical protein YcjC [Escherichia coli] Core             
PA4987  199  
53% similar to aldehyde dehydrogenase 
[Azotobacter vinelandii] ; 48% similar to 
hypothetical ycjC gene product of 
[Escherichia coli] 
Core       
PA5301 YcjC 182   62% similar to hypothetical protein YcjC [Escherichia coli] Core             
PA5403   68   77% similar to putative transcriptional regulator YozG [Bacillus subtilis] Core             
DksA/TraR                 
PA0612 PtrB 66  
59% similar to hypothetical protein YbiI (over 
N-terminal 75% of ORF) [Escherichia coli] RGP 3 PF01258 
 zf-dskA_traR, 
Prokaryotic 
dksA/traR C4-
type zinc 
finger 
    
PA4723 DksA 148   86% similar to dosage-dependent dnaK suppressor protein DksA [Escherichia coli] Core PF01258 
 zf-dskA_traR, 
Prokaryotic 
dksA/traR C4-
type zinc 
finger 
        
PA4870 YbiI 88  
84% similar to hypothetical protein YbiI 
[Escherichia coli] Core PF01258 
 zf-dskA_traR, 
Prokaryotic 
dksA/traR C4-
type zinc 
finger 
    
PA5536   134   59% similar to dnaK suppressor protein DksA [Escherichia coli] Core PF01258 
 zf-dskA_traR, 
Prokaryotic 
dksA/traR C4-
type zinc 
finger 
        
RpoN-binding                 
PA0873 PhhR 519   Core PF00158 
Sigma-54 
interaction 
domain 
PF00989 PAS, PAS fold   
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PA1097 FleQ 490   66% similar to sigma 54 transcriptional activator [Vibrio cholerae] Core PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
PF06490 
FleQ, 
Flagellar 
regulatory 
protein FleQ 
PF00158 
Sigma-54 
interactio
n domain 
PA1099 FleR 473  
68% similar to two-component response 
regulator [Vibrio cholerae] Core PF00158 
Sigma-54 
interaction 
domain 
PF00072 
Response 
regulator 
receiver 
domain 
PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, 
Fis family 
PA1196   466   53% similar to arginine catabolism positive regulator RocR [Bacillus subtilis] Core PF07728 
AAA_5, 
ATPase 
family 
associated 
with various 
cellular 
activities 
(AAA) 
PF08448 PAS_4, PAS fold 
PF02954; 
PF00158 
HTH_8, 
Bacterial 
regulatory 
protein, 
Fis 
family;      
Sigma-54 
interactio
n domain 
PA1335  425  
67% similar to C4-dicarboxylate transport 
transcription regulator DctD [Rhizobium 
meliloti] 
Core PF02954 HTH_8,  Fis family PF00158 
Sigma54_ac
tivat, PF00072 
Response 
regulator 
PA1663   503   
55% similar to response regulator of 
hydrogenase 3 activity HydG [Escherichia 
coli] 
Core PF00158 
Sigma-54 
interaction 
domain 
PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
    
PA1945  442  
57% similar to hydG gene product of 
[Escherichia coli] Core PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
PF00158 
Sigma-54 
interaction 
domain   
PA2005   481   
58% similar to Acetoacetate metabolism 
regulatory protein AtoC [Escherichia coli] ; 
53% similar to nifA gene product of 
[Azotobacter vinelandii] 
Core PF00158 
Sigma-54 
interaction 
domain 
PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
PF08448 PAS_4, PAS fold 
PA2354  376  
58% similar to transcriptional protein FtrC 
[Caulobacter crescentus] Core PF00158 
Sigma-54 
interaction 
domain 
PF07728 
AAA_5, 
ATPase 
family 
associated 
with various 
cellular  
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PA2359   361   60% similar to a region of transcriptional protein FtrC [Caulobacter crescentus] Core PF07728 
AAA_5, 
ATPase 
family 
associated 
with various 
cellular 
activities 
(AAA) 
PF00158 
Sigma-5 4 
interaction 
domain 
    
PA2449  511  
58% similar phenylalanine hydroxylase gene 
cluster transcription activator PhhR 
[Pseudomonas aeruginosa] 
Core PF00158 
Sigma-54 
interaction 
domain     
PA2665   517   
63% similar to putative 2-component 
transcriptional regulator YgaA [Escherichia 
coli] 
Core PF00158 
Sigma-54 
interaction 
domain 
PF01590 GAF, GAF domain     
PA3932  324  
55% similar to regulator for prp operon PrpR 
[Escherichia coli] Core PF00158 
Sigma-54 
interaction 
domain     
PA4021   643   57% similar to transcription factor AcoR [Alcaligenes eutrophus] Core PF00158 
Sigma-54 
interaction 
domain 
PF07728 
AAA_5, 
ATPase 
family 
associated 
with various 
cellular 
activities 
(AAA) 
PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, 
Fis family 
PA4147 AcoR 625  
59% similar to the acoR gene product of 
[Alcaligenes eutrophus] Core PF00158 
Sigma-54 
interaction 
domain 
PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
  
PA4493 RoxR 186   
67% similar to putative photosynthetic 
response regulator PrrA [Rhodobacter 
sphaeroides]; 66% similar to RegA 
[Rhodovulum sulfidophilum] 
Core PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
PF00072 
Response 
regulator 
receiver 
domain 
    
PA4547 PilR 445   Core PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
PF00072 
Response 
regulator 
receiver 
domain 
PF00158 
Sigma-54 
interactio
n domain 
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PA4581 RtcR 531   79% similar to regulator RtcR [Escherichia coli] Core PF00158 
Sigma-54 
interaction 
domain 
PF06956 
RtcR, 
Regulator of 
RNA 
terminal 
phosphate 
cyclase 
    
PA4726 CbrB 478  
99% similar to regulator CbrB [Azotobacter 
vinelandii DJ; 90% similar to NifA 
[Alcaligenes faecalis] 
Core PF07728 
AAA_5, 
ATPase 
family 
associated 
with various 
cellular 
activities 
(AAA) 
PF00158 
Sigma-54 
interaction 
domain 
PF00072 
Response 
regulator 
receiver 
domain 
PA4853 Fis 107   80% similar to Fis protein [Escherichia coli] Core PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
        
PA5125 NtrC 476  79% similar to S.typhimurium NtrC Core PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
PF07728 
AAA_5, 
ATPase 
family 
associated 
with various 
cellular 
activities 
(AAA) 
PF00158; 
PF00072 
Sigma-54 
interactio
n domain;    
Response 
regulator 
receiver 
domain 
PA5166  462  
67% similar to C4-dicarboxylate transport 
system regulatory protein DctD [Rhizobium 
meliloti] 
Core PF00072 
Response 
regulator 
receiver 
domain 
PF00158 
Sigma-54 
interaction 
domain   
PA5483 AlgB 449   
100% similar to AlgB [Azotobacter vinelandi]; 
97% response regulator Desulfomicrobium 
baculatum DSM 4028] 
Core PF02954 
HTH_8, 
Bacterial 
regulatory 
protein, Fis 
family 
PF00158 
Sigma-54 
interaction 
domain 
PF00072 
Response 
regulator 
receiver 
domain 
PA5511 MifR 447   69% similar to DctD gene product [R. meliloti] Core PF00158 
Sigma-54 
interaction 
domain 
PF00072 
Response 
regulator 
receiver 
domain 
    
GntR                       
PA0120  228 FadR 
45% similar to putative transcriptional 
regulator LldR [Escherichia coli]; Part of two 
gene operon 
Core PF07729 FCD, FCD domain.     
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PA0121   244 FadR 44% similar to hypothetical transcriptional regulator [Streptomyces ambofaciens] Core PF07729 
FCD, FCD 
domain.         
PA0253  158 MarR 
55% similar to MarR regulator [Salmonella 
typhimurium] Core PF01047  MarR family     
PA0275   228 GntR 48% similar to hypothetical protein Rv3676 [Mycobacterium tuberculosis] Core PF00027 
cNMP_bindin
g, Cyclic 
nucleotide-
binding 
domain. 
        
PA0424 MexR 147 MarR 48% similar to HosA protein [Escherichia coli] Core PF01047  MarR family     
PA0487   252   54% similar to molybdate uptake regulatory protein ModE [Escherichia coli] Core PF03459 
 TOBE 
domain to 
bind ligands 
PF00126 HTH_1 PF03459 TOBE 
PA0797  240 FadR 
48% similar YdhC protein [[Bacillus 
subtilis]];  3 gene operon, Ist gene, the other 
two genes are involved in citrate synthase 
activity 
Core PF07729 FCD, FCD domain.     
PA0942   186 MarR 51% similar to a region of regulatory protein PecS [Erwinia chrysanthemi] Core PF01047  MarR family         
PA1142  238 HutC 
65% similar to PhnR, probable repressor 
protein in phnXWRSTUV locus for uptake and 
metabolism of 2-aminoethylphosphonate 
[Salmonella typhimurium] 
Core PF07702 UTRA, UTRA domain.     
PA1269   222 FadR 44% similar to putative transcriptional regulator [Streptomyces coelicolor] Core PF07729 
FCD, FCD 
domain.         
PA1285  149 MarR 
56% similar to hypothetical protein 
Rv1049[Mycobacterium tuberculosis] Core PF01047  MarR family     
PA1374   168 GntR superfamily 
51% similar to hypothetical protein Rv3095 
[Mycobacterium tuberculosis] Core PF01638 
  HxlR-like 
HTH 
Weak 
MarR       
PA1467  323  
52% similar to putative repressor 
[Streptomyces peucetius] Core       
PA1490   258   59% similar to repressor GlpR [Pseudomonas aeruginosa] Core             
PA1520  259 FadR 
48% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core PF07729 
FCD, FCD 
domain.     
PA1526   219 GntR superfamily 
46% similar to hypothetical protein 
[Escherichia coli]; 1st gene in a 2-gene operon 
(2nd gene - Hypo) 
Core   
No discernible 
second 
domain 
        
PA1603  140 MarR 
50% similar to HosA protein [Escherichia 
coli] Core PF01047  MarR family     
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PA1627   215 FadR 
70% similar to unknown ORF [Pseudomonas 
marginalis pv. alfalfae]; 1st gene in a 2-gene 
operon; the other gene is probable major 
facilitator superfamily (MFS) transporter 
Core PF07729 FCD, FCD domain.         
PA1653  158 MarR 
61% similar to PetP protein Rhodobacter 
capsulatus Core PF01047  MarR family     
PA2032 YjiR 474 MocR 72% similar to putative regulator YjiR [Escherichia coli] 
RGP 
20 PF00155 
Aminotransfer
ase class I and 
II. 
        
PA2100  477 MocR 
49% similar to hypothetical transcriptional 
regulator [Rhodobacter sphaeroides]; Human 
homolog 
RGP 
21 PF00155 
Aminotransfer
ase class I and 
II.     
PA2299   249 HutC 
53% similar to putative transcriptional 
regulator YvoA [[Bacillus subtilis]]; 3rd gene 
in a 3-gene operon ; The other two code for 
probable ferridoxin and oxidoreductase 
Core PF07702 UTRA, UTRA domain.         
PA2320 GntR,  GnuR 343  56% similarity to GntR [Escherchia coli] Core PF00532 
Peripla_BP_1, 
Periplasmic 
binding 
proteins and 
sugar binding 
domain of the 
LacI family. 
    
PA2692   174 Rrf2 subfamily 
55% similar to hypothetical protein [Bacillus 
halodurans]; Homologous to NsrR 
[Pectobacterium carotovorum subsp. 
carotovorum PC1] 
Core PF02082 
Rrf2, 
Transcriptiona
l regulator. 
        
PA2802  239 HutC 
56% similar to probable repressor protein 
PhnR [Salmonella typhimurium] Core PF07702 
UTRA, UTRA 
domain.     
PA2825 OspR 163 MarR 69% similar to hypothetical protein [Acinetobacter sp. ADP1] Core PF01047  MarR family         
PA2849 OhrR 151 MarR 74% similar to hypothetical protein [Acinetobacter sp. ADP1] Core PF01047  MarR family     
PA2897  479 MocR 
59% similar to putative regulator YjiR 
[Escherichia coli]; Human Homolog;  Core PF00155 
Aminotransfer
ase class I and 
II.     
PA3067   147 MarR 50% similar to hypothetical protein Rv0880 [Mycobacterium tuberculosis]   PF01047  MarR family         
PA3249  298 HutC 
60% similar to regulator PhnR [Salmonella 
typhimurium] Core PF07702 
UTRA, UTRA 
domain.     
PA3341   144 MarR 62% simialr to transcriptional regulator SlyA [Salmonella typhimurium] Core PF01047  MarR family         
PA3381 PhnF 240 HutC 58% similar to PhnF protein [Escherichia coli]; 10th gene in a 13-gene operon Core PF07702 
UTRA, UTRA 
domain.     
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PA3458   157 MarR 48% similar to transcriptional regulator YkoM [[Bacillus subtilis]] Core PF01047  MarR family         
PA3583 GlpR 251 Core 
PA3757   247 HutC 
55% similar to putative transcriptional 
regulator YvoA [[Bacillus subtilis]]; First gene 
in a 5-gene operon involved in N-
acetylglucosamine catabolism 
Core PF07702 UTRA, UTRA domain.         
PA3815 IscR 163 Rrf2 subfamily 
84% similar to unknown hypothetical protein 
[A. vinelandii]  Core PF02082 
 Rrf2, 
Transcriptiona
l regulator     
PA4132   471 MocR 64% similar to putative transcriptional regulator [Escherichia coli] Core PF00155 
Aminotransfer
ase class I and 
II. 
        
PA4135  140 MarR 
73% similar to homoprotocatechuate 
degradation operon regulator HpcR 
[Escherichia coli] 
Core PF01047  MarR family     
PA4165   496 MocR 
53% similar to putative regulatory protein 
MocR [Rhizobium leguminosarum bv. viciae]; 
Human Homolog 
Core PF00155 
Aminotransfer
ase class I and 
II. 
        
PA4169  142 
Rrf2 
subfamily 
57% similar to hypothetical protein YwnA 
[Bacillus subtilis] Core PF02082 
 Rrf2, 
Transcriptiona
l regulator     
PA4185   242 FadR 47% similar to putative transcriptional regulator [Streptomyces coelicolor] Core PF07729 
FCD, FCD 
domain.         
PA4764 Fur 134 GntR superfamily 
77% similar to Regulatory protein Fur 
[Escherichia coli] Core PF01475 
 FUR, Ferric 
uptake 
regulator 
family 
    
PA4769 LldR 257 FadR 
66% similar to transcriptional regulator for 
pyruvate dehydrogenase complex PdhR 
[Escherichia coli] 
Core PF07729 FCD, FCD domain.         
PA4906 VanR 237 FadR 
66% similar to hypothetical protein AF009672 
[Acinetobacter sp. ADP1]; Part of a 2-gene 
operon, upstream gene is a probable 
dehydogenase 
Core PF07729 FCD, FCD domain.     
PA5105 HutC 250 HutC 
94% similar to hutC gene product of 
Pseudomonas putida; 1st gene in a 2-gene 
operon (2nd gene - Hypo) 
Core PF07702 UTRA, UTRA domain.         
PA5157 MarR 156 MarR 60% similar to MarR protein  [Escherichia coli] Core PF01047  MarR family     
PA5283   458 MocR 48% similar to putative transcriptional regulator [Bacillus subtilis] (Human homolog) Core PF00155 
Aminotransfer
ase class I and 
II. 
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PA5356 GlcC 251 FadR 
78% similar to GlcC protein [Escherichia 
coli]; 1st gene in a 3-gene operon;  2nd-Hyp 
and 3rd-  4-hydroxybenzoate-octaprenyl 
transferase  
Core PF07729 FCD, FCD domain.     
PA5431   491 MocR 
52% similar to hypothetical regulator MocR 
[Rhizobium meliloti]; 1st gene in a 2-gene 
operon (2nd gene - Hypo) 
Core PF00155 
Aminotransfer
ase class I and 
II. 
        
PA5499 Np20 167  
54% similar to zinc-uptake regulator Zur 
[Escherichia coli]; PMID: 8971720;  1st gene 
in a 3-gene operon;  2nd & 3rd involved in Zn 
tranport 
Core PF01475 
FUR, Ferric 
uptake 
regulator 
family. 
    
PA5525   246 FadR 
49% similar to nta operon transcriptional 
regulator [Escherichia coli]; 2nd gene in a part 
of 2-gene operon; downstream gene is a 
probable short-chain dehydrogenase 
Core PF07729 FCD, FCD domain.         
PA5550 GlmR 257  
60% similar to regulator for glucitol operon, 
SrlR [Escherichia coli] Core       
PA0268   473 MocR 
55% similar to putative regulatory protein 
MocR [Rhizobium leguminosarum bv. viciae]: 
Has a human homolog 
Core PF00155 
Aminotransfer
ase class I and 
II. 
        
H-NS (silencing)               
PA2667 MvaU 117  
64% similar to P16 subunit of heteromeric 
transcriptional activator MvaT [Pseudomonas 
mevalonii] 
Core       
PA4315 MvaT 124   
82% similar to heteromeric transcriptional 
activator MvaT P16 subunit [Pseudomonas 
mevalonii] 
Core PB003306 Pfam-B_3306 
PF00816
.14 
Histone_HN
S     
IclR                       
PA0155 PcaR 279  
88% similar to regulatory protein PcaR 
[Pseudomonas putida] other       
PA0236   259   49% similar to repressor protein IclR [Escherichia coli] Core             
PA1015  266  
42% similar to glycerol operon regulatory 
protein GylR [Streptomyces coelicolor] Core       
PA1630   288   58% similar to hypothetical protein [Bordetella pertussis] Core             
PA2010  267  
49% similar to putative transcriptional 
regulatory protein OhbR [Pseudomonas 
aeruginosa] 
Core       
PA3174   242   0 Core             
PA3508  277  
57% similar to hypothetical protein 
[Acinetobacter sp. ADP1] RGP34       
  306
PA4157   262   
51% similar to putative transcriptional 
regulatory protein OhbR [Pseudomonas 
aeruginosa] 
Core             
PA4341   256   45% similar to transcriptional regulator for mhp operon [Escherichia coli] Core             
LacI/GalR               
PA1949 RbsR 337  
62% similar to regulator for rbs operon RbsR 
[Escherichia coli] Core       
PA2259 PtxS 340   0 Core             
PA3184 HexR 285  
76% similar to HexR protein [Escherichia 
coli] Core PF01418   RpiR family PF01380 
 SIS (Sugar 
ISomerase) 
domain   
PA3563 FruR 329   62% similar to transcriptional repressor of fru operon FruR [Escherichia coli] Core             
PA4596  172  
74% similar to nfxB gene product of 
[Pseudomonas aeruginosa] Core       
PA4600 NfxB 187   95% similar to nfxB (excluding frameshift) [P. aeruginosa] Core             
PA5438   293   63% similar to putative regulator HexR [Pseudomonas aeruginosa] Core PF01418   RpiR family PF01380 
 SIS (Sugar 
ISomerase) 
domain 
    
LuxR                       
PA0034  207  
75% similar to BvgA positive transcription 
regulator, putative [Bordetella pertussis] ; Core PF00072 
Response 
regulator PF00196 GerE   
PA0533   496   
44% similar to a region of putative sensory 
transduction histidine kinase 
[Methanobacterium thermoautotrophicum] 
Core PF00196 GerE PF00989 PAS 
PF08448; 
PB00136
0; 
PB00254
6 
PAS_4;      
Pfam-
B_1360; 
Pfam-
B_2546 
PA0601  210  
66% similar to VsrD protein [Burkholderia 
solanacearum] Core PF00072 
Response 
regulator PF08266 GerE 
PB00104
1 
Pfam-
B_1041 
PA1136   243   42% similar to transcriptional activator LasR [Pseudomonas aeruginosa] Core PF03472 
Autoinducer 
binding PF00196 GerE     
PA1347  230  
65% similar to a region of putative regulator 
FimZ [Salmonella typhimurium] Core PF00196 GerE PF08448 PAS_4   
PA1397   210   
56% similar to nitrate/nitrite response 
regulator NarP (sensor NarQ) [Escherichia 
coli] 
Core PF00072 Response regulator PF00196 GerE     
PA1430 LasR 239  
100% identical to transcription activator LasR 
[Pseudomonas aeruginosa] Core PF03472 
Autoinducer 
binding PF00196 GerE   
  307
PA1484   268   50% similar to DMSO reductase regulatory protein DorX [Rhodobacter sphaeroides] Core PF00196 GerE 
PB0001
46 Pfam-B_146     
PA1759  901  
44% similar to regulator AcoK [Klebsiella 
pneumoniae] Core PF00196 GerE 
PB0082
87 
Pfam-
B_8287   
PA1760   907   44% similar to regulator AcoK [Klebsiella pneumoniae] Core PF00196 GerE 
PB0014
29 
Pfam-
B_1429 
PB00828
7 
Pfam-
B_8287 
PA1898 QscR, PhzR 237  
29% identity, 46% similarity to LasR 
[Pseudomonas aeruginosa] ;27% identity, 
45% similarity to LuxR [Vibrio fischeri] ; 33% 
identity, 49% similarity to SolR [Ralstonia 
solanacearum] ; 49% similar to positive 
regulatory protein PhzR [Pseudomonas 
aureofaciens]; 53% similar, 32% identity to 
regulatory protein RhlR [Pseudomonas 
aeruginosa] 
Core PF03472 Autoinducer binding PF00196 GerE   
PA1978 ErbR, AgmR 221   
100% identical to agmR gene product of [P. 
aeruginosa] Core PF00072 
Response 
regulator PF00196 GerE     
PA1980 EraR, ExaE 225  
57% similar to uhpA gene product of 
[Salmonella typhimurium] Core PF00072 
Response 
regulator PF00196 GerE   
PA2376   213   54% similar to nitrate/nitrite regulatory protein NarL [Pseudomonas aeruginosa] Core PF00072 
Response 
regulator PF00196 GerE     
PA2586 GacA 214  
99% similar to response regulator GacA 
[Pseudomonas aeruginosa] Core PF00072 
Response 
regulator PF00196 GerE 
PB00064
5 
Pfam-
B_645 
PA2591 VqsR 268   46% similar to DMSO reductase regulatory protein DorX  [Rhodobacter sphaeroides] Core PF00196 GerE 
PB0001
46 Pfam-B_146     
PA2899  212  
53% similar to biosynthesis positive regulator 
RcsB [Escherichia coli] Core PF00072 
Response 
regulator PF00196 GerE   
PA3045   207   77% similar to putative transcription regulator BvgA [Bordetella pertussis] Core PF00072 
Response 
regulator PF00196 GerE     
PA3420  827   Core PF00196 GerE 
PB0103
63 
Pfam-
B_10363   
PA3477 RhlR 241     Core PF03472 Autoinducer binding PF00196 GerE     
PA3599  261  
47% similar to dorX gene product of 
[Rhodobacter sphaeroides] Core PF00196 GerE 
PB0001
46 Pfam-B_146 
PB00064
5 
Pfam-
B_645 
PA3604 ErdR 217   61% similar to glycerol metabolism activator (AGMR protein) [P. aeruginosa] Core PF00072 
Response 
regulator PF00196 GerE     
PA3714  213  
62% similar to RcsB protein [Erwinia 
amylovora] Core PF00072 
Response 
regulator PF00196 GerE   
PA3771   325   54% similar to a region of putative regulatory protein [Streptomyces coelicolor] Core PF00196 GerE 
PB0050
70 
Pfam-
B_5070     
PA3879 NarL 219 74% similar to E. coli NarL protein. Core PF00072 Response PF00196 GerE 
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regulator 
PA3921   906   42% similar to regulator AcoK [Klebsiella pneumoniae] Core PF00196 GerE 
PB0014
29 
Pfam-
B_1429 
PB00142
9; 
PB00455
0; 
PB00952
5; 
PB01036
3 
Pfam-
B_1429; 
Pfam-
B_4550; 
Pfam-
B_9525; 
Pfam-
B_10363 
PA3948 RocA1 209  
74% similar to bvgA gene product of 
[Bordetella pertussis] Core PF00072 
Response 
regulator PF00196 GerE   
PA4074   222   54% similar to regulator protein MoaR [Klebsiella aerogenes] Core PF03472 
Autoinducer 
binding PF00196 GerE 
PB00014
6 
Pfam-
B_146 
PA4080 RcsB 214  
63% similar to rcsB gene product of 
[Escherichia coli] Core PF00072 
Response 
regulator PF00196 GerE   
PA4196 bfiR 214   62% similar to transcriptional regulatory protein FixJ [Azorhizobium caulinodans]  Core PF00196 
GerE, 
Bacterial 
regulatory 
proteins, luxR 
family 
PF08281 
Sigma70_r4
_2, Sigma-
70, region 4 
PF00072 
Response 
regulator 
receiver 
domain 
PA4296 PprB 275  
54% similar to NtrC-type response regulator 
[Eubacterium acidaminophilum] ; 43% similar 
to regulatory components ofsensory 
transduction system Synechocystis sp. 
Core PF00072 Response regulator PF00196 
GerE, 
Bacterial 
regulatory 
proteins, 
LuxR 
family 
  
PA4806   227   46% similar to DMSO reductase regulatory protein DorX [Rhodobacter sphaeroides] Core PF00196 GerE         
LysR                       
PA0032  304  
49% similar to glycine cleavage system 
transcriptional activator protein GcvA 
[Escherichia coli] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA0037 TrpI 295   97% similarity to TrpI protein [Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0056  306  
55% similar to regulator GstR [Rhizobium 
leguminosarum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0123   302   51% similar to transcriptional activator PtxR [Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0133  305  
47% similar to transcriptional regulator OxyR 
[Mycobacterium xenopi] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0152 PcaQ 275   56% similar to regulatory protein PcaQ [Agrobacterium tumefaciens] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
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PA0159  312  
52% similar to regulator GstR 
[Bradyrhizobium japonicum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0181   310   48% similar to putative transcriptional regulator YeaT [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0191  305  
59% similar to transcriptional control factor 
SdsB Pseudomonas sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0207   297   51% similar to glycine cleavage activator protein GcvA [Escherichia coli] RGP 1 PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0217 MdcR 309  
65% similar to malonate decarboxylase operon 
regulator MdcR [Klebsiella pneumoniae] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0218   306   49% similar to putative transcriptional regulator YvbU [[Bacillus subtilis]] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0233  313  
61% similar to putative transcriptional 
regulator [Rhizobium leguminosarum bv. 
trifolii] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA0272   310   44% similar to MexT protein [Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0289 GpuR 320  
39% similar to LysR-type regulatory protein 
[Comamonas sp. JS765] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0448   302   55% similar to GcvA gene product of E. coli. Core PF00126 HTH_1 PF03466 LysR_substrate     
PA0477  308  
47% similar to DNA-binding protein NahR 
Pseudomonas putida ; 48% similar to MexT 
protein [Pseudomonas aeruginosa] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA0479   316   46% similar to putative transcriptional regulator YhaJ [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0491  308  
46% similar to oxidative stress transcriptional 
regulator OxyR [Xanthomonas campestris] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0528   292   49% similar to positive regulator CynR [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0701  328  
43% similar to iron-regulated virulence 
regulator [Vibrio cholerae] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0708   284   53% similar to putative transcriptional regulator YneJ [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA0739  304  
75% similar to SdsB (regulator of sdsA) 
Pseudomonas sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0784   309   
50% similar to glycine cleavage system 
transcriptional activator GcvA [Haemophilus 
influenzae Rd] 
Core PF00126 HTH_1 PF03466 LysR_substrate     
PA0815  317  
46% similar to putative transcriptional 
regulator YjiE [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
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PA0816   294   
60% similar to Brg1 [Bordetella pertussis], a 
transcriptional regulator that is controlled by 
the oxygen-responsive transcriptional regulator 
Btr under anaerobic conditions. 
Core PF00126 HTH_1 PF03466 LysR_substrate     
PA0876  314  
54% similar to putative transcriptional 
regulator Synechocystis sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA0877   298   60% similar to hypothetical protein [Acinetobacter lwoffii K24] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1003 MvfR, PqsR 332  
99% identical to previously identified 
hypothetical protein [Pseudomonas 
aeruginosa] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA1067   304   54% similar to regulator GstR [Bradyrhizobium japonicum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1128  303  
60% similar to YcaN, hypothetical 
transcriptional regulator [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1138   291   49% similar to transcription activator [Azospirillum brasilense] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1141  300  
51% similar to probable transcriptional 
regulator LrhA [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1145   300   40% similar to positive transcriptional control factor SdsB Pseudomonas sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1184  296  
59% similar to glycine cleavage activator 
protein GcvA [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1201   304   60% similar to putative transcriptional regulator Synechocystis sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1223  297  
53% similar to regulator SyrM1 [Rhizobium 
sp. NGR234] 
RGP 
11 PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1264   288   47% similar to regulator HexA [Erwinia carotovora subsp. carotovora] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1309  286  
52% similar to putative transcriptional 
regulator YwfK [[Bacillus subtilis]] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1312   303   57% similar to PtxR [Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1328  302  
55% similar to a region of putative 
transcriptional regulator YcaN [Escherichia 
coli] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA1399   306   49% similar to putative regulatory protein [Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1413 YneJ 290  
69% similar to putative transcriptional 
regulator YneJ [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1422 GbuR 297   49% similar to regulatory protein cfxR [Alcaligenes eutrophus] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
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PA1570  293  
54% similar to transcriptional regulator protein 
RbcR [Chromatium vinosum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1738   304   62% similar to putative transcriptional regulator YcaN [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1754 CysB 324   Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA1826   301   
50% similar to regulator of catechol 
degradation (CatM) [Acinetobacter 
calcoaceticus] 
  PF00126 HTH_1 PF03466 LysR_substrate     
PA1853  287  
80% similar to ORF286, hypothetical protein 
in the 30-kb denitrification gene cluster 
[Pseudomonas stutzeri] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA1859   295   69% similar to putative transcriptional regulator YafC [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1915 515 Core PF07905 PucR 
PA1961   311   50% similar to putative transcriptional regulator YafC [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA1998 DhcR 306  
52% similar to ybhD, yfeR, and yfhT 
hypothetical transcriptional regulatory proteins 
[Escherichia coli] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA2054 CynR 295   66% similar to cynR gene product of [Escherichia coli] 
RGP 
20 PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2056  300  
54% similar to regulator GstR 
[Bradyrhizobium japonicum] 
RGP 
20 PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2076   300   44% similar to putative LysR-type transcriptional regulator Pseudomonas putida Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2115  317  
47% similar to putative transcriptional 
regulator YrdL [[Bacillus subtilis]] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2121   301   50% similar to transcriptional activator nahR of [Pseudomonas putida-plasmid] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2123  310  
55% similar to putative transcriptional 
regulator YhcS [Haemophilus influenzae Rd] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2206   315   54% similar to galactose binding protein regulator [Azospirillum brasilense] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2220 OprR 306  
Identical to putative transcriptional regulator 
OprR [Pseudomonas aeruginosa] 
RGP 
23 PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2258 PtxR 312     Core PF00126 HTH_1 PF03466 LysR_substrate     
PA2267  298  
45% similar to putative transcriptional 
activator MauR [Paracoccus denitrificans] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2316   297   55% similar to hypothetical yafC gene product of [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
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PA2334  303  
56% similar to positive transcriptional control 
factor SdsB Pseudomonas sp. 
RGP 
53 PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2383   306   50% similar to positive regulator of gcv operon GcvA [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2417  312  
53% similar to transcriptional regulator PtxR 
[Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2432 BexR 304   55% similar to putative transcriptional regulator Synechocystis sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2447  307  
51% similar to hypothetical protein 
[Haemophilus influenzae] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2469   304   52% similar to galactose binding protein regulator [Azospirillum brasilense] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2492 MexT 347  
100% similar to a region of MexT protein 
[Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2497   292   52% similar to transcriptional regulator HexA [Erwinia carotovora subsp. atroseptica] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2510 CatR 290  
81% similar to catR regulatory protein 
Pseudomonas putida Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2534   303   58% similar to putative transcriptional regulator YhjC [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2547  305  
56% similar to regulator GstR 
[Bradyrhizobium japonicum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2551   310   54% similar to transcriptional activator NahR [Pseudomonas putida plasmid NAH7] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2601  298  
46% similar to activator, hydrogen peroxide-
inducible genes, OxyR [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2681   309   53% similar to regulator PtxR [Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2758  295  
46% similar to DNA binding protein HpkR 
[Pseudomonas syringae pv. syringae] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2834  319  
47% similar to putative regulatory protein 
[Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2838   323   53% similar to regulator GstR [Bradyrhizobium japonicum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2846  284  
56% similar to 2,2-dialkylglycine 
decarboxylase repressor protein [Burkholderia 
cepacia] 
Core PF00126 HTH_1 PF03466 LysR_substrate   
PA2848   339   49% similar to regulator GstR [Bradyrhizobium japonicum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2877  297  
62% similar to putative transcriptional 
regulator YhjC [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
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PA2879 HpkR 296   74% similar to putative DNA binding protein HpkR [Pseudomonas syringae pv. syringae] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA2921  329  
50% similar to regulator TsaR [Comamonas 
testosteroni] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA2930   308   52% similar to putative regulatory protein TrpI Pseudomonas syringae Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3122 YibL 297  
93% similar to hypothetical gene product YibL 
[Azotobacter vinelandii] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3124   303   59% similar to hypothetical gene product YafC [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3135  306  
55% similar to putative transcriptional 
regulator Synechocystis sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3225   309   48% similar to putative transcriptional regulator Yeey [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3321  304  
52% similar to regulatory protein MexT 
[Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3398   308   59% similar to putative transcriptional regulator YeiE [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3433 YwbI 297  
59% similar to putative transcriptional 
regulator YwbI [[Bacillus subtilis]] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3565   306   50% similar to GstR [Rhizobium leguminosarum] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3587 MetR 306  
63% similar to regulator MetR [Escherichia 
coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3594   295   55% similar to putative transcriptional regulator YnfL [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3630  302  
53-56% similar to numerous transcriptional 
regulators Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3711   301   43% similar to putative transcriptional regulator YgiP [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3776  302  
52% similar to regulator BudR [Klebsiella 
terrigena] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3778   311   46% similar to regulator CbbRI [Rhodobacter capsulatus] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3845  298  
52% similar to positive regulator GcvA 
[Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA3895   317   55% similar to putative transcriptional regulator Synechocystis sp. Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA3995  297  
51% similar to the HexA gene product of 
[Erwinia carotovora subsp. atroseptica] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA4109 AmpR 296     Core PF00126 HTH_1 PF03466 LysR_substrate     
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PA4145  296  
48% similar to transcriptional activator PtxR 
[Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA4174   307   55% similar to putative transcriptional regulatorYhjC [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA4203  284  
61% similar to putative transcriptional 
regulator YneJ [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA4363 IciA 300   56% similar to inhibitor of chromosome initiaton IciA [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA4902  298  
51% similar to putative regulatory protein 
[Pseudomonas stutzeri] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA4914   312   53% similar to positive regulator GcvA [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA4989  294  
46% similar to DNA binding protein HpkR 
[Pseudomonas syringae pv. syringae] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA5029 YnfL 301   72% similar to putative transcriptional regulator YnfL [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA5085  318  
47% similar to regulatory protein LysR 
[Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA5179   293   
47% similar to putative LysR-type 
transcriptional regulator [Mycobacterium 
leprae] 
Core PF00126 HTH_1 PF03466 LysR_substrate     
PA5189  302  
51% similar to putative regulatory protein 
[Pseudomonas aeruginosa] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA5218   304   57% similar to hypothetical ynfL gene product of [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA5293  305  
53% similar to positive regulator GcvA 
[Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA5344 OxyR 310   60% similar to oxyR gene product of [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA5382 YeiE 297  
64% similarity to putative transcriptional 
regulator YeiE [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA5428   302   56% similar to putative transcriptional regulator YjiE [Escherichia coli] Core PF00126 HTH_1 PF03466 
LysR_substr
ate     
PA5437  311  
62% similar to regulator CbbRI [Rhodobacter 
capsulatus] Core PF00126 HTH_1 PF03466 
LysR_substr
ate   
PA5261 AlgR 248   
88% similar to encystment and alginate 
biosynthesis regulatory protein [Azotobacter 
vinelandii] 
Core PF00072 
Response 
regulator 
receiver 
domain 
PF04397 
LytTR, 
LytT DNA-
binding 
domain 
    
MerR                       
  315
PA2016 LiuR, GnyR 134  
85% identical to transcriptional regulator, 
putative [P. putida KT2440] ; 59% similar to 
putative transcriptional regulator YbbI 
[Escherichia coli] 
Core PF00376 MerR PF09278 MerR-DNA-bind   
PA2273 SoxR 156   
Identical to unpublished SoxR of P. 
aeruginosa (gi|2495412|sp|Q51506|) ; 77% 
similar to SoxR gene product of [Escherichia 
coli] 
Core PB000200 Pfam-B_200 PF00376 MerR 
PB01600
9; 
PF09278 
Pfam-
B_16009; 
MerR-
DNA-
binding 
PA2718  162  
52% similar to putative transcriptional 
regulator YbbI [Escherichia coli] Core PF00376 MerR PF09278 
MerR-
DNA-bind   
PA3689 YhdM 156   66% similar to putative regulatory protein YhdM [Haemophilus influenzae] Core PF00376 MerR PF09278 
MerR-
DNA-bind     
PA4659  299  
47% similar to putative transcriptional 
regulator YcgE [Escherichia coli] Core 
PB00020
0 Pfam-B_200 PF00376 MerR   
PA4778 CueR, YbbI 132   
65% similar to putative transcriptional 
regulator YbbI [Escherichia coli] Core PF00376 MerR PF05103 DivIVA PF09278 
MerR-
DNA-
binding 
PA4878  270  
47% similar to a region of multi-drug efflux 
transporter regulator TipA [Streptomyces 
lividans] 
Core PF00376 MerR PF06445 
AraC-
binding 
domain   
PA5116   141   49% similar to activator SoxR [Escherichia coli] Core PF00376 MerR PF09278 
MerR-
DNA-bind     
OmpC family               
PA5200 AmgR 247   OmpR similar E.coli Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
    
OmpR-PhoP class               
PA4032  238  
52% similar to hypothetical protein Rv1033c 
(response regulator homolog TrcR) 
[Mycobacterium tuberculosis]; 51% similar to 
phosphate regulatory protein PhoB 
[Bradyrhizobium japonicum] 
 PF0072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
  
PA4381   227   91% similar to ColR [Pseudomonas fluorescens] Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
    
RpiR                       
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PA5506   285   44% similar to RpiR protein [Escherichia coli] Core PF01418   RpiR family PF01380 
 SIS (Sugar 
ISomerase) 
domain 
    
TetR                       
PA0167  221  
60% similar to putative regulator YcdC 
[Escherichia coli] Core PF08362  
TetR_C_3, 
YcdC-like 
protein, C-
terminal 
region 
    
PA0243   222   
44% similar to putative transcriptional 
regulator [Methanobacterium 
thermoautotrophicum] 
Core PF00440  
TetR_N, 
Bacterial 
regulatory 
proteins, tetR 
family  
        
PA0294 AguR 221  
49% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core PF00440  
TetR_N, 
Bacterial 
regulatory 
proteins, tetR 
family  
    
PA0367   215   53% similar to hypothetical protein Pseudomonas putida Core             
PA0436  206  
54% similar to putative tet operon regulator 
YcdC [Escherichia coli] Core PF08362 
TetR_C_3, 
YcdC-like 
protein, C-
terminal 
region 
    
PA0475   189   47% similar to hypothetical protein Rv0196 [Mycobacterium tuberculosis] Core             
PA0828  227  
50% similar to a region of putative 
transcriptional regulator [Aquifex aeolicus] Core       
PA0839   196   48% similar to hypothetical protein [Escherichia coli] Core             
PA1226  202  
45% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core       
PA1241   186   46% similar to hypothetical protein YxaF [Bacillus subtilis] Core             
PA1283  186  
48% similar to hypothetical protein 
Synechocystis sp. Core       
PA1290   197   
54% similar to unidentified reading frame L 
(ORFL TetC protein) in transposon Tn10 
[Escherichia coli] 
Core             
PA1315  204  
49% similar to MtrR protein [Neisseria 
gonorrhoeae] Core       
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PA1403   210   43% similar to a region of hypothetical protein Rv1963c [Mycobacterium tuberculosis] Core             
PA1504  216  
57% similar to putative tet operon regulator 
YcdC [Escherichia coli] Core PF08362  
TetR_C_3, 
YcdC-like 
protein, C-
terminal 
region 
    
PA1539   282   53% similar to a region of hypothetical protein YijC [Escherichia coli]   PF00440           
PA1836  193  
45% similar to putative repressor [Bacillus 
megaterium] Core       
PA1864   216   54% similar to putative tet operon regulator YcdC [Escherichia coli] Core PF08362 
TetR_C_3, 
YcdC-like 
protein, C-
terminal 
region 
        
PA2020  210  
72% similar to transcriptional regulator AmrR 
[Burkholderia pseudomallei] Core PF08361 
TetR_C_2, 
MAATS-type 
transcriptional 
repressor, C-
terminal 
region 
     
PA2196   194   63% similar to hypothetical protein [Escherichia coli] Core             
PA2270  196  
52% similar to hypothetical protein 
Synechocystis sp. Core       
PA2484   204   65% similar to SocA3 protein Myxococcus xanthus Core             
PA2766 193 Core 
PA2885 AtuR 198   50% similar to hypothetical protein Rv3557c [Mycobacterium tuberculosis] Core             
PA2931 CifR 196  
63% similar to socA3 protein Myxococcus 
xanthus Core       
PA2957   212   44% similar to putative transcriptional regulator [Streptomyces coelicolor] Core             
PA3006 PsrA 233 90% similar to PsrA Pseudomonas putida Core 
PA3034   185   54% similar to putative transcriptional regulator Streptomyces lividans Core             
PA3133 180 Core 
  318
PA3574 NalD 212   
46% similar to acrR gene product, a probable 
transcriptional regulator from [Escherichia 
coli] 
Core PF08361 
TetR_C_2, 
MAATS-type 
transcriptional 
repressor, C-
terminal 
region 
        
PA3678  212  
47% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core       
PA3699   237   65% similar to a region of hypothetical protein Rv3066 [Mycobacterium tuberculosis] Core             
PA3721 NalC 213  
43% similar to putative transcriptional 
regulator [Streptomyces coelicolor] Core       
PA3973   215   45% similar to hypothetical protein Rv3557c [Mycobacterium tuberculosis] Core             
PA4831  186  
54% similar to a region of acrAB operon 
repressor AcrR [Escherichia coli] Core       
PA4890 DesT 209   52% similar to hypothetical protein YijC [Escherichia coli] Core             
PA4984  215  
46% similar to regulatory protein BetI 
[Escherichia coli] Core       
PA5059   205   
86% similar to PhaD [Pseudomonas sp.]; 99% 
similar to hypothetical protein 3 (phaC2 3' 
region) 
Core             
PA5374 BetI 197 71% similar to E. coli betI gene product Core 
CRP                       
PA0652 Vfr 214   Core PF00325 Crp 
PF00027
.22 
cNMP_bind
ing   
PA1544 Anr 244   100% identical to transcriptional activator Anr [Pseudomonas aeruginosa] Core PF00325 Crp 
PF00027
.22 
cNMP_bind
ing     
Unclassified                 
PA0116  157  
65% similar to hypothetical protein Rv3095 
[Mycobacterium tuberculosis] Core 
PF01638
.10 HxlR     
PA0463 CreB 229   
68% similar to E. coli catabolic regulation 
response regulator creB gene product ; 71% 
similar to Aeromonas jandaei response 
regulator protein 
Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
    
PA0527 Dnr 227  
100% identical to Dnr protein [Pseudomonas 
aeruginosa] Core PF00027 
cNMP_bindin
g     
PA0610 PrtN 104     Core PF11112.1 
PyocinActivat
or         
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PA0707 ToxR, RegA 259  
99% identity to ToxR (exotoxin A regulatory 
protein) [P. aeruginosa] Core PF07720 
TPR_3, 
tetratricopepti
de repeat     
PA0756   223   
72% similarity to trans-activating 
transcriptional regulatory protein tctD 
[Salmonella typhimurium] 
Core PF00486   PF00072 
Response 
regulator 
receiver 
domain 
    
PA0929  239  
53% similar to Response-regulator BaeR 
protein [Escherichia coli]; 64% similar to PfeR 
protein [Pseudomonas aeruginosa] 
Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
  
PA1157   236   
63% similar to transcriptional regulatory 
protein RstA (RstB sensor) [Escherichia coli] ; 
64% similar to response regulator OmpR 
(sensor, EnvZ) 
Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
    
PA1179 PhoP 225  
71% similar to regulatory protein PhoP 
[Salmonella typhimurium] ; 62% similar to 
trans-activating protein tctD [Salmonella 
typhimurium] 
Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
  
PA1431 RsaL 80     ??             
PA1437  229  
81% similar to transcriptional activator protein 
CzcR [Ralstonia eutropha] ; 74% similar to 
transcriptional activator protein CopR 
[Pseudomonas syringae] 
Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
  
PA1607   146   60% similar to hypothetical protein Rv3095[Mycobacterium tuberculosis] Core 
PF01638
.10 HxlR         
PA1637 KdpE  230 69% similar to kdpE gene product of [E. coli]  PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
  
PA1704 PcrR 144   
64% similar to LcrR [Yersinia enterocolitica] ; 
99% similar to PcrR [Pseudomonas 
aeruginosa] ; 64% similar to low calcium 
response locusprotein LcrR [Yersinia pestis] 
Core PF09621.3 LcrR         
PA1799 ParR 235  64% similar to RstA [Escherichia coli] Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
  
PA2479   226   
64% similar to putative 2-component 
transcriptional regulator YgiX [Escherichia 
coli] 
Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
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PA2523  224  
75% similar to regulator protein CzcR 
[Ralstonia eutropha] Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
  
PA2572   447   
57% similar to a region of putative DNA-
binding protein HupR1 Rhodobacter 
capsulatus 
Core PF00072 
Response 
regulator 
receiver 
domain 
        
PA2657  223  
62% similar to putative 2-component 
transcriptional regulator YgiX [Escherichia 
coli] 
Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
  
PA2686 PfeR 305   PfeR activator of the ferric enterobactin receptor (PfeA) Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
    
PA2713  159  
61% similar to hypothetical protein Rv3095 
[Mycobacterium tuberculosis] Core 
PF01638
.10 HxlR     
PA2736   117     RGP 28 
PF01047
.15 MarR         
PA2809 CopR 226  
82% similar to transcriptional activator CopR 
Pseudomonas syringae Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
  
PA2881                       
PA3007 LexA 204  
77% similar to LexA protein [Escherichia 
coli] Core PF01726 
LexA_DNA_b
ind 
PF00717
.16 
Peptidase_S
24   
PA3077   223   68% similar to ColR [Pseudomonas fluorescens] Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
    
PA3192 GltR 242  
99% similar to GltR [Pseudomonas 
aeruginosa] Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
  
PA3204   225   65% similar to E. coli cpxR gene product. Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
    
PA3385 AmrZ 108 Core PF03869 Arc 
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PA3864 DauR 210   44% similar to hypothetical protein [[Streptomyces coelicolor] A3(2)] Core 
PF08348
.4 PAS_6         
PA4057 NrdR, YbaD 154  
82% similar to hypothetical ybaD gene product 
of [Escherichia coli] Core 
PF03477
.9 ATP-cone     
PA4101 BfmR 246   63% similar to glucose uptake regulatory gene glrR [Pseudomonas aeruginosa] 
RGP 
44 PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
    
PA4182  212  
51% similar to hypothetical protein YKL070w 
[Saccharomyces cerevisiae] Core 
PF04299
.5 FMN_bind_2     
PA4776 PmrA 221   
70% similar to putative 2-component 
transcriptional regulator YgiX [Escherichia 
coli] 
Core PF00486 
Transcriptiona
l regulatory 
protein, C 
terminal 
PF00072 
Response 
regulator 
receiver 
domain 
    
PA4885 IrlR 229  
79% similar to IrlR gene product of 
Burkholderia pseudomallei; 81% similar to 
czcR [Ralstonia eutropha]; 78% similar to 
transcriptional activatorprotein CopR 
[Pseudomonas syringae] 
Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
  
PA4983   244   63% similar to DmsR [Rhodobacter sphaeroides] Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
    
PA5360 PhoB 229   96% similar to phoB gene product of [P. aeruginosa] Core PF00072 
Response 
regulator 
receiver 
domain 
PF00486 
Transcriptio
nal 
regulatory 
protein, C 
terminal 
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Supplementary Table 2: Transcription factor interacting partners. Genes that are differentially regulated by each transcriptional 
regulator were identified using the Pseudomonas database (Winsor et al., 2009), published data (Madan Babu et al., 2006) and data 
mining using STRING 8.3 (http://string.embl.de/). The data presented in this table was used as the input data for Cytoscape 
(www.cytoscape.org) to generate Fig 3.2. 
 
ORF # Gene Name 
No. of 
regulated 
genes 
Genes regulated 
 PA0652    vfr 96 PA0066, PA0165, PA0224, PA0265, PA0347, PA0376, PA0551, PA0552, PA0589, PA0653, PA0689, PA0783, PA0836, PA1092, PA1097, PA1183, PA1288, PA1337, PA1384, PA1430, PA1562, PA1580, PA1581, PA1582, PA1583, PA1584, PA1585, PA1586, PA1587, PA1588, PA1589, PA1629, 
 PA1544    anr 77 PA0836, PA1172, PA1173, PA1174, PA1175, PA1176, PA1317, PA1318, PA1319, PA1320, PA1321, PA1337, PA1475, PA1476, PA1477, PA1479, PA1480, PA1481, PA1482, PA1483, PA1546, PA1561, PA1562, PA1581, PA1582, PA1583, PA1584, PA1585, PA1586, PA1588, PA1589, PA1780, 
 PA2738    himA 57 PA0066, PA0353, PA0482, PA0836, PA0888, PA0962, PA0993, PA0994, PA1326, PA1339, PA1376, PA1580, PA1585, PA1586, PA1588, PA1589, PA1629, PA1631, PA1818, PA2634, PA2637, PA2638, PA2639, PA2640, PA2641, PA2642, PA2643, PA2644, PA2645, PA2646, PA2647, PA2648, 
 PA4983      52 PA0265, PA0482, PA0599, PA0854, PA1183, PA1317, PA1318, PA1319, PA1320, PA1321, PA1376, PA1562, PA1580, PA1581, PA1582, PA1583, PA1584, PA1585, PA1586, PA1587, PA1588, PA1589, PA1787, PA2623, PA2634, PA2637, PA2638, PA2639, PA2640, PA2641, PA2642, PA2643, 
 PA3879    narL 37 PA1172, PA1173, PA1174, PA1175, PA1176, PA1475, PA1476, PA1477, PA1479, PA1480, PA1481, PA1482, PA1483, PA1780, PA1781, PA2611, PA2637, PA2638, PA2639, PA2640, PA2641, PA2642, PA2643, PA2644, PA2645, PA2646, PA2647, PA2648, PA2649, PA3724, PA3872, PA3873, 
 PA5308    lrp 36 PA0059, PA0316, PA0353, PA0993, PA0994, PA1070, PA1071, PA1072, PA1073, PA1074, PA1217, PA1326, PA1760, PA2443, PA3118, PA3120, PA3121, PA3167, PA3700, PA3972, PA4097, PA4503, PA4504, PA4505, PA4506, PA4695, PA4696, PA5013, PA5035, PA5036, PA5213, PA5214, 
 PA4853    fis 26 PA1155, PA1156, PA1581, PA1582, PA1583, PA1584, PA1585, PA1586, PA1587, PA1588, PA1589, PA1787, PA1804, PA3769, PA3770, PA4022, PA4343, PA4538, PA4740, PA4741, PA4742, PA4743, PA4744, PA4745, PA4746, PA4852 
 PA5360    phoB 22 PA0688, PA3127, PA3296, PA3372, PA3373, PA3374, PA3375, PA3376, PA3377, PA3378, PA3379, PA3380, PA3381, PA3382, PA3383, PA3384, PA3981, PA4874, PA5361, PA5365, PA5366, PA5367 
 PA1754    cysB 21 PA0280, PA0281, PA0282, PA0932, PA1393, PA1493, PA1756, PA1838, PA2356, PA2357, PA2709, PA3444, PA3540, PA3935, PA3936, PA3937, PA3938, PA4130, PA4442, PA4443, PA4513 
 PA4764    fur 17 PA1165, PA1618, PA1902, PA1922, PA2466, PA2688, PA3899, PA3900, PA4158, PA4159, PA4160, PA4161, PA4228, PA4231, PA4468, PA5521, PA5531 
 PA3563    fruR 16 PA0551, PA0552, PA1376, PA1498, PA1770, PA1780, PA1781, PA2611, PA2623, PA2634, PA3181, PA3194, PA3560, PA3561, PA3562, PA5192 
 PA0893    argR 14 PA0895, PA0896, PA0897, PA0898, PA0899, PA0901, PA2042, PA3068, PA3537, PA3934, PA4976, PA4977, PA5152, PA5170 
 PA3007    lexA 14 PA0576, PA0577, PA0579, PA1886, PA2585, PA3008, PA3138, PA3617, PA4232, PA4234, PA4660, PA4763, PA4821, PA5443 
 PA0253      12 PA0254, PA0272, PA1928, PA1929, PA2002, PA2077, PA2113, PA2965, PA3703, PA3805, PA5237, PA5489 
 PA2510    catR 12 PA2513, PA2518, PA2740, PA3279, PA3280, PA3656, PA4408, PA4417, PA4418, PA4759, PA5045, PA5259 
 PA3898      12 PA0305, PA0854, PA1384, PA1619, PA2028, PA2854, PA3183, PA3764, PA4378, PA4468, PA4997, PA5157 
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 PA0424    mexR 11 PA0425, PA0426, PA2020, PA2492, PA2495, PA3168, PA3574, PA3720, PA3721, PA4600, PA4964 
 PA1097    fleQ 11 PA1098, PA1099, PA1100, PA1443, PA1452, PA1453, PA1454, PA1455, PA2020, PA3385, PA4462 
 PA1179    phoP 11 PA1180, PA1343, PA1559, PA1560, PA1979, PA3552, PA3559, PA4773, PA4777, PA5199, PA5361 
 PA0272      10 PA1928, PA1929, PA2002, PA2077, PA2113, PA2965, PA3703, PA3805, PA5237, PA5489 
 PA0762    algU 10 PA0376, PA0576, PA0766, PA3337, PA4572, PA5011, PA5012, PA5077, PA5078, PA5261 
 PA1430    lasR 9 PA1432, PA1871, PA2586, PA2587, PA3476, PA3477, PA3622, PA3724, PA3861 
 PA3204    9 PA0766, PA3644, PA3645, PA3646, PA3725, PA3737, PA4953, PA4954, PA5489 
 PA0527    dnr 8 PA1544, PA1546, PA1781, PA1920, PA2020, PA3391, PA3392, PA3879 
 PA0547    8 PA0960, PA0962, PA0963, PA2326, PA4943, PA4946, PA4967, PA5471 
 PA0873    phhR 8 PA0292, PA1750, PA3000, PA3139, PA3166, PA4462, PA5039, PA5434 
 PA3477    rhlR 8 PA3478, PA3479, PA3622, PA3724, PA3861, PA4407, PA4408, PA4409 
 PA5125    ntrC 8 PA0888, PA1339, PA5075, PA5119, PA5124, PA5287, PA5288, PA5484 
 PA0001    dnaA 7 PA0002, PA0003, PA0376, PA1155, PA1156, PA3769, PA3770 
 PA1003    mvfR 7 PA1430, PA1690, PA1725, PA2227, PA2587, PA3477, PA3861 
 PA1099    fleR 7 PA1100, PA1101, PA1430, PA1454, PA1713, PA1714, PA4462 
 PA2273    soxR 7 PA2740, PA3280, PA3656, PA3718, PA4417, PA4759, PA5259 
 PA1619    6 PA0305, PA0854, PA3183, PA4468, PA4615, PA5157 
 PA1998    dhcR 5 PA1999, PA2000, PA5384, PA5388, PA5389 
 PA2016    liuR 5 PA2320, PA2886, PA2888, PA2891, PA2893 
 PA2020      5 PA2642, PA3391, PA3721, PA4671, PA5471 
 PA2259    ptxS 5 PA2260, PA2261, PA2262, PA2263, PA4315 
 PA3583    glpR 5 PA0347, PA3581, PA3582, PA3584, PA5235 
 PA4280    birA 5 PA0420, PA0500, PA0501, PA0503, PA0504 
 PA0487      4 PA1861, PA1863, PA4210, PA4811 
 PA0610    prtN 4 PA0611, PA0612, PA0651, PA4590 
 PA0780    pruR 4 PA0781, PA0782, PA0783, PA0982 
 PA1432    lasI 4 PA1898, PA2227, PA3477, PA4296 
 PA1760      4 PA2163, PA2339, PA2340, PA2341 
 PA1949    rbsR 4 PA1946, PA1947, PA1948, PA1950 
 PA1979    eraS 4 PA1980, PA2586, PA3948, PA5483 
 PA2551    4 PA1217, PA3118, PA3120, PA3121 
 PA2586    gacA 4 PA3476, PA3477, PA3622, PA4856 
 PA2665    4 PA1779, PA3697, PA4811, PA4893 
 PA3540    algD 4 PA5125, PA5200, PA5261, PA5483 
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 PA5200    amgR 4 PA0045, PA1288, PA5261, PA5361 
 PA5261    algR 4 PA5262, PA5322, PA5483, PA5484 
 PA5356    glcC 4 PA0482, PA5352, PA5353, PA5355 
 PA5380    gbdR 4 PA5398, PA5399, PA5410, PA5411 
 PA0037    trpI 3 PA0609, PA3166, PA4590 
 PA0152    pcaQ 3 PA0153, PA0154, PA0247 
 PA0928    gacS 3 PA1898, PA2586, PA3006 
 PA0996    pqsA 3 PA1003, PA1430, PA3477 
 PA1184    3 PA5213, PA5214, PA5215 
 PA1637    kdpE 3 PA1633, PA1634, PA1635 
 PA1713    exsA 3 PA1714, PA1716, PA3841 
 PA1898    qscR 3 PA2586, PA3006, PA3476 
 PA2054    cynR 3 PA2052, PA2053, PA2500 
 PA2118    ada 3 PA1686, PA3306, PA3972 
 PA2258    ptxR 3 PA2259, PA2426, PA3479 
 PA2320    gntR 3 PA2321, PA3181, PA3194 
 PA2809    copR 3 PA2810, PA5199, PA5361 
 PA2885    atuR 3 PA2886, PA2888, PA2891 
 PA3006    psrA 3 PA3007, PA3571, PA3622 
 PA3184      3 PA3193, PA3194, PA5036 
 PA3476    rhlI 3 PA3477, PA4723, PA5261 
 PA3587    metR 3 PA1843, PA4602, PA5124 
 PA3899    3 PA2914, PA3900, PA3901 
 PA4080      3 PA2978, PA3816, PA5563 
 PA4109    ampR 3 PA4110, PA4393, PA4522 
 PA4341      3 PA0247, PA4127, PA4152 
 PA4363    iciA 3 PA0001, PA0002, PA0003 
 PA4462    rpoN 3 PA4547, PA5125, PA5483 
 PA4547    pilR 3 PA4549, PA4556, PA5124 
 PA4600    nfxB 3 PA4964, PA5263, PA5348 
 PA4769    3 PA1587, PA5015, PA5016 
 PA5085      3 PA0836, PA2683, PA5277 
 PA5344    oxyR 3 PA0139, PA0140, PA0962 
 PA5374    betI 3 PA3933, PA5372, PA5373 
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 PA5550    glmR 3 PA2274, PA4457, PA5552 
 PA0036    trpB 2 PA0037, PA3587 
 PA0155    pcaR 2 PA0159, PA4974 
 PA0159      2 PA1294, PA4974 
 PA0287    gpuP 2 PA0289, PA1422 
 PA0288    gpuA 2 PA0289, PA1422 
 PA0289    gpuR 2 PA1418, PA1421 
 PA0370      2 PA2273, PA2510 
 PA0409    pilH 2 PA0416, PA3587 
 PA0416    chpD 2 PA0417, PA1456 
 PA0425    mexA 2 PA2020, PA3721 
 PA0482    glcB 2 PA2273, PA2809 
 PA0506    2 PA3006, PA3571 
 PA0519    nirS 2 PA0527, PA1544 
 PA0520    nirQ 2 PA0527, PA1544 
 PA0576    rpoD 2 PA0652, PA1544 
 PA0611    prtR 2 PA0612, PA4590 
 PA0831    oruR 2 PA2020, PA4402 
 PA0888    aotJ 2 PA0893, PA4315 
 PA1085    flgJ 2 PA1097, PA1099 
 PA1588    sucC 2 PA2273, PA2510 
 PA1589    sucD 2 PA2273, PA2510 
 PA1710    exsC 2 PA1713, PA3006 
 PA1957      2 PA0761, PA4919 
 PA1978    erbR 2 PA1982, PA3583 
 PA2012    liuD 2 PA2016, PA2885 
 PA2014    liuB 2 PA2016, PA2885 
 PA2219    opdE 2 PA2273, PA2510 
 PA2227    vqsM 2 PA3476, PA4296 
 PA2272    pbpC 2 PA2273, PA2510 
 PA2492    mexT 2 PA2493, PA2495 
 PA2523      2 PA2809, PA2810 
 PA2570    lecA 2 PA3477, PA4315 
 PA2571      2 PA3587, PA5261 
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 PA2686    pfeR 2 PA2687, PA2688 
 PA2810    copS 2 PA5200, PA5360 
 PA2951    etfA 2 PA3006, PA3571 
 PA2952    etfB 2 PA3006, PA3571 
 PA2953    2 PA3006, PA3571 
 PA3574    nalD 2 PA0425, PA0426 
 PA4227    pchR 2 PA4228, PA4229 
 PA4581    rtcR 2 PA4583, PA4585 
 PA4726    cbrB 2 PA5105, PA5124 
 PA5199    amgS 2 PA5200, PA5360 
 PA0017    1 PA2586 
 PA0024    hemF 1 PA0527 
 PA0041    1 PA0652 
 PA0044    exoT 1 PA1713 
 PA0176    aer2 1 PA1544 
 PA0186      1 PA1754 
 PA0240    1 PA3782 
 PA0254      1 PA0272 
 PA0286    desA 1 PA4890 
 PA0292    aguA 1 PA0294 
 PA0293    aguB 1 PA0294 
 PA0296    spuI 1 PA4726 
 PA0297    spuA 1 PA4726 
 PA0298    spuB 1 PA4726 
 PA0299    spuC 1 PA4726 
 PA0328      1 PA0893 
 PA0408    pilG 1 PA0416 
 PA0410    pilI 1 PA0416 
 PA0411    pilJ 1 PA0416 
 PA0412    pilK 1 PA0416 
 PA0413    chpA 1 PA0416 
 PA0414    chpB 1 PA0416 
 PA0415    chpC 1 PA0416 
 PA0523    norC 1 PA0527 
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 PA0572    1 PA0652 
 PA0705    migA 1 PA5499 
 PA0755    opdH 1 PA0756 
 PA0756      1 PA0757 
 PA0763    mucA 1 PA5483 
 PA0779      1 PA2665 
 PA0844    plcH 1 PA5380 
 PA0870    phhC 1 PA0873 
 PA0871    phhB 1 PA0873 
 PA0872    phhA 1 PA0873 
 PA0887    acsA 1 PA1980 
 PA0889    aotQ 1 PA0893 
 PA0890    aotM 1 PA0893 
 PA0891      1 PA0893 
 PA0892    aotP 1 PA0893 
 PA0905    rsmA 1 PA2586 
 PA0932    cysM 1 PA2354 
 PA0969    tolQ 1 PA2686 
 PA1000    pqsE 1 PA1003 
 PA1002    phnB 1 PA5499 
 PA1077    flgB 1 PA1097 
 PA1078    flgC 1 PA1097 
 PA1082    flgG 1 PA1097 
 PA1084    flgI 1 PA1097 
 PA1093    1 PA1097 
 PA1094    fliD 1 PA1097 
 PA1098    fleS 1 PA1099 
 PA1174    napA 1 PA3879 
 PA1178    oprH 1 PA1179 
 PA1196      1 PA3861 
 PA1418    1 PA1422 
 PA1421    gbuA 1 PA1422 
 PA1458    1 PA5261 
 PA1461    motD 1 PA2259 
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 PA1543    apt 1 PA1544 
 PA1546    hemN 1 PA3879 
 PA1557    ccoN2 1 PA5261 
 PA1609    fabB 1 PA4890 
 PA1610    fabA 1 PA4890 
 PA1690    pscU 1 PA4109 
 PA1712    exsB 1 PA1713 
 PA1714    exsD 1 PA2519 
 PA1725    pscL 1 PA4109 
 PA1796    folD 1 PA4600 
 PA1850    1 PA2063 
 PA1920    nrdD 1 PA3879 
 PA1977    1 PA1978 
 PA1980    eraR 1 PA1982 
 PA1999    dhcA 1 PA5389 
 PA2000    dhcB 1 PA5389 
 PA2011    liuE 1 PA2016 
 PA2013    liuC 1 PA2016 
 PA2015    liuA 1 PA2016 
 PA2018      1 PA2020 
 PA2193    hcnA 1 PA5261 
 PA2354      1 PA3444 
 PA2491    1 PA2492 
 PA2495    oprN 1 PA4600 
 PA2507    catA 1 PA2510 
 PA2508    catC 1 PA2510 
 PA2511    1 PA2512 
 PA2515    xylL 1 PA2519 
 PA2519    xylS 1 PA3571 
 PA2522    czcC 1 PA2809 
 PA2561    1 PA5360 
 PA2585    uvrC 1 PA2586 
 PA2587    pqsH 1 PA5499 
 PA2611    cysG 1 PA4723 
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 PA2637    nuoA 1 PA2686 
 PA2664    fhp 1 PA2665 
 PA2696    1 PA1850 
 PA3082    gbt 1 PA5380 
 PA3094    1 PA5322 
 PA3168    gyrA 1 PA4600 
 PA3175    1 PA5105 
 PA3176    gltS 1 PA3184 
 PA3182    pgl 1 PA3184 
 PA3183    zwf 1 PA3184 
 PA3257    prc 1 PA5483 
 PA3266    capB 1 PA3168 
 PA3385    amrZ 1 PA5262 
 PA3391    nosR 1 PA3587 
 PA3479    rhlA 1 PA5261 
 PA3545    algG 1 PA5483 
 PA3547    algL 1 PA5483 
 PA3569    mmsB 1 PA3571 
 PA3570    mmsA 1 PA3571 
 PA3581    glpF 1 PA3583 
 PA3594    1 PA3004 
 PA3689      1 PA3690 
 PA3710    1 PA3782 
 PA3720      1 PA3721 
 PA3721    nalC 1 PA4598 
 PA3724    lasB 1 PA4723 
 PA3782    1 PA5065 
 PA3815    iscR 1 PA4236 
 PA3875    narG 1 PA3879 
 PA3878    narX 1 PA3879 
 PA3946     two-compo 1 PA3948 
 PA3947    rocR 1 PA3948 
 PA4101    bfmR 1 PA4208 
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 PA4222      1 PA4227 
 PA4223    1 PA4227 
 PA4224    pchG 1 PA4227 
 PA4225    pchF 1 PA4227 
 PA4226    pchE 1 PA4227 
 PA4293    pprA 1 PA4296 
 PA4295    fppA 1 PA4296 
 PA4296    pprB 1 PA4305 
 PA4446    algW 1 PA5483 
 PA4498    1 PA4499 
 PA4525    pilA 1 PA4547 
 PA4550    fimU 1 PA5261 
 PA4597    oprJ 1 PA4600 
 PA4598    mexD 1 PA4600 
 PA4599    mexC 1 PA4600 
 PA4723    dksA 1 PA5338 
 PA4725    cbrA 1 PA4726 
 PA4844    1 PA5360 
 PA4888    desB 1 PA4890 
 PA4889    1 PA4890 
 PA5092    hutI 1 PA5105 
 PA5098    hutH 1 PA5105 
 PA5100    hutU 1 PA5105 
 PA5124    ntrB 1 PA5125 
 PA5157      1 PA1619 
 PA5255    algQ 1 PA5261 
 PA5259    hemD 1 PA5261 
 PA5260    hemC 1 PA5261 
 PA5292    pchP 1 PA5380 
 PA5373    betB 1 PA5374 
 PA5384      1 PA5389 
 PA5388    1 PA5389 
 PA5483    algB 1 PA5484 
 PA5549    glmS 1 PA5550 
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Table S1: Key to identifying the AmpR-dependent, and AmpR- and ß-lactam 
dependent genes from the venn diagram (Fig 4.4). Condition A: PAO1 uninduced vs 
PAO1 induced; Condition B: PAO∆ampR uninduced vs PAO∆ampR induced; Condition 
C: PAO1 uninduced vs PAO∆ampR uninduced; Condition D: PAO1 induced vs 
PAO∆ampR induced. NA- not applicable. 
 
Regulation Condition Condition Condition 
AmpR 
Regulation 
AmpR dependent, 
ß-lactam 
independent 
C- up D- up -- Negative 
C- down D- down -- Positive 
C- up B- up -- Negative 
C- down B- down -- Positive 
A- up B- down C- down Positive 
A- down C- up D- up Negative 
AmpR dependent, 
ß-lactam dependent 
A- down B- up -- Negative 
A- up B- down -- Positive 
A- up D- down -- Positive 
A- down D- up B- up Negative 
AmpR 
independent, ß-
lactam dependent 
C- down D- up -- NA 
C- up D- down -- NA 
A- down B-down -- NA 
A- up B- up -- NA 
A- up D- up -- NA 
A- up C- down D- up NA 
B- up D- down C- up NA 
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Table S2: ß-lactam-dependent genes. The 206 ß-lactam stress-dependent genes are 
separated into upregulated and downregulated genes with the corresponding corrected p-
values for the fold change (FC) observed. The genes are arranged based on either 
functional categorization. Locus tag annotations are from the Pseudomonas Genome 
database (31). 
A 
Downregulated genes 
Locus Tag Gene Name Product Name FC 
Corrected 
p-value 
Adaptation, Protection       
PA4078  probable nonribosomal peptide synthetase -3.6 4.07E-03 
Amino acid biosynthesis and metabolism     
PA5098 hutH histidine ammonia-lyase -21.4 2.15E-03 
PA5100 hutU urocanase -10.5 2.61E-03 
PA3700 lysS lysyl-tRNA synthetase -2.1 5.78E-03 
Carbon compound catabolism       
PA0792 prpD propionate catabolic protein PrpD -3.8 8.44E-03 
PA2300 chiC chitinase -20.2 4.17E-04 
Cell wall / LPS / capsule ; Adaptation, Protection     
PA1130 rhlC rhamnosyltransferase 2 -5.4 5.32E-03 
Central intermediary metabolism     
PA5549 glmS glucosamine--fructose-6-phosphate aminotransferase -2.5 2.28E-03 
Energy metabolism       
PA3930 cioA cyanide insensitive terminal oxidase -3.8 6.69E-03 
Hypothetical, unclassified, unknown     
PA0088 hypothetical protein -3.2 4.39E-03 
PA0122 conserved hypothetical protein -9.2 6.61E-03 
PA0271 hypothetical protein -3.0 3.10E-03 
PA1494 conserved hypothetical protein -2.5 4.94E-03 
PA1896 hypothetical protein -2.7 1.76E-03 
PA2066 hypothetical protein -4.8 5.07E-03 
PA2111 hypothetical protein -2.3 2.78E-03 
PA2223 hypothetical protein -3.4 9.59E-03 
PA2274 hypothetical protein -8.7 3.92E-03 
PA2441 hypothetical protein -3.4 5.33E-03 
PA2448 hypothetical protein -7.9 5.07E-03 
PA2684 conserved hypothetical protein -2.2 2.78E-03 
PA3229 hypothetical protein -2.1 4.66E-03 
PA3734 hypothetical protein -4.1 8.70E-03 
PA3928 hypothetical protein -3.5 7.28E-03 
PA4035 hypothetical protein -2.6 2.61E-03 
PA4141 hypothetical protein -8.7 3.29E-03 
PA5106 conserved hypothetical protein -10.4 4.45E-03 
PA5201 conserved hypothetical protein -2.5 2.15E-03 
PA5220 hypothetical protein -9.4 4.71E-03 
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Membrane proteins       
PA0070 hypothetical protein -2.0 7.24E-03 
PA1895 hypothetical protein -3.3 3.71E-03 
PA5183 hypothetical protein -4.3 4.45E-03 
PA1212  
probable major facilitator superfamily 
(MFS) transporter -2.9 7.31E-03 
PA2068  
probable major facilitator superfamily 
(MFS) transporter -11.7 3.42E-03 
PA2327 probable permease of ABC transporter -5.8 6.57E-03 
PA4034 aqpZ aquaporin Z -26.1 2.15E-03 
PA5095 probable permease of ABC transporter -12.0 2.15E-03 
PA5097 probable amino acid permease -20.7 2.78E-03 
PA5099 probable transporter -12.4 4.21E-03 
Motility & Attachment       
PA0171 hypothetical protein -3.0 3.68E-03 
PA3361 lecB fucose-binding lectin PA-IIL -2.1 9.12E-03 
Protein secretion/export apparatus     
PA1718 pscE type III export protein PscE -3.2 3.71E-03 
PA3820 secF secretion protein SecF -2.4 9.63E-03 
Putative 
enzymes         
PA0130 probable aldehyde dehydrogenase -2.1 9.12E-03 
PA0372 probable zinc protease -2.3 2.91E-03 
PA1914 conserved hypothetical protein -14.8 7.12E-03 
PA2067 probable hydrolase -12.0 1.76E-03 
PA2069 probable carbamoyl transferase -35.4 2.66E-03 
PA4715 probable aminotransferase -4.7 6.10E-03 
PA5093  
probable histidine/phenylalanine ammonia-
lyase -12.5 3.73E-03 
PA0075 pppA PppA -2.9 5.96E-03 
Secreted Factors (toxins, enzymes, alginate)     
PA0852 cbpD chitin-binding protein CbpD precursor -6.7 3.41E-03 
PA1901 phzC2 phenazine biosynthesis protein PhzC -9.2 5.62E-03 
PA1902 phzD2 phenazine biosynthesis protein PhzD -10.7 4.07E-03 
PA1903 phzE2 phenazine biosynthesis protein PhzE -17.1 5.81E-03 
PA1904 phzF2 probable phenazine biosynthesis protein -15.8 3.98E-03 
PA1905 phzG2 probable pyridoxamine 5'-phosphate oxidase -19.8 3.44E-03 
PA1871 lasA LasA protease precursor -7.9 6.80E-03 
Transcription, RNA processing and degradation     
PA4238 rpoA DNA-directed RNA polymerase alpha chain -2.0 3.91E-03 
Translation, post-translational modification, degradation     
PA2619 infA initiation factor -3.0 4.45E-03 
PA4241 rpsM 30S ribosomal protein S13 -2.6 9.03E-03 
PA0090 clpV1 ClpV1 -3.6 4.02E-03 
Transport of small molecules       
PA0603  
probable ATP-binding component of ABC 
transporter -2.0 7.74E-03 
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PA5094  
probable ATP-binding component of ABC 
transporter -12.7 2.78E-03 
PA5096   probable binding protein component of ABC transporter -11.5 4.94E-03 
Upregulated genes       
Locus Tag Gene Name Product Name FC 
Corrected 
p-value 
Adaptation, Protection       
PA0176 aer2 aerotaxis transducer Aer2 4.9 7.74E-03 
PA0177  
probable purine-binding chemotaxis 
protein 3.1 9.87E-03 
PA1646 probable chemotaxis transducer 2.6 7.41E-03 
PA2570 lecA LecA 41.7 1.60E-03 
PA2654 probable chemotaxis transducer 3.2 2.78E-03 
PA2788 probable chemotaxis transducer 2.1 4.77E-03 
PA3236  
probable glycine betaine-binding protein 
precursor 11.3 2.78E-03 
PA3349 probable chemotaxis protein 2.4 5.78E-03 
PA4310 pctB chemotactic transducer PctB 2.6 3.40E-03 
PA4566 obg GTP-binding protein Obg 2.6 4.12E-03 
PA4633 probable chemotaxis transducer 3.0 3.54E-03 
PA5072 probable chemotaxis transducer 2.2 4.36E-03 
Amino acid biosynthesis and metabolism     
PA4759 dapB dihydrodipicolinate reductase 2.6 9.12E-03 
PA5379 sdaB L-serine dehydratase 4.1 5.30E-03 
PA5398 dgcA DgcA, Dimethylglycine catabolism 8.4 2.15E-03 
PA5399 dgcB DgcB, Dimethylglycine catabolism 7.3 2.78E-03 
PA5410 gbcA GbcA 13.8 2.96E-03 
PA5411 gbcB GbcB 7.1 2.78E-03 
PA5416 soxB sarcosine oxidase beta subunit 11.6 2.95E-03 
PA5417 soxD sarcosine oxidase delta subunit 15.8 2.78E-03 
PA5419 soxG sarcosine oxidase gamma subunit 6.5 7.74E-03 
PA5429 aspA aspartate ammonia-lyase 2.4 9.12E-03 
Carbon compound catabolism       
PA4124 hpcB homoprotocatechuate 2,3-dioxygenase 4.0 8.81E-03 
PA5418 soxA sarcosine oxidase alpha subunit 7.4 3.46E-03 
Cell wall / LPS / capsule       
PA1078 flgC flagellar basal-body rod protein FlgC 3.4 4.45E-03 
PA1079 flgD flagellar basal-body rod modification protein FlgD 3.0 5.78E-03 
PA1080 flgE flagellar hook protein FlgE 3.3 7.19E-03 
PA1087 flgL flagellar hook-associated protein type 3 FlgL 2.8 7.41E-03 
PA1094 fliD flagellar capping protein FliD 2.2 9.23E-03 
PA1959 bacA bacitracin resistance protein 4.2 7.71E-03 
PA4700 mrcB penicillin-binding protein 1B 3.5 3.71E-03 
Central intermediary metabolism     
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PA4640 mqoB malate:quinone oxidoreductase 2.5 4.32E-03 
PA4880 probable bacterioferritin 4.2 9.12E-03 
PA5421 fdhA glutathione-independent formaldehyde dehydrogenase 5.2 9.59E-03 
Chaperones & heat shock proteins     
PA3126 ibpA heat-shock protein IbpA 2.7 9.90E-03 
Chemotaxis ; Adaptation, Protection ; Motility & Attachment     
PA1452 flhA flagellar biosynthesis protein FlhA 2.7 8.47E-03 
DNA replication, recombination, modification and repair     
PA3745 rpsP 30S ribosomal protein S16 4.3 9.29E-03 
PA4763 recN DNA repair protein RecN 2.5 6.57E-03 
Energy metabolism       
PA2953  
electron transfer flavoprotein-ubiquinone 
oxidoreductase 2.7 8.27E-03 
PA5400  
probable electron transfer flavoprotein 
alpha subunit 4.2 5.76E-03 
PA5491 probable cytochrome 2.3 4.70E-03 
Hypothetical, unclassified, unknown     
PA0026 plcB phospholipase C,  PlcB 2.9 7.51E-03 
PA0277 conserved hypothetical protein 6.6 4.66E-03 
PA0572 hypothetical protein 2.8 9.87E-03 
PA0578 conserved hypothetical protein 4.7 9.29E-03 
PA0613 hypothetical protein 6.2 5.45E-03 
PA0718 hypothetical protein of bacteriophage Pf1 3.2 9.59E-03 
PA0922 hypothetical protein 2.6 7.55E-03 
PA1029 hypothetical protein 2.7 4.45E-03 
PA1030 hypothetical protein 3.2 8.39E-03 
PA1093 hypothetical protein 2.3 7.43E-03 
PA1095 hypothetical protein 2.5 3.64E-03 
PA1096 hypothetical protein 2.3 2.15E-03 
PA1441 hypothetical protein 3.0 2.69E-03 
PA1967 hypothetical protein 3.7 8.26E-03 
PA1970 hypothetical protein 15.6 1.38E-03 
PA2171 hypothetical protein 2.6 9.12E-03 
PA2288 hypothetical protein 2.9 2.28E-03 
PA2366 uricase PuuD 10.2 4.33E-03 
PA2367 hypothetical protein 8.4 4.45E-03 
PA2368 hypothetical protein 8.6 4.45E-03 
PA2370 hypothetical protein 4.6 5.83E-03 
PA2485 hypothetical protein 2.7 9.12E-03 
PA2759 hypothetical protein 2.5 8.33E-03 
PA2762 hypothetical protein 5.1 2.95E-03 
PA2971 conserved hypothetical protein 3.3 1.92E-03 
PA3179 conserved hypothetical protein 2.4 2.15E-03 
PA3274 hypothetical protein 2.9 9.95E-03 
PA3414 hypothetical protein 3.2 8.52E-03 
PA3500 conserved hypothetical protein 4.2 3.92E-03 
PA3501 hypothetical protein 5.6 6.67E-03 
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PA3502 hypothetical protein 5.4 7.01E-03 
PA3510 hypothetical protein 7.6 3.57E-03 
PA3513 hypothetical protein 5.4 6.65E-03 
PA3520 hypothetical protein 7.3 4.74E-03 
PA3691 hypothetical protein 2.6 9.12E-03 
PA3952 hypothetical protein 2.1 9.12E-03 
PA4354 conserved hypothetical protein 21.5 3.18E-03 
PA4359 conserved hypothetical protein 2.7 9.95E-03 
PA4623 hypothetical protein 20.0 1.39E-03 
PA4635 conserved hypothetical protein 5.2 3.73E-03 
PA4746 conserved hypothetical protein 5.5 9.20E-03 
PA4826 hypothetical protein 3.8 7.33E-03 
PA4852 conserved hypothetical protein 4.1 3.95E-03 
PA4881 hypothetical protein 106.7 7.22E-04 
PA4908 hypothetical protein 3.7 5.81E-03 
PA4917 hypothetical protein 2.8 7.43E-03 
PA4985 hypothetical protein 2.9 3.54E-03 
PA5378 hypothetical protein 2.8 7.69E-03 
PA5395 conserved hypothetical protein 2.2 9.63E-03 
PA5396 hypothetical protein 11.4 3.54E-03 
PA5397 hypothetical protein 13.1 2.78E-03 
PA5401 hypothetical protein 8.3 4.57E-03 
PA5446 hypothetical protein 2.7 9.12E-03 
PA5465 hypothetical protein 3.0 6.65E-03 
PA5471 hypothetical protein 5.1 6.26E-03 
Membrane proteins       
PA0109 hypothetical protein 2.1 7.33E-03 
PA0241  
probable major facilitator superfamily 
(MFS) transporter 2.6 9.51E-03 
PA1073 braD branched-chain amino acid transport protein BraD 2.6 2.78E-03 
PA2369 hypothetical protein 3.1 7.12E-03 
PA3512 probable permease of ABC transporter 5.3 4.21E-03 
PA4933 hypothetical protein 5.8 8.81E-03 
PA4940 conserved hypothetical protein 4.6 8.27E-03 
PA5409 hypothetical protein 2.3 2.15E-03 
Nucleotide biosynthesis and metabolism     
PA3654 pyrH uridylate kinase 3.5 6.24E-03 
PA5420 purU2 formyltetrahydrofolate deformylase 5.4 9.79E-03 
Protein secretion/export apparatus     
PA4276 secE secretion protein SecE 4.2 5.13E-03 
Putative 
enzymes         
PA2152 probable trehalose synthase 2.5 9.12E-03 
PA2491 probable oxidoreductase 2.1 9.59E-03 
PA3503 hypothetical protein 3.9 5.71E-03 
PA3504 probable aldehyde dehydrogenase 5.2 4.86E-03 
PA3507 probable short-chain dehydrogenase 5.1 4.12E-03 
PA3509 probable hydrolase 6.0 2.78E-03 
 338 
 
PA3511 probable short-chain dehydrogenase 6.8 4.02E-03 
PA4986 probable oxidoreductase 2.7 5.71E-03 
Secreted Factors (toxins, enzymes, alginate)     
PA3478 rhlB rhamnosyltransferase chain B 6.0 3.71E-03 
PA3479 rhlA rhamnosyltransferase chain A 20.5 1.60E-03 
PA5112 estA esterase EstA 2.1 3.73E-03 
Transcription, RNA processing and degradation     
PA3743 trmD tRNA (guanine-N1)-methyltransferase 17.9 3.35E-03 
PA4264 rpsJ 30S ribosomal protein S10 3.3 5.38E-03 
Transcriptional regulators       
PA1196 probable transcriptional regulator 2.6 9.89E-03 
PA3508 probable transcriptional regulator 5.8 5.71E-03 
PA4296 pprB two-component response regulator, PprB 3.3 8.60E-03 
Translation, post-translational modification, degradation     
PA0580 gcp O-sialoglycoprotein endopeptidase 3.3 8.70E-03 
PA0905 rsmA RsmA, regulator of secondary metabolites 2.3 9.63E-03 
PA2741 rplT 50S ribosomal protein L20 2.2 7.71E-03 
PA4542 clpB ClpB protein 2.1 9.90E-03 
PA4567 rpmA 50S ribosomal protein L27 4.5 5.62E-03 
PA4568 rplU 50S ribosomal protein L21 7.0 4.81E-03 
PA4742 truB tRNA pseudouridine 55 synthase 3.5 9.10E-03 
PA4932 rplI 50S ribosomal protein L9 4.6 8.70E-03 
PA4934 rpsR 30S ribosomal protein S18 4.2 9.29E-03 
PA5316 rpmB 50S ribosomal protein L28 2.3 5.97E-03 
PA5470 probable peptide chain release factor 5.0 6.86E-03 
Transport of small molecules       
PA1074 braC branched-chain amino acid transport protein BraC 2.9 4.45E-03 
PA1260  
amino acid ABC transporter periplasmic 
binding protein 3.3 3.73E-03 
PA1435  
probable Resistance-Nodulation-Cell 
Division (RND) efflux membrane fusion 
protein precursor 
5.2 4.50E-03 
PA2019  
Resistance-Nodulation-Cell Division 
(RND) multidrug efflux membrane fusion 
protein precursor 
2.0 9.89E-03 
PA2812  
probable ATP-binding component of ABC 
transporter 3.7 2.40E-03 
PA3514  
probable ATP-binding component of ABC 
transporter 8.1 4.20E-03 
PA5468   probable citrate transporter 2.7 4.37E-03 
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Table S3: AmpR-dependent genes. The 313 AmpR-dependent genes are separated into 
upregulated and downregulated genes with the corresponding corrected p-values for the 
fold change (FC) observed. The genes are arranged based on either (A) functional 
categorization, or (B) fold change. Locus tag annotations are from the Pseudomonas 
Genome database (31). 
 
Downregulated genes 
Locus Tag Gene Name Product Name FC 
Corrected 
p-value 
Adaptation, Protection 
PA0074 ppkA serine/threonine protein kinase PpkA -2.3 8.41E-03 
PA1127 probable oxidoreductase -2.0 4.74E-03 
PA2826 probable glutathione peroxidase -2.2 5.96E-03 
PA3109 hypothetical protein -2.6 9.59E-03 
PA5117 typA regulatory protein TypA -3.6 8.06E-03 
Amino acid biosynthesis and metabolism 
PA0132 beta-alanine--pyruvate transaminase -3.9 9.29E-03 
PA1337 ansB glutaminase-asparaginase -2.4 3.35E-03 
PA1812 mltD 
membrane-bound lytic murein 
transglycosylase D precursor -2.1 5.32E-03 
PA2443 sdaA L-serine dehydratase -10.6 4.02E-03 
PA2444 glyA2 serine hydroxymethyltransferase -7.1 1.76E-03 
PA2629 purB adenylosuccinate lyase -2.3 9.89E-03 
PA5323 argB acetylglutamate kinase -2.6 4.45E-03 
PA5415 glyA1 serine hydroxymethyltransferase -2.1 5.91E-03 
Biosynthesis of cofactors, prosthetic groups and carriers 
PA4664 hemK probable methyl transferase -2.0 9.51E-03 
Carbon compound catabolism 
PA0208 mdcA malonate decarboxylase alpha subunit -2.4 3.91E-03 
PA2414 L-sorbosone dehydrogenase -2.2 8.90E-03 
Cell division 
PA0857 bolA morphogene protein BolA -2.3 2.78E-03 
Cell wall / LPS / capsule 
PA2232 pslB 
probable phosphomannose isomerase/GDP-
mannose pyrophosphorylase -3.2 8.70E-03 
PA2234 pslD PslD -3.0 8.27E-03 
PA3646 lpxD 
UDP-3-O-[3-hydroxylauroyl] glucosamine N-
acyltransferase -2.1 4.78E-03 
PA5077 mdoH 
periplasmic glucans biosynthesis protein 
MdoH -2.2 4.86E-03 
PA5163 rmlA glucose-1-phosphate thymidylyltransferase -2.1 4.66E-03 
PA5322 algC phosphomannomutase AlgC -2.3 4.45E-03 
Central intermediary metabolism 
PA2023 galU UTP--glucose-1-phosphate uridylyltransferase -2.5 4.75E-03 
PA2193 hcnA hydrogen cyanide synthase HcnA -7.3 4.68E-03 
PA2194 hcnB hydrogen cyanide synthase HcnB -5.3 7.08E-03 
PA2195 hcnC hydrogen cyanide synthase HcnC -4.6 4.02E-03 
PA2442 gcvT2 glycine cleavage system protein T2 -4.8 3.36E-03 
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PA2445 gcvP2 glycine cleavage system protein P2 -14.3 5.03E-03 
PA4100 probable dehydrogenase -2.7 6.81E-03 
Energy metabolism 
PA0854 fumC2 fumarate hydratase -2.4 9.59E-03 
PA4470 fumC1 fumarate hydratase -17.3 5.97E-03 
PA5553 atpC ATP synthase epsilon chain -2.2 5.71E-03 
Fatty acid and phospholipid metabolism 
PA0798 pmtA phospholipid methyltransferase -2.3 5.91E-03 
PA1869 probable acyl carrier protein -6.0 4.66E-03 
Hypothetical, unclassified, unknown 
PA0062 hypothetical protein -4.9 2.91E-03 
PA0076 hypothetical protein -2.5 3.34E-03 
PA0078 hypothetical protein -2.9 8.66E-03 
PA0079 hypothetical protein -2.9 5.97E-03 
PA0080 hypothetical protein -2.5 4.94E-03 
PA0169 hypothetical protein -3.3 2.95E-03 
PA0170 hypothetical protein -3.5 4.20E-03 
PA0269 conserved hypothetical protein -3.4 3.18E-03 
PA0270 hypothetical protein -3.0 8.85E-03 
PA0370 conserved hypothetical protein -2.5 3.73E-03 
PA0371 hypothetical protein -2.5 3.68E-03 
PA0468 hypothetical protein -2.2 6.12E-03 
PA0567 conserved hypothetical protein -3.2 9.87E-03 
PA0713 hypothetical protein -3.1 7.40E-03 
PA0732 hypothetical protein -2.9 4.45E-03 
PA0737 hypothetical protein -2.0 9.86E-03 
PA0943 hypothetical protein -2.0 3.65E-03 
PA1471 hypothetical protein -6.5 2.78E-03 
PA1605 hypothetical protein -2.3 7.41E-03 
PA1657 conserved hypothetical protein -8.4 3.19E-03 
PA1658 conserved hypothetical protein -9.7 1.60E-03 
PA1659 hypothetical protein -7.9 1.91E-03 
PA1660 hypothetical protein -4.7 8.44E-03 
PA1661 hypothetical protein -3.6 3.95E-03 
PA1664 hypothetical protein -6.3 4.73E-03 
PA1665 hypothetical protein -7.6 2.00E-03 
PA1666 hypothetical protein -6.1 3.68E-03 
PA1667 hypothetical protein -6.0 2.90E-03 
PA1668 hypothetical protein -4.1 3.98E-03 
PA1669 hypothetical protein -4.0 5.46E-03 
PA1732 conserved hypothetical protein -2.6 6.70E-03 
PA1892 hypothetical protein -2.6 9.29E-03 
PA1894 hypothetical protein -3.8 2.55E-03 
PA1897 hypothetical protein -2.8 6.00E-03 
PA1951 hypothetical protein -2.1 9.36E-03 
PA1968 hypothetical protein -2.5 6.60E-03 
PA1969 hypothetical protein -2.5 7.41E-03 
PA2030 hypothetical protein -4.1 8.89E-03 
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PA2031 hypothetical protein -3.2 8.70E-03 
PA2034 hypothetical protein -4.8 5.91E-03 
PA2080 kynU kynureninase KynU -7.2 2.29E-03 
PA2081 kynB kynurenine formamidase, KynB -5.9 1.73E-03 
PA2222 hypothetical protein -3.1 4.94E-03 
PA2235 pslE hypothetical protein -3.0 3.18E-03 
PA2236 pslF hypothetical protein -2.8 6.78E-03 
PA2238 pslH hypothetical protein -2.5 7.89E-03 
PA2242 pslL hypothetical protein -2.7 3.41E-03 
PA2289 conserved hypothetical protein -2.3 7.15E-03 
PA2384 hypothetical protein -5.7 9.36E-03 
PA2412 conserved hypothetical protein -2.2 3.95E-03 
PA2452 hypothetical protein -5.1 3.95E-03 
PA2630 conserved hypothetical protein -2.8 9.59E-03 
PA2702 hypothetical protein -2.0 4.45E-03 
PA2703 hypothetical protein -2.2 9.03E-03 
PA3042 hypothetical protein -2.9 8.70E-03 
PA3413 conserved hypothetical protein -3.6 7.60E-03 
PA3484 hypothetical protein -2.1 7.63E-03 
PA3572 hypothetical protein -4.7 1.86E-03 
PA3791 hypothetical protein -2.1 9.75E-03 
PA4033 hypothetical protein -26.9 4.02E-03 
PA4154 conserved hypothetical protein -3.8 5.96E-03 
PA4182 hypothetical protein -2.6 5.46E-03 
PA4204 ppgL periplasmic gluconolactonase, PpgL -3.3 2.15E-03 
PA4384 hypothetical protein -3.0 4.66E-03 
PA4458 conserved hypothetical protein -2.0 2.15E-03 
PA4459 conserved hypothetical protein -2.7 6.00E-03 
PA4469 hypothetical protein -9.7 9.29E-03 
PA4625 hypothetical protein -2.9 8.25E-03 
PA5023 conserved hypothetical protein -2.2 4.66E-03 
PA5052 hypothetical protein -2.0 8.60E-03 
PA5104 conserved hypothetical protein -2.5 4.45E-03 
PA5180 conserved hypothetical protein -6.4 3.95E-03 
PA5202 hypothetical protein -2.3 6.86E-03 
PA5463 hypothetical protein -2.0 8.59E-03 
Membrane proteins 
PA0605 probable permease of ABC transporter -3.0 4.74E-03 
PA0606 probable permease of ABC transporter -2.4 4.43E-03 
PA2403 hypothetical protein -3.3 7.28E-03 
PA2415 hypothetical protein -2.3 2.78E-03 
PA2763 hypothetical protein -3.6 8.47E-03 
PA2811 probable permease of ABC-2 transporter -4.6 6.12E-03 
PA3692 probable outer membrane protein precursor -7.8 3.46E-03 
PA3821 secD secretion protein SecD -2.0 6.09E-03 
PA4467 hypothetical protein -9.9 6.69E-03 
PA4503 probable permease of ABC transporter -4.0 5.32E-03 
PA4504 probable permease of ABC transporter -4.2 4.76E-03 
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PA5182 hypothetical protein -3.2 3.34E-03 
Nucleotide biosynthesis and metabolism 
PA4855 purD phosphoribosylamine--glycine ligase -2.0 8.66E-03 
PA5496 nrdJb 
class II ribonucleotide-diphosphate reductase 
subunit, NrdJb -3.0 5.62E-03 
PA5497 nrdJa 
class II ribonucleotide-diphosphate reductase 
subunit, NrdJa -3.3 8.44E-03 
Protein secretion/export apparatus 
PA0077 icmF1 IcmF1 -3.0 8.66E-03 
PA1709 popD 
Translocator outer membrane protein PopD 
precursor -6.2 1.38E-03 
PA1711 exsE ExsE -3.6 3.35E-03 
PA5210 probable secretion pathway ATPase -2.3 3.31E-03 
Putative enzymes 
PA0507 probable acyl-CoA dehydrogenase -3.8 6.26E-03 
PA0534 conserved hypothetical protein -3.1 7.91E-03 
PA0853 probable oxidoreductase -2.6 4.45E-03 
PA1662 probable ClpA/B-type protease -5.0 3.41E-03 
PA1893 hypothetical protein -2.9 4.77E-03 
PA2237 pslG probable glycosyl hydrolase -2.4 6.82E-03 
PA2239 pslI probable transferase -3.0 4.02E-03 
PA2263 probable 2-hydroxyacid dehydrogenase -2.2 3.95E-03 
PA2317 probable oxidoreductase 2.9 2.78E-03 
PA2682 conserved hypothetical protein -3.0 7.58E-03 
PA3427 probable short-chain dehydrogenases -3.8 8.59E-03 
PA3454 probable acyl-CoA thiolase -3.9 4.33E-03 
PA4171 probable protease -2.4 4.86E-03 
PA5150 probable short-chain dehydrogenase -2.0 5.46E-03 
PA5181 probable oxidoreductase -8.6 5.96E-03 
Secreted Factors (toxins, enzymes, alginate) 
PA0085 hcp1 Hcp1 -3.7 3.09E-03 
PA0263 hcpC secreted protein Hcp -7.7 4.66E-03 
PA1707 pcrH regulatory protein PcrH -3.8 3.98E-03 
PA3841 exoS exoenzyme S -3.5 1.16E-03 
PA3842 probable chaperone -2.9 5.73E-03 
Transcription, RNA processing and degradation 
PA4740 pnp polyribonucleotide nucleotidyltransferase -2.1 5.49E-03 
Transcriptional regulators 
PA0479 probable transcriptional regulator -2.1 9.90E-03 
PA1663 probable transcriptional regulator -3.9 5.13E-03 
PA2281 probable transcriptional regulator -2.1 9.89E-03 
PA2588 probable transcriptional regulator -27.9 3.77E-03 
PA5105 hutC histidine utilization repressor HutC -3.1 8.27E-03 
PA5483 algB two-component response regulator AlgB -2.4 7.83E-03 
Translation, post-translational modification, degradation 
PA0594 surA peptidyl-prolyl cis-trans isomerase SurA -2.4 6.26E-03 
PA1670 stp1 
serine/threonine phosphoprotein phosphatase 
Stp1 -2.3 3.81E-03 
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Transport of small molecules 
PA2987 
probable ATP-binding component of ABC 
transporter -2.1 3.68E-03 
PA4206 mexH 
probable RND efflux membrane fusion 
protein precursor -21.4 2.54E-03 
PA4500 
probable binding protein component of ABC 
transporter -5.2 3.73E-03 
PA4502 
probable binding protein component of ABC 
transporter -4.9 3.41E-03 
PA4505 
probable ATP-binding component of ABC 
transporter -3.3 3.71E-03 
PA4506 
probable ATP-binding component of ABC 
dipeptide transporter -3.8 2.99E-03 
Two-component regulatory systems 
PA5484 probable two-component sensor -3.0 7.01E-03 
Upregulated genes 
Locus Tag Gene Name Product Name FC 
Corrected 
p-value 
Adaptation, 
Protection       
PA0180 probable chemotaxis transducer 2.1 5.78E-03 
PA0923 dinB DNA Polymerase IV, DinB 4.5 6.05E-03 
PA2652 probable chemotaxis transducer 2.6 8.67E-03 
PA3007 lexA repressor protein LexA 2.7 7.28E-03 
PA3348 
probable chemotaxis protein 
methyltransferase 2.2 3.64E-03 
PA4309 pctA chemotactic transducer PctA 3.2 7.83E-03 
PA4356 xenB xenobiotic reductase 3.2 5.96E-03 
PA4378 inaA InaA protein 3.0 6.68E-03 
PA4520 probable chemotaxis transducer 2.1 3.69E-03 
Amino acid biosynthesis and metabolism     
PA0245 aroQ2 3-dehydroquinate dehydratase 2.9 3.71E-03 
PA4565 proB glutamate 5-kinase 2.9 5.03E-03 
Biosynthesis of cofactors, prosthetic groups and carriers     
PA4919 pncB1 nicotinate phosphoribosyltransferase 6.3 3.95E-03 
Carbon compound catabolism     
PA0153 pcaH protocatechuate 3,4-dioxygenase, beta subunit 3.3 3.42E-03 
PA0154 pcaG 
protocatechuate 3,4-dioxygenase, alpha 
subunit 2.2 6.25E-03 
PA0226 probable CoA transferase, subunit A 4.4 9.97E-03 
PA0230 pcaB 3-carboxy-cis,cis-muconate cycloisomerase 3.3 7.08E-03 
PA0231 pcaD beta-ketoadipate enol-lactone hydrolase 3.7 5.16E-03 
PA0232 pcaC gamma-carboxymuconolactone decarboxylase 4.1 8.44E-03 
PA2862 lipA lactonizing lipase precursor 3.6 5.97E-03 
PA4123 hpcC 
5-carboxy-2-hydroxymuconate semialdehyde 
dehydrogenase 6.7 3.18E-03 
PA4125 hpcD 
5-carboxymethyl-2-hydroxymuconate 
isomerase 5.8 6.12E-03 
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Cell wall / LPS / capsule 
      
PA1082 flgG flagellar basal-body rod protein FlgG 2.9 8.52E-03 
PA3160 wzz O-antigen chain length regulator 3.7 8.81E-03 
PA4480 mreC rod shape-determining protein MreC 4.8 6.34E-03 
Central intermediary metabolism     
PA2813 probable glutathione S-transferase 2.6 9.10E-03 
PA3629 adhC alcohol dehydrogenase class III 3.2 4.98E-03 
Chemotaxis         
PA0179 probable two-component response regulator 3.2 9.57E-03 
DNA replication, recombination, modification and repair     
PA0577 dnaG DNA primase 4.7 8.39E-03 
PA3617 recA RecA protein 3.3 5.46E-03 
Energy metabolism       
PA0105 coxB cytochrome c oxidase, subunit II 2.5 8.21E-03 
PA3621 fdxA ferredoxin I 3.1 5.32E-03 
PA4430 probable cytochrome b 2.2 2.00E-03 
Hypothetical, unclassified, unknown     
PA0124 hypothetical protein 2.8 3.81E-03 
PA0128 conserved hypothetical protein 3.3 7.28E-03 
PA0466 hypothetical protein 3.1 9.12E-03 
PA0529 conserved hypothetical protein 3.0 8.58E-03 
PA0614 hypothetical protein 6.7 8.26E-03 
PA0615 hypothetical protein 6.5 5.78E-03 
PA0717 hypothetical protein of bacteriophage Pf1 3.5 3.44E-03 
PA0729 hypothetical protein 9.4 3.41E-03 
PA0910 hypothetical protein 8.5 6.26E-03 
PA0911 hypothetical protein 6.8 7.83E-03 
PA1016 hypothetical protein 2.6 7.58E-03 
PA1164 conserved hypothetical protein 2.1 3.66E-03 
PA1299 conserved hypothetical protein 3.0 3.41E-03 
PA1333 hypothetical protein 2.6 5.97E-03 
PA1439 conserved hypothetical protein 2.2 7.28E-03 
PA1545 hypothetical protein 2.7 6.65E-03 
PA1744 hypothetical protein 3.1 5.62E-03 
PA2362 hypothetical protein 2.4 9.87E-03 
PA2365 conserved hypothetical protein 9.4 4.50E-03 
PA2487 hypothetical protein 11.6 2.26E-03 
PA2765 hypothetical protein 14.6 1.60E-03 
PA2780 hypothetical protein 2.6 4.66E-03 
PA2901 hypothetical protein 16.5 4.43E-03 
PA3008 hypothetical protein 4.1 7.71E-03 
PA3306 hypothetical protein 14.9 2.90E-03 
PA3353 hypothetical protein 2.3 6.40E-03 
PA3371 hypothetical protein 2.5 9.87E-03 
PA3499 hypothetical protein 2.4 6.97E-03 
PA3505 hypothetical protein 5.7 3.92E-03 
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PA3649 conserved hypothetical protein 2.1 6.31E-03 
PA3741 hypothetical protein 7.1 6.52E-03 
PA3880 conserved hypothetical protein 2.4 5.62E-03 
PA3922 conserved hypothetical protein 2.4 8.59E-03 
PA3923 hypothetical protein 3.6 6.26E-03 
PA3951 conserved hypothetical protein 2.1 8.33E-03 
PA4121 conserved hypothetical protein 4.9 6.75E-03 
PA4326 hypothetical protein 3.1 7.63E-03 
PA4379 conserved hypothetical protein 5.0 3.41E-03 
PA4582 conserved hypothetical protein 7.6 3.19E-03 
PA4584 conserved hypothetical protein 3.7 7.29E-03 
PA4918 hypothetical protein 16.9 2.59E-03 
PA4921 hypothetical protein 4.2 3.77E-03 
PA5292 pchP phosphorylcholine phosphatase 2.3 9.89E-03 
PA5543 hypothetical protein 2.0 5.81E-03 
Membrane proteins       
PA0229 pcaT dicarboxylic acid transporter PcaT 4.6 6.78E-03 
PA0240 probable porin 2.3 8.70E-03 
PA0465 creD inner membrane protein CreD 4.7 9.95E-03 
PA1072 braE 
branched-chain amino acid transport protein 
BraE 2.8 4.45E-03 
PA1436 probable RND efflux transporter 3.9 6.31E-03 
PA2495 oprN 
Multidrug efflux outer membrane protein 
OprN precursor 102.6 1.05E-04 
PA2988 conserved hypothetical protein 2.2 5.73E-03 
PA3041 hypothetical protein 4.1 5.13E-03 
PA3228 
probable ATP-binding/permease fusion ABC 
transporter 3.5 1.38E-03 
PA3234 probable sodium:solute symporter 3.3 8.62E-03 
PA3235 conserved hypothetical protein 3.0 5.47E-03 
PA3336 
probable major facilitator superfamily (MFS) 
transporter 2.3 3.19E-03 
PA3526 probable outer membrane protein precursor 2.3 3.64E-03 
PA3575 hypothetical protein 2.2 6.11E-03 
PA3602 conserved hypothetical protein 2.3 6.70E-03 
PA4126 
probable major facilitator superfamily (MFS) 
transporter 2.4 9.20E-03 
PA4911 
probable permease-ABC branched-chain 
amino acid transporter 5.1 2.78E-03 
PA4912 
branched chain amino acid ABC transporter 
membrane protein 6.6 2.15E-03 
PA5561 atpI ATP synthase protein I 2.6 5.05E-03 
Motility & Attachment 
      
PA1092 fliC flagellin type B 2.5 9.63E-03 
PA1099 fleR two-component response regulator 3.0 7.63E-03 
Non-coding RNA 
gene       
PA3621.1 rsmZ regulatory RNA RsmZ 4.8 9.25E-03 
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Protein secretion/export apparatus     
PA2863 lipH lipase modulator protein 2.2 4.85E-03 
Putative enzymes       
PA0242 hypothetical protein 2.6 7.19E-03 
PA0244 hypothetical protein 2.9 4.52E-03 
PA1296 probable 2-hydroxyacid dehydrogenase 3.2 3.44E-03 
PA3498 probable oxidoreductase 2.4 7.51E-03 
PA3506 probable decarboxylase 4.8 5.76E-03 
PA3628 probable esterase 2.9 5.71E-03 
PA3817 probable methyltransferase 4.2 5.32E-03 
PA5048 probable nuclease 3.2 9.01E-03 
Related to phage, transposon, or plasmid     
PA0616 hypothetical protein 6.9 7.25E-03 
PA0617 probable bacteriophage protein 7.8 8.66E-03 
PA0618 probable bacteriophage protein 7.2 7.74E-03 
PA0619 probable bacteriophage protein 5.9 9.87E-03 
PA0620 probable bacteriophage protein 7.5 5.76E-03 
PA0621 conserved hypothetical protein 7.7 6.53E-03 
PA0622 probable bacteriophage protein 6.0 4.45E-03 
PA0623 probable bacteriophage protein 6.3 7.01E-03 
PA0633 hypothetical protein 7.5 5.76E-03 
PA0634 hypothetical protein 6.6 7.15E-03 
PA0637 conserved hypothetical protein 7.0 8.11E-03 
PA0638 probable bacteriophage protein 6.3 9.02E-03 
PA0641 probable bacteriophage protein 5.6 9.59E-03 
PA0643 hypothetical protein 6.0 8.59E-03 
Secreted Factors (toxins, enzymes, alginate)     
PA0843 plcR 
phospholipase accessory protein PlcR 
precursor 2.2 2.16E-03 
Transcription, RNA processing and degradation     
PA2840 probable ATP-dependent RNA helicase 3.5 4.17E-04 
PA2975 rluC 
ribosomal large subunit pseudouridine 
synthase C 6.5 6.17E-03 
PA3744 rimM 16S rRNA processing protein 6.2 4.66E-03 
PA4275 nusG transcription antitermination protein NusG 2.7 9.69E-03 
Transcriptional regulators 
      
PA0762 algU sigma factor AlgU 5.4 3.35E-03 
PA1300 probable sigma-70 factor, ECF subfamily 2.5 9.59E-03 
PA5380 gbdR GbdR 2.6 5.75E-03 
PA0764 mucB 
negative regulator for alginate biosynthesis 
MucB 2.5 8.79E-03 
PA0610 prtN transcriptional regulator PrtN 6.1 5.58E-03 
PA0611 prtR transcriptional regulator PrtR 2.9 8.52E-03 
PA0612 ptrB repressor, PtrB 6.0 2.78E-03 
Transport of small molecules     
PA0913 mgtE probable Mg transporter MgtE 3.1 6.25E-03 
PA1070 braG 
branched-chain amino acid transport protein 
BraG 2.5 4.02E-03 
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PA1071 braF 
branched-chain amino acid transport protein 
BraF 2.2 7.55E-03 
PA1256 
amino acid ABC transporter ATP binding 
protein 2.3 8.26E-03 
PA3038 probable porin 2.3 4.85E-03 
PA3889 
probable binding protein component of ABC 
transporter 2.2 9.95E-03 
PA4909 
probable ATP-binding component of ABC 
transporter 3.7 3.92E-03 
PA4910 
branched chain amino acid ABC transporter 
ATP binding protein 5.7 4.16E-03 
PA4913 
probable binding protein component of ABC 
transporter 4.7 5.71E-03 
PA2493 mexE 
Resistance-Nodulation-Cell Division (RND) 
multidrug efflux membrane fusion protein 
MexE precursor 6.9 2.72E-03 
PA2494 mexF 
Resistance-Nodulation-Cell Division (RND) 
multidrug efflux transporter MexF 88.7 7.22E-04 
PA0958 oprD 
Basic amino acid, basic peptide and imipenem 
outer membrane porin OprD precursor 2.2 3.49E-03 
PA5376 
probable ATP-binding component of ABC 
transporter 2.2 6.12E-03 
Two-component regulatory systems     
PA0757 probable two-component sensor 2.3 3.77E-03 
PA1098 fleS two-component sensor 2.5 6.65E-03 
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Table S4: AmpR, ß-lactam-dependent genes. The 207 genes that are specifically 
dependent on AmpR, and ß-lactam stress are separated into upregulated and 
downregulated genes with the corresponding corrected p-values for the fold change (FC) 
observed. The genes are arranged based on either (A) functional categorization, or (B) 
fold change. Locus tag annotations are from the Pseudomonas Genome database (31). 
 
Downregulated genes       
Locus Tag Gene Name Product Name FC Corrected p-value 
Adaptation, Protection       
PA4671 probable ribosomal protein L25 -2.6 9.07E-03 
Amino acid biosynthesis and metabolism     
PA0390 metX homoserine O-acetyltransferase -2.5 6.29E-03 
PA0932 cysM cysteine synthase B -2.0 2.90E-03 
PA1750 phospho-2-dehydro-3-deoxyheptonate aldolase -2.4 8.53E-03 
PA4846 aroQ1 3-dehydroquinate dehydratase -2.3 6.79E-03 
Biosynthesis of cofactors, prosthetic groups and carriers     
PA0024 hemF coproporphyrinogen III oxidase, aerobic -3.2 6.65E-03 
PA4280 birA BirA bifunctional protein -3.0 9.14E-03 
PA5118 thiI thiazole biosynthesis protein ThiI -2.9 7.95E-03 
PA3652 uppS undecaprenyl pyrophosphate synthetase -2.3 6.65E-03 
PA0342 thyA thymidylate synthase -2.1 8.99E-03 
Carbon compound 
catabolism       
PA0227 probable CoA transferase, subunit B -3.1 6.65E-03 
PA5192 pckA phosphoenolpyruvate carboxykinase -3.0 6.04E-04 
PA4670 prs ribose-phosphate pyrophosphokinase -4.0 9.10E-03 
Cell division         
PA5563 soj chromosome partitioning protein Soj -2.1 9.71E-03 
Cell wall / LPS / capsule       
PA4450 murA UDP-N-acetylglucosamine 1-carboxyvinyltransferase -2.1 9.73E-03 
PA4545 comL competence protein ComL -2.1 7.95E-03 
PA4481 mreB rod shape-determining protein MreB -4.4 6.51E-03 
Central intermediary metabolism     
PA4563 rpsT 30S ribosomal protein S20 -5.9 9.92E-03 
Chaperones & heat shock proteins     
PA5193 yrfI heat shock protein HSP33 -2.5 6.65E-03 
DNA replication, recombination, modification and repair     
PA3620 mutS DNA mismatch repair protein MutS -2.6 9.22E-03 
Hypothetical, unclassified, unknown     
PA0045 hypothetical protein -4.2 7.48E-03 
PA0046 hypothetical protein -3.4 9.10E-03 
PA1768 hypothetical protein -3.4 7.86E-03 
PA2318 hypothetical protein -3.1 8.53E-03 
PA2427 hypothetical protein -2.2 9.12E-03 
PA2451 hypothetical protein -2.2 9.58E-03 
PA2486 hypothetical protein -4.0 7.00E-03 
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PA2660 hypothetical protein -2.6 9.73E-03 
PA2823 conserved hypothetical protein -2.0 9.10E-03 
PA3453 conserved hypothetical protein -2.8 9.34E-03 
PA3472 hypothetical protein -5.4 8.53E-03 
PA3483 hypothetical protein -2.0 7.09E-03 
PA3664 conserved hypothetical protein -2.1 7.95E-03 
PA3906 hypothetical protein -2.4 9.39E-03 
PA3908 hypothetical protein -2.2 7.86E-03 
PA4004 conserved hypothetical protein -2.7 6.65E-03 
PA4122 conserved hypothetical protein -3.0 7.53E-03 
PA4438 conserved hypothetical protein -3.4 6.65E-03 
PA4451 conserved hypothetical protein -3.7 7.09E-03 
PA4460 conserved hypothetical protein -2.1 8.44E-03 
PA4492 conserved hypothetical protein -2.2 8.57E-03 
PA4574 conserved hypothetical protein -2.2 6.33E-03 
PA4673 conserved hypothetical protein -2.8 7.09E-03 
PA4753 conserved hypothetical protein -2.3 8.09E-03 
PA4817 hypothetical protein -2.0 7.48E-03 
PA5441 hypothetical protein -2.0 7.09E-03 
Membrane proteins       
PA3794 hypothetical protein -2.3 4.37E-03 
PA3828 conserved hypothetical protein -2.7 9.24E-03 
PA5568 conserved hypothetical protein -3.2 6.35E-03 
PA4205 mexG hypothetical protein 
-
30.2 1.18E-03 
PA4207 mexI 
probable Resistance-Nodulation-Cell Division (RND) efflux 
transporter 
-
10.8 2.29E-03 
PA4208 opmD probable outer membrane protein precursor 
-
10.8 1.60E-03 
PA4292 probable phosphate transporter -2.4 9.10E-03 
Nucleotide biosynthesis and metabolism     
PA0944 purN phosphoribosylaminoimidazole synthetase -2.2 9.73E-03 
PA3527 pyrC dihydroorotase -2.5 8.09E-03 
PA5298 xanthine phosphoribosyltransferase -3.2 9.75E-03 
PA5336 gmk guanylate kinase -3.0 8.86E-03 
Protein secretion/export apparatus     
PA1708 popB translocator protein PopB -2.0 9.63E-03 
PA5128 secB secretion protein SecB -2.5 7.43E-03 
Putative enzymes       
PA0386 probable oxidase -2.4 7.33E-03 
PA4073 probable aldehyde dehydrogenase -3.3 8.33E-03 
PA4209 phzM probable phenazine-specific methyltransferase -3.8 3.95E-03 
PA4217 phzS flavin-containing monooxygenase 
-
28.0 2.90E-03 
PA4389 probable short-chain dehydrogenase -2.1 7.86E-03 
Secreted Factors (toxins, enzymes, alginate)     
PA4210 phzA1 probable phenazine biosynthesis protein -3.5 3.81E-03 
PA4211 phzB1 probable phenazine biosynthesis protein 
-
20.7 5.11E-03 
Transcription, RNA processing and degradation     
PA0592 ksgA rRNA (adenine-N6,N6)-dimethyltransferase -2.6 8.56E-03 
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PA4745 nusA N utilization substance protein A -2.3 8.39E-03 
PA4262 rplD 50S ribosomal protein L4 -3.0 6.33E-03 
Transcriptional regulators       
PA4853 fis DNA-binding protein Fis -3.3 6.65E-03 
PA0463 creB two-component response regulator CreB -2.1 8.39E-03 
PA3604 probable two-component response regulator -2.2 6.96E-03 
Translation, post-translational modification, degradation     
PA0579 rpsU 30S ribosomal protein S21 -3.5 9.32E-03 
PA2851 efp translation elongation factor P -4.3 6.96E-03 
PA2970 rpmF 50S ribosomal protein L32 -3.8 7.34E-03 
PA3656 rpsB 30S ribosomal protein S2 -4.0 9.34E-03 
PA3742 rplS 50S ribosomal protein L19 -2.7 6.83E-03 
PA4239 rpsD 30S ribosomal protein S4 -2.4 6.51E-03 
PA4244 rplO 50S ribosomal protein L15 -2.6 6.01E-03 
PA4246 rpsE 30S ribosomal protein S5 -2.4 4.37E-03 
PA4247 rplR 50S ribosomal protein L18 -2.9 7.53E-03 
PA4248 rplF 50S ribosomal protein L6 -2.7 8.90E-03 
PA4249 rpsH 30S ribosomal protein S8 -2.8 6.58E-03 
PA4251 rplE 50S ribosomal protein L5 -2.4 6.33E-03 
PA4253 rplN 50S ribosomal protein L14 -3.0 9.10E-03 
PA4254 rpsQ 30S ribosomal protein S17 -2.4 4.37E-03 
PA4257 rpsC 30S ribosomal protein S3 -2.7 8.90E-03 
PA4261 rplW 50S ribosomal protein L23 -2.9 3.81E-03 
PA4263 rplC 50S ribosomal protein L3 -2.8 6.94E-03 
PA4266 fusA1 elongation factor G -2.1 9.73E-03 
PA4272 rplJ 50S ribosomal protein L10 -3.7 6.33E-03 
PA4274 rplK 50S ribosomal protein L11 -2.0 5.03E-03 
PA4665 prfA peptide chain release factor 1 -2.2 6.65E-03 
PA4672 peptidyl-tRNA hydrolase -3.3 9.10E-03 
PA4935 rpsF 30S ribosomal protein S6 -3.7 6.74E-03 
PA5049 rpmE 50S ribosomal protein L31 -4.0 8.29E-03 
PA5569 rnpA ribonuclease P protein component -3.5 5.03E-03 
PA3818 extragenic suppressor protein SuhB -2.7 9.10E-03 
PA4743 rbfA ribosome-binding factor A -2.8 9.34E-03 
Transport of small molecules       
PA2983 probable tolQ-type transport protein -2.7 6.74E-03 
PA3407 hasAp heme acquisition protein HasAp 
-
15.8 1.39E-03 
Upregulated genes       
Locus Tag Gene Name Product Name FC Corrected p-value 
Adaptation, Protection       
PA1001 phnA anthranilate synthase component I 5.7 7.31E-03 
PA2573 probable chemotaxis transducer 4.3 5.19E-03 
PA3866 pyocin protein 2.1 9.34E-03 
PA4110 ampC beta-lactamase precursor 2.0 3.84E-02 
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Amino acid biosynthesis and metabolism     
PA1217 probable 2-isopropylmalate synthase 13.8 6.51E-03 
PA3418 ldh leucine dehydrogenase 5.1 8.29E-03 
PA1002 phnB anthranilate synthase component II 4.7 5.30E-03 
Biosynthesis of cofactors, prosthetic groups and carriers     
PA0502 probable biotin biosynthesis protein bioH 2.3 7.53E-03 
PA1000 pqsE Quinolone signal response protein 3.6 6.94E-03 
Carbon compound 
catabolism       
PA0743 probable 3-hydroxyisobutyrate dehydrogenase 6.1 8.10E-03 
PA2290 gcd glucose dehydrogenase 3.9 4.89E-03 
Central intermediary metabolism     
PA4130 probable sulfite or nitrite reductase 3.4 9.10E-03 
Energy metabolism       
PA1177 napE periplasmic nitrate reductase protein NapE 5.5 8.53E-03 
PA1317 cyoA cytochrome o ubiquinol oxidase subunit II 3.9 8.51E-03 
PA3032 snr1 cytochrome c Snr1 5.2 3.81E-03 
PA3415 probable dihydrolipoamide acetyltransferase 8.1 6.51E-03 
PA3416 probable pyruvate dehydrogenase E1 component, beta chain 8.2 6.96E-03 
Hypothetical, unclassified, unknown     
PA0028 hypothetical protein 2.5 8.55E-03 
PA0484 conserved hypothetical protein 3.9 6.79E-03 
PA0586 conserved hypothetical protein 4.7 6.33E-03 
PA0587 conserved hypothetical protein 4.5 9.10E-03 
PA0588 conserved hypothetical protein 3.6 8.61E-03 
PA0959 hypothetical protein 2.3 8.93E-03 
PA1043 hypothetical protein 2.3 6.65E-03 
PA1088 hypothetical protein 3.1 9.73E-03 
PA1090 hypothetical protein 2.6 5.03E-03 
PA1091 fgtA flagellar glycosyl transferase, FgtA 3.1 3.60E-03 
PA1135 conserved hypothetical protein 3.8 5.57E-03 
PA1213 hypothetical protein 5.5 5.30E-03 
PA1214 hypothetical protein 4.9 8.55E-03 
PA1216 hypothetical protein 15.9 6.99E-03 
PA1218 hypothetical protein 10.8 7.00E-03 
PA1219 hypothetical protein 5.0 4.37E-03 
PA1221 hypothetical protein 4.9 6.15E-03 
PA1356 hypothetical protein 2.6 7.87E-03 
PA1728 hypothetical protein 5.0 8.53E-03 
PA1784 hypothetical protein 6.3 6.83E-03 
PA1887 hypothetical protein 9.8 7.53E-03 
PA1888 hypothetical protein 12.0 7.86E-03 
PA2166 hypothetical protein 8.9 5.57E-03 
PA2174 hypothetical protein 5.3 9.10E-03 
PA2226 hypothetical protein 2.5 8.16E-03 
PA2328 hypothetical protein 8.7 1.04E-03 
PA2330 hypothetical protein 17.5 8.29E-03 
PA2374 hypothetical protein 4.1 6.96E-03 
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PA2381 hypothetical protein 7.5 8.44E-03 
PA2566 conserved hypothetical protein 4.0 9.34E-03 
PA2699 hypothetical protein 3.9 9.10E-03 
PA2747 hypothetical protein 12.1 7.31E-03 
PA2937 hypothetical protein 4.3 8.53E-03 
PA3089 hypothetical protein 2.9 9.50E-03 
PA3688 hypothetical protein 4.9 9.10E-03 
PA4132 conserved hypothetical protein 2.4 7.81E-03 
PA4298 hypothetical protein 14.1 8.29E-03 
PA4362 hypothetical protein 3.1 8.56E-03 
PA4421 conserved hypothetical protein 2.1 7.37E-03 
PA4573 hypothetical protein 4.2 9.51E-03 
PA4583 conserved hypothetical protein 2.1 9.12E-03 
PA4608 hypothetical protein 2.8 9.73E-03 
PA4648 hypothetical protein 13.5 4.37E-03 
PA4650 hypothetical protein 2.1 6.65E-03 
PA4653 hypothetical protein 3.8 3.60E-03 
PA4685 hypothetical protein 2.6 5.03E-03 
PA4702 hypothetical protein 6.3 4.37E-03 
PA4738 conserved hypothetical protein 15.6 7.30E-04 
PA4739 conserved hypothetical protein 16.8 6.65E-03 
PA5061 conserved hypothetical protein 4.2 6.51E-03 
PA5101 hypothetical protein 3.2 8.55E-03 
PA5191 hypothetical protein 2.2 8.23E-03 
PA5481 hypothetical protein 5.9 7.42E-03 
PA1874 hypothetical protein 22.1 5.09E-03 
Membrane proteins       
PA0007 hypothetical protein 2.6 9.73E-03 
PA1042 conserved hypothetical protein 2.7 9.05E-03 
PA1119 probable outer membrane protein precursor 2.2 9.22E-03 
PA2072 conserved hypothetical protein 2.2 9.80E-03 
PA3370 hypothetical protein 3.7 7.86E-03 
PA3789 hypothetical protein 2.9 7.09E-03 
PA5482 hypothetical protein 11.1 6.65E-03 
PA4614 mscL conductance mechanosensitive channel 2.3 5.57E-03 
PA4297 tadG TadG 3.5 7.64E-03 
PA4301 tadB TadB 4.0 6.33E-03 
Motility & Attachment       
PA4299 tadD TadD 16.9 5.03E-03 
PA4305 rcpC RcpC 4.6 9.73E-03 
PA4306 flp Type IVb pilin, Flp 35.7 3.60E-03 
PA4651 probable pili assembly chaperone 11.6 1.42E-03 
Protein secretion/export apparatus     
PA1877 probable secretion protein 8.6 9.73E-03 
PA1875 probable outer membrane protein precursor 11.5 8.53E-03 
PA4302 tadA TadA ATPase 7.1 6.51E-03 
PA4304 rcpA RcpA 8.7 7.33E-03 
Putative enzymes       
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PA0704 probable amidase 3.6 8.56E-03 
PA0804 probable oxidoreductase 2.5 9.10E-03 
PA0838 probable glutathione peroxidase 2.4 9.34E-03 
PA1880 probable oxidoreductase 4.1 9.50E-03 
PA2024 probable ring-cleaving dioxygenase 6.1 2.46E-03 
PA5546 conserved hypothetical protein 4.6 7.09E-03 
Related to phage, transposon, or plasmid     
PA0644 hypothetical protein 5.0 9.73E-03 
Secreted Factors (toxins, enzymes, alginate)     
PA4175 piv protease IV 3.8 9.50E-03 
PA1876 probable ATP-binding/permease fusion ABC transporter 9.0 5.57E-03 
Transcription, RNA processing and degradation     
PA4585 rtcA RNA 3'-terminal phosphate cyclase 2.1 9.12E-03 
Transcriptional regulators       
PA3622 rpoS sigma factor RpoS 2.2 6.65E-03 
PA5059 probable transcriptional regulator 4.0 6.33E-03 
PA0175 probable chemotaxis protein methyltransferase 5.9 5.03E-03 
PA4781 probable two-component response regulator 2.8 9.10E-03 
PA2329 probable ATP-binding component of ABC transporter 14.7 7.53E-03 
PA3858 probable amino acid-binding protein 2.3 5.19E-03 
PA4497 probable binding protein component of ABC transporter 2.3 9.78E-03 
Two-component regulatory systems     
PA4293 pprA two-component sensor PprA 4.1 8.90E-03 
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Table S5: Regulation of QS-related genes by AmpR. List of genes that are significantly differentially 
regulated in PAO1 and PAO∆ampR in the presence and absence of ß-lactam stress. For sake of clarity, only 
significant fold changes (FC) and their corresponding corrected p-values in the various conditions are 
shown. Annotations for the locus tags are from the Pseudomonas Genome database (31). 
 
Locus 
Tag 
Gene 
Name Product Name 
AmpR 
dependent 
AmpR, ß-
lactam 
dependent 
FC 
p-
value FC 
p-
value 
Adaptation, protection 
PA4520 probable chemotaxis transducer 2.1 
3.7E-
03 
PA1127 probable oxidoreductase 
-
2.0 
4.7E-
03 
Amino acid biosynthesis and metabolism 
PA0132 beta-alanine--pyruvate transaminase 
-
3.9 
9.3E-
03 
PA1812 mltD 
membrane-bound lytic murein transglycosylase 
D precursor 
-
2.1 
5.3E-
03 
PA2629 purB adenylosuccinate lyase 
-
2.3 
9.9E-
03 
Carbon compound catabolism 
PA0153 pcaH protocatechuate 3,4-dioxygenase, beta subunit 3.3 
3.4E-
03 
PA0154 pcaG protocatechuate 3,4-dioxygenase, alpha subunit 2.2 
6.2E-
03 
PA0226 probable CoA transferase, subunit A 4.4 
1.0E-
02 
PA4123 hpcC 
5-carboxy-2-hydroxymuconate semialdehyde 
dehydrogenase 6.7 
3.2E-
03 
PA4125 hpcD 5-carboxymethyl-2-hydroxymuconate isomerase 5.8 
6.1E-
03 
PA0227 probable CoA transferase, subunit B -3.1 
6.6E-
03 
Cell wall / LPS / capsule 
PA5163 rmlA glucose-1-phosphate thymidylyltransferase 
-
2.1 
4.7E-
03 
Central intermediary metabolism 
PA4130 probable sulfite or nitrite reductase 3.4 
9.1E-
03 
Energy metabolism 
PA0105 coxB cytochrome c oxidase, subunit II 2.5 
8.2E-
03 
PA3621 fdxA ferredoxin I 3.1 
5.3E-
03 
PA3032 snr1 cytochrome c Snr1 5.2 
3.8E-
03 
PA0854 fumC2 fumarate hydratase 
-
2.4 
9.6E-
03 
Hypothetical, unclassified, unknown 
PA0079 hypothetical protein 
-
2.9 
6.0E-
03 
PA0080 hypothetical protein 
-
2.5 
4.9E-
03 
PA0269 conserved hypothetical protein 
-
3.4 
3.2E-
03 
PA0270 hypothetical protein 
-
3.0 
8.9E-
03 
PA0468 hypothetical protein 
-
2.2 
6.1E-
03 
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PA0614 hypothetical protein 6.7 
8.3E-
03 
PA0615 hypothetical protein 6.5 
5.8E-
03 
PA0910 hypothetical protein 8.5 
6.3E-
03 
PA0943 hypothetical protein 
-
2.0 
3.7E-
03 
PA1892 hypothetical protein 
-
2.6 
9.3E-
03 
PA2030 hypothetical protein 
-
4.1 
8.9E-
03 
PA2031 hypothetical protein 
-
3.2 
8.7E-
03 
PA2780 hypothetical protein 2.6 
4.7E-
03 
PA3572 hypothetical protein 
-
4.7 
1.9E-
03 
PA3880 conserved hypothetical protein 2.4 
5.6E-
03 
PA4121 conserved hypothetical protein 4.9 
6.7E-
03 
PA5543 hypothetical protein 2.0 
5.8E-
03 
PA1768 hypothetical protein -3.4 
7.9E-
03 
PA1784 hypothetical protein 6.3 
6.8E-
03 
PA2328 hypothetical protein 8.7 
1.0E-
03 
PA2330 hypothetical protein 17.5 
8.3E-
03 
PA2566 conserved hypothetical protein 4.0 
9.3E-
03 
PA2660 hypothetical protein -2.6 
9.7E-
03 
PA4122 conserved hypothetical protein -3.0 
7.5E-
03 
PA4132 conserved hypothetical protein 2.4 
7.8E-
03 
PA4298 hypothetical protein 14.1 
8.3E-
03 
PA4817 hypothetical protein -2.0 
7.5E-
03 
PA1897 hypothetical protein 
-
2.8 
6.0E-
03 
PA0717 hypothetical protein of bacteriophage Pf1 3.5 
3.4E-
03 
Membrane proteins 
PA3789 hypothetical protein 2.9 
7.1E-
03 
PA4126 
probable major facilitator superfamily (MFS) 
transporter 2.4 
9.2E-
03 
PA4297 tadG TadG 3.5 
7.6E-
03 
PA1072 braE 
branched-chain amino acid transport protein 
BraE 2.8 
4.4E-
03 
PA3234 probable sodium:solute symporter 3.3 
8.6E-
03 
PA4911 
probable permease of ABC branched-chain 
amino acid transporter 5.1 
2.8E-
03 
PA4912 
branched chain amino acid ABC transporter 
membrane protein 6.6 
2.1E-
03 
Non-coding RNA gene 
PA3621.1 rsmZ regulatory RNA RsmZ 4.8 
9.2E-
03 
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Protein secretion/export apparatus 
PA1875 probable outer membrane protein precursor 11.5 
8.5E-
03 
Putative enzymes 
PA1893 hypothetical protein 
-
2.9 
4.8E-
03 
PA2682 conserved hypothetical protein 
-
3.0 
7.6E-
03 
PA4073 probable aldehyde dehydrogenase -3.3 
8.3E-
03 
PA5546 conserved hypothetical protein 4.6 
7.1E-
03 
Related to phage, transposon, or plasmid 
PA0616 hypothetical protein 6.9 
7.2E-
03 
PA0617 probable bacteriophage protein 7.8 
8.7E-
03 
PA0618 probable bacteriophage protein 7.2 
7.7E-
03 
PA0619 probable bacteriophage protein 5.9 
9.9E-
03 
PA0620 probable bacteriophage protein 7.5 
5.8E-
03 
PA0621 conserved hypothetical protein 7.7 
6.5E-
03 
PA0622 probable bacteriophage protein 6.0 
4.4E-
03 
PA0623 probable bacteriophage protein 6.3 
7.0E-
03 
PA0637 conserved hypothetical protein 7.0 
8.1E-
03 
PA0638 probable bacteriophage protein 6.3 
9.0E-
03 
PA0641 probable bacteriophage protein 5.6 
9.6E-
03 
PA0643 hypothetical protein 6.0 
8.6E-
03 
PA0644 hypothetical protein 5.0 
9.7E-
03 
Secreted Factors (toxins, enzymes, alginate) 
PA4175 piv protease IV 3.8 
9.5E-
03 
PA5380 gbdR GbdR 2.6 
5.8E-
03 
PA5059 probable transcriptional regulator 4.0 
6.3E-
03 
Translation, post-translational modification, degradation 
PA2851 efp translation elongation factor P -4.3 
7.0E-
03 
Transport of small molecules 
PA1070 braG 
branched-chain amino acid transport protein 
BraG 2.5 
4.0E-
03 
PA4910 
branched chain amino acid ABC transporter ATP 
binding protein 5.7 
4.2E-
03 
PA4913 
probable binding protein component of ABC 
transporter 4.7 
5.7E-
03 
PA2329 
probable ATP-binding component of ABC 
transporter 14.7 
7.5E-
03 
PA4497   
probable binding protein component of ABC 
transporter     2.3 
9.8E-
03 
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Table S6: Regulation of biofilm-specific genes by AmpR. Significantly differentially regulated genes in 
PAO1 and PAO∆ampR in the presence and absence of ß-lactam antibiotics. For sake of clarity, only 
significant fold changes (FC) and their corresponding corrected p-values are shown. Locus tag annotations 
are from the Pseudomonas Genome database (31). 
 
Locus 
Tag 
Gene 
Name Product Name 
AmpR 
dependent 
AmpR, ß-lactam 
dependent 
FC p-value FC p-value 
Adaptation, Protection 
PA4356 xenB xenobiotic reductase 3.2 6.0E-03 
PA4671 probable ribosomal protein L25 -2.6 9.1E-03 
PA0074 ppkA 
serine/threonine protein kinase 
PpkA -2.3 8.4E-03 
Amino acid biosynthesis and metabolism 
PA2444 glyA2 serine hydroxymethyltransferase -7.1 1.8E-03 
PA5415 glyA1 serine hydroxymethyltransferase -2.1 5.9E-03 
PA1217 
probable 2-isopropylmalate 
synthase 13.8 6.5E-03 
Carbon compound catabolism 
PA5192 pckA 
phosphoenolpyruvate 
carboxykinase -3.0 6.0E-04 
Cell wall / LPS / capsule 
PA5322 algC phosphomannomutase AlgC -2.3 4.4E-03 
Central intermediary metabolism 
PA2445 gcvP2 glycine cleavage system protein P2 
-
14.3 5.0E-03 
Hypothetical, unclassified, unknown 
PA0062 hypothetical protein -4.9 2.9E-03 
PA0076 hypothetical protein -2.5 3.3E-03 
PA0170 hypothetical protein -3.5 4.2E-03 
PA0529 conserved hypothetical protein 3.0 8.6E-03 
PA0737 hypothetical protein -2.0 9.9E-03 
PA1471 hypothetical protein -6.5 2.8E-03 
PA2365 conserved hypothetical protein 9.4 4.5E-03 
PA3484 hypothetical protein -2.1 7.6E-03 
PA4154 conserved hypothetical protein -3.8 6.0E-03 
PA4154 conserved hypothetical protein 2.5 8.7E-03 
PA5202 hypothetical protein -2.3 6.9E-03 
PA0028 hypothetical protein 2.5 8.5E-03 
PA0046 hypothetical protein -3.4 9.1E-03 
PA0588 conserved hypothetical protein 3.6 8.6E-03 
PA1216 hypothetical protein 15.9 7.0E-03 
PA2174 hypothetical protein 5.3 9.1E-03 
PA3688 hypothetical protein 4.9 9.1E-03 
PA4421 conserved hypothetical protein 2.1 7.4E-03 
PA4421 conserved hypothetical protein 2.9 3.4E-03 
PA5441 hypothetical protein -2.0 7.1E-03 
Membrane proteins 
PA5182 hypothetical protein -3.2 3.3E-03 
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PA5568 conserved hypothetical protein -3.2 6.3E-03 
PA3821 secD secretion protein SecD -2.0 6.1E-03 
Protein secretion/export apparatus 
PA5128 secB secretion protein SecB -2.5 7.4E-03 
Putative 
enzymes 
PA0853 probable oxidoreductase -2.6 4.4E-03 
PA2024 probable ring-cleaving dioxygenase 6.1 2.5E-03 
Transcription, RNA processing and degradation 
PA3744 rimM 16S rRNA processing protein 6.2 4.7E-03 
PA4262 rplD 50S ribosomal protein L4 -3.0 6.3E-03 
Transcriptional regulators 
PA4781 
probable two-component response 
regulator 2.8 9.1E-03 
Translation, post-translational modification, degradation 
PA2970 rpmF 50S ribosomal protein L32 -3.8 7.3E-03 
PA4244 rplO 50S ribosomal protein L15 -2.6 6.0E-03 
PA4246 rpsE 30S ribosomal protein S5 -2.4 4.4E-03 
PA4247 rplR 50S ribosomal protein L18 -2.9 7.5E-03 
PA4248 rplF 50S ribosomal protein L6 -2.7 8.9E-03 
PA4261 rplW 50S ribosomal protein L23 -2.9 3.8E-03 
PA4272 rplJ 50S ribosomal protein L10 -3.7 6.3E-03 
PA4743 rbfA ribosome-binding factor A     -2.8 9.3E-03 
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Table S7: Genes in RGPs that are AmpR-regulated. AmpR regulates genes that are part of the different 
RGPs both in the presence and absence of a ß-lactam antibiotic, listed here with the corresponding fold 
changes (FC) and p-value. Locus tag annotations are from the Pseudomonas Genome database (31). 
 
AmpR-Dependent 
Locus 
Tag 
Gene 
Name Product Name Function Class FC 
Corrected 
p-Value 
 
RGP01      
PA0208 mdcA malonate decarboxylase alpha subunit 
Carbon compound 
catabolism -2.4 3.91E-03 
 
RGP02      
PA0263 hcpC secreted protein Hcp Secreted Factors (toxins, enzymes, alginate) -7.7 4.66E-03 
 
RGP03      
PA0614  hypothetical protein 
Hypothetical, unclassified, 
unknown 6.7 8.26E-03 
PA0615  hypothetical protein 
Hypothetical, unclassified, 
unknown 6.5 5.78E-03 
PA0616  hypothetical protein 
Related to phage, 
transposon, or plasmid 6.9 7.25E-03 
PA0617  
probable bacteriophage 
protein 
Related to phage, 
transposon, or plasmid 7.8 8.66E-03 
PA0618  
probable bacteriophage 
protein 
Related to phage, 
transposon, or plasmid 7.2 7.74E-03 
PA0619  
probable bacteriophage 
protein 
Related to phage, 
transposon, or plasmid 5.9 9.87E-03 
PA0620  
probable bacteriophage 
protein 
Related to phage, 
transposon, or plasmid 7.5 5.76E-03 
PA0621  
conserved hypothetical 
protein 
Related to phage, 
transposon, or plasmid 7.7 6.53E-03 
PA0622  
probable bacteriophage 
protein 
Related to phage, 
transposon, or plasmid 6.0 4.45E-03 
PA0623  
probable bacteriophage 
protein 
Related to phage, 
transposon, or plasmid 6.3 7.01E-03 
 
RGP04      
PA0641  
probable bacteriophage 
protein 
Related to phage, 
transposon, or plasmid 5.6 9.59E-03 
PA0643  hypothetical protein 
Related to phage, 
transposon, or plasmid 6.0 8.59E-03 
 
RGP05      
PA0729  hypothetical protein 
Hypothetical, unclassified, 
unknown 9.4 3.41E-03 
PA0717  
hypothetical protein of 
bacteriophage Pf1 
Hypothetical, unclassified, 
unknown 3.5 3.44E-03 
 
RGP09      
PA1092 fliC flagellin type B Motility & Attachment 2.5 9.63E-03 
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RGP20      
PA2030  hypothetical protein 
Hypothetical, unclassified, 
unknown -4.1 8.89E-03 
PA2031  hypothetical protein 
Hypothetical, unclassified, 
unknown -3.2 8.70E-03 
PA2034  hypothetical protein 
Hypothetical, unclassified, 
unknown -4.8 5.91E-03 
 
RGP23      
PA2232 pslB 
probable phosphomannose 
isomerase/GDP-mannose 
pyrophosphorylase 
Cell wall / LPS / capsule -3.2 8.70E-03 
PA2234 pslD PslD 
Cell wall / LPS / capsule ; 
Transport of small 
molecules 
-3.0 8.27E-03 
PA2222  hypothetical protein 
Hypothetical, unclassified, 
unknown -3.1 4.94E-03 
PA2235 pslE hypothetical protein Hypothetical, unclassified, unknown -3.0 3.18E-03 
 
RGP31      
PA3160 wzz O-antigen chain length regulator Cell wall / LPS / capsule 3.7 8.81E-03 
 
RGP34      
PA3499  hypothetical protein 
Hypothetical, unclassified, 
unknown 2.4 6.97E-03 
PA3505  hypothetical protein 
Hypothetical, unclassified, 
unknown 5.7 3.92E-03 
PA3498  probable oxidoreductase Putative enzymes 
-
24.6 7.22E-04 
PA3506 probable decarboxylase Putative enzymes 4.8 5.76E-03 
 
RGP44      
PA4100  probable dehydrogenase 
Central intermediary 
metabolism -2.7 6.81E-03 
 
RGP62      
PA5150   probable short-chain dehydrogenase Putative enzymes -2.0 5.46E-03 
AmpR-ß-lactam Dependent 
Locus 
Tag 
Gene 
Name Product Name Function Class FC 
Corrected 
p-Value 
 
RGP04       
PA0644  hypothetical protein 
Related to phage, 
transposon, or plasmid 5.0 9.73E-03 
 
RGP09      
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PA1088  hypothetical protein 
Hypothetical, unclassified, 
unknown 3.1 9.73E-03 
PA1090  hypothetical protein 
Hypothetical, unclassified, 
unknown 2.6 5.03E-03 
PA1091 fgtA flagellar glycosyl transferase, FgtA 
Hypothetical, unclassified, 
unknown 3.1 3.60E-03 
 
RGP20      
PA2024  
probable ring-cleaving 
dioxygenase Putative enzymes 6.1 2.46E-03 
 
RGP23      
PA2226  hypothetical protein 
Hypothetical, unclassified, 
unknown 2.5 8.16E-03 
 
RGP37      
PA3866 pyocin protein Adaptation, Protection  2.1 9.34E-03 
 
RGP42      
PA4673   conserved hypothetical protein 
Hypothetical, unclassified, 
unknown -2.8 7.09E-03 
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Table S8: Exclusively AmpR-, and AmpR-ß-lactam-dependent genes. The list of 219 genes, derived 
from the lists in Tables S3A and 4A, that are specifically dependent on AmpR, both without and with ß-
lactam stress, and are not differentially regulated in any of the 20 other published transcriptome studies (see 
text for details). Genes are listed as either up- or down-regulated with the corresponding corrected p-values 
for the fold change (FC) observed.  Locus tag annotations are from the Pseudomonas Genome database 
(31). 
 
AmpR-dependent; Downregulated     
Locus 
Tag 
Gene 
Name Product Name FC 
Corrected p-
value 
Adaptation, Protection       
PA2703 hypothetical protein -2.2 9.03E-03 
PA3109 hypothetical protein -2.6 9.59E-03 
PA5117 typA regulatory protein TypA -3.6 8.06E-03 
Amino acid biosynthesis and metabolism     
PA1337 ansB glutaminase-asparaginase -2.4 3.35E-03 
PA2443 sdaA L-serine dehydratase -10.6 4.02E-03 
PA5323 argB acetylglutamate kinase -2.6 4.45E-03 
Biosynthesis of cofactors, prosthetic groups and carriers     
PA4664 hemK probable methyl transferase -2.0 9.51E-03 
Carbon compound catabolism     
PA0208 mdcA malonate decarboxylase alpha subunit -2.4 3.91E-03 
Cell division       
PA0857 bolA morphogene protein BolA -2.3 2.78E-03 
Cell wall / LPS / 
capsule       
PA2232 pslB probable phosphomannose isomerase/GDP-mannose pyrophosphorylase -3.2 8.70E-03 
PA2235 pslE hypothetical protein -3.0 3.18E-03 
PA2236 pslF hypothetical protein -2.8 6.78E-03 
PA2238 pslH hypothetical protein -2.5 7.89E-03 
PA3646 lpxD UDP-3-O-[3-hydroxylauroyl] glucosamine N-acyltransferase -2.1 4.78E-03 
PA5077 mdoH periplasmic glucans biosynthesis protein MdoH -2.2 4.86E-03 
PA4625 hypothetical protein -2.9 8.25E-03 
PA2234 pslD PslD -3.0 8.27E-03 
Central intermediary metabolism     
PA2023 galU UTP--glucose-1-phosphate uridylyltransferase -2.5 4.75E-03 
PA4100 probable dehydrogenase -2.7 6.81E-03 
PA2442 gcvT2 glycine cleavage system protein T2 -4.8 3.36E-03 
Energy metabolism       
PA5553 atpC ATP synthase epsilon chain -2.2 5.71E-03 
Fatty acid and phospholipid metabolism     
PA0798 pmtA phospholipid methyltransferase -2.3 5.91E-03 
Hypothetical, unclassified, unknown     
PA0169 hypothetical protein -3.3 2.95E-03 
PA0370 conserved hypothetical protein -2.5 3.73E-03 
PA0371 hypothetical protein -2.5 3.68E-03 
PA0713 hypothetical protein -3.1 7.40E-03 
PA1605 hypothetical protein -2.3 7.41E-03 
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PA1732 conserved hypothetical protein -2.6 6.70E-03 
PA1968 hypothetical protein -2.5 6.60E-03 
PA1969 hypothetical protein -2.5 7.41E-03 
PA2222 hypothetical protein -3.1 4.94E-03 
PA2242 pslL hypothetical protein -2.7 3.41E-03 
PA2289 conserved hypothetical protein -2.3 7.15E-03 
PA3042 hypothetical protein -2.9 8.70E-03 
PA4182 hypothetical protein -2.6 5.46E-03 
PA4204 ppgL periplasmic gluconolactonase, PpgL -3.3 2.15E-03 
PA4384 hypothetical protein -3.0 4.66E-03 
PA4458 conserved hypothetical protein -2.0 2.15E-03 
PA4459 conserved hypothetical protein -2.7 6.00E-03 
PA5023 conserved hypothetical protein -2.2 4.66E-03 
PA5052 hypothetical protein -2.0 8.60E-03 
PA5104 conserved hypothetical protein -2.5 4.45E-03 
PA5463 hypothetical protein -2.0 8.59E-03 
PA0567 conserved hypothetical protein -3.2 9.87E-03 
PA3791 hypothetical protein -2.1 9.75E-03 
Membrane proteins       
PA2763 hypothetical protein -3.6 8.47E-03 
PA0606 probable permease of ABC transporter -2.4 4.43E-03 
PA2811 probable permease of ABC-2 transporter -4.6 6.12E-03 
Nucleotide biosynthesis and metabolism     
PA5496 nrdJb class II ribonucleotide-diphosphate reductase subunit, NrdJb -3.0 5.62E-03 
PA5497 nrdJa class II ribonucleotide-diphosphate reductase subunit, NrdJa -3.3 8.44E-03 
Protein secretion/export apparatus     
PA0077 icmF1 IcmF1 -3.0 8.66E-03 
PA5210 probable secretion pathway ATPase -2.3 3.31E-03 
Putative enzymes       
PA0507 probable acyl-CoA dehydrogenase -3.8 6.26E-03 
PA0534 conserved hypothetical protein -3.1 7.91E-03 
PA2317 probable oxidoreductase 2.9 2.78E-03 
PA3427 probable short-chain dehydrogenases -3.8 8.59E-03 
PA3454 probable acyl-CoA thiolase -3.9 4.33E-03 
PA5181 probable oxidoreductase -8.6 5.96E-03 
PA2237 pslG probable glycosyl hydrolase -2.4 6.82E-03 
PA2239 pslI probable transferase -3.0 4.02E-03 
PA2702 hypothetical protein -2.0 4.45E-03 
Transcriptional regulators     
PA0479 probable transcriptional regulator -2.1 9.90E-03 
PA2281 probable transcriptional regulator -2.1 9.89E-03 
PA5105 hutC histidine utilization repressor HutC -3.1 8.27E-03 
Translation, post-translational modification, degradation     
PA0594 surA peptidyl-prolyl cis-trans isomerase SurA -2.4 6.26E-03 
Transport of small molecules     
PA2987   probable ATP-binding component of ABC transporter -2.1 3.68E-03 
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AmpR-dependent; Upregulated     
Locus 
Tag 
Gene 
Name Product Name FC 
Corrected p-
value 
Adaptation, Protection       
PA4378 inaA InaA protein 3.0 6.68E-03 
PA2652 probable chemotaxis transducer 2.6 8.67E-03 
PA3348 probable chemotaxis protein methyltransferase 2.2 3.64E-03 
PA4309 pctA chemotactic transducer PctA 3.2 7.83E-03 
PA0923 dinB DNA Polymerase IV, DinB 4.5 6.05E-03 
Amino acid biosynthesis and metabolism     
PA0245 aroQ2 3-dehydroquinate dehydratase 2.9 3.71E-03 
PA4565 proB glutamate 5-kinase 2.9 5.03E-03 
Biosynthesis of cofactors, prosthetic groups and carriers     
PA4919 pncB1 nicotinate phosphoribosyltransferase 6.3 3.95E-03 
Carbon compound catabolism     
PA0230 pcaB 3-carboxy-cis,cis-muconate cycloisomerase 3.3 7.08E-03 
PA0231 pcaD beta-ketoadipate enol-lactone hydrolase 3.7 5.16E-03 
PA0232 pcaC gamma-carboxymuconolactone decarboxylase 4.1 8.44E-03 
PA2862 lipA lactonizing lipase precursor 3.6 5.97E-03 
Cell wall / LPS / 
capsule       
PA3160 wzz O-antigen chain length regulator 3.7 8.81E-03 
PA1082 flgG flagellar basal-body rod protein FlgG 2.9 8.52E-03 
Central intermediary metabolism     
PA2813 probable glutathione S-transferase 2.6 9.10E-03 
PA3629 adhC alcohol dehydrogenase class III 3.2 4.98E-03 
DNA replication, recombination, modification and repair     
PA0577 dnaG DNA primase 4.7 8.39E-03 
Hypothetical, unclassified, unknown     
PA0124 hypothetical protein 2.8 3.81E-03 
PA0729 hypothetical protein 9.4 3.41E-03 
PA0911 hypothetical protein 6.8 7.83E-03 
PA1016 hypothetical protein 2.6 7.58E-03 
PA1164 conserved hypothetical protein 2.1 3.66E-03 
PA1299 conserved hypothetical protein 3.0 3.41E-03 
PA1439 conserved hypothetical protein 2.2 7.28E-03 
PA1545 hypothetical protein 2.7 6.65E-03 
PA1744 hypothetical protein 3.1 5.62E-03 
PA2362 hypothetical protein 2.4 9.87E-03 
PA2487 hypothetical protein 11.6 2.26E-03 
PA2765 hypothetical protein 14.6 1.60E-03 
PA2901 hypothetical protein 16.5 4.43E-03 
PA3306 hypothetical protein 14.9 2.90E-03 
PA3353 hypothetical protein 2.3 6.40E-03 
PA3499 hypothetical protein 2.4 6.97E-03 
PA3505 hypothetical protein 5.7 3.92E-03 
PA3649 conserved hypothetical protein 2.1 6.31E-03 
PA3741 hypothetical protein 7.1 6.52E-03 
PA3951 conserved hypothetical protein 2.1 8.33E-03 
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PA4326 hypothetical protein 3.1 7.63E-03 
PA4379 conserved hypothetical protein 5.0 3.41E-03 
PA4918 hypothetical protein 16.9 2.59E-03 
PA4921 hypothetical protein 4.2 3.77E-03 
PA5292 pchP phosphorylcholine phosphatase 2.3 9.89E-03 
Membrane proteins       
PA2988 conserved hypothetical protein 2.2 5.73E-03 
PA3526 probable outer membrane protein precursor 2.3 3.64E-03 
PA3575 hypothetical protein 2.2 6.11E-03 
PA5561 atpI ATP synthase protein I 2.6 5.05E-03 
PA0240 probable porin 2.3 8.70E-03 
PA3228  
probable ATP-binding/permease fusion ABC 
transporter 3.5 1.38E-03 
Motility & Attachment       
PA1099 fleR two-component response regulator 3.0 7.63E-03 
Non-coding RNA gene       
PA3621.1 rsmZ regulatory RNA rsmZ 4.8 9.25E-03 
Protein secretion/export apparatus     
PA2863 lipH lipase modulator protein 2.2 4.85E-03 
Putative enzymes       
PA0242 hypothetical protein 2.6 7.19E-03 
PA0244 hypothetical protein 2.9 4.52E-03 
PA1296 probable 2-hydroxyacid dehydrogenase 3.2 3.44E-03 
PA3498 probable oxidoreductase 2.4 7.51E-03 
PA3506 probable decarboxylase 4.8 5.76E-03 
PA3628 probable esterase 2.9 5.71E-03 
PA3817 probable methyltransferase 4.2 5.32E-03 
PA5048 probable nuclease 3.2 9.01E-03 
Secreted Factors (toxins, enzymes, alginate)     
PA0843 plcR phospholipase accessory protein PlcR precursor 2.2 2.16E-03 
Transcription, RNA processing and degradation     
PA2840 probable ATP-dependent RNA helicase 3.5 4.17E-04 
PA2975 rluC ribosomal large subunit pseudouridine synthase C 6.5 6.17E-03 
PA4275 nusG transcription antitermination protein NusG 2.7 9.69E-03 
Transport of small molecules     
PA1256 amino acid ABC transporter ATP binding protein 2.3 8.26E-03 
PA5376  
probable ATP-binding component of ABC 
transporter 2.2 6.12E-03 
Two-component regulatory systems     
PA0757 probable two-component sensor 2.3 3.77E-03 
PA1098 fleS two-component sensor 2.5 6.65E-03 
 
 
     
AmpR-ß-lactam dependent; Downregulated genes     
Locus 
Tag 
Gene 
Name Product Name FC 
Corrected p-
value 
Amino acid biosynthesis and metabolism     
PA0390 metX homoserine O-acetyltransferase -2.5 6.29E-03 
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PA1750 phospho-2-dehydro-3-deoxyheptonate aldolase -2.4 8.53E-03 
PA4846 aroQ1 3-dehydroquinate dehydratase -2.3 6.79E-03 
PA0932 cysM cysteine synthase B -2.0 2.90E-03 
Biosynthesis of cofactors, prosthetic groups and carriers     
PA0024 hemF coproporphyrinogen III oxidase, aerobic -3.2 6.65E-03 
PA4280 birA BirA bifunctional protein -3.0 9.14E-03 
PA5118 thiI thiazole biosynthesis protein ThiI -2.9 7.95E-03 
PA3652 uppS undecaprenyl pyrophosphate synthetase -2.3 6.65E-03 
PA0342 thyA thymidylate synthase -2.1 8.99E-03 
Cell division       
PA5563 soj chromosome partitioning protein Soj -2.1 9.71E-03 
Cell wall / LPS / 
capsule       
PA4450 murA UDP-N-acetylglucosamine 1-carboxyvinyltransferase -2.1 9.73E-03 
PA4545 comL competence protein ComL -2.1 7.95E-03 
PA4481 mreB rod shape-determining protein MreB -4.4 6.51E-03 
Chaperones & heat shock proteins     
PA5193 yrfI heat shock protein HSP33 -2.5 6.65E-03 
DNA replication, recombination, modification and repair     
PA3620 mutS DNA mismatch repair protein MutS -2.6 9.22E-03 
Hypothetical, unclassified, unknown     
PA3472 hypothetical protein -5.4 8.53E-03 
PA4451 conserved hypothetical protein -3.7 7.09E-03 
PA4438 conserved hypothetical protein -3.4 6.65E-03 
PA2318 hypothetical protein -3.1 8.53E-03 
PA3453 conserved hypothetical protein -2.8 9.34E-03 
PA4004 conserved hypothetical protein -2.7 6.65E-03 
PA4574 conserved hypothetical protein -2.2 6.33E-03 
PA4492 conserved hypothetical protein -2.2 8.57E-03 
PA3664 conserved hypothetical protein -2.1 7.95E-03 
PA4460 conserved hypothetical protein -2.1 8.44E-03 
PA2823 conserved hypothetical protein -2.0 9.10E-03 
PA3483 hypothetical protein -2.0 7.09E-03 
Membrane proteins       
PA3828 conserved hypothetical protein -2.7 9.24E-03 
PA3794 hypothetical protein -2.3 4.37E-03 
PA4292 probable phosphate transporter -2.4 9.10E-03 
Nucleotide biosynthesis and metabolism     
PA5298 xanthine phosphoribosyltransferase -3.2 9.75E-03 
PA5336 gmk guanylate kinase -3.0 8.86E-03 
PA3527 pyrC dihydroorotase -2.5 8.09E-03 
PA0944 purN phosphoribosylaminoimidazole synthetase -2.2 9.73E-03 
Putative enzymes       
PA0386 probable oxidase -2.4 7.33E-03 
PA4389 probable short-chain dehydrogenase -2.1 7.86E-03 
Transcription, RNA processing and degradation     
PA0592 ksgA rRNA (adenine-N6,N6)-dimethyltransferase -2.6 8.56E-03 
PA4745 nusA N utilization substance protein A -2.3 8.39E-03 
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PA4853 fis DNA-binding protein Fis -3.3 6.65E-03 
PA3604 probable two-component response regulator -2.2 6.96E-03 
PA0463 creB two-component response regulator CreB -2.1 8.39E-03 
Translation, post-translational modification, degradation     
PA3656 rpsB 30S ribosomal protein S2 -4.0 9.34E-03 
PA4935 rpsF 30S ribosomal protein S6 -3.7 6.74E-03 
PA5569 rnpA ribonuclease P protein component -3.5 5.03E-03 
PA4253 rplN 50S ribosomal protein L14 -3.0 9.10E-03 
PA4263 rplC 50S ribosomal protein L3 -2.8 6.94E-03 
PA4257 rpsC 30S ribosomal protein S3 -2.7 8.90E-03 
PA4239 rpsD 30S ribosomal protein S4 -2.4 6.51E-03 
PA4254 rpsQ 30S ribosomal protein S17 -2.4 4.37E-03 
PA4251 rplE 50S ribosomal protein L5 -2.4 6.33E-03 
PA4665 prfA peptide chain release factor 1 -2.2 6.65E-03 
PA4274 rplK 50S ribosomal protein L11 -2.0 5.03E-03 
PA3818 extragenic suppressor protein SuhB -2.7 9.10E-03 
Transport of small molecules     
PA2983   probable tolQ-type transport protein -2.7 6.74E-03 
AmpR-ß-lactam dependent; Upregulated genes     
Locus 
Tag 
Gene 
Name Product Name FC 
Corrected p-
value 
Biosynthesis of cofactors, prosthetic groups and carriers     
PA0502 probable biotin biosynthesis protein bioH 2.3 7.53E-03 
Hypothetical, unclassified, unknown     
PA5191 hypothetical protein 2.2 8.23E-03 
PA0959 hypothetical protein 2.3 8.93E-03 
PA1043 hypothetical protein 2.3 6.65E-03 
PA2226 hypothetical protein 2.5 8.16E-03 
PA1090 hypothetical protein 2.6 5.03E-03 
PA4685 hypothetical protein 2.6 5.03E-03 
PA1356 hypothetical protein 2.6 7.87E-03 
PA4608 hypothetical protein 2.8 9.73E-03 
PA3089 hypothetical protein 2.9 9.50E-03 
PA1091 fgtA flagellar glycosyl transferase, FgtA 3.1 3.60E-03 
PA1088 hypothetical protein 3.1 9.73E-03 
PA4362 hypothetical protein 3.1 8.56E-03 
PA5101 hypothetical protein 3.2 8.55E-03 
PA1135 conserved hypothetical protein 3.8 5.57E-03 
PA2699 hypothetical protein 3.9 9.10E-03 
PA0484 conserved hypothetical protein 3.9 6.79E-03 
PA2374 hypothetical protein 4.1 6.96E-03 
PA1728 hypothetical protein 5.0 8.53E-03 
PA2381 hypothetical protein 7.5 8.44E-03 
PA1874 hypothetical protein 22.1 5.09E-03 
Membrane proteins       
PA2072 conserved hypothetical protein 2.2 9.80E-03 
PA1042 conserved hypothetical protein 2.7 9.05E-03 
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PA4614 mscL conductance mechanosensitive channel 2.3 5.57E-03 
PA1119 probable outer membrane protein precursor 2.2 9.22E-03 
Protein secretion/export apparatus     
PA1877 probable secretion protein 8.6 9.73E-03 
Putative enzymes       
PA0838 probable glutathione peroxidase 2.4 9.34E-03 
PA0804 probable oxidoreductase 2.5 9.10E-03 
PA0704 probable amidase 3.6 8.56E-03 
Secreted Factors (toxins, enzymes, alginate) ; Protein secretion/export apparatus ; Transport of small 
molecules  
PA1876  
probable ATP-binding/permease fusion ABC 
transporter 9.0 5.57E-03 
Transport of small molecules     
PA3858   probable amino acid-binding protein 2.3 5.19E-03 
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Table S9: Phenotypic microarray analysis of PAO1 and PAO∆ampR. Phenotypic microarray analysis 
was performed using Biolog plates, as explained in the text. Phenotypes gained indicate negative regulation 
by AmpR of these phenotypes, whereas phenotypes lost are those that are positively regulated by AmpR. 
 
Phenotypes Gained 
Plate no. Substrate Nature of substrate 
PM05  L-Histidine Nutritional supplement 
PM05  L-Leucine Nutritional supplement 
PM05  L-Serine Nutritional supplement 
PM05  L-Citrulline Nutritional supplement 
PM05  (-)Shikimic acid Nutritional supplement 
PM05  Spermidine Nutritional supplement 
PM05  Pyridoxal Nutritional supplement 
Phenotypes Lost 
Plate no. Substrate Nature of substrate 
PM02A L-Pyroglutamic acid C-Source, amino acid 
PM03B Uric acid N-Source, other 
PM11C Amoxicillin wall, lactam 
PM11C Potassium tellurite toxic anion 
PM11C Cephalothin wall, cephalosporin 
PM12B Penicillin G wall, lactam 
PM12B Oxacillin wall, lactam 
PM12B Paromomycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B Vancomycin wall 
PM12B Sisomicin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B Novobiocin DNA topoisomerase 
PM12B 2,4-Diamino-6,7-diisopropylpteridine folate antagonist, vibriostatic agent 
PM12B Tobramycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B Spectinomycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B Spiramycin protein synthesis, 50S ribosomal subunit, macrolide 
PM12B Rifampicin RNA polymerase 
PM14A Sodium metavanadate toxic anion, PO4 analog 
PM14A Sodium orthovanadate toxic anion, PO4 analog 
PM15B Guanidine hydrochloride membrane, chaotropic agent 
PM15B Cefmetazole wall, cephalosporin 
PM15B D- Cycloserine wall 
PM15B Alexidine membrane, electron transport, biguanide 
PM15B 3,4- Dimethoxybenzyl alcohol oxidizing agent, free radical-peroxidase substrate 
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PM15B 2- Nitroimidazole nitro compound, oxidizing agent, ribonucleotide DP reductase inhibitor 
PM16A Cefotaxime wall, cephalosporin 
PM16A Streptomycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM16A Chromium (III) chloride toxic cation 
PM17A 4-Aminopyridine ion channel inhibitor, K+ 
PM17A Lithium chloride toxic cation 
PM18C Azathioprine nucleic acid analog, purine 
PM18C Poly-L-lysine membrane, detergent, cationic 
PM18C Pentachlorophenol respiration, ionophore, H+ 
PM18C Sodium Bromate toxic anion 
PM18C Sodium periodate toxic anion, oxidizing agent 
PM18C Semicarbazide hydrochloride amine oxidase inhibitor, carcinogen 
PM18C 5-Fluoro-5`-deoxyuridine nucleic acid analog, pyrimidine, DNA synthesis 
PM19  Coumarin DNA intercalator 
PM19  Harmane imidazoline binding sites, agonist 
PM19  7-Hydroxycoumarin DNA intercalator 
PM19  Phenethicilllin wall, lactam 
PM19  
Lauryl sulfobetaine (N-Dodecyl-N,N-
dimethyl-3- ammonio-1-
propanesulfonate) 
membrane, detergent, zwitterionic 
PM20B Amitriptyline membrane, transport 
PM20B Orphenadrine anti-cholinergic 
PM20B Ciprofloxacin DNA topoisomerase 
PM20B Oxytetracycline protein synthesis, 30S ribosomal subunit, tetracycline 
PM20B Captan fungicide, carbamate 
PM20B Tolylfluanid fungicide, phenylsulphamide 
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Table S10: Primers used in this work. All primers were designed as part of this study. 
qRT in the primer name indicates that the primer was designed for qPCR. 
 
Primer Name Sequence 
      KMampRUF1 5'- GGAATTCAGCCTGGAACTTCCGCAATCTCGACGAGA -3' 
      KMampRUR1 5- GAGCATTCTAGCTAGCTAGGTTCGCCACCGAAGTGAGTACC -3' 
      KMampRDF2 5'- CTAGCTAGCTAGAATGCTCAATGGGGTCGAACCAATCTCTGCTCC 
-3' 
      KMampRDR2 5'- CGGGATCCGATGCTCGGGTTGGAATAGA -3' 
      DBS_ampRF2 
5'- 
GGGGTACCGAAGGAGATATACCTTGGTTCGACCCCATTTGCCGCTGAAC 
-3' 
      DBS_ampRR2 5'- CGAGCTCTCTCCCCCGCGCCTCAAC -3' 
      DBS_qRT_clpXF 5'- TGCGATTACGATGTGGAGA -3' 
      DBS_qRT_clpXR 5'- CCCTCGATGAGCTTCAGCA -3' 
      DBS_qRT_ampCF 5'- CGCCGTACAACCGGTGAT -3' 
      DBS_qRT_ampCR 5'- CGGCCGTCCTCTTTCGA -3' 
      DBS_qRT_ampGF 5'- GGCCTGACCTATGCGTTGTT -3' 
      DBS_qRT_ampGR 5'- CGACGGGTTGACGTGGAT -3' 
      DBS_qRT_ampPF 5'- ACCGCCGCCTGGTCAT -3' 
      DBS_qRT_ampPR 5'- CAGGCCGATGGGAATGC -3' 
      DBS_qRT_ampDF 5'- TCAGGAGCCCGATGCATTTCGATT -3' 
      DBS_qRT_ampDR 5'- ACGCAGGTTGAAATTCGGTGAAGG -3' 
      DBS_qRT_ampDh2F2 5'- CGCAGCGTGTTGCACATC -3' 
     DBS_qRT_ampDh2R2 5'- GGGTGAAGGCCAGTAGAACGAA -3' 
     DBS_qRT_ampDh3F2 5'- CGACGGCGTGTTCACCTT -3' 
     DBS_qRT_ampDh3R2 5'- CAGGATGTTCTTCGCCAGTTG -3' 
      DBS_qRT_nagZF 5'- ATGCAAGGCTCTCTGATGCTCGAC -3' 
      DBS_qRT_nagZR 5'- ATCATCTTCGCTCGCAACATCGAG -3' 
      DBS_qRT_mexTF 5'- ACCTCATGGGTTGTGACTGTATCC -3' 
      DBS_qRT_mexTR 5'- TAGGATCACTGACAGGCATAGCCA -3' 
      DBS_qRT_mexRF 5'- GTTCGTTGCATAGCGTTGTCCTCA -3' 
      DBS_qRT_mexRR 5'- TTGATAACCGGCCATCGAGCTAAA -3' 
      DBS_qRT_oprDF2 5'- TTTCCGCAGGTAGCACTCAGT -3' 
      DBS_qRT_oprDR2 5'- CTTCGCTTCGGCCTGATC -3' 
      DBS_qRT_lasAF 5'- TTCTGTGATCGATTCGGCTCGGTT -3' 
      DBS_qRT_lasAR 5'- ACCCGGGAAGACAACTATCAGCTT -3' 
      DBS_qRT_lecAF 5'- CACCATTGTGTTTCCTGGCGTTCA -3' 
      DBS_qRT_lecAR 5'- AGAAGGCAACGTCGACTCGTTGAT -3' 
      DBS_qRT_lecBF 5'- AGACAGCGTAACAATCGAACGAGC -3' 
      DBS_qRT_lecBR 5'- AGGACGCATCGTTCAGCCAATCTA -3' 
      DBS_qRT_rpoSF 5'- CGGCGAGTTGGTCATCATCAAACA -3' 
      DBS_qRT_rpoSR 5'- ATCGATTGCCCTACCTTGACCTGT -3' 
      DBS_qRT_fleRSF 5'- TAGAGAAGATGCGCAAGTACGGCA -3' 
      DBS_qRT_fleRSR 5'- TGTCGGTCGACGGAGATATAGCAA -3' 
      DBS_qRT_pcrHF 5'- CGCTCAACCGCTTCATCCAGAAAT -3' 
      DBS_qRT_pcrHR 5'- TAGAGGTATCCATGAACCAGCCGA -3' 
      DBS_qRT_exsEF 5'- CCGTTTCGATCTGCATTTCGGCTT -3' 
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      DBS_qRT_exsER 5'- CAACTGACCCTCGAATGCTTCGA -3' 
      DBS_qRT_rsmZF2 5'- GACGGTACTGGGTGTCAAAGG -3' 
      DBS_qRT_rsmZR2 5'- TGGTAAATTTCCTCCCGGTGTA -3' 
      DBS_qRT_prtRF 5'- TCCCTGCACCCATGTGAAATCTCT -3' 
      DBS_qRT_prtRR 5'- ATCGGCAATCTACAGACCGATGGA -3' 
      DBS_qRT_creBF 5'- GCATATCCTGATCGTCGAAGATG -3' 
      DBS_qRT_creBR 5'- GGCCTGCAGGGCGTAGA -3' 
      DBS_qRT_creDF 5'- CGCCATCGCCCTACTCAT -3' 
      DBS_qRT_creDR 5'- GGCGATCGCGGATCAG -3' 
      DBS_qRT_prtNF 5'- CTGGTTTCGCAACCTGAACAAGGA -3' 
      DBS_qRT_prtNR 5'- TAGTCACAAGGCCATGCAGTTCGT -3' 
      DBS_qRT_algTF 5'- AACCCAGGAACAGGATCAGCAACT -3' 
      DBS_qRT_algTR 5'- AGATACTGGGATTGATCGTGCGGT -3' 
      DBS_qRT_PA3602F 5'- ACGAATTCATCAGCCACTCGATGC -3' 
      DBS_qRT_PA3602R 5'- TGTTCAACGTCTCGGCGATGAGTT -3' 
      DBS_qRT_mexEF 5'- TCATCGAACAACCGCTGAACGAGT -3' 
      DBS_qRT_mexER 5'- ATGAAGGCGCACTGGTGAAGAAAG -3' 
      DBS_qRT_PA4121F 5'- ATCAAGACACCGAATACCCGCAAC -3' 
      DBS_qRT_PA4121R 5'- TACGTGATCGTCAACGAGTTCAGC -3' 
      DBS_qRT_popBF 5'- AACTCAAGCTGACCGAAATCGAGC -3' 
      DBS_qRT_popBR 5'- ACAACCAGCAGAAGATCAGGGAGT -3' 
      DBS_qRT_hcnAF 5'- TTGAACGTCAACACGATATCCAGCCC -3' 
      DBS_qRT_hcnAR 5'- AGACCGTGCTCAACGTGCTCAAT -3' 
      DBS_qRT_flgCF 5'- GTCGAGGAAATGGCCGACATGATT -3' 
      DBS_qRT_flgCR 5'- ACCGCCAAACAGATGATGCAGAAG -3' 
      DBS_qRT_PA2069F 5'- AAACCAGGTGCTGGGCATGTTCAA -3' 
      DBS_qRT_PA2069R 5'- AACGCACCGAGTTCATGCCATT -3' 
      DBS_qRT_PA2331F 5'- TTATATCCCGAATCTGCTCGGCGT -3' 
      DBS_qRT_PA2331R 5'- ATGGCTGCGACTTCTGCGTT -3' 
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Supplementary Table 1: Key to identifying AmpR-regulated genes. Using the data from Figure 5.2, 
AmpR-regulated genes, both in the presence and absence of ß-lactam stress, were identified using this table. 
Condition 1: PAO1 uninduced vs. PAO1 induced; Condition II: PAO∆ampR uninduced vs. PAO∆ampR 
induced; Condition III: PAO1 uninduced vs. PAO∆ampR uninduced; Condition IV: PAO1 induced vs. 
PAO∆ampR induced. Out of the 1703 genes in Figure 5.2, 1623 genes were categorized here. Eighty genes 
in the following categories were omitted from further analysis for the following reasons: regulated in all 
four conditions [category O (24 genes)]; could not be assigned unambiguously [category H (44 genes), 
category K (1 gene), category M (4 genes), category N (7 genes)]. 
 
Regulation Venn Category 
# Genes 
Regulated 
(Total in 
Category) 
Condition (Expression) Regulation 
AmpR-
dependent,      
ß-lactam 
independent 
(654) 
B 135 (281) II (up)  Negative 
B 146 (281) II (down) Positive 
C 132 (171) III (up) Negative 
C 39 (171) III (down) Positive 
J 70 (185) III (up), IV (up) Negative 
J 115 (185) III (down), IV (down)  Positive 
M 2 (12) I (down), III (up), IV (up) Negative 
M 6 (12) I (up), III (down), IV (down) Positive 
N 2 (27) II (up), III (up), IV (up)  Negative 
N 7 (27) 
II (down), III (down), IV 
(down) Positive 
AmpR-ß-
lactam-
dependent 
(483) 
D 239 (392) IV (up) Negative 
D 153 (392) IV (down) Positive 
H 72 (116) I (up), IV (down) Positive 
L 11 (26) I (up), II (down), IV (down) Positive 
L 8 (26) I (down), II (up), IV (up) Negative 
AmpR-
independent,     
ß-lactam-
dependent 
(486) 
A 26 (108) I (down) Negative 
A 82 (108) I (up) Positive 
G 49 (65) II (down), III (up) Negative 
G 16 (65) II (up), III (down) Positive 
F 16 (47) I (down), III (down) Negative 
F 31 (47) I (up), III (up)  Positive 
I 84 (198) II (down), IV (down) Negative 
I 114 (198) II (up), IV (up) Positive 
E 19 (50) I (down), II (down) Negative 
E 31 (50) I (up), II (up) Positive 
L 6 (26) 
I (down), II (down), IV 
(down) Negative 
L 1 (26) I (up), II (up), IV (up) Positive 
N 8 (27) II (down), III (up), IV (down) Negative 
N 3 (27) II (up), III (down), IV (up) Positive 
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Supplementary Table 2: AmpR-dependent genes. The positively and negatively AmpR-regulated genes are classified based on information in Supplementary 
Table 1. Only genes that are > 2.0, Bonferroni correction (<0.05) are listed. Functional categorization, gene ID and gene/product names are from the 
Pseudomonas Genome database (Winsor et al 2011). Lack of expression of a gene under any of the four conditions is denoted as NA.  
 
Gene ID Gene name Product Name 
Condition 1 Condition 2 Condition 3 Condition 4 
FC Corrected p-value FC 
Corrected 
p-value FC 
Corrected 
p-value FC 
Corrected 
p-value 
Genes positively regulated by AmpR (313) 
Adaptation, Protection 
PA1001 phnA anthranilate synthase component I NA NA NA NA -20.0 8.86E-11 -81.2 0.00E+00 
PA2385 pvdQ 3-oxo-C12-homoserine lactone acylase PvdQ NA NA NA NA -11.2 1.10E-07 NA NA 
PA2386 pvdA L-ornithine N5-oxygenase NA NA NA NA -5.3 0.00E+00 -7.2 6.05E-14 
PA2392 pvdP PvdP NA NA NA NA -102.6 0.00E+00 -18.5 0.00E+00 
PA2394 pvdN PvdN NA NA NA NA -7.8 1.74E-08 -67.1 5.35E-14 
PA2395 pvdO PvdO NA NA NA NA -82.9 0.00E+00 -2.9 7.65E-06 
PA2411   probable thioesterase NA NA NA NA -5.2 9.31E-14 -23.4 0.00E+00 
PA2413 pvdH L-2,4-diaminobutyrate:2-ketoglutarate 4-aminotransferase, PvdH NA NA NA NA -3.5 5.94E-10 -4.1 1.05E-10 
PA2424 pvdL PvdL NA NA NA NA -5.2 1.80E-05 -7.1 1.19E-05 
PA2425 pvdG PvdG NA NA NA NA -7.6 5.66E-07 -37.6 2.58E-08 
PA2788   probable chemotaxis transducer NA NA NA NA -12.4 2.08E-06 NA NA 
PA2850 ohr organic hydroperoxide resistance protein NA NA 
-
30.6 4.59E-08 NA NA NA NA 
PA2867   probable chemotaxis transducer NA NA -2.6 6.69E-08 NA NA NA NA 
PA3327   probable non-ribosomal peptide synthetase NA NA NA NA -22.3 0.00E+00 
-
113.0 1.03E-14 
PA3331   cytochrome P450 NA NA NA NA -15.7 7.89E-14 -160.0 0.00E+00 
PA3450   probable antioxidant protein NA NA NA NA -4.3 8.61E-07 NA NA 
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PA3475 pheC cyclohexadienyl dehydratase precursor NA NA NA NA -3.8 1.58E-06 -3.6 7.51E-09 
PA4236 katA catalase NA NA NA NA -2.1 1.58E-09 NA NA 
PA4468 sodM superoxide dismutase NA NA NA NA -34.8 3.26E-07 NA NA 
PA4566 obg GTP-binding protein Obg NA NA -2.2 1.38E-11 NA NA NA NA 
Amino acid biosynthesis and metabolism 
PA0292 aguA agmatine deiminase NA NA -6.9 5.28E-12 NA NA NA NA 
PA0297 spuA probable glutamine amidotransferase NA NA -2.2 2.29E-06 NA NA NA NA 
PA1002 phnB anthranilate synthase component II NA NA NA NA -31.4 1.36E-06 NA NA 
PA1217   probable 2-isopropylmalate synthase NA NA NA NA -39.7 3.85E-08 NA NA 
PA1757 thrH homoserine kinase NA NA -3.6 1.65E-07 NA NA NA NA 
PA3121 leuC 3-isopropylmalate dehydratase large subunit NA NA 
-
10.8 5.82E-09 NA NA NA NA 
PA3418 ldh leucine dehydrogenase NA NA NA NA -5.9 3.35E-07 NA NA 
PA3736 hom homoserine dehydrogenase NA NA -2.2 2.53E-06 NA NA NA NA 
PA5092 hutI imidazolone-5-propionate hydrolase HutI NA NA 
-
21.7 5.35E-06 NA NA NA NA 
Antibiotic Resistance and susceptibility 
PA5471   hypothetical protein NA NA -3.1 2.96E-12 NA NA NA NA 
Biosynthesis of cofactors, prosthetic groups and carriers 
PA0350 folA dihydrofolate reductase NA NA -5.1 2.38E-08 NA NA NA NA 
PA0582 folB dihydroneopterin aldolase NA NA -3.6 1.11E-06 NA NA NA NA 
PA0996 pqsA probable coenzyme A ligase NA NA NA NA -17.3 3.99E-15 -101.7 0.00E+00 
PA0997 pqsB PqsB NA NA NA NA -25.2 4.83E-14 -8.4 0.00E+00 
PA0998 pqsC PqsC NA NA NA NA -81.3 7.75E-14 -89.2 0.00E+00 
PA0999 pqsD 3-oxoacyl-[acyl-carrier-protein] synthase III NA NA NA NA -5.9 1.24E-13 -18.5 0.00E+00 
PA1000 pqsE Quinolone signal response protein NA NA NA NA -8.2 0.00E+00 -190.3 0.00E+00 
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PA3627 ygbB 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase NA NA -2.4 3.63E-07 NA NA NA NA 
PA4055 ribC riboflavin synthase alpha chain NA NA -2.7 1.46E-05 NA NA NA NA 
Carbon compound catabolism 
PA0211 mdcD malonate decarboxylase beta subunit NA NA -20.3 1.18E-05 NA NA NA NA 
PA0810   probable haloacid dehalogenase NA NA -25.0 9.50E-07 NA NA NA NA 
PA2300 chiC chitinase NA NA NA NA -232.8 0.00E+00 -14.9 0.00E+00 
PA2507 catA catechol 1,2-dioxygenase NA NA -8.0 5.38E-09 NA NA NA NA 
PA2514 antC anthranilate dioxygenase reductase NA NA -8.7 3.03E-09 -2.1 1.90E-05 -31.2 0.00E+00 
PA5418 soxA sarcosine oxidase alpha subunit NA NA -15.9 5.01E-07 NA NA NA NA 
Cell wall / LPS / capsule ; Motility & Attachment 
PA1078 flgC flagellar basal-body rod protein FlgC NA NA -2.9 1.24E-06 NA NA NA NA 
PA1094 fliD flagellar capping protein FliD NA NA -2.0 2.20E-08 NA NA NA NA 
Central intermediary metabolism 
PA0654 speD S-adenosylmethionine decarboxylase proenzyme NA NA -2.9 4.36E-12 NA NA NA NA 
PA2193 hcnA hydrogen cyanide synthase HcnA NA NA NA NA -150.1 6.88E-14 -9.7 0.00E+00 
PA2194 hcnB hydrogen cyanide synthase HcnB NA NA NA NA -4.5 7.21E-10 -5.0 5.09E-14 
PA2195 hcnC hydrogen cyanide synthase HcnC NA NA NA NA -3.9 5.31E-10 -12.2 0.00E+00 
PA2393   probable dipeptidase precursor NA NA NA NA -17.1 1.15E-10 -64.0 2.08E-13 
PA3629 adhC alcohol dehydrogenase class III NA NA -2.3 2.79E-07 NA NA NA NA 
PA4130   probable sulfite or nitrite reductase NA NA NA NA -12.0 0.00E+00 -32.1 0.00E+00 
PA5058 phaC2 
poly(3-hydroxyalkanoic acid) synthase 
2 NA NA NA NA -6.9 1.10E-05 -25.6 5.40E-06 
PA5421 fdhA glutathione-independent formaldehyde dehydrogenase NA NA -4.7 1.87E-06 NA NA NA NA 
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Chemotaxis 
PA0415 chpC probable chemotaxis protein NA NA -2.4 1.26E-05 NA NA NA NA 
DNA replication, recombination, modification and repair 
PA3867   probable DNA invertase NA NA -22.8 3.04E-06 NA NA NA NA 
Energy metabolism 
PA1175 napD NapD protein of periplasmic nitrate reductase NA NA NA NA -3.8 1.75E-05 -43.5 1.74E-09 
PA1320 cyoD cytochrome o ubiquinol oxidase subunit IV NA NA NA NA -35.2 2.73E-07 NA NA 
PA3930 cioA cyanide insensitive terminal oxidase NA NA NA NA -4.0 5.69E-10 -9.7 0.00E+00 
PA4133   cytochrome c oxidase subunit (cbb3-type) NA NA NA NA -24.3 5.31E-14 -38.0 0.00E+00 
PA5490 cc4 cytochrome c4 precursor NA NA -2.1 0.00E+00 NA NA NA NA 
Fatty acid and phospholipid metabolism 
PA3333 fabH2 3-oxoacyl-[acyl-carrier-protein] synthase III NA NA NA NA 
-
147.6 3.15E-14 -37.0 0.00E+00 
PA3334   probable acyl carrier protein 2.8 0.00E+00 NA NA -118.2 0.00E+00 
-
359.1 1.64E-13 
PA4050 pgpA phosphatidylglycerophosphatase A NA NA -3.6 7.94E-09 NA NA NA NA 
PA4351   probable acyltransferase NA NA NA NA -30.4 2.03E-06 -27.7 2.09E-06 
Hypothetical, unclassified, unknown 
PA0050   hypothetical protein NA NA NA NA -4.5 0.00E+00 -4.4 8.02E-15 
PA0057   hypothetical protein NA NA -24.7 1.11E-06 NA NA NA NA 
PA0066   conserved hypothetical protein NA NA -5.1 7.49E-08 NA NA NA NA 
PA0122   conserved hypothetical protein NA NA NA NA -14.7 1.07E-13 -42.9 1.48E-13 
PA0128   conserved hypothetical protein NA NA -5.1 5.15E-12 NA NA NA NA 
PA0160   hypothetical protein NA NA -47.1 5.36E-12 -2.4 1.52E-06 -77.2 5.35E-14 
PA0200   hypothetical protein NA NA NA NA -4.0 0.00E+00 -9.7 0.00E+00 
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PA0264   hypothetical protein NA NA -21.0 7.91E-06 NA NA NA NA 
PA0284   hypothetical protein NA NA NA NA -64.6 8.56E-13 -39.2 1.19E-08 
PA0320   conserved hypothetical protein NA NA -37.4 1.11E-09 NA NA NA NA 
PA0387   conserved hypothetical protein NA NA -2.7 4.49E-06 NA NA NA NA 
PA0433   hypothetical protein NA NA -20.1 1.26E-05 NA NA NA NA 
PA0569   hypothetical protein NA NA NA NA -25.1 1.87E-05 NA NA 
PA0570   hypothetical protein NA NA -25.2 8.47E-07 NA NA NA NA 
PA0587   conserved hypothetical protein NA NA NA NA -4.9 1.59E-06 NA NA 
PA0591   conserved hypothetical protein NA NA -3.6 2.87E-06 NA NA NA NA 
PA0614   hypothetical protein NA NA -3.1 1.53E-13 NA NA NA NA 
PA0671   hypothetical protein NA NA -3.3 7.38E-07 NA NA NA NA 
PA0719   hypothetical protein of bacteriophage Pf1 NA NA 
-
34.8 4.83E-09 NA NA NA NA 
PA0774   conserved hypothetical protein NA NA -4.0 5.47E-06 NA NA NA NA 
PA0805   hypothetical protein NA NA -2.7 3.70E-13 NA NA NA NA 
PA0812   hypothetical protein NA NA -8.7 1.81E-07 NA NA NA NA 
PA0814   conserved hypothetical protein NA NA -30.2 5.78E-08 NA NA NA NA 
PA0826   hypothetical protein NA NA -27.4 2.61E-07 NA NA NA NA 
PA0910   hypothetical protein NA NA -2.4 1.50E-14 NA NA NA NA 
PA0911   hypothetical protein NA NA -3.1 6.56E-14 NA NA NA NA 
PA0983   conserved hypothetical protein NA NA NA NA -73.9 2.82E-14 -49.9 9.97E-11 
PA1134   hypothetical protein NA NA -25.2 8.47E-07 NA NA NA NA 
PA1216   hypothetical protein NA NA NA NA -38.0 8.26E-08 -76.9 1.03E-14 
PA1299   conserved hypothetical protein NA NA -4.3 2.58E-07 NA NA NA NA 
PA1371   hypothetical protein NA NA NA NA -2.6 1.79E-05 NA NA 
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PA1377   conserved hypothetical protein NA NA -2.9 1.22E-05 NA NA NA NA 
PA1378   hypothetical protein NA NA NA NA -26.0 1.28E-05 NA NA 
PA1533   conserved hypothetical protein NA NA NA NA -2.0 2.85E-07 NA NA 
PA1539   hypothetical protein NA NA -25.8 6.10E-07 NA NA NA NA 
PA1656   hypothetical protein NA NA NA NA -5.9 2.94E-09 NA NA 
PA1657   conserved hypothetical protein 2.7 2.58E-13 NA NA -79.2 1.86E-14 -226.7 0.00E+00 
PA1664   hypothetical protein NA NA NA NA -33.5 5.43E-07 -50.9 6.21E-11 
PA1888   hypothetical protein NA NA NA NA -28.5 4.59E-06 NA NA 
PA2031   hypothetical protein NA NA NA NA -27.8 6.11E-06 -28.2 1.73E-06 
PA2033   hypothetical protein NA NA NA NA -26.0 1.30E-05 NA NA 
PA2066   hypothetical protein NA NA NA NA -40.7 2.57E-08 -33.7 1.43E-07 
PA2126   conserved hypothetical protein NA NA -27.5 2.44E-07 NA NA NA NA 
PA2274   hypothetical protein NA NA NA NA -37.5 1.00E-07 NA NA 
PA2330   hypothetical protein NA NA NA NA -31.0 1.59E-06 NA NA 
PA2362   hypothetical protein NA NA NA NA -34.3 3.99E-07 -3.4 4.54E-06 
PA2363   hypothetical protein NA NA NA NA -9.5 1.30E-05 -6.8 1.01E-05 
PA2366   uricase PuuD NA NA NA NA -55.7 3.99E-11 -8.8 5.10E-07 
PA2367   hypothetical protein NA NA NA NA -8.1 3.77E-11 -57.7 2.93E-12 
PA2380   hypothetical protein NA NA -37.0 1.43E-09 NA NA NA NA 
PA2412   conserved hypothetical protein NA NA NA NA -13.3 1.86E-14 -10.7 0.00E+00 
PA2427   hypothetical protein NA NA NA NA -55.5 4.23E-11 NA NA 
PA2605   conserved hypothetical protein NA NA -3.6 4.52E-06 NA NA NA NA 
PA2627   conserved hypothetical protein NA NA -28.2 1.70E-07 NA NA NA NA 
PA2661   hypothetical protein NA NA -39.2 4.15E-10 NA NA NA NA 
PA2669   hypothetical protein NA NA - 3.67E-06 NA NA NA NA 
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22.5 
PA2679   hypothetical protein NA NA -23.3 2.38E-06 NA NA NA NA 
PA2747   hypothetical protein NA NA NA NA -4.8 8.82E-09 NA NA 
PA2781   hypothetical protein NA NA -25.6 6.75E-07 NA NA NA NA 
PA2799   hypothetical protein NA NA NA NA -47.3 1.51E-09 -23.9 1.12E-05 
PA2941   hypothetical protein NA NA -20.4 1.13E-05 NA NA NA NA 
PA2955   hypothetical protein NA NA -3.3 4.24E-06 NA NA NA NA 
PA2980   conserved hypothetical protein NA NA -2.9 1.11E-07 NA NA NA NA 
PA3008   hypothetical protein NA NA -2.3 1.13E-10 NA NA NA NA 
PA3069   hypothetical protein NA NA NA NA -42.1 1.40E-08 -58.1 2.42E-12 
PA3088   conserved hypothetical protein NA NA -3.6 1.62E-05 NA NA NA NA 
PA3089   hypothetical protein NA NA NA NA -31.8 1.12E-06 NA NA 
PA3127   hypothetical protein NA NA -21.8 5.20E-06 NA NA NA NA 
PA3199   conserved hypothetical protein NA NA -4.3 1.68E-05 NA NA NA NA 
PA3209   conserved hypothetical protein NA NA -23.5 2.04E-06 NA NA NA NA 
PA3273   hypothetical protein NA NA -21.9 4.91E-06 NA NA NA NA 
PA3289   hypothetical protein NA NA NA NA -28.5 4.50E-06 NA NA 
PA3329   hypothetical protein NA NA NA NA -14.7 0.00E+00 -151.3 0.00E+00 
PA3332   conserved hypothetical protein NA NA -30.8 4.11E-08 -6.8 0.00E+00 
-
320.3 1.40E-13 
PA3386   conserved hypothetical protein NA NA -23.9 1.66E-06 NA NA NA NA 
PA3612   conserved hypothetical protein NA NA NA NA -63.9 1.13E-12 -32.4 2.64E-07 
PA3616   conserved hypothetical protein NA NA -3.1 1.13E-13 NA NA NA NA 
PA3688   hypothetical protein NA NA NA NA -4.8 1.89E-07 - 6.60E-14 
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104.1 
PA3707 wspB hypothetical protein NA NA -4.3 1.66E-06 NA NA NA NA 
PA3784   hypothetical protein NA NA NA NA -4.4 1.62E-11 -8.8 5.04E-14 
PA3785   conserved hypothetical protein NA NA NA NA -3.0 7.44E-13 -3.6 3.86E-14 
PA3786   hypothetical protein NA NA NA NA -2.1 1.56E-05 -2.9 4.52E-08 
PA3931   conserved hypothetical protein NA NA NA NA -6.2 9.11E-10 -3.9 2.09E-07 
PA4018   hypothetical protein NA NA -31.7 2.51E-08 NA NA NA NA 
PA4129   hypothetical protein NA NA -44.8 1.92E-11 -7.2 0.00E+00 
-
440.6 1.03E-14 
PA4132   conserved hypothetical protein NA NA NA NA -4.8 0.00E+00 -10.5 0.00E+00 
PA4134   hypothetical protein NA NA NA NA -320.9 0.00E+00 
-
236.5 0.00E+00 
PA4220   hypothetical protein NA NA NA NA -41.9 1.51E-08 -76.4 0.00E+00 
PA4294   hypothetical protein NA NA NA NA -37.3 1.10E-07 -28.3 1.61E-06 
PA4336   conserved hypothetical protein NA NA -29.9 6.69E-08 NA NA NA NA 
PA4471   hypothetical protein NA NA -22.1 4.37E-06 NA NA NA NA 
PA4536   hypothetical protein 2.8 1.34E-05 NA NA -26.3 1.16E-05 -4.9 2.99E-09 
PA4607   hypothetical protein NA NA NA NA -2.7 0.00E+00 -2.3 0.00E+00 
PA4634   hypothetical protein NA NA -28.5 1.47E-07 NA NA NA NA 
PA4702   hypothetical protein NA NA NA NA -5.7 1.10E-09 NA NA 
PA4800   hypothetical protein NA NA -21.9 4.98E-06 NA NA NA NA 
PA5139   hypothetical protein NA NA -41.0 1.49E-10 NA NA NA NA 
PA5220   hypothetical protein NA NA NA NA -10.5 7.39E-14 -34.1 0.00E+00 
PA5275   conserved hypothetical protein NA NA -3.6 5.51E-07 NA NA NA NA 
PA5294   hypothetical protein NA NA -29.9 7.04E-08 NA NA NA NA 
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PA5343   hypothetical protein NA NA -3.1 3.10E-06 NA NA NA NA 
PA5359   hypothetical protein NA NA NA NA -2.5 2.51E-10 -3.6 4.81E-14 
PA5381   hypothetical protein NA NA -4.3 1.51E-08 NA NA NA NA 
PA5414   hypothetical protein NA NA -2.5 1.46E-06 NA NA NA NA 
PA5543   hypothetical protein NA NA -22.0 4.78E-06 NA NA NA NA 
Membrane proteins 
PA1540   conserved hypothetical protein NA NA -26.5 4.12E-07 NA NA NA NA 
PA2068   probable major facilitator superfamily (MFS) transporter NA NA NA NA -87.3 4.55E-14 
-
104.9 0.00E+00 
PA2331   hypothetical protein NA NA NA NA -5.2 1.33E-05 -51.2 5.50E-11 
PA2568   hypothetical protein NA NA -42.9 5.28E-11 NA NA NA NA 
PA2653   probable transporter NA NA -19.8 1.49E-05 NA NA NA NA 
PA3234   probable sodium:solute symporter NA NA -2.7 6.89E-07 NA NA NA NA 
PA3275   conserved hypothetical protein NA NA NA NA -43.0 9.54E-09 NA NA 
PA3281   hypothetical protein NA NA -22.2 4.12E-06 NA NA NA NA 
PA3336   probable major facilitator superfamily (MFS) transporter NA NA NA NA -7.0 1.47E-11 -16.6 5.35E-14 
PA3608 potB polyamine transport protein PotB NA NA -19.6 1.68E-05 NA NA NA NA 
PA3788   hypothetical protein NA NA NA NA -59.7 7.14E-12 -5.8 1.56E-13 
PA3794   hypothetical protein NA NA -38.4 6.39E-10 NA NA NA NA 
PA4205         hypothetical protein NA NA NA NA -269.6 0.00E+00 
-
257.1 0.00E+00 
PA4207 mexI probable Resistance-Nodulation-Cell Division (RND) efflux transporter NA NA NA NA -11.5 0.00E+00 -10.2 5.04E-14 
PA4208 opmD probable outer membrane protein precursor NA NA NA NA -10.1 6.22E-14 -33.1 0.00E+00 
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PA4218 ampP AmpP NA NA NA NA -81.6 0.00E+00 -12.7 1.46E-12 
PA4219   hypothetical protein NA NA NA NA -49.9 5.03E-10 -42.4 2.86E-09 
PA4223   probable ATP-binding component of ABC transporter NA NA NA NA -29.5 0.00E+00 -20.5 5.04E-14 
PA4317   hypothetical protein NA NA -2.0 4.43E-08 NA NA NA NA 
PA5097   probable amino acid permease NA NA -8.0 2.80E-06 NA NA NA NA 
PA5099   probable transporter NA NA -21.2 6.98E-06 NA NA NA NA 
PA5211   conserved hypothetical protein NA NA NA NA -31.3 1.39E-06 NA NA 
PA5219   hypothetical protein NA NA NA NA -9.5 3.72E-06 -36.1 4.92E-08 
PA5469   conserved hypothetical protein NA NA -22.9 2.90E-06 NA NA NA NA 
Motility & Attachment 
PA4306 flp Type IVb pilin, Flp NA NA -60.0 0.00E+00 -5.2 0.00E+00 
-
524.7 1.92E-13 
Non-coding RNA gene 
PA1030.
1 P8 P8 2.8 2.46E-06 NA NA -30.3 2.14E-06 -92.1 1.03E-14 
PA2958.
1 rgsA RgsA NA NA -2.9 9.71E-14 -2.0 5.61E-13 -3.4 0.00E+00 
PA4277.
3   tRNA-Tyr NA NA -2.0 0.00E+00 -5.5 0.00E+00 -8.4 0.00E+00 
PA4581.
1   tRNA-Arg NA NA -3.1 3.62E-13 NA NA NA NA 
PA4704.
1 prrF1 regulatory RNA PrrF1 NA NA NA NA -3.9 0.00E+00 NA NA 
Protein secretion/export apparatus 
PA1715 pscB type III export apparatus protein NA NA -20.7 9.31E-06 NA NA NA NA 
PA1719 pscF type III export protein PscF NA NA NA NA -27.5 7.00E-06 -27.8 1.99E-06 
PA2674   probable type II secretion system protein NA NA 
-
32.0 2.20E-08 NA NA NA NA 
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PA3104 xcpP secretion protein XcpP NA NA NA NA -2.0 1.73E-07 NA NA 
PA4142   probable secretion protein NA NA NA NA -45.1 3.80E-09 NA NA 
PA4304 rcpA RcpA NA NA NA NA -11.9 1.30E-07 -8.8 3.80E-08 
Putative Enzymes 
PA0483   probable acetyltransferase NA NA NA NA -26.6 1.01E-05 NA NA 
PA0829   probable hydrolase NA NA -23.2 2.40E-06 NA NA NA NA 
PA0953   probable thioredoxin NA NA -3.1 1.02E-10 NA NA NA NA 
PA1662   probable ClpA/B-type protease NA NA NA NA -9.3 1.64E-05 NA NA 
PA2067   probable hydrolase NA NA NA NA -14.3 0.00E+00 -139.6 6.29E-14 
PA2069   probable carbamoyl transferase NA NA NA NA -167.1 0.00E+00 
-
204.0 0.00E+00 
PA2402   probable non-ribosomal peptide synthetase NA NA NA NA -4.5 4.50E-06 -7.4 7.27E-08 
PA2546   probable ring-cleaving dioxygenase NA NA -20.3 1.18E-05 NA NA NA NA 
PA3328   probable FAD-dependent monooxygenase NA NA NA NA -85.1 1.18E-14 -25.3 0.00E+00 
PA3330   probable short chain dehydrogenase 2.0 2.91E-08 NA NA -21.4 0.00E+00 -30.2 0.00E+00 
PA3883   probable short-chain dehydrogenase NA NA -21.1 7.63E-06 NA NA NA NA 
PA4131   probable iron-sulfur protein NA NA NA NA -8.5 3.50E-13 -21.0 0.00E+00 
PA4209 phzM probable phenazine-specific methyltransferase NA NA NA NA -18.5 3.99E-15 
-
121.5 3.15E-14 
PA4217 phzS flavin-containing monooxygenase NA NA NA NA -7.7 0.00E+00 -326.7 2.74E-13 
PA5150   probable short-chain dehydrogenase NA NA -23.7 1.84E-06 NA NA NA NA 
Related to phage, transposon, or plasmid 
PA0616   hypothetical protein NA NA -3.7 7.09E-13 NA NA NA NA 
PA0617   probable bacteriophage protein NA NA -3.0 0.00E+00 NA NA NA NA 
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PA0618   probable bacteriophage protein NA NA -4.1 0.00E+00 NA NA NA NA 
PA0619   probable bacteriophage protein NA NA -4.0 0.00E+00 NA NA NA NA 
PA0620   probable bacteriophage protein NA NA -3.6 0.00E+00 NA NA NA NA 
PA0622   probable bacteriophage protein NA NA -3.5 0.00E+00 NA NA NA NA 
PA0623   probable bacteriophage protein NA NA -3.2 0.00E+00 NA NA NA NA 
PA0624   hypothetical protein NA NA -3.4 0.00E+00 NA NA NA NA 
PA0625   hypothetical protein NA NA -3.1 0.00E+00 NA NA NA NA 
PA0626   hypothetical protein NA NA -3.2 0.00E+00 NA NA NA NA 
PA0627   conserved hypothetical protein NA NA -3.3 6.47E-13 NA NA NA NA 
PA0628   conserved hypothetical protein NA NA -2.7 5.82E-13 NA NA NA NA 
PA0629   conserved hypothetical protein NA NA -3.5 0.00E+00 NA NA NA NA 
PA0630   hypothetical protein NA NA -3.0 3.78E-13 NA NA NA NA 
PA0631   hypothetical protein NA NA -3.0 2.27E-13 NA NA NA NA 
PA0633   hypothetical protein NA NA -3.9 0.00E+00 NA NA NA NA 
PA0634   hypothetical protein NA NA -3.8 0.00E+00 NA NA NA NA 
PA0636   hypothetical protein NA NA -3.0 6.56E-13 NA NA NA NA 
PA0637   conserved hypothetical protein NA NA -3.4 2.79E-13 NA NA NA NA 
PA0639   conserved hypothetical protein NA NA -2.5 4.52E-13 NA NA NA NA 
PA0640   probable bacteriophage protein NA NA -3.7 6.13E-13 NA NA NA NA 
PA0641   probable bacteriophage protein NA NA -3.2 0.00E+00 NA NA NA NA 
PA0644   hypothetical protein NA NA -2.7 1.04E-13 NA NA NA NA 
PA0645   hypothetical protein NA NA -4.4 0.00E+00 NA NA NA NA 
PA0648   hypothetical protein NA NA -2.8 0.00E+00 NA NA NA NA 
Secreted Factors (toxins, enzymes, alginate) 
PA0852 cbpD chitin-binding protein CbpD precursor NA NA NA NA -5.7 0.00E+00 -4.4 0.00E+00 
PA1871 lasA LasA protease precursor NA NA NA NA -5.8 5.62E-11 -7.3 4.66E-12 
PA1899 phzA2 probable phenazine biosynthesis protein NA NA NA NA -203.0 0.00E+00 
-
352.5 1.50E-14 
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PA1900 phzB2 probable phenazine biosynthesis protein NA NA NA NA -270.6 0.00E+00 
-
205.6 0.00E+00 
PA1901 phzC2 phenazine biosynthesis protein PhzC NA NA NA NA -8.4 9.74E-14 -188.7 0.00E+00 
PA1902 phzD2 phenazine biosynthesis protein PhzD NA NA NA NA -117.4 0.00E+00 
-
115.1 0.00E+00 
PA1903 phzE2 phenazine biosynthesis protein PhzE NA NA NA NA -91.6 0.00E+00 -129.6 4.11E-14 
PA1904 phzF2 probable phenazine biosynthesis protein 2.1 5.56E-08 NA NA -13.8 4.10E-13 -21.4 0.00E+00 
PA1905 phzG2 probable pyridoxamine 5'-phosphate oxidase NA NA NA NA 
-
113.1 0.00E+00 
-
121.9 0.00E+00 
PA2396 pvdF pyoverdine synthetase F NA NA NA NA -4.4 5.82E-14 -5.8 2.73E-15 
PA2399 pvdD pyoverdine synthetase D NA NA NA NA -6.0 2.42E-09 -4.0 1.33E-06 
PA2939   probable aminopeptidase NA NA NA NA -6.7 0.00E+00 -8.1 0.00E+00 
PA3478 rhlB rhamnosyltransferase chain B NA NA NA NA -22.6 0.00E+00 -28.2 0.00E+00 
PA3479 rhlA rhamnosyltransferase chain A NA NA NA NA -18.1 0.00E+00 -299.3 1.73E-13 
PA3724 lasB elastase LasB NA NA NA NA -16.5 8.67E-14 -18.8 4.06E-13 
PA4175 piv protease IV NA NA NA NA -3.0 5.56E-07 NA NA 
PA4210 phzA1 probable phenazine biosynthesis protein NA NA NA NA -169.2 0.00E+00 
-
220.3 0.00E+00 
PA4211 phzB1 probable phenazine biosynthesis protein NA NA NA NA -367.3 2.88E-13 
-
381.9 2.58E-13 
PA4212 phzC1 phenazine biosynthesis protein PhzC NA NA NA NA -41.3 0.00E+00 -129.7 0.00E+00 
PA4213 phzD1 phenazine biosynthesis protein PhzD NA NA NA NA -109.8 5.95E-14 
-
172.6 0.00E+00 
PA4214 phzE1 phenazine biosynthesis protein PhzE NA NA NA NA -77.8 4.83E-14 -87.7 2.36E-14 
PA4215 phzF1 probable phenazine biosynthesis protein NA NA NA NA -21.9 4.29E-14 -15.6 0.00E+00 
PA4216 phzG1 probable pyridoxamine 5'-phosphate oxidase NA NA NA NA -10.9 9.50E-13 -12.7 0.00E+00 
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PA4225 pchF pyochelin synthetase NA NA NA NA -13.4 3.99E-15 -23.6 1.28E-14 
PA4226 pchE dihydroaeruginoic acid synthetase NA NA NA NA -62.7 4.55E-14 -26.6 0.00E+00 
PA4228 pchD pyochelin biosynthesis protein PchD NA NA NA NA -43.7 4.29E-14 -25.3 0.00E+00 
PA4229 pchC pyochelin biosynthetic protein PchC NA NA NA NA -125.0 0.00E+00 -85.5 0.00E+00 
PA4230 pchB salicylate biosynthesis protein PchB NA NA NA NA -193.1 0.00E+00 
-
187.8 0.00E+00 
PA4231 pchA salicylate biosynthesis isochorismate synthase NA NA NA NA 
-
125.5 0.00E+00 -95.4 4.64E-14 
Transcription, RNA processing and degradation 
PA3743 trmD tRNA (guanine-N1)-methyltransferase NA NA -2.2 0.00E+00 NA NA NA NA 
Transcriptional Regulators 
PA1099 fleR two-component response regulator NA NA -13.0 3.96E-11 NA NA NA NA 
PA1285   probable transcriptional regulator NA NA NA NA -4.1 8.56E-13 NA NA 
PA1397   probable two-component response regulator NA NA 
-
20.8 9.08E-06 NA NA NA NA 
PA1456 cheY two-component response regulator CheY NA NA -2.2 3.63E-07 NA NA NA NA 
PA1799 parR two-component response regulator, ParR NA NA 
-
30.9 3.92E-08 NA NA NA NA 
PA1859   probable transcriptional regulator NA NA -19.7 1.56E-05 NA NA NA NA 
PA2312   probable transcriptional regulator NA NA -22.6 3.45E-06 NA NA NA NA 
PA2426 pvdS sigma factor PvdS NA NA NA NA -7.6 3.49E-09 -38.2 1.93E-08 
PA2588   probable transcriptional regulator NA NA NA NA -9.7 8.45E-14 -2.9 2.32E-06 
PA2622 cspD cold-shock protein CspD NA NA NA NA -2.1 1.99E-12 NA NA 
PA2686 pfeR two-component response regulator PfeR NA NA NA NA -38.6 6.29E-08 NA NA 
PA2834   probable transcriptional regulator NA NA -22.8 3.04E-06 NA NA NA NA 
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PA3027   probable transcriptional regulator NA NA -34.0 7.49E-09 NA NA NA NA 
PA3423   probable transcriptional regulator NA NA -23.5 2.04E-06 NA NA NA NA 
PA3477 rhlR transcriptional regulator RhlR NA NA NA NA -4.5 0.00E+00 -3.6 0.00E+00 
PA3622 rpoS sigma factor RpoS NA NA NA NA -2.3 7.89E-14 NA NA 
PA3948 rocA1 two-component response regulator RocA1 NA NA -4.3 1.68E-05 NA NA NA NA 
PA4145   probable transcriptional regulator NA NA -29.5 8.43E-08 NA NA NA NA 
PA4296 pprB two-component response regulator, PprB NA NA NA NA -3.5 1.60E-05 NA NA 
PA4984   probable transcriptional regulator NA NA -20.3 1.18E-05 NA NA NA NA 
PA5059   probable transcriptional regulator NA NA NA NA -49.7 5.31E-10 NA NA 
PA5255 algQ Alginate regulatory protein AlgQ NA NA -2.1 7.66E-14 NA NA NA NA 
Translation, post-translational modification, degradation 
PA1712 exsB exoenzyme S synthesis protein B NA NA NA NA -45.7 3.00E-09 NA NA 
PA3326 clpP2 ClpP2 NA NA NA NA -5.5 1.50E-14 -5.1 9.71E-14 
PA5018 msrA peptide methionine sulfoxide reductase NA NA -2.4 1.68E-05 NA NA NA NA 
PA5240 trxA thioredoxin NA NA -2.0 0.00E+00 NA NA NA NA 
PA5316 rpmB 50S ribosomal protein L28 NA NA -2.2 0.00E+00 NA NA NA NA 
Transport of small molecules 
PA2592   probable periplasmic spermidine/putrescine-binding protein NA NA NA NA -3.4 4.14E-11 -2.8 8.45E-14 
PA2983   probable tolQ-type transport protein NA NA -2.2 1.56E-05 NA NA NA NA 
PA3373   conserved hypothetical protein NA NA -5.1 1.15E-07 NA NA NA NA 
PA4206 mexH 
probable Resistance-Nodulation-Cell 
Division (RND) efflux membrane 
fusion protein precursor 
NA NA NA NA -11.3 0.00E+00 -7.8 3.15E-14 
PA4221 fptA Fe(III)-pyochelin outer membrane receptor precursor NA NA NA NA -25.4 3.99E-15 -29.2 0.00E+00 
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PA4222   probable ATP-binding component of ABC transporter NA NA NA NA -11.6 1.85E-10 -66.6 4.11E-14 
PA4224 pchG pyochelin biosynthetic protein PchG NA NA NA NA -56.3 3.15E-11 -13.6 3.69E-14 
Two-component regulatory systems 
PA0409 pilH twitching motility protein PilH NA NA -3.5 4.93E-14 NA NA NA NA 
                      
                      
Genes negatively regulated by AmpR (341) 
Adaptation, Protection 
PA0140 ahpF alkyl hydroperoxide reductase subunit F NA NA 3.0 4.76E-07 NA NA NA NA 
PA1008 bcp bacterioferritin comigratory protein NA NA NA NA 2.4 2.35E-09 NA NA 
PA1457 cheZ chemotaxis protein CheZ NA NA 2.2 3.03E-07 NA NA NA NA 
PA4356 xenB xenobiotic reductase NA NA NA NA 10.5 0.00E+00 4.4 2.93E-10 
PA4378 inaA InaA protein NA NA 2.2 5.78E-06 NA NA NA NA 
PA5117 typA regulatory protein TypA NA NA NA NA 3.2 6.38E-09 2.3 3.74E-07 
Amino acid biosynthesis and metabolism 
PA0393 proC pyrroline-5-carboxylate reductase NA NA NA NA 2.2 2.67E-06 2.9 3.65E-09 
PA0904 lysC aspartate kinase alpha and beta chain NA NA NA NA 2.0 8.49E-07 NA NA 
PA1004 nadA quinolinate synthetase A NA NA NA NA 2.1 9.75E-06 NA NA 
PA1010 dapA dihydrodipicolinate synthase NA NA NA NA 2.0 2.49E-10 NA NA 
PA1421 gbuA guanidinobutyrase NA NA 28.5 3.92E-06 NA NA NA NA 
PA1685 masA enolase-phosphatase E-1 NA NA 3.1 2.66E-06 NA NA NA NA 
PA1818 ldcA lysine-specific pyridoxal 5'-phosphate-dependent carboxylase, LdcA NA NA NA NA 2.2 2.51E-07 NA NA 
PA1999 dhcA DhcA, dehydrocarnitine CoA transferase, subunit A NA NA 2.0 0.00E+00 NA NA NA NA 
PA2629 purB adenylosuccinate lyase NA NA NA NA 2.2 1.80E-05 NA NA 
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PA3167 serC 3-phosphoserine aminotransferase NA NA NA NA 2.2 6.38E-08 NA NA 
PA5140 hisF1 imidazoleglycerol-phosphate synthase, cyclase subunit NA NA 3.7 1.76E-06 NA NA NA NA 
PA5203 gshA glutamate--cysteine ligase NA NA 2.4 1.37E-05 NA NA NA NA 
PA5373 betB betaine aldehyde dehydrogenase NA NA NA NA 3.4 4.44E-07 5.1 1.87E-09 
Biosynthesis of cofactors, prosthetic groups and carriers 
PA0510   probable uroporphyrin-III c-methyltransferase NA NA 48.9 6.85E-10 NA NA NA NA 
PA0518 nirM cytochrome c-551 precursor NA NA 43.5 7.17E-09 NA NA NA NA 
PA1986 pqqB pyrroloquinoline quinone biosynthesis protein B NA NA NA NA 7.4 5.76E-06 29.9 9.02E-08 
PA3030 mobA molybdopterin-guanine dinucleotide biosynthesis protein MobA NA NA 34.4 3.34E-07 NA NA NA NA 
PA3812 iscA probable iron-binding protein IscA NA NA 2.5 3.47E-14 NA NA NA NA 
PA3917 moaD molybdopterin converting factor, small subunit NA NA 2.8 4.77E-07 NA NA NA NA 
PA3976 thiE thiamin-phosphate pyrophosphorylase NA NA NA NA 3.2 1.29E-07 NA NA 
PA4044 dxs 1-deoxyxylulose-5-phosphate synthase NA NA NA NA 2.8 1.69E-07 NA NA 
PA4053 ribE 6,7-dimethyl-8-ribityllumazine synthase NA NA NA NA 3.0 0.00E+00 NA NA 
PA4054 ribB GTP cyclohydrolase II / 3,4-dihydroxy-2-butanone 4-phosphate synthase NA NA NA NA 2.6 2.53E-07 NA NA 
PA5259 hemD uroporphyrinogen-III synthetase NA NA 4.1 0.00E+00 NA NA NA NA 
Carbon compound catabolism 
PA0210 mdcC malonate decarboxylase delta subunit NA NA NA NA 4.2 3.66E-07 45.6 2.49E-11 
PA0231 pcaD beta-ketoadipate enol-lactone hydrolase NA NA 25.9 1.17E-05 NA NA NA NA 
PA2008 fahA fumarylacetoacetase NA NA NA NA 2.3 2.26E-13 NA NA 
PA2011 liuE 3-hydroxy-3-methylglutaryl-CoA lyase NA NA 2.9 1.98E-11 NA NA NA NA 
PA2414   L-sorbosone dehydrogenase NA NA 25.9 1.17E-05 NA NA NA NA 
PA3569 mmsB 3-hydroxyisobutyrate dehydrogenase NA NA NA NA 2.0 7.71E-08 2.4 6.55E-13 
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PA3636 kdsA 2-dehydro-3-deoxyphosphooctonate aldolase NA NA NA NA 2.0 1.74E-08 NA NA 
Cell division 
PA0857 bolA morphogene protein BolA NA NA 2.1 7.84E-08 NA NA NA NA 
PA3245 minE cell division topological specificity factor MinE NA NA 2.4 4.03E-14 NA NA NA NA 
PA4413 ftsW cell division protein FtsW NA NA 2.5 5.64E-11 NA NA NA NA 
Cell wall / LPS / capsule 
PA1222   probable membrane-bound lytic murein transglycolase A NA NA NA NA 3.1 1.42E-05 NA NA 
PA3150 wbpG LPS biosynthesis protein WbpG NA NA 2.0 9.14E-13 NA NA NA NA 
PA3552 arnB ArnB NA NA NA NA 7.9 6.76E-10 NA NA 
PA3666 dapD tetrahydrodipicolinate succinylase NA NA NA NA 2.3 7.51E-07 NA NA 
PA4001 sltB1 soluble lytic transglycosylase B NA NA 2.0 4.15E-07 NA NA NA NA 
PA4545 comL competence protein ComL NA NA NA NA 2.5 5.05E-10 NA NA 
PA4624 cdrB cyclic diguanylate-regulated TPS partner B, CdrB NA NA 2.6 1.51E-07 NA NA NA NA 
PA5077 mdoH periplasmic glucans biosynthesis protein MdoH NA NA 2.1 7.64E-06 NA NA NA NA 
PA5164 rmlC dTDP-4-dehydrorhamnose 3,5-epimerase NA NA 2.4 1.32E-07 NA NA NA NA 
PA5452 wbpW phosphomannose isomerase/GDP-mannose WbpW NA NA 3.9 2.29E-06 NA NA NA NA 
Central intermediary metabolism 
PA0265 gabD succinate-semialdehyde dehydrogenase NA NA NA NA 2.6 5.69E-10 3.7 1.95E-14 
PA0266 gabT 4-aminobutyrate aminotransferase NA NA NA NA 2.6 3.31E-11 3.2 4.64E-14 
PA2001 atoB acetyl-CoA acetyltransferase NA NA NA NA 2.3 1.50E-14 2.4 4.11E-14 
PA2442 gcvT2 glycine cleavage system protein T2 NA NA 2.1 1.05E-11 NA NA NA NA 
PA2726   probable radical activating enzyme NA NA NA NA 18.9 3.08E-13 NA NA 
PA2813   probable glutathione S-transferase NA NA NA NA 6.7 0.00E+00 176.3 0.00E+00 
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PA3181   2-keto-3-deoxy-6-phosphogluconate aldolase NA NA NA NA 4.7 6.71E-08 103.2 0.00E+00 
PA3182 pgl 6-phosphogluconolactonase NA NA NA NA 4.2 3.98E-06 2.8 3.58E-08 
PA4031 ppa inorganic pyrophosphatase NA NA NA NA 2.0 0.00E+00 NA NA 
PA5215 gcvT1 glycine-cleavage system protein T1 NA NA NA NA 2.1 2.26E-11 NA NA 
PA5435   probable transcarboxylase subunit NA NA NA NA 2.2 2.89E-09 2.7 1.03E-14 
PA5436   probable biotin carboxylase subunit of a transcarboxylase NA NA NA NA 2.1 1.13E-07 NA NA 
Chaperones & heat shock proteins 
PA2614 lolA periplasmic chaperone LolA NA NA NA NA 2.3 1.29E-09 NA NA 
PA3810 hscA heat shock protein HscA NA NA 2.1 1.26E-06 NA NA NA NA 
Chemotaxis ; Adaptation, Protection ; Motility & Attachment 
PA1445 fliO flagellar protein FliO NA NA 6.9 6.54E-10 NA NA NA NA 
DNA replication, recombination, modification and repair 
PA3642 rnhB ribonuclease HII NA NA NA NA 2.8 6.84E-07 NA NA 
PA3832 holC DNA polymerase III, chi subunit NA NA 6.9 1.99E-10 NA NA NA NA 
Energy metabolism 
PA0362 fdx1 ferredoxin [4Fe-4S] NA NA NA NA 2.1 5.52E-06 2.6 4.56E-09 
PA1555.
1 ccoQ2 
Cytochrome c oxidase, cbb3-type, 
CcoQ subunit NA NA NA NA 12.6 2.82E-14 3.1 1.91E-09 
PA1581 sdhC succinate dehydrogenase (C subunit) NA NA NA NA 2.5 0.00E+00 NA NA 
PA1586 sucB dihydrolipoamide succinyltransferase (E2 subunit) NA NA NA NA 2.1 0.00E+00 NA NA 
PA1588 sucC succinyl-CoA synthetase beta chain NA NA NA NA 2.4 3.00E-13 NA NA 
PA1589 sucD succinyl-CoA synthetase alpha chain NA NA NA NA 2.7 1.47E-13 2.7 0.00E+00 
PA1787 acnB aconitate hydratase 2 NA NA NA NA 2.0 4.01E-14 NA NA 
PA2638 nuoB NADH dehydrogenase I chain B NA NA NA NA 2.0 2.02E-10 NA NA 
PA2639 nuoD NADH dehydrogenase I chain C,D NA NA NA NA 2.1 3.62E-07 2.8 1.54E-10 
PA2640 nuoE NADH dehydrogenase I chain E NA NA NA NA 2.0 1.37E-08 2.2 2.07E-12 
PA2642 nuoG NADH dehydrogenase I chain G NA NA NA NA 2.1 4.26E-06 2.6 4.66E-12 
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PA2643 nuoH NADH dehydrogenase I chain H NA NA NA NA 2.4 3.61E-07 NA NA 
PA2647 nuoL NADH dehydrogenase I chain L NA NA NA NA 2.6 2.81E-08 NA NA 
PA2953   electron transfer flavoprotein-ubiquinone oxidoreductase NA NA NA NA 2.2 2.67E-07 2.1 2.01E-08 
PA2994 nqrF Na+-translocating NADH:quinone oxidoreductase, subunit Nqr6 NA NA NA NA 2.3 6.89E-07 2.0 5.45E-06 
PA2996 nqrD Na+-translocating NADH:uniquinone oxidoreductase subunit Nqr4 NA NA NA NA 3.0 8.48E-06 NA NA 
PA3621 fdxA ferredoxin I NA NA NA NA 2.0 7.87E-09 NA NA 
PA4333   probable fumarase NA NA NA NA 2.5 7.32E-09 NA NA 
PA4810 fdnI nitrate-inducible formate dehydrogenase, gamma subunit NA NA NA NA 15.8 7.75E-14 3.1 5.18E-06 
PA5129 grx glutaredoxin NA NA NA NA 2.1 4.09E-08 3.6 5.09E-14 
Fatty acid and phospholipid metabolism 
PA2537   probable acyltransferase NA NA 3.2 4.08E-06 NA NA NA NA 
PA4339   probable phospholipase NA NA 31.7 1.02E-06 NA NA NA NA 
PA4848 accC biotin carboxylase NA NA NA NA 2.0 2.71E-11 NA NA 
Hypothetical, unclassified, unknown 
PA0141   conserved hypothetical protein NA NA 3.5 1.57E-06 NA NA NA NA 
PA0309   hypothetical protein NA NA NA NA 2.7 3.82E-06 NA NA 
PA0315   hypothetical protein NA NA 2.6 0.00E+00 NA NA NA NA 
PA0370   conserved hypothetical protein NA NA NA NA 3.2 3.40E-06 NA NA 
PA0392   conserved hypothetical protein NA NA NA NA 2.2 1.55E-06 NA NA 
PA0442   hypothetical protein NA NA NA NA 2.1 1.36E-05 4.1 3.52E-14 
PA0490   hypothetical protein NA NA 46.6 1.87E-09 NA NA NA NA 
PA0754   hypothetical protein NA NA 4.8 1.17E-05 NA NA NA NA 
PA0760   conserved hypothetical protein NA NA 2.8 5.59E-07 NA NA NA NA 
PA0821   hypothetical protein NA NA 37.7 8.26E-08 NA NA NA NA 
PA0957   hypothetical protein NA NA 33.5 4.77E-07 NA NA NA NA 
PA1006   conserved hypothetical protein - 4.96E-09 NA NA 2.6 2.36E-06 54.3 2.58E-13 
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37.5 
PA1063   hypothetical protein NA NA 54.3 6.55E-11 NA NA NA NA 
PA1069   hypothetical protein NA NA 2.0 3.96E-06 NA NA NA NA 
PA1106   hypothetical protein NA NA 4.1 6.47E-06 NA NA NA NA 
PA1191   hypothetical protein NA NA 34.6 3.12E-07 NA NA NA NA 
PA1333   hypothetical protein -68.5 0.00E+00 NA NA 2.1 3.33E-06 132.2 0.00E+00 
PA1469   hypothetical protein NA NA NA NA 10.5 3.94E-06 NA NA 
PA1638   conserved hypothetical protein NA NA 45.2 3.41E-09 NA NA NA NA 
PA1668   hypothetical protein NA NA 31.5 1.12E-06 NA NA NA NA 
PA1753   conserved hypothetical protein NA NA 3.5 5.64E-06 NA NA NA NA 
PA1755   hypothetical protein NA NA NA NA 37.8 8.26E-10 59.0 2.75E-14 
PA1766   hypothetical protein NA NA NA NA 3.0 6.60E-09 NA NA 
PA1768   hypothetical protein NA NA NA NA 3.2 9.20E-09 NA NA 
PA1789   hypothetical protein NA NA 2.1 7.51E-06 NA NA NA NA 
PA1814   hypothetical protein NA NA 2.1 1.48E-05 NA NA NA NA 
PA1830   hypothetical protein NA NA 2.0 0.00E+00 NA NA NA NA 
PA1831   hypothetical protein NA NA NA NA 2.3 8.09E-14 NA NA 
PA1841   hypothetical protein NA NA NA NA 3.7 9.54E-07 NA NA 
PA1889   hypothetical protein NA NA 3.0 8.33E-06 NA NA NA NA 
PA1942   hypothetical protein NA NA NA NA 63.1 5.73E-13 355.5 8.45E-14 
PA1957   hypothetical protein NA NA 38.9 5.04E-08 NA NA NA NA 
PA1969   hypothetical protein NA NA 2.2 2.21E-06 NA NA NA NA 
PA1970   hypothetical protein NA NA NA NA 54.8 5.95E-14 114.1 5.09E-14 
PA2111   hypothetical protein NA NA NA NA 2.0 0.00E+00 2.2 0.00E+00 
PA2145   hypothetical protein NA NA NA NA 32.9 1.19E-08 51.5 1.15E-12 
PA2242 pslL hypothetical protein NA NA 3.5 1.23E-05 NA NA NA NA 
PA2251   hypothetical protein NA NA 6.9 7.05E-06 NA NA NA NA 
PA2311   hypothetical protein NA NA NA NA 4.2 8.30E-07 43.0 9.49E-11 
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PA2345   conserved hypothetical protein NA NA 9.7 3.88E-06 NA NA NA NA 
PA2485   hypothetical protein NA NA NA NA 3.8 0.00E+00 7.7 2.07E-13 
PA2486   hypothetical protein NA NA 3.5 8.78E-14 4.2 1.06E-05 175.5 0.00E+00 
PA2651   conserved hypothetical protein NA NA 3.6 2.48E-07 NA NA NA NA 
PA2655   hypothetical protein NA NA NA NA 42.5 5.82E-11 3.1 4.39E-06 
PA2713   conserved hypothetical protein NA NA 28.5 3.92E-06 NA NA NA NA 
PA2753   hypothetical protein NA NA 2.8 4.26E-07 NA NA NA NA 
PA2779   hypothetical protein NA NA NA NA 4.2 2.14E-10 5.1 0.00E+00 
PA2819   hypothetical protein NA NA 5.5 5.95E-07 NA NA NA NA 
PA2827   conserved hypothetical protein NA NA 3.2 3.90E-09 NA NA NA NA 
PA2869   hypothetical protein NA NA NA NA 10.5 1.09E-08 NA NA 
PA2901   hypothetical protein NA NA NA NA 2.6 4.59E-09 NA NA 
PA3012   hypothetical protein NA NA 54.7 5.42E-11 NA NA NA NA 
PA3015   hypothetical protein NA NA 6.9 7.05E-06 NA NA NA NA 
PA3080   hypothetical protein NA NA NA NA 5.3 6.27E-06 37.4 1.82E-09 
PA3110   hypothetical protein NA NA 2.8 3.97E-09 NA NA NA NA 
PA3229   hypothetical protein NA NA NA NA 76.8 0.00E+00 794.6 3.08E-13 
PA3440   conserved hypothetical protein NA NA NA NA 2.5 6.26E-11 NA NA 
PA3572   hypothetical protein NA NA NA NA 2.1 3.56E-08 NA NA 
PA3580   conserved hypothetical protein NA NA 43.6 6.75E-09 NA NA NA NA 
PA3674   hypothetical protein NA NA 3.5 3.21E-07 NA NA NA NA 
PA3712   hypothetical protein NA NA 3.6 9.50E-11 NA NA NA NA 
PA3741   hypothetical protein NA NA NA NA 3.5 1.54E-05 64.3 6.69E-14 
PA3850   hypothetical protein NA NA NA NA 2.9 6.39E-11 NA NA 
PA3869   hypothetical protein NA NA NA NA 34.2 5.91E-09 NA NA 
PA3906   hypothetical protein NA NA NA NA 2.4 2.61E-06 NA NA 
PA3962   hypothetical protein NA NA NA NA 3.4 3.42E-08 4.1 9.76E-08 
PA3967   hypothetical protein NA NA NA NA 3.5 6.29E-06 34.8 6.97E-09 
PA3988   hypothetical protein NA NA NA NA 2.0 3.75E-06 NA NA 
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PA3998   conserved hypothetical protein NA NA 2.0 0.00E+00 NA NA NA NA 
PA4004   conserved hypothetical protein NA NA NA NA 4.2 6.38E-07 NA NA 
PA4045   conserved hypothetical protein NA NA NA NA 3.4 3.54E-07 4.1 4.86E-08 
PA4049   hypothetical protein NA NA 4.1 1.08E-05 NA NA NA NA 
PA4111   hypothetical protein NA NA 5.5 3.62E-08 NA NA NA NA 
PA4204 ppgL periplasmic gluconolactonase, PpgL NA NA 3.2 1.57E-06 NA NA NA NA 
PA4325   hypothetical protein NA NA NA NA 2.6 2.08E-07 NA NA 
PA4379   conserved hypothetical protein NA NA NA NA 2.0 1.67E-09 NA NA 
PA4405   hypothetical protein NA NA NA NA 5.3 6.71E-08 NA NA 
PA4438   conserved hypothetical protein NA NA NA NA 8.7 0.00E+00 2.7 3.97E-06 
PA4458   conserved hypothetical protein NA NA 2.2 1.45E-07 NA NA NA NA 
PA4460   conserved hypothetical protein NA NA NA NA 2.2 1.74E-13 2.1 4.34E-08 
PA4487   conserved hypothetical protein NA NA 2.9 6.16E-11 NA NA NA NA 
PA4488   conserved hypothetical protein NA NA 3.2 2.53E-07 NA NA NA NA 
PA4531   hypothetical protein NA NA 65.2 6.49E-13 NA NA NA NA 
PA4603   hypothetical protein NA NA 5.5 1.60E-08 NA NA NA NA 
PA4608   hypothetical protein NA NA 2.8 4.77E-07 NA NA NA NA 
PA4637   hypothetical protein NA NA 2.3 4.11E-06 NA NA NA NA 
PA4643   hypothetical protein NA NA NA NA 4.2 1.08E-06 NA NA 
PA4661 pagL Lipid A 3-O-deacylase NA NA NA NA 2.1 0.00E+00 2.2 0.00E+00 
PA4673   conserved hypothetical protein NA NA NA NA 2.4 1.17E-07 NA NA 
PA4684   hypothetical protein NA NA NA NA 3.5 1.82E-05 NA NA 
PA4691   hypothetical protein NA NA 33.7 4.45E-07 NA NA NA NA 
PA4692   conserved hypothetical protein NA NA NA NA 3.6 1.04E-05 NA NA 
PA4718   hypothetical protein NA NA NA NA 2.9 1.26E-05 NA NA 
PA4866   conserved hypothetical protein NA NA 26.4 9.58E-06 NA NA NA NA 
PA4881   hypothetical protein NA NA NA NA 192.1 2.82E-14 200.1 0.00E+00 
PA5061   conserved hypothetical protein NA NA 2.0 0.00E+00 NA NA NA NA 
PA5137   hypothetical protein NA NA NA NA 7.4 4.76E-07 NA NA 
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PA5184   hypothetical protein NA NA NA NA 4.2 6.16E-06 NA NA 
PA5209   hypothetical protein NA NA NA NA 4.0 1.85E-06 NA NA 
PA5222   hypothetical protein NA NA 2.2 8.02E-07 NA NA NA NA 
PA5257   hypothetical protein NA NA 2.1 9.47E-08 NA NA NA NA 
PA5340   hypothetical protein NA NA NA NA 3.4 9.35E-08 NA NA 
PA5406   hypothetical protein NA NA NA NA 2.9 1.06E-07 3.1 1.01E-05 
PA5457   hypothetical protein NA NA 8.3 5.46E-07 NA NA NA NA 
PA5462   hypothetical protein NA NA 5.5 7.92E-11 NA NA NA NA 
PA5467   hypothetical protein NA NA 37.7 8.26E-08 NA NA NA NA 
PA5517   conserved hypothetical protein NA NA 6.9 7.51E-08 NA NA NA NA 
PA5532   hypothetical protein NA NA 27.0 7.20E-06 NA NA NA NA 
PA5537   hypothetical protein NA NA 32.8 6.40E-07 NA NA NA NA 
Membrane proteins 
PA0291 oprE Anaerobically-induced outer membrane porin OprE precursor NA NA NA NA 2.0 4.13E-07 NA NA 
PA0303 spuG polyamine transport protein PotH NA NA NA NA 3.2 6.85E-07 3.1 6.63E-10 
PA0334   probable major facilitator superfamily (MFS) transporter NA NA NA NA 14.7 1.45E-05 NA NA 
PA0752   conserved hypothetical protein NA NA 11.1 5.64E-06 NA NA NA NA 
PA0789   probable amino acid permease NA NA NA NA 2.3 9.45E-08 NA NA 
PA1048   probable outer membrane protein precursor NA NA 2.6 0.00E+00 NA NA NA NA 
PA1073 braD branched-chain amino acid transport protein BraD NA NA NA NA 2.7 8.22E-08 4.1 4.46E-07 
PA1126   hypothetical protein NA NA 6.9 8.15E-08 NA NA NA NA 
PA1170   conserved hypothetical protein NA NA NA NA 7.4 3.21E-07 NA NA 
PA1577   hypothetical protein NA NA NA NA 25.6 6.69E-07 NA NA 
PA1767   hypothetical protein NA NA 2.3 1.49E-08 NA NA NA NA 
PA2114   probable major facilitator superfamily (MFS) transporter NA NA NA NA 2.3 7.75E-14 NA NA 
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PA2241 pslK PslL NA NA NA NA 5.8 1.80E-05 NA NA 
PA2415   hypothetical protein NA NA 32.1 8.49E-07 NA NA NA NA 
PA2495 oprN Multidrug efflux outer membrane protein OprN precursor NA NA NA NA 345.7 0.00E+00 496.8 3.36E-13 
PA2710   hypothetical protein NA NA 5.5 1.24E-05 NA NA NA NA 
PA2811   probable permease of ABC-2 transporter NA NA NA NA 3.2 1.11E-07 2.5 7.47E-07 
PA2868   hypothetical protein NA NA NA NA 8.4 9.75E-09 NA NA 
PA3041   hypothetical protein NA NA 8.3 0.00E+00 NA NA NA NA 
PA3145 wbpL glycosyltransferase WbpL NA NA 2.4 1.66E-12 NA NA NA NA 
PA3602   conserved hypothetical protein NA NA NA NA 3.8 1.11E-08 NA NA 
PA3827   conserved hypothetical protein NA NA 2.3 4.77E-07 NA NA NA NA 
PA4338   hypothetical protein NA NA 5.1 8.11E-07 NA NA NA NA 
PA4355   probable major facilitator superfamily (MFS) transporter NA NA NA NA 8.4 1.07E-05 10.3 8.55E-11 
PA4455   probable permease of ABC transporter NA NA NA NA 2.3 6.35E-10 NA NA 
PA4754   hypothetical protein NA NA NA NA 2.3 2.50E-07 2.8 1.21E-13 
PA5155   
amino acid 
(lysine/arginine/ornithine/histidine/octo
pine) ABC transporter membrane 
protein 
NA NA NA NA 3.5 1.57E-09 4.1 4.15E-09 
PA5170 arcD arginine/ornithine antiporter NA NA 2.1 8.49E-14 NA NA NA NA 
PA5230   probable permease of ABC transporter NA NA 2.4 8.24E-07 NA NA NA NA 
PA5231   probable ATP-binding/permease fusion ABC transporter NA NA 3.8 2.30E-11 NA NA NA NA 
PA5430   hypothetical protein NA NA NA NA 2.7 3.90E-06 NA NA 
PA5479 gltP proton-glutamate symporter NA NA NA NA 2.3 8.05E-08 NA NA 
Motility & Attachment 
PA0171   hypothetical protein NA NA NA NA 4.2 1.32E-09 NA NA 
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Non-coding RNA gene 
PA0887.
1 P7 P7 NA NA NA NA 6.3 0.00E+00 3.1 5.35E-14 
PA1112.
1     NA NA NA NA 2.3 0.00E+00 NA NA 
PA3366.
1 amiL AmiL NA NA NA NA 2.5 1.82E-13 NA NA 
PA4406.
1     NA NA 2.5 0.00E+00 NA NA NA NA 
PA4541.
1   tRNA-Lys NA NA NA NA 2.7 0.00E+00 NA NA 
Nucleotide biosynthesis and metabolism 
PA0401   noncatalytic dihydroorotase-like protein NA NA 2.6 6.88E-07 NA NA NA NA 
PA0945 purM phosphoribosylaminoimidazole synthetase NA NA NA NA 2.0 7.03E-06 2.1 1.54E-06 
PA1013 purC phosphoribosylaminoimidazole-succinocarboxamide synthase NA NA NA NA 2.0 2.77E-06 NA NA 
PA2876 pyrF orotidine 5'-phosphate decarboxylase NA NA 6.9 9.97E-07 NA NA NA NA 
PA2962 tmk thymidylate kinase NA NA NA NA 3.4 1.11E-05 3.8 2.65E-12 
PA4314 purU1 formyltetrahydrofolate deformylase NA NA NA NA 2.0 1.09E-06 NA NA 
PA4855 purD phosphoribosylamine--glycine ligase NA NA NA NA 2.5 1.48E-05 NA NA 
PA5336 gmk guanylate kinase NA NA NA NA 4.9 6.05E-07 NA NA 
Protein secretion/export apparatus 
PA0071 tagR1 TagR1 NA NA 2.1 8.53E-09 NA NA NA NA 
PA0091 vgrG1 VgrG1 NA NA NA NA 3.2 9.81E-06 NA NA 
PA3099 xcpV general secretion pathway protein I NA NA 4.1 1.69E-05 NA NA NA NA 
PA3100 xcpU General secretion pathway outer membrane protein H precursor NA NA 2.8 7.09E-07 NA NA NA NA 
PA4559 lspA prolipoprotein signal peptidase NA NA NA NA 2.1 1.45E-05 NA NA 
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PA5069 tatB translocation protein TatB NA NA NA NA 2.6 2.32E-07 NA NA 
Putative enzymes 
PA0075 pppA PppA NA NA 4.8 2.65E-07 NA NA NA NA 
PA0478   probable N-acetyltransferase NA NA NA NA 10.5 6.86E-09 28.7 1.71E-07 
PA0597   probable nucleotidyl transferase NA NA NA NA 3.2 1.39E-05 3.1 2.62E-10 
PA0766 mucD serine protease MucD precursor NA NA 2.3 0.00E+00 NA NA NA NA 
PA0838   probable glutathione peroxidase NA NA 3.7 7.88E-10 NA NA NA NA 
PA0954   probable acylphosphatase NA NA 4.1 2.30E-07 NA NA NA NA 
PA1137   probable oxidoreductase NA NA 34.7 3.00E-07 NA NA NA NA 
PA1287   probable glutathione peroxidase NA NA 4.1 2.48E-07 NA NA NA NA 
PA1296   probable 2-hydroxyacid dehydrogenase NA NA 2.4 1.18E-05 NA NA NA NA 
PA1306   probable HIT family protein NA NA NA NA 2.9 8.81E-06 4.1 4.46E-07 
PA1344   probable short-chain dehydrogenase NA NA 2.8 9.38E-07 NA NA NA NA 
PA1621   probable hydrolase NA NA 6.9 6.47E-06 NA NA NA NA 
PA1655   probable glutathione S-transferase NA NA 3.8 4.87E-11 NA NA NA NA 
PA1742   probable amidotransferase NA NA NA NA 2.5 9.88E-12 NA NA 
PA1821   probable enoyl-CoA hydratase/isomerase NA NA NA NA 2.7 2.61E-10 NA NA 
PA1984 exaC NAD+ dependent aldehyde dehydrogenase ExaC NA NA NA NA 7.7 8.72E-06 5.1 3.45E-09 
PA2491   probable oxidoreductase NA NA NA NA 8.7 2.51E-13 7.4 0.00E+00 
PA2553   probable acyl-CoA thiolase NA NA NA NA 2.1 2.38E-07 NA NA 
PA2554   probable short-chain dehydrogenase NA NA NA NA 2.8 4.57E-12 3.9 6.14E-14 
PA2579 kynA L-Tryptophan:oxygen 2,3-oxidoreductase (decyclizing) KynA NA NA NA NA 2.9 5.95E-14 NA NA 
PA3053   probable hydrolytic enzyme NA NA 33.9 4.04E-07 NA NA NA NA 
PA3106   probable short-chain dehydrogenase NA NA 4.8 5.49E-07 NA NA NA NA 
PA3460   probable acetyltransferase NA NA 6.5 3.58E-07 NA NA NA NA 
PA4022   probable aldehyde dehydrogenase NA NA NA NA 2.7 0.00E+00 NA NA 
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PA4576   probable ATP-dependent protease NA NA NA NA 2.3 2.40E-06 NA NA 
PA5432   probable acetyltransferase NA NA NA NA 19.5 1.87E-05 NA NA 
Secreted Factors (toxins, enzymes, alginate) 
PA1844 tse1 Tse1 NA NA 29.4 2.66E-06 NA NA NA NA 
Transcription, RNA processing and degradation 
PA2626 trmU tRNA methyltransferase NA NA NA NA 3.1 1.79E-10 NA NA 
PA3861 rhl ATP-dependent RNA helicase RhlB NA NA NA NA 2.0 1.77E-05 NA NA 
PA4238 rpoA DNA-directed RNA polymerase alpha chain NA NA NA NA 2.0 2.82E-14 NA NA 
PA4262 rplD 50S ribosomal protein L4 NA NA NA NA 2.2 0.00E+00 NA NA 
Transcriptional regulators 
PA0233   probable transcriptional regulator NA NA 29.1 3.11E-06 NA NA NA NA 
PA0448   probable transcriptional regulator NA NA 3.3 2.81E-07 NA NA NA NA 
PA0601   probable two-component response regulator NA NA 5.5 1.68E-05 NA NA NA NA 
PA0764 mucB negative regulator for alginate biosynthesis MucB NA NA 2.3 0.00E+00 NA NA NA NA 
PA1015   probable transcriptional regulator NA NA NA NA 21.9 5.20E-06 NA NA 
PA1850   probable transcriptional regulator NA NA NA NA 21.8 5.43E-06 NA NA 
PA2320 gntR transcriptional regulator GntR NA NA 26.5 8.99E-06 NA NA NA NA 
PA3133   probable transcriptional regulator NA NA 50.4 3.53E-10 NA NA NA NA 
PA4174   probable transcriptional regulator NA NA 29.6 2.46E-06 NA NA NA NA 
PA5483 algB two-component response regulator AlgB NA NA 3.1 6.72E-07 NA NA NA NA 
Translation, post-translational modification, degradation 
PA0579 rpsU 30S ribosomal protein S21 NA NA NA NA 2.1 0.00E+00 NA NA 
PA1796 folD 5,10-methylene-tetrahydrofolate dehydrogenase / cyclohydrolase NA NA NA NA 2.4 9.36E-06 NA NA 
PA2740 pheS phenylalanyl-tRNA synthetase, alpha-subunit NA NA NA NA 2.2 5.58E-06 NA NA 
 403 
 
PA2742 rpmI 50S ribosomal protein L35 NA NA NA NA 2.0 2.93E-13 NA NA 
PA3655 tsf elongation factor Ts NA NA NA NA 2.0 0.00E+00 NA NA 
PA3656 rpsB 30S ribosomal protein S2 NA NA NA NA 2.2 0.00E+00 NA NA 
PA3818   extragenic suppressor protein SuhB NA NA NA NA 2.3 1.16E-06 NA NA 
PA4237 rplQ 50S ribosomal protein L17 NA NA NA NA 3.3 6.55E-13 NA NA 
PA4244 rplO 50S ribosomal protein L15 NA NA NA NA 2.3 5.02E-14 NA NA 
PA4245 rpmD 50S ribosomal protein L30 NA NA NA NA 2.0 1.99E-13 NA NA 
PA4246 rpsE 30S ribosomal protein S5 NA NA NA NA 2.0 1.86E-13 NA NA 
PA4248 rplF 50S ribosomal protein L6 NA NA NA NA 2.5 2.48E-13 NA NA 
PA4250 rpsN 30S ribosomal protein S14 NA NA NA NA 2.3 4.15E-13 NA NA 
PA4256 rplP 50S ribosomal protein L16 NA NA NA NA 2.0 3.49E-13 NA NA 
PA4257 rpsC 30S ribosomal protein S3 NA NA NA NA 2.2 4.21E-13 NA NA 
PA4258 rplV 50S ribosomal protein L22 NA NA NA NA 2.2 8.86E-14 NA NA 
PA4260 rplB 50S ribosomal protein L2 NA NA NA NA 2.0 2.77E-13 NA NA 
PA4267 rpsG 30S ribosomal protein S7 NA NA NA NA 2.1 0.00E+00 NA NA 
PA4268 rpsL 30S ribosomal protein S12 NA NA NA NA 2.0 3.30E-13 NA NA 
PA4272 rplJ 50S ribosomal protein L10 NA NA NA NA 2.1 4.21E-13 NA NA 
PA4273 rplA 50S ribosomal protein L1 NA NA NA NA 2.1 3.57E-13 NA NA 
PA4558   probable peptidyl-prolyl cis-trans isomerase, FkbP-type NA NA NA NA 2.1 1.80E-05 NA NA 
PA4567 rpmA 50S ribosomal protein L27 NA NA NA NA 2.0 4.01E-14 NA NA 
PA4665 prfA peptide chain release factor 1 NA NA NA NA 2.7 6.05E-07 NA NA 
PA4743 rbfA ribosome-binding factor A NA NA NA NA 3.0 2.94E-12 NA NA 
PA4932 rplI 50S ribosomal protein L9 NA NA NA NA 2.3 4.08E-13 NA NA 
PA5254   probable peptidyl-prolyl cis-trans isomerase, FkbP-type NA NA NA NA 4.2 7.23E-07 NA NA 
Transport of small molecules 
PA0866 aroP2 aromatic amino acid transport protein AroP2 NA NA NA NA 2.6 1.47E-11 2.7 3.52E-14 
 404 
 
PA1071 braF branched-chain amino acid transport protein BraF NA NA NA NA 3.0 1.38E-06 NA NA 
PA1074 braC branched-chain amino acid transport protein BraC NA NA NA NA 2.2 8.45E-14 NA NA 
PA1862 modB molybdenum transport protein ModB NA NA NA NA 6.3 2.88E-06 39.8 5.06E-10 
PA2041   probable amino acid permease NA NA NA NA 7.0 1.27E-05 5.1 4.72E-07 
PA2113 opdO pyroglutamate porin OpdO NA NA NA NA 2.4 1.50E-14 2.2 0.00E+00 
PA2408   probable ATP-binding component of ABC transporter NA NA 8.3 7.48E-08 NA NA NA NA 
PA2493 mexE 
Resistance-Nodulation-Cell Division 
(RND) multidrug efflux membrane 
fusion protein MexE precursor 
NA NA NA NA 298.8 0.00E+00 113.0 2.70E-13 
PA2494 mexF 
Resistance-Nodulation-Cell Division 
(RND) multidrug efflux transporter 
MexF 
NA NA NA NA 578.6 1.82E-13 547.2 0.00E+00 
PA2760 oprQ OprQ NA NA NA NA 2.7 3.26E-13 NA NA 
PA2812   probable ATP-binding component of ABC transporter NA NA NA NA 5.4 2.82E-14 4.4 1.95E-14 
PA3187   probable ATP-binding component of ABC transporter NA NA 6.9 1.79E-11 NA NA NA NA 
PA3531 bfrB bacterioferritin NA NA NA NA 2.1 5.09E-09 NA NA 
PA3838   probable ATP-binding component of ABC transporter NA NA NA NA 5.9 1.89E-11 77.5 4.11E-14 
PA4064   probable ATP-binding component of ABC transporter NA NA 29.1 3.04E-06 NA NA NA NA 
PA4466   probable phosphoryl carrier protein NA NA 2.1 4.31E-06 4.2 8.63E-08 3.1 1.60E-12 
PA4500   probable binding protein component of ABC transporter NA NA NA NA 2.0 8.61E-06 NA NA 
PA4514   probable outer membrane receptor for iron transport NA NA 5.5 4.82E-06 NA NA NA NA 
PA4590 pra protein activator NA NA 2.8 1.17E-05 NA NA NA NA 
 405 
 
PA5076   probable binding protein component of ABC transporter NA NA NA NA 2.5 2.42E-09 NA NA 
PA5152   probable ATP-binding component of ABC transporter NA NA NA NA 3.1 3.78E-12 2.5 8.06E-13 
PA5217   probable binding protein component of ABC iron transporter NA NA 2.7 2.60E-09 NA NA NA NA 
 
 406 
 
Supplementary Table 3: AmpR-ß-lactam-dependent genes. The genes that are either positively or negatively regulated by AmpR when exposed to ß-lactam 
stress are classified based on information in Supplementary Table 1. Only genes that are > 2.0, Bonferroni correction (<0.05) is listed. Functional categorization, 
gene ID and gene/product names are from the Pseudomonas Genome database (27). Lack of expression of a gene under any of the four conditions is denoted as 
NA. 
 
Gene ID Gene name Product Name 
Condition 1 Condition 2 Condition 3 Condition 4 
FC Corrected p-value FC 
Corrected 
p-value FC 
Corrected 
p-value FC 
Corrected 
p-value 
Genes positively regulated by AmpR upon b-lactam exposure (236) 
Adaptation, Protection 
PA0176 aer2 aerotaxis transducer Aer2 NA NA NA NA NA NA -5.2 4.53E-07 
PA0177   probable purine-binding chemotaxis protein NA NA NA NA NA NA -73.9 4.27E-14 
PA0848   probable alkyl hydroperoxide reductase NA NA NA NA NA NA -4.9 3.48E-07 
PA1561 aer aerotaxis receptor Aer NA NA NA NA NA NA -2.8 2.21E-07 
PA2400 pvdJ PvdJ NA NA NA NA NA NA -4.4 8.65E-06 
PA2703 tsi2 Tsi2 NA NA NA NA NA NA -30.7 5.57E-07 
PA2826   probable glutathione peroxidase 4.3 6.54E-09 NA NA NA NA -2.9 1.13E-06 
PA4110 ampC beta-lactamase precursor 14.2 1.11E-13 NA NA NA NA -24.3 1.50E-14 
PA4915   probable chemotaxis transducer NA NA NA NA NA NA -12.7 7.54E-10 
Amino acid biosynthesis and metabolism 
PA0407 gshB glutathione synthetase NA NA NA NA NA NA -4.4 1.72E-07 
PA0546 metK methionine adenosyltransferase NA NA NA NA NA NA -2.2 1.95E-13 
PA3537 argF ornithine carbamoyltransferase, anabolic 3.8 5.55E-06 NA NA NA NA -3.9 1.92E-06 
PA4519 speC ornithine decarboxylase NA NA NA NA NA NA -2.9 4.17E-08 
Biosynthesis of cofactors, prosthetic groups and carriers 
PA0672 hemO heme oxygenase NA NA NA NA NA NA -3.4 1.93E-07 
PA1049 pdxH pyridoxine 5'-phosphate oxidase NA NA NA NA NA NA -2.6 8.07E-06 
 407 
 
PA3397 fpr ferredoxin--NADP+ reductase NA NA NA NA NA NA -2.8 0.00E+00 
Carbon compound catabolism 
PA2509 catB muconate cycloisomerase I NA NA NA NA NA NA -44.8 9.76E-10 
PA5350 rubA2 Rubredoxin 2 2.1 1.44E-05 NA NA NA NA -2.9 3.28E-09 
PA5351 rubA1 Rubredoxin 1 2.5 0.00E+00 NA NA NA NA -2.3 6.60E-14 
Cell division 
PA1462   probable plasmid partitioning protein 2.1 2.17E-07 NA NA NA NA -3.4 0.00E+00 
Cell wall / LPS / capsule 
PA1077 flgB flagellar basal-body rod protein FlgB NA NA NA NA NA NA -88.0 2.36E-14 
PA1079 flgD flagellar basal-body rod modification protein FlgD NA NA NA NA NA NA -2.9 8.59E-07 
PA1101 fliF Flagella M-ring outer membrane protein precursor NA NA NA NA NA NA -2.7 2.92E-09 
PA1130 rhlC rhamnosyltransferase 2 NA NA NA NA NA NA -36.7 3.72E-08 
Central intermediary metabolism 
PA0710 gloA2 lactoylglutathione lyase NA NA NA NA NA NA -36.3 4.53E-08 
PA4443 cysD ATP sulfurylase small subunit NA NA NA NA NA NA -2.6 2.74E-09 
PA4865 ureA urease gamma subunit 5.7 4.49E-06 NA NA NA NA -47.4 3.02E-10 
PA4868 ureC urease alpha subunit NA NA NA NA NA NA -33.8 1.40E-07 
Chemotaxis, Adaptation, Protection 
PA0178   probable two-component sensor NA NA NA NA NA NA -5.2 1.88E-07 
DNA replication, recombination, modification and repair 
PA4042 xseB exodeoxyribonuclease VII small subunit 2.8 3.91E-06 NA NA NA NA -2.9 1.13E-06 
Energy metabolism 
PA1317 cyoA cytochrome o ubiquinol oxidase subunit II NA NA NA NA NA NA -43.3 1.96E-09 
PA1318 cyoB cytochrome o ubiquinol oxidase subunit I NA NA NA NA NA NA -5.8 4.86E-06 
 408 
 
PA1319 cyoC cytochrome o ubiquinol oxidase subunit III NA NA NA NA NA NA -34.2 1.15E-07 
PA1883   
probable NADH-
ubiquinone/plastoquinone 
oxidoreductase 
NA NA NA NA NA NA -36.0 5.12E-08 
PA1983 exaB cytochrome c550 32.8 4.68E-07 NA NA NA NA -32.8 2.16E-07 
PA2646 nuoK NADH dehydrogenase I chain K 2.4 4.37E-06 -3.6 1.65E-07 NA NA -4.9 4.71E-13 
PA2998 nqrB 
Na+-translocating 
NADH:ubiquinone 
oxidoreductase subunit Nrq2 
NA NA NA NA NA NA -2.4 1.05E-05 
Fatty acid and phospholipid metabolism 
PA2856 tesA acyl-CoA thioesterase I precursor NA NA NA NA NA NA -2.4 8.32E-07 
PA3223 azoR3 AzoR3, azoreductase 3 NA NA NA NA NA NA -5.8 9.35E-09 
Hypothetical, unclassified, unknown 
PA0015   hypothetical protein 6.6 1.37E-13 NA NA NA NA -3.4 3.93E-13 
PA0028   hypothetical protein NA NA NA NA NA NA -47.6 2.73E-10 
PA0052   hypothetical protein NA NA NA NA NA NA -33.5 1.59E-07 
PA0055   hypothetical protein NA NA NA NA NA NA -4.9 2.57E-08 
PA0065   hypothetical protein 5.7 2.08E-10 NA NA NA NA -2.6 1.08E-05 
PA0115   conserved hypothetical protein 7.1 1.10E-10 NA NA NA NA -4.9 3.38E-09 
PA0144   hypothetical protein 2.8 1.28E-05 NA NA NA NA -6.8 5.10E-11 
PA0187   hypothetical protein 35.2 1.64E-07 NA NA NA NA -35.2 7.32E-08 
PA0255   conserved hypothetical protein 5.1 1.24E-10 NA NA NA NA -2.9 5.10E-07 
PA0271   hypothetical protein NA NA NA NA NA NA -25.2 6.47E-06 
PA0346   hypothetical protein NA NA NA NA NA NA -39.6 1.04E-08 
PA0384   hypothetical protein 27.8 4.08E-06 NA NA NA NA -27.8 1.99E-06 
PA0419   conserved hypothetical protein NA NA NA NA NA NA -5.8 6.94E-08 
PA0431   hypothetical protein NA NA NA NA NA NA -8.8 0.00E+00 
PA0481   hypothetical protein 7.1 7.01E-11 NA NA NA NA -80.9 5.39E-15 
 409 
 
PA0484   conserved hypothetical protein NA NA NA NA NA NA -69.6 2.18E-14 
PA0486   conserved hypothetical protein NA NA NA NA NA NA -36.8 3.55E-08 
PA0526   hypothetical protein 36.8 8.06E-08 NA NA NA NA -36.8 3.55E-08 
PA0563   conserved hypothetical protein NA NA NA NA NA NA -2.2 2.73E-15 
PA0581   conserved hypothetical protein NA NA NA NA NA NA -5.8 9.72E-10 
PA0588   conserved hypothetical protein NA NA NA NA NA NA -2.4 3.27E-12 
PA0664   hypothetical protein 2.1 2.02E-07 NA NA NA NA -2.1 3.21E-08 
PA0734   hypothetical protein 4.3 5.13E-08 NA NA NA NA -2.9 4.72E-06 
PA0823   hypothetical protein 30.7 1.18E-06 NA NA NA NA -30.7 5.57E-07 
PA0874   hypothetical protein NA NA NA NA NA NA -26.9 3.04E-06 
PA0938   hypothetical protein NA NA NA NA NA NA -2.2 0.00E+00 
PA0980   hypothetical protein NA NA NA NA NA NA -2.9 7.65E-06 
PA1036   hypothetical protein NA NA NA NA NA NA -2.6 1.47E-06 
PA1040   hypothetical protein NA NA NA NA NA NA -28.8 1.28E-06 
PA1043   hypothetical protein NA NA NA NA NA NA -3.4 9.38E-06 
PA1117   hypothetical protein 14.2 1.62E-13 NA NA NA NA -4.9 6.65E-11 
PA1133   hypothetical protein 40.9 1.30E-08 NA NA NA NA -40.9 5.61E-09 
PA1154   conserved hypothetical protein NA NA NA NA NA NA -26.9 3.04E-06 
PA1198   conserved hypothetical protein NA NA NA NA NA NA -2.4 0.00E+00 
PA1215   hypothetical protein NA NA NA NA NA NA -27.9 1.95E-06 
PA1244   hypothetical protein NA NA NA NA NA NA -2.8 0.00E+00 
PA1358   hypothetical protein 72.0 0.00E+00 NA NA NA NA -3.9 2.93E-07 
PA1369   hypothetical protein NA NA NA NA NA NA -2.3 8.58E-07 
PA1394   hypothetical protein 4.3 1.57E-08 -34.4 6.00E-09 NA NA -84.5 4.11E-14 
PA1440   hypothetical protein NA NA NA NA NA NA -2.1 1.05E-07 
PA1531   hypothetical protein NA NA NA NA NA NA -41.4 4.50E-09 
PA1545   hypothetical protein NA NA NA NA NA NA -2.3 2.06E-09 
PA1550   hypothetical protein NA NA NA NA NA NA -2.9 1.16E-08 
 410 
 
PA1575   hypothetical protein NA NA NA NA NA NA -26.0 4.49E-06 
PA1728   hypothetical protein 3.2 9.16E-13 NA NA NA NA -2.6 3.96E-10 
PA1745   hypothetical protein NA NA NA NA NA NA -29.4 1.00E-06 
PA1874   hypothetical protein NA NA NA NA NA NA -12.7 7.98E-07 
PA1967   hypothetical protein NA NA NA NA NA NA -57.3 3.39E-12 
PA2036   hypothetical protein 8.5 2.50E-06 NA NA NA NA -41.3 4.80E-09 
PA2045   conserved hypothetical protein 55.0 2.39E-11 NA NA NA NA -55.0 9.82E-12 
PA2198   hypothetical protein 8.5 3.67E-09 NA NA NA NA -62.5 3.43E-13 
PA2288   hypothetical protein 2.2 1.42E-13 -3.4 6.77E-14 NA NA -5.5 0.00E+00 
PA2365   conserved hypothetical protein NA NA NA NA NA NA -4.9 8.50E-08 
PA2372   hypothetical protein NA NA NA NA NA NA -3.4 1.03E-07 
PA2406   hypothetical protein NA NA NA NA NA NA -25.6 5.40E-06 
PA2410   hypothetical protein 2.8 1.67E-05 NA NA NA NA -3.2 1.12E-06 
PA2423   hypothetical protein NA NA NA NA NA NA -3.2 1.48E-07 
PA2434   hypothetical protein NA NA NA NA NA NA -26.3 3.95E-06 
PA2487   hypothetical protein 26.3 8.04E-06 NA NA NA NA -26.3 3.95E-06 
PA2496   hypothetical protein NA NA NA NA NA NA -27.8 1.99E-06 
PA2504   hypothetical protein NA NA NA NA NA NA -81.4 0.00E+00 
PA2564   hypothetical protein NA NA NA NA NA NA -60.7 7.49E-13 
PA2565   hypothetical protein NA NA NA NA NA NA -33.7 1.43E-07 
PA2566   conserved hypothetical protein NA NA NA NA NA NA -42.3 2.99E-09 
PA2706   hypothetical protein 4.3 8.85E-06 -22.1 4.37E-06 NA NA -54.4 1.30E-11 
PA2721   hypothetical protein NA NA NA NA NA NA -44.9 9.43E-10 
PA3198   conserved hypothetical protein NA NA NA NA NA NA -3.4 4.14E-06 
PA3288   hypothetical protein NA NA NA NA NA NA -4.9 2.32E-08 
PA3325   conserved hypothetical protein NA NA NA NA NA NA -32.4 2.64E-07 
PA3335   hypothetical protein NA NA NA NA NA NA -76.3 2.18E-14 
PA3390   hypothetical protein 5.7 4.49E-06 NA NA NA NA -47.4 3.02E-10 
 411 
 
PA3446   conserved hypothetical protein 2.6 2.03E-06 NA NA NA NA -4.4 1.99E-11 
PA3520   hypothetical protein 73.7 0.00E+00 NA NA NA NA -73.7 0.00E+00 
PA3623   conserved hypothetical protein NA NA NA NA NA NA -2.3 0.00E+00 
PA3684   hypothetical protein 2.6 2.08E-10 NA NA NA NA -4.4 0.00E+00 
PA3698   hypothetical protein 5.1 4.23E-13 NA NA NA NA -2.9 1.73E-08 
PA3752   hypothetical protein NA NA NA NA NA NA -36.8 3.55E-08 
PA3755   conserved hypothetical protein NA NA NA NA NA NA -2.1 1.67E-06 
PA3793   hypothetical protein 2.0 1.28E-05 -6.5 9.93E-14 NA NA -6.8 2.58E-14 
PA3797   conserved hypothetical protein 2.6 3.75E-07 NA NA NA NA -2.5 3.94E-07 
PA3808   conserved hypothetical protein 2.5 2.72E-13 NA NA NA NA -2.3 7.31E-12 
PA3905   hypothetical protein 2.5 3.24E-10 NA NA NA NA -13.6 0.00E+00 
PA3911   conserved hypothetical protein NA NA NA NA NA NA -27.8 1.99E-06 
PA3928   hypothetical protein 84.0 5.05E-14 NA NA NA NA -84.0 5.24E-14 
PA4009   hypothetical protein NA NA NA NA NA NA -33.5 1.59E-07 
PA4027   hypothetical protein NA NA NA NA NA NA -24.1 1.05E-05 
PA4059   hypothetical protein NA NA NA NA NA NA -38.0 2.11E-08 
PA4093   hypothetical protein NA NA NA NA NA NA -34.4 1.03E-07 
PA4183   hypothetical protein NA NA NA NA NA NA -30.7 5.57E-07 
PA4200   hypothetical protein NA NA NA NA NA NA -24.9 7.55E-06 
PA4327   hypothetical protein NA NA NA NA NA NA -35.6 6.13E-08 
PA4337   hypothetical protein 8.5 1.63E-05 NA NA NA NA -35.2 7.32E-08 
PA4349   hypothetical protein NA NA NA NA NA NA -40.0 8.38E-09 
PA4352   conserved hypothetical protein NA NA NA NA NA NA -2.3 3.69E-14 
PA4357   conserved hypothetical protein 29.6 1.94E-06 NA NA NA NA -29.6 9.24E-07 
PA4362   hypothetical protein NA NA NA NA NA NA -3.9 1.00E-05 
PA4364   hypothetical protein 35.7 1.30E-07 NA NA NA NA -35.7 5.77E-08 
PA4530   conserved hypothetical protein NA NA NA NA NA NA -71.5 0.00E+00 
PA4533   hypothetical protein NA NA NA NA NA NA -4.9 6.98E-09 
PA4535   hypothetical protein 2.5 9.73E-11 NA NA NA NA -4.1 0.00E+00 
 412 
 
PA4582   conserved hypothetical protein NA NA NA NA NA NA -2.3 2.62E-11 
PA4583   conserved hypothetical protein NA NA NA NA NA NA -3.8 3.69E-14 
PA4610   hypothetical protein 17.0 0.00E+00 NA NA NA NA -5.8 1.82E-12 
PA4635   conserved hypothetical protein 2.8 6.39E-07 -37.3 1.21E-09 NA NA -101.9 2.36E-14 
PA4648   hypothetical protein NA NA NA NA NA NA -26.2 4.21E-06 
PA4650   hypothetical protein NA NA NA NA NA NA -26.5 3.71E-06 
PA4677   hypothetical protein NA NA NA NA NA NA -5.4 5.23E-08 
PA4679   hypothetical protein 2.4 1.88E-05 NA NA NA NA -2.4 5.13E-06 
PA4714   conserved hypothetical protein NA NA NA NA NA NA -5.8 4.40E-12 
PA4736   hypothetical protein 2.5 1.02E-10 NA NA NA NA -3.9 0.00E+00 
PA4790   conserved hypothetical protein 67.0 2.68E-14 NA NA NA NA -6.8 2.25E-09 
PA4830   hypothetical protein NA NA NA NA NA NA -53.2 2.26E-11 
PA4840   conserved hypothetical protein 2.2 1.83E-09 -2.2 1.19E-05 NA NA -3.6 0.00E+00 
PA4916   hypothetical protein NA NA NA NA NA NA -3.9 8.92E-12 
PA5026   hypothetical protein NA NA NA NA NA NA -31.7 3.54E-07 
PA5101   hypothetical protein NA NA NA NA NA NA -27.0 2.91E-06 
PA5123   hypothetical protein NA NA NA NA NA NA -37.6 2.53E-08 
PA5185   conserved hypothetical protein 3.5 4.36E-07 NA NA NA NA -4.9 2.31E-09 
PA5286   conserved hypothetical protein NA NA NA NA NA NA -2.1 2.92E-10 
PA5333   conserved hypothetical protein 2.8 6.42E-09 NA NA NA NA -2.3 7.31E-07 
PA5339   conserved hypothetical protein NA NA NA NA NA NA -2.1 3.47E-10 
PA5405   hypothetical protein 30.7 1.18E-06 NA NA NA NA -30.7 5.57E-07 
PA5423   hypothetical protein NA NA NA NA NA NA -2.2 9.04E-06 
Membrane proteins 
PA0007   hypothetical protein NA NA NA NA NA NA -25.2 6.36E-06 
PA1118   hypothetical protein 3.1 1.26E-08 NA NA NA NA -5.4 1.09E-13 
PA1131   probable major facilitator superfamily (MFS) transporter NA NA NA NA NA NA -62.3 3.57E-13 
 413 
 
PA1297   probable metal transporter 8.5 1.12E-06 NA NA NA NA -43.9 1.46E-09 
PA1541   probable drug efflux transporter NA NA NA NA NA NA -58.4 2.11E-12 
PA1547   hypothetical protein 4.3 1.46E-06 NA NA NA NA -5.8 2.81E-08 
PA1650   probable transporter NA NA NA NA NA NA -24.1 1.05E-05 
PA1825   hypothetical protein NA NA NA NA NA NA -5.8 1.02E-08 
PA2306 ambA AmbA NA NA NA NA NA NA -4.4 5.03E-11 
PA2327   probable permease of ABC transporter NA NA NA NA NA NA -28.2 1.73E-06 
PA2409   probable permease of ABC transporter NA NA NA NA NA NA -8.8 7.14E-11 
PA2501   hypothetical protein 3.5 1.11E-13 NA NA NA NA -4.9 5.59E-14 
PA2663 ppyR psl and pyoverdine operon regulator, PpyR NA NA NA NA NA NA -27.8 1.99E-06 
PA3235   conserved hypothetical protein NA NA NA NA NA NA -2.9 7.64E-10 
PA3370   hypothetical protein 48.9 3.87E-10 NA NA NA NA -48.9 1.59E-10 
PA3432   hypothetical protein NA NA NA NA NA NA -36.8 3.55E-08 
PA3789   hypothetical protein NA NA NA NA NA NA -30.4 6.24E-07 
PA3897   hypothetical protein 23.9 2.37E-05 NA NA NA NA -23.9 1.17E-05 
PA3920   probable metal transporting P-type ATPase 4.8 1.92E-07 NA NA NA NA -10.7 8.43E-11 
PA3966   hypothetical protein NA NA NA NA NA NA -2.4 2.22E-09 
PA4046   hypothetical protein NA NA NA NA NA NA -3.9 6.00E-07 
PA4507   hypothetical protein NA NA NA NA NA NA -34.0 1.24E-07 
PA5132   hypothetical protein 11.3 6.08E-06 -21.4 6.46E-06 NA NA -35.1 7.75E-08 
Motility & Attachment 
PA1461 motD MotD 2.4 2.67E-06 NA NA NA NA -2.4 6.34E-07 
PA3361 lecB fucose-binding lectin PA-IIL NA NA NA NA NA NA -4.9 1.13E-11 
PA4086 cupB1 probable fimbrial subunit CupB1 25.2 1.31E-05 NA NA NA NA -25.2 6.47E-06 
PA4305 rcpC RcpC NA NA NA NA NA NA -8.8 8.24E-11 
 414 
 
PA4551 pilV type 4 fimbrial biogenesis protein PilV NA NA NA NA NA NA -25.7 5.09E-06 
PA4555 pilY2 type 4 fimbrial biogenesis protein PilY2 NA NA NA NA NA NA -61.9 4.31E-13 
Non-coding RNA gene 
PA2819.3   tRNA-Glu 2.8 1.77E-06 -57.6 0.00E+00 NA NA -94.5 0.00E+00 
Nucleotide biosynthesis and metabolism 
PA0143 nuh purine nucleosidase Nuh NA NA NA NA NA NA -2.2 2.19E-06 
PA0849 trxB2 thioredoxin reductase 2 NA NA NA NA NA NA -4.2 4.39E-14 
Protein secretion/export apparatus 
PA1692   probable translocation protein in type III secretion NA NA NA NA NA NA -26.9 3.04E-06 
PA1705 pcrG regulator in type III secretion 24.2 2.05E-05 NA NA NA NA -24.2 1.01E-05 
PA1713 exsA transcriptional regulator ExsA NA NA NA NA NA NA -5.8 6.00E-07 
PA1875   probable outer membrane protein precursor NA NA NA NA NA NA -28.1 1.78E-06 
PA3095 xcpZ general secretion pathway protein M NA NA NA NA NA NA -6.8 5.40E-13 
PA3098 xcpW general secretion pathway protein J NA NA NA NA NA NA -7.8 1.18E-11 
Putative enzymes 
PA0534   conserved hypothetical protein NA NA NA NA NA NA -2.9 2.05E-07 
PA0817   probable ring-cleaving dioxygenase 3.3 2.41E-09 NA NA NA NA -2.3 4.01E-06 
PA1914   conserved hypothetical protein NA NA NA NA NA NA -29.3 1.05E-06 
PA2024   probable ring-cleaving dioxygenase 11.3 8.90E-11 
-
20.7 9.31E-06 NA NA -67.9 5.04E-14 
PA2271   probable acetyltransferase 8.5 2.17E-06 NA NA NA NA -41.8 3.86E-09 
PA2379   probable oxidoreductase NA NA NA NA NA NA -5.8 1.41E-11 
PA3295   probable HIT family protein 2.8 1.04E-06 NA NA NA NA -2.9 2.70E-07 
PA4026   probable acetyltransferase NA NA NA NA NA NA -5.8 8.72E-12 
 415 
 
Transcription, RNA processing and degradation 
PA5197 rimK ribosomal protein S6 modification protein NA NA NA NA NA NA -3.9 1.63E-06 
Transcriptional regulators 
PA0175   probable chemotaxis protein methyltransferase NA NA NA NA NA NA -25.6 5.51E-06 
PA0547   probable transcriptional regulator 2.0 4.43E-12 NA NA NA NA -2.7 1.75E-14 
PA1109   probable transcriptional regulator NA NA NA NA NA NA -27.6 2.19E-06 
PA1359   probable transcriptional regulator 8.5 1.40E-09 NA NA NA NA -5.8 1.41E-08 
PA1455 fliA sigma factor FliA NA NA NA NA NA NA -2.9 2.85E-10 
PA2809 copR two-component response regulator, CopR NA NA NA NA NA NA -31.6 3.64E-07 
PA2877   probable transcriptional regulator NA NA NA NA NA NA -24.1 1.05E-05 
PA3034   probable transcriptional regulator 6.4 0.00E+00 NA NA NA NA -4.4 4.09E-12 
PA3077   probable two-component response regulator 8.5 2.20E-09 NA NA NA NA -5.8 2.10E-08 
PA3351 flgM FlgM 2.0 0.00E+00 NA NA NA NA -2.4 4.81E-14 
PA3630   probable transcriptional regulator NA NA NA NA NA NA -31.6 3.70E-07 
PA4070   probable transcriptional regulator NA NA NA NA NA NA -30.2 6.91E-07 
PA4077   probable transcriptional regulator 34.7 2.02E-07 NA NA NA NA -34.7 9.20E-08 
PA4135   probable transcriptional regulator 2.2 1.47E-05 NA NA NA NA -3.4 4.26E-10 
PA4203   probable transcriptional regulator NA NA NA NA NA NA -33.6 1.50E-07 
PA4987   probable transcriptional regulator NA NA NA NA NA NA -4.9 3.48E-07 
 416 
 
Translation, post-translational modification, degradation 
PA1165 pcpS PcpS NA NA NA NA NA NA -39.4 1.11E-08 
PA1670 stp1 
serine/threonine 
phosphoprotein phosphatase 
Stp1 
NA NA NA NA NA NA -4.9 4.29E-06 
PA2371   probable ClpA/B-type protease NA NA NA NA NA NA -28.2 1.73E-06 
PA3227 ppiA peptidyl-prolyl cis-trans isomerase A NA NA NA NA NA NA -2.9 6.82E-06 
PA3601   conserved hypothetical protein NA NA NA NA NA NA -27.2 2.65E-06 
PA3717   probable peptidyl-prolyl cis-trans isomerase, FkbP-type 11.3 2.72E-13 NA NA NA NA -3.9 2.65E-08 
PA4482 gatC Glu-tRNA(Gln) amidotransferase subunit C NA NA NA NA NA NA -4.9 8.36E-14 
Transport of small molecules 
PA0487   probable molybdenum transport regulator 8.5 2.16E-08 NA NA NA NA -5.8 1.46E-07 
PA0958 oprD 
Basic amino acid, basic peptide 
and imipenem outer membrane 
porin OprD precursor 
NA NA NA NA NA NA -3.0 2.52E-13 
PA3407 hasAp heme acquisition protein HasAp NA NA NA NA NA NA -34.9 8.55E-08 
PA3753   conserved hypothetical protein 2.2 6.17E-07 -75.1 0.00E+00 NA NA -150.5 0.00E+00 
 
 
 
 
 
 
 
 
 
 
 
 417 
 
Genes negatively regulated by AmpR upon ß-lactam exposure (247) 
Gene ID Gene name Product Name 
Condition 1 Condition 2 Condition 3 Condition 4 
Fold 
Change 
Corrected 
p-value 
Fold 
Cha
nge 
Corrected 
p-value 
Fold 
Change 
Corrected 
p-value 
Fold 
Change 
Corrected 
p-value 
Adaptation, Protection 
PA3553 arnC ArnC NA NA NA NA NA NA 53.7 3.65E-13 
PA3624 pcm 
L-isoaspartate protein 
carboxylmethyltransferase type 
II 
NA NA NA NA NA NA 2.0 4.42E-08 
PA4671   probable ribosomal protein L25 NA NA NA NA NA NA 2.2 0.00E+00 
Amino acid biosynthesis and metabolism 
PA5278 dapF diaminopimelate epimerase NA NA NA NA NA NA 2.0 2.02E-06 
PA2446 gcvH2 glycine cleavage system protein H2 NA NA NA NA NA NA 2.1 4.91E-14 
PA5413 ltaA low specificity l-threonine aldolase NA NA NA NA NA NA 2.3 2.24E-06 
PA2247 bkdA1 2-oxoisovalerate dehydrogenase (alpha subunit) NA NA NA NA NA NA 2.4 5.09E-14 
PA3117 asd aspartate semialdehyde dehydrogenase NA NA NA NA NA NA 2.4 1.73E-11 
PA5067 hisE phosphoribosyl-ATP pyrophosphohydrolase NA NA NA NA NA NA 3.6 4.64E-14 
PA5417 soxD sarcosine oxidase delta subunit NA NA NA NA NA NA 21.3 7.88E-06 
PA3570 mmsA methylmalonate-semialdehyde dehydrogenase NA NA NA NA NA NA 2.3 6.69E-14 
PA2000 dhcB DhcB, dehydrocarnitine CoA transferase, subunit B NA NA NA NA NA NA 2.7 0.00E+00 
PA2250 lpdV lipoamide dehydrogenase-Val NA NA NA NA NA NA 2.0 0.00E+00 
PA4758 carA carbamoyl-phosphate synthase small chain NA NA NA NA NA NA 2.2 1.07E-08 
PA0402 pyrB aspartate carbamoyltransferase NA NA NA NA NA NA 2.6 4.58E-07 
 418 
 
Antibiotic resistance and susceptibility ; Membrane proteins 
PA0157 triB 
Resistance-Nodulation-Cell 
Division (RND) triclosan efflux 
membrane fusion protein, TriB 
NA NA NA NA NA NA 4.1 3.03E-06 
` 
PA0551 epd D-erythrose 4-phosphate dehydrogenase NA NA NA NA NA NA 2.5 3.97E-09 
PA4529 coaE dephosphocoenzyme A kinase NA NA NA NA NA NA 2.6 1.21E-07 
PA1275 cobD cobalamin biosynthetic protein CobD NA NA NA NA NA NA 6.2 6.55E-07 
PA2905 cobH precorrin isomerase CobH NA NA NA NA NA NA 65.5 5.09E-14 
PA0024 hemF coproporphyrinogen III oxidase, aerobic -2.6 1.80E-05 2.8 5.65E-06 NA NA 3.1 7.66E-08 
PA5320 coaC 
Phosphopantothenoylcysteine 
synthase/(R)-4'-phospho-N-
pantothenoylcysteine 
decarboxylase 
NA NA NA NA NA NA 3.9 3.13E-09 
Carbon compound catabolism 
PA2013 liuC putative 3-methylglutaconyl-CoA hydratase NA NA NA NA NA NA 2.2 3.74E-06 
PA2007 maiA maleylacetoacetate isomerase NA NA NA NA NA NA 2.6 0.00E+00 
PA1311 phnX 2-phosphonoacetaldehyde hydrolase NA NA NA NA NA NA 24.8 1.30E-06 
PA2862 lipA lactonizing lipase precursor NA NA NA NA NA NA 21.9 5.72E-06 
Cell division 
PA4408 ftsA cell division protein FtsA NA NA NA NA NA NA 2.2 1.49E-12 
PA5563 soj chromosome partitioning protein Soj NA NA NA NA NA NA 3.9 0.00E+00 
Cell wall / LPS / capsule 
PA3643 lpxB lipid A-disaccharide synthase NA NA NA NA NA NA 2.0 7.76E-07 
PA5162 rmlD dTDP-4-dehydrorhamnose reductase NA NA NA NA NA NA 2.5 4.76E-11 
 419 
 
PA2236 pslF PslF NA NA NA NA NA NA 3.6 2.60E-08 
PA2238 pslH PslH NA NA NA NA NA NA 5.6 5.14E-09 
Central intermediary metabolism 
PA5046   malic enzyme NA NA NA NA NA NA 2.2 0.00E+00 
PA2023 galU UTP--glucose-1-phosphate uridylyltransferase NA NA NA NA NA NA 2.2 2.02E-11 
PA0102   probable carbonic anhydrase NA NA NA NA NA NA 2.2 1.22E-06 
PA4956 rhdA thiosulfate:cyanide sulfurtransferase NA NA NA NA NA NA 3.4 3.14E-08 
PA1780 nirD assimilatory nitrite reductase small subunit NA NA NA NA NA NA 20.9 9.60E-06 
PA0555 fda fructose-1,6-bisphosphate aldolase NA NA NA NA NA NA 2.3 4.39E-14 
PA1614 gpsA glycerol-3-phosphate dehydrogenase, biosynthetic NA NA NA NA NA NA 5.1 3.36E-13 
Chemotaxis 
PA1459   probable methyltransferase NA NA NA NA NA NA 2.8 2.68E-10 
PA1448 fliR flagellar biosynthetic protein FliR NA NA NA NA NA NA 26.4 5.58E-07 
PA0410 pilI twitching motility protein PilI NA NA NA NA NA NA 3.1 7.57E-07 
DNA replication, recombination, modification and repair 
PA5147 mutY A / G specific adenine glycosylase NA NA NA NA NA NA 2.4 9.25E-06 
PA0357 mutM formamidopyrimidine-DNA glycosylase NA NA NA NA NA NA 2.6 5.28E-06 
PA5345 recG ATP-dependent DNA helicase RecG NA NA NA NA NA NA 2.9 9.51E-06 
PA5280 sss site-specific recombinase Sss NA NA NA NA NA NA 6.2 4.40E-07 
PA3738 xerD integrase/recombinase XerD NA NA NA NA NA NA 22.9 3.50E-06 
Energy metabolism 
PA2637 nuoA NADH dehydrogenase I chain A NA NA NA NA NA NA 2.1 2.36E-14 
 420 
 
PA5491   probable cytochrome NA NA NA NA NA NA 2.2 0.00E+00 
PA4571   probable cytochrome c NA NA NA NA NA NA 2.3 2.66E-06 
PA0794   probable aconitate hydratase NA NA NA NA NA NA 2.3 1.06E-05 
PA3809 fdx2 ferredoxin [2Fe-2S] NA NA NA NA NA NA 2.3 5.04E-10 
PA2641 nuoF NADH dehydrogenase I chain F NA NA NA NA NA NA 2.7 1.73E-10 
PA2649 nuoN NADH dehydrogenase I chain N NA NA NA NA NA NA 4.0 1.27E-13 
PA3195 gapA glyceraldehyde 3-phosphate dehydrogenase NA NA NA NA NA NA 2.8 4.03E-06 
PA3194 edd phosphogluconate dehydratase NA NA NA NA NA NA 2.9 2.17E-06 
PA1557 ccoN2 Cytochrome c oxidase, cbb3-type, CcoN subunit NA NA NA NA NA NA 2.1 7.13E-06 
PA1555 ccoP2 Cytochrome c oxidase, cbb3-type, CcoP subunit NA NA NA NA NA NA 2.2 3.75E-07 
Fatty acid and phospholipid metabolism 
PA2969 plsX fatty acid biosynthesis protein PlsX NA NA NA NA NA NA 2.7 2.65E-08 
PA0447 gcdH glutaryl-CoA dehydrogenase NA NA NA NA NA NA 3.1 0.00E+00 
PA0796 prpB carboxyphosphonoenolpyruvate phosphonomutase NA NA NA NA NA NA 2.2 9.11E-07 
Hypothetical, unclassified, unknown 
PA0100   hypothetical protein NA NA NA NA NA NA 2.0 6.80E-06 
PA0394   conserved hypothetical protein NA NA NA NA NA NA 2.0 2.88E-08 
PA4000   hypothetical protein NA NA NA NA NA NA 2.0 2.30E-12 
PA0317   hypothetical protein NA NA NA NA NA NA 2.0 3.84E-06 
PA4454   conserved hypothetical protein NA NA NA NA NA NA 2.1 2.63E-12 
PA3801   conserved hypothetical protein NA NA NA NA NA NA 2.1 3.67E-13 
PA3980   conserved hypothetical protein NA NA NA NA NA NA 2.1 4.74E-06 
PA5526   hypothetical protein NA NA NA NA NA NA 2.2 0.00E+00 
PA0446   conserved hypothetical protein NA NA NA NA NA NA 2.2 1.19E-10 
 421 
 
PA3214   hypothetical protein NA NA NA NA NA NA 2.3 9.52E-06 
PA5446   hypothetical protein NA NA NA NA NA NA 2.3 4.39E-14 
PA2112   conserved hypothetical protein NA NA NA NA NA NA 2.4 0.00E+00 
PA5492   conserved hypothetical protein NA NA NA NA NA NA 2.4 7.77E-09 
PA3263   conserved hypothetical protein NA NA NA NA NA NA 2.4 1.64E-06 
PA3731   conserved hypothetical protein NA NA NA NA NA NA 2.4 2.71E-08 
PA2110   hypothetical protein NA NA NA NA NA NA 2.5 0.00E+00 
PA2894   hypothetical protein NA NA NA NA NA NA 2.6 8.23E-06 
PA2733   conserved hypothetical protein NA NA NA NA NA NA 2.6 1.07E-08 
PA3345   hypothetical protein NA NA NA NA NA NA 2.6 8.61E-07 
PA2959   conserved hypothetical protein NA NA NA NA NA NA 2.6 7.67E-11 
PA2080 kynU kynureninase KynU NA NA NA NA NA NA 2.7 2.41E-08 
PA0388   hypothetical protein NA NA NA NA NA NA 2.7 1.56E-09 
PA0542   conserved hypothetical protein NA NA NA NA NA NA 2.7 1.56E-09 
PA4697   hypothetical protein NA NA NA NA NA NA 2.7 6.53E-09 
PA0598   hypothetical protein NA NA NA NA NA NA 2.7 9.96E-06 
PA5303   conserved hypothetical protein NA NA NA NA NA NA 2.7 5.35E-14 
PA0462   hypothetical protein NA NA NA NA NA NA 2.8 2.70E-08 
PA5422   hypothetical protein NA NA NA NA NA NA 2.9 5.19E-08 
PA1114   hypothetical protein NA NA NA NA NA NA 3.1 1.10E-05 
PA4322   conserved hypothetical protein NA NA NA NA NA NA 3.1 1.10E-05 
PA4335   hypothetical protein NA NA NA NA NA NA 3.1 4.39E-06 
PA4841   conserved hypothetical protein NA NA NA NA NA NA 3.1 7.57E-07 
PA0385   hypothetical protein NA NA NA NA NA NA 3.1 7.51E-06 
PA1639   hypothetical protein NA NA NA NA NA NA 3.1 8.98E-09 
PA3284   hypothetical protein NA NA NA NA NA NA 3.1 5.46E-06 
PA4605   conserved hypothetical protein NA NA NA NA NA NA 3.1 1.07E-08 
PA0553   hypothetical protein NA NA NA NA NA NA 3.1 8.20E-09 
PA1034   hypothetical protein NA NA NA NA NA NA 3.1 8.20E-09 
 422 
 
PA4746   conserved hypothetical protein NA NA NA NA NA NA 3.3 0.00E+00 
PA3200   conserved hypothetical protein NA NA NA NA NA NA 3.6 6.76E-06 
PA5459   hypothetical protein NA NA NA NA NA NA 3.6 3.42E-06 
PA4321   hypothetical protein NA NA NA NA NA NA 3.8 1.29E-06 
PA3084   hypothetical protein NA NA NA NA NA NA 3.8 6.37E-10 
PA2986   conserved hypothetical protein NA NA NA NA NA NA 3.9 1.22E-08 
PA0568   hypothetical protein NA NA NA NA NA NA 4.1 4.06E-07 
PA1514   ureidoglycolate hydrolaseYbbT NA NA NA NA NA NA 4.1 1.66E-06 
PA1837   hypothetical protein NA NA NA NA NA NA 4.1 1.22E-06 
PA4062   hypothetical protein NA NA NA NA NA NA 4.1 7.19E-09 
PA0389   hypothetical protein NA NA NA NA NA NA 4.8 4.91E-14 
PA4579   hypothetical protein NA NA NA NA NA NA 4.8 5.72E-07 
PA2230   hypothetical protein NA NA NA NA NA NA 5.1 3.56E-07 
PA2441   hypothetical protein NA NA NA NA NA NA 5.1 1.76E-10 
PA2632   hypothetical protein NA NA NA NA NA NA 5.1 1.10E-07 
PA0022   conserved hypothetical protein NA NA NA NA NA NA 6.2 5.95E-11 
PA3670   hypothetical protein NA NA NA NA NA NA 6.7 8.82E-08 
PA5145   hypothetical protein NA NA NA NA NA NA 7.2 2.60E-07 
PA1193   hypothetical protein NA NA NA NA NA NA 7.2 2.12E-11 
PA3680   conserved hypothetical protein NA NA NA NA NA NA 7.2 6.79E-10 
PA4617   conserved hypothetical protein NA NA NA NA NA NA 11.3 1.67E-12 
PA2670   hypothetical protein NA NA NA NA NA NA 20.8 1.02E-05 
PA0977   hypothetical protein NA NA NA NA NA NA 21.1 8.70E-06 
PA1123   hypothetical protein NA NA NA NA NA NA 21.3 7.88E-06 
PA4182   hypothetical protein NA NA NA NA NA NA 21.4 7.49E-06 
PA2874   hypothetical protein NA NA NA NA NA NA 21.5 7.10E-06 
PA2422   hypothetical protein NA NA NA NA NA NA 21.7 6.39E-06 
PA1517   conserved hypothetical protein NA NA NA NA NA NA 22.1 5.14E-06 
PA0104   hypothetical protein NA NA NA NA NA NA 22.9 3.43E-06 
 423 
 
PA1489   hypothetical protein NA NA NA NA NA NA 23.0 3.33E-06 
PA0709   hypothetical protein NA NA NA NA NA NA 23.0 3.23E-06 
PA5407   hypothetical protein NA NA NA NA NA NA 23.5 2.52E-06 
PA3066   hypothetical protein NA NA NA NA NA NA 23.9 2.09E-06 
PA3283   conserved hypothetical protein NA NA NA NA NA NA 24.0 1.96E-06 
PA1139   hypothetical protein NA NA NA NA NA NA 24.2 1.79E-06 
PA2292   hypothetical protein NA NA NA NA NA NA 24.3 1.72E-06 
PA4985   hypothetical protein NA NA NA NA NA NA 25.1 1.13E-06 
PA3991   hypothetical protein NA NA NA NA NA NA 25.9 7.26E-07 
PA0711   hypothetical protein NA NA NA NA NA NA 27.0 4.15E-07 
PA1234   hypothetical protein NA NA NA NA NA NA 27.2 3.81E-07 
PA2625   conserved hypothetical protein NA NA NA NA NA NA 29.1 1.42E-07 
PA1761   hypothetical protein NA NA NA NA NA NA 31.2 4.51E-08 
PA4169   conserved hypothetical protein NA NA NA NA NA NA 31.9 3.22E-08 
PA5408   hypothetical protein NA NA NA NA NA NA 38.7 9.39E-10 
PA1135   conserved hypothetical protein NA NA NA NA NA NA 39.1 7.60E-10 
PA1593   hypothetical protein NA NA NA NA NA NA 43.3 8.24E-11 
PA2264   conserved hypothetical protein NA NA NA NA NA NA 47.7 8.25E-12 
PA1641   hypothetical protein NA NA NA NA NA NA 49.1 4.05E-12 
PA5533   hypothetical protein NA NA NA NA NA NA 55.6 1.27E-13 
PA4753   conserved hypothetical protein -30.0 2.19E-07 6.9 5.20E-14 NA NA 108.6 0.00E+00 
PA1518   conserved hypothetical protein -24.8 2.96E-06 53.9 7.87E-11 NA NA 53.9 3.13E-13 
PA0469   hypothetical protein -24.8 2.99E-06 4.8 2.38E-06 NA NA 55.8 1.40E-13 
PA0541   hypothetical protein -4.9 4.55E-09 2.2 1.32E-05 NA NA 8.2 4.39E-14 
PA3767   conserved hypothetical protein -4.2 4.40E-06 3.2 7.00E-07 NA NA 7.2 1.03E-13 
PA4612   conserved hypothetical protein NA NA NA NA NA NA 24.8 1.30E-06 
PA0718   hypothetical protein of bacteriophage Pf1 NA NA NA NA NA NA 23.5 2.52E-06 
 
 424 
 
Membrane proteins 
PA3819   conserved hypothetical protein NA NA NA NA NA NA 2.1 0.00E+00 
PA1053   conserved hypothetical protein NA NA NA NA NA NA 2.2 5.59E-14 
PA5568   conserved hypothetical protein NA NA NA NA NA NA 2.3 2.98E-09 
PA5250   conserved hypothetical protein NA NA NA NA NA NA 3.8 2.05E-10 
PA2004   conserved hypothetical protein NA NA NA NA NA NA 4.8 5.77E-09 
PA2929   hypothetical protein NA NA NA NA NA NA 5.1 9.48E-08 
PA3362   hypothetical protein NA NA NA NA NA NA 5.1 5.35E-09 
PA3748   conserved hypothetical protein NA NA NA NA NA NA 7.2 2.09E-06 
PA2751   conserved hypothetical protein NA NA NA NA NA NA 22.8 3.64E-06 
PA2936   hypothetical protein NA NA NA NA NA NA 23.5 2.52E-06 
PA2784   hypothetical protein NA NA NA NA NA NA 24.5 1.50E-06 
PA2712   hypothetical protein NA NA NA NA NA NA 31.7 3.60E-08 
PA1055   conserved hypothetical protein -27.9 6.43E-07 5.5 1.75E-09 NA NA 80.8 2.36E-14 
PA0070 tagQ1 TagQ1 NA NA NA NA NA NA 2.2 4.11E-14 
PA0984   colicin immunity protein NA NA NA NA NA NA 3.1 8.30E-06 
PA1911 femR sigma factor regulator, FemR NA NA NA NA NA NA 21.6 6.86E-06 
PA4233   probable major facilitator superfamily (MFS) transporter NA NA NA NA NA NA 2.1 8.92E-07 
PA1341   amino acid ABC transporter membrane protein NA NA NA NA NA NA 2.3 8.39E-06 
PA4503   probable permease of ABC transporter NA NA NA NA NA NA 2.6 4.97E-07 
PA4765 omlA Outer membrane lipoprotein OmlA precursor NA NA NA NA NA NA 3.1 7.54E-13 
PA5504   D-methionine ABC transporter membrane protein NA NA NA NA NA NA 3.1 2.86E-10 
PA2533   probable sodium:alanine symporter NA NA NA NA NA NA 3.6 1.95E-07 
PA0890 aotM arginine/ornithine transport protein AotM NA NA NA NA NA NA 3.6 1.85E-13 
 425 
 
PA4707   probable permease of ABC transporter NA NA NA NA NA NA 10.3 1.26E-12 
PA5216   probable permease of ABC iron transporter NA NA NA NA NA NA 12.3 6.54E-10 
PA3585 glpM membrane protein GlpM NA NA NA NA NA NA 20.7 1.05E-05 
PA0786   probable transporter NA NA NA NA NA NA 22.4 4.59E-06 
PA3888   probable permease of ABC transporter NA NA NA NA NA NA 37.9 1.43E-09 
PA4990   SMR multidrug efflux transporter NA NA NA NA NA NA 20.6 1.16E-05 
Motility & Attachment 
PA0406 tonB3 TonB3 NA NA NA NA NA NA 6.2 8.79E-07 
Non-coding RNA gene 
PA3368.1   tRNA-Arg NA NA NA NA NA NA 2.1 0.00E+00 
PA3133.2   tRNA-Ala NA NA NA NA NA NA 2.4 0.00E+00 
Nucleotide biosynthesis and metabolism 
PA0944 purN phosphoribosylaminoimidazole synthetase NA NA NA NA NA NA 2.6 4.02E-10 
PA3527 pyrC dihydroorotase NA NA NA NA NA NA 3.6 2.67E-09 
Protein secretion/export apparatus 
PA0086 tagJ1 TagJ1 NA NA NA NA NA NA 2.2 7.28E-06 
PA0089 tssG1 TssG1 NA NA NA NA NA NA 2.6 9.13E-09 
PA0077 tssM1 TssM1 NA NA NA NA NA NA 2.6 1.82E-07 
PA0080 tssJ1 TssJ1 -25.4 2.22E-06 5.5 1.88E-13 NA NA 117.7 2.75E-14 
PA1718 pscE type III export protein PscE NA NA NA NA NA NA 33.5 1.37E-08 
PA1699 pcr1 Pcr1 NA NA NA NA NA NA 24.5 1.50E-06 
Putative enzymes 
PA2631   probable acetyl transferase NA NA NA NA NA NA 2.1 5.03E-06 
PA5312   probable aldehyde NA NA NA NA NA NA 2.1 4.94E-08 
 426 
 
dehydrogenase 
PA0506   probable acyl-CoA dehydrogenase NA NA NA NA NA NA 2.4 2.13E-11 
PA0318   conserved hypothetical protein NA NA NA NA NA NA 3.1 1.01E-05 
PA5521   probable short-chain dehydrogenase NA NA NA NA NA NA 3.1 2.40E-11 
PA0130   probable aldehyde dehydrogenase NA NA NA NA NA NA 3.3 4.83E-07 
PA1047   probable esterase NA NA NA NA NA NA 3.4 5.13E-11 
PA5313   probable pyridoxal-dependent aminotransferase NA NA NA NA NA NA 3.7 1.32E-09 
PA0840   probable oxidoreductase NA NA NA NA NA NA 4.6 3.10E-07 
PA2040   probable glutamine synthetase NA NA NA NA NA NA 5.5 4.76E-11 
PA3427   probable short-chain dehydrogenases NA NA NA NA NA NA 7.2 1.16E-08 
PA1537   probable short-chain dehydrogenase NA NA NA NA NA NA 23.1 3.10E-06 
PA2550   probable acyl-CoA dehydrogenase NA NA NA NA NA NA 33.4 1.48E-08 
PA5020   probable acyl-CoA dehydrogenase NA NA NA NA NA NA 38.0 1.36E-09 
PA0656   probable HIT family protein NA NA NA NA NA NA 40.4 3.82E-10 
PA3554 arnA ArnA NA NA NA NA NA NA 3.5 3.74E-06 
PA0705 migA alpha-1,6-rhamnosyltransferase MigA NA NA NA NA NA NA 3.1 3.10E-06 
PA2237 pslG PslG NA NA NA NA NA NA 3.1 6.60E-07 
Secreted Factors (toxins, enzymes, alginate) 
PA0085 hcp1 Hcp1 NA NA NA NA NA NA 2.1 0.00E+00 
PA2702 tse2 Tse2 NA NA NA NA NA NA 4.1 6.90E-07 
Transcription, RNA processing and degradation 
PA3823 tgt queuine tRNA-ribosyltransferase NA NA NA NA NA NA 2.1 2.94E-06 
 427 
 
Transcriptional regulators 
PA3285   probable sigma-70 factor, ECF subfamily NA NA NA NA NA NA 3.1 3.92E-06 
PA0961   probable cold-shock protein NA NA NA NA NA NA 3.6 1.50E-14 
PA0479   probable transcriptional regulator NA NA NA NA NA NA 21.6 6.86E-06 
PA1961   probable transcriptional regulator NA NA NA NA NA NA 21.9 5.72E-06 
PA3571 mmsR transcriptional regulator MmsR NA NA NA NA NA NA 22.2 4.95E-06 
PA1399   probable transcriptional regulator NA NA NA NA NA NA 22.3 4.77E-06 
PA2432 bexR bistable expression regulator, BexR NA NA NA NA NA NA 22.4 4.42E-06 
PA4436   probable transcriptional regulator NA NA NA NA NA NA 22.8 3.64E-06 
PA2718   probable transcriptional regulator NA NA NA NA NA NA 28.0 2.47E-07 
PA1142   probable transcriptional regulator NA NA NA NA NA NA 28.6 1.77E-07 
PA5116   probable transcriptional regulator NA NA NA NA NA NA 32.1 2.86E-08 
PA5342   probable transcriptional regulator NA NA NA NA NA NA 42.7 1.13E-10 
PA4983   probable two-component response regulator NA NA NA NA NA NA 5.1 1.20E-06 
PA3363 amiR aliphatic amidase regulator NA NA NA NA NA NA 4.1 9.26E-06 
PA3184   probable transcriptional regulator NA NA NA NA NA NA 7.2 3.81E-09 
PA2510 catR transcriptional regulator CatR NA NA NA NA NA NA 23.5 2.52E-06 
PA0155 pcaR transcriptional regulator PcaR NA NA NA NA NA NA 24.4 1.57E-06 
PA3192 gltR two-component response regulator GltR NA NA NA NA NA NA 3.6 5.85E-07 
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Translation, post-translational modification, degradation 
PA3701 prfB peptide chain release factor 2 NA NA NA NA NA NA 2.0 4.71E-07 
PA4498   probable metallopeptidase NA NA NA NA NA NA 2.2 1.08E-05 
PA3262   probable peptidyl-prolyl cis-trans isomerase, FkbP-type NA NA NA NA NA NA 2.5 3.86E-14 
PA0538 dsbB disulfide bond formation protein NA NA NA NA NA NA 4.1 1.66E-06 
PA4572 fklB peptidyl-prolyl cis-trans isomerase FklB NA NA NA NA NA NA 4.1 2.75E-14 
Transport of small molecules 
PA5074   probable ATP-binding component of ABC transporter NA NA NA NA NA NA 2.7 7.03E-06 
PA1964   probable ATP-binding component of ABC transporter NA NA NA NA NA NA 5.1 2.66E-06 
PA3188   probable permease of ABC sugar transporter NA NA NA NA NA NA 8.2 5.42E-11 
PA1183 dctA C4-dicarboxylate transport protein NA NA NA NA NA NA 20.9 9.85E-06 
PA0295   probable periplasmic polyamine binding protein NA NA NA NA NA NA 25.8 7.82E-07 
PA3372   conserved hypothetical protein NA NA NA NA NA NA 35.5 4.90E-09 
PA0950   probable arsenate reductase NA NA NA NA NA NA 2.1 4.84E-07 
PA3153 wzx O-antigen translocase NA NA NA NA NA NA 2.4 5.39E-15 
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Table 4: ß-lactam-dependent genes. The genes that are either positively or negatively regulated when exposed to ß-lactam stress in the absence of AmpR are 
classified based on information in Supplementary Table 1. Only genes that are expressed > 2.0, FDR-corrected (Bonferroni, <0.05) are listed. Functional 
categorization, gene ID and gene/product names are from the Pseudomonas Genome database (27). Lack of expression of a gene under any of the four 
conditions is denoted as NA. 
 
Gene 
ID 
Gene 
name Product Name 
Condition 1 Condition 2 Condition 3 Condition 4 
FC Corrected p-value FC 
Corrected 
p-value FC 
Corrected 
p-value FC 
Corrected 
p-value 
Genes positively regulated in an AmpR-independent, ß-lactam-dependent manner (278) 
Adaptation, Protection 
PA0059 osmC osmotically inducible protein OsmC NA NA 9.7 0.00E+00 NA NA 3.6 1.57E-10 
Amino acid biosynthesis and metabolism 
PA0025 aroE shikimate dehydrogenase NA NA 4.8 1.43E-06 NA NA 3.6 2.88E-06 
PA0896 aruF arginine/ornithine succinyltransferase AI subunit 2.0 2.91E-10 NA NA NA NA NA NA 
PA1338 ggt gamma-glutamyltranspeptidase precursor NA NA 2.6 9.04E-07 NA NA 3.6 2.19E-11 
PA2443 sdaA L-serine dehydratase NA NA 2.3 1.95E-10 NA NA 2.2 4.10E-11 
PA2612 serS seryl-tRNA synthetase NA NA 2.1 5.43E-07 NA NA 3.0 1.27E-13 
PA3107 metZ o-succinylhomoserine sulfhydrylase NA NA 2.2 2.03E-07 NA NA 2.3 5.30E-09 
PA3997 lipB lipoate-protein ligase B 2.0 2.60E-06 NA NA NA NA NA NA 
PA4449 hisG ATP-phosphoribosyltransferase NA NA 2.2 8.79E-09 NA NA 6.5 0.00E+00 
PA4602 glyA3 serine hydroxymethyltransferase 2.0 1.64E-07 NA NA 2.4 9.05E-13 NA NA 
PA4731 panD aspartate 1-decarboxylase precursor 2.8 2.48E-05 71.8 1.50E-14 NA NA NA NA 
PA4846 aroQ1 3-dehydroquinate dehydratase NA NA 3.0 0.00E+00 NA NA 4.2 0.00E+00 
PA5015 aceE pyruvate dehydrogenase NA NA 2.0 4.46E-08 NA NA 2.6 0.00E+00 
PA5171 arcA arginine deiminase 2.1 2.39E-11 2.2 6.77E-14 NA NA NA NA 
PA5172 arcB ornithine carbamoyltransferase, NA NA 2.4 0.00E+00 NA NA 2.0 3.52E-14 
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catabolic 
PA5173 arcC carbamate kinase 2.3 1.20E-08 NA NA NA NA NA NA 
PA5323 argB acetylglutamate kinase NA NA 2.1 2.58E-10 NA NA 2.1 1.24E-11 
Biosynthesis of cofactors, prosthetic groups and carriers 
PA0583   hypothetical protein 5.7 1.13E-06 NA NA NA NA NA NA 
PA3029 moaB2 molybdopterin biosynthetic protein B2 3.1 6.26E-10 NA NA 2.8 1.25E-07 NA NA 
PA4047 ribA GTP cyclohydrolase II 3.1 7.10E-11 NA NA 3.0 5.42E-10 NA NA 
PA4728 folK 
2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
pyrophosphokinase 
NA NA 8.3 1.01E-11 NA NA 84.0 3.86E-14 
Carbon compound catabolism 
PA0232 pcaC gamma-carboxymuconolactone decarboxylase NA NA 6.9 4.48E-11 NA NA 5.1 2.50E-11 
PA4127 hpcG 2-oxo-hept-3-ene-1,7-dioate hydratase 26.8 6.45E-06 NA NA NA NA NA NA 
Cell division 
PA4419 ftsL cell division protein FtsL NA NA 2.4 1.98E-08 NA NA 2.4 1.23E-09 
PA5564 gidB glucose inhibited division protein B NA NA 5.5 2.19E-14 NA NA 2.5 4.45E-08 
Cell wall / LPS / capsule 
PA2232 pslB PslB NA NA 2.5 4.91E-09 NA NA 2.6 2.02E-11 
PA2235 pslE PslE NA NA 2.4 3.42E-07 NA NA 2.3 1.12E-07 
PA3999 dacC D-ala-D-ala-carboxypeptidase NA NA 2.2 8.78E-14 NA NA 2.0 1.51E-13 
PA4415 mraY phospho-N-acetylmuramoyl-pentapeptide-transferase 2.0 4.46E-07 NA NA NA NA NA NA 
PA4668   probable lipoprotein localization protein LolB 3.6 3.65E-09 NA NA NA NA NA NA 
PA5163 rmlA glucose-1-phosphate thymidylyltransferase NA NA 2.5 5.49E-12 NA NA 2.1 1.71E-10 
PA5276 lppL Lipopeptide LppL precursor 5.7 0.00E+00 NA NA 4.2 4.55E-14 NA NA 
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PA5322 algC phosphomannomutase AlgC NA NA 2.6 1.06E-13 NA NA 3.3 0.00E+00 
Central intermediary metabolism 
PA3524 gloA1 lactoylglutathione lyase 2.0 5.32E-07 NA NA 2.0 4.42E-06 NA NA 
PA4880   probable bacterioferritin 26.9 6.17E-06 NA NA NA NA NA NA 
Chemotaxis ; Adaptation, Protection ; Motility & Attachment 
PA1446 fliP flagellar biosynthetic protein FliP 2.3 4.37E-06 NA NA NA NA NA NA 
DNA replication, recombination, modification and repair 
PA0002 dnaN DNA polymerase III, beta chain 2.1 9.60E-12 NA NA NA NA NA NA 
PA0720   helix destabilizing protein of bacteriophage Pf1 8.5 1.98E-07 NA NA NA NA NA NA 
PA0965 ruvC Holliday junction resolvase RuvC 2.8 3.41E-08 NA NA NA NA NA NA 
PA1534 recR recombination protein RecR 4.7 9.40E-07 NA NA NA NA NA NA 
PA1815 rnhA ribonuclease H 2.8 1.80E-11 NA NA NA NA NA NA 
PA2961 holB DNA polymerase III, delta prime subunit NA NA 10.4 0.00E+00 NA NA 2.6 3.54E-07 
Energy metabolism 
PA1562 acnA aconitate hydratase 1 NA NA 4.0 1.28E-12 NA NA 3.0 4.48E-11 
PA2995 nqrE 
Na+-translocating 
NADH:quinone oxidoreductase 
subunit Nqr5 
NA NA 2.2 8.00E-07 NA NA 3.3 2.68E-13 
PA2997 nqrC 
Na+-translocating 
NADH:ubiquinone 
oxidoreductase subunit Nrq3 
2.5 4.15E-07 NA NA NA NA NA NA 
PA3183 zwf glucose-6-phosphate 1-dehydrogenase 2.7 1.40E-06 2.8 3.20E-07 NA NA NA NA 
PA4975   NAD(P)H quinone oxidoreductase 5.7 2.50E-05 NA NA NA NA NA NA 
Fatty acid and phospholipid metabolism 
PA1806 fabI NADH-dependent enoyl-ACP reductase 3.6 2.85E-07 NA NA NA NA NA NA 
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PA4888 desB acyl-CoA delta-9-desaturase, DesB 8.5 5.51E-06 NA NA NA NA NA NA 
Hypothetical, unclassified, unknown 
PA0047   hypothetical protein 3.3 6.23E-08 3.7 2.40E-09 NA NA NA NA 
PA0061   hypothetical protein NA NA 62.5 1.98E-12 NA NA 4.1 2.05E-07 
PA0124   hypothetical protein NA NA 4.1 3.12E-07 NA NA 3.1 1.45E-06 
PA0127   hypothetical protein 5.7 3.64E-07 NA NA NA NA NA NA 
PA0168   conserved hypothetical protein NA NA 3.2 1.85E-06 NA NA 3.6 2.39E-08 
PA0169   hypothetical protein NA NA 2.5 3.34E-06 NA NA 3.8 4.30E-11 
PA0170   hypothetical protein 4.7 3.80E-10 NA NA 4.2 2.56E-08 NA NA 
PA0261   hypothetical protein NA NA 27.5 6.00E-06 NA NA 27.5 3.22E-07 
PA0274   hypothetical protein 11.3 2.88E-06 NA NA NA NA NA NA 
PA0329   conserved hypothetical protein NA NA 3.7 0.00E+00 -2.5 2.41E-11 2.7 4.11E-14 
PA0332   hypothetical protein 3.2 2.03E-10 NA NA NA NA NA NA 
PA0359   hypothetical protein 5.7 1.99E-05 NA NA 14.7 0.00E+00 NA NA 
PA0404   conserved hypothetical protein NA NA 47.2 1.43E-09 NA NA 47.2 1.09E-11 
PA0460   hypothetical protein 2.0 2.16E-08 3.1 0.00E+00 NA NA NA NA 
PA0466   hypothetical protein NA NA 158.1 0.00E+00 NA NA 158.1 0.00E+00 
PA0505   hypothetical protein NA NA 59.3 7.93E-12 
-
112.
5 
0.00E+00 NA NA 
PA0537   conserved hypothetical protein 2.2 2.33E-09 2.8 0.00E+00 NA NA NA NA 
PA0567   conserved hypothetical protein NA NA 43.0 8.53E-09 NA NA 43.0 9.49E-11 
PA0769   hypothetical protein NA NA 3.7 2.34E-12 NA NA 4.1 1.03E-14 
PA0778 icp inhibitor of cysteine peptidase NA NA 5.5 4.59E-08 NA NA 67.6 4.91E-14 
PA0803   hypothetical protein NA NA 31.0 1.35E-06 NA NA 31.0 5.03E-08 
PA0856   hypothetical protein 2.0 2.68E-10 2.0 7.18E-14 NA NA NA NA 
PA0925   hypothetical protein 8.5 7.30E-08 NA NA NA NA NA NA 
PA0926   hypothetical protein 4.3 1.98E-05 NA NA NA NA NA NA 
PA0948   hypothetical protein NA NA 32.6 7.05E-07 - 5.32E-06 NA NA 
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28.1 
PA0952   hypothetical protein NA NA 35.6 1.99E-07 NA NA 35.6 4.55E-09 
PA1324   hypothetical protein NA NA 3.5 8.70E-11 NA NA 5.1 4.64E-14 
PA1343   hypothetical protein 8.5 4.44E-07 NA NA 10.5 3.29E-09 NA NA 
PA1395   hypothetical protein 8.5 1.04E-07 NA NA NA NA NA NA 
PA1439   conserved hypothetical protein 5.7 1.26E-08 NA NA NA NA NA NA 
PA1471   hypothetical protein NA NA 5.5 1.00E-10 NA NA 4.1 1.84E-10 
PA1560   hypothetical protein NA NA 2.8 2.53E-06 NA NA 6.2 6.14E-14 
PA1592   hypothetical protein NA NA 4.2 0.00E+00 NA NA 3.5 0.00E+00 
PA1744   hypothetical protein 32.8 4.68E-07 NA NA 60.0 0.00E+00 NA NA 
PA1747   hypothetical protein 76.0 1.55E-13 36.2 1.57E-07 NA NA NA NA 
PA1774 crfX CrfX protein 3.3 0.00E+00 NA NA NA NA NA NA 
PA1817   hypothetical protein 36.8 8.06E-08 NA NA 22.5 3.81E-06 NA NA 
PA1855   hypothetical protein NA NA 30.8 1.47E-06 NA NA 30.8 5.61E-08 
PA1879   hypothetical protein 25.9 9.68E-06 NA NA NA NA NA NA 
PA1892   hypothetical protein 38.9 3.23E-08 37.1 1.08E-07 NA NA NA NA 
PA1963   hypothetical protein 53.8 4.28E-11 51.3 2.44E-10 NA NA NA NA 
PA2021   hypothetical protein NA NA 30.4 1.76E-06 NA NA 30.4 6.97E-08 
PA2029   hypothetical protein NA NA 4.1 7.35E-07 NA NA 68.4 5.59E-14 
PA2106   hypothetical protein 4.7 1.23E-05 3.7 9.34E-07 NA NA NA NA 
PA2127   conserved hypothetical protein 4.5 6.61E-07 NA NA NA NA NA NA 
PA2174   hypothetical protein NA NA 44.3 5.00E-09 NA NA 44.3 5.00E-11 
PA2226   hypothetical protein NA NA 27.3 6.44E-06 -28.3 4.97E-06 NA NA 
PA2293   hypothetical protein NA NA 28.3 4.21E-06 NA NA 28.3 2.05E-07 
PA2368   hypothetical protein 50.6 1.81E-10 NA NA NA NA NA NA 
PA2484   conserved hypothetical protein NA NA 3.2 3.05E-06 NA NA 3.6 4.57E-08 
PA2560   hypothetical protein 2.4 3.23E-12 3.2 2.25E-12 NA NA NA NA 
PA2598   hypothetical protein 26.5 7.31E-06 NA NA NA NA NA NA 
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PA2607   conserved hypothetical protein 4.3 3.08E-07 NA NA NA NA NA NA 
PA2658   hypothetical protein NA NA 4.1 1.41E-06 -3.8 1.07E-05 NA NA 
PA2730   hypothetical protein NA NA 5.8 0.00E+00 -3.3 5.40E-07 NA NA 
PA2736   hypothetical protein 2.0 2.48E-05 2.8 1.12E-09 NA NA NA NA 
PA2737   conserved hypothetical protein NA NA 2.4 1.68E-09 -2.7 1.02E-12 NA NA 
PA2792   hypothetical protein NA NA 4.1 6.88E-07 NA NA 6.2 2.66E-10 
PA2797   hypothetical protein 3.1 1.55E-13 2.1 9.12E-07 NA NA NA NA 
PA2864   conserved hypothetical protein NA NA 5.5 1.45E-07 NA NA 4.1 1.86E-07 
PA2872   hypothetical protein 7.1 1.37E-06 NA NA NA NA NA NA 
PA2883   hypothetical protein 2.8 6.09E-06 2.8 1.58E-05 NA NA NA NA 
PA2935   hypothetical protein NA NA 28.5 3.92E-06 NA NA 28.5 1.88E-07 
PA2956   conserved hypothetical protein 7.1 8.86E-11 NA NA NA NA NA NA 
PA2972   conserved hypothetical protein NA NA 5.5 6.36E-06 NA NA 47.3 1.05E-11 
PA3010   hypothetical protein 3.6 8.86E-11 NA NA NA NA NA NA 
PA3018   hypothetical protein 14.2 7.00E-09 49.8 4.60E-10 NA NA NA NA 
PA3022   hypothetical protein NA NA 2.8 1.46E-09 -2.9 1.20E-10 NA NA 
PA3031   hypothetical protein NA NA 3.2 1.79E-13 NA NA 3.1 6.14E-14 
PA3040   conserved hypothetical protein NA NA 4.8 0.00E+00 -3.3 5.85E-08 2.4 1.08E-08 
PA3042   hypothetical protein NA NA 2.8 4.56E-08 NA NA 3.1 1.06E-10 
PA3051   hypothetical protein 5.7 1.85E-06 NA NA NA NA NA NA 
PA3056   hypothetical protein 2.8 3.07E-06 5.5 5.48E-07 NA NA NA NA 
PA3057   hypothetical protein NA NA 29.6 2.46E-06 NA NA 29.6 1.05E-07 
PA3072   hypothetical protein 58.0 6.07E-12 NA NA 35.4 3.06E-09 NA NA 
PA3123   conserved hypothetical protein NA NA 3.2 1.34E-09 -2.7 1.19E-06 2.4 1.02E-07 
PA3203   hypothetical protein 2.4 1.84E-06 NA NA NA NA NA NA 
PA3274   hypothetical protein 24.9 1.47E-05 NA NA NA NA NA NA 
PA3291   hypothetical protein NA NA 37.0 1.12E-07 NA NA 37.0 2.25E-09 
PA3307   hypothetical protein NA NA 2.3 1.30E-05 NA NA 2.6 1.41E-07 
PA3338   hypothetical protein 5.7 2.74E-06 NA NA NA NA NA NA 
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PA3412   hypothetical protein NA NA 25.3 1.47E-05 NA NA 25.3 9.73E-07 
PA3425   hypothetical protein NA NA 39.7 3.64E-08 NA NA 39.7 5.53E-10 
PA3470   hypothetical protein 4.3 2.17E-09 NA NA 3.2 1.71E-05 NA NA 
PA3501   hypothetical protein 32.8 4.68E-07 62.5 1.98E-12 NA NA NA NA 
PA3626   conserved hypothetical protein 2.5 7.56E-06 NA NA NA NA NA NA 
PA3668   conserved hypothetical protein 4.3 1.84E-05 NA NA NA NA NA NA 
PA3691   hypothetical protein NA NA 8.8 0.00E+00 NA NA 5.9 2.01E-13 
PA3716   hypothetical protein 2.1 1.01E-05 NA NA NA NA NA NA 
PA3762   hypothetical protein 2.4 6.16E-06 NA NA NA NA NA NA 
PA3952   hypothetical protein NA NA 2.8 5.60E-09 NA NA 2.5 6.26E-09 
PA3982   conserved hypothetical protein NA NA 3.7 7.18E-14 NA NA 2.7 4.11E-14 
PA3986   hypothetical protein NA NA 63.4 1.35E-12 -27.4 7.38E-06 NA NA 
PA4028   hypothetical protein NA NA 61.7 2.79E-12 NA NA 61.7 0.00E+00 
PA4033 mucE MucE NA NA 50.7 3.12E-10 NA NA 50.7 1.72E-12 
PA4090   hypothetical protein NA NA 47.0 1.53E-09 -65.0 7.36E-13 NA NA 
PA4116 bphO heme oxygenase, BphO 2.1 2.95E-06 NA NA NA NA NA NA 
PA4154   conserved hypothetical protein 14.2 4.24E-09 3.5 1.92E-08 NA NA NA NA 
PA4346   hypothetical protein NA NA 4.1 1.34E-11 NA NA 2.1 8.80E-06 
PA4388   hypothetical protein NA NA 37.2 1.01E-07 -28.9 3.82E-06 NA NA 
PA4392   conserved hypothetical protein NA NA 5.5 1.84E-08 NA NA 71.3 4.91E-14 
PA4422   conserved hypothetical protein NA NA 3.5 7.56E-07 NA NA 2.6 8.55E-06 
PA4537   hypothetical protein 42.0 8.09E-09 NA NA 25.6 6.69E-07 NA NA 
PA4570   hypothetical protein 31.9 6.88E-07 NA NA 19.5 1.87E-05 NA NA 
PA4699   hypothetical protein 2.2 1.77E-07 2.6 1.11E-08 NA NA NA NA 
PA4870   conserved hypothetical protein 5.7 8.94E-07 NA NA NA NA NA NA 
PA4965   hypothetical protein NA NA 2.2 2.39E-06 NA NA 2.8 8.32E-11 
PA5062   conserved hypothetical protein 26.0 9.13E-06 NA NA 31.7 2.33E-08 NA NA 
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PA5078   conserved hypothetical protein NA NA 2.2 1.37E-08 NA NA 2.0 1.37E-08 
PA5108   hypothetical protein 2.1 3.93E-10 4.6 8.07E-14 NA NA NA NA 
PA5120   hypothetical protein NA NA 50.7 3.12E-10 NA NA 50.7 1.72E-12 
PA5148   conserved hypothetical protein NA NA 3.8 6.31E-14 NA NA 2.8 2.75E-14 
PA5178   conserved hypothetical protein NA NA 4.6 0.00E+00 NA NA 2.9 0.00E+00 
PA5208   conserved hypothetical protein 2.8 1.57E-06 NA NA NA NA NA NA 
PA5212   hypothetical protein 3.8 1.39E-14 2.8 1.06E-12 NA NA NA NA 
PA5229   conserved hypothetical protein NA NA 3.2 4.80E-08 NA NA 2.4 1.57E-06 
PA5258   hypothetical protein 2.0 9.23E-06 NA NA NA NA NA NA 
PA5271   hypothetical protein NA NA 4.1 8.78E-14 NA NA 2.1 7.40E-08 
PA5279   conserved hypothetical protein 2.4 1.88E-05 NA NA NA NA NA NA 
PA5330   hypothetical protein 2.2 5.08E-06 NA NA NA NA NA NA 
PA5456   hypothetical protein 3.8 2.79E-06 NA NA NA NA NA NA 
PA5461   hypothetical protein 2.0 1.62E-13 NA NA NA NA NA NA 
PA5494   hypothetical protein 2.6 0.00E+00 NA NA NA NA NA NA 
PA5519   conserved hypothetical protein NA NA 60.3 4.92E-12 NA NA 5.1 2.58E-08 
PA5545   conserved hypothetical protein NA NA 3.7 6.90E-10 NA NA 2.7 1.84E-08 
PA5551   hypothetical protein NA NA 26.8 7.87E-06 -41.7 1.65E-08 NA NA 
 
Membrane proteins 
PA0013   conserved hypothetical protein 5.7 4.07E-08 NA NA NA NA NA NA 
PA0340   conserved hypothetical protein NA NA 4.8 1.01E-06 NA NA 3.6 2.09E-06 
PA0465 creD inner membrane protein CreD 9.0 0.00E+00 27.7 0.00E+00 NA NA 2.2 8.64E-10 
PA0833   hypothetical protein 2.5 0.00E+00 2.9 2.19E-14 NA NA NA NA 
PA1119 yfiB YfiB NA NA 2.3 1.23E-06 NA NA 2.1 2.83E-06 
PA1199   probable lipoprotein 3.2 1.11E-13 NA NA 2.1 1.07E-05 NA NA 
PA1288   probable outer membrane protein precursor 2.0 5.81E-10 NA NA 2.3 0.00E+00 NA NA 
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PA1496   probable potassium channel 7.1 4.79E-06 NA NA NA NA NA NA 
PA1676   hypothetical protein NA NA 3.5 9.17E-09 NA NA 5.1 7.91E-14 
PA1773 cmaX CmaX protein 2.1 1.30E-07 NA NA NA NA NA NA 
PA2757   hypothetical protein NA NA 30.8 1.47E-06 NA NA 30.8 5.61E-08 
PA2763   hypothetical protein NA NA 65.2 6.49E-13 NA NA 65.2 4.64E-14 
PA2775   hypothetical protein 3.1 4.06E-12 NA NA 2.6 1.39E-07 NA NA 
PA2777   conserved hypothetical protein NA NA 3.3 5.77E-07 NA NA 3.1 1.46E-07 
PA2900   probable outer membrane protein precursor 2.5 2.11E-06 NA NA NA NA NA NA 
PA3278   hypothetical protein 4.5 0.00E+00 NA NA NA NA NA NA 
PA3369   hypothetical protein NA NA 49.1 6.39E-10 -76.2 0.00E+00 NA NA 
PA3558 arnF ArnF NA NA 33.1 5.79E-07 NA NA 33.1 1.77E-08 
PA3692 lptF Lipotoxon F, LptF NA NA 6.8 0.00E+00 NA NA 10.2 1.74E-13 
PA3890   probable permease of ABC transporter NA NA 51.6 2.10E-10 NA NA 51.6 1.06E-12 
PA4014   hypothetical protein 7.1 9.95E-12 NA NA 6.3 5.86E-10 NA NA 
PA4034 aqpZ aquaporin Z NA NA 11.1 4.03E-14 NA NA 4.1 0.00E+00 
PA4940   conserved hypothetical protein 2.8 1.92E-05 NA NA 3.2 1.42E-06 NA NA 
PA5107 blc outer membrane lipoprotein Blc 2.6 6.54E-09 2.9 1.70E-13 NA NA NA NA 
PA5154   probable permease of ABC transporter 3.5 7.84E-09 NA NA 3.2 5.67E-07 NA NA 
PA5167   probable c4-dicarboxylate-binding protein NA NA 3.7 2.80E-14 NA NA 12.3 0.00E+00 
PA5182   hypothetical protein NA NA 2.6 8.07E-14 NA NA 3.6 0.00E+00 
PA5183   hypothetical protein NA NA 2.8 1.95E-10 NA NA 3.4 0.00E+00 
PA5424   conserved hypothetical protein 2.1 1.37E-10 2.8 5.20E-14 NA NA NA NA 
Non-coding RNA gene 
PA4272
.1 P27 P27 2.8 0.00E+00 NA NA 3.2 1.50E-14 NA NA 
PA4276   tRNA-Trp NA NA 2.1 4.62E-14 -2.0 3.12E-13 NA NA 
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.1 
PA4704
.2 prrF2 regulatory RNA PrrF2 NA NA 2.6 1.15E-13 -4.8 0.00E+00 NA NA 
PA4758
.1 P32 P32 2.8 1.45E-12 NA NA 2.1 7.59E-06 NA NA 
PA5181
.1 P34 P34 NA NA 2.8 9.88E-07 NA NA 3.1 7.15E-09 
Nucleotide biosynthesis and metabolism 
PA5426 purE phosphoribosylaminoimidazole carboxylase, catalytic subunit 2.8 8.16E-08 NA NA NA NA NA NA 
Protein secretion/export apparatus 
PA0076 tagF1 TagF1 4.3 1.75E-09 3.7 3.28E-07 NA NA NA NA 
PA0081 fha1 Fha1 NA NA 3.4 7.04E-10 NA NA 2.5 3.90E-08 
PA0088 tssF1 TssF1 NA NA 2.5 2.35E-07 NA NA 5.1 1.95E-14 
PA3221 csaA CsaA protein 11.3 2.41E-13 NA NA 6.3 2.16E-06 NA NA 
Putative enzymes 
PA0745   probable enoyl-CoA hydratase/isomerase NA NA 2.1 4.49E-13 NA NA 2.3 1.95E-14 
PA1023   probable short-chain dehydrogenase 11.3 2.19E-05 NA NA NA NA NA NA 
PA1615   probable lipase 2.5 2.64E-09 3.3 0.00E+00 NA NA NA NA 
PA1683   probable sugar aldolase NA NA 3.7 7.49E-08 NA NA 2.7 8.51E-07 
PA1828   probable short-chain dehydrogenase NA NA 2.4 1.13E-06 NA NA 3.6 2.47E-12 
PA1832   probable protease 2.4 8.27E-07 NA NA NA NA NA NA 
PA2119   alcohol dehydrogenase (Zn-dependent) 3.1 3.80E-10 NA NA NA NA NA NA 
PA3302   conserved hypothetical protein 2.5 5.67E-07 NA NA 2.3 1.09E-05 NA NA 
PA3568   probable acetyl-coa synthetase NA NA 2.3 6.74E-06 NA NA 3.4 3.25E-11 
PA4128   conserved hypothetical protein 11.3 5.08E-06 NA NA NA NA NA NA 
PA4615   probable oxidoreductase 3.1 1.11E-07 NA NA NA NA NA NA 
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PA5234   probable oxidoreductase 5.1 1.11E-07 NA NA NA NA NA NA 
PA5281   probable hydrolase 5.7 2.29E-05 NA NA NA NA NA NA 
PA5546   conserved hypothetical protein NA NA 2.9 1.45E-07 -3.2 6.55E-09 NA NA 
Related to phage, transposon, or plasmid 
PA0986   conserved hypothetical protein NA NA 25.9 1.17E-05 NA NA 25.9 7.26E-07 
Secreted Factors (toxins, enzymes, alginate) 
PA0423 pasP PasP NA NA 3.1 0.00E+00 -2.4 0.00E+00 NA NA 
Transcriptional regulators 
PA0403 pyrR transcriptional regulator PyrR NA NA 3.0 2.47E-10 NA NA 3.8 0.00E+00 
PA0463 creB two-component response regulator CreB 5.0 3.00E-08 NA NA 4.7 1.27E-07 NA NA 
PA0491   probable transcriptional regulator 38.7 3.48E-08 NA NA NA NA NA NA 
PA0527 dnr transcriptional regulator Dnr 4.0 3.81E-07 NA NA NA NA NA NA 
PA0535   probable transcriptional regulator 5.7 2.00E-09 NA NA NA NA NA NA 
PA0839   probable transcriptional regulator NA NA 4.8 8.22E-09 NA NA 81.1 5.59E-14 
PA1179 phoP two-component response regulator PhoP NA NA 2.5 0.00E+00 NA NA 2.1 0.00E+00 
PA1261   probable transcriptional regulator NA NA 30.4 1.76E-06 NA NA 30.4 6.97E-08 
PA1300   probable sigma-70 factor, ECF subfamily 8.5 2.88E-06 NA NA NA NA NA NA 
PA1403   probable transcriptional regulator 5.7 7.62E-06 NA NA NA NA NA NA 
PA1437   probable two-component response regulator NA NA 49.6 5.05E-10 NA NA 49.6 3.04E-12 
PA2016 liuR regulator of liu genes NA NA 2.0 2.08E-11 NA NA 2.0 3.89E-12 
PA2093   probable sigma-70 factor, ECF subfamily 42.2 7.35E-09 NA NA NA NA NA NA 
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PA2798   probable two-component response regulator 2.1 6.55E-09 NA NA NA NA NA NA 
PA2885 atuR putative repressor of atu genes 4.0 4.51E-08 NA NA NA NA NA NA 
PA2957   probable transcriptional regulator 2.6 1.03E-08 NA NA NA NA NA NA 
PA3458   probable transcriptional regulator 4.7 2.74E-08 NA NA NA NA NA NA 
PA3899   probable sigma-70 factor, ECF subfamily 4.7 9.09E-08 26.8 7.87E-06 NA NA NA NA 
PA4853 fis DNA-binding protein Fis 2.6 1.63E-12 NA NA 2.5 4.18E-11 NA NA 
PA5261 algR alginate biosynthesis regulatory protein AlgR NA NA 2.9 0.00E+00 NA NA 2.1 1.35E-13 
PA5403   probable transcriptional regulator 34.7 2.02E-07 NA NA 21.2 7.63E-06 NA NA 
PA5550 glmR GlmR transcriptional regulator 3.8 6.16E-07 NA NA NA NA NA NA 
Translation, post-translational modification, degradation 
PA0019 def polypeptide deformylase NA NA 2.1 7.20E-08 NA NA 2.6 4.60E-13 
PA0090 clpV1 ClpV1 NA NA 2.1 1.99E-06 NA NA 2.8 7.68E-11 
PA0355 pfpI protease PfpI NA NA 25.3 1.47E-05 NA NA 25.3 9.73E-07 
PA0767 lepA GTP-binding protein LepA 2.0 1.04E-05 NA NA NA NA NA NA 
PA0837 slyD peptidyl-prolyl cis-trans isomerase SlyD 2.4 6.71E-11 NA NA 2.1 1.05E-07 NA NA 
PA1996 ppiC1 peptidyl-prolyl cis-trans isomerase C1 5.7 1.60E-06 NA NA NA NA NA NA 
PA2755 eco ecotin precursor NA NA 2.4 2.42E-10 NA NA 2.1 5.98E-09 
PA2970 rpmF 50S ribosomal protein L32 2.2 6.56E-13 NA NA NA NA NA NA 
PA3114 truA tRNA-pseudouridine synthase I NA NA 4.1 3.03E-09 NA NA 4.1 7.91E-11 
PA3600   conserved hypothetical protein NA NA 44.7 4.14E-09 NA NA 44.7 3.99E-11 
PA4255 rpmC 50S ribosomal protein L29 2.0 0.00E+00 NA NA 2.4 3.12E-13 NA NA 
PA5256 dsbH disulfide bond formation protein NA NA 8.3 1.17E-11 NA NA 3.1 2.20E-07 
PA5569 rnpA ribonuclease P protein comp. 2.4 1.42E-13 NA NA 2.1 2.75E-12 NA NA 
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Transport of small molecules 
PA0970 tolR TolR protein 2.3 5.18E-10 2.3 1.76E-07 NA NA NA NA 
PA1339   amino acid ABC transporter ATP binding protein 2.4 1.84E-07 2.3 7.82E-07 NA NA NA NA 
PA1493 cysP sulfate-binding protein of ABC transporter 3.0 6.40E-11 NA NA NA NA NA NA 
PA2291   probable glucose-sensitive porin NA NA 6.2 4.93E-06 NA NA 9.2 2.65E-08 
PA3186 oprB 
Glucose/carbohydrate outer 
membrane porin OprB 
precursor 
NA NA 2.8 2.47E-12 NA NA 5.9 0.00E+00 
PA3189   probable permease of ABC sugar transporter NA NA 9.0 1.28E-13 NA NA 2.7 5.17E-07 
PA3190   
probable binding protein 
component of ABC sugar 
transporter 
NA NA 4.2 8.78E-14 NA NA 2.8 0.00E+00 
PA3441   probable molybdopterin-binding protein 33.3 3.87E-07 31.7 1.02E-06 NA NA NA NA 
PA4235 bfrA bacterioferritin 2.4 8.15E-08 NA NA NA NA NA NA 
PA4502   probable binding protein component of ABC transporter NA NA 2.4 2.09E-06 NA NA 2.5 5.39E-08 
PA4506   
probable ATP-binding 
component of ABC dipeptide 
transporter 
3.8 1.08E-05 NA NA NA NA NA NA 
Two-component regulatory systems 
PA3879 narL two-component response regulator NarL 7.1 1.47E-07 NA NA NA NA NA NA 
PA5484 kinB KinB NA NA 2.8 1.13E-05 NA NA 2.8 9.37E-07 
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Genes negatively regulated in an AmpR-independent, ß-lactam-dependent manner (208) 
Gene 
ID 
Gene 
name Product Name 
Condition 1 Condition 2 Condition 3 Condition 4 
Fold 
Chang
e 
Corrected 
p-value 
Fold 
Chan
ge 
Corrected 
p-value 
Fold 
Cha
nge 
Corrected 
p-value 
Fold 
Change 
Corrected 
p-value 
Adaptation, Protection 
PA1150 pys2 pyocin S2 NA NA -4.4 0.00E+00 NA NA -3.8 0.00E+00 
PA1151 imm2 pyocin S2 immunity protein NA NA -3.1 0.00E+00 NA NA -3.2 2.47E-13 
PA3007 lexA repressor protein LexA NA NA -4.0 0.00E+00 NA NA -2.6 3.15E-14 
PA3866   pyocin protein NA NA -3.3 0.00E+00 NA NA -2.4 4.27E-14 
Amino acid biosynthesis and metabolism 
PA0009 glyQ glycyl-tRNA synthetase alpha chain NA NA -2.0 3.89E-07 2.4 9.54E-10 NA NA 
PA4565 proB glutamate 5-kinase NA NA -2.1 2.16E-10 2.1 8.47E-10 NA NA 
PA5098 hutH histidine ammonia-lyase NA NA -14.5 9.80E-12 3.8 1.55E-06 NA NA 
PA5100 hutU urocanase NA NA -13.7 0.00E+00 NA NA -5.4 3.61E-06 
PA5143 hisB imidazoleglycerol-phosphate dehydratase -123.3 0.00E+00 -10.1 1.50E-14 NA NA NA NA 
Antibiotic resistance and susceptibility 
PA0807 ampDh3 AmpDh3 -2.1 0.00E+00 -4.5 0.00E+00 NA NA NA NA 
PA3719 armR antirepressor for MexR, ArmR -29.2 3.39E-07 -54.1 1.22E-13 NA NA NA NA 
Biosynthesis of cofactors, prosthetic groups and carriers 
PA0381 thiG thiamine biosynthesis protein, thiazole moiety NA NA -8.7 1.21E-11 NA NA -7.8 1.57E-10 
PA0512   conserved hypothetical protein NA NA -25.5 7.28E-07 25.5 7.21E-07 NA NA 
PA1272 cobO cob(I)alamin adenosyltransferase NA NA -35.8 2.73E-09 NA NA -46.9 3.73E-10 
PA1985 pqqA pyrroloquinoline quinone biosynthesis protein A -32.8 5.34E-08 -60.8 0.00E+00 NA NA NA NA 
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PA3633 ygbP 4-diphosphocytidyl-2-C-methylerythritol synthase NA NA -3.3 1.42E-05 NA NA -3.4 1.87E-06 
PA4891 ureE urease accessory protein UreE NA NA -26.1 5.32E-07 26.1 5.25E-07 NA NA 
Carbon compound catabolism 
PA0887 acsA acetyl-coenzyme A synthetase NA NA -2.6 0.00E+00 2.1 2.74E-13 NA NA 
PA2508 catC muconolactone delta-isomerase NA NA -45.2 1.57E-11 NA NA -24.7 8.15E-06 
PA2512 antA anthranilate dioxygenase large subunit NA NA -5.6 1.42E-13 NA NA -12.7 0.00E+00 
PA2513 antB anthranilate dioxygenase small subunit NA NA -89.0 0.00E+00 NA NA -233.6 0.00E+00 
PA4125 hpcD 5-carboxymethyl-2-hydroxymuconate isomerase NA NA -22.3 4.01E-06 22.3 4.16E-06 NA NA 
Central intermediary metabolism 
PA4864 ureD urease accessory protein NA NA -20.8 8.97E-06 20.8 9.37E-06 NA NA 
DNA replication, recombination, modification and repair 
PA3617 recA RecA protein NA NA -2.9 0.00E+00 NA NA -2.1 4.64E-14 
PA4232 ssb single-stranded DNA-binding protein NA NA -2.2 6.98E-14 2.2 6.88E-14 NA NA 
PA4763 recN DNA repair protein RecN NA NA -5.5 0.00E+00 NA NA -4.4 0.00E+00 
Energy metabolism 
PA0523 norC nitric-oxide reductase subunit C NA NA -19.9 1.46E-05 19.9 1.53E-05 NA NA 
PA1172 napC cytochrome c-type protein NapC NA NA -36.7 1.67E-09 NA NA -48.1 2.21E-10 
PA3929 cioB cyanide insensitive terminal oxidase -2.2 1.53E-06 NA NA -6.7 2.82E-14 NA NA 
Hypothetical, unclassified, unknown 
PA0014   hypothetical protein -26.0 1.69E-06 -32.1 2.07E-08 NA NA NA NA 
PA0020   hypothetical protein NA NA -2.0 4.45E-06 2.4 3.67E-08 NA NA 
PA0045   hypothetical protein -3.2 1.43E-05 NA NA NA NA NA NA 
PA0053   hypothetical protein NA NA -103.1 4.03E-14 NA NA -28.2 1.73E-06 
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PA0116   hypothetical protein NA NA -55.4 6.31E-14 NA NA -45.5 7.30E-10 
PA0161   hypothetical protein NA NA -4.3 2.49E-14 NA NA -2.9 5.14E-10 
PA0250   conserved hypothetical protein -3.0 1.96E-07 NA NA -2.7 6.91E-06 NA NA 
PA0277   conserved hypothetical protein NA NA -4.1 3.07E-11 3.6 5.10E-10 NA NA 
PA0449   hypothetical protein -6.4 2.39E-11 -2.7 1.38E-06 NA NA NA NA 
PA0468   hypothetical protein NA NA -5.8 7.61E-06 NA NA -5.8 3.09E-06 
PA0540   hypothetical protein -30.5 1.70E-07 NA NA NA NA NA NA 
PA0578   conserved hypothetical protein NA NA -107.1 0.00E+00 NA NA -111.7 4.06E-14 
PA0613   hypothetical protein NA NA -7.4 0.00E+00 NA NA -3.0 2.85E-13 
PA0615   hypothetical protein NA NA -3.2 5.03E-13 NA NA -2.3 7.47E-14 
PA0808   hypothetical protein -2.1 1.17E-05 -10.8 0.00E+00 NA NA -3.9 2.85E-06 
PA0819   hypothetical protein NA NA -29.8 7.27E-08 NA NA -24.4 9.09E-06 
PA0907   hypothetical protein NA NA -3.8 0.00E+00 NA NA -2.9 0.00E+00 
PA0908   hypothetical protein -2.4 0.00E+00 -3.0 0.00E+00 NA NA NA NA 
PA0922   hypothetical protein NA NA -6.1 0.00E+00 NA NA -3.9 0.00E+00 
PA0940   hypothetical protein NA NA -34.4 6.00E-09 34.4 5.49E-09 NA NA 
PA0947   conserved hypothetical protein NA NA -3.6 1.43E-12 NA NA -3.7 1.59E-13 
PA0959   hypothetical protein NA NA -2.7 8.59E-10 NA NA -3.5 3.15E-14 
PA1030   hypothetical protein NA NA -4.3 1.94E-12 NA NA -3.6 2.22E-09 
PA1035   hypothetical protein -3.9 8.85E-06 NA NA NA NA NA NA 
PA1039   conserved hypothetical protein NA NA -27.7 2.22E-07 NA NA -45.5 7.30E-10 
PA1095   hypothetical protein NA NA -3.6 3.47E-14 NA NA -2.7 6.05E-14 
PA1152   hypothetical protein NA NA -8.0 2.80E-14 NA NA -9.7 0.00E+00 
PA1168   hypothetical protein -36.8 7.05E-09 -27.3 2.79E-07 NA NA NA NA 
PA1314   hypothetical protein NA NA -22.6 3.34E-06 22.6 3.46E-06 NA NA 
PA1332   hypothetical protein NA NA -47.6 4.11E-12 4.2 5.43E-06 NA NA 
PA1362   hypothetical protein NA NA -27.0 3.18E-07 27.0 3.14E-07 NA NA 
PA1402   hypothetical protein NA NA -19.7 1.56E-05 19.7 1.64E-05 NA NA 
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PA1536   conserved hypothetical protein -21.9 1.33E-05 NA NA NA NA NA NA 
PA1574   conserved hypothetical protein NA NA -4.0 2.49E-14 NA NA -2.4 3.07E-07 
PA1679   hypothetical protein NA NA -22.5 3.67E-06 NA NA -64.5 1.32E-13 
PA1743   hypothetical protein NA NA -36.5 1.84E-09 36.5 1.65E-09 NA NA 
PA1751   hypothetical protein NA NA -46.4 8.13E-12 NA NA -38.0 2.11E-08 
PA1842   hypothetical protein NA NA -24.1 1.48E-06 NA NA -39.6 1.04E-08 
PA1870   hypothetical protein -22.2 1.13E-05 NA NA NA NA NA NA 
PA1936   hypothetical protein NA NA -21.8 5.20E-06 NA NA -35.7 5.77E-08 
PA2146   conserved hypothetical protein NA NA -26.1 5.32E-07 26.1 5.25E-07 NA NA 
PA2381   hypothetical protein -5.3 9.84E-14 NA NA -7.1 2.21E-14 NA NA 
PA2405   hypothetical protein NA NA -26.5 4.12E-07 NA NA -43.5 1.74E-09 
PA2436   hypothetical protein NA NA -20.1 1.26E-05 20.1 1.33E-05 NA NA 
PA2450   hypothetical protein NA NA -33.4 1.01E-08 NA NA -46.9 3.73E-10 
PA2506   hypothetical protein -21.6 1.54E-05 NA NA NA NA NA NA 
PA2569   hypothetical protein NA NA -3.6 6.60E-13 3.0 1.10E-10 -2.4 3.79E-06 
PA2606   conserved hypothetical protein NA NA -48.7 2.31E-12 NA NA -59.9 1.10E-12 
PA2660   hypothetical protein NA NA -28.3 1.62E-07 NA NA -46.4 4.73E-10 
PA2780   hypothetical protein NA NA -3.6 7.89E-07 5.3 5.83E-09 NA NA 
PA3033   hypothetical protein NA NA -3.6 3.20E-08 2.6 8.07E-06 NA NA 
PA3085   hypothetical protein NA NA -3.6 1.20E-08 5.3 1.71E-11 NA NA 
PA3140   hypothetical protein NA NA -92.9 0.00E+00 14.7 0.00E+00 NA NA 
PA3178   hypothetical protein NA NA -69.5 1.04E-13 3.2 1.75E-06 -57.0 4.01E-12 
PA3237   hypothetical protein -21.3 1.79E-05 -19.7 1.56E-05 NA NA NA NA 
PA3250   hypothetical protein NA NA -20.7 9.46E-06 NA NA -40.7 6.23E-09 
PA3352   hypothetical protein NA NA -2.6 4.03E-14 NA NA -2.5 1.03E-14 
PA3413   conserved hypothetical protein NA NA -2.3 2.49E-14 2.7 6.88E-14 NA NA 
PA3414   hypothetical protein NA NA -5.8 0.00E+00 NA NA -5.8 0.00E+00 
PA3435   conserved hypothetical protein -2.7 2.76E-08 NA NA NA NA NA NA 
PA3451   hypothetical protein -45.0 1.05E-10 -20.9 8.60E-06 NA NA NA NA 
 446 
 
PA3463   conserved hypothetical protein -30.7 1.57E-07 -56.9 0.00E+00 NA NA NA NA 
PA3472   hypothetical protein NA NA -4.3 1.24E-10 3.2 5.44E-08 NA NA 
PA3492   conserved hypothetical protein NA NA -29.6 7.90E-08 14.7 1.72E-06 NA NA 
PA3530   conserved hypothetical protein -4.2 3.94E-14 NA NA -2.9 2.10E-08 NA NA 
PA3536   hypothetical protein NA NA -74.9 0.00E+00 NA NA -61.4 5.51E-13 
PA3577   hypothetical protein -20.7 2.38E-05 NA NA NA NA NA NA 
PA3611   hypothetical protein NA NA -2.4 1.01E-06 2.3 2.15E-06 NA NA 
PA3634   conserved hypothetical protein NA NA -3.6 4.57E-08 5.3 1.07E-10 NA NA 
PA3662   hypothetical protein NA NA -3.6 1.16E-14 3.5 5.95E-14 NA NA 
PA3705 wspD hypothetical protein -30.8 1.47E-07 NA NA NA NA NA NA 
PA3722   hypothetical protein NA NA -4.7 0.00E+00 NA NA -5.8 0.00E+00 
PA3787   conserved hypothetical protein -3.1 3.93E-06 NA NA -4.1 4.10E-07 NA NA 
PA3822   conserved hypothetical protein NA NA -2.7 0.00E+00 2.5 1.50E-14 NA NA 
PA3951   conserved hypothetical protein -23.4 6.01E-06 NA NA NA NA NA NA 
PA3990   conserved hypothetical protein NA NA -85.9 0.00E+00 NA NA -46.9 3.73E-10 
PA4029   conserved hypothetical protein -5.3 3.49E-07 NA NA NA NA NA NA 
PA4298   hypothetical protein -24.9 2.88E-06 NA NA NA NA NA NA 
PA4573   hypothetical protein NA NA -42.9 5.28E-11 NA NA -46.9 3.73E-10 
PA4574   conserved hypothetical protein NA NA -6.5 1.69E-12 3.8 8.31E-09 -4.9 1.37E-08 
PA4575   hypothetical protein -34.6 2.25E-08 NA NA -34.6 3.55E-07 NA NA 
PA4580   conserved hypothetical protein NA NA -8.0 2.80E-14 2.9 3.73E-07 -5.8 5.62E-10 
PA4674   conserved hypothetical protein NA NA -3.6 3.79E-14 NA NA -3.4 1.36E-13 
PA4682   hypothetical protein -24.8 2.95E-06 NA NA NA NA NA NA 
PA4739   conserved hypothetical protein -2.1 5.81E-10 -4.3 7.18E-14 NA NA -2.9 5.40E-09 
PA4782   hypothetical protein NA NA -2.5 2.81E-08 14.7 9.31E-14 NA NA 
PA4793   hypothetical protein NA NA -2.4 3.60E-06 2.3 7.35E-06 -2.2 1.20E-05 
PA4794   hypothetical protein NA NA -36.3 2.08E-09 NA NA -29.7 8.54E-07 
PA4826   hypothetical protein -2.8 0.00E+00 -10.8 0.00E+00 NA NA -2.9 2.70E-07 
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PA4917   hypothetical protein NA NA -3.8 0.00E+00 NA NA -5.8 0.00E+00 
PA4918   hypothetical protein NA NA -3.7 0.00E+00 2.4 0.00E+00 NA NA 
PA5126   hypothetical protein NA NA -46.8 6.33E-12 NA NA -61.4 5.51E-13 
PA5227   conserved hypothetical protein -2.6 1.34E-07 NA NA -2.4 6.82E-06 NA NA 
PA5246   conserved hypothetical protein NA NA -27.7 2.22E-07 27.7 2.15E-07 NA NA 
PA5247   conserved hypothetical protein NA NA -81.6 8.97E-14 NA NA -89.2 5.59E-14 
PA5269   hypothetical protein NA NA -2.9 1.72E-05 NA NA -2.9 5.34E-06 
PA5289   hypothetical protein NA NA -67.1 8.97E-14 NA NA -55.0 9.82E-12 
PA5397   hypothetical protein -26.7 1.17E-06 -24.7 1.06E-06 NA NA NA NA 
PA5402   hypothetical protein -37.3 5.49E-09 NA NA NA NA NA NA 
PA5465   hypothetical protein NA NA -3.6 1.11E-10 3.5 2.07E-10 NA NA 
PA5527   hypothetical protein NA NA -3.4 8.49E-14 2.5 1.54E-09 NA NA 
Membrane proteins 
PA0109   hypothetical protein NA NA -41.7 1.03E-10 NA NA -34.2 1.15E-07 
PA0215   malonate transporter MadL NA NA -43.3 4.46E-11 NA NA -70.9 2.73E-15 
PA0738   conserved hypothetical protein NA NA -35.6 3.01E-09 35.6 2.73E-09 NA NA 
PA0783 putP sodium/proline symporter PutP NA NA -3.0 2.25E-06 2.8 9.14E-06 NA NA 
PA0811   probable major facilitator superfamily (MFS) transporter NA NA -10.1 2.57E-09 NA NA -6.8 4.92E-06 
PA0985 pyoS5 pyocin S5 NA NA -5.0 0.00E+00 NA NA -3.2 6.05E-14 
PA1042   conserved hypothetical protein NA NA -43.8 3.32E-11 NA NA -47.9 2.46E-10 
PA1072 braE branched-chain amino acid transport protein BraE NA NA -2.4 1.19E-05 3.4 6.21E-09 NA NA 
PA1513   hypothetical protein -24.0 4.42E-06 NA NA NA NA NA NA 
PA1958   probable transporter NA NA -30.4 5.15E-08 8.4 9.24E-06 -24.9 7.27E-06 
PA2558   probable transport protein -27.3 8.74E-07 NA NA -27.3 7.61E-06 NA NA 
PA2576   hypothetical protein NA NA -43.8 3.32E-11 9.5 3.00E-08 NA NA 
PA3231   hypothetical protein NA NA -27.5 2.44E-07 27.5 2.37E-07 NA NA 
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PA3526   probable outer membrane protein precursor NA NA -5.1 1.00E-08 NA NA -5.4 5.44E-10 
PA3647   probable outer membrane protein precursor -2.0 2.74E-09 NA NA NA NA NA NA 
PA3747   conserved hypothetical protein -2.7 1.34E-06 NA NA NA NA NA NA 
PA3837   probable permease of ABC transporter NA NA -4.0 1.99E-06 NA NA -3.9 1.31E-06 
PA5095   probable permease of ABC transporter -27.7 6.91E-07 NA NA NA NA NA NA 
PA5482   hypothetical protein NA NA -54.1 1.22E-13 NA NA -133.0 1.95E-14 
Motility & Attachment 
PA0992 cupC1 fimbrial subunit CupC1 NA NA -21.3 6.93E-06 NA NA -34.9 8.55E-08 
PA1080 flgE flagellar hook protein FlgE NA NA -3.1 1.98E-07 NA NA -2.9 5.90E-07 
PA1081 flgF flagellar basal-body rod protein FlgF NA NA -3.9 3.21E-10 4.2 5.07E-11 NA NA 
PA1083 flgH flagellar L-ring protein precursor FlgH NA NA -10.8 5.76E-14 2.4 4.26E-06 NA NA 
PA1087 flgL flagellar hook-associated protein type 3 FlgL NA NA -12.3 3.71E-11 NA NA -9.7 8.51E-09 
PA1092 fliC flagellin type B NA NA -2.5 0.00E+00 NA NA -2.3 0.00E+00 
PA1100 fliE flagellar hook-basal body complex protein FliE -3.2 9.42E-11 -2.4 3.91E-08 NA NA NA NA 
PA1107   conserved hypothetical protein -21.7 1.44E-05 NA NA NA NA NA NA 
PA1447 fliQ flagellar biosynthetic protein FliQ -26.3 1.46E-06 -64.9 0.00E+00 NA NA NA NA 
PA4299 tadD TadD -25.6 2.01E-06 NA NA -25.6 1.52E-05 NA NA 
Non-coding RNA gene 
PA0668
.5   5S ribosomal RNA -2.3 0.00E+00 NA NA NA NA NA NA 
PA0836
.1 P5 P5 -33.3 4.23E-08 NA NA 
-
33.3 5.98E-07 NA NA 
PA4451 P35 P35 -38.1 3.64E-09 NA NA - 7.76E-08 NA NA 
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.1 38.1 
PA5471
.1   PA5471 leader peptide -56.3 3.33E-13 NA NA 
-
56.3 3.15E-11 NA NA 
Putative enzymes 
PA0249   probable acetyltransferase NA NA -29.4 8.89E-08 NA NA -32.1 2.92E-07 
PA2580   conserved hypothetical protein NA NA -22.2 4.12E-06 NA NA -24.3 9.60E-06 
PA3172   probable hydrolase NA NA -4.0 4.04E-08 3.3 6.66E-07 -3.4 1.20E-06 
PA3968   probable pseudouridine synthase -4.6 1.16E-06 NA NA -6.2 6.36E-07 NA NA 
PA4114   lysine decarboxylase -4.2 1.76E-06 NA NA NA NA NA NA 
PA4709   probable hemin degrading factor -39.9 1.44E-09 NA NA NA NA NA NA 
PA5445   probable coenzyme A transferase NA NA -4.2 5.04E-10 2.5 5.91E-06 NA NA 
Related to phage, transposon, or plasmid 
PA0621   conserved hypothetical protein -2.0 9.38E-13 -4.3 0.00E+00 NA NA -2.1 2.44E-13 
PA0632   hypothetical protein -2.1 0.00E+00 -5.7 0.00E+00 NA NA -2.2 0.00E+00 
PA0635   hypothetical protein -2.1 0.00E+00 -3.4 0.00E+00 NA NA NA NA 
PA0638   probable bacteriophage protein -2.3 5.88E-13 -3.4 1.90E-13 NA NA NA NA 
PA0642   hypothetical protein NA NA -3.8 5.73E-13 NA NA -2.0 0.00E+00 
PA0643   hypothetical protein NA NA -3.7 6.06E-13 NA NA -2.2 0.00E+00 
PA0646   hypothetical protein NA NA -3.7 7.28E-13 NA NA -2.1 0.00E+00 
PA0647   hypothetical protein -2.4 5.93E-13 -5.4 1.24E-13 NA NA NA NA 
PA0909   hypothetical protein NA NA -6.7 0.00E+00 NA NA -4.2 0.00E+00 
Transcription, RNA processing and degradation 
PA0733   probable pseudouridylate synthase NA NA -31.6 2.70E-08 10.5 2.31E-06 NA NA 
Transcriptional regulators 
PA0367   probable transcriptional regulator -4.6 5.84E-06 -3.6 3.31E-07 NA NA NA NA 
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PA0424 mexR multidrug resistance operon repressor MexR NA NA -59.2 0.00E+00 NA NA -97.1 4.11E-14 
PA0610 prtN transcriptional regulator PrtN -2.2 1.50E-13 -9.9 0.00E+00 NA NA -3.4 0.00E+00 
PA0611 prtR transcriptional regulator PrtR NA NA -4.2 0.00E+00 NA NA -2.3 6.21E-09 
PA0612 ptrB repressor, PtrB NA NA -5.1 0.00E+00 NA NA -2.1 3.14E-13 
PA0708   probable transcriptional regulator NA NA -20.5 1.05E-05 NA NA -25.2 6.47E-06 
PA0831 oruR transcriptional regulator OruR -6.7 7.91E-07 NA NA NA NA NA NA 
PA0906   probable transcriptional regulator NA NA -3.9 1.50E-14 2.3 4.71E-09 NA NA 
PA1603   probable transcriptional regulator NA NA -41.4 1.21E-10 NA NA -34.0 1.28E-07 
PA2277 arsR ArsR protein -26.9 1.05E-06 NA NA NA NA NA NA 
PA2332   probable transcriptional regulator -20.9 2.22E-05 NA NA NA NA NA NA 
PA2387 fpvI FpvI NA NA -27.4 2.66E-07 NA NA -29.9 7.84E-07 
PA2511   probable transcriptional regulator NA NA -26.2 4.88E-07 NA NA -64.5 1.37E-13 
PA3067   probable transcriptional regulator NA NA -39.5 3.57E-10 NA NA -32.4 2.64E-07 
PA3220   probable transcriptional regulator NA NA -45.8 1.10E-11 NA NA -37.6 2.58E-08 
PA3341   probable transcriptional regulator -2.6 8.89E-08 NA NA -2.6 4.28E-07 NA NA 
PA4109 ampR transcriptional regulator AmpR -6.7 0.00E+00 -6.4 0.00E+00 NA NA NA NA 
PA4227 pchR transcriptional regulator PchR -7.4 8.51E-09 NA NA -5.0 2.15E-06 NA NA 
PA4764 fur ferric uptake regulation protein NA NA -2.2 0.00E+00 NA NA -2.6 0.00E+00 
PA5308 lrp leucine-responsive regulatory protein -4.6 1.25E-07 NA NA NA NA NA NA 
PA5374 betI transcriptional regulator BetI NA NA -5.8 3.89E-15 3.9 0.00E+00 NA NA 
Translation, post-translational modification, degradation 
PA2618   hypothetical protein NA NA -30.9 3.92E-08 NA NA -30.4 6.24E-07 
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PA3049 rmf ribosome modulation factor -2.3 0.00E+00 NA NA -2.5 0.00E+00 NA NA 
PA5049 rpmE 50S ribosomal protein L31 NA NA -2.1 0.00E+00 2.1 0.00E+00 NA NA 
PA5315 rpmG 50S ribosomal protein L33 NA NA -3.3 0.00E+00 2.2 0.00E+00 -2.3 0.00E+00 
PA5470   probable peptide chain release factor NA NA -12.3 0.00E+00 NA NA -4.9 4.93E-07 
Transport of small molecules 
PA0892 aotP arginine/ornithine transport protein AotP NA NA -2.1 1.40E-08 2.5 1.36E-11 NA NA 
PA3790 oprC 
Putative copper transport outer 
membrane porin OprC 
precursor 
NA NA -4.0 9.12E-07 NA NA -4.3 7.52E-08 
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Table 5: Functional enrichment of genes: AmpR-, AmpR-ß-lactam- and ß-lactam-dependent genes (Appendix; Supplementary 
information for Chapter 5; Tables 2, 3 and 4) were tested for enrichment of functional categories using GOEAST (518). There was no 
significant enrichment in the AmpR-ß-lactam-dependent and ß-lactam-dependent gene sets. 
 
AmpR +ve 
GOID Ontology Term # in list 
# in 
genome
Log-
odd 
ratio 
p-value 
GO:0050896 biological_process response to stimulus 25 208 0.989 4.51E-02 
GO:0006518 biological_process peptide metabolic process 8 15 3.138 2.27E-04 
GO:0009237 biological_process siderophore metabolic process 8 9 3.875 1.51E-06 
GO:0019184 biological_process nonribosomal peptide biosynthetic process 8 12 3.46 2.85E-05 
GO:0019290 biological_process siderophore biosynthetic process 8 9 3.875 1.51E-06 
GO:0019748 biological_process secondary metabolic process 8 10 3.723 3.58E-06 
GO:0043043 biological_process peptide biosynthetic process 8 13 3.345 5.87E-05 
GO:0043603 biological_process cellular amide metabolic process 8 21 2.653 4.12E-03 
GO:0043604 biological_process amide biosynthetic process 8 17 2.958 6.79E-04 
GO:0044550 biological_process secondary metabolite biosynthetic process 8 10 3.723 3.58E-06 
GO:0016999 biological_process antibiotic metabolic process 4 6 3.46 3.31E-02 
GO:0017000 biological_process antibiotic biosynthetic process 4 6 3.46 3.31E-02 
GO:0017144 biological_process drug metabolic process 4 6 3.46 3.31E-02 
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AmpR -ve 
GOID Ontology Term # in list 
# in 
genome
Log-
odd 
ratio 
p-value 
GO:0005737 cellular_component cytoplasm 14 48 1.714 1.85E-02 
GO:0005840 cellular_component ribosome 13 31 2.238 1.36E-03 
GO:0030529 cellular_component ribonucleoprotein complex 13 32 2.193 1.42E-03 
GO:0043226 cellular_component organelle 13 48 1.608 5.60E-02 
GO:0043228 cellular_component non-membrane-bounded organelle 13 48 1.608 5.60E-02 
GO:0043229 cellular_component intracellular organelle 13 48 1.608 5.60E-02 
GO:0043232 cellular_component intracellular non-membrane-bounded organelle 13 48 1.608 5.60E-02 
GO:0044391 cellular_component ribosomal subunit 13 31 2.238 1.36E-03 
GO:0044422 cellular_component organelle part 13 42 1.8 1.85E-02 
GO:0044444 cellular_component cytoplasmic part 14 44 1.84 8.04E-03 
GO:0044446 cellular_component intracellular organelle part 13 33 2.148 1.62E-03 
GO:0006119 biological_process oxidative phosphorylation 6 12 2.492 8.07E-02 
GO:0016310 biological_process phosphorylation 6 12 2.492 8.07E-02 
GO:0015934 cellular_component large ribosomal subunit 9 18 2.492 5.63E-03 
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